data_2hdp_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2hdp _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo . . . . . 0 CA--C 1.545 1.049 0 N-CA-C 115.089 1.15 . . . . 0.0 115.089 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 7.6 t -51.33 156.87 1.09 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 128.317 2.647 . . . . 0.0 111.771 173.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 3.8 p -134.82 -2.4 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.847 0.859 . . . . 0.0 113.019 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 13.1 mt -131.11 -49.61 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.622 1.169 . . . . 0.0 112.591 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.7 m -65.99 -60.69 2.59 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.689 1.196 . . . . 0.0 113.957 -174.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -160.29 -9.21 0.05 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 85.57 16.36 64.15 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-N 119.963 1.256 . . . . 0.0 113.245 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -64.61 151.16 92.64 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 127.003 2.121 . . . . 0.0 112.982 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -54.48 -8.05 1.04 Allowed 'Trans proline' 0 CA--C 1.544 1.018 1 C-N-CA 125.526 4.151 . . . . 0.0 119.717 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -59.79 153.89 19.56 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 120.236 1.38 . . . . 0.0 112.459 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -128.12 150.2 50.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.887 2.475 . . . . 0.0 110.779 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -172.71 80.99 0.08 OUTLIER Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.665 1.126 . . . . 0.0 113.468 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 19.8 t -65.14 142.49 58.33 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.082 0.941 . . . . 0.0 110.245 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.88 142.47 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.854 1.662 . . . . 0.0 110.773 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 98.8 t -130.05 121.61 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.585 1.154 . . . . 0.0 111.303 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.3 125.43 43.51 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.949 2.9 . . . . 0.0 112.977 175.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 49.92 34.96 23.94 Favored Glycine 0 CA--C 1.54 1.618 0 N-CA-C 116.578 1.391 . . . . 0.0 116.578 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm 77.42 9.21 2.59 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 127.711 2.404 . . . . 0.0 114.351 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 78.5 p -118.58 161.7 19.62 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 127.405 2.282 . . . . 0.0 107.641 172.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -153.17 166.29 31.52 Favored Glycine 0 CA--C 1.523 0.571 0 O-C-N 119.891 -1.756 . . . . 0.0 115.668 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -120.12 128.49 53.5 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 126.499 1.92 . . . . 0.0 112.022 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 55.3 tp -120.59 153.23 37.08 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.432 2.293 . . . . 0.0 111.364 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 34.2 mtm 90.72 54.27 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 129.44 3.096 . . . . 0.0 112.804 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -155.73 163.88 39.31 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 128.316 2.646 . . . . 0.0 108.992 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 15.3 p -91.54 175.02 7.06 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 122.896 1.332 . . . . 0.0 112.828 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -65.15 -36.08 83.11 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.049 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 25.2 m -67.39 -46.32 73.61 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 117.143 -1.408 . . . . 0.0 110.547 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 37.9 m -48.28 -56.46 7.96 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.442 1.474 . . . . 0.0 109.89 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.53 -52.59 65.0 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.43 1.492 . . . . 0.0 112.578 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -56.79 -42.05 78.8 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.459 1.503 . . . . 0.0 112.243 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -59.31 -54.02 51.61 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.012 1.725 . . . . 0.0 110.375 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . 0.254 0.4 OUTLIER -68.09 -31.14 70.55 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 179.233 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -62.88 -56.54 16.36 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.667 1.987 . . . . 0.0 112.226 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -62.86 -33.49 75.38 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -76.42 -3.16 35.6 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.633 1.573 . . . . 0.0 112.179 173.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 64.2 t30 48.24 42.12 17.11 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 128.066 2.546 . . . . 0.0 112.599 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -70.52 129.64 89.91 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 124.611 1.164 . . . . 0.0 112.949 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.33 123.74 8.44 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.616 2.211 . . . . 0.0 108.117 170.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 25.3 t -31.14 129.52 0.27 Allowed Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 128.311 2.645 . . . . 0.0 114.289 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -65.58 -3.86 8.6 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.286 2.658 . . . . 0.0 114.74 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 43.6 t -126.09 -59.59 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.281 1.432 . . . . 0.0 111.259 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 63.8 m -76.0 -19.83 58.35 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.351 1.861 . . . . 0.0 113.137 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 63.5 9.14 3.98 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 127.217 2.207 . . . . 0.0 114.028 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -82.81 137.95 43.69 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 125.007 1.323 . . . . 0.0 112.213 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.85 119.35 6.15 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.149 2.566 . . . . 0.0 108.704 174.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 6.2 pt -66.95 147.08 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -174.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -115.16 -35.77 4.59 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 -174.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 1.4 ttp -145.9 151.37 37.75 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -171.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 4.4 mt -137.04 136.75 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 127.62 2.368 . . . . 0.0 109.08 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 15.7 m -140.04 150.02 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 124.704 1.202 . . . . 0.0 112.953 177.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 55.5 mt -69.94 99.95 1.5 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.213 1.005 . . . . 0.0 108.612 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 26.2 m -101.26 94.89 6.18 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.119 1.768 . . . . 0.0 112.464 -174.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -83.7 164.11 19.84 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.401 1.48 . . . . 0.0 113.353 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -120.42 164.19 24.32 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.546 1.538 . . . . 0.0 112.555 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo . . . . . 0 C--N 1.353 0.815 0 C-N-CA 124.482 3.454 . . . . 0.0 113.915 -179.879 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 CA--C 1.541 0.865 0 CA-C-O 121.095 0.373 . . . . 0.0 112.978 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 438' ' ' CYS . . . . . 0.403 ' SG ' ' N ' ' B' ' 439' ' ' VAL . 40.1 t -54.59 178.06 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 127.583 2.353 . . . . 0.0 113.22 175.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 439' ' ' VAL . . . . . 0.403 ' N ' ' SG ' ' B' ' 438' ' ' CYS . 7.4 p -111.76 -11.47 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.39 1.876 . . . . 0.0 112.343 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 7.3 mt -113.91 -66.76 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.739 1.215 . . . . 0.0 111.341 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 17.0 p -73.57 -43.73 59.09 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 120.519 1.509 . . . . 0.0 108.869 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 57.87 13.5 2.13 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.936 2.894 . . . . 0.0 113.903 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . -85.22 -27.41 33.56 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 121.576 -0.703 . . . . 0.0 112.459 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -115.5 155.12 47.62 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 126.941 2.096 . . . . 0.0 115.384 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -56.84 155.17 28.56 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.094 3.196 . . . . 0.0 113.238 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -65.47 32.03 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 127.761 2.424 . . . . 0.0 116.148 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -81.78 89.96 6.34 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.061 -1.649 . . . . 0.0 109.822 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 165.93 58.8 0.03 OUTLIER Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.36 0.981 . . . . 0.0 112.401 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 43.3 t -59.3 126.29 27.06 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.394 1.097 . . . . 0.0 109.99 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 2.4 mp -102.07 142.81 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.187 1.395 . . . . 0.0 110.418 -176.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 88.5 t -130.01 132.88 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.856 0.862 . . . . 0.0 111.241 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -121.18 96.21 5.0 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 128.519 2.728 . . . . 0.0 110.047 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 71.21 -91.48 0.46 Allowed Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.716 1.627 . . . . 0.0 114.057 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -120.25 -2.19 10.16 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.169 1.788 . . . . 0.0 113.916 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 82.3 p -127.77 167.87 15.91 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.468 1.907 . . . . 0.0 109.882 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -150.67 177.52 28.67 Favored Glycine 0 CA--C 1.527 0.806 0 O-C-N 121.054 -1.029 . . . . 0.0 114.324 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.11 148.22 43.89 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.138 1.375 . . . . 0.0 114.524 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.8 tt -116.12 153.16 32.26 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 130.188 3.395 . . . . 0.0 110.388 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 29.1 tpp 78.48 30.72 0.38 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 116.65 2.092 . . . . 0.0 116.65 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -136.08 149.89 48.91 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.6 1.56 . . . . 0.0 108.88 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 29.3 p -88.1 172.14 9.74 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.674 1.226 . . . . 0.0 113.918 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.17 -36.11 78.95 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.736 175.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 63.4 m -62.53 -63.5 1.21 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.143 0.977 . . . . 0.0 109.964 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 77.5 m -53.79 -42.98 68.9 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.815 1.246 . . . . 0.0 112.754 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -60.67 -48.26 82.57 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.31 -0.869 . . . . 0.0 112.046 173.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -59.75 -43.22 94.37 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 120.771 -1.206 . . . . 0.0 111.205 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -57.79 -54.96 40.94 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.222 1.009 . . . . 0.0 111.09 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.32 -30.39 71.53 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -67.44 -48.14 68.1 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.337 1.455 . . . . 0.0 112.359 175.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -59.01 -37.49 77.04 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.381 1.072 . . . . 0.0 111.56 176.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 39.4 tpt85 -76.21 -10.54 59.49 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.872 2.469 . . . . 0.0 112.393 174.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 64.1 t30 52.76 42.62 31.83 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.323 2.249 . . . . 0.0 111.919 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 34.2 tttp -70.01 129.04 91.24 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.644 1.178 . . . . 0.0 113.401 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.61 124.44 8.82 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 122.638 2.225 . . . . 0.0 107.579 169.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 40.2 t -30.72 128.36 0.27 Allowed Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 128.294 2.638 . . . . 0.0 114.734 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -66.53 -3.04 8.35 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.172 2.581 . . . . 0.0 114.585 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 41.8 t -127.68 -58.49 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.172 1.389 . . . . 0.0 111.619 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 60.6 m -77.31 -17.57 58.2 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.43 1.892 . . . . 0.0 112.679 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 44.6 mtm105 62.76 7.85 2.75 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.527 2.331 . . . . 0.0 114.368 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -86.38 143.03 35.93 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 123.829 0.851 . . . . 0.0 112.914 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.38 126.46 10.38 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.359 2.706 . . . . 0.0 110.218 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 7.3 pt -72.19 153.8 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -115.05 -41.84 3.28 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.515 1.526 . . . . 0.0 114.019 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.98 167.16 30.09 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -174.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 7.9 mt -134.33 137.38 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 128.097 2.559 . . . . 0.0 107.728 177.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 3.7 t -127.01 147.78 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.627 1.171 . . . . 0.0 112.539 -178.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.52 106.86 2.28 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.565 1.546 . . . . 0.0 107.545 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 50.1 m -103.63 126.0 50.49 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.22 1.408 . . . . 0.0 114.214 -171.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -123.63 178.79 5.04 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.364 2.266 . . . . 0.0 111.823 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -127.79 163.48 42.9 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.509 1.524 . . . . 0.0 112.579 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo . . . . . 0 C--N 1.353 0.802 0 C-N-CA 123.931 3.088 . . . . 0.0 114.085 -179.175 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . 0.252 45.8 Cg_exo . . . . . 0 CA--C 1.552 1.382 0 N-CA-C 116.525 1.702 . . . . 0.0 116.525 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 14.1 t -65.32 151.5 46.08 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 121.508 1.958 . . . . 0.0 109.343 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 13.2 m -132.59 -3.23 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 6.6 mt -133.26 -46.34 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 119.4 1.0 . . . . 0.0 112.852 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.5 m -67.55 -60.05 2.87 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -173.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -153.89 -14.04 0.14 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -176.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 83.94 7.15 85.96 Favored Glycine 0 CA--C 1.539 1.532 0 O-C-N 120.948 -1.095 . . . . 0.0 112.453 -173.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -55.01 155.04 8.98 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 129.07 2.948 . . . . 0.0 113.255 178.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.31 -10.25 4.51 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 125.186 3.924 . . . . 0.0 118.795 -178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -59.37 139.17 57.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.481 1.512 . . . . 0.0 112.8 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.2 150.04 50.19 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.27 1.828 . . . . 0.0 111.106 175.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -156.34 91.6 0.12 Allowed Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.667 1.603 . . . . 0.0 111.867 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 48.3 t -64.82 133.69 52.48 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.563 0.745 . . . . 0.0 110.89 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.16 144.73 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.424 1.889 . . . . 0.0 110.896 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 74.3 t -129.99 134.62 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.356 1.062 . . . . 0.0 111.198 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -125.07 94.96 4.32 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.497 2.319 . . . . 0.0 111.281 175.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 65.95 -93.32 0.18 Allowed Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.959 1.742 . . . . 0.0 114.709 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -111.0 -2.35 15.98 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.28 1.832 . . . . 0.0 114.362 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 6.5 p -130.65 170.0 14.88 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.229 2.212 . . . . 0.0 110.82 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -157.1 170.83 34.41 Favored Glycine 0 CA--C 1.533 1.176 0 O-C-N 120.902 -1.124 . . . . 0.0 113.854 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -120.08 140.04 51.64 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.432 1.893 . . . . 0.0 111.799 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 36.3 tp -134.67 153.26 52.07 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 127.553 2.341 . . . . 0.0 111.061 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 80.0 mtp 75.46 56.89 0.06 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 127.311 2.244 . . . . 0.0 112.054 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -151.53 148.52 28.12 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 129.391 3.076 . . . . 0.0 107.102 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 6.2 p -80.55 173.77 12.27 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 122.773 1.273 . . . . 0.0 112.321 177.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.38 -39.88 94.72 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.406 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 32.4 m -68.65 -44.52 73.98 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 116.505 -1.712 . . . . 0.0 110.918 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 53.8 m -46.64 -56.97 5.26 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 121.403 1.91 . . . . 0.0 110.926 175.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.72 -51.1 71.38 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.27 1.428 . . . . 0.0 112.778 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -58.77 -41.17 85.96 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.153 0.981 . . . . 0.0 112.667 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.37 -53.61 54.45 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.55 2.34 . . . . 0.0 110.768 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 15.0 mt -51.37 -54.42 26.66 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.658 1.183 . . . . 0.0 109.898 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -55.34 -48.03 74.8 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.486 1.114 . . . . 0.0 112.626 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -59.14 -40.99 87.21 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.555 1.542 . . . . 0.0 111.706 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -77.1 7.38 5.07 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 127.427 2.291 . . . . 0.0 113.569 175.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 75.76 0.85 3.45 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 130.387 3.475 . . . . 0.0 116.302 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -82.54 121.13 77.93 Favored Pre-proline 0 N--CA 1.473 0.702 0 CA-C-N 120.541 1.519 . . . . 0.0 109.555 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.51 -67.37 0.03 OUTLIER 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.149 2.566 . . . . 0.0 110.325 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 15.6 t -121.53 131.42 24.45 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 127.203 2.201 . . . . 0.0 110.346 176.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.72 -5.44 16.0 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.522 2.815 . . . . 0.0 114.589 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 36.7 t -131.46 -59.21 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 120.358 1.435 . . . . 0.0 113.414 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 21.6 m -71.56 -29.25 64.52 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.821 1.648 . . . . 0.0 110.613 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 64.89 7.49 3.99 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 128.172 2.589 . . . . 0.0 113.071 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -68.35 143.27 95.44 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 124.436 1.094 . . . . 0.0 110.765 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.05 110.08 2.53 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.563 2.842 . . . . 0.0 113.556 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 11.3 pt -66.06 153.58 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.496 0.665 . . . . 0.0 112.356 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -109.73 -47.53 3.34 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.071 1.348 . . . . 0.0 112.166 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.31 170.13 23.17 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.081 1.352 . . . . 0.0 112.676 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 13.0 mt -123.65 136.5 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 127.443 2.297 . . . . 0.0 106.435 175.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 14.3 m -131.89 150.11 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.68 99.92 2.21 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 6.3 t -87.71 150.12 23.81 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.887 -0.508 . . . . 0.0 111.606 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -139.28 156.84 46.78 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.638 1.575 . . . . 0.0 111.905 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -71.47 148.49 93.25 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.535 1.134 . . . . 0.0 113.002 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo . . . . . 0 CA--C 1.539 0.744 0 C-N-CA 123.75 2.967 . . . . 0.0 112.385 179.483 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo . . . . . 0 CA--C 1.545 1.025 0 N-CA-C 114.644 0.979 . . . . 0.0 114.644 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 2.2 p -63.02 -174.52 0.07 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.242 1.817 . . . . 0.0 114.865 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 5.6 p -138.65 -9.41 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 3.9 mt -119.59 -58.83 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 120.574 1.534 . . . . 0.0 112.996 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 13.7 p -67.82 -68.46 0.38 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -174.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -137.2 -13.54 1.58 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -169.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 77.53 35.38 36.93 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -172.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -86.52 151.2 52.82 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 124.557 1.143 . . . . 0.0 113.822 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -76.18 66.4 7.01 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 124.513 3.475 . . . . 0.0 113.543 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -131.98 165.58 23.62 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.65 1.98 . . . . 0.0 112.506 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -128.18 149.94 50.22 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 128.499 2.72 . . . . 0.0 111.791 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 168.01 75.95 0.04 OUTLIER Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.913 1.72 . . . . 0.0 112.303 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 35.7 t -62.61 141.27 58.57 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.759 0.779 . . . . 0.0 111.161 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 2.5 mp -105.07 139.12 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 C-N-CA 126.106 1.763 . . . . 0.0 109.654 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 88.9 t -130.0 131.7 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.197 0.999 . . . . 0.0 108.885 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.03 99.46 6.13 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.644 2.378 . . . . 0.0 110.516 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 65.33 -96.55 0.24 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 126.172 1.844 . . . . 0.0 113.792 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 38.6 mtmm -110.34 1.07 18.25 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.066 1.746 . . . . 0.0 113.693 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 44.7 p -130.1 170.05 14.53 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.434 1.494 . . . . 0.0 112.012 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -154.25 170.42 32.75 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 121.246 -0.909 . . . . 0.0 114.037 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -120.22 112.7 19.39 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.295 1.838 . . . . 0.0 111.667 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -88.94 153.18 21.24 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 22.6 mmt 64.65 67.37 0.56 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.591 2.357 . . . . 0.0 114.54 175.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -148.97 157.87 43.75 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 129.253 3.021 . . . . 0.0 107.822 174.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 22.0 p -90.79 174.98 7.17 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 123.048 1.404 . . . . 0.0 114.13 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.44 -31.8 72.78 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.58 176.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 44.8 m -66.7 -50.25 63.44 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.64 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 36.3 m -47.87 -63.98 0.91 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.15 1.38 . . . . 0.0 109.868 174.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -52.74 -47.16 67.58 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.305 1.842 . . . . 0.0 113.654 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -60.68 -36.88 79.86 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.956 -1.09 . . . . 0.0 112.281 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -55.41 -48.16 74.81 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.607 1.163 . . . . 0.0 110.951 175.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 6.5 mp -62.63 -47.72 82.5 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.55 0.74 . . . . 0.0 110.001 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -57.09 -42.48 80.83 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -55.02 -28.36 51.48 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -119.59 8.84 11.33 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.856 2.062 . . . . 0.0 113.019 177.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 60.1 t30 42.29 56.39 3.69 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 127.252 2.221 . . . . 0.0 112.075 -174.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -70.0 133.04 88.14 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -174.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.95 115.16 4.14 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.52 2.147 . . . . 0.0 107.633 169.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 51.9 t -22.45 125.33 0.11 Allowed Pre-proline 0 CA--C 1.558 1.276 0 C-N-CA 130.146 3.378 . . . . 0.0 116.236 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -66.61 -3.94 10.06 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.139 2.56 . . . . 0.0 114.235 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 45.0 t -110.26 -64.02 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.327 1.451 . . . . 0.0 111.488 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 25.0 p -105.24 1.23 27.94 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 63.36 11.07 5.2 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 127.73 2.412 . . . . 0.0 115.945 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -75.35 144.92 78.97 Favored Pre-proline 0 CA--C 1.55 0.976 0 O-C-N 121.391 -0.818 . . . . 0.0 111.916 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.15 116.18 4.56 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.438 2.759 . . . . 0.0 111.461 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.5 pp -55.16 142.79 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.825 1.25 . . . . 0.0 111.929 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -115.04 -45.56 2.95 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.107 0.963 . . . . 0.0 113.361 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.28 166.98 30.11 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -177.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 4.0 mt -139.39 133.99 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 128.203 2.601 . . . . 0.0 107.943 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 27.8 m -140.02 150.24 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.76 1.224 . . . . 0.0 111.986 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 56.8 mt -66.91 99.82 0.67 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 42.1 m -99.79 136.0 40.37 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.624 1.17 . . . . 0.0 112.227 -173.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -128.57 160.77 31.34 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.521 1.128 . . . . 0.0 112.619 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -145.86 155.99 51.8 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.919 1.688 . . . . 0.0 111.749 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 CA--C 1.537 0.631 0 C-N-CA 123.533 2.822 . . . . 0.0 112.428 179.168 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo . . . . . 0 CA--C 1.543 0.947 0 CA-C-O 117.745 -1.023 . . . . 0.0 112.781 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 8.0 t -58.74 147.66 32.33 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 120.531 1.514 . . . . 0.0 109.594 172.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 15.9 m -130.92 -1.15 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 10.0 mt -132.12 -47.33 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.23 1.012 . . . . 0.0 112.237 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.8 m -68.93 -62.69 1.27 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -173.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -155.44 -12.02 0.11 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -174.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 81.53 7.89 87.66 Favored Glycine 0 CA--C 1.542 1.772 0 O-C-N 120.47 -1.394 . . . . 0.0 112.424 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -59.09 152.45 51.27 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 129.669 3.187 . . . . 0.0 113.256 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -74.91 73.12 4.37 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 124.329 3.353 . . . . 0.0 113.886 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -128.91 144.12 51.09 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 127.15 2.18 . . . . 0.0 110.411 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.26 116.16 19.42 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -173.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -138.59 83.2 0.25 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.441 1.496 . . . . 0.0 111.663 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 16.4 t -66.12 140.21 58.2 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.077 0.939 . . . . 0.0 112.309 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.3 mp -115.1 141.2 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 126.832 2.053 . . . . 0.0 110.441 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 67.4 t -126.49 134.02 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.627 1.171 . . . . 0.0 111.134 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -118.78 98.04 6.02 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.451 2.7 . . . . 0.0 110.651 175.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 73.55 -87.42 0.62 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.849 1.69 . . . . 0.0 114.068 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -129.85 1.92 4.87 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.265 1.826 . . . . 0.0 113.431 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 72.8 p -131.2 170.06 15.08 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.204 2.202 . . . . 0.0 109.197 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -152.56 174.6 31.4 Favored Glycine 0 N--CA 1.466 0.69 0 O-C-N 120.541 -1.349 . . . . 0.0 113.273 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -120.09 105.84 11.39 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.368 1.067 . . . . 0.0 111.788 177.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 15.2 tp -81.67 153.18 26.75 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.011 2.524 . . . . 0.0 110.211 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 48.7 mtt 85.54 66.35 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 128.008 2.523 . . . . 0.0 111.976 178.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -158.86 145.09 16.85 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 127.719 2.408 . . . . 0.0 108.537 175.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 19.9 p -83.78 173.69 11.08 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 122.28 1.038 . . . . 0.0 110.746 174.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -64.72 -37.44 87.59 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.502 -0.749 . . . . 0.0 111.191 178.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 27.8 m -65.15 -49.03 71.44 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 117.132 -1.413 . . . . 0.0 110.661 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 32.9 m -48.06 -55.77 9.37 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 120.555 1.525 . . . . 0.0 110.57 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.55 92.4 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.846 1.258 . . . . 0.0 113.002 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -61.52 -43.32 99.08 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.817 -1.177 . . . . 0.0 111.586 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -62.52 -54.03 45.93 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.996 1.318 . . . . 0.0 111.514 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 2.5 pp -60.49 -37.72 81.98 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.644 0.656 . . . . 0.0 111.25 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -59.95 -52.11 66.79 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.186 1.395 . . . . 0.0 111.378 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -58.68 -35.99 73.48 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.246 1.418 . . . . 0.0 112.684 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -78.5 2.93 17.42 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.534 1.934 . . . . 0.0 113.402 175.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 28.5 m120 64.13 19.18 11.66 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 128.713 2.805 . . . . 0.0 114.62 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -72.72 135.81 80.77 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.693 1.197 . . . . 0.0 109.383 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.8 -85.57 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.037 2.491 . . . . 0.0 109.804 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 36.1 t -118.45 132.76 23.67 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.921 1.688 . . . . 0.0 110.874 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.63 -6.86 20.02 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.397 2.731 . . . . 0.0 114.119 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 40.6 t -116.36 -72.3 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 119.732 1.151 . . . . 0.0 112.752 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 25.8 p -96.25 1.31 51.99 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 86.4 mmt-85 65.54 6.67 3.9 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 128.01 2.524 . . . . 0.0 115.665 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -62.16 140.98 96.09 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-N 119.593 1.088 . . . . 0.0 111.686 177.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -69.45 112.17 2.95 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.385 2.723 . . . . 0.0 113.725 -176.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 22.8 pt -73.73 160.14 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.709 1.603 . . . . 0.0 113.39 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -112.55 -48.13 3.03 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.48 1.512 . . . . 0.0 113.19 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.14 170.3 22.28 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -175.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 8.1 mt -117.2 135.38 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 126.523 1.929 . . . . 0.0 107.821 173.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 37.3 t -129.48 147.9 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.979 1.312 . . . . 0.0 110.334 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . 0.271 0.0 OUTLIER -81.59 116.79 21.51 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.298 1.047 . . . . 0.0 108.348 177.031 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 6.5 m -115.84 99.04 7.01 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.271 -1.331 . . . . 0.0 114.134 -169.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -68.78 171.2 8.17 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.044 1.738 . . . . 0.0 112.937 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -134.33 164.04 46.86 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.81 1.644 . . . . 0.0 111.121 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo . . . . . 0 C--N 1.353 0.774 0 C-N-CA 124.341 3.361 . . . . 0.0 113.855 179.551 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo . . . . . 0 CA--C 1.536 0.596 0 N-CA-C 115.5 1.308 . . . . 0.0 115.5 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 14.6 t -55.22 145.95 20.15 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 120.546 1.521 . . . . 0.0 111.333 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 29.8 m -132.22 0.1 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.93 1.692 . . . . 0.0 113.615 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 1.7 mt -134.69 -48.37 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 116.932 -1.509 . . . . 0.0 114.731 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 25.2 p -77.68 -60.53 2.33 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 121.457 1.935 . . . . 0.0 115.16 -173.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -139.86 -8.32 1.22 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 74.63 17.63 79.97 Favored Glycine 0 CA--C 1.541 1.672 0 CA-C-N 119.818 1.19 . . . . 0.0 111.356 -173.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -61.23 155.15 58.36 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 127.541 2.337 . . . . 0.0 113.858 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.8 -1.32 9.15 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.363 3.375 . . . . 0.0 116.141 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -60.17 156.77 14.52 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.941 1.696 . . . . 0.0 112.672 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -128.09 150.14 50.09 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.848 2.059 . . . . 0.0 110.489 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -163.87 67.76 0.22 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.258 1.409 . . . . 0.0 112.417 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 45.0 t -57.47 128.22 35.92 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.732 1.213 . . . . 0.0 110.176 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.98 144.06 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.06 1.344 . . . . 0.0 110.189 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 88.8 t -129.28 126.64 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.767 1.227 . . . . 0.0 109.697 176.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.18 122.52 37.29 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 128.813 2.845 . . . . 0.0 112.647 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 64.1 -77.54 0.05 OUTLIER Glycine 0 CA--C 1.539 1.552 0 C-N-CA 126.207 1.861 . . . . 0.0 114.872 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -146.61 2.46 0.83 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 127.453 2.301 . . . . 0.0 113.212 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 71.5 p -131.72 170.12 15.24 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 127.575 2.35 . . . . 0.0 110.54 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -144.58 171.93 25.73 Favored Glycine 0 N--CA 1.47 0.93 0 O-C-N 120.479 -1.388 . . . . 0.0 115.248 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.25 135.2 55.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.424 1.889 . . . . 0.0 113.223 175.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 4.0 pp -119.77 153.33 35.85 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.662 2.385 . . . . 0.0 110.942 174.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 11.5 tpt 94.65 53.87 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 129.304 3.042 . . . . 0.0 111.689 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -159.93 150.17 18.61 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.763 2.425 . . . . 0.0 108.4 175.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 31.2 p -90.03 174.29 7.73 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 122.377 1.084 . . . . 0.0 111.591 175.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.43 -37.93 88.38 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.634 -0.667 . . . . 0.0 110.991 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 43.7 m -60.25 -54.37 46.52 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 117.616 -1.183 . . . . 0.0 110.48 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 59.5 m -51.79 -61.98 1.91 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.923 1.238 . . . . 0.0 111.002 175.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -47.17 -52.37 15.79 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.037 -1.04 . . . . 0.0 112.578 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -62.21 -37.94 87.25 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.466 1.106 . . . . 0.0 112.965 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -60.47 -50.65 72.74 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.482 1.513 . . . . 0.0 110.625 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -58.25 -46.23 86.33 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.849 0.459 . . . . 0.0 110.242 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -55.99 -46.57 78.66 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.297 1.039 . . . . 0.0 112.276 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -62.05 -39.1 91.21 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.624 1.569 . . . . 0.0 111.506 174.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -79.7 16.47 1.11 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 128.066 2.546 . . . . 0.0 113.196 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . 0.303 0.2 OUTLIER 59.8 8.13 1.28 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 130.667 3.587 . . . . 0.0 117.849 179.802 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -84.59 127.41 65.65 Favored Pre-proline 0 N--CA 1.474 0.731 0 CA-C-N 120.045 1.293 . . . . 0.0 108.158 173.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.33 -81.8 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 123.069 2.513 . . . . 0.0 112.263 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 41.3 t -81.95 131.87 55.71 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 124.425 1.09 . . . . 0.0 110.887 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -70.32 -5.28 16.18 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.945 2.43 . . . . 0.0 114.487 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 28.9 t -119.68 -75.9 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.986 1.266 . . . . 0.0 113.084 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 23.7 p -91.91 -1.11 57.46 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 26.9 ttt-85 64.87 18.78 11.63 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 127.306 2.242 . . . . 0.0 115.107 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -65.98 156.09 85.02 Favored Pre-proline 0 CA--C 1.554 1.122 0 O-C-N 121.049 -1.032 . . . . 0.0 111.347 174.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.88 105.89 1.59 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.71 2.94 . . . . 0.0 113.522 -177.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.16 154.26 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.091 1.356 . . . . 0.0 113.512 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -115.2 -43.0 3.11 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.026 2.131 . . . . 0.0 111.687 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.91 167.55 27.79 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.977 1.311 . . . . 0.0 114.303 -176.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 18.6 mt -134.23 135.21 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 129.099 2.96 . . . . 0.0 105.919 173.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.48 150.14 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.428 1.091 . . . . 0.0 113.367 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.61 99.93 1.37 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.01 86.39 3.97 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.835 1.254 . . . . 0.0 112.704 -173.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -63.6 169.69 3.74 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.919 1.288 . . . . 0.0 111.88 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -130.51 167.28 21.75 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 125.167 1.387 . . . . 0.0 111.16 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo . . . . . 0 C--N 1.352 0.726 0 C-N-CA 124.068 3.178 . . . . 0.0 113.778 -179.786 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo . . . . . 0 CA--C 1.544 0.995 0 N-CA-C 115.303 1.232 . . . . 0.0 115.303 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 41.3 t -57.33 -167.91 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 130.408 3.483 . . . . 0.0 112.778 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 9.7 p -132.74 -12.86 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.135 1.774 . . . . 0.0 112.748 177.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 14.3 mm -93.3 -60.1 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.332 1.053 . . . . 0.0 108.566 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 26.5 p -87.55 -44.8 10.99 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.699 1.199 . . . . 0.0 109.768 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . 0.274 14.0 pt20 52.01 22.0 1.7 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 128.981 2.913 . . . . 0.0 114.777 -174.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -94.26 -24.66 18.56 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 112.213 -0.355 . . . . 0.0 112.213 176.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -115.42 155.08 47.57 Favored Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 125.979 1.712 . . . . 0.0 115.125 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -51.41 140.15 44.21 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.683 3.589 . . . . 0.0 114.54 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -67.6 28.14 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 127.564 2.345 . . . . 0.0 117.091 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -77.87 89.83 4.08 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.46 -1.4 . . . . 0.0 110.774 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 162.35 57.86 0.02 OUTLIER Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.065 -0.853 . . . . 0.0 113.523 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 78.3 m -63.14 142.91 58.2 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.687 1.243 . . . . 0.0 110.596 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.6 mp -115.06 144.53 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 126.033 1.733 . . . . 0.0 111.377 -172.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 67.0 t -127.24 131.48 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.72 1.208 . . . . 0.0 111.657 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -119.88 97.2 5.5 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.681 2.792 . . . . 0.0 110.786 174.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.72 -91.48 0.33 Allowed Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.906 1.717 . . . . 0.0 114.046 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -118.88 -0.27 11.24 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.297 1.839 . . . . 0.0 113.849 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 67.1 p -133.24 170.08 15.96 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.603 1.961 . . . . 0.0 110.337 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -153.53 171.61 32.36 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.911 1.243 . . . . 0.0 112.899 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -120.11 133.7 55.45 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.531 1.132 . . . . 0.0 113.275 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 25.7 tp -89.64 153.13 20.98 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 129.006 2.922 . . . . 0.0 113.882 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 459' ' ' MET . . . . . . . . . . . . 0.354 25.8 ptm 59.45 57.2 3.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 129.28 3.032 . . . . 0.0 118.535 172.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -136.76 147.9 46.94 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.259 1.824 . . . . 0.0 108.145 170.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 31.3 p -82.04 165.24 20.82 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 120.24 1.382 . . . . 0.0 112.874 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.32 -38.82 84.92 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.123 177.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 96.3 m -61.2 -59.42 5.34 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.693 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 54.6 m -53.93 -48.27 70.39 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.701 1.137 . . . . 0.0 112.4 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -56.36 -51.54 67.91 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.554 0.742 . . . . 0.0 112.613 175.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -62.78 -39.71 95.06 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.03 1.332 . . . . 0.0 112.437 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -61.85 -54.18 45.68 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.177 1.391 . . . . 0.0 110.457 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 27.2 mt -50.2 -53.05 30.72 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.426 1.091 . . . . 0.0 110.089 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -52.89 -51.12 62.33 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.871 1.268 . . . . 0.0 112.644 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -61.79 -38.9 89.8 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.345 1.458 . . . . 0.0 112.698 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -75.87 -1.67 26.44 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.782 2.033 . . . . 0.0 113.361 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 35.8 t30 77.88 7.27 2.66 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 130.111 3.365 . . . . 0.0 115.482 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -78.21 123.93 85.88 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 120.655 -1.278 . . . . 0.0 108.332 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.0 -76.45 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.58 2.853 . . . . 0.0 111.589 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 27.1 t -120.33 132.16 24.21 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.637 1.975 . . . . 0.0 110.114 178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.12 -3.22 13.49 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.461 2.774 . . . . 0.0 113.428 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 39.2 t -113.44 -71.99 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.816 1.246 . . . . 0.0 112.272 -177.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 26.3 p -100.96 -2.61 31.36 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.44 1.496 . . . . 0.0 114.587 -176.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 65.89 8.67 5.51 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 128.067 2.547 . . . . 0.0 115.861 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -62.77 124.89 85.01 Favored Pre-proline 0 CA--C 1.553 1.092 0 CA-C-N 119.357 0.981 . . . . 0.0 111.287 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.38 114.49 1.46 Allowed 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.398 3.398 . . . . 0.0 114.882 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 16.4 pt -75.94 157.76 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.795 0.838 . . . . 0.0 113.233 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -115.1 -45.45 2.95 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.052 1.741 . . . . 0.0 112.749 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.68 170.09 22.82 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 13.9 mt -131.33 138.97 51.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 128.304 2.641 . . . . 0.0 107.37 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.22 150.04 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 CA-C-N 119.728 1.149 . . . . 0.0 113.843 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -62.78 99.92 0.18 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.518 1.927 . . . . 0.0 109.412 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 12.3 m -119.95 127.94 53.12 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.103 0.961 . . . . 0.0 112.242 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -118.93 161.73 19.7 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.183 1.393 . . . . 0.0 113.518 -176.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -74.92 163.61 67.05 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 125.333 1.453 . . . . 0.0 111.697 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo . . . . . 0 C--N 1.353 0.781 0 C-N-CA 123.925 3.083 . . . . 0.0 114.451 -178.565 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 CA--C 1.545 1.074 0 CA-C-O 116.771 -1.429 . . . . 0.0 114.705 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 32.7 t -55.99 142.92 34.14 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 121.502 1.956 . . . . 0.0 109.764 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.0 -0.36 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.399 1.079 . . . . 0.0 113.747 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 8.9 mt -132.94 -46.83 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.866 0.866 . . . . 0.0 112.299 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.3 m -72.13 -68.34 0.47 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -172.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -144.29 -10.45 0.65 Allowed 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -174.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 78.57 13.57 83.06 Favored Glycine 0 CA--C 1.542 1.766 0 CA-C-N 120.129 1.331 . . . . 0.0 112.668 -174.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -62.28 155.19 67.46 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 130.758 3.623 . . . . 0.0 113.952 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -67.71 -1.46 6.78 Favored 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 124.856 3.704 . . . . 0.0 116.211 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -60.93 135.14 57.7 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.007 1.723 . . . . 0.0 110.416 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.08 126.65 41.62 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.439 1.496 . . . . 0.0 113.31 -176.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -150.3 78.58 0.22 Allowed Glycine 0 CA--C 1.529 0.938 0 C-N-CA 125.405 1.479 . . . . 0.0 112.102 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 76.5 m -63.75 151.56 41.73 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 117.624 0.712 . . . . 0.0 110.987 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 4.6 mp -110.25 142.39 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 125.794 1.637 . . . . 0.0 111.216 -174.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 64.5 t -130.02 123.44 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.625 1.17 . . . . 0.0 108.234 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.24 106.24 9.72 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.843 2.057 . . . . 0.0 112.984 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 73.35 -83.75 0.64 Allowed Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.865 1.698 . . . . 0.0 114.746 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 454' ' ' LYS . . . . . 0.431 ' HA ' ' HE2' ' B' ' 454' ' ' LYS . 0.5 OUTLIER -127.57 -10.59 5.64 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.858 1.663 . . . . 0.0 114.021 -177.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 78.8 p -135.46 169.97 16.67 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.309 1.443 . . . . 0.0 111.078 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -144.32 168.8 26.56 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.192 0.901 . . . . 0.0 114.669 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -120.18 132.17 55.28 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.227 1.811 . . . . 0.0 112.649 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 4.4 pp -107.81 153.32 23.16 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.876 2.07 . . . . 0.0 111.872 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 44.0 ttm 86.19 69.16 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 128.531 2.732 . . . . 0.0 112.05 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -160.04 154.92 24.46 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 128.051 2.54 . . . . 0.0 108.538 176.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 14.3 p -90.05 174.99 7.34 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 122.354 1.073 . . . . 0.0 110.488 174.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -66.09 -31.72 72.76 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.425 -0.797 . . . . 0.0 111.616 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 40.8 m -72.25 -47.03 53.38 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 117.007 -1.473 . . . . 0.0 110.427 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 50.6 m -45.22 -57.6 3.85 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 120.306 1.412 . . . . 0.0 109.962 172.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.96 -49.89 76.16 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.234 1.814 . . . . 0.0 113.549 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -60.88 -37.5 82.41 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.091 1.356 . . . . 0.0 112.797 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -59.34 -52.15 66.88 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.966 1.306 . . . . 0.0 110.661 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 19.1 mt -57.33 -48.97 77.61 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.016 1.327 . . . . 0.0 109.978 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -56.21 -51.7 67.12 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.957 1.303 . . . . 0.0 113.244 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -52.26 -40.74 62.12 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.535 1.534 . . . . 0.0 113.426 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 32.3 ptt85 -97.45 5.99 48.88 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.684 1.594 . . . . 0.0 113.938 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 44.82 48.43 9.06 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.487 2.715 . . . . 0.0 112.332 -177.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -69.99 118.46 63.72 Favored Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 124.268 1.027 . . . . 0.0 111.896 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -62.58 123.33 12.18 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.294 1.996 . . . . 0.0 107.76 172.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 52.6 t -26.85 122.25 0.23 Allowed Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 128.72 2.808 . . . . 0.0 115.742 -173.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -65.5 -3.92 8.6 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 122.657 2.238 . . . . 0.0 113.931 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 33.9 t -107.47 -62.87 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.527 1.531 . . . . 0.0 111.347 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 26.6 p -110.09 0.97 18.58 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 63.55 11.32 5.57 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 127.84 2.456 . . . . 0.0 115.953 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -68.65 151.55 97.18 Favored Pre-proline 0 CA--C 1.551 1.01 0 O-C-N 121.373 -0.83 . . . . 0.0 111.534 176.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.84 111.26 2.98 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.594 2.863 . . . . 0.0 112.442 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.9 109.97 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 126.84 2.056 . . . . 0.0 109.982 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -107.3 -57.08 2.12 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -171.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.21 165.39 27.65 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -177.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 2.7 mt -134.96 141.41 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 127.399 2.28 . . . . 0.0 109.94 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.99 148.84 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.038 0.935 . . . . 0.0 111.826 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.0 99.8 0.91 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 17.3 m -109.23 86.87 2.37 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.221 1.008 . . . . 0.0 111.502 -174.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -77.18 159.32 29.81 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -176.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -74.12 156.28 87.77 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.617 1.567 . . . . 0.0 111.964 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo . . . . . 0 C--N 1.352 0.744 0 C-N-CA 124.156 3.237 . . . . 0.0 114.324 178.316 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 CA--C 1.542 0.909 0 N-CA-C 114.974 1.106 . . . . 0.0 114.974 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 8.4 t -58.44 178.38 0.1 Allowed 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 127.538 2.335 . . . . 0.0 114.25 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 33.6 m -134.83 -0.22 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 -173.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 6.8 mt -118.93 -56.58 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-N 121.106 1.775 . . . . 0.0 112.413 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 7.8 p -51.17 -84.85 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.116 2.166 . . . . 0.0 114.064 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -148.47 -15.8 0.33 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 131.516 3.926 . . . . 0.0 111.998 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 92.1 69.22 1.15 Allowed Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.082 1.325 . . . . 0.0 113.009 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -99.21 154.47 37.29 Favored Pre-proline 0 N--CA 1.48 1.026 0 C-N-CA 125.125 1.37 . . . . 0.0 110.888 175.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.71 125.05 15.83 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.648 2.899 . . . . 0.0 112.056 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.58 99.96 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -175.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -128.04 89.85 2.99 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.612 1.165 . . . . 0.0 107.912 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 151.96 58.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.845 0 C-N-CA 123.907 0.765 . . . . 0.0 112.459 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 35.7 t -59.57 138.31 57.75 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.34 1.07 . . . . 0.0 110.943 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.8 mp -114.96 140.62 35.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 C-N-CA 127.271 2.229 . . . . 0.0 110.772 -174.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 73.1 t -130.04 131.72 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.416 1.086 . . . . 0.0 111.641 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -111.42 100.96 9.45 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.755 2.422 . . . . 0.0 108.505 171.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 73.67 -85.0 0.65 Allowed Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.488 1.518 . . . . 0.0 112.939 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -137.08 4.86 2.75 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.338 1.855 . . . . 0.0 114.348 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 51.2 p -131.37 170.04 15.19 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.467 1.907 . . . . 0.0 110.248 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -160.08 175.56 36.87 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 120.804 -1.185 . . . . 0.0 114.561 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -120.03 100.02 6.96 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.083 1.753 . . . . 0.0 110.222 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 11.2 tp -76.69 92.75 3.56 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 128.212 2.605 . . . . 0.0 111.193 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -169.53 -27.41 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -103.35 164.06 11.88 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.085 1.311 . . . . 0.0 114.373 -174.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 32.0 p -85.92 168.34 14.29 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-O 122.123 0.963 . . . . 0.0 112.241 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.07 -42.35 90.16 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.224 -0.923 . . . . 0.0 111.678 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 86.9 m -54.98 -58.81 6.1 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.334 1.054 . . . . 0.0 109.628 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 84.0 m -57.51 -43.89 84.59 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.118 1.367 . . . . 0.0 112.629 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.71 -50.85 69.21 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.76 0.824 . . . . 0.0 111.775 174.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -65.49 -38.49 89.91 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.292 1.037 . . . . 0.0 112.089 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -60.57 -52.43 65.2 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.909 1.284 . . . . 0.0 110.845 177.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 19.6 mt -50.48 -49.81 54.37 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.764 1.226 . . . . 0.0 110.273 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 50.9 tttt -55.37 -51.64 66.15 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.942 1.297 . . . . 0.0 112.368 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -60.3 -42.47 95.57 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.555 1.542 . . . . 0.0 111.797 175.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -69.68 -3.96 17.49 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 127.372 2.269 . . . . 0.0 113.209 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 63.96 20.12 12.06 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 128.478 2.711 . . . . 0.0 114.291 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -70.05 127.7 92.16 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 173.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -64.18 -56.07 0.51 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.846 2.364 . . . . 0.0 112.057 -177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 13.2 t -152.95 137.6 10.93 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 128.335 2.654 . . . . 0.0 108.412 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -70.08 -5.19 15.81 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.205 2.604 . . . . 0.0 114.179 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 24.7 t -120.16 -75.26 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 119.99 1.268 . . . . 0.0 113.197 -178.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 10.6 p -92.19 -1.57 57.06 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.978 1.711 . . . . 0.0 114.516 -176.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 61.54 24.74 14.79 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 127.635 2.374 . . . . 0.0 115.878 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -93.72 121.14 65.25 Favored Pre-proline 0 CA--C 1.558 1.279 0 CA-C-N 119.1 0.864 . . . . 0.0 109.912 174.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -42.87 112.09 0.25 Allowed 'Trans proline' 0 CA--C 1.547 1.139 1 C-N-CA 125.375 4.05 . . . . 0.0 119.727 -173.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 1.9 pp -70.59 128.69 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 126.466 1.906 . . . . 0.0 110.386 173.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -115.18 -16.59 11.54 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -174.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 5.7 tmm? -145.87 147.67 32.04 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.299 0.954 . . . . 0.0 112.953 -173.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 13.5 mt -137.2 133.27 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 126.736 2.014 . . . . 0.0 109.763 174.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 3.4 m -119.24 150.16 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 125.709 1.604 . . . . 0.0 112.4 176.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.55 99.88 3.74 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 175.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 24.8 m -88.63 143.81 26.7 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -174.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -123.6 152.32 42.04 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.107 2.163 . . . . 0.0 110.507 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . 0.459 ' H ' ' CD ' ' A' ' 491' ' ' PRO . 56.2 p90 -138.39 -29.53 0.01 OUTLIER Pre-proline 0 CA--C 1.552 1.033 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 491' ' ' PRO . . . . . 0.459 ' CD ' ' H ' ' A' ' 490' ' ' PHE . 87.5 Cg_exo . . . . . 0 C--N 1.359 1.12 0 C-N-CA 123.255 2.636 . . . . 0.0 114.218 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo . . . . . 0 CA--C 1.556 1.62 0 N-CA-C 110.2 -0.731 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 11.4 t -47.72 148.03 1.68 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.67 1.588 . . . . 0.0 111.722 175.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 25.7 t -117.93 -11.25 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.611 1.565 . . . . 0.0 112.093 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 10.0 mt -128.62 -53.26 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -174.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 2.1 m -69.82 -68.97 0.38 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.594 1.958 . . . . 0.0 115.371 -171.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -144.82 -10.24 0.6 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -173.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.51 11.38 82.04 Favored Glycine 0 CA--C 1.542 1.764 0 CA-C-N 119.638 1.108 . . . . 0.0 112.603 -174.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -67.48 155.04 92.0 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 127.738 2.415 . . . . 0.0 111.957 177.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.61 142.45 13.74 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.729 2.952 . . . . 0.0 115.112 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -63.82 34.98 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 129.305 3.042 . . . . 0.0 116.164 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -81.35 89.77 6.12 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.491 -1.381 . . . . 0.0 108.139 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 170.51 48.37 0.04 OUTLIER Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.993 0.806 . . . . 0.0 112.846 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 48.4 t -55.32 133.52 49.59 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.106 1.362 . . . . 0.0 109.732 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 2.1 mp -104.53 150.18 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 126.001 1.72 . . . . 0.0 109.736 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 40.2 t -124.68 140.12 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 122.362 1.077 . . . . 0.0 110.652 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -125.22 94.92 4.3 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 128.355 2.662 . . . . 0.0 109.106 175.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 66.63 -84.18 0.11 Allowed Glycine 0 CA--C 1.538 1.51 0 C-N-CA 124.796 1.189 . . . . 0.0 113.333 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -130.4 0.93 4.56 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 128.057 2.543 . . . . 0.0 113.81 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 27.7 p -112.39 170.15 8.37 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.978 2.111 . . . . 0.0 109.735 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -154.17 167.49 32.33 Favored Glycine 0 CA--C 1.528 0.879 0 O-C-N 120.692 -1.255 . . . . 0.0 114.844 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -120.08 143.11 48.31 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.172 1.389 . . . . 0.0 113.11 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 9.9 tt -126.66 153.09 45.85 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 130.434 3.493 . . . . 0.0 108.985 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 9.5 ttt 100.22 19.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 128.796 2.838 . . . . 0.0 114.529 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -140.94 152.93 45.38 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.901 1.68 . . . . 0.0 110.368 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 13.1 p -82.2 174.51 11.11 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.619 1.2 . . . . 0.0 113.198 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.51 -46.31 86.97 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.406 177.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 49.0 m -65.86 -42.84 89.91 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 117.345 -1.312 . . . . 0.0 112.391 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 55.5 m -49.83 -55.36 14.49 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 120.382 1.447 . . . . 0.0 109.588 173.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -62.8 -40.75 98.31 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.622 1.569 . . . . 0.0 113.587 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -60.6 -44.02 96.75 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.554 1.542 . . . . 0.0 111.582 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -57.46 -58.37 8.6 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.108 1.363 . . . . 0.0 110.647 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.3 pp -64.03 -32.22 73.7 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -67.41 -47.39 70.41 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.906 1.682 . . . . 0.0 111.434 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -60.08 -38.7 83.66 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.234 1.014 . . . . 0.0 111.945 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -76.59 -6.41 51.83 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.7 1.6 . . . . 0.0 113.018 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 64.3 t30 52.7 39.31 28.27 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 128.135 2.574 . . . . 0.0 112.144 -177.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -73.92 132.3 80.35 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.328 1.451 . . . . 0.0 112.177 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -70.61 119.1 6.08 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.492 2.128 . . . . 0.0 107.612 170.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 42.9 t -20.75 125.7 0.08 OUTLIER Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 129.157 2.983 . . . . 0.0 116.44 -176.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -65.91 -1.8 5.67 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 122.845 2.363 . . . . 0.0 114.172 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 45.2 t -113.96 -69.51 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.671 1.588 . . . . 0.0 111.34 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 28.3 p -93.45 -7.57 44.08 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? 61.4 13.52 5.07 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 127.158 2.183 . . . . 0.0 114.67 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -74.1 159.19 84.52 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.418 1.087 . . . . 0.0 111.806 176.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -69.61 130.2 19.1 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.973 2.449 . . . . 0.0 112.087 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.59 110.4 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 126.161 1.784 . . . . 0.0 110.816 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -87.41 -61.14 1.79 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.542 1.137 . . . . 0.0 113.303 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.17 170.06 22.1 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.057 1.343 . . . . 0.0 113.922 -174.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 13.3 mt -133.03 140.69 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 127.714 2.405 . . . . 0.0 108.643 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 5.2 m -131.75 150.03 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 125.215 1.406 . . . . 0.0 112.956 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.51 99.93 3.14 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.78 95.8 6.05 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.306 1.442 . . . . 0.0 112.541 -173.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -68.55 161.71 27.33 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.306 1.442 . . . . 0.0 111.209 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -133.29 165.4 37.03 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 125.314 1.446 . . . . 0.0 111.59 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo . . . . . 0 C--N 1.352 0.752 0 C-N-CA 124.345 3.364 . . . . 0.0 114.124 -179.592 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo . . . . . 0 CA--C 1.544 1.01 0 N-CA-C 113.141 0.4 . . . . 0.0 113.141 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 8.0 p -68.47 -177.28 0.9 Allowed 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 16.8 m -139.09 -8.83 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 4.2 mt -110.74 -62.26 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 121.132 1.787 . . . . 0.0 112.539 -177.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 19.7 p -65.63 -64.32 0.89 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -176.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . 0.504 HE21 ' NH2' ' A' ' 444' ' ' ARG . 43.4 mt-30 -143.64 -13.19 0.67 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 116.981 2.215 . . . . 0.0 116.981 -173.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 81.94 28.07 43.25 Favored Glycine 0 CA--C 1.536 1.381 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -172.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . 0.504 ' NH2' HE21 ' A' ' 442' ' ' GLN . 12.8 ptp180 -72.84 155.07 90.97 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 125.142 1.377 . . . . 0.0 111.534 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -70.07 1.82 4.29 Favored 'Trans proline' 0 CA--C 1.548 1.214 0 C-N-CA 124.03 3.153 . . . . 0.0 116.135 -178.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -63.56 156.71 25.67 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 127.016 2.126 . . . . 0.0 112.827 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -128.05 150.23 50.03 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 129.193 2.997 . . . . 0.0 111.956 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 176.77 84.29 0.06 OUTLIER Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.3 1.428 . . . . 0.0 113.671 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 42.2 t -62.36 139.58 58.54 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.978 0.911 . . . . 0.0 111.526 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.6 mp -115.11 148.75 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.95 1.7 . . . . 0.0 111.043 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 93.9 t -130.0 131.71 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.316 1.047 . . . . 0.0 111.517 177.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -125.04 100.15 6.44 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 128.097 2.559 . . . . 0.0 112.397 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.69 -89.6 0.38 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.579 1.562 . . . . 0.0 114.25 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -120.6 -4.5 9.78 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.955 1.702 . . . . 0.0 113.797 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 47.4 p -131.7 170.0 15.39 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.945 1.698 . . . . 0.0 111.176 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -141.81 176.12 22.17 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.546 1.07 . . . . 0.0 115.159 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.11 144.64 47.52 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.106 2.162 . . . . 0.0 112.784 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 34.0 tp -135.13 153.17 52.09 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.407 2.683 . . . . 0.0 110.904 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 47.3 mtt 82.97 29.77 0.09 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 128.748 2.819 . . . . 0.0 113.528 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -134.01 139.91 46.35 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 127.107 2.163 . . . . 0.0 107.563 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 30.6 p -79.42 175.04 10.97 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 122.883 1.325 . . . . 0.0 113.52 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.52 -36.08 81.45 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.46 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 53.8 m -63.94 -53.12 55.27 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 117.372 -1.299 . . . . 0.0 110.508 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 28.8 m -48.98 -54.24 16.44 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 120.394 1.452 . . . . 0.0 111.052 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.97 -49.48 76.67 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.806 1.242 . . . . 0.0 112.949 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -62.59 -41.66 99.1 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.559 1.144 . . . . 0.0 111.443 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -61.18 -57.96 10.28 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.0 1.72 . . . . 0.0 111.159 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 1.7 pp -59.51 -37.01 77.19 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.046 0.384 . . . . 0.0 111.495 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -61.9 -52.15 65.25 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.263 1.425 . . . . 0.0 111.827 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -59.94 -34.89 73.85 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.927 1.291 . . . . 0.0 112.599 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -78.34 2.92 16.99 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.625 1.97 . . . . 0.0 113.424 175.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 28.2 m120 64.16 21.01 12.42 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 128.582 2.753 . . . . 0.0 114.991 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -70.47 134.02 86.81 Favored Pre-proline 0 CA--C 1.544 0.732 0 O-C-N 121.102 -0.999 . . . . 0.0 108.606 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.38 -56.28 0.3 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.264 1.976 . . . . 0.0 111.223 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 1.8 t -155.2 145.26 15.72 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 129.858 3.263 . . . . 0.0 109.008 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.99 -12.47 32.53 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.018 2.478 . . . . 0.0 114.849 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 15.3 t -140.23 -56.16 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 120.707 1.594 . . . . 0.0 114.297 -177.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 16.8 m -71.5 -22.42 61.79 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.107 2.163 . . . . 0.0 112.207 -177.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 79.2 mtm-85 63.3 11.81 5.71 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.894 2.478 . . . . 0.0 113.527 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -75.94 132.85 73.46 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.503 1.121 . . . . 0.0 109.02 174.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.02 110.11 1.66 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.69 2.26 . . . . 0.0 114.412 -176.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.0 pp -65.28 141.38 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.519 1.528 . . . . 0.0 111.836 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -114.98 -28.04 7.16 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.89 1.276 . . . . 0.0 114.24 -176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -154.63 162.57 41.07 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.274 1.03 . . . . 0.0 113.699 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 6.8 mt -129.19 137.71 56.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 127.725 2.41 . . . . 0.0 107.219 176.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 12.2 p -134.27 150.03 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.792 1.237 . . . . 0.0 112.312 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -75.21 99.74 4.1 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.489 0.716 . . . . 0.0 109.07 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.1 m -112.3 105.6 13.94 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.797 0.839 . . . . 0.0 109.599 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -87.04 161.54 18.11 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.177 1.391 . . . . 0.0 113.959 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -72.08 161.32 79.47 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 126.876 2.07 . . . . 0.0 112.387 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo . . . . . 0 C--N 1.353 0.766 0 C-N-CA 124.563 3.508 . . . . 0.0 114.422 178.775 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 CA--C 1.543 0.938 0 CA-C-O 117.977 -0.926 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 15.8 t -59.54 146.69 39.69 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.859 1.209 . . . . 0.0 109.295 173.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.98 -1.22 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.488 1.115 . . . . 0.0 113.723 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 4.1 mt -132.95 -45.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 119.431 1.014 . . . . 0.0 112.805 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 2.7 m -71.16 -60.55 2.17 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -152.17 -17.78 0.18 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -176.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 83.31 10.23 82.56 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-N 119.575 1.079 . . . . 0.0 112.439 -175.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -71.13 155.1 93.62 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 127.281 2.232 . . . . 0.0 113.237 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.96 7.7 0.04 OUTLIER 'Trans proline' 0 CA--C 1.553 1.449 1 C-N-CA 126.012 4.475 . . . . 0.0 120.103 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -61.47 151.28 33.18 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 120.652 1.569 . . . . 0.0 112.301 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -128.13 150.23 50.07 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.63 1.572 . . . . 0.0 112.336 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -167.88 79.9 0.1 Allowed Glycine 0 CA--C 1.531 1.083 0 C-N-CA 126.552 2.025 . . . . 0.0 111.523 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 49.1 t -68.04 135.36 52.16 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 117.719 0.76 . . . . 0.0 110.532 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.04 143.33 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.912 1.685 . . . . 0.0 111.855 -177.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 53.2 t -129.53 137.54 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.156 1.382 . . . . 0.0 110.681 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -124.0 104.07 8.68 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 129.6 3.16 . . . . 0.0 110.472 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.85 -87.42 0.29 Allowed Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.437 1.494 . . . . 0.0 113.62 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -131.22 5.04 4.43 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.47 1.908 . . . . 0.0 114.308 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 82.0 p -133.97 170.05 16.21 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.537 1.935 . . . . 0.0 110.693 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -159.08 174.44 36.03 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 120.781 -1.2 . . . . 0.0 113.309 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -120.29 144.51 47.77 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.528 1.131 . . . . 0.0 113.38 175.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 4.1 pp -110.78 153.22 25.66 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.333 1.853 . . . . 0.0 112.792 178.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 22.8 ttt 85.33 67.89 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 129.084 2.954 . . . . 0.0 113.116 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -158.1 152.18 24.15 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.122 2.569 . . . . 0.0 108.675 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 13.3 p -91.61 171.56 9.09 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 122.074 0.94 . . . . 0.0 111.74 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.57 -36.75 85.25 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.641 -0.662 . . . . 0.0 111.467 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 38.4 m -68.76 -50.02 53.95 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 116.528 -1.701 . . . . 0.0 109.976 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 19.2 m -46.19 -57.77 4.24 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 121.237 1.835 . . . . 0.0 110.943 174.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.84 -51.3 67.97 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.787 1.235 . . . . 0.0 112.599 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -62.78 -37.94 88.64 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.236 -0.915 . . . . 0.0 112.778 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -61.22 -51.21 69.94 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.215 1.806 . . . . 0.0 110.96 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 20.9 mt -54.94 -53.63 53.14 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.858 1.263 . . . . 0.0 109.67 175.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -52.94 -48.07 67.59 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.431 1.492 . . . . 0.0 112.644 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -61.45 -41.67 97.58 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.462 1.505 . . . . 0.0 112.204 175.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -70.82 -16.74 62.75 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.189 1.396 . . . . 0.0 113.613 176.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 35.3 t30 105.13 -3.99 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.89 1 C-N-CA 132.428 4.291 . . . . 0.0 115.047 175.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -80.7 123.7 82.35 Favored Pre-proline 0 N--CA 1.472 0.663 0 CA-C-N 120.784 1.629 . . . . 0.0 109.882 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.77 -69.08 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.823 2.349 . . . . 0.0 111.655 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 7.1 t -111.12 135.18 20.9 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 126.346 1.859 . . . . 0.0 111.727 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -79.88 -7.55 14.41 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.351 2.7 . . . . 0.0 114.261 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 29.1 t -102.93 -72.87 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 119.748 1.158 . . . . 0.0 112.085 -177.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 26.5 p -100.65 -3.58 30.07 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.048 1.739 . . . . 0.0 113.647 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . 0.338 15.5 ptp180 53.85 23.6 3.95 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 128.797 2.839 . . . . 0.0 116.026 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -65.51 146.76 98.94 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 123.361 0.664 . . . . 0.0 109.579 173.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.02 112.2 2.66 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.337 2.691 . . . . 0.0 113.714 -175.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.5 pp -71.63 160.04 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.879 1.672 . . . . 0.0 113.209 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -111.38 -54.06 2.64 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.471 1.908 . . . . 0.0 110.818 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.33 170.21 21.21 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.83 1.252 . . . . 0.0 113.425 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 14.7 mt -121.14 137.94 53.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 127.302 2.241 . . . . 0.0 106.76 174.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 10.8 m -134.43 149.94 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 52.8 mt -73.34 99.94 3.05 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.704 1.202 . . . . 0.0 108.358 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 33.5 m -116.65 112.63 21.53 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.607 1.563 . . . . 0.0 112.29 -175.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -100.7 171.06 7.93 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.775 1.63 . . . . 0.0 112.692 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -139.05 156.09 72.51 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.331 1.452 . . . . 0.0 111.751 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 C--N 1.35 0.654 0 C-N-CA 123.599 2.866 . . . . 0.0 111.495 -179.828 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo . . . . . 0 CA--C 1.536 0.618 0 N-CA-C 115.683 1.378 . . . . 0.0 115.683 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 8.0 t -54.55 148.0 13.15 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.264 1.026 . . . . 0.0 111.752 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.35 -3.37 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 121.173 -0.955 . . . . 0.0 113.317 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 7.3 mt -129.65 -48.15 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.871 0.869 . . . . 0.0 112.774 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.2 m -68.0 -62.81 1.23 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -156.87 -15.01 0.09 Allowed 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 88.29 8.33 71.6 Favored Glycine 0 CA--C 1.54 1.629 0 O-C-N 120.652 -1.28 . . . . 0.0 112.657 -174.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -59.67 151.45 62.22 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 128.718 2.807 . . . . 0.0 114.336 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.8 88.39 1.31 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.448 3.432 . . . . 0.0 113.258 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -136.96 161.79 35.06 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 127.375 2.27 . . . . 0.0 111.023 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -125.61 150.08 47.85 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.668 1.587 . . . . 0.0 109.972 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -179.93 80.43 0.06 OUTLIER Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.309 1.909 . . . . 0.0 111.498 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 50.5 t -66.29 133.39 50.48 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.877 0.871 . . . . 0.0 110.008 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.03 141.21 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.878 1.271 . . . . 0.0 110.766 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 92.3 t -130.01 133.96 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.426 1.091 . . . . 0.0 111.8 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -124.92 107.88 11.32 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 128.693 2.797 . . . . 0.0 110.204 174.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 66.29 -93.6 0.2 Allowed Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.993 1.759 . . . . 0.0 113.625 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -126.16 7.19 7.18 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.72 2.008 . . . . 0.0 113.611 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 79.7 p -130.52 170.12 14.66 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.656 1.982 . . . . 0.0 110.541 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.33 -178.4 30.44 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.816 -1.177 . . . . 0.0 115.345 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -120.07 136.51 54.55 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.038 2.135 . . . . 0.0 110.404 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 26.4 tp -121.38 152.97 38.42 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.615 1.966 . . . . 0.0 111.206 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 41.4 mtm 64.97 68.34 0.51 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 127.62 2.368 . . . . 0.0 113.018 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -151.96 148.16 27.42 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 129.163 2.985 . . . . 0.0 107.252 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 17.2 p -77.92 165.89 23.55 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 122.472 1.13 . . . . 0.0 111.828 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.7 -38.67 91.34 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.698 -0.626 . . . . 0.0 111.165 177.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 23.8 m -62.16 -48.8 78.48 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 116.911 -1.519 . . . . 0.0 111.133 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 16.6 m -49.24 -51.66 31.96 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 120.809 1.64 . . . . 0.0 111.386 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.19 -47.06 84.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.42 1.088 . . . . 0.0 112.835 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -65.88 -40.57 91.73 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 121.216 -0.927 . . . . 0.0 111.937 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -61.43 -56.83 15.83 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.624 1.97 . . . . 0.0 111.471 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 2.8 pp -59.98 -35.89 75.97 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 118.133 0.424 . . . . 0.0 111.317 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -63.48 -48.63 76.86 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.886 1.274 . . . . 0.0 110.853 175.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -58.64 -39.36 80.32 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.314 1.446 . . . . 0.0 111.409 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -74.12 3.79 6.53 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 127.163 2.185 . . . . 0.0 113.746 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 67.51 15.82 9.86 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 128.949 2.9 . . . . 0.0 115.227 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 5.7 tppp? -70.17 129.96 90.09 Favored Pre-proline 0 N--CA 1.475 0.802 0 O-C-N 120.832 -1.168 . . . . 0.0 109.106 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.33 -49.48 1.26 Allowed 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.847 2.365 . . . . 0.0 111.38 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 1.7 t -158.36 142.28 11.27 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 131.576 3.95 . . . . 0.0 107.995 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.76 -11.32 29.35 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.081 2.521 . . . . 0.0 115.026 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 17.1 t -137.75 -55.93 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 120.54 1.518 . . . . 0.0 113.739 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 22.4 m -69.88 -25.47 63.72 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.739 1.616 . . . . 0.0 111.432 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 33.5 mtp-105 61.38 13.78 5.24 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 127.911 2.484 . . . . 0.0 113.244 -175.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -76.73 130.85 75.14 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.227 1.411 . . . . 0.0 108.484 174.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -64.46 109.61 1.24 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.549 2.166 . . . . 0.0 113.679 -176.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.1 pp -63.21 137.78 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.683 1.593 . . . . 0.0 111.861 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -115.18 -20.8 10.26 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 2.6 ttp -150.95 146.68 26.42 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.13 0.972 . . . . 0.0 112.763 -174.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 7.6 mt -130.78 131.47 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 127.478 2.311 . . . . 0.0 107.763 174.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.39 150.09 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 119.487 1.039 . . . . 0.0 113.707 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.18 99.87 3.52 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 10.2 t -89.41 156.19 18.85 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.372 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -135.7 170.33 16.14 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.161 2.185 . . . . 0.0 111.374 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -133.56 156.57 79.48 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 124.887 1.275 . . . . 0.0 111.706 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo . . . . . 0 CA--C 1.538 0.692 0 C-N-CA 123.434 2.756 . . . . 0.0 112.369 179.753 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo . . . . . 0 CA--C 1.54 0.786 0 CA-C-O 117.635 -1.069 . . . . 0.0 114.696 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 42.2 t -56.13 143.91 31.31 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 120.182 1.355 . . . . 0.0 111.029 177.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 28.5 m -123.68 -15.13 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 10.5 pt -137.12 -26.41 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.5 m -75.9 -64.47 1.08 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 120.64 1.563 . . . . 0.0 112.137 -177.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -145.39 -12.81 0.52 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 76.73 11.88 84.97 Favored Glycine 0 CA--C 1.544 1.886 0 CA-C-N 119.992 1.269 . . . . 0.0 112.487 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -59.54 155.11 40.7 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 129.997 3.319 . . . . 0.0 113.618 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.65 -1.69 10.21 Favored 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 124.354 3.37 . . . . 0.0 115.463 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -52.65 146.8 9.55 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 127.042 2.137 . . . . 0.0 111.577 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -116.21 150.16 37.97 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.757 2.023 . . . . 0.0 110.735 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -159.68 68.12 0.26 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 128.169 2.795 . . . . 0.0 109.349 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 33.8 t -63.8 133.28 53.15 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.063 0.945 . . . . 0.0 110.429 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -114.57 143.21 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.35 1.06 . . . . 0.0 112.057 -175.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 89.6 t -129.08 136.84 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.926 1.29 . . . . 0.0 110.629 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -125.04 95.05 4.36 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 129.456 3.102 . . . . 0.0 110.096 176.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.96 -91.5 0.35 Allowed Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.809 1.671 . . . . 0.0 114.227 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -121.49 4.34 10.18 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 126.318 1.847 . . . . 0.0 114.338 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 66.4 p -134.77 170.09 16.37 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.249 2.22 . . . . 0.0 109.903 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -160.18 174.45 36.93 Favored Glycine 0 CA--C 1.529 0.921 0 O-C-N 120.658 -1.276 . . . . 0.0 113.766 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -120.26 141.99 49.46 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.906 1.282 . . . . 0.0 113.072 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.41 153.26 36.8 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.152 2.581 . . . . 0.0 110.526 177.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 49.5 mtt 93.17 62.96 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 129.826 3.25 . . . . 0.0 111.486 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -160.01 149.59 17.97 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 127.205 2.202 . . . . 0.0 109.489 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 19.4 p -88.3 174.93 7.89 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.851 0.834 . . . . 0.0 110.232 172.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -39.81 94.77 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.397 -0.814 . . . . 0.0 112.416 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 68.9 m -68.13 -48.06 66.42 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 116.105 -1.902 . . . . 0.0 110.606 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 16.6 m -45.61 -59.07 2.95 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 121.601 2.001 . . . . 0.0 111.263 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.88 -43.95 86.35 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.028 1.331 . . . . 0.0 114.062 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -68.92 -42.51 76.73 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.354 -0.841 . . . . 0.0 111.777 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -62.35 -53.91 48.19 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.006 2.122 . . . . 0.0 112.358 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.3 pp -57.54 -36.49 71.69 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.319 0.509 . . . . 0.0 111.197 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -66.68 -46.21 76.39 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.452 0.701 . . . . 0.0 111.767 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -59.23 -35.11 73.07 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.853 1.261 . . . . 0.0 111.704 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -76.3 3.77 10.21 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 127.322 2.249 . . . . 0.0 113.457 175.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 39.3 t30 76.38 8.49 3.28 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 130.013 3.325 . . . . 0.0 115.649 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -70.14 129.46 90.64 Favored Pre-proline 0 N--CA 1.475 0.818 0 O-C-N 120.755 -1.216 . . . . 0.0 109.242 175.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -69.76 -43.23 2.78 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.072 2.515 . . . . 0.0 114.695 -176.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.56 149.3 36.65 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 128.251 2.62 . . . . 0.0 110.313 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.24 -17.69 61.32 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.361 2.707 . . . . 0.0 115.369 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.09 -63.31 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 -172.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 28.8 p -89.16 -19.47 25.44 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -172.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . 0.259 3.9 ptm180 94.15 4.8 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 131.252 3.821 . . . . 0.0 116.182 174.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -67.67 111.99 9.12 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 125.08 1.352 . . . . 0.0 110.387 178.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -46.64 107.84 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 124.269 3.313 . . . . 0.0 116.099 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 pp -62.86 146.95 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.178 1.391 . . . . 0.0 113.45 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -112.1 -29.76 7.48 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.781 1.632 . . . . 0.0 114.187 -173.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.03 161.34 33.97 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.63 1.172 . . . . 0.0 113.468 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 14.1 mt -129.51 136.48 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 127.518 2.327 . . . . 0.0 108.231 175.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 16.9 m -137.61 150.16 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.726 1.21 . . . . 0.0 113.479 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.22 99.85 4.86 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 177.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 1.9 t -93.79 157.61 16.06 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -129.27 143.3 50.8 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.32 1.448 . . . . 0.0 112.403 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -73.39 164.53 60.37 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 125.137 1.375 . . . . 0.0 111.56 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo . . . . . 0 CA--C 1.539 0.726 0 C-N-CA 124.226 3.284 . . . . 0.0 114.272 179.718 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo . . . . . 0 CA--C 1.546 1.102 0 N-CA-C 114.447 0.903 . . . . 0.0 114.447 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 10.0 t -61.01 159.21 11.94 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 128.228 2.611 . . . . 0.0 111.029 171.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.71 -0.63 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.378 1.071 . . . . 0.0 113.442 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 10.4 mt -133.94 -48.86 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 119.735 1.152 . . . . 0.0 112.866 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.5 m -67.61 -60.16 2.77 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.439 1.496 . . . . 0.0 114.228 -173.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -151.53 -16.13 0.2 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -174.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.62 10.69 82.95 Favored Glycine 0 CA--C 1.542 1.755 0 O-C-N 120.812 -1.18 . . . . 0.0 113.173 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -61.96 155.04 65.46 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 128.39 2.676 . . . . 0.0 112.339 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -66.27 1.66 2.35 Favored 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.459 3.439 . . . . 0.0 117.3 -177.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -60.96 144.9 52.3 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.871 1.214 . . . . 0.0 110.62 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -128.19 150.07 50.17 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.68 1.992 . . . . 0.0 111.683 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -162.69 98.92 0.17 Allowed Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.742 1.639 . . . . 0.0 112.51 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 46.4 t -68.21 133.2 48.47 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.517 0.727 . . . . 0.0 110.638 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.2 mp -113.0 135.4 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.181 1.392 . . . . 0.0 110.463 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 45.4 t -130.04 130.32 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.422 1.089 . . . . 0.0 109.65 176.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.2 99.09 5.93 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.908 2.083 . . . . 0.0 112.206 178.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 75.9 -84.36 0.91 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.732 1.634 . . . . 0.0 114.711 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -124.99 -11.53 7.09 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.761 1.624 . . . . 0.0 114.3 -176.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 72.9 p -135.33 168.89 18.37 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.455 1.502 . . . . 0.0 110.573 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -142.96 178.44 21.24 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.35 0.976 . . . . 0.0 113.829 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -120.27 147.03 45.49 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.866 1.266 . . . . 0.0 113.839 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 12.2 tp -111.4 153.27 26.3 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 128.84 2.856 . . . . 0.0 113.551 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 16.7 mtt 69.47 59.74 0.31 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.68 2.392 . . . . 0.0 115.835 173.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -149.56 163.04 38.96 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.286 1.434 . . . . 0.0 111.046 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 11.6 p -87.25 174.49 8.56 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 122.393 1.092 . . . . 0.0 112.484 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -67.04 -40.15 87.13 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.72 -0.612 . . . . 0.0 111.197 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 27.8 m -64.73 -41.98 95.55 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 117.528 -1.225 . . . . 0.0 111.651 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 34.6 m -49.29 -63.61 1.05 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.242 1.417 . . . . 0.0 109.187 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -53.92 -45.17 71.11 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.021 1.728 . . . . 0.0 113.109 176.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -60.11 -37.26 79.47 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.756 1.222 . . . . 0.0 112.352 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -59.85 -49.34 78.1 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.446 1.099 . . . . 0.0 110.922 175.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 5.9 mp -58.75 -46.7 86.84 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 122.847 0.459 . . . . 0.0 109.882 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -57.39 -48.06 80.07 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.132 0.973 . . . . 0.0 112.906 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -56.83 -28.05 60.98 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.183 1.393 . . . . 0.0 113.911 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -107.45 -0.55 22.17 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.708 2.003 . . . . 0.0 112.979 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 60.3 t30 45.49 50.59 10.21 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.943 2.497 . . . . 0.0 111.319 -174.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -73.33 130.6 84.08 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.601 0.761 . . . . 0.0 112.876 -174.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -70.43 115.35 4.15 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.51 2.14 . . . . 0.0 107.568 170.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 53.8 t -23.07 123.35 0.15 Allowed Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 129.211 3.005 . . . . 0.0 115.682 -176.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -65.34 -3.62 7.87 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.127 2.551 . . . . 0.0 114.531 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 47.0 t -109.08 -65.5 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.346 1.458 . . . . 0.0 111.31 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 24.5 p -104.63 0.74 28.82 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 62.84 10.29 4.2 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 127.795 2.438 . . . . 0.0 115.898 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -68.68 149.28 97.99 Favored Pre-proline 0 CA--C 1.552 1.058 0 C-N-CA 123.87 0.868 . . . . 0.0 111.732 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.39 112.96 3.47 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.662 2.908 . . . . 0.0 112.009 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.92 109.97 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 126.547 1.939 . . . . 0.0 110.463 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -103.65 -55.79 2.33 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -172.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.31 161.87 37.18 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -177.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 4.6 mt -135.02 136.53 51.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 126.998 2.119 . . . . 0.0 108.847 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 16.9 m -133.21 150.01 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.935 0.894 . . . . 0.0 112.555 176.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 3.8 tt -82.53 99.75 9.69 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 5.1 t -90.87 162.66 14.7 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.157 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -131.68 148.44 52.59 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.451 1.5 . . . . 0.0 112.038 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -78.06 160.6 73.28 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 125.444 1.498 . . . . 0.0 110.969 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo . . . . . 0 C--N 1.351 0.683 0 C-N-CA 123.322 2.682 . . . . 0.0 111.784 -177.796 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 CA--C 1.537 0.659 0 N-CA-C 113.235 0.437 . . . . 0.0 113.235 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 1.9 p -67.85 175.54 2.98 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 34.8 m -135.94 -3.32 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -176.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 7.7 mt -114.77 -64.43 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 120.319 1.418 . . . . 0.0 112.588 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 21.5 p -68.85 -59.19 3.25 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -147.35 -17.8 0.39 Allowed 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.531 2.049 . . . . 0.0 116.531 -172.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 90.65 30.65 11.35 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.035 1.303 . . . . 0.0 110.778 -174.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 35.0 mtt-85 -62.65 149.38 89.09 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 124.929 1.292 . . . . 0.0 111.595 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.96 -10.49 29.01 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.448 2.765 . . . . 0.0 114.297 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -58.99 153.56 17.32 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 129.593 3.157 . . . . 0.0 113.002 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -128.2 150.16 50.14 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.319 2.248 . . . . 0.0 110.625 176.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -167.06 75.11 0.14 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 127.047 2.26 . . . . 0.0 110.291 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 33.1 t -59.89 122.4 14.17 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.643 0.777 . . . . 0.0 111.854 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 1.2 mp -95.66 134.09 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.966 1.306 . . . . 0.0 109.794 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 95.5 t -127.97 130.38 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.279 1.032 . . . . 0.0 111.353 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -115.06 94.92 4.95 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 128.597 2.759 . . . . 0.0 110.12 174.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.83 -94.92 0.31 Allowed Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.856 1.693 . . . . 0.0 114.372 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -111.97 -1.19 15.51 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.02 1.728 . . . . 0.0 113.648 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 70.1 p -132.28 170.01 15.66 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.655 1.582 . . . . 0.0 111.351 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -157.69 174.64 35.08 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 121.114 -0.991 . . . . 0.0 113.655 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -120.22 110.8 17.03 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.259 1.424 . . . . 0.0 111.411 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 9.8 tp -81.22 153.31 27.24 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.339 2.655 . . . . 0.0 113.033 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 23.7 mtt 79.58 57.99 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 127.786 2.435 . . . . 0.0 114.663 172.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -148.8 150.27 32.77 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.992 2.117 . . . . 0.0 108.319 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 31.7 p -86.47 175.0 8.6 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 122.649 1.214 . . . . 0.0 112.798 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.98 -33.78 76.87 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.2 174.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 37.4 m -63.86 -54.25 37.89 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 117.284 -1.341 . . . . 0.0 109.88 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 21.5 m -47.58 -59.71 3.06 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.126 1.33 . . . . 0.0 111.234 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.95 -48.02 76.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.679 1.192 . . . . 0.0 113.767 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -66.05 -41.72 90.48 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.209 -0.932 . . . . 0.0 111.722 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -63.39 -54.86 30.11 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.785 1.634 . . . . 0.0 112.101 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.5 pp -59.07 -37.89 78.15 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.238 0.472 . . . . 0.0 110.926 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -65.68 -42.99 90.62 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.74 0.816 . . . . 0.0 112.174 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -59.23 -37.86 78.54 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.031 1.332 . . . . 0.0 111.043 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 48.1 mtm105 -77.04 9.67 2.84 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 127.031 2.133 . . . . 0.0 113.646 174.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . 0.313 0.0 OUTLIER 72.56 3.4 4.67 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 130.742 3.617 . . . . 0.0 116.823 178.415 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -72.08 131.12 85.65 Favored Pre-proline 0 CA--C 1.545 0.752 0 O-C-N 121.091 -1.006 . . . . 0.0 109.947 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.51 -72.47 0.02 OUTLIER 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.152 2.568 . . . . 0.0 109.651 176.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 9.3 t -120.92 136.26 25.43 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 127.897 2.479 . . . . 0.0 109.674 175.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.87 -8.18 19.97 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.343 2.696 . . . . 0.0 114.902 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 41.6 t -111.36 -74.84 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 119.877 1.217 . . . . 0.0 112.613 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 16.7 p -92.5 -5.4 51.9 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.57 1.548 . . . . 0.0 113.694 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 61.94 16.22 7.89 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.743 2.417 . . . . 0.0 114.761 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -64.36 139.4 97.7 Favored Pre-proline 0 CA--C 1.549 0.938 0 O-C-N 121.477 -0.764 . . . . 0.0 109.796 175.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.54 113.64 2.79 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.162 2.574 . . . . 0.0 112.612 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 16.5 pt -70.93 157.55 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.54 1.136 . . . . 0.0 113.528 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -115.02 -40.7 3.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.324 1.849 . . . . 0.0 112.978 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.63 167.22 31.11 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -176.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 6.9 mt -135.99 129.03 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 129.169 2.987 . . . . 0.0 106.369 174.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.68 150.15 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.9 107.22 2.57 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 174.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 23.3 m -103.18 88.23 3.09 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.212 1.805 . . . . 0.0 110.086 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -60.78 153.64 23.85 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.772 2.029 . . . . 0.0 115.1 -176.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -61.88 156.12 58.51 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 126.276 1.831 . . . . 0.0 112.531 176.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 CA--C 1.538 0.709 0 C-N-CA 123.308 2.672 . . . . 0.0 112.591 179.869 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo . . . . . 0 CA--C 1.541 0.837 0 N-CA-C 117.253 1.982 . . . . 0.0 117.253 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 30.5 t -51.27 148.12 5.06 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 120.166 1.348 . . . . 0.0 112.663 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.8 -14.9 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 9.4 pt -136.36 -26.55 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.5 m -76.28 -60.12 2.47 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 120.719 1.599 . . . . 0.0 112.064 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -154.17 -13.76 0.13 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -176.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.51 11.55 81.75 Favored Glycine 0 CA--C 1.541 1.687 0 CA-C-N 120.011 1.278 . . . . 0.0 112.198 -173.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 9.4 ptm85 -55.97 155.05 12.69 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 129.592 3.157 . . . . 0.0 114.024 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.7 4.9 4.18 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 124.551 3.501 . . . . 0.0 115.762 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -58.52 157.98 8.26 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.182 1.793 . . . . 0.0 112.586 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -119.66 150.04 40.99 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 128.423 2.689 . . . . 0.0 111.898 -175.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 176.84 82.66 0.06 OUTLIER Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.575 1.56 . . . . 0.0 113.015 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 48.0 t -71.33 138.82 49.57 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 118.152 0.976 . . . . 0.0 109.864 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.6 mp -115.01 144.11 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.651 1.58 . . . . 0.0 110.44 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 97.1 t -129.91 131.34 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.242 1.017 . . . . 0.0 109.527 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -125.05 94.98 4.33 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.91 2.484 . . . . 0.0 111.281 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.49 -89.64 0.36 Allowed Glycine 0 CA--C 1.534 1.281 0 C-N-CA 125.689 1.614 . . . . 0.0 114.386 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -121.56 -0.85 9.65 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 126.348 1.859 . . . . 0.0 113.868 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 16.8 p -130.66 170.12 14.74 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 128.223 2.609 . . . . 0.0 109.787 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -157.79 177.06 34.73 Favored Glycine 0 CA--C 1.529 0.932 0 O-C-N 120.688 -1.258 . . . . 0.0 113.947 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -120.34 135.91 54.87 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.715 1.606 . . . . 0.0 113.842 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 4.0 pp -119.9 153.35 36.0 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.294 2.638 . . . . 0.0 109.451 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 25.0 ttt 78.26 66.3 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.762 2.025 . . . . 0.0 111.094 -177.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -160.03 154.5 23.84 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 128.898 2.879 . . . . 0.0 108.314 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 22.7 p -86.91 172.21 10.23 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.113 0.959 . . . . 0.0 111.21 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -64.94 -35.39 81.01 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.435 -0.79 . . . . 0.0 111.223 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 25.2 m -64.44 -49.2 72.39 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 117.212 -1.375 . . . . 0.0 111.152 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 29.4 m -46.93 -55.58 7.83 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 120.469 1.486 . . . . 0.0 109.924 174.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -59.99 -45.39 92.89 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.923 1.689 . . . . 0.0 113.52 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -60.1 -44.5 94.78 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.228 1.411 . . . . 0.0 111.523 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -62.35 -54.09 45.51 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.341 1.057 . . . . 0.0 111.473 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.4 pp -60.87 -32.05 71.49 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 118.579 0.627 . . . . 0.0 111.958 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -68.24 -48.56 64.79 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.269 1.428 . . . . 0.0 111.734 174.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -55.8 -43.67 77.07 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.632 1.573 . . . . 0.0 111.02 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -75.31 -6.94 52.45 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 127.067 2.147 . . . . 0.0 113.642 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 64.0 t30 50.79 41.13 26.04 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 128.074 2.55 . . . . 0.0 112.173 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -78.15 126.58 83.31 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 125.519 1.528 . . . . 0.0 113.367 -176.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -74.56 129.03 12.35 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.813 2.342 . . . . 0.0 107.526 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 48.2 t -27.01 123.79 0.23 Allowed Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 128.195 2.598 . . . . 0.0 115.493 -176.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.76 -1.66 6.31 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 122.959 2.439 . . . . 0.0 114.33 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 49.1 t -123.64 -59.55 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.686 1.594 . . . . 0.0 111.233 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 69.7 m -78.12 -19.78 53.4 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.682 1.993 . . . . 0.0 112.84 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 61.62 11.79 4.12 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 127.339 2.255 . . . . 0.0 114.198 -177.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -87.17 148.19 44.36 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 123.975 0.91 . . . . 0.0 112.95 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.25 124.55 7.9 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.863 3.042 . . . . 0.0 111.97 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.98 143.04 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.643 1.177 . . . . 0.0 112.859 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -115.17 -40.25 3.49 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.51 1.524 . . . . 0.0 113.656 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.5 166.58 31.82 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -176.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 8.0 mt -133.07 139.22 49.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 127.534 2.333 . . . . 0.0 108.732 176.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.06 150.11 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.944 1.297 . . . . 0.0 113.329 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 55.8 mt -73.29 99.87 3.0 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.294 1.037 . . . . 0.0 109.182 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 6.3 t -95.44 151.53 19.21 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -141.91 158.72 43.44 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.325 1.45 . . . . 0.0 112.558 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -80.54 158.44 71.23 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 123.842 0.857 . . . . 0.0 112.947 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo . . . . . 0 C--N 1.355 0.886 0 C-N-CA 124.565 3.51 . . . . 0.0 113.853 179.386 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo . . . . . 0 CA--C 1.54 0.776 0 N-CA-C 115.923 1.47 . . . . 0.0 115.923 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 44.3 t -46.91 138.67 6.18 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 121.178 1.808 . . . . 0.0 112.45 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.61 -28.74 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 125.173 1.389 . . . . 0.0 112.258 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 8.3 pt -138.01 -24.86 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 -173.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.5 m -73.21 -57.67 3.86 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.731 1.605 . . . . 0.0 112.083 -176.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -154.94 -14.85 0.12 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 81.16 11.06 84.03 Favored Glycine 0 CA--C 1.542 1.766 0 CA-C-N 119.993 1.27 . . . . 0.0 112.513 -174.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -64.7 155.18 83.06 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 129.785 3.234 . . . . 0.0 113.122 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -69.12 4.48 1.89 Allowed 'Trans proline' 0 CA--C 1.548 1.224 0 C-N-CA 124.569 3.512 . . . . 0.0 117.055 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -56.74 139.7 49.86 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 120.166 1.348 . . . . 0.0 110.59 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -128.17 113.86 16.26 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.192 1.797 . . . . 0.0 114.646 -170.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -144.62 82.79 0.2 Allowed Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.55 1.548 . . . . 0.0 112.527 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 49.3 t -65.0 142.17 58.53 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 117.872 0.836 . . . . 0.0 110.565 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 2.2 mp -107.17 141.64 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 125.816 1.646 . . . . 0.0 110.121 -177.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 96.9 t -130.09 132.79 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.277 1.031 . . . . 0.0 110.398 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -125.01 94.98 4.34 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.313 2.245 . . . . 0.0 110.841 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.74 -92.44 0.24 Allowed Glycine 0 CA--C 1.534 1.275 0 C-N-CA 126.259 1.885 . . . . 0.0 114.648 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -111.88 -7.89 14.14 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.334 1.854 . . . . 0.0 113.345 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 19.7 p -124.24 170.01 11.19 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.618 1.967 . . . . 0.0 111.125 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -160.8 174.9 37.51 Favored Glycine 0 CA--C 1.532 1.099 0 O-C-N 121.088 -1.007 . . . . 0.0 113.999 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -120.28 113.46 20.43 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.319 1.848 . . . . 0.0 113.333 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -97.37 153.18 18.24 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.923 1.289 . . . . 0.0 112.023 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 40.1 tpp 75.58 68.51 0.07 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.86 2.064 . . . . 0.0 111.244 177.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -157.25 150.22 23.54 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 129.293 3.037 . . . . 0.0 108.616 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 17.1 p -86.46 170.46 11.93 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.616 1.198 . . . . 0.0 111.781 176.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.49 -30.28 70.58 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.095 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 25.0 m -69.96 -50.5 41.22 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 117.303 -1.332 . . . . 0.0 109.9 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 35.0 m -47.65 -56.84 6.38 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 120.371 1.441 . . . . 0.0 110.105 173.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.15 -46.47 82.71 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.938 1.695 . . . . 0.0 113.403 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -65.86 -37.43 86.15 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.561 -1.337 . . . . 0.0 111.822 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 21.2 tptp -63.49 -52.36 61.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.122 0.969 . . . . 0.0 111.105 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.59 -30.32 70.6 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.073 0.397 . . . . 0.0 111.704 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -68.58 -46.06 70.38 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.033 1.333 . . . . 0.0 111.829 173.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -57.64 -42.44 83.41 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.864 1.265 . . . . 0.0 110.982 174.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -72.78 -11.05 60.46 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.459 1.904 . . . . 0.0 113.528 175.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 63.8 t30 52.41 40.45 29.49 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.814 2.446 . . . . 0.0 111.754 -175.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -74.2 116.13 49.69 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 126.357 1.863 . . . . 0.0 113.781 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.1 132.49 22.89 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.41 2.073 . . . . 0.0 107.671 170.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 47.1 t -32.58 125.11 0.39 Allowed Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 127.656 2.382 . . . . 0.0 115.214 -175.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.94 -3.18 10.94 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.146 2.564 . . . . 0.0 114.381 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 42.6 t -124.74 -60.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.076 1.35 . . . . 0.0 111.726 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 58.6 m -75.01 -18.78 60.29 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.635 1.974 . . . . 0.0 112.432 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 64.6 5.12 2.56 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.554 2.342 . . . . 0.0 114.081 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -83.8 148.99 55.78 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 124.204 1.002 . . . . 0.0 113.144 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.11 124.04 8.77 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.037 2.491 . . . . 0.0 110.405 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.2 pp -60.95 128.61 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.526 1.13 . . . . 0.0 110.932 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -115.08 -26.82 7.55 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -175.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 1.7 ttp -149.86 150.35 31.8 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.241 1.016 . . . . 0.0 112.624 -175.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 10.4 mt -137.24 130.05 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 127.138 2.175 . . . . 0.0 107.941 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 27.0 m -140.07 150.23 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 124.378 1.071 . . . . 0.0 112.913 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 66.6 tp -63.7 99.89 0.25 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.065 1.746 . . . . 0.0 108.683 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 41.4 m -110.8 108.48 18.33 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -170.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -85.72 178.41 7.35 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.239 1.816 . . . . 0.0 112.997 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -129.84 168.64 15.78 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 125.953 1.701 . . . . 0.0 111.552 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo . . . . . 0 C--N 1.353 0.798 0 C-N-CA 124.249 3.299 . . . . 0.0 113.887 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 CA--C 1.549 1.233 0 N-CA-C 113.036 0.36 . . . . 0.0 113.036 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 6.7 p -60.29 173.04 0.72 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.646 1.579 . . . . 0.0 114.579 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 28.6 m -130.75 -3.61 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -175.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 4.5 mt -117.88 -59.99 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 120.529 1.513 . . . . 0.0 112.796 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 7.0 p -69.39 -68.75 0.38 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -174.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -144.56 -13.95 0.57 Allowed 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 -171.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 88.92 40.86 6.09 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.426 1.012 . . . . 0.0 110.859 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -97.83 155.31 37.26 Favored Pre-proline 0 N--CA 1.481 1.107 0 C-N-CA 125.854 1.662 . . . . 0.0 112.406 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -44.08 121.44 2.98 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.949 3.1 . . . . 0.0 114.461 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.14 31.86 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 131.127 3.771 . . . . 0.0 118.944 -176.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -76.58 89.85 3.32 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 119.952 -1.718 . . . . 0.0 109.541 -178.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 164.97 57.21 0.02 OUTLIER Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.049 -0.862 . . . . 0.0 114.085 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 52.5 t -57.24 138.58 54.54 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.899 1.35 . . . . 0.0 110.91 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.4 mp -115.13 136.18 52.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 C-N-CA 126.687 1.995 . . . . 0.0 109.216 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 90.1 t -127.28 132.42 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.634 0.774 . . . . 0.0 110.924 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -124.35 106.14 10.0 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.011 2.525 . . . . 0.0 111.471 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 68.46 -89.92 0.23 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.703 1.621 . . . . 0.0 114.177 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -124.69 -0.97 7.99 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.152 1.781 . . . . 0.0 113.997 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 54.9 p -133.25 170.02 16.04 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.898 1.679 . . . . 0.0 110.296 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -152.01 175.12 30.87 Favored Glycine 0 CA--C 1.526 0.771 0 O-C-N 120.88 -1.138 . . . . 0.0 113.512 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -120.28 145.64 46.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.045 1.338 . . . . 0.0 114.181 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 94.8 mt -123.35 153.48 40.25 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 129.504 3.122 . . . . 0.0 110.686 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 50.5 mtt 90.7 31.39 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 128.757 2.823 . . . . 0.0 113.37 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -139.42 134.9 33.01 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.739 2.016 . . . . 0.0 107.583 173.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 22.1 p -80.98 175.11 10.97 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 122.667 1.222 . . . . 0.0 112.842 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.9 -36.93 70.73 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.731 0.812 . . . . 0.0 112.254 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 87.7 m -66.38 -52.56 45.57 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.197 0.999 . . . . 0.0 110.748 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 98.5 m -52.41 -50.54 62.32 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.31 1.044 . . . . 0.0 110.747 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.9 -44.54 91.23 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.177 1.391 . . . . 0.0 112.769 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -61.92 -43.26 99.21 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.785 1.234 . . . . 0.0 111.099 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -61.58 -57.11 13.39 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.117 0.967 . . . . 0.0 111.255 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.0 pp -59.11 -33.44 70.85 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 118.373 0.533 . . . . 0.0 112.227 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -68.05 -50.71 53.56 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.393 1.477 . . . . 0.0 112.217 175.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -56.81 -40.39 75.9 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.698 1.599 . . . . 0.0 111.502 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -79.93 -0.97 37.31 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.409 2.284 . . . . 0.0 113.403 176.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 46.24 39.22 5.9 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 128.866 2.866 . . . . 0.0 113.752 -177.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -69.98 127.93 92.06 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.478 1.511 . . . . 0.0 114.01 -176.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.09 128.19 11.22 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 122.834 2.356 . . . . 0.0 107.864 169.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 32.3 t -29.72 128.99 0.24 Allowed Pre-proline 0 CA--C 1.558 1.26 0 C-N-CA 128.07 2.548 . . . . 0.0 115.106 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -66.74 -2.56 7.81 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.181 2.588 . . . . 0.0 114.617 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 53.5 t -127.07 -59.48 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.393 1.477 . . . . 0.0 111.476 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 65.0 m -77.14 -24.59 51.61 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.595 1.958 . . . . 0.0 112.671 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 62.44 9.91 3.66 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 127.128 2.171 . . . . 0.0 113.81 -175.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -81.81 151.33 67.48 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.134 0.973 . . . . 0.0 113.068 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -77.46 121.09 5.47 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 123.978 3.119 . . . . 0.0 111.919 177.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.55 153.35 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.988 1.315 . . . . 0.0 112.231 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 18.7 tp60 -115.01 -48.6 2.82 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.1 170.27 20.36 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -176.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 7.9 mt -127.21 138.57 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.087 2.155 . . . . 0.0 108.396 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 16.8 m -133.87 150.09 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.52 1.128 . . . . 0.0 112.215 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 74.6 mt -68.56 99.85 1.04 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.849 0.86 . . . . 0.0 109.57 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 12.1 m -99.4 116.52 31.74 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.059 1.344 . . . . 0.0 114.271 -173.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -102.65 170.45 8.01 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.437 1.895 . . . . 0.0 111.921 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -136.25 157.91 74.63 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.793 1.637 . . . . 0.0 112.132 -176.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 CA--C 1.538 0.69 0 C-N-CA 123.347 2.698 . . . . 0.0 112.478 179.789 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo . . . . . 0 CA--C 1.543 0.959 0 N-CA-C 114.857 1.061 . . . . 0.0 114.857 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.69 -179.74 0.4 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.131 1.372 . . . . 0.0 114.359 176.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 19.3 m -131.06 -4.56 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 3.5 mt -121.63 -62.65 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 120.947 1.703 . . . . 0.0 113.677 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 31.4 p -70.61 -67.83 0.47 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 -174.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -140.98 -10.05 1.0 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 116.825 2.158 . . . . 0.0 116.825 -172.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 85.16 33.93 16.15 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 119.64 1.109 . . . . 0.0 110.759 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 44.0 mtt-85 -65.61 136.39 96.02 Favored Pre-proline 0 N--CA 1.477 0.882 0 CA-C-O 117.272 -1.347 . . . . 0.0 110.763 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -73.87 67.12 4.91 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 124.538 3.492 . . . . 0.0 111.235 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -141.75 153.4 44.57 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 128.508 2.723 . . . . 0.0 111.423 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -128.09 120.57 27.69 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.9 1.68 . . . . 0.0 111.8 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -136.04 70.8 0.49 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.652 1.596 . . . . 0.0 111.176 178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 51.0 t -54.65 123.09 12.13 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.196 1.398 . . . . 0.0 110.49 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.32 138.16 20.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 124.937 1.295 . . . . 0.0 109.801 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 96.0 t -129.97 130.48 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.78 0.832 . . . . 0.0 110.254 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.13 105.03 8.85 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 128.603 2.761 . . . . 0.0 110.76 176.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 65.84 -93.75 0.19 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.868 1.699 . . . . 0.0 114.147 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -120.69 -0.14 10.27 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.457 1.903 . . . . 0.0 113.529 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 36.1 p -124.42 165.23 18.11 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.71 2.004 . . . . 0.0 110.638 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -158.81 169.57 35.17 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 120.985 -1.072 . . . . 0.0 113.908 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -120.33 138.67 53.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.619 1.968 . . . . 0.0 113.227 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.7 pp -120.74 153.32 37.15 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.813 2.045 . . . . 0.0 112.352 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 30.1 ttm 108.66 -7.35 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 131.08 3.752 . . . . 0.0 114.441 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -99.96 154.63 18.23 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.903 -1.123 . . . . 0.0 111.557 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 30.4 p -84.6 175.1 9.47 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 123.344 1.545 . . . . 0.0 113.594 178.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.41 -28.35 69.72 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.791 174.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 83.7 m -72.2 -51.02 23.06 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.567 1.076 . . . . 0.0 110.253 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 67.9 m -49.66 -54.8 16.5 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.662 1.185 . . . . 0.0 110.386 173.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.37 -49.46 76.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.209 1.403 . . . . 0.0 112.931 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -60.0 -40.07 87.95 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.952 1.301 . . . . 0.0 112.168 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -61.72 -52.98 62.06 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.38 1.072 . . . . 0.0 110.978 176.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 44.9 mt -52.22 -49.93 62.98 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.184 0.993 . . . . 0.0 110.107 175.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -54.14 49.54 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.988 1.315 . . . . 0.0 112.681 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -54.86 -43.54 73.18 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.903 1.681 . . . . 0.0 112.281 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -78.88 -6.93 57.35 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.835 2.054 . . . . 0.0 113.366 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 62.4 t30 49.4 42.55 22.5 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 128.521 2.729 . . . . 0.0 112.082 -175.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -75.47 117.04 60.32 Favored Pre-proline 0 N--CA 1.47 0.539 0 C-N-CA 125.552 1.541 . . . . 0.0 113.116 -176.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.9 130.93 21.34 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.106 1.871 . . . . 0.0 108.834 171.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 41.5 t -33.0 125.53 0.41 Allowed Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 128.298 2.639 . . . . 0.0 114.168 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -66.88 -1.45 6.05 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 123.112 2.541 . . . . 0.0 114.307 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.67 -59.14 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.698 1.599 . . . . 0.0 111.346 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 81.8 m -76.83 -14.39 59.91 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.364 1.866 . . . . 0.0 113.027 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . 0.304 14.7 ptm180 55.23 13.43 0.85 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 128.496 2.718 . . . . 0.0 115.108 -175.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -89.53 144.33 31.89 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 123.938 0.895 . . . . 0.0 112.294 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -68.71 122.32 9.26 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.158 2.572 . . . . 0.0 109.442 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 1.8 pt -64.89 137.76 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 O-C-N 121.661 -0.649 . . . . 0.0 112.132 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -115.2 -33.74 5.24 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 117.234 2.309 . . . . 0.0 117.234 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -143.27 152.18 41.4 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.82 0.848 . . . . 0.0 113.236 -171.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 5.1 mt -141.03 131.04 26.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 127.649 2.38 . . . . 0.0 109.038 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 27.7 m -140.12 150.13 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.985 1.314 . . . . 0.0 111.928 176.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 2.2 tt -66.1 105.9 1.49 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.569 1.148 . . . . 0.0 108.273 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.2 96.58 7.3 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -171.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -74.02 171.47 13.43 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.086 1.754 . . . . 0.0 113.295 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -132.78 168.19 19.11 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 127.554 2.342 . . . . 0.0 110.474 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo . . . . . 0 C--N 1.352 0.758 0 C-N-CA 124.425 3.417 . . . . 0.0 113.983 -178.84 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . 0.278 87.9 Cg_exo . . . . . 0 CA--C 1.553 1.462 0 N-CA-C 117.477 2.068 . . . . 0.0 117.477 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 28.4 t -67.06 150.67 48.88 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 121.899 2.136 . . . . 0.0 109.342 174.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 4.1 p -134.52 -1.68 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 121.221 -0.925 . . . . 0.0 113.301 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 7.2 mt -135.55 -45.66 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.057 0.943 . . . . 0.0 112.974 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.3 m -69.45 -59.49 2.95 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -173.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -152.02 -16.37 0.18 Allowed 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -175.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 80.34 17.01 74.88 Favored Glycine 0 CA--C 1.539 1.591 0 O-C-N 120.973 -1.079 . . . . 0.0 111.865 -174.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 -72.21 155.06 91.96 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 127.549 2.34 . . . . 0.0 112.607 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.0 71.05 5.14 Favored 'Trans proline' 0 CA--C 1.55 1.29 0 C-N-CA 123.929 3.086 . . . . 0.0 113.363 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -129.32 143.17 50.74 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 127.959 2.504 . . . . 0.0 108.842 176.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -128.02 150.27 50.0 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.115 1.366 . . . . 0.0 112.593 -176.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -151.12 80.39 0.19 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 128.076 2.751 . . . . 0.0 109.201 178.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 42.2 t -63.55 119.09 9.15 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.505 1.122 . . . . 0.0 110.794 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -102.07 141.71 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.768 1.227 . . . . 0.0 111.745 -177.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 90.0 t -130.08 133.53 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.778 1.231 . . . . 0.0 111.931 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -124.99 95.03 4.35 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.53 2.732 . . . . 0.0 110.685 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.4 -97.74 0.41 Allowed Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.73 1.633 . . . . 0.0 114.561 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -107.86 -2.71 19.63 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 126.224 1.81 . . . . 0.0 113.168 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 51.0 p -132.25 170.01 15.64 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.124 1.77 . . . . 0.0 110.808 -178.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -161.26 175.99 37.84 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.201 1.381 . . . . 0.0 112.233 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -120.29 142.58 48.96 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.754 1.222 . . . . 0.0 113.927 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 4.6 pp -111.32 153.25 26.23 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.522 1.929 . . . . 0.0 112.0 175.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 459' ' ' MET . . . . . . . . . . . . 0.253 25.2 mmt 70.42 68.94 0.2 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 128.08 2.552 . . . . 0.0 114.996 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -154.23 138.52 16.63 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 128.659 2.784 . . . . 0.0 106.757 171.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 6.3 p -77.57 172.33 13.53 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 120.224 1.375 . . . . 0.0 112.127 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.36 -44.95 95.28 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.648 -0.657 . . . . 0.0 111.117 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 29.2 m -62.67 -44.37 96.42 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 116.664 -1.636 . . . . 0.0 111.375 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 35.5 m -48.1 -69.97 0.11 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 120.704 1.593 . . . . 0.0 110.541 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -50.33 -49.12 54.77 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.526 1.53 . . . . 0.0 112.539 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -57.13 -42.5 81.03 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.602 0.761 . . . . 0.0 112.49 177.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -61.51 -45.49 93.97 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.815 1.246 . . . . 0.0 111.746 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.1 -46.92 84.71 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 174.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 43.5 tptt -57.35 -46.21 83.55 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.004 0.922 . . . . 0.0 112.204 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -61.07 -34.01 74.23 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.001 1.32 . . . . 0.0 112.326 174.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -81.82 0.72 38.11 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.663 1.985 . . . . 0.0 113.407 175.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 84.11 -2.28 1.05 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 131.242 3.817 . . . . 0.0 115.516 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 5.8 tppp? -79.55 130.26 68.68 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 119.815 1.189 . . . . 0.0 109.366 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.34 -92.74 0.01 OUTLIER 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 123.375 2.717 . . . . 0.0 112.22 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 43.7 t -65.8 130.36 94.47 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 124.477 1.111 . . . . 0.0 112.532 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.55 -1.67 11.38 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 123.255 2.636 . . . . 0.0 114.062 177.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 32.8 t -122.01 -72.1 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 119.972 1.26 . . . . 0.0 113.359 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 29.8 p -92.87 -9.27 40.85 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -175.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 77.55 12.85 1.95 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 128.518 2.727 . . . . 0.0 115.138 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -64.9 156.93 78.15 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 124.606 1.163 . . . . 0.0 112.049 175.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.99 100.34 1.2 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.035 3.157 . . . . 0.0 113.284 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 pp -79.09 155.76 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.651 1.181 . . . . 0.0 112.355 179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -115.02 -26.92 7.53 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.845 1.258 . . . . 0.0 113.756 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.95 164.81 33.08 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.473 1.109 . . . . 0.0 113.914 -177.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 14.2 mt -132.6 132.43 59.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 128.444 2.698 . . . . 0.0 106.359 173.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 24.0 m -134.74 150.2 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 64.3 tp -73.05 99.91 2.87 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.19 1.796 . . . . 0.0 108.624 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 2.5 t -93.21 163.94 13.43 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -135.59 177.76 7.57 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.671 2.388 . . . . 0.0 110.942 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -124.34 157.97 62.86 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 125.306 1.443 . . . . 0.0 111.387 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 C--N 1.351 0.675 0 C-N-CA 123.111 2.541 . . . . 0.0 111.455 -179.646 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo . . . . . 0 CA--C 1.539 0.759 0 CA-C-O 117.175 -1.261 . . . . 0.0 113.668 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 27.5 t -55.25 143.33 28.35 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 120.876 1.671 . . . . 0.0 110.18 173.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 32.6 m -121.23 -14.69 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 9.9 pt -137.09 -26.17 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 -178.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.2 m -77.67 -59.64 2.7 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 120.549 1.522 . . . . 0.0 112.512 -176.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -151.88 -15.53 0.19 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -176.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.89 9.47 84.39 Favored Glycine 0 CA--C 1.541 1.714 0 CA-C-N 119.946 1.248 . . . . 0.0 112.544 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -56.56 155.07 14.93 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 129.427 3.091 . . . . 0.0 113.616 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -72.43 2.93 4.58 Favored 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 124.91 3.74 . . . . 0.0 115.817 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -59.05 142.95 49.97 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.887 2.075 . . . . 0.0 111.62 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -128.1 122.45 32.07 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.371 1.469 . . . . 0.0 112.73 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -138.97 75.21 0.38 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.46 1.981 . . . . 0.0 110.516 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 31.4 t -62.85 138.29 58.49 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.017 0.909 . . . . 0.0 110.282 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 1.4 mp -109.09 142.03 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 125.317 1.447 . . . . 0.0 109.928 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 96.0 t -124.12 131.92 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.293 1.037 . . . . 0.0 110.288 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -123.08 100.06 6.68 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 129.02 2.928 . . . . 0.0 110.725 177.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.97 -93.5 0.27 Allowed Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.914 1.721 . . . . 0.0 113.783 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -120.63 4.71 10.6 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.463 1.905 . . . . 0.0 114.061 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 60.5 p -132.58 170.12 15.63 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.701 2.0 . . . . 0.0 110.417 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -151.24 174.19 30.51 Favored Glycine 0 CA--C 1.528 0.845 0 O-C-N 120.925 -1.109 . . . . 0.0 113.799 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.28 108.14 13.81 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.982 1.713 . . . . 0.0 111.741 174.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 48.3 tp -92.01 153.07 19.67 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.075 2.15 . . . . 0.0 110.153 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 21.9 ttt 80.31 67.58 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.588 2.355 . . . . 0.0 111.778 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -159.87 147.67 16.88 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 129.705 3.202 . . . . 0.0 107.353 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 17.9 p -84.33 173.64 10.78 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 122.447 1.118 . . . . 0.0 111.457 175.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -34.19 77.32 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.134 177.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 22.2 m -70.4 -45.87 65.12 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 117.086 -1.435 . . . . 0.0 110.687 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 41.1 m -50.79 -53.76 29.23 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 120.946 1.703 . . . . 0.0 110.143 173.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -59.77 -40.29 87.75 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.412 1.485 . . . . 0.0 113.065 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -68.09 -40.98 82.54 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.85 -1.156 . . . . 0.0 111.182 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -60.23 -54.15 49.19 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.352 1.461 . . . . 0.0 112.135 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.1 pp -58.18 -36.63 73.35 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 118.923 0.783 . . . . 0.0 111.309 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -65.24 -49.96 67.63 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.768 1.627 . . . . 0.0 111.35 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -58.88 -39.57 81.8 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.956 1.302 . . . . 0.0 111.967 177.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -73.5 0.15 13.31 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 126.468 1.907 . . . . 0.0 113.506 175.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 55.5 t30 61.46 24.01 14.18 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 128.298 2.639 . . . . 0.0 113.949 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -79.42 133.64 59.64 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.455 1.102 . . . . 0.0 108.904 177.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -65.41 -68.25 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.586 2.191 . . . . 0.0 108.927 176.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 34.1 t -143.01 125.13 8.68 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 127.511 2.325 . . . . 0.0 109.315 174.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.54 -2.26 11.89 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.105 2.537 . . . . 0.0 113.382 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 25.4 t -111.18 -64.41 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.978 1.311 . . . . 0.0 112.234 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 27.9 p -109.89 2.5 19.87 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.244 1.418 . . . . 0.0 114.786 -177.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 63.48 7.98 3.3 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 128.061 2.544 . . . . 0.0 116.518 175.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -67.28 135.73 93.5 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-N 119.097 0.862 . . . . 0.0 110.649 176.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.73 115.56 4.14 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.409 2.739 . . . . 0.0 113.423 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.9 pp -70.61 151.38 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 125.286 1.434 . . . . 0.0 114.047 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -115.0 -44.2 3.05 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.842 2.057 . . . . 0.0 113.448 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.41 166.79 31.55 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -175.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 10.1 mt -133.76 136.37 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 128.646 2.778 . . . . 0.0 107.789 176.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 19.5 m -140.02 150.16 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.64 102.56 0.93 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 7.1 m -94.73 95.65 8.87 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -173.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -75.0 156.68 36.0 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.977 1.311 . . . . 0.0 112.685 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -86.06 164.89 37.03 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 125.708 1.603 . . . . 0.0 111.819 177.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo . . . . . 0 C--N 1.353 0.801 0 C-N-CA 124.2 3.267 . . . . 0.0 114.598 -179.61 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo . . . . . 0 CA--C 1.542 0.887 0 N-CA-C 117.379 2.03 . . . . 0.0 117.379 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 16.2 t -55.99 161.85 2.14 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 128.951 2.9 . . . . 0.0 111.319 172.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 18.8 m -129.65 -14.98 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 10.5 pt -137.29 -26.74 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.7 m -76.17 -57.8 3.66 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 120.646 1.566 . . . . 0.0 111.936 -178.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -149.0 -18.98 0.3 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 80.69 11.14 84.33 Favored Glycine 0 CA--C 1.54 1.603 0 O-C-N 120.959 -1.088 . . . . 0.0 113.366 -176.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -69.53 155.1 94.15 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 127.976 2.51 . . . . 0.0 113.548 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -52.54 -9.03 0.48 Allowed 'Trans proline' 0 CA--C 1.545 1.043 1 C-N-CA 125.965 4.443 . . . . 0.0 119.309 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -58.41 141.43 51.52 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 120.227 1.376 . . . . 0.0 111.569 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.18 150.14 50.14 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.021 2.128 . . . . 0.0 111.777 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -159.94 85.19 0.12 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 126.262 1.887 . . . . 0.0 110.046 176.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 42.3 t -58.54 139.11 56.26 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 117.839 0.819 . . . . 0.0 111.467 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.8 mp -115.13 140.87 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.074 1.749 . . . . 0.0 109.596 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 60.0 t -127.38 136.04 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.767 0.827 . . . . 0.0 109.47 175.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -125.11 94.85 4.29 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.752 2.421 . . . . 0.0 109.818 175.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 58.78 -99.61 0.13 Allowed Glycine 0 CA--C 1.534 1.273 0 C-N-CA 126.175 1.845 . . . . 0.0 114.71 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -86.55 -19.86 28.83 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.881 1.673 . . . . 0.0 114.636 -176.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 67.6 p -133.07 170.06 15.93 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.856 1.262 . . . . 0.0 112.729 -176.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -142.36 169.19 25.54 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.575 1.083 . . . . 0.0 113.968 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.18 134.0 55.36 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.95 1.7 . . . . 0.0 112.047 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.51 153.43 31.17 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 128.999 2.92 . . . . 0.0 111.473 -179.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 459' ' ' MET . . . . . . . . . . . . 0.424 19.1 ptp 70.4 69.36 0.21 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 128.714 2.806 . . . . 0.0 113.881 -178.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -158.31 143.24 16.35 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 130.25 3.42 . . . . 0.0 105.864 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 21.8 p -79.64 174.99 11.02 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 119.787 1.176 . . . . 0.0 111.846 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -63.38 -31.39 72.53 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.421 -0.799 . . . . 0.0 110.735 176.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 25.6 m -70.46 -44.63 67.37 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 117.542 -1.218 . . . . 0.0 110.987 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 60.1 m -51.37 -53.9 31.76 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 120.426 1.466 . . . . 0.0 109.433 172.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.62 -47.12 83.08 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.566 1.547 . . . . 0.0 112.648 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.14 -40.54 94.19 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.096 1.358 . . . . 0.0 111.718 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -59.29 -55.02 40.19 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.607 1.163 . . . . 0.0 110.591 176.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 23.9 mt -51.62 -50.36 60.41 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.704 1.202 . . . . 0.0 110.109 177.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.44 -54.79 42.61 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.755 1.222 . . . . 0.0 114.153 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -60.17 -38.45 83.25 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.149 1.38 . . . . 0.0 112.584 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -82.19 -4.22 56.57 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.537 1.535 . . . . 0.0 112.902 175.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 49.07 50.71 17.48 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 129.055 2.942 . . . . 0.0 112.151 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -70.02 148.98 96.33 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.514 0.726 . . . . 0.0 112.642 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -81.95 11.86 2.99 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 124.016 3.144 . . . . 0.0 113.435 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 34.6 t 73.24 88.66 0.08 OUTLIER Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 128.493 2.717 . . . . 0.0 108.585 -173.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.75 -23.19 25.69 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.27 2.646 . . . . 0.0 114.869 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 20.1 t -73.32 -51.71 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 126.567 1.947 . . . . 0.0 113.213 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 26.1 p -128.59 0.39 5.54 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 -174.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 66.56 30.12 8.61 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 127.485 2.314 . . . . 0.0 114.841 175.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -107.48 102.87 46.47 Favored Pre-proline 0 CA--C 1.554 1.135 0 C-N-CA 126.695 1.998 . . . . 0.0 111.112 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.45 124.53 10.86 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.06 3.173 . . . . 0.0 115.235 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.4 pp -57.52 151.48 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.716 2.007 . . . . 0.0 113.327 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -115.03 -57.27 2.28 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.057 1.343 . . . . 0.0 112.018 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.64 170.22 20.78 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 4.4 mt -121.47 148.24 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.867 2.067 . . . . 0.0 108.603 175.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 6.2 m -134.48 150.18 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.808 1.643 . . . . 0.0 111.189 176.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.91 99.9 4.66 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 56.9 m -79.27 156.02 28.28 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.952 0.901 . . . . 0.0 112.545 -176.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -138.53 164.09 30.33 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.981 2.112 . . . . 0.0 110.257 178.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -124.05 168.82 11.81 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 125.944 1.698 . . . . 0.0 110.907 -178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo . . . . . 0 C--N 1.348 0.547 0 C-N-CA 123.14 2.56 . . . . 0.0 110.895 178.3 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo . . . . . 0 CA--C 1.541 0.864 0 N-CA-C 115.085 1.148 . . . . 0.0 115.085 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 438' ' ' CYS . . . . . 0.4 ' SG ' ' N ' ' B' ' 439' ' ' VAL . 21.3 t -68.17 -175.95 0.66 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.969 1.708 . . . . 0.0 112.506 174.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 439' ' ' VAL . . . . . 0.4 ' N ' ' SG ' ' B' ' 438' ' ' CYS . 6.0 p -141.84 -1.66 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.481 1.513 . . . . 0.0 114.193 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 19.4 mt -118.74 -65.78 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 120.072 1.305 . . . . 0.0 113.393 -176.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 22.8 p -52.67 -74.69 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -141.0 -11.34 0.98 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.571 2.348 . . . . 0.0 113.311 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 79.61 30.69 43.39 Favored Glycine 0 CA--C 1.536 1.364 0 O-C-N 121.556 -0.715 . . . . 0.0 112.634 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -69.73 155.05 94.19 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.737 1.615 . . . . 0.0 111.95 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.89 -2.19 0.32 Allowed 'Trans proline' 0 CA--C 1.549 1.257 1 C-N-CA 125.778 4.319 . . . . 0.0 118.982 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -73.26 142.43 47.23 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.5 1.52 . . . . 0.0 111.861 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.31 149.98 50.27 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.335 1.854 . . . . 0.0 111.692 174.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -160.14 84.73 0.12 Allowed Glycine 0 CA--C 1.53 0.978 0 C-N-CA 126.453 1.977 . . . . 0.0 111.295 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 33.3 t -61.26 137.09 58.24 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.914 0.886 . . . . 0.0 111.402 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.07 147.19 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 126.215 1.806 . . . . 0.0 110.427 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 33.7 t -127.51 138.48 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.151 0.98 . . . . 0.0 110.527 175.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -125.05 95.02 4.34 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 128.868 2.867 . . . . 0.0 109.935 175.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.53 -93.36 0.37 Allowed Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.824 1.678 . . . . 0.0 113.804 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -117.48 -0.31 11.96 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 126.408 1.883 . . . . 0.0 113.532 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 47.4 p -127.13 170.06 12.77 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.469 1.908 . . . . 0.0 110.15 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -159.09 170.93 35.55 Favored Glycine 0 N--CA 1.468 0.772 0 O-C-N 120.592 -1.317 . . . . 0.0 114.062 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.02 139.15 52.94 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.264 1.425 . . . . 0.0 112.01 178.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 56.0 tp -130.02 153.2 48.66 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.737 2.415 . . . . 0.0 110.995 -176.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 28.1 ttm 95.21 29.16 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 129.061 2.944 . . . . 0.0 113.783 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -133.14 151.38 51.99 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.629 1.972 . . . . 0.0 109.556 176.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 22.3 p -75.43 168.86 19.19 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 122.881 1.324 . . . . 0.0 113.312 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.21 -35.18 80.27 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.919 177.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 19.7 m -64.14 -52.9 56.9 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.89 176.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 18.1 m -53.51 -52.89 58.16 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.727 1.149 . . . . 0.0 111.239 175.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -51.85 -41.39 61.8 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.267 1.427 . . . . 0.0 112.669 173.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -69.93 -27.35 64.69 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.045 1.338 . . . . 0.0 113.266 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -57.54 -42.28 82.65 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 120.18 1.355 . . . . 0.0 111.202 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -54.56 -44.54 73.01 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.957 1.303 . . . . 0.0 110.099 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -66.06 -50.29 64.67 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.451 0.7 . . . . 0.0 111.444 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -53.45 -41.63 66.31 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.419 1.488 . . . . 0.0 113.758 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -99.33 11.32 39.43 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.424 1.49 . . . . 0.0 114.845 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 63.3 t30 47.89 60.66 3.41 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.212 2.205 . . . . 0.0 113.803 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -121.58 143.35 37.78 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 128.693 2.797 . . . . 0.0 108.985 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.92 -85.23 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.19 0 C-N-CA 122.798 2.332 . . . . 0.0 112.853 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 5.7 t -127.02 140.37 37.63 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 127.01 2.124 . . . . 0.0 111.328 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.54 -5.56 16.69 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.514 2.809 . . . . 0.0 114.412 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 55.1 t -119.32 -74.22 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.736 1.153 . . . . 0.0 112.602 -177.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 24.6 p -93.85 0.6 56.3 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.611 1.564 . . . . 0.0 114.007 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 58.71 14.62 3.25 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 128.193 2.597 . . . . 0.0 115.892 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -68.58 138.99 91.28 Favored Pre-proline 0 CA--C 1.552 1.034 0 CA-C-N 119.244 0.929 . . . . 0.0 110.645 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.75 113.05 2.61 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.562 2.842 . . . . 0.0 113.757 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.6 pp -69.16 159.34 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.357 1.463 . . . . 0.0 113.758 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -115.12 -56.83 2.33 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.991 2.116 . . . . 0.0 111.243 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.96 170.21 19.9 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.568 1.147 . . . . 0.0 113.51 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 10.5 mt -118.25 138.11 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 127.62 2.368 . . . . 0.0 106.191 174.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 14.7 p -129.02 147.19 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 119.382 0.992 . . . . 0.0 113.497 -177.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.3 99.92 1.63 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.979 1.311 . . . . 0.0 107.876 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 6.0 t -98.87 155.17 17.52 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -144.56 167.17 23.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.395 1.878 . . . . 0.0 111.269 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -123.36 153.34 65.4 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 125.333 1.453 . . . . 0.0 111.689 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 C--N 1.351 0.693 0 C-N-CA 123.592 2.861 . . . . 0.0 111.546 -179.063 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo . . . . . 0 CA--C 1.552 1.415 0 CA-C-O 119.175 -0.427 . . . . 0.0 112.042 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 23.0 t -63.59 154.86 31.4 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 119.747 1.158 . . . . 0.0 110.154 174.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 31.0 m -129.43 -14.61 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 10.4 pt -137.08 -26.4 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.4 m -73.68 -60.76 2.1 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 120.921 1.691 . . . . 0.0 112.051 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -153.54 -13.85 0.15 Allowed 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -176.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 80.08 8.9 87.23 Favored Glycine 0 CA--C 1.541 1.682 0 O-C-N 120.747 -1.221 . . . . 0.0 112.853 -175.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -62.17 155.01 67.55 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 128.175 2.59 . . . . 0.0 113.415 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.03 75.22 3.78 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 124.143 3.229 . . . . 0.0 113.611 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -135.02 148.01 49.81 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.994 2.518 . . . . 0.0 109.218 176.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -128.05 148.09 50.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.013 0.925 . . . . 0.0 111.367 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -159.1 86.62 0.12 Allowed Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.872 1.701 . . . . 0.0 112.822 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 49.3 t -68.63 136.2 52.62 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.896 0.848 . . . . 0.0 110.115 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.0 140.32 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.811 1.244 . . . . 0.0 111.448 -178.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 93.3 t -126.89 131.4 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.138 1.375 . . . . 0.0 111.742 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -114.23 94.98 5.05 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 128.608 2.763 . . . . 0.0 109.727 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.82 -91.41 0.42 Allowed Glycine 0 CA--C 1.535 1.29 0 C-N-CA 126.218 1.866 . . . . 0.0 113.97 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -121.93 5.11 9.91 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 126.506 1.922 . . . . 0.0 113.494 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 74.6 p -135.6 170.06 16.55 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.018 2.127 . . . . 0.0 109.823 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -160.14 179.18 35.84 Favored Glycine 0 N--CA 1.47 0.908 0 O-C-N 120.538 -1.351 . . . . 0.0 114.45 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -120.41 133.87 55.36 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.239 1.415 . . . . 0.0 113.849 174.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -110.16 153.26 24.99 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.596 1.558 . . . . 0.0 111.487 173.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 41.8 ttm 99.73 60.0 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 129.825 3.25 . . . . 0.0 112.487 177.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -160.05 158.31 30.22 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.306 1.842 . . . . 0.0 110.936 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 13.7 p -88.71 175.07 7.67 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 122.441 1.115 . . . . 0.0 111.63 173.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -37.16 84.3 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.028 -1.045 . . . . 0.0 110.672 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 26.6 m -63.21 -49.69 73.19 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 117.18 -1.391 . . . . 0.0 109.847 176.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 60.0 m -47.12 -56.23 6.95 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 120.35 1.432 . . . . 0.0 110.291 173.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -56.85 -47.3 80.69 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.905 1.682 . . . . 0.0 114.398 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -74.4 -31.64 62.4 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 120.055 1.298 . . . . 0.0 112.682 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -62.63 -55.5 26.49 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.897 1.679 . . . . 0.0 110.942 177.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 2.3 pp -59.0 -37.88 77.89 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 117.8 0.273 . . . . 0.0 111.131 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -63.11 -49.3 74.96 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.121 1.368 . . . . 0.0 111.759 176.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -58.0 -39.6 78.66 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.598 1.559 . . . . 0.0 111.561 176.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -76.0 5.56 6.45 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 127.078 2.151 . . . . 0.0 113.866 175.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 45.3 t30 65.21 18.72 11.53 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 128.771 2.828 . . . . 0.0 115.438 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -70.13 130.04 90.07 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 120.821 -1.174 . . . . 0.0 108.82 175.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.77 -51.3 0.93 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.772 2.315 . . . . 0.0 111.695 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 3.4 t -153.85 140.08 12.6 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 129.375 3.07 . . . . 0.0 108.019 174.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -71.29 -6.37 19.03 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.261 2.641 . . . . 0.0 114.583 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 46.4 t -125.08 -70.86 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 119.829 1.195 . . . . 0.0 113.404 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 24.6 p -97.13 3.62 51.58 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.803 1.641 . . . . 0.0 114.797 -175.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 59.62 20.21 8.81 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 127.763 2.425 . . . . 0.0 116.054 175.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -81.04 115.99 59.65 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 124.544 1.138 . . . . 0.0 109.376 175.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -47.32 108.32 0.16 Allowed 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 124.373 3.382 . . . . 0.0 117.264 -175.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.0 pp -66.41 134.52 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 126.124 1.77 . . . . 0.0 112.14 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -115.24 -16.61 11.5 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.55 1.54 . . . . 0.0 115.026 -176.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 1.8 ttp -150.32 148.17 28.51 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.122 0.969 . . . . 0.0 113.021 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 14.4 mt -131.99 139.42 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 127.363 2.265 . . . . 0.0 107.936 173.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 10.0 m -134.68 150.23 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.565 1.146 . . . . 0.0 113.403 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 63.5 tp -70.13 99.87 1.56 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 173.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 4.8 t -98.98 159.1 15.2 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -172.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -142.6 171.18 14.4 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.392 2.277 . . . . 0.0 111.606 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -138.54 156.63 73.15 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.98 1.712 . . . . 0.0 111.028 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo . . . . . 0 C--N 1.351 0.674 0 C-N-CA 123.627 2.884 . . . . 0.0 111.482 -179.61 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo . . . . . 0 CA--C 1.55 1.318 0 N-CA-C 117.361 2.024 . . . . 0.0 117.361 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 40.0 t -61.26 145.82 49.99 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 121.838 2.108 . . . . 0.0 109.684 175.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 35.3 m -123.15 -15.17 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 8.4 pt -137.66 -25.32 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.8 m -77.28 -63.64 1.32 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.656 1.571 . . . . 0.0 112.211 -176.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -144.16 -11.74 0.64 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -177.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 75.84 16.16 80.84 Favored Glycine 0 CA--C 1.545 1.914 0 CA-C-N 120.117 1.326 . . . . 0.0 112.42 -174.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -65.58 155.2 86.4 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 130.484 3.513 . . . . 0.0 113.021 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -68.96 -3.61 11.82 Favored 'Trans proline' 0 CA--C 1.546 1.089 0 C-N-CA 124.161 3.241 . . . . 0.0 115.956 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -59.35 134.7 57.25 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.341 1.456 . . . . 0.0 110.17 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -128.24 138.68 52.54 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.22 1.808 . . . . 0.0 110.344 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -139.25 83.58 0.24 Allowed Glycine 0 CA--C 1.526 0.779 0 C-N-CA 127.482 2.467 . . . . 0.0 109.761 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 50.7 t -59.4 138.52 57.63 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.01 0.924 . . . . 0.0 111.013 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.05 142.4 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 125.647 1.579 . . . . 0.0 109.478 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 14.5 t -116.81 142.31 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.325 1.05 . . . . 0.0 109.463 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -125.11 94.83 4.28 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 128.016 2.527 . . . . 0.0 107.165 175.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 60.87 -91.85 0.06 OUTLIER Glycine 0 CA--C 1.541 1.706 0 C-N-CA 124.759 1.171 . . . . 0.0 113.829 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -118.71 6.17 11.56 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 127.441 2.297 . . . . 0.0 113.514 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 41.5 p -121.74 170.21 9.97 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.629 2.372 . . . . 0.0 110.441 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -162.6 167.48 37.11 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 120.598 -1.313 . . . . 0.0 114.688 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -120.12 141.31 49.94 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.552 1.541 . . . . 0.0 113.034 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 79.8 mt -119.26 153.21 35.37 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.268 2.627 . . . . 0.0 110.959 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 20.2 mmt 76.44 65.25 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.588 2.355 . . . . 0.0 113.19 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -155.81 135.02 12.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 129.749 3.22 . . . . 0.0 105.438 172.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 13.1 p -77.22 174.72 10.42 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 120.958 1.708 . . . . 0.0 111.96 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.47 -37.22 82.82 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.59 -0.694 . . . . 0.0 111.827 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 84.7 m -72.49 -44.21 62.58 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 116.194 -1.86 . . . . 0.0 110.684 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 53.0 m -46.36 -57.33 4.72 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 121.596 1.998 . . . . 0.0 110.474 173.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.03 -52.42 65.34 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.482 1.513 . . . . 0.0 112.663 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -59.82 -38.58 82.4 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 121.091 -1.006 . . . . 0.0 113.083 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -62.19 -48.05 81.76 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.153 1.781 . . . . 0.0 111.416 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 14.5 mt -54.88 -50.73 68.02 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.894 0.878 . . . . 0.0 109.631 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -55.86 -46.5 78.2 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.155 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -58.59 -42.23 87.58 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.244 1.417 . . . . 0.0 111.725 175.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -76.35 0.45 19.45 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 127.407 2.283 . . . . 0.0 113.713 175.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 71.73 6.92 5.81 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 129.71 3.204 . . . . 0.0 115.508 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.11 135.88 47.48 Favored Pre-proline 0 CA--C 1.544 0.75 0 O-C-N 120.664 -1.272 . . . . 0.0 109.342 175.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -78.06 -110.22 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.286 0 C-N-CA 123.212 2.608 . . . . 0.0 108.78 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 15.2 t -70.7 139.64 86.22 Favored Pre-proline 0 CA--C 1.556 1.183 0 O-C-N 120.76 -1.213 . . . . 0.0 112.65 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.17 -4.23 14.57 Favored 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 123.612 2.875 . . . . 0.0 114.115 175.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 61.3 t -129.02 -68.29 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 29.6 p -88.08 -6.37 57.96 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 120.393 1.451 . . . . 0.0 113.575 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 61.27 9.18 2.39 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 128.487 2.715 . . . . 0.0 115.12 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -66.39 153.38 92.91 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-N 118.763 0.71 . . . . 0.0 111.925 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.48 119.88 6.98 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.357 2.705 . . . . 0.0 113.01 -177.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.65 159.5 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.567 1.547 . . . . 0.0 112.91 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.08 -60.72 1.85 Allowed 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.036 1.735 . . . . 0.0 110.893 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.99 170.32 21.57 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.679 1.992 . . . . 0.0 112.581 -177.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 13.2 mt -115.98 135.47 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 126.388 1.875 . . . . 0.0 108.036 174.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 15.0 m -134.3 150.0 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.578 1.151 . . . . 0.0 112.595 177.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.58 99.94 5.93 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 56.1 m -101.03 104.03 15.16 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.199 0.6 . . . . 0.0 111.313 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -78.63 172.48 13.63 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.811 2.444 . . . . 0.0 112.45 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -115.6 167.03 10.79 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 126.254 1.822 . . . . 0.0 111.787 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo . . . . . 0 C--N 1.351 0.702 0 C-N-CA 124.104 3.203 . . . . 0.0 113.785 179.352 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo . . . . . 0 CA--C 1.546 1.109 0 N-CA-C 112.672 0.22 . . . . 0.0 112.672 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 15.0 p -70.19 -179.02 1.82 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.921 1.288 . . . . 0.0 112.7 177.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.08 -3.81 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -177.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 4.7 mt -121.88 -62.42 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 120.147 1.339 . . . . 0.0 113.498 -178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . 0.256 3.6 p -66.69 -61.95 1.7 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 -173.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -154.61 -15.47 0.12 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -175.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 100.44 51.19 1.24 Allowed Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.878 1.704 . . . . 0.0 110.585 -176.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -105.75 155.0 38.93 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 125.291 1.436 . . . . 0.0 112.526 -176.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -46.62 118.8 2.8 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.252 2.635 . . . . 0.0 113.877 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 29.13 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 129.375 3.07 . . . . 0.0 118.818 -175.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.77 89.84 2.32 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 120.288 -1.507 . . . . 0.0 109.207 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 170.09 42.01 0.03 OUTLIER Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.034 1.302 . . . . 0.0 112.118 -177.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 45.4 t -49.96 121.35 5.28 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.673 1.589 . . . . 0.0 111.846 -178.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 4.4 mp -83.45 123.85 39.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 125.689 1.595 . . . . 0.0 107.718 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 96.5 t -127.08 123.15 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 121.679 0.752 . . . . 0.0 111.061 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -120.3 106.81 12.24 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 128.113 2.565 . . . . 0.0 111.393 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.65 -92.22 0.43 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.749 1.642 . . . . 0.0 113.934 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -127.06 4.44 6.47 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.574 1.95 . . . . 0.0 113.183 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 60.1 p -133.53 170.15 15.94 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.32 1.848 . . . . 0.0 110.668 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -159.26 173.91 36.13 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.326 0.965 . . . . 0.0 113.301 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -120.11 131.82 55.19 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.899 1.28 . . . . 0.0 112.784 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 1.9 tt -92.85 153.27 18.93 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 129.487 3.115 . . . . 0.0 112.133 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 16.0 ttp 86.5 31.07 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.964 2.506 . . . . 0.0 117.213 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -139.28 135.01 33.39 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.018 1.327 . . . . 0.0 108.801 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 26.3 p -79.59 175.01 11.0 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 123.051 1.405 . . . . 0.0 114.317 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.24 -41.06 78.84 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.678 1.191 . . . . 0.0 111.869 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 78.8 m -60.8 -53.0 62.66 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.721 1.208 . . . . 0.0 110.358 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 90.5 m -52.08 -53.7 39.22 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.561 1.144 . . . . 0.0 111.056 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -56.02 -50.16 71.66 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.363 1.065 . . . . 0.0 112.671 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -64.91 -38.17 90.07 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.212 1.005 . . . . 0.0 112.414 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -61.02 -52.99 62.65 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.359 1.464 . . . . 0.0 110.573 177.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 29.8 mt -51.77 -51.47 56.07 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.397 1.079 . . . . 0.0 109.782 175.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -54.22 -48.63 70.85 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.175 0.99 . . . . 0.0 112.342 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -59.86 -41.55 91.7 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.326 1.45 . . . . 0.0 111.983 175.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -75.72 -0.99 22.78 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 127.065 2.146 . . . . 0.0 113.44 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 38.9 t30 75.44 7.1 4.02 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 130.086 3.354 . . . . 0.0 115.425 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -80.89 128.7 70.56 Favored Pre-proline 0 CA--C 1.543 0.697 0 O-C-N 120.612 -1.305 . . . . 0.0 109.154 175.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.11 -87.82 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 123.326 2.684 . . . . 0.0 110.415 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 37.4 t -96.78 132.44 26.07 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.67 1.588 . . . . 0.0 111.031 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.56 -4.7 14.89 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.272 2.648 . . . . 0.0 113.794 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 24.4 t -112.46 -74.19 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 119.772 1.169 . . . . 0.0 112.634 -177.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 25.4 p -95.82 -3.64 45.23 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.422 1.489 . . . . 0.0 114.318 -177.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 67.12 10.58 7.81 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 127.75 2.42 . . . . 0.0 115.162 176.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -62.97 149.68 89.81 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 124.0 0.92 . . . . 0.0 111.663 177.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -68.77 106.89 1.56 Allowed 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.892 3.061 . . . . 0.0 113.682 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 1.5 pp -71.86 145.77 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.352 1.461 . . . . 0.0 111.405 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -115.22 -24.25 8.57 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.2 168.13 27.88 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -176.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 10.0 mt -139.29 132.49 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 128.784 2.833 . . . . 0.0 106.731 174.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.11 150.08 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 125.003 1.321 . . . . 0.0 112.153 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 64.5 mt -69.54 99.84 1.33 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.632 0.729 . . . . 0.0 109.295 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.15 112.67 25.88 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.89 1.676 . . . . 0.0 113.601 -174.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -127.83 169.05 14.33 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.903 1.281 . . . . 0.0 113.854 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -73.55 159.67 84.07 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 127.098 2.159 . . . . 0.0 112.821 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo . . . . . 0 C--N 1.351 0.698 0 C-N-CA 123.562 2.842 . . . . 0.0 111.501 178.787 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo . . . . . 0 CA--C 1.544 0.989 0 N-CA-C 113.255 0.444 . . . . 0.0 113.255 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 8.5 p -66.98 -163.32 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 126.832 2.053 . . . . 0.0 115.021 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 96.4 t -125.67 -22.72 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -174.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 2.5 mt -129.4 -56.8 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 -171.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 27.8 p -69.19 -61.97 1.57 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 -172.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -148.75 -9.09 0.36 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 116.716 2.117 . . . . 0.0 116.716 -173.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 86.59 30.56 21.14 Favored Glycine 0 CA--C 1.534 1.248 0 O-C-N 120.693 -1.254 . . . . 0.0 111.196 -175.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 44.6 mtt-85 -65.44 135.98 96.08 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 125.526 1.53 . . . . 0.0 111.388 -177.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.78 77.88 1.79 Allowed 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 123.815 3.01 . . . . 0.0 110.328 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -150.05 160.67 43.46 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.024 2.13 . . . . 0.0 113.188 -170.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -128.21 150.11 50.17 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 128.967 2.907 . . . . 0.0 111.104 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 176.45 76.92 0.05 OUTLIER Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.825 1.678 . . . . 0.0 112.323 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 19.7 t -61.55 140.69 58.08 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.934 0.894 . . . . 0.0 111.869 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 2.0 mp -109.96 140.8 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 126.257 1.823 . . . . 0.0 109.281 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 94.6 t -130.06 135.39 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.659 0.742 . . . . 0.0 110.891 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.04 100.09 6.42 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 128.192 2.597 . . . . 0.0 110.728 174.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.55 -94.14 0.27 Allowed Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.005 1.764 . . . . 0.0 114.323 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -116.9 -0.33 12.26 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.274 1.83 . . . . 0.0 113.457 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 16.5 p -129.88 166.06 20.76 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.512 1.125 . . . . 0.0 110.793 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.11 166.82 33.19 Favored Glycine 0 CA--C 1.528 0.871 0 O-C-N 121.015 -1.053 . . . . 0.0 113.976 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -115.65 116.69 28.54 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.768 2.027 . . . . 0.0 110.682 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 43.2 tp -107.97 153.1 23.56 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.516 2.327 . . . . 0.0 110.63 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 62.5 mtt 105.73 -5.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 130.92 3.688 . . . . 0.0 115.686 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -99.87 160.5 14.26 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.432 1.014 . . . . 0.0 111.305 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 21.7 p -79.64 173.45 12.58 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 123.198 1.475 . . . . 0.0 113.874 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.63 -23.62 65.37 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.612 174.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 51.4 m -73.94 -50.76 18.59 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 117.823 -1.084 . . . . 0.0 110.145 178.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 60.7 m -49.0 -53.2 21.0 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.777 1.231 . . . . 0.0 110.476 173.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.72 -49.58 76.06 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.861 1.664 . . . . 0.0 112.927 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -61.42 -40.67 95.27 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.826 -1.171 . . . . 0.0 111.655 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -62.31 -54.53 39.29 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.98 1.712 . . . . 0.0 111.328 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.3 pp -62.91 -31.84 73.0 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.71 -0.619 . . . . 0.0 112.034 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -68.29 -46.65 69.78 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.052 1.341 . . . . 0.0 112.226 175.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -58.45 -40.97 84.05 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.464 1.105 . . . . 0.0 111.503 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -74.88 -8.43 56.44 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.566 1.546 . . . . 0.0 113.118 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 50.45 41.05 24.5 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.47 2.708 . . . . 0.0 111.74 -176.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -71.73 127.56 90.72 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.385 1.474 . . . . 0.0 114.053 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.76 127.55 10.95 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.808 2.338 . . . . 0.0 107.333 169.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 40.9 t -30.62 125.44 0.3 Allowed Pre-proline 0 CA--C 1.555 1.159 0 C-N-CA 127.914 2.486 . . . . 0.0 115.2 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.1 -1.78 6.83 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.072 2.515 . . . . 0.0 114.328 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 58.4 t -124.04 -59.8 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.796 1.638 . . . . 0.0 111.17 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 85.7 m -75.11 -22.54 58.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.089 1.756 . . . . 0.0 112.766 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? 62.5 9.12 3.22 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 127.161 2.184 . . . . 0.0 113.419 -175.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -83.1 146.72 52.22 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.769 1.227 . . . . 0.0 112.266 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.67 121.94 7.44 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.18 2.587 . . . . 0.0 110.375 175.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.4 pp -61.05 144.12 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.22 1.008 . . . . 0.0 111.369 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -115.02 -38.87 3.77 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.75 165.85 35.3 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 8.2 mt -135.36 135.83 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.674 2.389 . . . . 0.0 108.475 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 20.0 m -140.01 150.05 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.126 0.97 . . . . 0.0 113.312 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.95 100.0 1.89 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 36.5 m -96.64 88.95 4.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.794 1.237 . . . . 0.0 111.483 -174.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -61.81 129.05 39.16 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.946 1.698 . . . . 0.0 112.892 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -47.71 -40.48 30.68 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 118.817 2.895 . . . . 0.0 118.817 -176.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo . . . . . 0 C--N 1.355 0.896 0 C-N-CA 123.979 3.119 . . . . 0.0 115.028 -178.256 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 CA--C 1.544 1.02 0 N-CA-C 117.417 2.045 . . . . 0.0 117.417 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 11.2 t -50.53 153.21 1.68 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 128.323 2.649 . . . . 0.0 111.892 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 22.0 m -135.35 -0.37 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.656 1.183 . . . . 0.0 113.708 178.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 8.2 mt -128.73 -48.18 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 119.565 1.075 . . . . 0.0 112.255 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 441' ' ' CYS . . . . . 0.434 ' CB ' HH12 ' A' ' 444' ' ' ARG . 1.9 m -71.2 -68.93 0.41 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -173.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -146.55 -11.39 0.46 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.313 1.598 . . . . 0.0 115.313 -173.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.5 16.78 70.19 Favored Glycine 0 CA--C 1.541 1.717 0 CA-C-N 119.836 1.198 . . . . 0.0 113.051 -175.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . 0.434 HH12 ' CB ' ' A' ' 441' ' ' CYS . 11.8 ptp85 -57.47 154.3 24.49 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 127.22 2.208 . . . . 0.0 112.499 178.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.18 -10.23 26.53 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 123.807 3.005 . . . . 0.0 116.388 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -59.39 147.52 35.97 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.201 1.4 . . . . 0.0 112.05 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -128.33 150.16 50.2 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.21 2.604 . . . . 0.0 111.667 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -168.44 86.35 0.09 OUTLIER Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.252 1.882 . . . . 0.0 112.517 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 47.7 t -60.4 142.94 54.3 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.686 1.194 . . . . 0.0 110.862 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 mp -115.0 132.21 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.578 1.551 . . . . 0.0 109.595 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 69.6 t -115.56 129.05 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.337 1.055 . . . . 0.0 108.591 176.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -125.08 94.95 4.32 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.184 2.194 . . . . 0.0 112.74 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 77.06 -77.77 1.48 Allowed Glycine 0 CA--C 1.535 1.284 0 C-N-CA 126.048 1.785 . . . . 0.0 113.899 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -135.22 -10.17 2.24 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.36 1.864 . . . . 0.0 113.754 -178.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 42.1 p -122.61 170.07 10.39 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.418 2.287 . . . . 0.0 110.084 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -157.33 170.19 34.45 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.893 -1.129 . . . . 0.0 114.186 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -119.99 145.19 47.02 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.619 1.968 . . . . 0.0 112.231 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 35.3 tp -121.71 153.07 38.69 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.832 2.053 . . . . 0.0 109.962 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 25.1 ttt 82.44 68.97 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 128.483 2.713 . . . . 0.0 112.42 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -160.12 151.08 19.09 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 129.169 2.987 . . . . 0.0 107.192 175.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 23.0 p -85.89 174.99 8.89 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 122.397 1.094 . . . . 0.0 111.195 175.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -63.37 -33.68 76.07 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.482 -0.761 . . . . 0.0 110.726 177.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 21.3 m -68.28 -48.52 64.78 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 117.39 -1.29 . . . . 0.0 110.655 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 31.4 m -48.33 -54.72 12.82 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 120.373 1.442 . . . . 0.0 110.007 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -59.8 -43.31 94.53 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.633 1.573 . . . . 0.0 113.12 177.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -64.61 -40.97 96.43 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.752 -1.217 . . . . 0.0 111.631 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -59.67 -55.41 34.75 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.151 1.38 . . . . 0.0 110.921 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.4 pp -62.46 -32.75 73.67 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -69.58 -43.66 72.38 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.826 1.25 . . . . 0.0 113.069 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -54.8 -38.79 67.76 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.713 1.605 . . . . 0.0 111.868 177.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -91.76 -0.2 57.53 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.566 1.946 . . . . 0.0 113.331 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 64.8 t30 47.74 45.84 18.27 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 128.429 2.692 . . . . 0.0 112.627 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm -70.12 126.39 92.38 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.159 1.384 . . . . 0.0 113.148 -177.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.89 129.29 12.3 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 122.843 2.362 . . . . 0.0 107.91 170.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 53.6 t -31.94 123.89 0.37 Allowed Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 127.337 2.255 . . . . 0.0 114.655 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.51 -1.68 7.0 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.2 2.6 . . . . 0.0 114.136 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 48.2 t -122.6 -60.96 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.913 1.685 . . . . 0.0 111.002 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 86.0 m -76.54 -19.13 58.25 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.468 1.907 . . . . 0.0 113.319 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 62.29 6.78 1.99 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 127.18 2.192 . . . . 0.0 113.81 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -75.67 146.27 79.88 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 125.843 1.657 . . . . 0.0 113.382 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -78.02 120.19 4.93 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 124.159 3.239 . . . . 0.0 111.656 177.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.5 pp -63.09 141.48 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.055 0.942 . . . . 0.0 112.785 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -115.1 -45.64 2.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.462 1.505 . . . . 0.0 114.495 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.52 169.1 25.43 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -173.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 4.7 mt -133.65 143.43 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 128.453 2.701 . . . . 0.0 108.451 175.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 15.4 m -139.95 150.17 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.957 1.703 . . . . 0.0 111.214 177.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.33 99.95 2.05 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 176.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.94 102.39 14.75 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.364 1.066 . . . . 0.0 110.757 -176.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -72.53 143.13 48.44 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.656 1.182 . . . . 0.0 112.41 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -66.42 166.81 15.28 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 126.126 1.77 . . . . 0.0 112.201 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo . . . . . 0 C--N 1.354 0.819 0 C-N-CA 124.136 3.224 . . . . 0.0 114.398 -179.302 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 CA--C 1.549 1.24 0 N-CA-C 113.09 0.381 . . . . 0.0 113.09 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 12.5 t -56.41 173.03 0.19 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.002 1.721 . . . . 0.0 113.607 177.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.37 1.82 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 -175.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 15.0 mt -121.73 -60.99 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 120.39 1.45 . . . . 0.0 113.016 -177.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 12.9 p -54.34 -78.49 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.528 1.531 . . . . 0.0 114.607 -177.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -150.63 -12.86 0.24 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 127.34 2.256 . . . . 0.0 113.19 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 96.73 45.74 2.63 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.388 0.995 . . . . 0.0 113.187 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -84.33 155.34 63.18 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 126.095 1.758 . . . . 0.0 111.265 175.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -39.96 125.37 1.65 Allowed 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.716 3.611 . . . . 0.0 114.541 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -67.37 63.97 0.07 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.977 2.911 . . . . 0.0 113.5 -177.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -109.09 89.82 3.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.585 1.154 . . . . 0.0 108.034 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 164.66 51.58 0.02 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.155 0.884 . . . . 0.0 112.85 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 42.5 t -61.32 141.45 57.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.31 1.055 . . . . 0.0 109.887 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.11 137.79 47.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 125.717 1.607 . . . . 0.0 110.104 -174.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 83.0 t -126.52 128.81 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.006 0.923 . . . . 0.0 112.116 -177.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -111.31 94.89 5.2 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.713 2.805 . . . . 0.0 109.318 173.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.31 -96.02 0.32 Allowed Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.657 1.599 . . . . 0.0 114.186 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -112.51 0.93 15.67 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.374 1.87 . . . . 0.0 113.565 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 49.4 p -132.15 170.04 15.56 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.959 1.704 . . . . 0.0 110.515 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -161.18 177.19 37.62 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 120.615 -1.303 . . . . 0.0 113.573 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -120.29 140.19 51.61 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.479 1.512 . . . . 0.0 112.333 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.9 92.87 3.89 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.925 1.29 . . . . 0.0 112.13 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.58 -13.59 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 119.073 2.99 . . . . 0.0 119.073 -178.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -129.52 165.42 21.7 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 119.799 1.181 . . . . 0.0 114.041 -174.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 29.8 p -78.78 168.8 19.21 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 122.541 1.162 . . . . 0.0 111.376 175.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.4 -39.4 79.6 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.36 -0.838 . . . . 0.0 112.069 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 62.6 m -60.55 -55.94 27.37 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.108 0.963 . . . . 0.0 110.025 178.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 62.8 m -57.41 -45.15 84.91 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.191 0.996 . . . . 0.0 112.087 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.55 -39.88 81.46 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.024 1.329 . . . . 0.0 112.99 174.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -71.97 -39.35 69.38 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.101 1.36 . . . . 0.0 111.16 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -56.52 -54.49 45.27 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.582 1.153 . . . . 0.0 111.965 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . 0.315 0.0 OUTLIER -63.19 -27.25 69.23 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.547 1.067 . . . . 0.0 113.317 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -70.1 -45.11 67.62 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.413 1.485 . . . . 0.0 110.275 175.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -61.31 -35.76 78.27 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.929 1.292 . . . . 0.0 111.672 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -76.93 -1.17 27.23 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 126.451 1.9 . . . . 0.0 113.338 174.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 51.8 t30 65.18 22.01 12.18 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 128.918 2.887 . . . . 0.0 114.966 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -72.56 137.22 80.58 Favored Pre-proline 0 CA--C 1.544 0.735 0 O-C-N 120.969 -1.082 . . . . 0.0 109.382 176.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -63.52 -52.47 1.9 Allowed 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.465 2.11 . . . . 0.0 112.872 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 2.4 t -153.23 142.7 14.88 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 129.252 3.021 . . . . 0.0 108.482 175.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.33 -6.67 18.7 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.141 2.561 . . . . 0.0 114.187 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.1 -71.43 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 119.997 1.271 . . . . 0.0 113.996 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 27.6 p -94.07 -5.3 47.72 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 70.1 15.32 7.65 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 127.897 2.479 . . . . 0.0 115.397 175.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -74.69 132.96 77.14 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 119.309 0.958 . . . . 0.0 109.194 173.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.01 110.28 1.47 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.947 2.431 . . . . 0.0 114.486 -175.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.4 pp -64.27 155.33 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.536 1.534 . . . . 0.0 113.21 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -114.38 -46.59 2.97 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.798 2.039 . . . . 0.0 112.74 -176.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.12 170.09 21.35 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 14.9 mt -126.05 136.6 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 127.913 2.485 . . . . 0.0 107.492 176.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 12.7 p -123.68 148.02 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.344 1.057 . . . . 0.0 113.505 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.23 99.93 0.97 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.316 1.046 . . . . 0.0 108.193 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 26.6 m -96.13 103.7 15.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.004 1.722 . . . . 0.0 113.565 -173.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -89.66 75.74 7.4 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.585 1.183 . . . . 0.0 110.477 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -63.93 -29.92 4.5 Favored Pre-proline 0 CA--C 1.554 1.113 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo . . . . . 0 C--N 1.358 1.028 0 C-N-CA 123.265 2.644 . . . . 0.0 113.898 -179.582 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo . . . . . 0 CA--C 1.556 1.607 0 N-CA-C 114.149 0.788 . . . . 0.0 114.149 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 23.8 t -63.65 148.06 49.95 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.704 1.593 . . . . 0.0 110.201 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 29.4 m -132.06 -0.46 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.001 0.921 . . . . 0.0 113.444 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 6.4 mt -134.86 -46.22 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 119.441 1.019 . . . . 0.0 112.981 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.2 m -68.8 -64.19 0.91 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -173.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -154.14 -10.32 0.14 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -175.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.26 14.36 76.84 Favored Glycine 0 CA--C 1.541 1.714 0 O-C-N 120.693 -1.254 . . . . 0.0 113.261 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -59.53 154.39 44.88 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 127.729 2.411 . . . . 0.0 112.867 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.79 68.89 7.05 Favored 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 124.081 3.187 . . . . 0.0 112.68 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -135.02 147.05 49.57 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.057 1.743 . . . . 0.0 111.457 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -128.27 141.54 51.41 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.011 1.324 . . . . 0.0 111.06 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -136.11 76.31 0.38 Allowed Glycine 0 CA--C 1.525 0.657 0 C-N-CA 126.839 2.161 . . . . 0.0 108.76 175.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 85.2 m -66.89 108.98 2.75 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.404 0.682 . . . . 0.0 110.918 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . 0.459 ' H ' HD12 ' A' ' 450' ' ' ILE . 0.8 OUTLIER -78.72 140.47 16.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 126.451 1.9 . . . . 0.0 109.993 -178.074 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 77.9 t -129.63 132.67 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.093 0.957 . . . . 0.0 110.707 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -124.61 98.31 5.67 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.691 2.796 . . . . 0.0 110.118 177.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 66.31 -95.07 0.24 Allowed Glycine 0 CA--C 1.534 1.272 0 C-N-CA 126.056 1.789 . . . . 0.0 114.057 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -113.85 1.19 14.7 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.288 1.835 . . . . 0.0 113.753 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 81.9 p -131.27 170.03 15.16 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.095 1.758 . . . . 0.0 111.258 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.4 174.26 34.2 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.023 -1.048 . . . . 0.0 113.716 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -120.32 145.0 47.54 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.026 1.331 . . . . 0.0 112.978 175.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.37 153.21 40.67 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.421 2.288 . . . . 0.0 111.263 177.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 52.0 mtt 97.5 48.96 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 130.148 3.379 . . . . 0.0 113.503 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -155.3 148.13 24.38 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.257 1.823 . . . . 0.0 109.68 176.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 7.7 p -83.3 175.18 10.08 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 122.672 1.225 . . . . 0.0 112.236 176.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -59.09 -46.8 87.36 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.02 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 88.7 m -69.13 -41.52 77.23 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 116.353 -1.784 . . . . 0.0 111.926 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 46.4 m -47.16 -59.4 3.18 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 121.522 1.965 . . . . 0.0 110.405 175.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.36 87.91 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.531 1.532 . . . . 0.0 113.689 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -60.19 -41.93 93.99 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.645 -1.284 . . . . 0.0 111.824 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -61.79 -56.6 17.8 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.26 1.824 . . . . 0.0 111.221 177.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 3.4 pp -60.48 -37.26 80.49 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.205 0.457 . . . . 0.0 111.271 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.18 -48.36 80.39 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.71 1.204 . . . . 0.0 111.753 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -58.54 -37.87 76.58 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.384 1.474 . . . . 0.0 111.636 176.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -74.98 6.08 4.49 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 127.322 2.249 . . . . 0.0 113.7 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 39.8 t30 73.41 9.81 5.06 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 129.662 3.185 . . . . 0.0 115.601 177.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -72.42 131.12 85.08 Favored Pre-proline 0 N--CA 1.474 0.768 0 O-C-N 120.791 -1.193 . . . . 0.0 109.19 175.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.07 -82.06 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.283 2.655 . . . . 0.0 109.682 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 32.3 t -123.16 130.76 24.45 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 126.672 1.989 . . . . 0.0 109.471 175.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.23 -1.39 10.52 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.328 2.685 . . . . 0.0 113.874 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 37.6 t -118.19 -78.28 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.754 1.222 . . . . 0.0 111.946 -177.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 18.5 p -89.98 0.15 57.25 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.389 1.476 . . . . 0.0 114.427 -177.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 12.4 mpt_? 62.46 6.97 2.15 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 127.883 2.473 . . . . 0.0 115.525 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -60.51 138.04 92.5 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-N 119.25 0.932 . . . . 0.0 111.172 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.23 114.28 3.37 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.196 2.597 . . . . 0.0 112.317 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 20.3 pt -76.76 158.85 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.096 1.358 . . . . 0.0 114.159 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -115.19 -43.4 3.08 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.142 1.777 . . . . 0.0 114.04 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.93 170.03 23.07 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -171.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.2 pt -141.97 145.57 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 129.923 3.289 . . . . 0.0 108.209 169.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 11.4 m -137.69 150.17 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.139 1.776 . . . . 0.0 109.619 177.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.15 99.87 0.94 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.88 142.31 27.9 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -172.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -128.48 179.63 5.55 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.231 2.212 . . . . 0.0 111.188 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -134.54 158.19 75.67 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.088 1.355 . . . . 0.0 111.407 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 C--N 1.352 0.743 0 C-N-CA 123.2 2.6 . . . . 0.0 111.381 -179.561 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 CA--C 1.553 1.437 0 CA-C-O 118.805 -0.581 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 35.3 t -65.22 153.3 41.39 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 120.466 1.484 . . . . 0.0 110.014 174.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 67.5 t -129.09 -14.59 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.656 1.582 . . . . 0.0 111.848 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 7.1 mt -133.24 -45.8 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.2 m -67.44 -65.19 0.72 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.465 1.506 . . . . 0.0 113.981 -173.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -146.8 -12.55 0.44 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 76.82 10.56 86.01 Favored Glycine 0 CA--C 1.545 1.949 0 CA-C-N 119.893 1.224 . . . . 0.0 112.418 -173.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -58.45 154.34 33.96 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 129.424 3.09 . . . . 0.0 112.866 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -77.32 68.69 7.41 Favored 'Trans proline' 0 CA--C 1.549 1.246 0 C-N-CA 124.146 3.231 . . . . 0.0 113.031 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -131.61 149.03 52.64 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.821 2.049 . . . . 0.0 110.681 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -128.03 149.99 50.13 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.166 1.387 . . . . 0.0 111.077 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -155.06 84.89 0.14 Allowed Glycine 0 CA--C 1.531 1.047 0 C-N-CA 127.038 2.256 . . . . 0.0 111.163 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 42.0 t -67.73 120.27 13.81 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.2 1.0 . . . . 0.0 110.148 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.68 139.7 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 125.561 1.544 . . . . 0.0 109.918 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 93.6 t -130.07 127.6 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.748 1.219 . . . . 0.0 108.748 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -125.2 95.09 4.35 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.886 2.074 . . . . 0.0 111.632 177.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 71.55 -87.28 0.43 Allowed Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.689 1.614 . . . . 0.0 115.172 178.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -122.52 -4.36 8.78 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.25 1.82 . . . . 0.0 113.765 -177.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 30.0 p -129.66 170.16 14.16 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.648 2.379 . . . . 0.0 110.056 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -158.69 171.27 35.37 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 120.981 -1.074 . . . . 0.0 113.505 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -120.02 137.43 54.1 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.936 1.694 . . . . 0.0 112.838 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 33.2 tp -121.63 153.16 38.47 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 129.023 2.929 . . . . 0.0 110.054 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 19.7 mmt 80.89 57.37 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.617 2.367 . . . . 0.0 112.959 177.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -154.0 153.56 32.18 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 128.222 2.609 . . . . 0.0 109.493 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 10.3 p -85.51 175.07 9.03 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 122.343 1.068 . . . . 0.0 111.926 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.24 -36.76 85.14 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.705 -0.664 . . . . 0.0 112.374 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 87.0 m -73.61 -42.11 61.95 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 117.074 -1.441 . . . . 0.0 111.142 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 55.3 m -48.57 -54.91 12.68 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 120.638 1.563 . . . . 0.0 109.548 172.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -60.72 -49.75 76.26 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.142 1.777 . . . . 0.0 113.262 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -58.97 -41.09 86.7 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.796 1.238 . . . . 0.0 111.734 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -58.9 -55.26 37.43 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.41 1.084 . . . . 0.0 110.552 176.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.73 -30.47 71.44 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -69.03 -47.81 64.49 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.213 1.405 . . . . 0.0 112.377 174.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -59.53 -40.49 87.35 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.811 1.244 . . . . 0.0 111.407 176.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -75.23 -7.89 55.12 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.721 1.609 . . . . 0.0 112.93 174.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 51.68 43.59 29.79 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 128.823 2.849 . . . . 0.0 112.091 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -70.05 117.64 55.97 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 125.238 1.415 . . . . 0.0 112.095 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -80.93 74.4 5.56 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 124.558 3.505 . . . . 0.0 111.193 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 30.7 t 22.4 105.13 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 130.561 3.544 . . . . 0.0 117.093 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.03 -19.5 8.78 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.79 2.993 . . . . 0.0 115.681 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 46.6 t -102.82 -63.68 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.52 1.928 . . . . 0.0 112.219 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 84.8 m -78.25 -18.75 54.95 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.288 1.835 . . . . 0.0 113.871 -176.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 63.24 7.01 2.61 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.878 2.471 . . . . 0.0 114.074 -176.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -83.84 149.59 57.02 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 124.302 1.041 . . . . 0.0 112.793 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.78 124.23 9.56 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.528 2.819 . . . . 0.0 112.212 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.99 117.23 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 126.671 1.988 . . . . 0.0 110.388 177.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -115.1 -46.32 2.91 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -174.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 1.1 ttp -143.18 155.1 44.47 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.699 1.136 . . . . 0.0 113.419 -174.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 12.8 mt -138.14 136.23 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 127.063 2.145 . . . . 0.0 109.506 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 16.2 m -138.65 150.18 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 125.5 1.52 . . . . 0.0 112.761 176.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 1.5 tt -74.95 99.95 3.99 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.313 1.045 . . . . 0.0 109.346 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 7.4 t -90.13 155.35 19.1 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -134.39 162.89 30.97 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.642 1.977 . . . . 0.0 112.703 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -93.4 167.64 13.63 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 125.277 1.431 . . . . 0.0 110.89 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo . . . . . 0 C--N 1.351 0.675 0 C-N-CA 124.1 3.2 . . . . 0.0 113.72 -179.854 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo . . . . . 0 CA--C 1.552 1.404 0 CA-C-O 121.024 0.343 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 1.7 t -68.53 166.42 17.02 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 126.114 1.766 . . . . 0.0 109.966 169.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 99.3 t -127.03 -18.5 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 O-C-N 120.346 -1.471 . . . . 0.0 111.971 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 8.3 mt -133.03 -47.06 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 119.43 1.014 . . . . 0.0 113.707 -172.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.4 m -62.86 -54.83 32.73 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.163 1.385 . . . . 0.0 113.222 -175.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -160.46 -12.75 0.05 Allowed 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 85.8 1.22 87.3 Favored Glycine 0 CA--C 1.542 1.775 0 O-C-N 120.731 -1.231 . . . . 0.0 113.533 -176.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -59.16 154.98 37.39 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 129.301 3.04 . . . . 0.0 114.034 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.41 115.67 4.38 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.413 2.742 . . . . 0.0 111.685 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -171.12 146.14 2.36 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 129.162 2.985 . . . . 0.0 108.773 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -112.12 150.21 31.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 128.091 2.557 . . . . 0.0 113.216 -174.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 171.08 82.76 0.05 OUTLIER Glycine 0 CA--C 1.532 1.094 0 C-N-CA 126.263 1.887 . . . . 0.0 112.587 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.32 144.22 55.98 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.139 0.97 . . . . 0.0 110.776 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 3.0 mp -115.09 140.86 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.387 1.475 . . . . 0.0 110.371 -177.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 98.7 t -130.06 130.23 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.12 0.968 . . . . 0.0 109.256 175.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -124.97 95.14 4.39 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.521 2.328 . . . . 0.0 111.141 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.96 -88.17 0.38 Allowed Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.069 1.795 . . . . 0.0 114.197 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -123.4 -1.63 8.59 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 126.567 1.947 . . . . 0.0 113.465 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 16.4 p -127.04 170.1 12.68 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.423 2.289 . . . . 0.0 110.373 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -158.75 176.44 35.63 Favored Glycine 0 CA--C 1.531 1.085 0 O-C-N 120.992 -1.067 . . . . 0.0 114.046 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -120.19 142.39 49.04 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.884 1.674 . . . . 0.0 112.059 177.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 45.7 tp -129.66 150.49 50.96 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.476 2.31 . . . . 0.0 109.962 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 27.8 mtm 76.21 58.41 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 129.495 3.118 . . . . 0.0 112.18 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -148.83 153.96 38.84 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.033 2.133 . . . . 0.0 110.561 177.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 14.3 p -83.36 169.38 15.69 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 122.345 1.069 . . . . 0.0 112.79 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -65.49 -37.6 87.29 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.747 -0.595 . . . . 0.0 111.768 178.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 27.6 m -63.58 -46.26 86.67 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 117.388 -1.292 . . . . 0.0 111.787 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 46.2 m -48.52 -56.1 9.23 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 120.417 1.462 . . . . 0.0 110.453 174.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -60.64 -43.54 97.43 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.974 1.709 . . . . 0.0 113.08 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -62.55 -42.3 99.45 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.642 1.177 . . . . 0.0 111.616 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -59.73 -56.47 21.41 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.185 1.394 . . . . 0.0 111.083 176.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.2 pp -62.39 -35.3 78.76 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 119.23 -0.414 . . . . 0.0 111.793 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.6 -48.12 76.11 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.358 0.981 . . . . 0.0 112.047 175.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -56.4 -43.53 79.39 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.676 1.59 . . . . 0.0 111.554 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -76.58 -5.23 46.83 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.382 1.873 . . . . 0.0 113.59 176.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 54.7 36.69 26.78 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 127.68 2.392 . . . . 0.0 111.734 -176.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -81.31 114.88 52.72 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 126.642 1.977 . . . . 0.0 111.835 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.34 129.33 17.84 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.292 1.995 . . . . 0.0 108.121 172.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 42.6 t -12.88 117.78 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 129.739 3.216 . . . . 0.0 116.19 -177.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.3 -0.13 2.65 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 123.141 2.561 . . . . 0.0 114.694 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 53.1 t -123.21 -60.11 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.145 1.778 . . . . 0.0 111.216 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 82.1 m -79.17 -15.29 58.3 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.499 1.92 . . . . 0.0 113.557 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . 0.295 51.8 ptt85 53.52 17.05 1.05 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 128.175 2.59 . . . . 0.0 115.029 -174.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -85.26 150.13 53.99 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 124.226 1.011 . . . . 0.0 112.335 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.3 118.4 5.66 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.703 2.936 . . . . 0.0 112.167 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.64 129.01 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 125.354 1.461 . . . . 0.0 111.149 178.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -109.54 -41.52 4.56 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -177.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.04 166.97 31.19 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 5.4 mt -135.17 138.67 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 127.471 2.309 . . . . 0.0 108.943 177.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 17.0 m -139.8 150.0 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 64.8 mt -73.8 99.86 3.3 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 176.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 14.4 t -98.12 150.69 21.17 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.768 0.827 . . . . 0.0 112.844 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -144.4 172.79 12.46 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.3 1.84 . . . . 0.0 111.661 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -117.99 162.11 31.12 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.442 1.097 . . . . 0.0 111.878 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo . . . . . 0 C--N 1.353 0.785 0 C-N-CA 124.243 3.295 . . . . 0.0 114.054 179.796 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo . . . . . 0 CA--C 1.544 0.993 0 N-CA-C 114.932 1.089 . . . . 0.0 114.932 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 1.5 t -50.69 142.7 10.74 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.563 1.545 . . . . 0.0 111.356 176.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.3 -1.22 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.934 1.294 . . . . 0.0 114.012 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 19.4 mt -123.21 -53.38 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.838 0.855 . . . . 0.0 112.027 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 2.4 m -71.88 -69.83 0.37 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.437 1.495 . . . . 0.0 114.355 -172.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -159.89 -1.16 0.07 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 -176.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 91.61 11.78 60.26 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-N 120.222 1.374 . . . . 0.0 113.998 -177.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -59.71 155.23 41.76 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 127.391 2.276 . . . . 0.0 112.76 176.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.11 146.55 37.95 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.468 2.779 . . . . 0.0 113.935 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.91 36.8 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -81.11 89.8 6.0 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.368 -1.457 . . . . 0.0 108.968 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 162.85 57.56 0.02 OUTLIER Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.762 1.649 . . . . 0.0 111.208 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 53.5 t -61.32 134.86 57.41 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.382 0.673 . . . . 0.0 110.254 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.23 137.23 37.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 126.248 1.819 . . . . 0.0 109.71 -176.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 86.0 t -130.06 129.06 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.011 0.924 . . . . 0.0 109.061 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -125.17 95.41 4.48 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.762 2.025 . . . . 0.0 111.701 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 73.19 -85.79 0.59 Allowed Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.844 1.688 . . . . 0.0 114.963 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 454' ' ' LYS . . . . . 0.435 ' HA ' ' HE2' ' B' ' 454' ' ' LYS . 0.6 OUTLIER -123.97 -7.66 7.79 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.188 1.795 . . . . 0.0 113.584 -177.418 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 28.1 p -125.51 170.1 11.77 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 127.179 2.192 . . . . 0.0 110.65 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -154.72 174.95 32.96 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 121.28 -0.888 . . . . 0.0 114.084 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -120.25 142.56 48.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.359 1.463 . . . . 0.0 113.446 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.5 pp -129.58 153.29 48.21 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.306 2.643 . . . . 0.0 110.625 177.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 28.9 tpp 93.8 -7.09 0.13 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 128.976 2.91 . . . . 0.0 113.442 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -99.99 144.9 28.5 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.394 1.078 . . . . 0.0 109.404 175.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 15.4 p -82.35 174.42 11.14 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 122.196 0.998 . . . . 0.0 112.591 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.08 -37.07 78.83 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.499 -0.75 . . . . 0.0 112.16 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 60.5 m -73.69 -41.85 62.08 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 117.751 -1.119 . . . . 0.0 110.767 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 27.6 m -53.07 -57.3 10.87 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.767 1.167 . . . . 0.0 109.172 171.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -50.56 -48.34 57.52 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.243 1.817 . . . . 0.0 112.967 176.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -61.21 -30.29 70.34 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.306 1.442 . . . . 0.0 112.635 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -61.26 -43.62 98.58 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.424 1.011 . . . . 0.0 111.55 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -57.55 -39.61 77.04 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.427 0.691 . . . . 0.0 110.219 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -68.65 -50.75 48.74 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.987 0.515 . . . . 0.0 111.841 176.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -53.97 -45.04 71.25 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.892 1.677 . . . . 0.0 112.156 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -82.93 -7.62 59.65 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 126.501 1.92 . . . . 0.0 113.584 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 50.33 50.72 18.17 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 127.813 2.445 . . . . 0.0 111.292 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -100.73 115.7 65.03 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 126.572 1.949 . . . . 0.0 113.323 -175.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.57 129.13 19.4 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 122.51 2.14 . . . . 0.0 107.823 171.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 48.3 t -17.02 118.97 0.06 OUTLIER Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 129.951 3.3 . . . . 0.0 116.447 -174.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -65.16 0.73 2.44 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.554 2.836 . . . . 0.0 114.277 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 43.3 t -127.61 -60.41 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.7 1.6 . . . . 0.0 111.283 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 63.2 m -77.5 -16.04 58.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.58 1.952 . . . . 0.0 113.637 -177.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 60.0 7.8 1.27 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 127.239 2.216 . . . . 0.0 114.401 -175.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -79.19 149.36 72.74 Favored Pre-proline 0 CA--C 1.547 0.842 0 O-C-N 121.461 -0.774 . . . . 0.0 112.117 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.3 123.28 10.1 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.027 2.485 . . . . 0.0 110.788 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.75 109.97 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 125.205 1.402 . . . . 0.0 109.761 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -96.55 -58.17 2.12 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.571 1.149 . . . . 0.0 113.541 -174.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.49 162.97 34.43 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -177.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 13.3 mt -137.41 136.64 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 127.316 2.246 . . . . 0.0 108.599 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 19.4 m -136.25 150.19 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.473 1.109 . . . . 0.0 113.5 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 5.1 tt -68.27 103.15 1.52 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.668 1.587 . . . . 0.0 107.654 175.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 5.7 t -98.02 161.75 13.57 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -175.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -129.77 130.59 45.57 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.457 1.903 . . . . 0.0 111.254 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 490' ' ' PHE . . . . . 0.429 ' H ' ' CD ' ' B' ' 491' ' ' PRO . 44.3 p90 -134.03 -27.36 0.02 OUTLIER Pre-proline 0 CA--C 1.551 1.011 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -178.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 491' ' ' PRO . . . . . 0.429 ' CD ' ' H ' ' B' ' 490' ' ' PHE . 89.2 Cg_exo . . . . . 0 C--N 1.359 1.121 0 C-N-CA 123.182 2.588 . . . . 0.0 114.321 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo . . . . . 0 CA--C 1.536 0.584 0 N-CA-C 116.187 1.572 . . . . 0.0 116.187 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 46.3 t -56.65 144.48 32.07 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 120.607 1.548 . . . . 0.0 111.153 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 32.1 m -123.1 -15.31 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 10.2 pt -137.52 -25.73 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.7 m -75.23 -65.3 0.9 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 120.72 1.6 . . . . 0.0 111.709 -177.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -145.98 -11.13 0.5 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 78.23 9.69 86.79 Favored Glycine 0 CA--C 1.546 1.978 0 CA-C-N 120.35 1.432 . . . . 0.0 112.824 -174.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -57.94 155.24 24.62 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 131.565 3.946 . . . . 0.0 114.164 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.6 -5.85 15.21 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 124.33 3.353 . . . . 0.0 115.495 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -54.58 139.77 37.18 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.503 1.921 . . . . 0.0 110.461 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.14 150.1 50.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.182 1.793 . . . . 0.0 112.855 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -157.39 88.14 0.12 Allowed Glycine 0 CA--C 1.532 1.119 0 C-N-CA 126.306 1.907 . . . . 0.0 112.32 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 48.9 t -65.16 133.06 50.74 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 117.765 0.782 . . . . 0.0 110.647 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -110.9 144.22 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.931 1.692 . . . . 0.0 110.948 -177.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 72.7 t -129.92 134.63 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.528 1.131 . . . . 0.0 111.624 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.23 97.35 5.19 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 128.894 2.877 . . . . 0.0 110.569 174.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 65.46 -99.31 0.38 Allowed Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.859 1.695 . . . . 0.0 114.349 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -103.68 -6.29 21.72 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.032 1.733 . . . . 0.0 113.582 -178.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 44.4 p -131.5 170.07 15.21 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.384 1.473 . . . . 0.0 111.422 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -151.55 173.42 30.89 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.313 1.435 . . . . 0.0 112.216 178.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -120.06 146.48 45.87 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.222 1.009 . . . . 0.0 113.451 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.15 153.16 27.42 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.34 2.656 . . . . 0.0 111.721 -177.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 6.8 tpt 71.69 65.01 0.15 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.275 2.23 . . . . 0.0 114.323 174.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -150.9 154.93 38.1 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.635 2.374 . . . . 0.0 109.374 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 1.8 p -90.28 171.1 9.72 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.218 0.917 . . . . 0.0 111.195 174.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -65.43 -36.6 84.42 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.325 -0.859 . . . . 0.0 111.345 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 32.6 m -70.02 -42.4 73.03 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 117.623 -1.18 . . . . 0.0 110.944 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 56.4 m -50.07 -61.16 2.31 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.693 1.197 . . . . 0.0 108.642 173.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.0 -45.29 75.07 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.783 1.633 . . . . 0.0 113.251 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -58.61 -37.21 75.38 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.661 1.185 . . . . 0.0 112.316 178.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -58.37 -44.12 88.71 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.271 1.028 . . . . 0.0 111.06 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 6.7 mp -65.62 -45.09 84.42 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.008 0.523 . . . . 0.0 109.924 174.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -56.27 -47.4 78.65 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.51 1.524 . . . . 0.0 113.972 -176.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -54.96 -27.71 45.83 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -120.04 8.89 11.07 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 127.561 2.345 . . . . 0.0 113.187 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 38.36 60.67 1.26 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 128.509 2.724 . . . . 0.0 112.879 -174.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -69.94 118.77 66.54 Favored Pre-proline 0 N--CA 1.473 0.68 0 C-N-CA 125.485 1.514 . . . . 0.0 113.225 -176.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -55.44 121.91 10.77 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.319 2.679 . . . . 0.0 109.088 170.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 53.2 t -29.68 121.12 0.3 Allowed Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 128.413 2.685 . . . . 0.0 115.32 -174.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -66.41 -3.97 9.86 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 122.901 2.4 . . . . 0.0 113.907 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 39.2 t -107.15 -64.75 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.472 1.509 . . . . 0.0 111.294 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 24.6 p -107.8 3.27 24.28 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -176.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 71.8 mtp85 63.64 8.66 3.81 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 128.182 2.593 . . . . 0.0 116.424 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -71.22 147.84 93.51 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 123.882 0.873 . . . . 0.0 111.853 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.7 106.83 2.34 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.609 2.872 . . . . 0.0 112.607 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 pp -59.65 135.82 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.704 1.202 . . . . 0.0 111.246 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -115.15 -30.74 6.24 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -177.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.29 165.62 34.34 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -175.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 6.9 mt -133.25 140.19 47.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 127.611 2.365 . . . . 0.0 108.269 176.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 9.5 m -126.83 146.92 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.032 0.933 . . . . 0.0 111.728 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.05 99.82 4.73 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 6.4 t -92.57 172.73 8.18 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.676 0.79 . . . . 0.0 113.095 -175.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -149.41 171.21 16.93 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.135 2.174 . . . . 0.0 111.217 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -138.73 154.13 72.77 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.507 1.523 . . . . 0.0 110.521 176.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 CA--C 1.538 0.718 0 C-N-CA 123.458 2.772 . . . . 0.0 112.497 -179.765 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo . . . . . 0 CA--C 1.549 1.273 0 N-CA-C 112.522 0.162 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.26 166.71 0.54 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.549 1.539 . . . . 0.0 114.047 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 30.0 m -130.88 -3.66 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -175.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 32.9 mm -111.79 -61.29 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.464 1.106 . . . . 0.0 111.33 -177.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.2 m -62.96 -80.14 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 128.198 2.599 . . . . 0.0 114.626 -172.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -144.12 -5.59 0.77 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.092 1.357 . . . . 0.0 114.59 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 78.83 35.28 31.9 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 119.813 1.188 . . . . 0.0 111.281 -174.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -87.69 155.31 53.46 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 128.518 2.727 . . . . 0.0 111.843 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -43.47 125.99 5.01 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 124.06 3.173 . . . . 0.0 114.059 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 41.69 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 130.392 3.477 . . . . 0.0 117.06 -177.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -81.74 89.85 6.32 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.178 -1.576 . . . . 0.0 109.735 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 168.48 59.33 0.03 OUTLIER Glycine 0 CA--C 1.529 0.935 0 C-N-CA 123.96 0.791 . . . . 0.0 113.464 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 42.6 t -58.58 134.95 57.19 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.367 1.084 . . . . 0.0 110.205 178.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.1 mp -106.1 133.77 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 126.207 1.803 . . . . 0.0 108.211 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 92.6 t -120.46 130.39 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 121.656 0.741 . . . . 0.0 110.001 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.01 109.98 13.62 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 128.448 2.699 . . . . 0.0 110.757 177.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 68.22 -89.78 0.21 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.736 1.636 . . . . 0.0 112.938 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.41 4.04 4.3 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.604 1.962 . . . . 0.0 114.069 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 62.8 p -127.5 170.03 13.03 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.147 1.779 . . . . 0.0 110.742 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -150.5 171.41 30.35 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 121.075 -1.015 . . . . 0.0 114.626 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -120.35 143.49 48.37 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.428 1.491 . . . . 0.0 113.975 176.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 82.8 mt -125.11 153.24 43.27 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.958 2.903 . . . . 0.0 111.243 178.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 60.8 mtt 107.15 -2.68 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 1 C-N-CA 132.027 4.131 . . . . 0.0 113.551 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -108.24 145.63 34.02 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.73 1.212 . . . . 0.0 109.87 175.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 14.8 p -82.01 174.88 10.83 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 122.796 1.284 . . . . 0.0 112.103 178.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -59.68 -37.75 79.64 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.633 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 87.4 m -70.62 -44.63 66.83 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 117.326 -1.321 . . . . 0.0 110.979 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 77.3 m -50.16 -53.25 29.03 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 120.462 1.483 . . . . 0.0 109.734 171.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -59.64 -43.33 93.91 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.794 1.638 . . . . 0.0 113.294 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -63.15 -42.66 99.48 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.913 1.285 . . . . 0.0 111.044 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -59.68 -56.55 20.45 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.687 1.195 . . . . 0.0 110.944 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.62 -33.23 72.46 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 122.691 0.396 . . . . 0.0 111.928 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -68.18 -48.02 66.41 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.841 1.257 . . . . 0.0 112.38 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -58.15 -40.79 82.26 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.862 1.265 . . . . 0.0 111.355 176.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 29.0 mmt85 -76.49 -7.79 55.85 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.203 1.801 . . . . 0.0 113.475 175.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 64.0 t30 52.63 40.33 29.92 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 128.012 2.525 . . . . 0.0 112.233 -177.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -74.55 131.37 80.09 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 125.647 1.579 . . . . 0.0 112.737 -177.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -71.9 123.54 9.41 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.732 2.288 . . . . 0.0 107.924 170.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 43.9 t -14.54 119.24 0.04 OUTLIER Pre-proline 0 CA--C 1.557 1.224 0 C-N-CA 130.062 3.345 . . . . 0.0 115.994 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -65.8 -1.13 4.58 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 123.202 2.601 . . . . 0.0 114.72 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 35.6 t -114.02 -60.79 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.281 1.432 . . . . 0.0 111.919 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 28.0 p -114.77 6.69 15.63 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -176.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . 0.31 13.8 ptm180 54.07 14.86 0.77 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 129.288 3.035 . . . . 0.0 117.56 177.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -68.02 152.32 96.52 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 123.852 0.861 . . . . 0.0 111.722 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -74.1 106.17 2.17 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 124.034 3.156 . . . . 0.0 113.344 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 pp -60.21 136.14 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.621 1.169 . . . . 0.0 111.494 177.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -115.07 -40.72 3.43 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.909 1.284 . . . . 0.0 113.678 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.21 167.46 30.3 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -176.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 6.0 mt -129.79 139.08 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 127.958 2.503 . . . . 0.0 107.587 175.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 14.1 p -131.54 146.42 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.137 0.975 . . . . 0.0 112.427 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.51 99.95 1.04 Allowed 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 1.8 m -102.27 95.54 6.37 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.244 1.418 . . . . 0.0 111.687 -174.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -83.22 159.78 21.91 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.46 1.104 . . . . 0.0 113.83 -178.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -78.71 158.85 75.17 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 125.643 1.577 . . . . 0.0 112.226 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo . . . . . 0 C--N 1.353 0.797 0 C-N-CA 124.39 3.393 . . . . 0.0 113.572 178.04 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo . . . . . 0 CA--C 1.552 1.422 0 CA-C-O 120.682 0.201 . . . . 0.0 112.149 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 10.6 t -42.97 145.9 0.44 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.796 2.038 . . . . 0.0 111.972 174.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.13 -27.95 3.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 124.081 0.952 . . . . 0.0 112.613 -175.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 7.9 pt -141.39 -24.65 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 117.727 2.492 . . . . 0.0 117.727 -172.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.7 m -77.02 -64.61 1.09 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 120.617 1.553 . . . . 0.0 114.398 -174.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -153.03 -10.08 0.16 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -171.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 87.16 10.21 71.93 Favored Glycine 0 CA--C 1.541 1.691 0 CA-C-N 119.959 1.254 . . . . 0.0 113.13 -176.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -64.72 155.22 83.02 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 128.589 2.755 . . . . 0.0 113.43 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -46.72 139.51 13.7 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 124.396 3.398 . . . . 0.0 116.446 -177.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.33 13.44 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 131.436 3.894 . . . . 0.0 118.918 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.04 89.78 5.96 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.503 -1.373 . . . . 0.0 112.039 -177.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -178.59 44.58 0.09 OUTLIER Glycine 0 CA--C 1.529 0.906 0 CA-C-O 118.899 -0.945 . . . . 0.0 113.63 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 42.9 t -57.42 135.97 56.6 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.86 1.33 . . . . 0.0 110.689 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.4 mp -108.23 142.93 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 126.647 1.979 . . . . 0.0 109.037 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 95.1 t -129.76 133.41 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.419 0.628 . . . . 0.0 110.497 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -124.91 96.76 4.99 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.692 2.397 . . . . 0.0 111.087 176.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 71.54 -89.16 0.44 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 126.06 1.79 . . . . 0.0 114.075 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -124.07 0.79 8.53 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 126.238 1.815 . . . . 0.0 114.232 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 16.8 p -127.14 167.58 15.82 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.122 2.169 . . . . 0.0 109.922 178.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.51 172.18 34.23 Favored Glycine 0 CA--C 1.527 0.79 0 O-C-N 121.166 -0.959 . . . . 0.0 113.985 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -119.97 137.28 54.16 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.249 1.82 . . . . 0.0 111.192 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 60.0 tp -133.12 153.35 51.6 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.005 2.122 . . . . 0.0 111.601 -173.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 459' ' ' MET . . . . . . . . . . . . 0.256 29.4 mtt 81.89 56.7 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.204 2.202 . . . . 0.0 113.104 178.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -158.84 150.61 20.92 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 130.398 3.479 . . . . 0.0 106.824 176.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 16.1 p -78.08 171.22 15.34 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 123.164 1.459 . . . . 0.0 113.582 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.81 -36.92 77.77 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.835 175.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 11.4 m -66.66 -47.22 73.2 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 117.413 -1.279 . . . . 0.0 110.943 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 49.5 m -49.86 -52.79 30.01 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 120.53 1.514 . . . . 0.0 109.664 173.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -60.11 -43.03 95.9 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.665 1.586 . . . . 0.0 113.37 176.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -64.79 -40.68 95.63 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.63 -1.294 . . . . 0.0 111.43 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -61.95 -56.47 18.84 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.519 1.127 . . . . 0.0 110.835 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.2 pp -58.46 -33.49 69.81 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 118.461 0.573 . . . . 0.0 112.163 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -66.75 -50.38 62.94 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.216 1.406 . . . . 0.0 112.02 174.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -58.23 -38.39 76.75 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.434 1.094 . . . . 0.0 111.643 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -78.16 -1.67 33.83 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 127.051 2.14 . . . . 0.0 113.351 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.34 37.24 5.66 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 129.04 2.936 . . . . 0.0 113.922 -177.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -70.11 116.56 45.6 Favored Pre-proline 0 CA--C 1.539 0.519 0 C-N-CA 126.412 1.885 . . . . 0.0 113.734 -177.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.31 139.11 37.57 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 N-CA-C 106.799 -2.039 . . . . 0.0 106.799 169.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 53.2 t -38.63 121.91 1.15 Allowed Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 126.32 1.848 . . . . 0.0 114.37 -176.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.2 -1.24 7.66 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.063 2.509 . . . . 0.0 114.045 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 48.2 t -122.15 -60.57 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.711 1.604 . . . . 0.0 111.333 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 64.5 m -76.49 -17.84 59.07 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.731 2.012 . . . . 0.0 112.841 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 73.8 mtp85 64.52 5.38 2.64 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 127.635 2.374 . . . . 0.0 114.203 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -84.54 147.22 48.93 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.107 0.963 . . . . 0.0 113.386 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.1 120.08 5.89 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.485 2.79 . . . . 0.0 111.531 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.4 pp -59.0 141.14 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.541 1.137 . . . . 0.0 111.436 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -115.01 -38.25 3.93 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -177.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.44 167.05 31.64 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -176.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 14.2 mt -131.95 143.14 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 127.639 2.376 . . . . 0.0 108.7 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 8.4 m -134.12 150.16 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.336 1.455 . . . . 0.0 112.6 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -72.78 99.9 2.74 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 3.5 m -88.0 104.88 17.06 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -172.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -78.57 166.48 22.51 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.14 1.776 . . . . 0.0 110.701 173.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -123.15 170.45 8.23 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 126.095 1.758 . . . . 0.0 111.364 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo . . . . . 0 C--N 1.351 0.681 0 C-N-CA 123.92 3.08 . . . . 0.0 113.688 -178.713 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo . . . . . 0 CA--C 1.538 0.709 0 N-CA-C 114.186 0.802 . . . . 0.0 114.186 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 18.6 t -70.43 -175.23 0.98 Allowed 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 122.22 1.01 . . . . 0.0 112.601 175.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 3.6 p -144.4 2.75 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 126.446 1.898 . . . . 0.0 112.749 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 41.9 mt -113.97 -61.14 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.259 1.024 . . . . 0.0 111.408 -175.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 8.1 p -56.35 -83.23 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.593 1.557 . . . . 0.0 113.526 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -147.53 -7.68 0.44 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 129.867 3.267 . . . . 0.0 112.577 -177.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 85.49 39.23 8.41 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.011 0.823 . . . . 0.0 113.073 -177.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -66.1 152.33 94.02 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 124.957 1.303 . . . . 0.0 111.191 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.82 66.7 5.84 Favored 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 124.546 3.497 . . . . 0.0 113.667 -176.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -141.52 145.89 35.71 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.9 2.48 . . . . 0.0 110.374 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.29 144.74 51.16 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.103 1.761 . . . . 0.0 112.379 176.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -156.9 87.28 0.12 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 126.632 2.063 . . . . 0.0 110.781 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 45.4 t -62.09 137.16 58.21 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 117.606 0.703 . . . . 0.0 110.969 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -114.93 148.64 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 126.301 1.84 . . . . 0.0 110.174 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 38.7 t -117.69 140.97 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.071 1.348 . . . . 0.0 109.071 174.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -125.18 94.86 4.29 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.794 2.438 . . . . 0.0 107.569 175.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 62.25 -91.7 0.07 OUTLIER Glycine 0 CA--C 1.542 1.745 0 C-N-CA 124.648 1.118 . . . . 0.0 113.612 -176.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 50.4 mmtm -120.98 6.64 10.35 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 127.612 2.365 . . . . 0.0 113.296 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 30.3 p -120.73 170.22 9.65 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 128.172 2.589 . . . . 0.0 109.501 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.17 170.0 33.79 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 120.368 -1.458 . . . . 0.0 113.328 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.23 145.48 46.98 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.606 1.162 . . . . 0.0 114.135 177.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 3.6 pp -116.13 153.21 32.18 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.488 1.915 . . . . 0.0 112.421 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 21.6 ttt 70.55 66.14 0.19 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.611 2.364 . . . . 0.0 113.88 176.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -154.52 145.89 23.01 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 128.247 2.619 . . . . 0.0 107.802 175.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 29.1 p -79.54 164.96 23.46 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 120.71 1.595 . . . . 0.0 112.398 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -63.81 -34.75 78.6 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.138 177.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 37.3 m -62.55 -57.62 10.47 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.517 1.127 . . . . 0.0 110.51 176.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 33.1 m -54.12 -47.31 71.97 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 120.057 1.299 . . . . 0.0 112.469 176.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.64 -44.27 90.01 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.779 0.832 . . . . 0.0 112.554 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -64.98 -40.66 95.3 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.749 -1.22 . . . . 0.0 111.479 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -59.63 -56.61 19.76 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.927 1.291 . . . . 0.0 111.072 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.1 pp -61.84 -34.33 75.76 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -65.19 -48.97 71.56 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.402 1.081 . . . . 0.0 112.154 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -52.26 -43.69 64.5 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.739 1.616 . . . . 0.0 112.639 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -90.81 4.7 50.98 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.517 1.527 . . . . 0.0 114.141 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 65.4 t30 49.87 40.81 21.56 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.796 2.438 . . . . 0.0 113.366 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -71.04 117.23 54.43 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 126.215 1.806 . . . . 0.0 111.582 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.62 123.01 12.74 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.102 2.535 . . . . 0.0 108.571 171.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 42.7 t -22.98 122.14 0.16 Allowed Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 128.384 2.674 . . . . 0.0 115.887 -174.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -65.47 -2.37 6.03 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 122.817 2.345 . . . . 0.0 114.151 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 46.4 t -112.57 -61.68 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.595 1.558 . . . . 0.0 111.659 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 32.1 p -105.38 -6.86 19.2 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 61.94 11.07 3.94 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 127.693 2.397 . . . . 0.0 115.769 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -69.61 155.33 93.7 Favored Pre-proline 0 CA--C 1.554 1.118 0 O-C-N 121.22 -0.925 . . . . 0.0 111.861 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.85 116.95 4.91 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.703 2.935 . . . . 0.0 111.978 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 1.9 pp -65.31 147.91 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.452 1.101 . . . . 0.0 112.361 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -115.15 -62.8 1.55 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.201 1.8 . . . . 0.0 111.691 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.8 170.31 22.75 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.062 1.345 . . . . 0.0 113.431 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 7.3 mt -123.65 142.66 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 126.879 2.072 . . . . 0.0 109.038 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 9.4 m -138.27 150.14 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.788 1.235 . . . . 0.0 112.714 176.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 58.7 tp -69.85 99.9 1.46 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.003 1.321 . . . . 0.0 109.385 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 7.3 t -87.28 159.47 18.78 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -142.17 124.76 15.82 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.934 2.094 . . . . 0.0 111.212 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -84.28 -31.61 0.48 Allowed Pre-proline 0 CA--C 1.555 1.138 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 175.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 C--N 1.36 1.183 0 C-N-CA 122.995 2.464 . . . . 0.0 113.8 178.708 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo . . . . . 0 CA--C 1.537 0.643 0 N-CA-C 116.002 1.501 . . . . 0.0 116.002 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 31.6 t -55.41 145.86 21.31 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 120.46 1.482 . . . . 0.0 111.645 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 15.8 m -134.85 -13.04 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.335 1.054 . . . . 0.0 113.251 177.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 24.1 mm -110.0 -43.98 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.91 1.284 . . . . 0.0 112.451 -177.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.1 m -79.89 -66.1 0.92 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -170.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -151.18 -14.31 0.21 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -174.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 84.75 12.41 74.86 Favored Glycine 0 CA--C 1.539 1.565 0 O-C-N 120.833 -1.167 . . . . 0.0 112.328 -174.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -61.52 155.11 61.17 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 127.883 2.473 . . . . 0.0 113.311 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.99 -6.38 7.76 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.32 3.347 . . . . 0.0 117.646 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -55.79 144.75 26.43 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.24 1.416 . . . . 0.0 111.161 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.12 141.11 51.58 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.545 1.938 . . . . 0.0 113.047 -176.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -163.43 82.57 0.12 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.853 1.692 . . . . 0.0 111.918 177.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 12.1 t -63.75 147.75 50.93 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.089 0.956 . . . . 0.0 110.899 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.4 mp -115.04 141.78 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 125.801 1.64 . . . . 0.0 109.376 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 80.7 t -123.35 137.21 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.489 1.116 . . . . 0.0 109.815 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -124.63 94.89 4.33 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.697 2.399 . . . . 0.0 108.044 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 60.86 -95.53 0.09 OUTLIER Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.327 1.442 . . . . 0.0 113.895 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -110.47 3.71 19.85 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.803 2.041 . . . . 0.0 113.359 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 22.1 p -126.52 170.12 12.34 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.167 1.787 . . . . 0.0 111.592 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.4 164.39 32.47 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 120.89 -1.131 . . . . 0.0 113.413 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -120.09 117.58 28.33 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.739 1.616 . . . . 0.0 111.869 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 7.3 tt -90.64 153.06 20.59 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.951 1.701 . . . . 0.0 110.863 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 3.4 tpt 86.19 64.95 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 128.274 2.63 . . . . 0.0 113.627 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -155.75 151.48 27.35 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.27 2.228 . . . . 0.0 108.987 175.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 14.1 p -89.21 175.0 7.54 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.834 0.826 . . . . 0.0 110.456 172.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.24 -38.58 91.74 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.342 -0.849 . . . . 0.0 110.972 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 38.1 m -67.66 -44.32 78.15 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 117.453 -1.26 . . . . 0.0 110.981 177.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 57.1 m -51.27 -60.22 3.36 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 120.288 1.404 . . . . 0.0 109.683 173.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -53.15 -40.5 64.34 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.197 1.799 . . . . 0.0 113.05 177.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -61.14 -31.37 71.09 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.467 1.107 . . . . 0.0 112.022 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -59.91 -51.03 71.42 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 120.106 1.321 . . . . 0.0 110.471 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -56.51 -45.07 81.25 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.088 0.955 . . . . 0.0 110.29 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -65.98 -51.94 53.96 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.632 1.173 . . . . 0.0 113.492 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -43.91 83.3 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.016 1.727 . . . . 0.0 111.673 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -79.21 -8.92 59.4 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.082 1.753 . . . . 0.0 112.962 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 48.02 47.13 19.1 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 128.058 2.543 . . . . 0.0 111.053 -175.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -87.2 123.5 69.89 Favored Pre-proline 0 N--CA 1.469 0.509 0 C-N-CA 124.711 1.205 . . . . 0.0 113.049 -174.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.47 90.69 1.1 Allowed 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 123.756 2.971 . . . . 0.0 109.599 175.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 33.7 t 18.85 113.95 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.141 1 C-N-CA 132.934 4.494 . . . . 0.0 118.115 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.98 -0.12 3.7 Favored 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 122.636 2.224 . . . . 0.0 113.759 176.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 35.2 t -110.12 -66.67 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.816 1.647 . . . . 0.0 111.616 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 28.3 p -95.68 -5.53 42.02 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 120.258 1.39 . . . . 0.0 114.604 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? 63.5 10.09 4.64 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.469 2.307 . . . . 0.0 115.172 178.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -74.81 153.66 87.06 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 124.503 1.121 . . . . 0.0 112.208 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -72.36 107.16 2.21 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.477 2.785 . . . . 0.0 111.384 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.0 pp -58.48 141.3 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.834 1.254 . . . . 0.0 111.107 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -115.09 -49.7 2.78 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -177.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.82 169.06 24.3 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -174.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 7.6 mt -131.94 139.57 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 128.496 2.719 . . . . 0.0 108.102 175.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 16.2 m -137.87 150.27 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.405 1.482 . . . . 0.0 111.615 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 60.4 tp -68.35 99.93 1.0 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.71 0.804 . . . . 0.0 108.939 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.67 90.72 3.59 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.985 1.314 . . . . 0.0 111.955 -173.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -59.8 124.48 20.3 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.349 1.46 . . . . 0.0 112.921 -179.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -68.74 159.05 83.92 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 124.609 1.164 . . . . 0.0 111.367 176.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo . . . . . 0 CA--C 1.538 0.702 0 C-N-CA 122.98 2.453 . . . . 0.0 112.412 179.184 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 CA--C 1.545 1.055 0 N-CA-C 113.948 0.711 . . . . 0.0 113.948 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 5.5 p -59.45 177.03 0.21 Allowed 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 115.961 1.838 . . . . 0.0 115.961 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 7.9 p -134.31 -9.19 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -172.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 6.9 mt -115.0 -62.56 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 119.937 1.244 . . . . 0.0 112.961 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 11.4 p -65.76 -59.31 4.03 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -174.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 18.1 tp60 -151.76 -18.27 0.19 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 -174.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 91.0 39.63 5.72 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -173.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -95.25 155.13 39.21 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 125.8 1.64 . . . . 0.0 112.787 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -48.31 126.68 14.17 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.686 2.924 . . . . 0.0 113.703 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -55.27 97.56 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 127.407 2.283 . . . . 0.0 114.635 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -128.05 89.86 2.99 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.041 1.336 . . . . 0.0 107.705 176.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 156.02 58.78 0.01 OUTLIER Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.687 1.137 . . . . 0.0 112.395 -177.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 44.3 t -57.1 115.47 2.66 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.906 1.283 . . . . 0.0 112.005 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.0 mp -88.73 122.4 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.736 1.614 . . . . 0.0 109.696 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 95.6 t -122.64 123.26 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.822 1.249 . . . . 0.0 110.483 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -108.02 101.59 10.83 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.099 2.56 . . . . 0.0 110.703 175.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.5 -88.25 0.35 Allowed Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.842 1.687 . . . . 0.0 113.759 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -129.49 6.95 5.27 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.335 1.854 . . . . 0.0 114.333 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 43.2 p -136.68 169.98 16.83 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.421 1.888 . . . . 0.0 110.367 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -161.44 169.85 37.05 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 120.618 -1.301 . . . . 0.0 114.527 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -120.21 99.94 6.89 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.992 1.717 . . . . 0.0 110.076 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.51 92.86 8.26 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 122.87 1.319 . . . . 0.0 110.709 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 28.1 ptm -156.39 1.45 0.14 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -176.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -143.84 174.67 10.62 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.085 1.354 . . . . 0.0 111.139 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 30.6 p -101.82 175.0 5.7 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 123.032 1.396 . . . . 0.0 113.734 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.02 -40.64 77.08 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.999 1.72 . . . . 0.0 112.535 -178.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 67.3 m -61.39 -53.56 55.0 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.089 0.956 . . . . 0.0 110.251 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 73.5 m -55.46 -49.12 73.32 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.387 1.075 . . . . 0.0 110.955 175.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.24 -54.91 37.47 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.708 1.203 . . . . 0.0 112.687 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -66.08 -33.83 76.68 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.025 -1.047 . . . . 0.0 112.73 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -59.75 -52.77 64.06 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.388 1.075 . . . . 0.0 110.379 176.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 22.6 mt -52.11 -51.22 59.15 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.7 1.2 . . . . 0.0 110.063 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -53.75 -49.02 69.1 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.948 1.299 . . . . 0.0 112.469 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -62.5 -40.57 97.14 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.075 1.35 . . . . 0.0 112.019 175.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 42.4 mmt180 -71.72 -6.35 40.62 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 126.401 1.88 . . . . 0.0 113.382 175.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 35.5 t30 83.87 4.14 0.81 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 130.928 3.691 . . . . 0.0 115.761 176.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -86.68 128.47 56.42 Favored Pre-proline 0 N--CA 1.475 0.775 0 CA-C-N 120.359 1.436 . . . . 0.0 109.799 176.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.16 -75.77 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.869 2.379 . . . . 0.0 111.701 178.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 41.6 t -109.26 133.3 20.83 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 126.554 1.942 . . . . 0.0 111.294 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.31 -5.39 16.14 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.337 2.691 . . . . 0.0 113.733 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 23.9 t -110.0 -76.99 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.472 1.109 . . . . 0.0 112.454 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 22.4 p -94.87 -4.99 45.97 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.862 1.665 . . . . 0.0 114.552 -176.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 65.2 13.43 8.74 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.487 2.315 . . . . 0.0 114.655 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -64.44 128.69 93.62 Favored Pre-proline 0 CA--C 1.552 1.035 0 O-C-N 121.34 -0.85 . . . . 0.0 110.793 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -49.19 113.72 1.02 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 124.536 3.49 . . . . 0.0 115.127 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.5 pp -71.7 142.58 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.776 1.231 . . . . 0.0 112.314 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -115.14 -34.87 4.88 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.733 1.613 . . . . 0.0 113.73 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 1.4 ttp -146.73 150.84 36.16 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 12.2 mt -139.07 130.81 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 128.363 2.665 . . . . 0.0 106.698 173.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 21.0 m -137.4 150.16 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 124.941 1.296 . . . . 0.0 113.573 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 5.7 tt -64.74 99.95 0.36 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.907 1.283 . . . . 0.0 109.019 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 45.6 m -95.35 113.32 24.98 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.527 1.531 . . . . 0.0 113.683 -173.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -75.46 100.85 4.62 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.07 1.348 . . . . 0.0 110.352 175.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -75.48 156.01 85.38 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 125.406 1.482 . . . . 0.0 111.585 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo . . . . . 0 C--N 1.351 0.695 0 C-N-CA 123.504 2.803 . . . . 0.0 111.566 -179.518 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 64.5 m . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.473 ' H ' ' HD2' ' A' ' 431' ' ' PRO . 58.5 tp -124.8 -47.81 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 126.869 2.067 . . . . 0.0 114.49 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.473 ' HD2' ' H ' ' A' ' 430' ' ' LEU . 73.3 Cg_endo -74.42 -173.74 1.58 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.555 2.17 . . . . 0.0 112.643 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 59.6 tp -53.4 -22.31 7.41 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.657 1.983 . . . . 0.0 114.709 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -63.59 29.71 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 128.882 2.873 . . . . 0.0 115.79 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -135.81 25.06 3.37 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 126.842 2.057 . . . . 0.0 114.012 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 88.4 mt -54.45 -50.45 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.607 1.163 . . . . 0.0 113.61 -177.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 50.76 70.43 2.01 Favored Pre-proline 0 CA--C 1.559 1.315 0 C-N-CA 126.096 1.758 . . . . 0.0 111.915 -176.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -76.63 -169.79 0.78 Allowed 'Trans proline' 0 CA--C 1.545 1.049 1 C-N-CA 125.931 4.42 . . . . 0.0 115.089 -175.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 7.6 t -51.33 156.87 1.09 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 128.317 2.647 . . . . 0.0 111.771 173.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 3.8 p -134.82 -2.4 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.847 0.859 . . . . 0.0 113.019 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 13.1 mt -131.11 -49.61 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.622 1.169 . . . . 0.0 112.591 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.7 m -65.99 -60.69 2.59 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.689 1.196 . . . . 0.0 113.957 -174.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -160.29 -9.21 0.05 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 85.57 16.36 64.15 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-N 119.963 1.256 . . . . 0.0 113.245 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -64.61 151.16 92.64 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 127.003 2.121 . . . . 0.0 112.982 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -54.48 -8.05 1.04 Allowed 'Trans proline' 0 CA--C 1.544 1.018 1 C-N-CA 125.526 4.151 . . . . 0.0 119.717 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -59.79 153.89 19.56 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 120.236 1.38 . . . . 0.0 112.459 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -128.12 150.2 50.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.887 2.475 . . . . 0.0 110.779 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -172.71 80.99 0.08 OUTLIER Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.665 1.126 . . . . 0.0 113.468 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 19.8 t -65.14 142.49 58.33 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.082 0.941 . . . . 0.0 110.245 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.88 142.47 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.854 1.662 . . . . 0.0 110.773 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 98.8 t -130.05 121.61 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.585 1.154 . . . . 0.0 111.303 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.3 125.43 43.51 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.949 2.9 . . . . 0.0 112.977 175.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 49.92 34.96 23.94 Favored Glycine 0 CA--C 1.54 1.618 0 N-CA-C 116.578 1.391 . . . . 0.0 116.578 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm 77.42 9.21 2.59 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 127.711 2.404 . . . . 0.0 114.351 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 78.5 p -118.58 161.7 19.62 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 127.405 2.282 . . . . 0.0 107.641 172.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -153.17 166.29 31.52 Favored Glycine 0 CA--C 1.523 0.571 0 O-C-N 119.891 -1.756 . . . . 0.0 115.668 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -120.12 128.49 53.5 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 126.499 1.92 . . . . 0.0 112.022 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 55.3 tp -120.59 153.23 37.08 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.432 2.293 . . . . 0.0 111.364 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 34.2 mtm 90.72 54.27 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 129.44 3.096 . . . . 0.0 112.804 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -155.73 163.88 39.31 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 128.316 2.646 . . . . 0.0 108.992 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 15.3 p -91.54 175.02 7.06 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 122.896 1.332 . . . . 0.0 112.828 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -65.15 -36.08 83.11 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.049 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 25.2 m -67.39 -46.32 73.61 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 117.143 -1.408 . . . . 0.0 110.547 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 37.9 m -48.28 -56.46 7.96 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.442 1.474 . . . . 0.0 109.89 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.53 -52.59 65.0 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.43 1.492 . . . . 0.0 112.578 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -56.79 -42.05 78.8 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.459 1.503 . . . . 0.0 112.243 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -59.31 -54.02 51.61 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.012 1.725 . . . . 0.0 110.375 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . 0.254 0.4 OUTLIER -68.09 -31.14 70.55 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 179.233 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -62.88 -56.54 16.36 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.667 1.987 . . . . 0.0 112.226 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -62.86 -33.49 75.38 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -76.42 -3.16 35.6 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.633 1.573 . . . . 0.0 112.179 173.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 64.2 t30 48.24 42.12 17.11 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 128.066 2.546 . . . . 0.0 112.599 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -70.52 129.64 89.91 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 124.611 1.164 . . . . 0.0 112.949 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.33 123.74 8.44 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.616 2.211 . . . . 0.0 108.117 170.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 25.3 t -31.14 129.52 0.27 Allowed Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 128.311 2.645 . . . . 0.0 114.289 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -65.58 -3.86 8.6 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.286 2.658 . . . . 0.0 114.74 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 43.6 t -126.09 -59.59 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.281 1.432 . . . . 0.0 111.259 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 63.8 m -76.0 -19.83 58.35 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.351 1.861 . . . . 0.0 113.137 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 63.5 9.14 3.98 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 127.217 2.207 . . . . 0.0 114.028 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -82.81 137.95 43.69 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 125.007 1.323 . . . . 0.0 112.213 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.85 119.35 6.15 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.149 2.566 . . . . 0.0 108.704 174.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 6.2 pt -66.95 147.08 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -174.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -115.16 -35.77 4.59 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 -174.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 1.4 ttp -145.9 151.37 37.75 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -171.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 4.4 mt -137.04 136.75 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 127.62 2.368 . . . . 0.0 109.08 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 15.7 m -140.04 150.02 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 124.704 1.202 . . . . 0.0 112.953 177.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 55.5 mt -69.94 99.95 1.5 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.213 1.005 . . . . 0.0 108.612 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 26.2 m -101.26 94.89 6.18 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.119 1.768 . . . . 0.0 112.464 -174.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -83.7 164.11 19.84 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.401 1.48 . . . . 0.0 113.353 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -120.42 164.19 24.32 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.546 1.538 . . . . 0.0 112.555 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo . . . . . 0 C--N 1.353 0.815 0 C-N-CA 124.482 3.454 . . . . 0.0 113.915 -179.879 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 98.5 mt -62.6 148.51 90.68 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.32 1.048 . . . . 0.0 113.605 -177.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -76.93 -3.68 14.05 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 123.899 3.066 . . . . 0.0 113.668 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 22.3 mt -141.76 159.92 41.24 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 128.013 2.525 . . . . 0.0 108.53 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 57.12 -10.61 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 129.76 3.224 . . . . 0.0 116.88 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -73.74 49.02 0.3 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 127.205 2.202 . . . . 0.0 113.551 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 13.1 mm -78.46 62.21 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.971 1.708 . . . . 0.0 110.034 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -73.87 158.71 85.63 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 126.746 2.018 . . . . 0.0 113.25 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -79.61 178.93 6.79 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.446 2.764 . . . . 0.0 112.978 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 438' ' ' CYS . . . . . 0.403 ' SG ' ' N ' ' B' ' 439' ' ' VAL . 40.1 t -54.59 178.06 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 127.583 2.353 . . . . 0.0 113.22 175.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 439' ' ' VAL . . . . . 0.403 ' N ' ' SG ' ' B' ' 438' ' ' CYS . 7.4 p -111.76 -11.47 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.39 1.876 . . . . 0.0 112.343 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 7.3 mt -113.91 -66.76 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.739 1.215 . . . . 0.0 111.341 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 17.0 p -73.57 -43.73 59.09 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 120.519 1.509 . . . . 0.0 108.869 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 57.87 13.5 2.13 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.936 2.894 . . . . 0.0 113.903 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . -85.22 -27.41 33.56 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 121.576 -0.703 . . . . 0.0 112.459 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -115.5 155.12 47.62 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 126.941 2.096 . . . . 0.0 115.384 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -56.84 155.17 28.56 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.094 3.196 . . . . 0.0 113.238 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -65.47 32.03 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 127.761 2.424 . . . . 0.0 116.148 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -81.78 89.96 6.34 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.061 -1.649 . . . . 0.0 109.822 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 165.93 58.8 0.03 OUTLIER Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.36 0.981 . . . . 0.0 112.401 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 43.3 t -59.3 126.29 27.06 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.394 1.097 . . . . 0.0 109.99 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 2.4 mp -102.07 142.81 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.187 1.395 . . . . 0.0 110.418 -176.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 88.5 t -130.01 132.88 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.856 0.862 . . . . 0.0 111.241 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -121.18 96.21 5.0 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 128.519 2.728 . . . . 0.0 110.047 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 71.21 -91.48 0.46 Allowed Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.716 1.627 . . . . 0.0 114.057 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -120.25 -2.19 10.16 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.169 1.788 . . . . 0.0 113.916 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 82.3 p -127.77 167.87 15.91 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.468 1.907 . . . . 0.0 109.882 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -150.67 177.52 28.67 Favored Glycine 0 CA--C 1.527 0.806 0 O-C-N 121.054 -1.029 . . . . 0.0 114.324 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.11 148.22 43.89 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.138 1.375 . . . . 0.0 114.524 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.8 tt -116.12 153.16 32.26 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 130.188 3.395 . . . . 0.0 110.388 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 29.1 tpp 78.48 30.72 0.38 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 116.65 2.092 . . . . 0.0 116.65 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -136.08 149.89 48.91 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.6 1.56 . . . . 0.0 108.88 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 29.3 p -88.1 172.14 9.74 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.674 1.226 . . . . 0.0 113.918 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.17 -36.11 78.95 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.736 175.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 63.4 m -62.53 -63.5 1.21 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.143 0.977 . . . . 0.0 109.964 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 77.5 m -53.79 -42.98 68.9 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.815 1.246 . . . . 0.0 112.754 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -60.67 -48.26 82.57 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.31 -0.869 . . . . 0.0 112.046 173.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -59.75 -43.22 94.37 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 120.771 -1.206 . . . . 0.0 111.205 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -57.79 -54.96 40.94 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.222 1.009 . . . . 0.0 111.09 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.32 -30.39 71.53 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -67.44 -48.14 68.1 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.337 1.455 . . . . 0.0 112.359 175.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -59.01 -37.49 77.04 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.381 1.072 . . . . 0.0 111.56 176.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 39.4 tpt85 -76.21 -10.54 59.49 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.872 2.469 . . . . 0.0 112.393 174.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 64.1 t30 52.76 42.62 31.83 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.323 2.249 . . . . 0.0 111.919 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 34.2 tttp -70.01 129.04 91.24 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.644 1.178 . . . . 0.0 113.401 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.61 124.44 8.82 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 122.638 2.225 . . . . 0.0 107.579 169.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 40.2 t -30.72 128.36 0.27 Allowed Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 128.294 2.638 . . . . 0.0 114.734 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -66.53 -3.04 8.35 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.172 2.581 . . . . 0.0 114.585 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 41.8 t -127.68 -58.49 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.172 1.389 . . . . 0.0 111.619 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 60.6 m -77.31 -17.57 58.2 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.43 1.892 . . . . 0.0 112.679 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 44.6 mtm105 62.76 7.85 2.75 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.527 2.331 . . . . 0.0 114.368 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -86.38 143.03 35.93 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 123.829 0.851 . . . . 0.0 112.914 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.38 126.46 10.38 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.359 2.706 . . . . 0.0 110.218 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 7.3 pt -72.19 153.8 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -115.05 -41.84 3.28 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.515 1.526 . . . . 0.0 114.019 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.98 167.16 30.09 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -174.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 7.9 mt -134.33 137.38 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 128.097 2.559 . . . . 0.0 107.728 177.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 3.7 t -127.01 147.78 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.627 1.171 . . . . 0.0 112.539 -178.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.52 106.86 2.28 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.565 1.546 . . . . 0.0 107.545 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 50.1 m -103.63 126.0 50.49 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.22 1.408 . . . . 0.0 114.214 -171.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -123.63 178.79 5.04 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.364 2.266 . . . . 0.0 111.823 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -127.79 163.48 42.9 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.509 1.524 . . . . 0.0 112.579 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo . . . . . 0 C--N 1.353 0.802 0 C-N-CA 123.931 3.088 . . . . 0.0 114.085 -179.175 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -136.01 62.4 45.91 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 126.601 1.96 . . . . 0.0 112.788 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -56.49 -34.3 94.57 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.288 2.658 . . . . 0.0 113.38 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -63.83 -15.07 57.92 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.25 -12.87 8.97 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.766 1.626 . . . . 0.0 111.789 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -96.61 -30.77 13.08 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.922 1.289 . . . . 0.0 113.169 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 3.9 mp -129.92 -53.94 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.72 1.608 . . . . 0.0 109.415 176.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . 0.268 38.8 mt-10 113.86 -53.38 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.335 1 C-N-CA 131.743 4.017 . . . . 0.0 117.333 174.523 . . . . . . . . 3 2 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . 0.252 45.8 Cg_exo -55.25 -82.2 0.01 OUTLIER 'Trans proline' 0 CA--C 1.552 1.382 0 C-N-CA 124.913 3.742 . . . . 0.0 116.525 -174.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 14.1 t -65.32 151.5 46.08 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 121.508 1.958 . . . . 0.0 109.343 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 13.2 m -132.59 -3.23 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 6.6 mt -133.26 -46.34 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 119.4 1.0 . . . . 0.0 112.852 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.5 m -67.55 -60.05 2.87 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -173.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -153.89 -14.04 0.14 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -176.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 83.94 7.15 85.96 Favored Glycine 0 CA--C 1.539 1.532 0 O-C-N 120.948 -1.095 . . . . 0.0 112.453 -173.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -55.01 155.04 8.98 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 129.07 2.948 . . . . 0.0 113.255 178.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.31 -10.25 4.51 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 125.186 3.924 . . . . 0.0 118.795 -178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -59.37 139.17 57.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.481 1.512 . . . . 0.0 112.8 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.2 150.04 50.19 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.27 1.828 . . . . 0.0 111.106 175.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -156.34 91.6 0.12 Allowed Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.667 1.603 . . . . 0.0 111.867 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 48.3 t -64.82 133.69 52.48 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.563 0.745 . . . . 0.0 110.89 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.16 144.73 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.424 1.889 . . . . 0.0 110.896 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 74.3 t -129.99 134.62 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.356 1.062 . . . . 0.0 111.198 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -125.07 94.96 4.32 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.497 2.319 . . . . 0.0 111.281 175.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 65.95 -93.32 0.18 Allowed Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.959 1.742 . . . . 0.0 114.709 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -111.0 -2.35 15.98 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.28 1.832 . . . . 0.0 114.362 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 6.5 p -130.65 170.0 14.88 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.229 2.212 . . . . 0.0 110.82 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -157.1 170.83 34.41 Favored Glycine 0 CA--C 1.533 1.176 0 O-C-N 120.902 -1.124 . . . . 0.0 113.854 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -120.08 140.04 51.64 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.432 1.893 . . . . 0.0 111.799 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 36.3 tp -134.67 153.26 52.07 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 127.553 2.341 . . . . 0.0 111.061 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 80.0 mtp 75.46 56.89 0.06 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 127.311 2.244 . . . . 0.0 112.054 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -151.53 148.52 28.12 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 129.391 3.076 . . . . 0.0 107.102 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 6.2 p -80.55 173.77 12.27 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 122.773 1.273 . . . . 0.0 112.321 177.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.38 -39.88 94.72 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.406 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 32.4 m -68.65 -44.52 73.98 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 116.505 -1.712 . . . . 0.0 110.918 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 53.8 m -46.64 -56.97 5.26 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 121.403 1.91 . . . . 0.0 110.926 175.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.72 -51.1 71.38 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.27 1.428 . . . . 0.0 112.778 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -58.77 -41.17 85.96 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.153 0.981 . . . . 0.0 112.667 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.37 -53.61 54.45 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.55 2.34 . . . . 0.0 110.768 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 15.0 mt -51.37 -54.42 26.66 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.658 1.183 . . . . 0.0 109.898 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -55.34 -48.03 74.8 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.486 1.114 . . . . 0.0 112.626 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -59.14 -40.99 87.21 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.555 1.542 . . . . 0.0 111.706 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -77.1 7.38 5.07 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 127.427 2.291 . . . . 0.0 113.569 175.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 75.76 0.85 3.45 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 130.387 3.475 . . . . 0.0 116.302 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -82.54 121.13 77.93 Favored Pre-proline 0 N--CA 1.473 0.702 0 CA-C-N 120.541 1.519 . . . . 0.0 109.555 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.51 -67.37 0.03 OUTLIER 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.149 2.566 . . . . 0.0 110.325 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 15.6 t -121.53 131.42 24.45 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 127.203 2.201 . . . . 0.0 110.346 176.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.72 -5.44 16.0 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.522 2.815 . . . . 0.0 114.589 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 36.7 t -131.46 -59.21 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 120.358 1.435 . . . . 0.0 113.414 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 21.6 m -71.56 -29.25 64.52 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.821 1.648 . . . . 0.0 110.613 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 64.89 7.49 3.99 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 128.172 2.589 . . . . 0.0 113.071 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -68.35 143.27 95.44 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 124.436 1.094 . . . . 0.0 110.765 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.05 110.08 2.53 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.563 2.842 . . . . 0.0 113.556 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 11.3 pt -66.06 153.58 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.496 0.665 . . . . 0.0 112.356 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -109.73 -47.53 3.34 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.071 1.348 . . . . 0.0 112.166 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.31 170.13 23.17 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.081 1.352 . . . . 0.0 112.676 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 13.0 mt -123.65 136.5 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 127.443 2.297 . . . . 0.0 106.435 175.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 14.3 m -131.89 150.11 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.68 99.92 2.21 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 6.3 t -87.71 150.12 23.81 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.887 -0.508 . . . . 0.0 111.606 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -139.28 156.84 46.78 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.638 1.575 . . . . 0.0 111.905 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -71.47 148.49 93.25 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.535 1.134 . . . . 0.0 113.002 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo . . . . . 0 CA--C 1.539 0.744 0 C-N-CA 123.75 2.967 . . . . 0.0 112.385 179.483 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 40.9 m . . . . . 0 CA--C 1.539 0.556 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . 0.464 ' H ' ' HD2' ' B' ' 431' ' ' PRO . 62.2 tp -144.75 -53.32 0.02 OUTLIER Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 126.0 1.72 . . . . 0.0 114.639 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . 0.464 ' HD2' ' H ' ' B' ' 430' ' ' LEU . 80.1 Cg_endo -71.12 159.92 50.71 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.973 1.782 . . . . 0.0 113.147 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 67.1 mt -54.31 -33.93 59.85 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.783 1.633 . . . . 0.0 113.453 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -66.27 -21.55 66.28 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.371 1.468 . . . . 0.0 113.493 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -109.31 -44.68 3.87 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.635 1.574 . . . . 0.0 112.539 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 45.4 mm -119.55 92.45 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 126.992 2.117 . . . . 0.0 107.914 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -60.41 145.96 85.54 Favored Pre-proline 0 CA--C 1.553 1.09 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -79.07 179.56 6.36 Favored 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 124.2 3.267 . . . . 0.0 114.644 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 2.2 p -63.02 -174.52 0.07 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.242 1.817 . . . . 0.0 114.865 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 5.6 p -138.65 -9.41 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 3.9 mt -119.59 -58.83 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 120.574 1.534 . . . . 0.0 112.996 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 13.7 p -67.82 -68.46 0.38 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -174.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -137.2 -13.54 1.58 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -169.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 77.53 35.38 36.93 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -172.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -86.52 151.2 52.82 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 124.557 1.143 . . . . 0.0 113.822 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -76.18 66.4 7.01 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 124.513 3.475 . . . . 0.0 113.543 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -131.98 165.58 23.62 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.65 1.98 . . . . 0.0 112.506 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -128.18 149.94 50.22 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 128.499 2.72 . . . . 0.0 111.791 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 168.01 75.95 0.04 OUTLIER Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.913 1.72 . . . . 0.0 112.303 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 35.7 t -62.61 141.27 58.57 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.759 0.779 . . . . 0.0 111.161 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 2.5 mp -105.07 139.12 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 C-N-CA 126.106 1.763 . . . . 0.0 109.654 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 88.9 t -130.0 131.7 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.197 0.999 . . . . 0.0 108.885 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.03 99.46 6.13 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.644 2.378 . . . . 0.0 110.516 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 65.33 -96.55 0.24 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 126.172 1.844 . . . . 0.0 113.792 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 38.6 mtmm -110.34 1.07 18.25 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.066 1.746 . . . . 0.0 113.693 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 44.7 p -130.1 170.05 14.53 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.434 1.494 . . . . 0.0 112.012 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -154.25 170.42 32.75 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 121.246 -0.909 . . . . 0.0 114.037 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -120.22 112.7 19.39 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.295 1.838 . . . . 0.0 111.667 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -88.94 153.18 21.24 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 22.6 mmt 64.65 67.37 0.56 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.591 2.357 . . . . 0.0 114.54 175.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -148.97 157.87 43.75 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 129.253 3.021 . . . . 0.0 107.822 174.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 22.0 p -90.79 174.98 7.17 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 123.048 1.404 . . . . 0.0 114.13 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.44 -31.8 72.78 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.58 176.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 44.8 m -66.7 -50.25 63.44 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.64 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 36.3 m -47.87 -63.98 0.91 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.15 1.38 . . . . 0.0 109.868 174.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -52.74 -47.16 67.58 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.305 1.842 . . . . 0.0 113.654 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -60.68 -36.88 79.86 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.956 -1.09 . . . . 0.0 112.281 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -55.41 -48.16 74.81 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.607 1.163 . . . . 0.0 110.951 175.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 6.5 mp -62.63 -47.72 82.5 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.55 0.74 . . . . 0.0 110.001 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -57.09 -42.48 80.83 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -55.02 -28.36 51.48 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -119.59 8.84 11.33 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.856 2.062 . . . . 0.0 113.019 177.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 60.1 t30 42.29 56.39 3.69 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 127.252 2.221 . . . . 0.0 112.075 -174.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -70.0 133.04 88.14 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -174.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.95 115.16 4.14 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.52 2.147 . . . . 0.0 107.633 169.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 51.9 t -22.45 125.33 0.11 Allowed Pre-proline 0 CA--C 1.558 1.276 0 C-N-CA 130.146 3.378 . . . . 0.0 116.236 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -66.61 -3.94 10.06 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.139 2.56 . . . . 0.0 114.235 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 45.0 t -110.26 -64.02 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.327 1.451 . . . . 0.0 111.488 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 25.0 p -105.24 1.23 27.94 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 63.36 11.07 5.2 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 127.73 2.412 . . . . 0.0 115.945 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -75.35 144.92 78.97 Favored Pre-proline 0 CA--C 1.55 0.976 0 O-C-N 121.391 -0.818 . . . . 0.0 111.916 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.15 116.18 4.56 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.438 2.759 . . . . 0.0 111.461 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.5 pp -55.16 142.79 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.825 1.25 . . . . 0.0 111.929 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -115.04 -45.56 2.95 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.107 0.963 . . . . 0.0 113.361 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.28 166.98 30.11 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -177.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 4.0 mt -139.39 133.99 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 128.203 2.601 . . . . 0.0 107.943 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 27.8 m -140.02 150.24 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.76 1.224 . . . . 0.0 111.986 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 56.8 mt -66.91 99.82 0.67 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 42.1 m -99.79 136.0 40.37 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.624 1.17 . . . . 0.0 112.227 -173.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -128.57 160.77 31.34 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.521 1.128 . . . . 0.0 112.619 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -145.86 155.99 51.8 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.919 1.688 . . . . 0.0 111.749 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 CA--C 1.537 0.631 0 C-N-CA 123.533 2.822 . . . . 0.0 112.428 179.168 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 48.3 m . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . 0.406 ' H ' ' HD2' ' A' ' 431' ' ' PRO . 10.3 tt -129.96 -59.88 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 126.976 2.11 . . . . 0.0 111.861 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . 0.406 ' HD2' ' H ' ' A' ' 430' ' ' LEU . 72.1 Cg_endo -69.77 161.05 47.41 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.834 1.69 . . . . 0.0 111.119 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 60.0 tp -53.37 -39.44 64.19 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.153 1.381 . . . . 0.0 113.628 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -80.4 -3.66 50.58 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.903 1.281 . . . . 0.0 114.033 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . 56.96 12.93 1.33 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 127.848 2.459 . . . . 0.0 116.506 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 65.2 mt -61.86 -44.77 99.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.407 1.483 . . . . 0.0 111.4 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 38.29 64.2 3.5 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 127.69 2.396 . . . . 0.0 115.007 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -72.93 -45.15 0.5 Allowed 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.722 2.282 . . . . 0.0 112.781 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 8.0 t -58.74 147.66 32.33 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 120.531 1.514 . . . . 0.0 109.594 172.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 15.9 m -130.92 -1.15 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 10.0 mt -132.12 -47.33 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.23 1.012 . . . . 0.0 112.237 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.8 m -68.93 -62.69 1.27 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -173.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -155.44 -12.02 0.11 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -174.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 81.53 7.89 87.66 Favored Glycine 0 CA--C 1.542 1.772 0 O-C-N 120.47 -1.394 . . . . 0.0 112.424 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -59.09 152.45 51.27 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 129.669 3.187 . . . . 0.0 113.256 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -74.91 73.12 4.37 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 124.329 3.353 . . . . 0.0 113.886 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -128.91 144.12 51.09 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 127.15 2.18 . . . . 0.0 110.411 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.26 116.16 19.42 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -173.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -138.59 83.2 0.25 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.441 1.496 . . . . 0.0 111.663 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 16.4 t -66.12 140.21 58.2 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.077 0.939 . . . . 0.0 112.309 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.3 mp -115.1 141.2 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 126.832 2.053 . . . . 0.0 110.441 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 67.4 t -126.49 134.02 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.627 1.171 . . . . 0.0 111.134 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -118.78 98.04 6.02 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.451 2.7 . . . . 0.0 110.651 175.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 73.55 -87.42 0.62 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.849 1.69 . . . . 0.0 114.068 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -129.85 1.92 4.87 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.265 1.826 . . . . 0.0 113.431 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 72.8 p -131.2 170.06 15.08 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.204 2.202 . . . . 0.0 109.197 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -152.56 174.6 31.4 Favored Glycine 0 N--CA 1.466 0.69 0 O-C-N 120.541 -1.349 . . . . 0.0 113.273 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -120.09 105.84 11.39 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.368 1.067 . . . . 0.0 111.788 177.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 15.2 tp -81.67 153.18 26.75 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.011 2.524 . . . . 0.0 110.211 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 48.7 mtt 85.54 66.35 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 128.008 2.523 . . . . 0.0 111.976 178.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -158.86 145.09 16.85 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 127.719 2.408 . . . . 0.0 108.537 175.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 19.9 p -83.78 173.69 11.08 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 122.28 1.038 . . . . 0.0 110.746 174.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -64.72 -37.44 87.59 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.502 -0.749 . . . . 0.0 111.191 178.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 27.8 m -65.15 -49.03 71.44 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 117.132 -1.413 . . . . 0.0 110.661 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 32.9 m -48.06 -55.77 9.37 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 120.555 1.525 . . . . 0.0 110.57 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.55 92.4 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.846 1.258 . . . . 0.0 113.002 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -61.52 -43.32 99.08 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.817 -1.177 . . . . 0.0 111.586 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -62.52 -54.03 45.93 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.996 1.318 . . . . 0.0 111.514 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 2.5 pp -60.49 -37.72 81.98 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.644 0.656 . . . . 0.0 111.25 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -59.95 -52.11 66.79 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.186 1.395 . . . . 0.0 111.378 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -58.68 -35.99 73.48 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.246 1.418 . . . . 0.0 112.684 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -78.5 2.93 17.42 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.534 1.934 . . . . 0.0 113.402 175.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 28.5 m120 64.13 19.18 11.66 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 128.713 2.805 . . . . 0.0 114.62 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -72.72 135.81 80.77 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.693 1.197 . . . . 0.0 109.383 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.8 -85.57 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.037 2.491 . . . . 0.0 109.804 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 36.1 t -118.45 132.76 23.67 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.921 1.688 . . . . 0.0 110.874 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.63 -6.86 20.02 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.397 2.731 . . . . 0.0 114.119 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 40.6 t -116.36 -72.3 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 119.732 1.151 . . . . 0.0 112.752 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 25.8 p -96.25 1.31 51.99 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 86.4 mmt-85 65.54 6.67 3.9 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 128.01 2.524 . . . . 0.0 115.665 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -62.16 140.98 96.09 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-N 119.593 1.088 . . . . 0.0 111.686 177.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -69.45 112.17 2.95 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.385 2.723 . . . . 0.0 113.725 -176.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 22.8 pt -73.73 160.14 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.709 1.603 . . . . 0.0 113.39 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -112.55 -48.13 3.03 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.48 1.512 . . . . 0.0 113.19 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.14 170.3 22.28 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -175.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 8.1 mt -117.2 135.38 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 126.523 1.929 . . . . 0.0 107.821 173.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 37.3 t -129.48 147.9 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.979 1.312 . . . . 0.0 110.334 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . 0.271 0.0 OUTLIER -81.59 116.79 21.51 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.298 1.047 . . . . 0.0 108.348 177.031 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 6.5 m -115.84 99.04 7.01 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.271 -1.331 . . . . 0.0 114.134 -169.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -68.78 171.2 8.17 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.044 1.738 . . . . 0.0 112.937 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -134.33 164.04 46.86 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.81 1.644 . . . . 0.0 111.121 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo . . . . . 0 C--N 1.353 0.774 0 C-N-CA 124.341 3.361 . . . . 0.0 113.855 179.551 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 96.7 mt -68.39 156.68 89.84 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.293 1.437 . . . . 0.0 110.731 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -42.82 -51.0 5.67 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 124.262 3.308 . . . . 0.0 115.827 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -64.94 -16.66 63.59 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -103.21 -25.76 13.24 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.984 1.714 . . . . 0.0 111.441 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -79.6 -48.66 13.41 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.737 1.615 . . . . 0.0 111.858 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 26.5 mm -83.27 68.58 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.583 1.153 . . . . 0.0 109.97 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -140.52 66.04 27.76 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 126.134 1.774 . . . . 0.0 109.512 176.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.15 -32.34 52.61 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.347 2.698 . . . . 0.0 115.5 -175.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 14.6 t -55.22 145.95 20.15 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 120.546 1.521 . . . . 0.0 111.333 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 29.8 m -132.22 0.1 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.93 1.692 . . . . 0.0 113.615 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 1.7 mt -134.69 -48.37 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 116.932 -1.509 . . . . 0.0 114.731 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 25.2 p -77.68 -60.53 2.33 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 121.457 1.935 . . . . 0.0 115.16 -173.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -139.86 -8.32 1.22 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 74.63 17.63 79.97 Favored Glycine 0 CA--C 1.541 1.672 0 CA-C-N 119.818 1.19 . . . . 0.0 111.356 -173.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -61.23 155.15 58.36 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 127.541 2.337 . . . . 0.0 113.858 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.8 -1.32 9.15 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.363 3.375 . . . . 0.0 116.141 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -60.17 156.77 14.52 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.941 1.696 . . . . 0.0 112.672 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -128.09 150.14 50.09 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.848 2.059 . . . . 0.0 110.489 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -163.87 67.76 0.22 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.258 1.409 . . . . 0.0 112.417 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 45.0 t -57.47 128.22 35.92 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.732 1.213 . . . . 0.0 110.176 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.98 144.06 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.06 1.344 . . . . 0.0 110.189 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 88.8 t -129.28 126.64 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.767 1.227 . . . . 0.0 109.697 176.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.18 122.52 37.29 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 128.813 2.845 . . . . 0.0 112.647 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 64.1 -77.54 0.05 OUTLIER Glycine 0 CA--C 1.539 1.552 0 C-N-CA 126.207 1.861 . . . . 0.0 114.872 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -146.61 2.46 0.83 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 127.453 2.301 . . . . 0.0 113.212 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 71.5 p -131.72 170.12 15.24 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 127.575 2.35 . . . . 0.0 110.54 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -144.58 171.93 25.73 Favored Glycine 0 N--CA 1.47 0.93 0 O-C-N 120.479 -1.388 . . . . 0.0 115.248 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.25 135.2 55.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.424 1.889 . . . . 0.0 113.223 175.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 4.0 pp -119.77 153.33 35.85 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.662 2.385 . . . . 0.0 110.942 174.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 11.5 tpt 94.65 53.87 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 129.304 3.042 . . . . 0.0 111.689 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -159.93 150.17 18.61 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.763 2.425 . . . . 0.0 108.4 175.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 31.2 p -90.03 174.29 7.73 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 122.377 1.084 . . . . 0.0 111.591 175.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.43 -37.93 88.38 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.634 -0.667 . . . . 0.0 110.991 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 43.7 m -60.25 -54.37 46.52 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 117.616 -1.183 . . . . 0.0 110.48 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 59.5 m -51.79 -61.98 1.91 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.923 1.238 . . . . 0.0 111.002 175.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -47.17 -52.37 15.79 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.037 -1.04 . . . . 0.0 112.578 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -62.21 -37.94 87.25 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.466 1.106 . . . . 0.0 112.965 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -60.47 -50.65 72.74 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.482 1.513 . . . . 0.0 110.625 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -58.25 -46.23 86.33 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.849 0.459 . . . . 0.0 110.242 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -55.99 -46.57 78.66 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.297 1.039 . . . . 0.0 112.276 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -62.05 -39.1 91.21 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.624 1.569 . . . . 0.0 111.506 174.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -79.7 16.47 1.11 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 128.066 2.546 . . . . 0.0 113.196 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . 0.303 0.2 OUTLIER 59.8 8.13 1.28 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 130.667 3.587 . . . . 0.0 117.849 179.802 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -84.59 127.41 65.65 Favored Pre-proline 0 N--CA 1.474 0.731 0 CA-C-N 120.045 1.293 . . . . 0.0 108.158 173.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.33 -81.8 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 123.069 2.513 . . . . 0.0 112.263 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 41.3 t -81.95 131.87 55.71 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 124.425 1.09 . . . . 0.0 110.887 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -70.32 -5.28 16.18 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.945 2.43 . . . . 0.0 114.487 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 28.9 t -119.68 -75.9 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.986 1.266 . . . . 0.0 113.084 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 23.7 p -91.91 -1.11 57.46 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 26.9 ttt-85 64.87 18.78 11.63 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 127.306 2.242 . . . . 0.0 115.107 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -65.98 156.09 85.02 Favored Pre-proline 0 CA--C 1.554 1.122 0 O-C-N 121.049 -1.032 . . . . 0.0 111.347 174.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.88 105.89 1.59 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.71 2.94 . . . . 0.0 113.522 -177.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.16 154.26 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.091 1.356 . . . . 0.0 113.512 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -115.2 -43.0 3.11 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.026 2.131 . . . . 0.0 111.687 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.91 167.55 27.79 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.977 1.311 . . . . 0.0 114.303 -176.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 18.6 mt -134.23 135.21 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 129.099 2.96 . . . . 0.0 105.919 173.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.48 150.14 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.428 1.091 . . . . 0.0 113.367 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.61 99.93 1.37 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.01 86.39 3.97 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.835 1.254 . . . . 0.0 112.704 -173.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -63.6 169.69 3.74 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.919 1.288 . . . . 0.0 111.88 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -130.51 167.28 21.75 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 125.167 1.387 . . . . 0.0 111.16 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo . . . . . 0 C--N 1.352 0.726 0 C-N-CA 124.068 3.178 . . . . 0.0 113.778 -179.786 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 39.2 m . . . . . 0 CA--C 1.539 0.527 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 96.2 mt -128.45 156.99 76.16 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.937 1.695 . . . . 0.0 112.121 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -52.72 -35.65 69.58 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.602 2.868 . . . . 0.0 114.881 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 45.7 tp -62.43 -49.36 75.75 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.594 1.158 . . . . 0.0 112.86 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -75.32 -21.77 58.17 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.561 -0.712 . . . . 0.0 112.542 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.36 -52.18 12.93 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.107 0.963 . . . . 0.0 110.574 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 23.8 mm -101.91 75.5 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 126.958 2.103 . . . . 0.0 107.245 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -45.33 129.43 6.01 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 126.213 1.805 . . . . 0.0 114.926 -173.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -86.78 -179.01 2.8 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.872 3.048 . . . . 0.0 115.303 -177.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 41.3 t -57.33 -167.91 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 130.408 3.483 . . . . 0.0 112.778 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 9.7 p -132.74 -12.86 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.135 1.774 . . . . 0.0 112.748 177.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 14.3 mm -93.3 -60.1 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.332 1.053 . . . . 0.0 108.566 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 26.5 p -87.55 -44.8 10.99 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.699 1.199 . . . . 0.0 109.768 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . 0.274 14.0 pt20 52.01 22.0 1.7 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 128.981 2.913 . . . . 0.0 114.777 -174.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -94.26 -24.66 18.56 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 112.213 -0.355 . . . . 0.0 112.213 176.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -115.42 155.08 47.57 Favored Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 125.979 1.712 . . . . 0.0 115.125 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -51.41 140.15 44.21 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.683 3.589 . . . . 0.0 114.54 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -67.6 28.14 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 127.564 2.345 . . . . 0.0 117.091 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -77.87 89.83 4.08 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.46 -1.4 . . . . 0.0 110.774 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 162.35 57.86 0.02 OUTLIER Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.065 -0.853 . . . . 0.0 113.523 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 78.3 m -63.14 142.91 58.2 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.687 1.243 . . . . 0.0 110.596 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.6 mp -115.06 144.53 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 126.033 1.733 . . . . 0.0 111.377 -172.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 67.0 t -127.24 131.48 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.72 1.208 . . . . 0.0 111.657 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -119.88 97.2 5.5 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.681 2.792 . . . . 0.0 110.786 174.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.72 -91.48 0.33 Allowed Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.906 1.717 . . . . 0.0 114.046 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -118.88 -0.27 11.24 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.297 1.839 . . . . 0.0 113.849 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 67.1 p -133.24 170.08 15.96 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.603 1.961 . . . . 0.0 110.337 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -153.53 171.61 32.36 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.911 1.243 . . . . 0.0 112.899 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -120.11 133.7 55.45 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.531 1.132 . . . . 0.0 113.275 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 25.7 tp -89.64 153.13 20.98 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 129.006 2.922 . . . . 0.0 113.882 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 459' ' ' MET . . . . . . . . . . . . 0.354 25.8 ptm 59.45 57.2 3.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 129.28 3.032 . . . . 0.0 118.535 172.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -136.76 147.9 46.94 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.259 1.824 . . . . 0.0 108.145 170.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 31.3 p -82.04 165.24 20.82 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 120.24 1.382 . . . . 0.0 112.874 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.32 -38.82 84.92 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.123 177.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 96.3 m -61.2 -59.42 5.34 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.693 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 54.6 m -53.93 -48.27 70.39 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.701 1.137 . . . . 0.0 112.4 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -56.36 -51.54 67.91 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.554 0.742 . . . . 0.0 112.613 175.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -62.78 -39.71 95.06 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.03 1.332 . . . . 0.0 112.437 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -61.85 -54.18 45.68 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.177 1.391 . . . . 0.0 110.457 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 27.2 mt -50.2 -53.05 30.72 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.426 1.091 . . . . 0.0 110.089 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -52.89 -51.12 62.33 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.871 1.268 . . . . 0.0 112.644 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -61.79 -38.9 89.8 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.345 1.458 . . . . 0.0 112.698 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -75.87 -1.67 26.44 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.782 2.033 . . . . 0.0 113.361 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 35.8 t30 77.88 7.27 2.66 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 130.111 3.365 . . . . 0.0 115.482 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -78.21 123.93 85.88 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 120.655 -1.278 . . . . 0.0 108.332 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.0 -76.45 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.58 2.853 . . . . 0.0 111.589 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 27.1 t -120.33 132.16 24.21 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.637 1.975 . . . . 0.0 110.114 178.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.12 -3.22 13.49 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.461 2.774 . . . . 0.0 113.428 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 39.2 t -113.44 -71.99 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.816 1.246 . . . . 0.0 112.272 -177.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 26.3 p -100.96 -2.61 31.36 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.44 1.496 . . . . 0.0 114.587 -176.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 65.89 8.67 5.51 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 128.067 2.547 . . . . 0.0 115.861 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -62.77 124.89 85.01 Favored Pre-proline 0 CA--C 1.553 1.092 0 CA-C-N 119.357 0.981 . . . . 0.0 111.287 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.38 114.49 1.46 Allowed 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.398 3.398 . . . . 0.0 114.882 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 16.4 pt -75.94 157.76 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.795 0.838 . . . . 0.0 113.233 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -115.1 -45.45 2.95 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.052 1.741 . . . . 0.0 112.749 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.68 170.09 22.82 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.208 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 13.9 mt -131.33 138.97 51.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 128.304 2.641 . . . . 0.0 107.37 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.22 150.04 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 CA-C-N 119.728 1.149 . . . . 0.0 113.843 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -62.78 99.92 0.18 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.518 1.927 . . . . 0.0 109.412 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 12.3 m -119.95 127.94 53.12 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.103 0.961 . . . . 0.0 112.242 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -118.93 161.73 19.7 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.183 1.393 . . . . 0.0 113.518 -176.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -74.92 163.61 67.05 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 125.333 1.453 . . . . 0.0 111.697 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo . . . . . 0 C--N 1.353 0.781 0 C-N-CA 123.925 3.083 . . . . 0.0 114.451 -178.565 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 42.0 m . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 10.0 mp -68.76 157.89 87.37 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.563 1.545 . . . . 0.0 110.173 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -46.38 -41.62 22.81 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.772 2.981 . . . . 0.0 114.897 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 2.5 pp -67.31 -21.83 65.65 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -98.74 -26.28 14.39 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.352 1.461 . . . . 0.0 111.348 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -85.78 -26.92 25.51 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.934 1.694 . . . . 0.0 114.192 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 30.1 mm 57.99 85.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 127.484 2.314 . . . . 0.0 111.055 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -120.18 58.91 6.08 Favored Pre-proline 0 CA--C 1.557 1.212 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.08 -42.1 38.83 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 124.853 3.702 . . . . 0.0 114.705 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 32.7 t -55.99 142.92 34.14 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 121.502 1.956 . . . . 0.0 109.764 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.0 -0.36 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.399 1.079 . . . . 0.0 113.747 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 8.9 mt -132.94 -46.83 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.866 0.866 . . . . 0.0 112.299 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.3 m -72.13 -68.34 0.47 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -172.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -144.29 -10.45 0.65 Allowed 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -174.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 78.57 13.57 83.06 Favored Glycine 0 CA--C 1.542 1.766 0 CA-C-N 120.129 1.331 . . . . 0.0 112.668 -174.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -62.28 155.19 67.46 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 130.758 3.623 . . . . 0.0 113.952 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -67.71 -1.46 6.78 Favored 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 124.856 3.704 . . . . 0.0 116.211 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -60.93 135.14 57.7 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.007 1.723 . . . . 0.0 110.416 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.08 126.65 41.62 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.439 1.496 . . . . 0.0 113.31 -176.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -150.3 78.58 0.22 Allowed Glycine 0 CA--C 1.529 0.938 0 C-N-CA 125.405 1.479 . . . . 0.0 112.102 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 76.5 m -63.75 151.56 41.73 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 117.624 0.712 . . . . 0.0 110.987 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 4.6 mp -110.25 142.39 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 125.794 1.637 . . . . 0.0 111.216 -174.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 64.5 t -130.02 123.44 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.625 1.17 . . . . 0.0 108.234 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.24 106.24 9.72 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.843 2.057 . . . . 0.0 112.984 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 73.35 -83.75 0.64 Allowed Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.865 1.698 . . . . 0.0 114.746 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 454' ' ' LYS . . . . . 0.431 ' HA ' ' HE2' ' B' ' 454' ' ' LYS . 0.5 OUTLIER -127.57 -10.59 5.64 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.858 1.663 . . . . 0.0 114.021 -177.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 78.8 p -135.46 169.97 16.67 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.309 1.443 . . . . 0.0 111.078 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -144.32 168.8 26.56 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.192 0.901 . . . . 0.0 114.669 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -120.18 132.17 55.28 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.227 1.811 . . . . 0.0 112.649 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 4.4 pp -107.81 153.32 23.16 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.876 2.07 . . . . 0.0 111.872 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 44.0 ttm 86.19 69.16 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 128.531 2.732 . . . . 0.0 112.05 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -160.04 154.92 24.46 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 128.051 2.54 . . . . 0.0 108.538 176.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 14.3 p -90.05 174.99 7.34 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 122.354 1.073 . . . . 0.0 110.488 174.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -66.09 -31.72 72.76 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.425 -0.797 . . . . 0.0 111.616 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 40.8 m -72.25 -47.03 53.38 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 117.007 -1.473 . . . . 0.0 110.427 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 50.6 m -45.22 -57.6 3.85 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 120.306 1.412 . . . . 0.0 109.962 172.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.96 -49.89 76.16 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.234 1.814 . . . . 0.0 113.549 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -60.88 -37.5 82.41 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.091 1.356 . . . . 0.0 112.797 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -59.34 -52.15 66.88 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.966 1.306 . . . . 0.0 110.661 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 19.1 mt -57.33 -48.97 77.61 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.016 1.327 . . . . 0.0 109.978 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -56.21 -51.7 67.12 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.957 1.303 . . . . 0.0 113.244 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -52.26 -40.74 62.12 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.535 1.534 . . . . 0.0 113.426 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 32.3 ptt85 -97.45 5.99 48.88 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.684 1.594 . . . . 0.0 113.938 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 44.82 48.43 9.06 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.487 2.715 . . . . 0.0 112.332 -177.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -69.99 118.46 63.72 Favored Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 124.268 1.027 . . . . 0.0 111.896 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -62.58 123.33 12.18 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.294 1.996 . . . . 0.0 107.76 172.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 52.6 t -26.85 122.25 0.23 Allowed Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 128.72 2.808 . . . . 0.0 115.742 -173.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -65.5 -3.92 8.6 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 122.657 2.238 . . . . 0.0 113.931 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 33.9 t -107.47 -62.87 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.527 1.531 . . . . 0.0 111.347 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 26.6 p -110.09 0.97 18.58 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 63.55 11.32 5.57 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 127.84 2.456 . . . . 0.0 115.953 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -68.65 151.55 97.18 Favored Pre-proline 0 CA--C 1.551 1.01 0 O-C-N 121.373 -0.83 . . . . 0.0 111.534 176.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.84 111.26 2.98 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.594 2.863 . . . . 0.0 112.442 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.9 109.97 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 126.84 2.056 . . . . 0.0 109.982 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -107.3 -57.08 2.12 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -171.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.21 165.39 27.65 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -177.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 2.7 mt -134.96 141.41 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 127.399 2.28 . . . . 0.0 109.94 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.99 148.84 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.038 0.935 . . . . 0.0 111.826 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.0 99.8 0.91 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 17.3 m -109.23 86.87 2.37 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.221 1.008 . . . . 0.0 111.502 -174.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -77.18 159.32 29.81 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -176.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -74.12 156.28 87.77 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.617 1.567 . . . . 0.0 111.964 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo . . . . . 0 C--N 1.352 0.744 0 C-N-CA 124.156 3.237 . . . . 0.0 114.324 178.316 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' SER . . . . . 0.478 ' N ' HD22 ' A' ' 433' ' ' ASN . 33.2 m . . . . . 0 CA--C 1.54 0.572 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 10.9 mp -69.29 156.18 92.1 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.377 1.471 . . . . 0.0 110.901 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -45.35 -42.98 17.48 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 124.07 3.18 . . . . 0.0 115.957 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -66.21 -14.83 62.52 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . 0.478 HD22 ' N ' ' A' ' 429' ' ' SER . 1.7 p-10 -127.23 -7.15 5.91 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.562 1.145 . . . . 0.0 113.143 177.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -61.39 -38.26 86.42 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.638 1.175 . . . . 0.0 112.943 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.31 7.45 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.978 1.711 . . . . 0.0 113.474 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 48.55 57.41 18.17 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 126.989 2.116 . . . . 0.0 113.015 -176.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.31 167.52 23.6 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.718 2.279 . . . . 0.0 114.974 -177.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 8.4 t -58.44 178.38 0.1 Allowed 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 127.538 2.335 . . . . 0.0 114.25 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 33.6 m -134.83 -0.22 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 -173.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 6.8 mt -118.93 -56.58 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-N 121.106 1.775 . . . . 0.0 112.413 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 7.8 p -51.17 -84.85 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.116 2.166 . . . . 0.0 114.064 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -148.47 -15.8 0.33 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 131.516 3.926 . . . . 0.0 111.998 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 92.1 69.22 1.15 Allowed Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.082 1.325 . . . . 0.0 113.009 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -99.21 154.47 37.29 Favored Pre-proline 0 N--CA 1.48 1.026 0 C-N-CA 125.125 1.37 . . . . 0.0 110.888 175.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.71 125.05 15.83 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.648 2.899 . . . . 0.0 112.056 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.58 99.96 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -175.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -128.04 89.85 2.99 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.612 1.165 . . . . 0.0 107.912 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 151.96 58.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.845 0 C-N-CA 123.907 0.765 . . . . 0.0 112.459 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 35.7 t -59.57 138.31 57.75 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.34 1.07 . . . . 0.0 110.943 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.8 mp -114.96 140.62 35.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 C-N-CA 127.271 2.229 . . . . 0.0 110.772 -174.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 73.1 t -130.04 131.72 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.416 1.086 . . . . 0.0 111.641 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -111.42 100.96 9.45 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.755 2.422 . . . . 0.0 108.505 171.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 73.67 -85.0 0.65 Allowed Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.488 1.518 . . . . 0.0 112.939 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -137.08 4.86 2.75 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.338 1.855 . . . . 0.0 114.348 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 51.2 p -131.37 170.04 15.19 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.467 1.907 . . . . 0.0 110.248 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -160.08 175.56 36.87 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 120.804 -1.185 . . . . 0.0 114.561 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -120.03 100.02 6.96 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.083 1.753 . . . . 0.0 110.222 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 11.2 tp -76.69 92.75 3.56 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 128.212 2.605 . . . . 0.0 111.193 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -169.53 -27.41 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -103.35 164.06 11.88 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.085 1.311 . . . . 0.0 114.373 -174.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 32.0 p -85.92 168.34 14.29 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-O 122.123 0.963 . . . . 0.0 112.241 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.07 -42.35 90.16 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.224 -0.923 . . . . 0.0 111.678 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 86.9 m -54.98 -58.81 6.1 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.334 1.054 . . . . 0.0 109.628 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 84.0 m -57.51 -43.89 84.59 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.118 1.367 . . . . 0.0 112.629 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.71 -50.85 69.21 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.76 0.824 . . . . 0.0 111.775 174.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -65.49 -38.49 89.91 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.292 1.037 . . . . 0.0 112.089 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -60.57 -52.43 65.2 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.909 1.284 . . . . 0.0 110.845 177.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 19.6 mt -50.48 -49.81 54.37 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.764 1.226 . . . . 0.0 110.273 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 50.9 tttt -55.37 -51.64 66.15 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.942 1.297 . . . . 0.0 112.368 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -60.3 -42.47 95.57 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.555 1.542 . . . . 0.0 111.797 175.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -69.68 -3.96 17.49 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 127.372 2.269 . . . . 0.0 113.209 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 63.96 20.12 12.06 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 128.478 2.711 . . . . 0.0 114.291 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -70.05 127.7 92.16 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 173.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -64.18 -56.07 0.51 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.846 2.364 . . . . 0.0 112.057 -177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 13.2 t -152.95 137.6 10.93 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 128.335 2.654 . . . . 0.0 108.412 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -70.08 -5.19 15.81 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.205 2.604 . . . . 0.0 114.179 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 24.7 t -120.16 -75.26 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 119.99 1.268 . . . . 0.0 113.197 -178.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 10.6 p -92.19 -1.57 57.06 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.978 1.711 . . . . 0.0 114.516 -176.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 61.54 24.74 14.79 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 127.635 2.374 . . . . 0.0 115.878 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -93.72 121.14 65.25 Favored Pre-proline 0 CA--C 1.558 1.279 0 CA-C-N 119.1 0.864 . . . . 0.0 109.912 174.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -42.87 112.09 0.25 Allowed 'Trans proline' 0 CA--C 1.547 1.139 1 C-N-CA 125.375 4.05 . . . . 0.0 119.727 -173.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 1.9 pp -70.59 128.69 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 126.466 1.906 . . . . 0.0 110.386 173.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -115.18 -16.59 11.54 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -174.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 5.7 tmm? -145.87 147.67 32.04 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.299 0.954 . . . . 0.0 112.953 -173.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 13.5 mt -137.2 133.27 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 126.736 2.014 . . . . 0.0 109.763 174.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 3.4 m -119.24 150.16 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 125.709 1.604 . . . . 0.0 112.4 176.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.55 99.88 3.74 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 175.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 24.8 m -88.63 143.81 26.7 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -174.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -123.6 152.32 42.04 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.107 2.163 . . . . 0.0 110.507 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . 0.459 ' H ' ' CD ' ' A' ' 491' ' ' PRO . 56.2 p90 -138.39 -29.53 0.01 OUTLIER Pre-proline 0 CA--C 1.552 1.033 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 491' ' ' PRO . . . . . 0.459 ' CD ' ' H ' ' A' ' 490' ' ' PHE . 87.5 Cg_exo . . . . . 0 C--N 1.359 1.12 0 C-N-CA 123.255 2.636 . . . . 0.0 114.218 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 41.3 p . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 23.0 tp -63.97 136.76 96.87 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.34 1.456 . . . . 0.0 109.244 176.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -44.23 -43.98 12.96 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.855 3.037 . . . . 0.0 115.498 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 71.7 mt -58.93 -36.68 75.17 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.473 1.109 . . . . 0.0 113.066 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -89.12 -19.01 26.06 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.599 1.56 . . . . 0.0 112.852 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -76.69 1.91 15.73 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.384 1.873 . . . . 0.0 115.192 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 15.4 mm 55.5 80.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 127.672 2.389 . . . . 0.0 112.554 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.13 156.31 59.75 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.839 1.656 . . . . 0.0 114.771 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -78.63 -155.4 0.05 OUTLIER 'Trans proline' 0 CA--C 1.556 1.62 0 C-N-CA 125.004 3.803 . . . . 0.0 110.2 174.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 11.4 t -47.72 148.03 1.68 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.67 1.588 . . . . 0.0 111.722 175.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 25.7 t -117.93 -11.25 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.611 1.565 . . . . 0.0 112.093 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 10.0 mt -128.62 -53.26 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -174.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 2.1 m -69.82 -68.97 0.38 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.594 1.958 . . . . 0.0 115.371 -171.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -144.82 -10.24 0.6 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -173.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.51 11.38 82.04 Favored Glycine 0 CA--C 1.542 1.764 0 CA-C-N 119.638 1.108 . . . . 0.0 112.603 -174.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -67.48 155.04 92.0 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 127.738 2.415 . . . . 0.0 111.957 177.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.61 142.45 13.74 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.729 2.952 . . . . 0.0 115.112 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -63.82 34.98 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 129.305 3.042 . . . . 0.0 116.164 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -81.35 89.77 6.12 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.491 -1.381 . . . . 0.0 108.139 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 170.51 48.37 0.04 OUTLIER Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.993 0.806 . . . . 0.0 112.846 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 48.4 t -55.32 133.52 49.59 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.106 1.362 . . . . 0.0 109.732 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 2.1 mp -104.53 150.18 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 126.001 1.72 . . . . 0.0 109.736 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 40.2 t -124.68 140.12 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 122.362 1.077 . . . . 0.0 110.652 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -125.22 94.92 4.3 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 128.355 2.662 . . . . 0.0 109.106 175.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 66.63 -84.18 0.11 Allowed Glycine 0 CA--C 1.538 1.51 0 C-N-CA 124.796 1.189 . . . . 0.0 113.333 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -130.4 0.93 4.56 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 128.057 2.543 . . . . 0.0 113.81 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 27.7 p -112.39 170.15 8.37 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.978 2.111 . . . . 0.0 109.735 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -154.17 167.49 32.33 Favored Glycine 0 CA--C 1.528 0.879 0 O-C-N 120.692 -1.255 . . . . 0.0 114.844 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -120.08 143.11 48.31 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.172 1.389 . . . . 0.0 113.11 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 9.9 tt -126.66 153.09 45.85 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 130.434 3.493 . . . . 0.0 108.985 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 9.5 ttt 100.22 19.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 128.796 2.838 . . . . 0.0 114.529 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -140.94 152.93 45.38 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.901 1.68 . . . . 0.0 110.368 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 13.1 p -82.2 174.51 11.11 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.619 1.2 . . . . 0.0 113.198 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.51 -46.31 86.97 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.406 177.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 49.0 m -65.86 -42.84 89.91 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 117.345 -1.312 . . . . 0.0 112.391 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 55.5 m -49.83 -55.36 14.49 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 120.382 1.447 . . . . 0.0 109.588 173.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -62.8 -40.75 98.31 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.622 1.569 . . . . 0.0 113.587 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -60.6 -44.02 96.75 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.554 1.542 . . . . 0.0 111.582 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -57.46 -58.37 8.6 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.108 1.363 . . . . 0.0 110.647 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.3 pp -64.03 -32.22 73.7 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -67.41 -47.39 70.41 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.906 1.682 . . . . 0.0 111.434 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -60.08 -38.7 83.66 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.234 1.014 . . . . 0.0 111.945 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -76.59 -6.41 51.83 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.7 1.6 . . . . 0.0 113.018 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 64.3 t30 52.7 39.31 28.27 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 128.135 2.574 . . . . 0.0 112.144 -177.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -73.92 132.3 80.35 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.328 1.451 . . . . 0.0 112.177 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -70.61 119.1 6.08 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.492 2.128 . . . . 0.0 107.612 170.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 42.9 t -20.75 125.7 0.08 OUTLIER Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 129.157 2.983 . . . . 0.0 116.44 -176.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -65.91 -1.8 5.67 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 122.845 2.363 . . . . 0.0 114.172 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 45.2 t -113.96 -69.51 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.671 1.588 . . . . 0.0 111.34 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 28.3 p -93.45 -7.57 44.08 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? 61.4 13.52 5.07 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 127.158 2.183 . . . . 0.0 114.67 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -74.1 159.19 84.52 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.418 1.087 . . . . 0.0 111.806 176.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -69.61 130.2 19.1 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.973 2.449 . . . . 0.0 112.087 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.59 110.4 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 126.161 1.784 . . . . 0.0 110.816 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -87.41 -61.14 1.79 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.542 1.137 . . . . 0.0 113.303 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.17 170.06 22.1 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.057 1.343 . . . . 0.0 113.922 -174.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 13.3 mt -133.03 140.69 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 127.714 2.405 . . . . 0.0 108.643 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 5.2 m -131.75 150.03 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 125.215 1.406 . . . . 0.0 112.956 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.51 99.93 3.14 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.78 95.8 6.05 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.306 1.442 . . . . 0.0 112.541 -173.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -68.55 161.71 27.33 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.306 1.442 . . . . 0.0 111.209 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -133.29 165.4 37.03 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 125.314 1.446 . . . . 0.0 111.59 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo . . . . . 0 C--N 1.352 0.752 0 C-N-CA 124.345 3.364 . . . . 0.0 114.124 -179.592 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 43.7 m . . . . . 0 CA--C 1.54 0.572 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 52.3 tp -135.1 97.38 13.58 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 126.601 1.96 . . . . 0.0 109.622 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -62.39 -27.89 77.87 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.676 2.25 . . . . 0.0 114.099 -176.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 63.4 tp -65.45 -36.0 82.6 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.189 0.904 . . . . 0.0 112.316 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -73.45 -33.71 65.03 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.844 0.858 . . . . 0.0 111.28 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -72.55 -59.29 2.79 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.34 1.056 . . . . 0.0 110.833 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 19.5 mm -84.97 62.11 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 126.723 2.009 . . . . 0.0 108.447 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -56.27 114.18 7.22 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 125.283 1.433 . . . . 0.0 114.067 -176.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -79.02 171.24 16.7 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.565 2.844 . . . . 0.0 113.141 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 8.0 p -68.47 -177.28 0.9 Allowed 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 16.8 m -139.09 -8.83 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 4.2 mt -110.74 -62.26 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 121.132 1.787 . . . . 0.0 112.539 -177.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 19.7 p -65.63 -64.32 0.89 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -176.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . 0.504 HE21 ' NH2' ' A' ' 444' ' ' ARG . 43.4 mt-30 -143.64 -13.19 0.67 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 116.981 2.215 . . . . 0.0 116.981 -173.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 81.94 28.07 43.25 Favored Glycine 0 CA--C 1.536 1.381 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -172.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . 0.504 ' NH2' HE21 ' A' ' 442' ' ' GLN . 12.8 ptp180 -72.84 155.07 90.97 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 125.142 1.377 . . . . 0.0 111.534 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -70.07 1.82 4.29 Favored 'Trans proline' 0 CA--C 1.548 1.214 0 C-N-CA 124.03 3.153 . . . . 0.0 116.135 -178.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -63.56 156.71 25.67 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 127.016 2.126 . . . . 0.0 112.827 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -128.05 150.23 50.03 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 129.193 2.997 . . . . 0.0 111.956 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 176.77 84.29 0.06 OUTLIER Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.3 1.428 . . . . 0.0 113.671 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 42.2 t -62.36 139.58 58.54 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.978 0.911 . . . . 0.0 111.526 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.6 mp -115.11 148.75 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.95 1.7 . . . . 0.0 111.043 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 93.9 t -130.0 131.71 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.316 1.047 . . . . 0.0 111.517 177.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -125.04 100.15 6.44 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 128.097 2.559 . . . . 0.0 112.397 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.69 -89.6 0.38 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.579 1.562 . . . . 0.0 114.25 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -120.6 -4.5 9.78 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.955 1.702 . . . . 0.0 113.797 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 47.4 p -131.7 170.0 15.39 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.945 1.698 . . . . 0.0 111.176 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -141.81 176.12 22.17 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.546 1.07 . . . . 0.0 115.159 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.11 144.64 47.52 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.106 2.162 . . . . 0.0 112.784 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 34.0 tp -135.13 153.17 52.09 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.407 2.683 . . . . 0.0 110.904 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 47.3 mtt 82.97 29.77 0.09 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 128.748 2.819 . . . . 0.0 113.528 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -134.01 139.91 46.35 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 127.107 2.163 . . . . 0.0 107.563 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 30.6 p -79.42 175.04 10.97 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 122.883 1.325 . . . . 0.0 113.52 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.52 -36.08 81.45 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.46 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 53.8 m -63.94 -53.12 55.27 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 117.372 -1.299 . . . . 0.0 110.508 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 28.8 m -48.98 -54.24 16.44 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 120.394 1.452 . . . . 0.0 111.052 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.97 -49.48 76.67 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.806 1.242 . . . . 0.0 112.949 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -62.59 -41.66 99.1 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.559 1.144 . . . . 0.0 111.443 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -61.18 -57.96 10.28 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.0 1.72 . . . . 0.0 111.159 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 1.7 pp -59.51 -37.01 77.19 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.046 0.384 . . . . 0.0 111.495 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -61.9 -52.15 65.25 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.263 1.425 . . . . 0.0 111.827 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -59.94 -34.89 73.85 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.927 1.291 . . . . 0.0 112.599 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -78.34 2.92 16.99 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.625 1.97 . . . . 0.0 113.424 175.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 28.2 m120 64.16 21.01 12.42 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 128.582 2.753 . . . . 0.0 114.991 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -70.47 134.02 86.81 Favored Pre-proline 0 CA--C 1.544 0.732 0 O-C-N 121.102 -0.999 . . . . 0.0 108.606 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.38 -56.28 0.3 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.264 1.976 . . . . 0.0 111.223 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 1.8 t -155.2 145.26 15.72 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 129.858 3.263 . . . . 0.0 109.008 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.99 -12.47 32.53 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.018 2.478 . . . . 0.0 114.849 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 15.3 t -140.23 -56.16 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 120.707 1.594 . . . . 0.0 114.297 -177.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 16.8 m -71.5 -22.42 61.79 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.107 2.163 . . . . 0.0 112.207 -177.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 79.2 mtm-85 63.3 11.81 5.71 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.894 2.478 . . . . 0.0 113.527 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -75.94 132.85 73.46 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.503 1.121 . . . . 0.0 109.02 174.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.02 110.11 1.66 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.69 2.26 . . . . 0.0 114.412 -176.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.0 pp -65.28 141.38 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.519 1.528 . . . . 0.0 111.836 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -114.98 -28.04 7.16 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.89 1.276 . . . . 0.0 114.24 -176.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -154.63 162.57 41.07 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.274 1.03 . . . . 0.0 113.699 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 6.8 mt -129.19 137.71 56.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 127.725 2.41 . . . . 0.0 107.219 176.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 12.2 p -134.27 150.03 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.792 1.237 . . . . 0.0 112.312 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -75.21 99.74 4.1 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.489 0.716 . . . . 0.0 109.07 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.1 m -112.3 105.6 13.94 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.797 0.839 . . . . 0.0 109.599 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -87.04 161.54 18.11 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.177 1.391 . . . . 0.0 113.959 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -72.08 161.32 79.47 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 126.876 2.07 . . . . 0.0 112.387 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo . . . . . 0 C--N 1.353 0.766 0 C-N-CA 124.563 3.508 . . . . 0.0 114.422 178.775 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 97.2 mt -69.15 158.81 85.6 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 125.389 1.476 . . . . 0.0 112.429 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -58.57 165.19 8.15 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.728 2.952 . . . . 0.0 113.68 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 7.2 tt -49.5 -39.26 33.35 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.294 1.438 . . . . 0.0 113.254 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -54.61 -24.73 22.61 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.84 1.656 . . . . 0.0 114.263 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -69.28 -22.49 63.81 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.36 -0.837 . . . . 0.0 112.737 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 35.1 mm -84.07 81.29 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 125.913 1.685 . . . . 0.0 107.421 176.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -109.48 60.79 0.3 Allowed Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 127.3 2.24 . . . . 0.0 115.07 -173.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.39 -45.35 1.82 Allowed 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.523 2.815 . . . . 0.0 112.563 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 15.8 t -59.54 146.69 39.69 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.859 1.209 . . . . 0.0 109.295 173.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.98 -1.22 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.488 1.115 . . . . 0.0 113.723 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 4.1 mt -132.95 -45.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 119.431 1.014 . . . . 0.0 112.805 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 2.7 m -71.16 -60.55 2.17 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -152.17 -17.78 0.18 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -176.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 83.31 10.23 82.56 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-N 119.575 1.079 . . . . 0.0 112.439 -175.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -71.13 155.1 93.62 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 127.281 2.232 . . . . 0.0 113.237 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.96 7.7 0.04 OUTLIER 'Trans proline' 0 CA--C 1.553 1.449 1 C-N-CA 126.012 4.475 . . . . 0.0 120.103 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -61.47 151.28 33.18 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 120.652 1.569 . . . . 0.0 112.301 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -128.13 150.23 50.07 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.63 1.572 . . . . 0.0 112.336 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -167.88 79.9 0.1 Allowed Glycine 0 CA--C 1.531 1.083 0 C-N-CA 126.552 2.025 . . . . 0.0 111.523 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 49.1 t -68.04 135.36 52.16 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 117.719 0.76 . . . . 0.0 110.532 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.04 143.33 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.912 1.685 . . . . 0.0 111.855 -177.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 53.2 t -129.53 137.54 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.156 1.382 . . . . 0.0 110.681 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -124.0 104.07 8.68 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 129.6 3.16 . . . . 0.0 110.472 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.85 -87.42 0.29 Allowed Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.437 1.494 . . . . 0.0 113.62 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -131.22 5.04 4.43 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.47 1.908 . . . . 0.0 114.308 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 82.0 p -133.97 170.05 16.21 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.537 1.935 . . . . 0.0 110.693 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -159.08 174.44 36.03 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 120.781 -1.2 . . . . 0.0 113.309 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -120.29 144.51 47.77 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.528 1.131 . . . . 0.0 113.38 175.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 4.1 pp -110.78 153.22 25.66 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.333 1.853 . . . . 0.0 112.792 178.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 22.8 ttt 85.33 67.89 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 129.084 2.954 . . . . 0.0 113.116 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -158.1 152.18 24.15 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.122 2.569 . . . . 0.0 108.675 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 13.3 p -91.61 171.56 9.09 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 122.074 0.94 . . . . 0.0 111.74 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.57 -36.75 85.25 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.641 -0.662 . . . . 0.0 111.467 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 38.4 m -68.76 -50.02 53.95 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 116.528 -1.701 . . . . 0.0 109.976 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 19.2 m -46.19 -57.77 4.24 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 121.237 1.835 . . . . 0.0 110.943 174.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.84 -51.3 67.97 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.787 1.235 . . . . 0.0 112.599 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -62.78 -37.94 88.64 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.236 -0.915 . . . . 0.0 112.778 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -61.22 -51.21 69.94 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.215 1.806 . . . . 0.0 110.96 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 20.9 mt -54.94 -53.63 53.14 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.858 1.263 . . . . 0.0 109.67 175.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -52.94 -48.07 67.59 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.431 1.492 . . . . 0.0 112.644 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -61.45 -41.67 97.58 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.462 1.505 . . . . 0.0 112.204 175.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -70.82 -16.74 62.75 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.189 1.396 . . . . 0.0 113.613 176.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 35.3 t30 105.13 -3.99 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.89 1 C-N-CA 132.428 4.291 . . . . 0.0 115.047 175.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -80.7 123.7 82.35 Favored Pre-proline 0 N--CA 1.472 0.663 0 CA-C-N 120.784 1.629 . . . . 0.0 109.882 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.77 -69.08 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.823 2.349 . . . . 0.0 111.655 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 7.1 t -111.12 135.18 20.9 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 126.346 1.859 . . . . 0.0 111.727 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -79.88 -7.55 14.41 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.351 2.7 . . . . 0.0 114.261 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 29.1 t -102.93 -72.87 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 119.748 1.158 . . . . 0.0 112.085 -177.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 26.5 p -100.65 -3.58 30.07 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.048 1.739 . . . . 0.0 113.647 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . 0.338 15.5 ptp180 53.85 23.6 3.95 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 128.797 2.839 . . . . 0.0 116.026 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -65.51 146.76 98.94 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 123.361 0.664 . . . . 0.0 109.579 173.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.02 112.2 2.66 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.337 2.691 . . . . 0.0 113.714 -175.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.5 pp -71.63 160.04 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.879 1.672 . . . . 0.0 113.209 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -111.38 -54.06 2.64 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.471 1.908 . . . . 0.0 110.818 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.33 170.21 21.21 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.83 1.252 . . . . 0.0 113.425 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 14.7 mt -121.14 137.94 53.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 127.302 2.241 . . . . 0.0 106.76 174.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 10.8 m -134.43 149.94 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 52.8 mt -73.34 99.94 3.05 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.704 1.202 . . . . 0.0 108.358 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 33.5 m -116.65 112.63 21.53 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.607 1.563 . . . . 0.0 112.29 -175.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -100.7 171.06 7.93 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.775 1.63 . . . . 0.0 112.692 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -139.05 156.09 72.51 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.331 1.452 . . . . 0.0 111.751 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 C--N 1.35 0.654 0 C-N-CA 123.599 2.866 . . . . 0.0 111.495 -179.828 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 41.1 m . . . . . 0 CA--C 1.54 0.573 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 54.1 tp -126.18 105.75 25.07 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 126.583 1.953 . . . . 0.0 110.735 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -48.89 152.52 4.52 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 124.106 3.204 . . . . 0.0 114.135 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 85.4 mt 63.97 -56.52 0.22 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 129.947 3.299 . . . . 0.0 113.042 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -55.14 -31.97 61.74 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.864 2.466 . . . . 0.0 113.48 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -96.14 -7.04 36.98 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 49.4 mm -66.57 -51.34 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.123 0.969 . . . . 0.0 110.961 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 31.43 73.29 0.51 Allowed Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 128.532 2.733 . . . . 0.0 113.962 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.44 -57.62 2.1 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 124.423 3.416 . . . . 0.0 115.683 -177.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 8.0 t -54.55 148.0 13.15 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.264 1.026 . . . . 0.0 111.752 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.35 -3.37 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 121.173 -0.955 . . . . 0.0 113.317 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 7.3 mt -129.65 -48.15 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.871 0.869 . . . . 0.0 112.774 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.2 m -68.0 -62.81 1.23 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -156.87 -15.01 0.09 Allowed 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 88.29 8.33 71.6 Favored Glycine 0 CA--C 1.54 1.629 0 O-C-N 120.652 -1.28 . . . . 0.0 112.657 -174.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -59.67 151.45 62.22 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 128.718 2.807 . . . . 0.0 114.336 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.8 88.39 1.31 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.448 3.432 . . . . 0.0 113.258 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -136.96 161.79 35.06 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 127.375 2.27 . . . . 0.0 111.023 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -125.61 150.08 47.85 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.668 1.587 . . . . 0.0 109.972 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -179.93 80.43 0.06 OUTLIER Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.309 1.909 . . . . 0.0 111.498 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 50.5 t -66.29 133.39 50.48 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.877 0.871 . . . . 0.0 110.008 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.03 141.21 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.878 1.271 . . . . 0.0 110.766 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 92.3 t -130.01 133.96 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.426 1.091 . . . . 0.0 111.8 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -124.92 107.88 11.32 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 128.693 2.797 . . . . 0.0 110.204 174.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 66.29 -93.6 0.2 Allowed Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.993 1.759 . . . . 0.0 113.625 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -126.16 7.19 7.18 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.72 2.008 . . . . 0.0 113.611 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 79.7 p -130.52 170.12 14.66 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.656 1.982 . . . . 0.0 110.541 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.33 -178.4 30.44 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.816 -1.177 . . . . 0.0 115.345 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -120.07 136.51 54.55 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.038 2.135 . . . . 0.0 110.404 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 26.4 tp -121.38 152.97 38.42 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.615 1.966 . . . . 0.0 111.206 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 41.4 mtm 64.97 68.34 0.51 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 127.62 2.368 . . . . 0.0 113.018 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -151.96 148.16 27.42 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 129.163 2.985 . . . . 0.0 107.252 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 17.2 p -77.92 165.89 23.55 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 122.472 1.13 . . . . 0.0 111.828 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.7 -38.67 91.34 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.698 -0.626 . . . . 0.0 111.165 177.316 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 23.8 m -62.16 -48.8 78.48 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 116.911 -1.519 . . . . 0.0 111.133 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 16.6 m -49.24 -51.66 31.96 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 120.809 1.64 . . . . 0.0 111.386 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.19 -47.06 84.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.42 1.088 . . . . 0.0 112.835 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -65.88 -40.57 91.73 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 121.216 -0.927 . . . . 0.0 111.937 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -61.43 -56.83 15.83 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.624 1.97 . . . . 0.0 111.471 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 2.8 pp -59.98 -35.89 75.97 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 118.133 0.424 . . . . 0.0 111.317 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -63.48 -48.63 76.86 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.886 1.274 . . . . 0.0 110.853 175.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -58.64 -39.36 80.32 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.314 1.446 . . . . 0.0 111.409 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -74.12 3.79 6.53 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 127.163 2.185 . . . . 0.0 113.746 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 67.51 15.82 9.86 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 128.949 2.9 . . . . 0.0 115.227 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 5.7 tppp? -70.17 129.96 90.09 Favored Pre-proline 0 N--CA 1.475 0.802 0 O-C-N 120.832 -1.168 . . . . 0.0 109.106 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.33 -49.48 1.26 Allowed 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.847 2.365 . . . . 0.0 111.38 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 1.7 t -158.36 142.28 11.27 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 131.576 3.95 . . . . 0.0 107.995 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.76 -11.32 29.35 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.081 2.521 . . . . 0.0 115.026 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 17.1 t -137.75 -55.93 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 120.54 1.518 . . . . 0.0 113.739 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 22.4 m -69.88 -25.47 63.72 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.739 1.616 . . . . 0.0 111.432 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 33.5 mtp-105 61.38 13.78 5.24 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 127.911 2.484 . . . . 0.0 113.244 -175.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -76.73 130.85 75.14 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.227 1.411 . . . . 0.0 108.484 174.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -64.46 109.61 1.24 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.549 2.166 . . . . 0.0 113.679 -176.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.1 pp -63.21 137.78 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.683 1.593 . . . . 0.0 111.861 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -115.18 -20.8 10.26 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 2.6 ttp -150.95 146.68 26.42 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.13 0.972 . . . . 0.0 112.763 -174.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 7.6 mt -130.78 131.47 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 127.478 2.311 . . . . 0.0 107.763 174.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.39 150.09 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 119.487 1.039 . . . . 0.0 113.707 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.18 99.87 3.52 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 10.2 t -89.41 156.19 18.85 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.372 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -135.7 170.33 16.14 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.161 2.185 . . . . 0.0 111.374 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -133.56 156.57 79.48 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 124.887 1.275 . . . . 0.0 111.706 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo . . . . . 0 CA--C 1.538 0.692 0 C-N-CA 123.434 2.756 . . . . 0.0 112.369 179.753 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 41.2 m . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.52 90.46 20.13 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.324 1.85 . . . . 0.0 111.669 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -47.45 -31.38 13.31 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.705 3.603 . . . . 0.0 115.599 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 1.6 pp -58.05 -20.18 37.31 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.064 1.745 . . . . 0.0 114.907 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -121.32 -2.45 9.54 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.189 1.796 . . . . 0.0 112.64 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -78.41 64.96 3.61 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.414 1.486 . . . . 0.0 112.756 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 28.8 mm -77.46 73.21 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.777 1.231 . . . . 0.0 109.838 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -138.04 67.86 48.67 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 126.454 1.902 . . . . 0.0 110.143 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.13 -38.89 63.67 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.092 2.528 . . . . 0.0 114.696 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 42.2 t -56.13 143.91 31.31 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 120.182 1.355 . . . . 0.0 111.029 177.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 28.5 m -123.68 -15.13 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 10.5 pt -137.12 -26.41 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.5 m -75.9 -64.47 1.08 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 120.64 1.563 . . . . 0.0 112.137 -177.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -145.39 -12.81 0.52 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 76.73 11.88 84.97 Favored Glycine 0 CA--C 1.544 1.886 0 CA-C-N 119.992 1.269 . . . . 0.0 112.487 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -59.54 155.11 40.7 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 129.997 3.319 . . . . 0.0 113.618 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.65 -1.69 10.21 Favored 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 124.354 3.37 . . . . 0.0 115.463 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -52.65 146.8 9.55 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 127.042 2.137 . . . . 0.0 111.577 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -116.21 150.16 37.97 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.757 2.023 . . . . 0.0 110.735 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -159.68 68.12 0.26 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 128.169 2.795 . . . . 0.0 109.349 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 33.8 t -63.8 133.28 53.15 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.063 0.945 . . . . 0.0 110.429 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -114.57 143.21 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.35 1.06 . . . . 0.0 112.057 -175.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 89.6 t -129.08 136.84 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.926 1.29 . . . . 0.0 110.629 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -125.04 95.05 4.36 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 129.456 3.102 . . . . 0.0 110.096 176.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.96 -91.5 0.35 Allowed Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.809 1.671 . . . . 0.0 114.227 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -121.49 4.34 10.18 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 126.318 1.847 . . . . 0.0 114.338 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 66.4 p -134.77 170.09 16.37 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.249 2.22 . . . . 0.0 109.903 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -160.18 174.45 36.93 Favored Glycine 0 CA--C 1.529 0.921 0 O-C-N 120.658 -1.276 . . . . 0.0 113.766 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -120.26 141.99 49.46 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.906 1.282 . . . . 0.0 113.072 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.41 153.26 36.8 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.152 2.581 . . . . 0.0 110.526 177.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 49.5 mtt 93.17 62.96 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 129.826 3.25 . . . . 0.0 111.486 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -160.01 149.59 17.97 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 127.205 2.202 . . . . 0.0 109.489 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 19.4 p -88.3 174.93 7.89 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.851 0.834 . . . . 0.0 110.232 172.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -39.81 94.77 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.397 -0.814 . . . . 0.0 112.416 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 68.9 m -68.13 -48.06 66.42 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 116.105 -1.902 . . . . 0.0 110.606 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 16.6 m -45.61 -59.07 2.95 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 121.601 2.001 . . . . 0.0 111.263 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.88 -43.95 86.35 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.028 1.331 . . . . 0.0 114.062 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -68.92 -42.51 76.73 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.354 -0.841 . . . . 0.0 111.777 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -62.35 -53.91 48.19 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.006 2.122 . . . . 0.0 112.358 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.3 pp -57.54 -36.49 71.69 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.319 0.509 . . . . 0.0 111.197 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -66.68 -46.21 76.39 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.452 0.701 . . . . 0.0 111.767 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -59.23 -35.11 73.07 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.853 1.261 . . . . 0.0 111.704 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -76.3 3.77 10.21 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 127.322 2.249 . . . . 0.0 113.457 175.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 39.3 t30 76.38 8.49 3.28 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 130.013 3.325 . . . . 0.0 115.649 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -70.14 129.46 90.64 Favored Pre-proline 0 N--CA 1.475 0.818 0 O-C-N 120.755 -1.216 . . . . 0.0 109.242 175.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -69.76 -43.23 2.78 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.072 2.515 . . . . 0.0 114.695 -176.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.56 149.3 36.65 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 128.251 2.62 . . . . 0.0 110.313 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.24 -17.69 61.32 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.361 2.707 . . . . 0.0 115.369 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.09 -63.31 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 -172.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 28.8 p -89.16 -19.47 25.44 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -172.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . 0.259 3.9 ptm180 94.15 4.8 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 131.252 3.821 . . . . 0.0 116.182 174.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -67.67 111.99 9.12 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 125.08 1.352 . . . . 0.0 110.387 178.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -46.64 107.84 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 124.269 3.313 . . . . 0.0 116.099 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 pp -62.86 146.95 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.178 1.391 . . . . 0.0 113.45 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -112.1 -29.76 7.48 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.781 1.632 . . . . 0.0 114.187 -173.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.03 161.34 33.97 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.63 1.172 . . . . 0.0 113.468 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 14.1 mt -129.51 136.48 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 127.518 2.327 . . . . 0.0 108.231 175.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 16.9 m -137.61 150.16 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.726 1.21 . . . . 0.0 113.479 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.22 99.85 4.86 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 177.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 1.9 t -93.79 157.61 16.06 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -129.27 143.3 50.8 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.32 1.448 . . . . 0.0 112.403 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -73.39 164.53 60.37 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 125.137 1.375 . . . . 0.0 111.56 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo . . . . . 0 CA--C 1.539 0.726 0 C-N-CA 124.226 3.284 . . . . 0.0 114.272 179.718 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -153.96 150.08 22.03 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 126.727 2.011 . . . . 0.0 111.037 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.17 149.59 90.97 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.052 1.834 . . . . 0.0 112.728 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 5.1 tp 62.04 -60.76 0.11 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 130.1 3.36 . . . . 0.0 115.205 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -65.25 -16.49 63.6 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -63.53 -37.81 88.73 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 27.3 mm 39.01 65.97 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 127.325 2.25 . . . . 0.0 111.645 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -40.55 102.84 0.27 Allowed Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 128.892 2.877 . . . . 0.0 114.311 -175.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -88.82 -179.1 2.09 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 124.53 3.487 . . . . 0.0 114.447 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 10.0 t -61.01 159.21 11.94 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 128.228 2.611 . . . . 0.0 111.029 171.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.71 -0.63 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.378 1.071 . . . . 0.0 113.442 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 10.4 mt -133.94 -48.86 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 119.735 1.152 . . . . 0.0 112.866 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.5 m -67.61 -60.16 2.77 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.439 1.496 . . . . 0.0 114.228 -173.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -151.53 -16.13 0.2 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -174.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.62 10.69 82.95 Favored Glycine 0 CA--C 1.542 1.755 0 O-C-N 120.812 -1.18 . . . . 0.0 113.173 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -61.96 155.04 65.46 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 128.39 2.676 . . . . 0.0 112.339 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -66.27 1.66 2.35 Favored 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.459 3.439 . . . . 0.0 117.3 -177.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -60.96 144.9 52.3 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.871 1.214 . . . . 0.0 110.62 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -128.19 150.07 50.17 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.68 1.992 . . . . 0.0 111.683 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -162.69 98.92 0.17 Allowed Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.742 1.639 . . . . 0.0 112.51 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 46.4 t -68.21 133.2 48.47 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.517 0.727 . . . . 0.0 110.638 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.2 mp -113.0 135.4 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.181 1.392 . . . . 0.0 110.463 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 45.4 t -130.04 130.32 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.422 1.089 . . . . 0.0 109.65 176.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.2 99.09 5.93 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.908 2.083 . . . . 0.0 112.206 178.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 75.9 -84.36 0.91 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.732 1.634 . . . . 0.0 114.711 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -124.99 -11.53 7.09 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.761 1.624 . . . . 0.0 114.3 -176.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 72.9 p -135.33 168.89 18.37 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.455 1.502 . . . . 0.0 110.573 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -142.96 178.44 21.24 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.35 0.976 . . . . 0.0 113.829 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -120.27 147.03 45.49 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.866 1.266 . . . . 0.0 113.839 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 12.2 tp -111.4 153.27 26.3 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 128.84 2.856 . . . . 0.0 113.551 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 16.7 mtt 69.47 59.74 0.31 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.68 2.392 . . . . 0.0 115.835 173.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -149.56 163.04 38.96 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.286 1.434 . . . . 0.0 111.046 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 11.6 p -87.25 174.49 8.56 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 122.393 1.092 . . . . 0.0 112.484 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -67.04 -40.15 87.13 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.72 -0.612 . . . . 0.0 111.197 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 27.8 m -64.73 -41.98 95.55 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 117.528 -1.225 . . . . 0.0 111.651 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 34.6 m -49.29 -63.61 1.05 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.242 1.417 . . . . 0.0 109.187 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -53.92 -45.17 71.11 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.021 1.728 . . . . 0.0 113.109 176.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -60.11 -37.26 79.47 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.756 1.222 . . . . 0.0 112.352 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -59.85 -49.34 78.1 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.446 1.099 . . . . 0.0 110.922 175.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 5.9 mp -58.75 -46.7 86.84 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 122.847 0.459 . . . . 0.0 109.882 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -57.39 -48.06 80.07 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.132 0.973 . . . . 0.0 112.906 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -56.83 -28.05 60.98 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.183 1.393 . . . . 0.0 113.911 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -107.45 -0.55 22.17 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.708 2.003 . . . . 0.0 112.979 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 60.3 t30 45.49 50.59 10.21 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.943 2.497 . . . . 0.0 111.319 -174.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -73.33 130.6 84.08 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.601 0.761 . . . . 0.0 112.876 -174.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -70.43 115.35 4.15 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.51 2.14 . . . . 0.0 107.568 170.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 53.8 t -23.07 123.35 0.15 Allowed Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 129.211 3.005 . . . . 0.0 115.682 -176.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -65.34 -3.62 7.87 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.127 2.551 . . . . 0.0 114.531 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 47.0 t -109.08 -65.5 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.346 1.458 . . . . 0.0 111.31 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 24.5 p -104.63 0.74 28.82 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 62.84 10.29 4.2 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 127.795 2.438 . . . . 0.0 115.898 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -68.68 149.28 97.99 Favored Pre-proline 0 CA--C 1.552 1.058 0 C-N-CA 123.87 0.868 . . . . 0.0 111.732 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.39 112.96 3.47 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.662 2.908 . . . . 0.0 112.009 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.92 109.97 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 126.547 1.939 . . . . 0.0 110.463 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -103.65 -55.79 2.33 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -172.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.31 161.87 37.18 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -177.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 4.6 mt -135.02 136.53 51.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 126.998 2.119 . . . . 0.0 108.847 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 16.9 m -133.21 150.01 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.935 0.894 . . . . 0.0 112.555 176.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 3.8 tt -82.53 99.75 9.69 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 5.1 t -90.87 162.66 14.7 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.157 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -131.68 148.44 52.59 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.451 1.5 . . . . 0.0 112.038 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -78.06 160.6 73.28 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 125.444 1.498 . . . . 0.0 110.969 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo . . . . . 0 C--N 1.351 0.683 0 C-N-CA 123.322 2.682 . . . . 0.0 111.784 -177.796 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.52 157.91 69.98 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.829 1.652 . . . . 0.0 111.456 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -60.17 -30.91 92.36 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.833 2.355 . . . . 0.0 113.579 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 62.8 tp -78.01 -43.01 30.74 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.83 0.852 . . . . 0.0 111.47 175.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -62.21 -33.97 75.57 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.987 1.315 . . . . 0.0 112.37 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -123.24 60.59 1.06 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.809 2.043 . . . . 0.0 109.857 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 9.6 tp -44.22 -63.54 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 129.806 3.242 . . . . 0.0 114.7 -177.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 64.3 mm-40 -148.85 88.82 5.1 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 126.532 1.933 . . . . 0.0 107.672 176.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.93 164.77 32.35 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.584 2.19 . . . . 0.0 113.235 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 1.9 p -67.85 175.54 2.98 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 34.8 m -135.94 -3.32 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -176.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 7.7 mt -114.77 -64.43 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 120.319 1.418 . . . . 0.0 112.588 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 21.5 p -68.85 -59.19 3.25 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -147.35 -17.8 0.39 Allowed 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.531 2.049 . . . . 0.0 116.531 -172.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 90.65 30.65 11.35 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.035 1.303 . . . . 0.0 110.778 -174.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 35.0 mtt-85 -62.65 149.38 89.09 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 124.929 1.292 . . . . 0.0 111.595 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.96 -10.49 29.01 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.448 2.765 . . . . 0.0 114.297 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -58.99 153.56 17.32 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 129.593 3.157 . . . . 0.0 113.002 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -128.2 150.16 50.14 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.319 2.248 . . . . 0.0 110.625 176.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -167.06 75.11 0.14 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 127.047 2.26 . . . . 0.0 110.291 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 33.1 t -59.89 122.4 14.17 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.643 0.777 . . . . 0.0 111.854 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 1.2 mp -95.66 134.09 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.966 1.306 . . . . 0.0 109.794 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 95.5 t -127.97 130.38 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.279 1.032 . . . . 0.0 111.353 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -115.06 94.92 4.95 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 128.597 2.759 . . . . 0.0 110.12 174.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.83 -94.92 0.31 Allowed Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.856 1.693 . . . . 0.0 114.372 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -111.97 -1.19 15.51 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.02 1.728 . . . . 0.0 113.648 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 70.1 p -132.28 170.01 15.66 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.655 1.582 . . . . 0.0 111.351 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -157.69 174.64 35.08 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 121.114 -0.991 . . . . 0.0 113.655 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -120.22 110.8 17.03 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.259 1.424 . . . . 0.0 111.411 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 9.8 tp -81.22 153.31 27.24 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.339 2.655 . . . . 0.0 113.033 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 23.7 mtt 79.58 57.99 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 127.786 2.435 . . . . 0.0 114.663 172.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -148.8 150.27 32.77 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.992 2.117 . . . . 0.0 108.319 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 31.7 p -86.47 175.0 8.6 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 122.649 1.214 . . . . 0.0 112.798 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.98 -33.78 76.87 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.2 174.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 37.4 m -63.86 -54.25 37.89 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 117.284 -1.341 . . . . 0.0 109.88 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 21.5 m -47.58 -59.71 3.06 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.126 1.33 . . . . 0.0 111.234 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.95 -48.02 76.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.679 1.192 . . . . 0.0 113.767 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -66.05 -41.72 90.48 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.209 -0.932 . . . . 0.0 111.722 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -63.39 -54.86 30.11 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.785 1.634 . . . . 0.0 112.101 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.5 pp -59.07 -37.89 78.15 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.238 0.472 . . . . 0.0 110.926 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -65.68 -42.99 90.62 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.74 0.816 . . . . 0.0 112.174 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -59.23 -37.86 78.54 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.031 1.332 . . . . 0.0 111.043 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 48.1 mtm105 -77.04 9.67 2.84 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 127.031 2.133 . . . . 0.0 113.646 174.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . 0.313 0.0 OUTLIER 72.56 3.4 4.67 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 130.742 3.617 . . . . 0.0 116.823 178.415 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -72.08 131.12 85.65 Favored Pre-proline 0 CA--C 1.545 0.752 0 O-C-N 121.091 -1.006 . . . . 0.0 109.947 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.51 -72.47 0.02 OUTLIER 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.152 2.568 . . . . 0.0 109.651 176.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 9.3 t -120.92 136.26 25.43 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 127.897 2.479 . . . . 0.0 109.674 175.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.87 -8.18 19.97 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.343 2.696 . . . . 0.0 114.902 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 41.6 t -111.36 -74.84 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 119.877 1.217 . . . . 0.0 112.613 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 16.7 p -92.5 -5.4 51.9 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.57 1.548 . . . . 0.0 113.694 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 61.94 16.22 7.89 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.743 2.417 . . . . 0.0 114.761 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -64.36 139.4 97.7 Favored Pre-proline 0 CA--C 1.549 0.938 0 O-C-N 121.477 -0.764 . . . . 0.0 109.796 175.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.54 113.64 2.79 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.162 2.574 . . . . 0.0 112.612 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 16.5 pt -70.93 157.55 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.54 1.136 . . . . 0.0 113.528 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -115.02 -40.7 3.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.324 1.849 . . . . 0.0 112.978 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.63 167.22 31.11 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -176.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 6.9 mt -135.99 129.03 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 129.169 2.987 . . . . 0.0 106.369 174.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.68 150.15 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.9 107.22 2.57 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 174.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 23.3 m -103.18 88.23 3.09 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.212 1.805 . . . . 0.0 110.086 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -60.78 153.64 23.85 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.772 2.029 . . . . 0.0 115.1 -176.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -61.88 156.12 58.51 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 126.276 1.831 . . . . 0.0 112.531 176.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 CA--C 1.538 0.709 0 C-N-CA 123.308 2.672 . . . . 0.0 112.591 179.869 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 78.4 p . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 95.8 mt -69.17 157.28 89.71 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.358 1.463 . . . . 0.0 111.279 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_exo -44.31 -50.38 7.92 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 124.295 3.33 . . . . 0.0 115.323 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -64.58 -9.69 20.99 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -112.72 -21.23 11.33 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.122 1.769 . . . . 0.0 111.794 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -87.65 1.73 52.91 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.88 2.072 . . . . 0.0 114.431 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.2 pp -65.52 69.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 128.095 2.558 . . . . 0.0 113.266 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -133.67 -42.43 0.03 OUTLIER Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 126.302 1.841 . . . . 0.0 115.667 -178.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -49.23 -69.32 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 124.969 3.78 . . . . 0.0 117.253 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 30.5 t -51.27 148.12 5.06 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 120.166 1.348 . . . . 0.0 112.663 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.8 -14.9 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 9.4 pt -136.36 -26.55 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.5 m -76.28 -60.12 2.47 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 120.719 1.599 . . . . 0.0 112.064 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -154.17 -13.76 0.13 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -176.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.51 11.55 81.75 Favored Glycine 0 CA--C 1.541 1.687 0 CA-C-N 120.011 1.278 . . . . 0.0 112.198 -173.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 9.4 ptm85 -55.97 155.05 12.69 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 129.592 3.157 . . . . 0.0 114.024 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.7 4.9 4.18 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 124.551 3.501 . . . . 0.0 115.762 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -58.52 157.98 8.26 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.182 1.793 . . . . 0.0 112.586 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -119.66 150.04 40.99 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 128.423 2.689 . . . . 0.0 111.898 -175.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 176.84 82.66 0.06 OUTLIER Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.575 1.56 . . . . 0.0 113.015 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 48.0 t -71.33 138.82 49.57 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 118.152 0.976 . . . . 0.0 109.864 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.6 mp -115.01 144.11 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.651 1.58 . . . . 0.0 110.44 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 97.1 t -129.91 131.34 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.242 1.017 . . . . 0.0 109.527 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -125.05 94.98 4.33 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.91 2.484 . . . . 0.0 111.281 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.49 -89.64 0.36 Allowed Glycine 0 CA--C 1.534 1.281 0 C-N-CA 125.689 1.614 . . . . 0.0 114.386 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -121.56 -0.85 9.65 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 126.348 1.859 . . . . 0.0 113.868 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 16.8 p -130.66 170.12 14.74 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 128.223 2.609 . . . . 0.0 109.787 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -157.79 177.06 34.73 Favored Glycine 0 CA--C 1.529 0.932 0 O-C-N 120.688 -1.258 . . . . 0.0 113.947 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -120.34 135.91 54.87 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.715 1.606 . . . . 0.0 113.842 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 4.0 pp -119.9 153.35 36.0 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.294 2.638 . . . . 0.0 109.451 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 25.0 ttt 78.26 66.3 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.762 2.025 . . . . 0.0 111.094 -177.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -160.03 154.5 23.84 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 128.898 2.879 . . . . 0.0 108.314 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 22.7 p -86.91 172.21 10.23 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.113 0.959 . . . . 0.0 111.21 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -64.94 -35.39 81.01 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.435 -0.79 . . . . 0.0 111.223 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 25.2 m -64.44 -49.2 72.39 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 117.212 -1.375 . . . . 0.0 111.152 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 29.4 m -46.93 -55.58 7.83 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 120.469 1.486 . . . . 0.0 109.924 174.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -59.99 -45.39 92.89 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.923 1.689 . . . . 0.0 113.52 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -60.1 -44.5 94.78 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.228 1.411 . . . . 0.0 111.523 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -62.35 -54.09 45.51 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.341 1.057 . . . . 0.0 111.473 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.4 pp -60.87 -32.05 71.49 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 118.579 0.627 . . . . 0.0 111.958 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -68.24 -48.56 64.79 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.269 1.428 . . . . 0.0 111.734 174.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -55.8 -43.67 77.07 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.632 1.573 . . . . 0.0 111.02 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -75.31 -6.94 52.45 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 127.067 2.147 . . . . 0.0 113.642 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 64.0 t30 50.79 41.13 26.04 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 128.074 2.55 . . . . 0.0 112.173 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -78.15 126.58 83.31 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 125.519 1.528 . . . . 0.0 113.367 -176.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -74.56 129.03 12.35 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.813 2.342 . . . . 0.0 107.526 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 48.2 t -27.01 123.79 0.23 Allowed Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 128.195 2.598 . . . . 0.0 115.493 -176.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.76 -1.66 6.31 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 122.959 2.439 . . . . 0.0 114.33 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 49.1 t -123.64 -59.55 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.686 1.594 . . . . 0.0 111.233 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 69.7 m -78.12 -19.78 53.4 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.682 1.993 . . . . 0.0 112.84 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 61.62 11.79 4.12 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 127.339 2.255 . . . . 0.0 114.198 -177.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -87.17 148.19 44.36 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 123.975 0.91 . . . . 0.0 112.95 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.25 124.55 7.9 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.863 3.042 . . . . 0.0 111.97 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.98 143.04 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.643 1.177 . . . . 0.0 112.859 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -115.17 -40.25 3.49 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.51 1.524 . . . . 0.0 113.656 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.5 166.58 31.82 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -176.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 8.0 mt -133.07 139.22 49.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 127.534 2.333 . . . . 0.0 108.732 176.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.06 150.11 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.944 1.297 . . . . 0.0 113.329 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 55.8 mt -73.29 99.87 3.0 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.294 1.037 . . . . 0.0 109.182 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 6.3 t -95.44 151.53 19.21 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -141.91 158.72 43.44 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.325 1.45 . . . . 0.0 112.558 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -80.54 158.44 71.23 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 123.842 0.857 . . . . 0.0 112.947 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo . . . . . 0 C--N 1.355 0.886 0 C-N-CA 124.565 3.51 . . . . 0.0 113.853 179.386 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 57.3 tp -62.02 -49.22 86.17 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 126.472 1.909 . . . . 0.0 115.29 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.19 160.05 48.25 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.071 1.847 . . . . 0.0 113.333 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.16 -34.02 71.59 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.992 1.317 . . . . 0.0 111.891 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -58.0 -16.98 14.45 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.151 1.78 . . . . 0.0 114.003 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -71.34 -17.4 62.44 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 176.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 32.8 mm 46.45 83.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 127.959 2.503 . . . . 0.0 113.069 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -126.25 62.02 44.36 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 125.764 1.625 . . . . 0.0 111.336 176.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -62.74 -64.07 0.08 OUTLIER 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 124.823 3.682 . . . . 0.0 115.923 -175.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 44.3 t -46.91 138.67 6.18 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 121.178 1.808 . . . . 0.0 112.45 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.61 -28.74 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 125.173 1.389 . . . . 0.0 112.258 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 8.3 pt -138.01 -24.86 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 -173.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.5 m -73.21 -57.67 3.86 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.731 1.605 . . . . 0.0 112.083 -176.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -154.94 -14.85 0.12 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 81.16 11.06 84.03 Favored Glycine 0 CA--C 1.542 1.766 0 CA-C-N 119.993 1.27 . . . . 0.0 112.513 -174.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -64.7 155.18 83.06 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 129.785 3.234 . . . . 0.0 113.122 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -69.12 4.48 1.89 Allowed 'Trans proline' 0 CA--C 1.548 1.224 0 C-N-CA 124.569 3.512 . . . . 0.0 117.055 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -56.74 139.7 49.86 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 120.166 1.348 . . . . 0.0 110.59 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -128.17 113.86 16.26 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.192 1.797 . . . . 0.0 114.646 -170.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -144.62 82.79 0.2 Allowed Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.55 1.548 . . . . 0.0 112.527 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 49.3 t -65.0 142.17 58.53 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 117.872 0.836 . . . . 0.0 110.565 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 2.2 mp -107.17 141.64 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 125.816 1.646 . . . . 0.0 110.121 -177.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 96.9 t -130.09 132.79 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.277 1.031 . . . . 0.0 110.398 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -125.01 94.98 4.34 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.313 2.245 . . . . 0.0 110.841 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.74 -92.44 0.24 Allowed Glycine 0 CA--C 1.534 1.275 0 C-N-CA 126.259 1.885 . . . . 0.0 114.648 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -111.88 -7.89 14.14 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.334 1.854 . . . . 0.0 113.345 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 19.7 p -124.24 170.01 11.19 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.618 1.967 . . . . 0.0 111.125 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -160.8 174.9 37.51 Favored Glycine 0 CA--C 1.532 1.099 0 O-C-N 121.088 -1.007 . . . . 0.0 113.999 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -120.28 113.46 20.43 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.319 1.848 . . . . 0.0 113.333 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -97.37 153.18 18.24 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.923 1.289 . . . . 0.0 112.023 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 40.1 tpp 75.58 68.51 0.07 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.86 2.064 . . . . 0.0 111.244 177.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -157.25 150.22 23.54 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 129.293 3.037 . . . . 0.0 108.616 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 17.1 p -86.46 170.46 11.93 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.616 1.198 . . . . 0.0 111.781 176.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.49 -30.28 70.58 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.095 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 25.0 m -69.96 -50.5 41.22 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 117.303 -1.332 . . . . 0.0 109.9 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 35.0 m -47.65 -56.84 6.38 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 120.371 1.441 . . . . 0.0 110.105 173.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.15 -46.47 82.71 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.938 1.695 . . . . 0.0 113.403 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -65.86 -37.43 86.15 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.561 -1.337 . . . . 0.0 111.822 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 21.2 tptp -63.49 -52.36 61.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.122 0.969 . . . . 0.0 111.105 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.59 -30.32 70.6 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.073 0.397 . . . . 0.0 111.704 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -68.58 -46.06 70.38 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.033 1.333 . . . . 0.0 111.829 173.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -57.64 -42.44 83.41 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.864 1.265 . . . . 0.0 110.982 174.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -72.78 -11.05 60.46 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.459 1.904 . . . . 0.0 113.528 175.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 63.8 t30 52.41 40.45 29.49 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.814 2.446 . . . . 0.0 111.754 -175.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -74.2 116.13 49.69 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 126.357 1.863 . . . . 0.0 113.781 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.1 132.49 22.89 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.41 2.073 . . . . 0.0 107.671 170.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 47.1 t -32.58 125.11 0.39 Allowed Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 127.656 2.382 . . . . 0.0 115.214 -175.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.94 -3.18 10.94 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.146 2.564 . . . . 0.0 114.381 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 42.6 t -124.74 -60.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.076 1.35 . . . . 0.0 111.726 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 58.6 m -75.01 -18.78 60.29 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.635 1.974 . . . . 0.0 112.432 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 64.6 5.12 2.56 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.554 2.342 . . . . 0.0 114.081 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -83.8 148.99 55.78 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 124.204 1.002 . . . . 0.0 113.144 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.11 124.04 8.77 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.037 2.491 . . . . 0.0 110.405 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.2 pp -60.95 128.61 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.526 1.13 . . . . 0.0 110.932 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -115.08 -26.82 7.55 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -175.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 1.7 ttp -149.86 150.35 31.8 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.241 1.016 . . . . 0.0 112.624 -175.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 10.4 mt -137.24 130.05 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 127.138 2.175 . . . . 0.0 107.941 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 27.0 m -140.07 150.23 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 124.378 1.071 . . . . 0.0 112.913 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 66.6 tp -63.7 99.89 0.25 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.065 1.746 . . . . 0.0 108.683 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 41.4 m -110.8 108.48 18.33 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -170.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -85.72 178.41 7.35 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.239 1.816 . . . . 0.0 112.997 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -129.84 168.64 15.78 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 125.953 1.701 . . . . 0.0 111.552 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo . . . . . 0 C--N 1.353 0.798 0 C-N-CA 124.249 3.299 . . . . 0.0 113.887 179.968 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 43.2 m . . . . . 0 CA--C 1.54 0.584 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 46.3 tp -133.65 89.89 29.73 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.546 1.939 . . . . 0.0 109.829 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -58.42 -37.87 92.86 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.881 2.387 . . . . 0.0 114.057 -175.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 4.4 pp -63.37 -13.55 40.59 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -106.1 -25.07 12.19 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.435 1.494 . . . . 0.0 111.689 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -83.61 -43.77 15.29 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.977 1.311 . . . . 0.0 113.045 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.1 mp -82.17 85.82 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.79 1.636 . . . . 0.0 107.223 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -53.44 126.63 47.41 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 126.817 2.047 . . . . 0.0 113.793 -176.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -76.47 -172.07 1.28 Allowed 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 124.471 3.448 . . . . 0.0 113.036 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 6.7 p -60.29 173.04 0.72 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.646 1.579 . . . . 0.0 114.579 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 28.6 m -130.75 -3.61 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -175.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 4.5 mt -117.88 -59.99 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 120.529 1.513 . . . . 0.0 112.796 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 7.0 p -69.39 -68.75 0.38 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -174.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -144.56 -13.95 0.57 Allowed 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 -171.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 88.92 40.86 6.09 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.426 1.012 . . . . 0.0 110.859 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -97.83 155.31 37.26 Favored Pre-proline 0 N--CA 1.481 1.107 0 C-N-CA 125.854 1.662 . . . . 0.0 112.406 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -44.08 121.44 2.98 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.949 3.1 . . . . 0.0 114.461 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.14 31.86 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 131.127 3.771 . . . . 0.0 118.944 -176.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -76.58 89.85 3.32 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 119.952 -1.718 . . . . 0.0 109.541 -178.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 164.97 57.21 0.02 OUTLIER Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.049 -0.862 . . . . 0.0 114.085 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 52.5 t -57.24 138.58 54.54 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.899 1.35 . . . . 0.0 110.91 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.4 mp -115.13 136.18 52.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 C-N-CA 126.687 1.995 . . . . 0.0 109.216 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 90.1 t -127.28 132.42 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.634 0.774 . . . . 0.0 110.924 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -124.35 106.14 10.0 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.011 2.525 . . . . 0.0 111.471 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 68.46 -89.92 0.23 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.703 1.621 . . . . 0.0 114.177 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -124.69 -0.97 7.99 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.152 1.781 . . . . 0.0 113.997 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 54.9 p -133.25 170.02 16.04 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.898 1.679 . . . . 0.0 110.296 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -152.01 175.12 30.87 Favored Glycine 0 CA--C 1.526 0.771 0 O-C-N 120.88 -1.138 . . . . 0.0 113.512 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -120.28 145.64 46.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.045 1.338 . . . . 0.0 114.181 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 94.8 mt -123.35 153.48 40.25 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 129.504 3.122 . . . . 0.0 110.686 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 50.5 mtt 90.7 31.39 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 128.757 2.823 . . . . 0.0 113.37 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -139.42 134.9 33.01 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.739 2.016 . . . . 0.0 107.583 173.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 22.1 p -80.98 175.11 10.97 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 122.667 1.222 . . . . 0.0 112.842 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.9 -36.93 70.73 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.731 0.812 . . . . 0.0 112.254 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 87.7 m -66.38 -52.56 45.57 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.197 0.999 . . . . 0.0 110.748 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 98.5 m -52.41 -50.54 62.32 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.31 1.044 . . . . 0.0 110.747 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.9 -44.54 91.23 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.177 1.391 . . . . 0.0 112.769 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -61.92 -43.26 99.21 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.785 1.234 . . . . 0.0 111.099 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -61.58 -57.11 13.39 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.117 0.967 . . . . 0.0 111.255 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.0 pp -59.11 -33.44 70.85 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 118.373 0.533 . . . . 0.0 112.227 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -68.05 -50.71 53.56 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.393 1.477 . . . . 0.0 112.217 175.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -56.81 -40.39 75.9 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.698 1.599 . . . . 0.0 111.502 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -79.93 -0.97 37.31 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.409 2.284 . . . . 0.0 113.403 176.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 46.24 39.22 5.9 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 128.866 2.866 . . . . 0.0 113.752 -177.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -69.98 127.93 92.06 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.478 1.511 . . . . 0.0 114.01 -176.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.09 128.19 11.22 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 122.834 2.356 . . . . 0.0 107.864 169.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 32.3 t -29.72 128.99 0.24 Allowed Pre-proline 0 CA--C 1.558 1.26 0 C-N-CA 128.07 2.548 . . . . 0.0 115.106 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -66.74 -2.56 7.81 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.181 2.588 . . . . 0.0 114.617 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 53.5 t -127.07 -59.48 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.393 1.477 . . . . 0.0 111.476 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 65.0 m -77.14 -24.59 51.61 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.595 1.958 . . . . 0.0 112.671 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 62.44 9.91 3.66 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 127.128 2.171 . . . . 0.0 113.81 -175.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -81.81 151.33 67.48 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.134 0.973 . . . . 0.0 113.068 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -77.46 121.09 5.47 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 123.978 3.119 . . . . 0.0 111.919 177.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.55 153.35 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.988 1.315 . . . . 0.0 112.231 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 18.7 tp60 -115.01 -48.6 2.82 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.1 170.27 20.36 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -176.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 7.9 mt -127.21 138.57 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.087 2.155 . . . . 0.0 108.396 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 16.8 m -133.87 150.09 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.52 1.128 . . . . 0.0 112.215 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 74.6 mt -68.56 99.85 1.04 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.849 0.86 . . . . 0.0 109.57 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 12.1 m -99.4 116.52 31.74 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.059 1.344 . . . . 0.0 114.271 -173.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -102.65 170.45 8.01 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.437 1.895 . . . . 0.0 111.921 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -136.25 157.91 74.63 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.793 1.637 . . . . 0.0 112.132 -176.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 CA--C 1.538 0.69 0 C-N-CA 123.347 2.698 . . . . 0.0 112.478 179.789 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 81.2 p . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.43 -59.72 12.05 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 125.901 1.68 . . . . 0.0 113.689 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -73.59 156.72 49.31 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.137 1.891 . . . . 0.0 111.894 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 63.8 tp -48.91 -47.34 43.47 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.566 1.546 . . . . 0.0 113.678 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -63.0 -7.55 5.51 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -112.44 -9.14 13.85 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.818 1.647 . . . . 0.0 113.058 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 74.7 mt -71.56 -46.93 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.074 0.852 . . . . 0.0 109.065 175.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 39.19 67.67 2.31 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 127.717 2.407 . . . . 0.0 113.606 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -77.82 163.11 29.12 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.317 2.678 . . . . 0.0 114.857 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.69 -179.74 0.4 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.131 1.372 . . . . 0.0 114.359 176.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 19.3 m -131.06 -4.56 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 3.5 mt -121.63 -62.65 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 120.947 1.703 . . . . 0.0 113.677 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 31.4 p -70.61 -67.83 0.47 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 -174.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -140.98 -10.05 1.0 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 116.825 2.158 . . . . 0.0 116.825 -172.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 85.16 33.93 16.15 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 119.64 1.109 . . . . 0.0 110.759 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 44.0 mtt-85 -65.61 136.39 96.02 Favored Pre-proline 0 N--CA 1.477 0.882 0 CA-C-O 117.272 -1.347 . . . . 0.0 110.763 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -73.87 67.12 4.91 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 124.538 3.492 . . . . 0.0 111.235 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -141.75 153.4 44.57 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 128.508 2.723 . . . . 0.0 111.423 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -128.09 120.57 27.69 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.9 1.68 . . . . 0.0 111.8 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -136.04 70.8 0.49 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.652 1.596 . . . . 0.0 111.176 178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 51.0 t -54.65 123.09 12.13 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.196 1.398 . . . . 0.0 110.49 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.32 138.16 20.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 124.937 1.295 . . . . 0.0 109.801 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 96.0 t -129.97 130.48 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.78 0.832 . . . . 0.0 110.254 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.13 105.03 8.85 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 128.603 2.761 . . . . 0.0 110.76 176.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 65.84 -93.75 0.19 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.868 1.699 . . . . 0.0 114.147 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -120.69 -0.14 10.27 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.457 1.903 . . . . 0.0 113.529 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 36.1 p -124.42 165.23 18.11 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.71 2.004 . . . . 0.0 110.638 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -158.81 169.57 35.17 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 120.985 -1.072 . . . . 0.0 113.908 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -120.33 138.67 53.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.619 1.968 . . . . 0.0 113.227 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.7 pp -120.74 153.32 37.15 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.813 2.045 . . . . 0.0 112.352 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 30.1 ttm 108.66 -7.35 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 131.08 3.752 . . . . 0.0 114.441 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -99.96 154.63 18.23 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.903 -1.123 . . . . 0.0 111.557 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 30.4 p -84.6 175.1 9.47 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 123.344 1.545 . . . . 0.0 113.594 178.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.41 -28.35 69.72 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.791 174.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 83.7 m -72.2 -51.02 23.06 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.567 1.076 . . . . 0.0 110.253 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 67.9 m -49.66 -54.8 16.5 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.662 1.185 . . . . 0.0 110.386 173.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.37 -49.46 76.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.209 1.403 . . . . 0.0 112.931 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -60.0 -40.07 87.95 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.952 1.301 . . . . 0.0 112.168 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -61.72 -52.98 62.06 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.38 1.072 . . . . 0.0 110.978 176.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 44.9 mt -52.22 -49.93 62.98 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.184 0.993 . . . . 0.0 110.107 175.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -54.14 49.54 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.988 1.315 . . . . 0.0 112.681 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -54.86 -43.54 73.18 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.903 1.681 . . . . 0.0 112.281 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -78.88 -6.93 57.35 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.835 2.054 . . . . 0.0 113.366 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 62.4 t30 49.4 42.55 22.5 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 128.521 2.729 . . . . 0.0 112.082 -175.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -75.47 117.04 60.32 Favored Pre-proline 0 N--CA 1.47 0.539 0 C-N-CA 125.552 1.541 . . . . 0.0 113.116 -176.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.9 130.93 21.34 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.106 1.871 . . . . 0.0 108.834 171.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 41.5 t -33.0 125.53 0.41 Allowed Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 128.298 2.639 . . . . 0.0 114.168 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -66.88 -1.45 6.05 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 123.112 2.541 . . . . 0.0 114.307 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.67 -59.14 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.698 1.599 . . . . 0.0 111.346 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 81.8 m -76.83 -14.39 59.91 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.364 1.866 . . . . 0.0 113.027 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . 0.304 14.7 ptm180 55.23 13.43 0.85 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 128.496 2.718 . . . . 0.0 115.108 -175.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -89.53 144.33 31.89 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 123.938 0.895 . . . . 0.0 112.294 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -68.71 122.32 9.26 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.158 2.572 . . . . 0.0 109.442 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 1.8 pt -64.89 137.76 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 O-C-N 121.661 -0.649 . . . . 0.0 112.132 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -115.2 -33.74 5.24 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 117.234 2.309 . . . . 0.0 117.234 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -143.27 152.18 41.4 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.82 0.848 . . . . 0.0 113.236 -171.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 5.1 mt -141.03 131.04 26.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 127.649 2.38 . . . . 0.0 109.038 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 27.7 m -140.12 150.13 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.985 1.314 . . . . 0.0 111.928 176.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 2.2 tt -66.1 105.9 1.49 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.569 1.148 . . . . 0.0 108.273 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.2 96.58 7.3 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -171.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -74.02 171.47 13.43 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.086 1.754 . . . . 0.0 113.295 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -132.78 168.19 19.11 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 127.554 2.342 . . . . 0.0 110.474 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo . . . . . 0 C--N 1.352 0.758 0 C-N-CA 124.425 3.417 . . . . 0.0 113.983 -178.84 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 79.5 p . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 10.4 mp -67.42 156.81 87.58 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 125.554 1.541 . . . . 0.0 112.114 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -71.24 176.56 7.71 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.522 2.815 . . . . 0.0 112.126 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -52.84 -19.57 2.62 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -59.76 -23.4 63.2 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.826 1.25 . . . . 0.0 112.602 175.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -72.34 -10.19 59.47 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.279 1.432 . . . . 0.0 113.972 177.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 42.5 mm -82.84 84.52 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 125.206 1.402 . . . . 0.0 108.089 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -56.03 -34.23 23.94 Favored Pre-proline 0 CA--C 1.555 1.137 0 N-CA-C 118.8 2.889 . . . . 0.0 118.8 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . 0.278 87.9 Cg_exo -43.25 -80.33 0.02 OUTLIER 'Trans proline' 0 CA--C 1.553 1.462 0 C-N-CA 125.173 3.916 . . . . 0.0 117.477 -175.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 28.4 t -67.06 150.67 48.88 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 121.899 2.136 . . . . 0.0 109.342 174.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 4.1 p -134.52 -1.68 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 121.221 -0.925 . . . . 0.0 113.301 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 7.2 mt -135.55 -45.66 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.057 0.943 . . . . 0.0 112.974 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.3 m -69.45 -59.49 2.95 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -173.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -152.02 -16.37 0.18 Allowed 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -175.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 80.34 17.01 74.88 Favored Glycine 0 CA--C 1.539 1.591 0 O-C-N 120.973 -1.079 . . . . 0.0 111.865 -174.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 -72.21 155.06 91.96 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 127.549 2.34 . . . . 0.0 112.607 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.0 71.05 5.14 Favored 'Trans proline' 0 CA--C 1.55 1.29 0 C-N-CA 123.929 3.086 . . . . 0.0 113.363 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -129.32 143.17 50.74 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 127.959 2.504 . . . . 0.0 108.842 176.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -128.02 150.27 50.0 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.115 1.366 . . . . 0.0 112.593 -176.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -151.12 80.39 0.19 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 128.076 2.751 . . . . 0.0 109.201 178.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 42.2 t -63.55 119.09 9.15 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.505 1.122 . . . . 0.0 110.794 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -102.07 141.71 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.768 1.227 . . . . 0.0 111.745 -177.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 90.0 t -130.08 133.53 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.778 1.231 . . . . 0.0 111.931 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -124.99 95.03 4.35 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.53 2.732 . . . . 0.0 110.685 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.4 -97.74 0.41 Allowed Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.73 1.633 . . . . 0.0 114.561 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -107.86 -2.71 19.63 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 126.224 1.81 . . . . 0.0 113.168 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 51.0 p -132.25 170.01 15.64 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.124 1.77 . . . . 0.0 110.808 -178.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -161.26 175.99 37.84 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.201 1.381 . . . . 0.0 112.233 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -120.29 142.58 48.96 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.754 1.222 . . . . 0.0 113.927 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 4.6 pp -111.32 153.25 26.23 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.522 1.929 . . . . 0.0 112.0 175.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 459' ' ' MET . . . . . . . . . . . . 0.253 25.2 mmt 70.42 68.94 0.2 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 128.08 2.552 . . . . 0.0 114.996 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -154.23 138.52 16.63 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 128.659 2.784 . . . . 0.0 106.757 171.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 6.3 p -77.57 172.33 13.53 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 120.224 1.375 . . . . 0.0 112.127 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.36 -44.95 95.28 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.648 -0.657 . . . . 0.0 111.117 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 29.2 m -62.67 -44.37 96.42 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 116.664 -1.636 . . . . 0.0 111.375 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 35.5 m -48.1 -69.97 0.11 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 120.704 1.593 . . . . 0.0 110.541 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -50.33 -49.12 54.77 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.526 1.53 . . . . 0.0 112.539 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -57.13 -42.5 81.03 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.602 0.761 . . . . 0.0 112.49 177.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -61.51 -45.49 93.97 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.815 1.246 . . . . 0.0 111.746 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.1 -46.92 84.71 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 174.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 43.5 tptt -57.35 -46.21 83.55 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.004 0.922 . . . . 0.0 112.204 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -61.07 -34.01 74.23 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.001 1.32 . . . . 0.0 112.326 174.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -81.82 0.72 38.11 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.663 1.985 . . . . 0.0 113.407 175.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 84.11 -2.28 1.05 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 131.242 3.817 . . . . 0.0 115.516 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 5.8 tppp? -79.55 130.26 68.68 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 119.815 1.189 . . . . 0.0 109.366 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.34 -92.74 0.01 OUTLIER 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 123.375 2.717 . . . . 0.0 112.22 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 43.7 t -65.8 130.36 94.47 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 124.477 1.111 . . . . 0.0 112.532 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.55 -1.67 11.38 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 123.255 2.636 . . . . 0.0 114.062 177.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 32.8 t -122.01 -72.1 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 119.972 1.26 . . . . 0.0 113.359 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 29.8 p -92.87 -9.27 40.85 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -175.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 77.55 12.85 1.95 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 128.518 2.727 . . . . 0.0 115.138 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -64.9 156.93 78.15 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 124.606 1.163 . . . . 0.0 112.049 175.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.99 100.34 1.2 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.035 3.157 . . . . 0.0 113.284 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 pp -79.09 155.76 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.651 1.181 . . . . 0.0 112.355 179.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -115.02 -26.92 7.53 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.845 1.258 . . . . 0.0 113.756 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.95 164.81 33.08 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.473 1.109 . . . . 0.0 113.914 -177.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 14.2 mt -132.6 132.43 59.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 128.444 2.698 . . . . 0.0 106.359 173.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 24.0 m -134.74 150.2 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 64.3 tp -73.05 99.91 2.87 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.19 1.796 . . . . 0.0 108.624 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 2.5 t -93.21 163.94 13.43 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -135.59 177.76 7.57 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.671 2.388 . . . . 0.0 110.942 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -124.34 157.97 62.86 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 125.306 1.443 . . . . 0.0 111.387 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 C--N 1.351 0.675 0 C-N-CA 123.111 2.541 . . . . 0.0 111.455 -179.646 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 39.9 m . . . . . 0 CA--C 1.54 0.585 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 91.1 mt -135.8 156.24 77.46 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 127.172 2.189 . . . . 0.0 110.79 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -62.1 -22.33 74.03 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.057 2.505 . . . . 0.0 113.466 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.9 -63.86 0.98 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.486 1.514 . . . . 0.0 109.004 174.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -54.23 -29.59 47.03 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.727 1.611 . . . . 0.0 113.245 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -62.65 -20.01 64.38 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.612 1.165 . . . . 0.0 113.983 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 24.0 mm -81.93 71.14 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 122.413 1.101 . . . . 0.0 108.8 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -131.39 60.78 54.94 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 125.843 1.657 . . . . 0.0 112.595 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -60.81 -49.1 9.14 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.922 3.082 . . . . 0.0 113.668 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 27.5 t -55.25 143.33 28.35 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 120.876 1.671 . . . . 0.0 110.18 173.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 32.6 m -121.23 -14.69 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 9.9 pt -137.09 -26.17 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 -178.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.2 m -77.67 -59.64 2.7 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 120.549 1.522 . . . . 0.0 112.512 -176.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -151.88 -15.53 0.19 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -176.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.89 9.47 84.39 Favored Glycine 0 CA--C 1.541 1.714 0 CA-C-N 119.946 1.248 . . . . 0.0 112.544 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -56.56 155.07 14.93 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 129.427 3.091 . . . . 0.0 113.616 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -72.43 2.93 4.58 Favored 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 124.91 3.74 . . . . 0.0 115.817 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -59.05 142.95 49.97 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.887 2.075 . . . . 0.0 111.62 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -128.1 122.45 32.07 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.371 1.469 . . . . 0.0 112.73 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -138.97 75.21 0.38 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.46 1.981 . . . . 0.0 110.516 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 31.4 t -62.85 138.29 58.49 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.017 0.909 . . . . 0.0 110.282 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 1.4 mp -109.09 142.03 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 125.317 1.447 . . . . 0.0 109.928 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 96.0 t -124.12 131.92 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.293 1.037 . . . . 0.0 110.288 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -123.08 100.06 6.68 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 129.02 2.928 . . . . 0.0 110.725 177.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.97 -93.5 0.27 Allowed Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.914 1.721 . . . . 0.0 113.783 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -120.63 4.71 10.6 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.463 1.905 . . . . 0.0 114.061 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 60.5 p -132.58 170.12 15.63 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.701 2.0 . . . . 0.0 110.417 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -151.24 174.19 30.51 Favored Glycine 0 CA--C 1.528 0.845 0 O-C-N 120.925 -1.109 . . . . 0.0 113.799 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.28 108.14 13.81 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.982 1.713 . . . . 0.0 111.741 174.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 48.3 tp -92.01 153.07 19.67 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.075 2.15 . . . . 0.0 110.153 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 21.9 ttt 80.31 67.58 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.588 2.355 . . . . 0.0 111.778 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -159.87 147.67 16.88 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 129.705 3.202 . . . . 0.0 107.353 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 17.9 p -84.33 173.64 10.78 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 122.447 1.118 . . . . 0.0 111.457 175.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -34.19 77.32 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.134 177.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 22.2 m -70.4 -45.87 65.12 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 117.086 -1.435 . . . . 0.0 110.687 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 41.1 m -50.79 -53.76 29.23 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 120.946 1.703 . . . . 0.0 110.143 173.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -59.77 -40.29 87.75 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.412 1.485 . . . . 0.0 113.065 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -68.09 -40.98 82.54 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.85 -1.156 . . . . 0.0 111.182 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -60.23 -54.15 49.19 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.352 1.461 . . . . 0.0 112.135 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.1 pp -58.18 -36.63 73.35 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 118.923 0.783 . . . . 0.0 111.309 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -65.24 -49.96 67.63 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.768 1.627 . . . . 0.0 111.35 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -58.88 -39.57 81.8 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.956 1.302 . . . . 0.0 111.967 177.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -73.5 0.15 13.31 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 126.468 1.907 . . . . 0.0 113.506 175.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 55.5 t30 61.46 24.01 14.18 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 128.298 2.639 . . . . 0.0 113.949 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -79.42 133.64 59.64 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.455 1.102 . . . . 0.0 108.904 177.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -65.41 -68.25 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.586 2.191 . . . . 0.0 108.927 176.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 34.1 t -143.01 125.13 8.68 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 127.511 2.325 . . . . 0.0 109.315 174.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.54 -2.26 11.89 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.105 2.537 . . . . 0.0 113.382 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 25.4 t -111.18 -64.41 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.978 1.311 . . . . 0.0 112.234 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 27.9 p -109.89 2.5 19.87 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.244 1.418 . . . . 0.0 114.786 -177.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 63.48 7.98 3.3 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 128.061 2.544 . . . . 0.0 116.518 175.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -67.28 135.73 93.5 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-N 119.097 0.862 . . . . 0.0 110.649 176.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.73 115.56 4.14 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.409 2.739 . . . . 0.0 113.423 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.9 pp -70.61 151.38 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 125.286 1.434 . . . . 0.0 114.047 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -115.0 -44.2 3.05 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.842 2.057 . . . . 0.0 113.448 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.41 166.79 31.55 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -175.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 10.1 mt -133.76 136.37 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 128.646 2.778 . . . . 0.0 107.789 176.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 19.5 m -140.02 150.16 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.64 102.56 0.93 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.178 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 7.1 m -94.73 95.65 8.87 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -173.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -75.0 156.68 36.0 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.977 1.311 . . . . 0.0 112.685 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -86.06 164.89 37.03 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 125.708 1.603 . . . . 0.0 111.819 177.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo . . . . . 0 C--N 1.353 0.801 0 C-N-CA 124.2 3.267 . . . . 0.0 114.598 -179.61 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 17.8 tp -54.82 136.1 65.29 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.597 1.559 . . . . 0.0 111.112 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -37.67 -46.2 1.84 Allowed 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 124.96 3.773 . . . . 0.0 115.905 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 47.8 tp -53.41 -29.47 35.15 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.091 1.757 . . . . 0.0 115.014 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 18.9 p30 -112.46 -7.69 13.91 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.874 1.27 . . . . 0.0 112.969 175.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -82.2 -33.6 29.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.374 1.07 . . . . 0.0 112.35 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 5.3 mm 66.01 18.87 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 126.32 1.848 . . . . 0.0 112.801 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 52.98 73.34 0.95 Allowed Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 126.199 1.799 . . . . 0.0 111.226 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -74.4 178.86 6.48 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 125.261 3.974 . . . . 0.0 117.379 -171.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 16.2 t -55.99 161.85 2.14 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 128.951 2.9 . . . . 0.0 111.319 172.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 18.8 m -129.65 -14.98 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 10.5 pt -137.29 -26.74 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.7 m -76.17 -57.8 3.66 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 120.646 1.566 . . . . 0.0 111.936 -178.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -149.0 -18.98 0.3 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 80.69 11.14 84.33 Favored Glycine 0 CA--C 1.54 1.603 0 O-C-N 120.959 -1.088 . . . . 0.0 113.366 -176.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -69.53 155.1 94.15 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 127.976 2.51 . . . . 0.0 113.548 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -52.54 -9.03 0.48 Allowed 'Trans proline' 0 CA--C 1.545 1.043 1 C-N-CA 125.965 4.443 . . . . 0.0 119.309 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -58.41 141.43 51.52 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 120.227 1.376 . . . . 0.0 111.569 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.18 150.14 50.14 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.021 2.128 . . . . 0.0 111.777 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -159.94 85.19 0.12 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 126.262 1.887 . . . . 0.0 110.046 176.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 42.3 t -58.54 139.11 56.26 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 117.839 0.819 . . . . 0.0 111.467 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.8 mp -115.13 140.87 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.074 1.749 . . . . 0.0 109.596 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 60.0 t -127.38 136.04 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.767 0.827 . . . . 0.0 109.47 175.309 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -125.11 94.85 4.29 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.752 2.421 . . . . 0.0 109.818 175.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 58.78 -99.61 0.13 Allowed Glycine 0 CA--C 1.534 1.273 0 C-N-CA 126.175 1.845 . . . . 0.0 114.71 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -86.55 -19.86 28.83 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.881 1.673 . . . . 0.0 114.636 -176.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 67.6 p -133.07 170.06 15.93 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.856 1.262 . . . . 0.0 112.729 -176.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -142.36 169.19 25.54 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.575 1.083 . . . . 0.0 113.968 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.18 134.0 55.36 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.95 1.7 . . . . 0.0 112.047 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.51 153.43 31.17 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 128.999 2.92 . . . . 0.0 111.473 -179.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 459' ' ' MET . . . . . . . . . . . . 0.424 19.1 ptp 70.4 69.36 0.21 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 128.714 2.806 . . . . 0.0 113.881 -178.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -158.31 143.24 16.35 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 130.25 3.42 . . . . 0.0 105.864 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 21.8 p -79.64 174.99 11.02 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 119.787 1.176 . . . . 0.0 111.846 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -63.38 -31.39 72.53 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.421 -0.799 . . . . 0.0 110.735 176.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 25.6 m -70.46 -44.63 67.37 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 117.542 -1.218 . . . . 0.0 110.987 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 60.1 m -51.37 -53.9 31.76 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 120.426 1.466 . . . . 0.0 109.433 172.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.62 -47.12 83.08 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.566 1.547 . . . . 0.0 112.648 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.14 -40.54 94.19 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.096 1.358 . . . . 0.0 111.718 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -59.29 -55.02 40.19 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.607 1.163 . . . . 0.0 110.591 176.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 23.9 mt -51.62 -50.36 60.41 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.704 1.202 . . . . 0.0 110.109 177.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.44 -54.79 42.61 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.755 1.222 . . . . 0.0 114.153 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -60.17 -38.45 83.25 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.149 1.38 . . . . 0.0 112.584 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -82.19 -4.22 56.57 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.537 1.535 . . . . 0.0 112.902 175.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 49.07 50.71 17.48 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 129.055 2.942 . . . . 0.0 112.151 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -70.02 148.98 96.33 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.514 0.726 . . . . 0.0 112.642 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -81.95 11.86 2.99 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 124.016 3.144 . . . . 0.0 113.435 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 34.6 t 73.24 88.66 0.08 OUTLIER Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 128.493 2.717 . . . . 0.0 108.585 -173.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.75 -23.19 25.69 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.27 2.646 . . . . 0.0 114.869 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 20.1 t -73.32 -51.71 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 126.567 1.947 . . . . 0.0 113.213 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 26.1 p -128.59 0.39 5.54 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 -174.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 66.56 30.12 8.61 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 127.485 2.314 . . . . 0.0 114.841 175.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -107.48 102.87 46.47 Favored Pre-proline 0 CA--C 1.554 1.135 0 C-N-CA 126.695 1.998 . . . . 0.0 111.112 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.45 124.53 10.86 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.06 3.173 . . . . 0.0 115.235 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.4 pp -57.52 151.48 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.716 2.007 . . . . 0.0 113.327 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -115.03 -57.27 2.28 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.057 1.343 . . . . 0.0 112.018 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.64 170.22 20.78 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 4.4 mt -121.47 148.24 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.867 2.067 . . . . 0.0 108.603 175.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 6.2 m -134.48 150.18 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.808 1.643 . . . . 0.0 111.189 176.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.91 99.9 4.66 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 56.9 m -79.27 156.02 28.28 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.952 0.901 . . . . 0.0 112.545 -176.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -138.53 164.09 30.33 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.981 2.112 . . . . 0.0 110.257 178.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -124.05 168.82 11.81 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 125.944 1.698 . . . . 0.0 110.907 -178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo . . . . . 0 C--N 1.348 0.547 0 C-N-CA 123.14 2.56 . . . . 0.0 110.895 178.3 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -51.62 119.57 13.64 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 127.248 2.219 . . . . 0.0 110.364 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -43.26 -44.86 10.07 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 124.985 3.79 . . . . 0.0 117.11 -175.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 63.4 mt -62.51 -34.91 77.82 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.781 0.832 . . . . 0.0 112.79 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -86.59 -21.4 26.86 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.121 1.368 . . . . 0.0 112.518 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -76.07 -13.09 60.22 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.452 1.501 . . . . 0.0 113.928 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 8.4 mm 52.14 59.46 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 127.265 2.226 . . . . 0.0 111.928 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 5.08 78.32 0.04 OUTLIER Pre-proline 0 N--CA 1.482 1.147 0 C-N-CA 130.124 3.37 . . . . 0.0 116.239 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -79.93 170.85 16.14 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.312 2.675 . . . . 0.0 115.085 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 438' ' ' CYS . . . . . 0.4 ' SG ' ' N ' ' B' ' 439' ' ' VAL . 21.3 t -68.17 -175.95 0.66 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.969 1.708 . . . . 0.0 112.506 174.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 439' ' ' VAL . . . . . 0.4 ' N ' ' SG ' ' B' ' 438' ' ' CYS . 6.0 p -141.84 -1.66 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.481 1.513 . . . . 0.0 114.193 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 19.4 mt -118.74 -65.78 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 120.072 1.305 . . . . 0.0 113.393 -176.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 22.8 p -52.67 -74.69 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -141.0 -11.34 0.98 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.571 2.348 . . . . 0.0 113.311 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 79.61 30.69 43.39 Favored Glycine 0 CA--C 1.536 1.364 0 O-C-N 121.556 -0.715 . . . . 0.0 112.634 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -69.73 155.05 94.19 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.737 1.615 . . . . 0.0 111.95 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.89 -2.19 0.32 Allowed 'Trans proline' 0 CA--C 1.549 1.257 1 C-N-CA 125.778 4.319 . . . . 0.0 118.982 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -73.26 142.43 47.23 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.5 1.52 . . . . 0.0 111.861 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.31 149.98 50.27 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.335 1.854 . . . . 0.0 111.692 174.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -160.14 84.73 0.12 Allowed Glycine 0 CA--C 1.53 0.978 0 C-N-CA 126.453 1.977 . . . . 0.0 111.295 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 33.3 t -61.26 137.09 58.24 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.914 0.886 . . . . 0.0 111.402 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.07 147.19 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 126.215 1.806 . . . . 0.0 110.427 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 33.7 t -127.51 138.48 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.151 0.98 . . . . 0.0 110.527 175.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -125.05 95.02 4.34 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 128.868 2.867 . . . . 0.0 109.935 175.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.53 -93.36 0.37 Allowed Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.824 1.678 . . . . 0.0 113.804 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -117.48 -0.31 11.96 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 126.408 1.883 . . . . 0.0 113.532 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 47.4 p -127.13 170.06 12.77 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.469 1.908 . . . . 0.0 110.15 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -159.09 170.93 35.55 Favored Glycine 0 N--CA 1.468 0.772 0 O-C-N 120.592 -1.317 . . . . 0.0 114.062 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.02 139.15 52.94 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.264 1.425 . . . . 0.0 112.01 178.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 56.0 tp -130.02 153.2 48.66 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.737 2.415 . . . . 0.0 110.995 -176.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 28.1 ttm 95.21 29.16 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 129.061 2.944 . . . . 0.0 113.783 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -133.14 151.38 51.99 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.629 1.972 . . . . 0.0 109.556 176.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 22.3 p -75.43 168.86 19.19 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 122.881 1.324 . . . . 0.0 113.312 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.21 -35.18 80.27 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.919 177.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 19.7 m -64.14 -52.9 56.9 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.89 176.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 18.1 m -53.51 -52.89 58.16 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.727 1.149 . . . . 0.0 111.239 175.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -51.85 -41.39 61.8 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.267 1.427 . . . . 0.0 112.669 173.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -69.93 -27.35 64.69 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.045 1.338 . . . . 0.0 113.266 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -57.54 -42.28 82.65 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 120.18 1.355 . . . . 0.0 111.202 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -54.56 -44.54 73.01 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.957 1.303 . . . . 0.0 110.099 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -66.06 -50.29 64.67 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.451 0.7 . . . . 0.0 111.444 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -53.45 -41.63 66.31 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.419 1.488 . . . . 0.0 113.758 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -99.33 11.32 39.43 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.424 1.49 . . . . 0.0 114.845 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 63.3 t30 47.89 60.66 3.41 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.212 2.205 . . . . 0.0 113.803 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -121.58 143.35 37.78 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 128.693 2.797 . . . . 0.0 108.985 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.92 -85.23 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.19 0 C-N-CA 122.798 2.332 . . . . 0.0 112.853 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 5.7 t -127.02 140.37 37.63 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 127.01 2.124 . . . . 0.0 111.328 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.54 -5.56 16.69 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.514 2.809 . . . . 0.0 114.412 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 55.1 t -119.32 -74.22 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.736 1.153 . . . . 0.0 112.602 -177.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 24.6 p -93.85 0.6 56.3 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.611 1.564 . . . . 0.0 114.007 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 58.71 14.62 3.25 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 128.193 2.597 . . . . 0.0 115.892 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -68.58 138.99 91.28 Favored Pre-proline 0 CA--C 1.552 1.034 0 CA-C-N 119.244 0.929 . . . . 0.0 110.645 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.75 113.05 2.61 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.562 2.842 . . . . 0.0 113.757 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.6 pp -69.16 159.34 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.357 1.463 . . . . 0.0 113.758 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -115.12 -56.83 2.33 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.991 2.116 . . . . 0.0 111.243 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.96 170.21 19.9 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.568 1.147 . . . . 0.0 113.51 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 10.5 mt -118.25 138.11 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 127.62 2.368 . . . . 0.0 106.191 174.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 14.7 p -129.02 147.19 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 119.382 0.992 . . . . 0.0 113.497 -177.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.3 99.92 1.63 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.979 1.311 . . . . 0.0 107.876 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 6.0 t -98.87 155.17 17.52 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -144.56 167.17 23.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.395 1.878 . . . . 0.0 111.269 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -123.36 153.34 65.4 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 125.333 1.453 . . . . 0.0 111.689 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 C--N 1.351 0.693 0 C-N-CA 123.592 2.861 . . . . 0.0 111.546 -179.063 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 63.7 m . . . . . 0 CA--C 1.538 0.513 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 91.1 mt -41.48 -51.31 8.79 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 126.581 1.952 . . . . 0.0 115.804 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -59.97 -8.12 7.39 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.428 2.085 . . . . 0.0 114.762 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 26.0 mt -117.5 -61.38 1.71 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.402 1.881 . . . . 0.0 111.464 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -77.78 -9.38 58.99 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 -177.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -119.9 -49.98 2.3 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.131 0.972 . . . . 0.0 111.919 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.44 -28.59 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 124.751 1.221 . . . . 0.0 110.95 176.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 47.84 72.9 1.11 Allowed Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 127.301 2.24 . . . . 0.0 113.121 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.33 -102.47 0.01 OUTLIER 'Trans proline' 0 CA--C 1.552 1.415 1 C-N-CA 125.379 4.053 . . . . 0.0 112.042 -178.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 23.0 t -63.59 154.86 31.4 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 119.747 1.158 . . . . 0.0 110.154 174.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 31.0 m -129.43 -14.61 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 10.4 pt -137.08 -26.4 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.4 m -73.68 -60.76 2.1 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 120.921 1.691 . . . . 0.0 112.051 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -153.54 -13.85 0.15 Allowed 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -176.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 80.08 8.9 87.23 Favored Glycine 0 CA--C 1.541 1.682 0 O-C-N 120.747 -1.221 . . . . 0.0 112.853 -175.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -62.17 155.01 67.55 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 128.175 2.59 . . . . 0.0 113.415 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.03 75.22 3.78 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 124.143 3.229 . . . . 0.0 113.611 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -135.02 148.01 49.81 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.994 2.518 . . . . 0.0 109.218 176.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -128.05 148.09 50.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.013 0.925 . . . . 0.0 111.367 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -159.1 86.62 0.12 Allowed Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.872 1.701 . . . . 0.0 112.822 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 49.3 t -68.63 136.2 52.62 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.896 0.848 . . . . 0.0 110.115 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.0 140.32 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.811 1.244 . . . . 0.0 111.448 -178.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 93.3 t -126.89 131.4 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.138 1.375 . . . . 0.0 111.742 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -114.23 94.98 5.05 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 128.608 2.763 . . . . 0.0 109.727 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.82 -91.41 0.42 Allowed Glycine 0 CA--C 1.535 1.29 0 C-N-CA 126.218 1.866 . . . . 0.0 113.97 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -121.93 5.11 9.91 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 126.506 1.922 . . . . 0.0 113.494 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 74.6 p -135.6 170.06 16.55 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.018 2.127 . . . . 0.0 109.823 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -160.14 179.18 35.84 Favored Glycine 0 N--CA 1.47 0.908 0 O-C-N 120.538 -1.351 . . . . 0.0 114.45 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -120.41 133.87 55.36 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.239 1.415 . . . . 0.0 113.849 174.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -110.16 153.26 24.99 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.596 1.558 . . . . 0.0 111.487 173.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 41.8 ttm 99.73 60.0 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 129.825 3.25 . . . . 0.0 112.487 177.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -160.05 158.31 30.22 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.306 1.842 . . . . 0.0 110.936 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 13.7 p -88.71 175.07 7.67 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 122.441 1.115 . . . . 0.0 111.63 173.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -37.16 84.3 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.028 -1.045 . . . . 0.0 110.672 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 26.6 m -63.21 -49.69 73.19 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 117.18 -1.391 . . . . 0.0 109.847 176.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 60.0 m -47.12 -56.23 6.95 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 120.35 1.432 . . . . 0.0 110.291 173.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -56.85 -47.3 80.69 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.905 1.682 . . . . 0.0 114.398 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -74.4 -31.64 62.4 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 120.055 1.298 . . . . 0.0 112.682 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -62.63 -55.5 26.49 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.897 1.679 . . . . 0.0 110.942 177.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 2.3 pp -59.0 -37.88 77.89 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 117.8 0.273 . . . . 0.0 111.131 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -63.11 -49.3 74.96 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.121 1.368 . . . . 0.0 111.759 176.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -58.0 -39.6 78.66 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.598 1.559 . . . . 0.0 111.561 176.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -76.0 5.56 6.45 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 127.078 2.151 . . . . 0.0 113.866 175.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 45.3 t30 65.21 18.72 11.53 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 128.771 2.828 . . . . 0.0 115.438 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -70.13 130.04 90.07 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 120.821 -1.174 . . . . 0.0 108.82 175.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.77 -51.3 0.93 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.772 2.315 . . . . 0.0 111.695 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 3.4 t -153.85 140.08 12.6 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 129.375 3.07 . . . . 0.0 108.019 174.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -71.29 -6.37 19.03 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.261 2.641 . . . . 0.0 114.583 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 46.4 t -125.08 -70.86 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 119.829 1.195 . . . . 0.0 113.404 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 24.6 p -97.13 3.62 51.58 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.803 1.641 . . . . 0.0 114.797 -175.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 59.62 20.21 8.81 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 127.763 2.425 . . . . 0.0 116.054 175.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -81.04 115.99 59.65 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 124.544 1.138 . . . . 0.0 109.376 175.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -47.32 108.32 0.16 Allowed 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 124.373 3.382 . . . . 0.0 117.264 -175.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.0 pp -66.41 134.52 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 126.124 1.77 . . . . 0.0 112.14 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -115.24 -16.61 11.5 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.55 1.54 . . . . 0.0 115.026 -176.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 1.8 ttp -150.32 148.17 28.51 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.122 0.969 . . . . 0.0 113.021 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 14.4 mt -131.99 139.42 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 127.363 2.265 . . . . 0.0 107.936 173.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 10.0 m -134.68 150.23 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.565 1.146 . . . . 0.0 113.403 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 63.5 tp -70.13 99.87 1.56 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 173.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 4.8 t -98.98 159.1 15.2 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -172.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -142.6 171.18 14.4 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.392 2.277 . . . . 0.0 111.606 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -138.54 156.63 73.15 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.98 1.712 . . . . 0.0 111.028 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo . . . . . 0 C--N 1.351 0.674 0 C-N-CA 123.627 2.884 . . . . 0.0 111.482 -179.61 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 CA--C 1.541 0.61 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 96.6 mt -71.97 165.86 46.11 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 125.742 1.617 . . . . 0.0 111.913 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -58.54 164.05 9.81 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.266 2.644 . . . . 0.0 113.713 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -56.19 -22.19 27.57 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -65.24 -34.28 77.99 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.112 0.965 . . . . 0.0 111.3 175.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -90.28 -52.76 4.77 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.764 1.625 . . . . 0.0 110.192 175.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 28.6 mm -83.89 72.42 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 125.134 1.373 . . . . 0.0 109.559 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -82.03 -14.14 0.21 Allowed Pre-proline 0 CA--C 1.562 1.429 0 N-CA-C 118.856 2.909 . . . . 0.0 118.856 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -43.44 -78.62 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.318 0 C-N-CA 124.78 3.653 . . . . 0.0 117.361 -177.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 40.0 t -61.26 145.82 49.99 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 121.838 2.108 . . . . 0.0 109.684 175.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 35.3 m -123.15 -15.17 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 8.4 pt -137.66 -25.32 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.8 m -77.28 -63.64 1.32 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.656 1.571 . . . . 0.0 112.211 -176.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -144.16 -11.74 0.64 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -177.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 75.84 16.16 80.84 Favored Glycine 0 CA--C 1.545 1.914 0 CA-C-N 120.117 1.326 . . . . 0.0 112.42 -174.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -65.58 155.2 86.4 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 130.484 3.513 . . . . 0.0 113.021 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -68.96 -3.61 11.82 Favored 'Trans proline' 0 CA--C 1.546 1.089 0 C-N-CA 124.161 3.241 . . . . 0.0 115.956 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -59.35 134.7 57.25 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.341 1.456 . . . . 0.0 110.17 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -128.24 138.68 52.54 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.22 1.808 . . . . 0.0 110.344 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -139.25 83.58 0.24 Allowed Glycine 0 CA--C 1.526 0.779 0 C-N-CA 127.482 2.467 . . . . 0.0 109.761 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 50.7 t -59.4 138.52 57.63 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.01 0.924 . . . . 0.0 111.013 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.05 142.4 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 125.647 1.579 . . . . 0.0 109.478 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 14.5 t -116.81 142.31 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.325 1.05 . . . . 0.0 109.463 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -125.11 94.83 4.28 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 128.016 2.527 . . . . 0.0 107.165 175.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 60.87 -91.85 0.06 OUTLIER Glycine 0 CA--C 1.541 1.706 0 C-N-CA 124.759 1.171 . . . . 0.0 113.829 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -118.71 6.17 11.56 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 127.441 2.297 . . . . 0.0 113.514 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 41.5 p -121.74 170.21 9.97 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.629 2.372 . . . . 0.0 110.441 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -162.6 167.48 37.11 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 120.598 -1.313 . . . . 0.0 114.688 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -120.12 141.31 49.94 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.552 1.541 . . . . 0.0 113.034 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 79.8 mt -119.26 153.21 35.37 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.268 2.627 . . . . 0.0 110.959 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 20.2 mmt 76.44 65.25 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.588 2.355 . . . . 0.0 113.19 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -155.81 135.02 12.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 129.749 3.22 . . . . 0.0 105.438 172.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 13.1 p -77.22 174.72 10.42 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 120.958 1.708 . . . . 0.0 111.96 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.47 -37.22 82.82 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.59 -0.694 . . . . 0.0 111.827 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 84.7 m -72.49 -44.21 62.58 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 116.194 -1.86 . . . . 0.0 110.684 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 53.0 m -46.36 -57.33 4.72 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 121.596 1.998 . . . . 0.0 110.474 173.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.03 -52.42 65.34 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.482 1.513 . . . . 0.0 112.663 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -59.82 -38.58 82.4 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 121.091 -1.006 . . . . 0.0 113.083 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -62.19 -48.05 81.76 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.153 1.781 . . . . 0.0 111.416 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 14.5 mt -54.88 -50.73 68.02 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.894 0.878 . . . . 0.0 109.631 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -55.86 -46.5 78.2 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.155 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -58.59 -42.23 87.58 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.244 1.417 . . . . 0.0 111.725 175.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -76.35 0.45 19.45 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 127.407 2.283 . . . . 0.0 113.713 175.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 71.73 6.92 5.81 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 129.71 3.204 . . . . 0.0 115.508 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.11 135.88 47.48 Favored Pre-proline 0 CA--C 1.544 0.75 0 O-C-N 120.664 -1.272 . . . . 0.0 109.342 175.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -78.06 -110.22 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.286 0 C-N-CA 123.212 2.608 . . . . 0.0 108.78 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 15.2 t -70.7 139.64 86.22 Favored Pre-proline 0 CA--C 1.556 1.183 0 O-C-N 120.76 -1.213 . . . . 0.0 112.65 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.17 -4.23 14.57 Favored 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 123.612 2.875 . . . . 0.0 114.115 175.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 61.3 t -129.02 -68.29 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 29.6 p -88.08 -6.37 57.96 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 120.393 1.451 . . . . 0.0 113.575 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 61.27 9.18 2.39 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 128.487 2.715 . . . . 0.0 115.12 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -66.39 153.38 92.91 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-N 118.763 0.71 . . . . 0.0 111.925 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.48 119.88 6.98 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.357 2.705 . . . . 0.0 113.01 -177.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.65 159.5 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.567 1.547 . . . . 0.0 112.91 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.08 -60.72 1.85 Allowed 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.036 1.735 . . . . 0.0 110.893 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.99 170.32 21.57 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.679 1.992 . . . . 0.0 112.581 -177.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 13.2 mt -115.98 135.47 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 126.388 1.875 . . . . 0.0 108.036 174.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 15.0 m -134.3 150.0 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.578 1.151 . . . . 0.0 112.595 177.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.58 99.94 5.93 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 56.1 m -101.03 104.03 15.16 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.199 0.6 . . . . 0.0 111.313 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -78.63 172.48 13.63 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.811 2.444 . . . . 0.0 112.45 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -115.6 167.03 10.79 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 126.254 1.822 . . . . 0.0 111.787 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo . . . . . 0 C--N 1.351 0.702 0 C-N-CA 124.104 3.203 . . . . 0.0 113.785 179.352 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 77.8 p . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.66 156.44 88.97 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.367 1.467 . . . . 0.0 110.319 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -45.78 -50.93 8.93 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.798 2.998 . . . . 0.0 114.413 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 3.9 pp -64.56 -22.33 66.94 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -93.08 -23.8 18.51 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.022 1.329 . . . . 0.0 112.283 178.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -89.06 -1.94 58.33 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.596 1.959 . . . . 0.0 115.253 -177.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 51.5 mm -51.23 -69.74 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 126.254 1.822 . . . . 0.0 112.55 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -146.57 97.88 4.27 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.927 1.691 . . . . 0.0 110.216 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -77.55 160.97 31.51 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.147 2.564 . . . . 0.0 112.672 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 15.0 p -70.19 -179.02 1.82 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.921 1.288 . . . . 0.0 112.7 177.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.08 -3.81 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -177.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 4.7 mt -121.88 -62.42 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 120.147 1.339 . . . . 0.0 113.498 -178.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . 0.256 3.6 p -66.69 -61.95 1.7 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 -173.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -154.61 -15.47 0.12 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -175.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 100.44 51.19 1.24 Allowed Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.878 1.704 . . . . 0.0 110.585 -176.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -105.75 155.0 38.93 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 125.291 1.436 . . . . 0.0 112.526 -176.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -46.62 118.8 2.8 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.252 2.635 . . . . 0.0 113.877 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 29.13 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 129.375 3.07 . . . . 0.0 118.818 -175.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.77 89.84 2.32 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 120.288 -1.507 . . . . 0.0 109.207 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 170.09 42.01 0.03 OUTLIER Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.034 1.302 . . . . 0.0 112.118 -177.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 45.4 t -49.96 121.35 5.28 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.673 1.589 . . . . 0.0 111.846 -178.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 4.4 mp -83.45 123.85 39.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 125.689 1.595 . . . . 0.0 107.718 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 96.5 t -127.08 123.15 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 121.679 0.752 . . . . 0.0 111.061 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -120.3 106.81 12.24 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 128.113 2.565 . . . . 0.0 111.393 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.65 -92.22 0.43 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.749 1.642 . . . . 0.0 113.934 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -127.06 4.44 6.47 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.574 1.95 . . . . 0.0 113.183 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 60.1 p -133.53 170.15 15.94 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.32 1.848 . . . . 0.0 110.668 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -159.26 173.91 36.13 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.326 0.965 . . . . 0.0 113.301 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -120.11 131.82 55.19 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.899 1.28 . . . . 0.0 112.784 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 1.9 tt -92.85 153.27 18.93 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 129.487 3.115 . . . . 0.0 112.133 -178.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 16.0 ttp 86.5 31.07 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.964 2.506 . . . . 0.0 117.213 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -139.28 135.01 33.39 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.018 1.327 . . . . 0.0 108.801 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 26.3 p -79.59 175.01 11.0 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 123.051 1.405 . . . . 0.0 114.317 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.24 -41.06 78.84 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.678 1.191 . . . . 0.0 111.869 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 78.8 m -60.8 -53.0 62.66 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.721 1.208 . . . . 0.0 110.358 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 90.5 m -52.08 -53.7 39.22 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.561 1.144 . . . . 0.0 111.056 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -56.02 -50.16 71.66 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.363 1.065 . . . . 0.0 112.671 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -64.91 -38.17 90.07 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.212 1.005 . . . . 0.0 112.414 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -61.02 -52.99 62.65 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.359 1.464 . . . . 0.0 110.573 177.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 29.8 mt -51.77 -51.47 56.07 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.397 1.079 . . . . 0.0 109.782 175.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -54.22 -48.63 70.85 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.175 0.99 . . . . 0.0 112.342 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -59.86 -41.55 91.7 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.326 1.45 . . . . 0.0 111.983 175.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -75.72 -0.99 22.78 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 127.065 2.146 . . . . 0.0 113.44 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 38.9 t30 75.44 7.1 4.02 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 130.086 3.354 . . . . 0.0 115.425 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -80.89 128.7 70.56 Favored Pre-proline 0 CA--C 1.543 0.697 0 O-C-N 120.612 -1.305 . . . . 0.0 109.154 175.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.11 -87.82 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 123.326 2.684 . . . . 0.0 110.415 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 37.4 t -96.78 132.44 26.07 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.67 1.588 . . . . 0.0 111.031 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.56 -4.7 14.89 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.272 2.648 . . . . 0.0 113.794 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 24.4 t -112.46 -74.19 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 119.772 1.169 . . . . 0.0 112.634 -177.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 25.4 p -95.82 -3.64 45.23 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.422 1.489 . . . . 0.0 114.318 -177.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 67.12 10.58 7.81 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 127.75 2.42 . . . . 0.0 115.162 176.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -62.97 149.68 89.81 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 124.0 0.92 . . . . 0.0 111.663 177.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -68.77 106.89 1.56 Allowed 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.892 3.061 . . . . 0.0 113.682 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 1.5 pp -71.86 145.77 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.352 1.461 . . . . 0.0 111.405 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -115.22 -24.25 8.57 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.2 168.13 27.88 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -176.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 10.0 mt -139.29 132.49 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 128.784 2.833 . . . . 0.0 106.731 174.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.11 150.08 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 125.003 1.321 . . . . 0.0 112.153 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 64.5 mt -69.54 99.84 1.33 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.632 0.729 . . . . 0.0 109.295 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.15 112.67 25.88 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.89 1.676 . . . . 0.0 113.601 -174.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -127.83 169.05 14.33 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.903 1.281 . . . . 0.0 113.854 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -73.55 159.67 84.07 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 127.098 2.159 . . . . 0.0 112.821 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo . . . . . 0 C--N 1.351 0.698 0 C-N-CA 123.562 2.842 . . . . 0.0 111.501 178.787 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 41.8 m . . . . . 0 CA--C 1.54 0.583 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 96.1 mt -137.68 161.27 61.21 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 127.601 2.36 . . . . 0.0 110.363 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -49.98 -34.12 36.56 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.683 2.922 . . . . 0.0 114.279 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 57.1 mt -57.26 -32.36 66.51 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.276 1.83 . . . . 0.0 113.106 177.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -103.29 -12.38 17.31 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.403 1.481 . . . . 0.0 112.65 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -73.81 -47.36 39.23 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.732 0.813 . . . . 0.0 110.07 176.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 21.5 mm -85.44 83.37 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 122.269 1.033 . . . . 0.0 108.942 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -116.52 -68.55 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.606 0 CA-C-O 117.251 -1.357 . . . . 0.0 110.469 176.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -73.32 155.09 51.38 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.207 1.938 . . . . 0.0 113.255 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 8.5 p -66.98 -163.32 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 126.832 2.053 . . . . 0.0 115.021 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 96.4 t -125.67 -22.72 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -174.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 2.5 mt -129.4 -56.8 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 -171.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 27.8 p -69.19 -61.97 1.57 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 -172.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -148.75 -9.09 0.36 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 116.716 2.117 . . . . 0.0 116.716 -173.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 86.59 30.56 21.14 Favored Glycine 0 CA--C 1.534 1.248 0 O-C-N 120.693 -1.254 . . . . 0.0 111.196 -175.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 44.6 mtt-85 -65.44 135.98 96.08 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 125.526 1.53 . . . . 0.0 111.388 -177.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.78 77.88 1.79 Allowed 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 123.815 3.01 . . . . 0.0 110.328 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -150.05 160.67 43.46 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.024 2.13 . . . . 0.0 113.188 -170.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -128.21 150.11 50.17 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 128.967 2.907 . . . . 0.0 111.104 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 176.45 76.92 0.05 OUTLIER Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.825 1.678 . . . . 0.0 112.323 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 19.7 t -61.55 140.69 58.08 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.934 0.894 . . . . 0.0 111.869 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 2.0 mp -109.96 140.8 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 126.257 1.823 . . . . 0.0 109.281 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 94.6 t -130.06 135.39 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.659 0.742 . . . . 0.0 110.891 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.04 100.09 6.42 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 128.192 2.597 . . . . 0.0 110.728 174.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.55 -94.14 0.27 Allowed Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.005 1.764 . . . . 0.0 114.323 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -116.9 -0.33 12.26 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.274 1.83 . . . . 0.0 113.457 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 16.5 p -129.88 166.06 20.76 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.512 1.125 . . . . 0.0 110.793 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.11 166.82 33.19 Favored Glycine 0 CA--C 1.528 0.871 0 O-C-N 121.015 -1.053 . . . . 0.0 113.976 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -115.65 116.69 28.54 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.768 2.027 . . . . 0.0 110.682 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 43.2 tp -107.97 153.1 23.56 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.516 2.327 . . . . 0.0 110.63 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 62.5 mtt 105.73 -5.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 130.92 3.688 . . . . 0.0 115.686 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -99.87 160.5 14.26 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.432 1.014 . . . . 0.0 111.305 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 21.7 p -79.64 173.45 12.58 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 123.198 1.475 . . . . 0.0 113.874 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.63 -23.62 65.37 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.612 174.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 51.4 m -73.94 -50.76 18.59 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 117.823 -1.084 . . . . 0.0 110.145 178.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 60.7 m -49.0 -53.2 21.0 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.777 1.231 . . . . 0.0 110.476 173.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.72 -49.58 76.06 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.861 1.664 . . . . 0.0 112.927 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -61.42 -40.67 95.27 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.826 -1.171 . . . . 0.0 111.655 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -62.31 -54.53 39.29 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.98 1.712 . . . . 0.0 111.328 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.3 pp -62.91 -31.84 73.0 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.71 -0.619 . . . . 0.0 112.034 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -68.29 -46.65 69.78 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.052 1.341 . . . . 0.0 112.226 175.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -58.45 -40.97 84.05 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.464 1.105 . . . . 0.0 111.503 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -74.88 -8.43 56.44 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.566 1.546 . . . . 0.0 113.118 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 50.45 41.05 24.5 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.47 2.708 . . . . 0.0 111.74 -176.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -71.73 127.56 90.72 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.385 1.474 . . . . 0.0 114.053 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.76 127.55 10.95 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.808 2.338 . . . . 0.0 107.333 169.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 40.9 t -30.62 125.44 0.3 Allowed Pre-proline 0 CA--C 1.555 1.159 0 C-N-CA 127.914 2.486 . . . . 0.0 115.2 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.1 -1.78 6.83 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.072 2.515 . . . . 0.0 114.328 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 58.4 t -124.04 -59.8 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.796 1.638 . . . . 0.0 111.17 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 85.7 m -75.11 -22.54 58.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.089 1.756 . . . . 0.0 112.766 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? 62.5 9.12 3.22 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 127.161 2.184 . . . . 0.0 113.419 -175.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -83.1 146.72 52.22 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.769 1.227 . . . . 0.0 112.266 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.67 121.94 7.44 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.18 2.587 . . . . 0.0 110.375 175.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.4 pp -61.05 144.12 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.22 1.008 . . . . 0.0 111.369 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -115.02 -38.87 3.77 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.75 165.85 35.3 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 8.2 mt -135.36 135.83 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.674 2.389 . . . . 0.0 108.475 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 20.0 m -140.01 150.05 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.126 0.97 . . . . 0.0 113.312 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.95 100.0 1.89 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 36.5 m -96.64 88.95 4.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.794 1.237 . . . . 0.0 111.483 -174.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -61.81 129.05 39.16 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.946 1.698 . . . . 0.0 112.892 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -47.71 -40.48 30.68 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 118.817 2.895 . . . . 0.0 118.817 -176.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo . . . . . 0 C--N 1.355 0.896 0 C-N-CA 123.979 3.119 . . . . 0.0 115.028 -178.256 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 CA--C 1.541 0.597 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 91.0 mt -140.74 156.92 68.75 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 128.276 2.63 . . . . 0.0 109.341 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -47.87 -45.97 22.99 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.536 2.824 . . . . 0.0 113.973 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 2.3 pp -66.1 -14.29 61.51 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -101.79 -26.9 13.3 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.686 1.594 . . . . 0.0 110.672 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -79.45 26.92 0.28 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 127.517 2.327 . . . . 0.0 113.181 176.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -60.23 -25.58 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 127.38 2.272 . . . . 0.0 115.017 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 49.55 68.41 3.51 Favored Pre-proline 0 CA--C 1.558 1.276 0 C-N-CA 126.205 1.802 . . . . 0.0 111.285 -174.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.62 -179.55 2.93 Favored 'Trans proline' 0 CA--C 1.544 1.02 1 C-N-CA 126.129 4.552 . . . . 0.0 117.417 -173.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 11.2 t -50.53 153.21 1.68 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 128.323 2.649 . . . . 0.0 111.892 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 22.0 m -135.35 -0.37 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.656 1.183 . . . . 0.0 113.708 178.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 8.2 mt -128.73 -48.18 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 119.565 1.075 . . . . 0.0 112.255 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 441' ' ' CYS . . . . . 0.434 ' CB ' HH12 ' A' ' 444' ' ' ARG . 1.9 m -71.2 -68.93 0.41 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -173.717 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -146.55 -11.39 0.46 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.313 1.598 . . . . 0.0 115.313 -173.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.5 16.78 70.19 Favored Glycine 0 CA--C 1.541 1.717 0 CA-C-N 119.836 1.198 . . . . 0.0 113.051 -175.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . 0.434 HH12 ' CB ' ' A' ' 441' ' ' CYS . 11.8 ptp85 -57.47 154.3 24.49 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 127.22 2.208 . . . . 0.0 112.499 178.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.18 -10.23 26.53 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 123.807 3.005 . . . . 0.0 116.388 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -59.39 147.52 35.97 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.201 1.4 . . . . 0.0 112.05 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -128.33 150.16 50.2 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.21 2.604 . . . . 0.0 111.667 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -168.44 86.35 0.09 OUTLIER Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.252 1.882 . . . . 0.0 112.517 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 47.7 t -60.4 142.94 54.3 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.686 1.194 . . . . 0.0 110.862 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 mp -115.0 132.21 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.578 1.551 . . . . 0.0 109.595 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 69.6 t -115.56 129.05 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.337 1.055 . . . . 0.0 108.591 176.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -125.08 94.95 4.32 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.184 2.194 . . . . 0.0 112.74 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 77.06 -77.77 1.48 Allowed Glycine 0 CA--C 1.535 1.284 0 C-N-CA 126.048 1.785 . . . . 0.0 113.899 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -135.22 -10.17 2.24 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.36 1.864 . . . . 0.0 113.754 -178.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 42.1 p -122.61 170.07 10.39 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.418 2.287 . . . . 0.0 110.084 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -157.33 170.19 34.45 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.893 -1.129 . . . . 0.0 114.186 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -119.99 145.19 47.02 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.619 1.968 . . . . 0.0 112.231 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 35.3 tp -121.71 153.07 38.69 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.832 2.053 . . . . 0.0 109.962 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 25.1 ttt 82.44 68.97 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 128.483 2.713 . . . . 0.0 112.42 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -160.12 151.08 19.09 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 129.169 2.987 . . . . 0.0 107.192 175.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 23.0 p -85.89 174.99 8.89 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 122.397 1.094 . . . . 0.0 111.195 175.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -63.37 -33.68 76.07 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.482 -0.761 . . . . 0.0 110.726 177.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 21.3 m -68.28 -48.52 64.78 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 117.39 -1.29 . . . . 0.0 110.655 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 31.4 m -48.33 -54.72 12.82 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 120.373 1.442 . . . . 0.0 110.007 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -59.8 -43.31 94.53 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.633 1.573 . . . . 0.0 113.12 177.543 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -64.61 -40.97 96.43 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.752 -1.217 . . . . 0.0 111.631 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -59.67 -55.41 34.75 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.151 1.38 . . . . 0.0 110.921 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.4 pp -62.46 -32.75 73.67 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -69.58 -43.66 72.38 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.826 1.25 . . . . 0.0 113.069 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -54.8 -38.79 67.76 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.713 1.605 . . . . 0.0 111.868 177.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -91.76 -0.2 57.53 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.566 1.946 . . . . 0.0 113.331 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 64.8 t30 47.74 45.84 18.27 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 128.429 2.692 . . . . 0.0 112.627 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm -70.12 126.39 92.38 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.159 1.384 . . . . 0.0 113.148 -177.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.89 129.29 12.3 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 122.843 2.362 . . . . 0.0 107.91 170.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 53.6 t -31.94 123.89 0.37 Allowed Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 127.337 2.255 . . . . 0.0 114.655 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.51 -1.68 7.0 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.2 2.6 . . . . 0.0 114.136 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 48.2 t -122.6 -60.96 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.913 1.685 . . . . 0.0 111.002 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 86.0 m -76.54 -19.13 58.25 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.468 1.907 . . . . 0.0 113.319 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 62.29 6.78 1.99 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 127.18 2.192 . . . . 0.0 113.81 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -75.67 146.27 79.88 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 125.843 1.657 . . . . 0.0 113.382 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -78.02 120.19 4.93 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 124.159 3.239 . . . . 0.0 111.656 177.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.5 pp -63.09 141.48 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.055 0.942 . . . . 0.0 112.785 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -115.1 -45.64 2.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.462 1.505 . . . . 0.0 114.495 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.52 169.1 25.43 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -173.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 4.7 mt -133.65 143.43 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 128.453 2.701 . . . . 0.0 108.451 175.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 15.4 m -139.95 150.17 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.957 1.703 . . . . 0.0 111.214 177.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.33 99.95 2.05 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 176.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.94 102.39 14.75 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.364 1.066 . . . . 0.0 110.757 -176.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -72.53 143.13 48.44 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.656 1.182 . . . . 0.0 112.41 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -66.42 166.81 15.28 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 126.126 1.77 . . . . 0.0 112.201 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo . . . . . 0 C--N 1.354 0.819 0 C-N-CA 124.136 3.224 . . . . 0.0 114.398 -179.302 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 43.3 m . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 22.4 tp -144.6 139.91 15.99 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 126.974 2.11 . . . . 0.0 109.224 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -42.48 -66.29 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 124.47 3.447 . . . . 0.0 116.134 -177.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -61.04 -30.31 70.24 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -67.12 -38.73 86.13 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.912 0.885 . . . . 0.0 111.263 176.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -78.35 -46.48 19.93 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.783 1.233 . . . . 0.0 112.604 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 70.1 mt -70.74 -38.71 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.73 1.612 . . . . 0.0 112.385 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 55.0 61.67 8.67 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 125.986 1.714 . . . . 0.0 111.696 -174.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -77.27 -171.08 1.06 Allowed 'Trans proline' 0 CA--C 1.549 1.24 0 C-N-CA 124.666 3.577 . . . . 0.0 113.09 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 12.5 t -56.41 173.03 0.19 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.002 1.721 . . . . 0.0 113.607 177.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.37 1.82 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 -175.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 15.0 mt -121.73 -60.99 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 120.39 1.45 . . . . 0.0 113.016 -177.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 12.9 p -54.34 -78.49 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.528 1.531 . . . . 0.0 114.607 -177.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -150.63 -12.86 0.24 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 127.34 2.256 . . . . 0.0 113.19 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 96.73 45.74 2.63 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.388 0.995 . . . . 0.0 113.187 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -84.33 155.34 63.18 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 126.095 1.758 . . . . 0.0 111.265 175.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -39.96 125.37 1.65 Allowed 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.716 3.611 . . . . 0.0 114.541 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -67.37 63.97 0.07 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.977 2.911 . . . . 0.0 113.5 -177.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -109.09 89.82 3.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.585 1.154 . . . . 0.0 108.034 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 164.66 51.58 0.02 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.155 0.884 . . . . 0.0 112.85 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 42.5 t -61.32 141.45 57.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.31 1.055 . . . . 0.0 109.887 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.11 137.79 47.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 125.717 1.607 . . . . 0.0 110.104 -174.78 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 83.0 t -126.52 128.81 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.006 0.923 . . . . 0.0 112.116 -177.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -111.31 94.89 5.2 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.713 2.805 . . . . 0.0 109.318 173.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.31 -96.02 0.32 Allowed Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.657 1.599 . . . . 0.0 114.186 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -112.51 0.93 15.67 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.374 1.87 . . . . 0.0 113.565 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 49.4 p -132.15 170.04 15.56 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.959 1.704 . . . . 0.0 110.515 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -161.18 177.19 37.62 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 120.615 -1.303 . . . . 0.0 113.573 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -120.29 140.19 51.61 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.479 1.512 . . . . 0.0 112.333 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.9 92.87 3.89 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.925 1.29 . . . . 0.0 112.13 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.58 -13.59 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 119.073 2.99 . . . . 0.0 119.073 -178.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -129.52 165.42 21.7 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 119.799 1.181 . . . . 0.0 114.041 -174.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 29.8 p -78.78 168.8 19.21 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 122.541 1.162 . . . . 0.0 111.376 175.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.4 -39.4 79.6 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.36 -0.838 . . . . 0.0 112.069 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 62.6 m -60.55 -55.94 27.37 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.108 0.963 . . . . 0.0 110.025 178.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 62.8 m -57.41 -45.15 84.91 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.191 0.996 . . . . 0.0 112.087 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.55 -39.88 81.46 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.024 1.329 . . . . 0.0 112.99 174.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -71.97 -39.35 69.38 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.101 1.36 . . . . 0.0 111.16 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -56.52 -54.49 45.27 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.582 1.153 . . . . 0.0 111.965 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . 0.315 0.0 OUTLIER -63.19 -27.25 69.23 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.547 1.067 . . . . 0.0 113.317 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -70.1 -45.11 67.62 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.413 1.485 . . . . 0.0 110.275 175.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -61.31 -35.76 78.27 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.929 1.292 . . . . 0.0 111.672 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -76.93 -1.17 27.23 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 126.451 1.9 . . . . 0.0 113.338 174.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 51.8 t30 65.18 22.01 12.18 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 128.918 2.887 . . . . 0.0 114.966 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -72.56 137.22 80.58 Favored Pre-proline 0 CA--C 1.544 0.735 0 O-C-N 120.969 -1.082 . . . . 0.0 109.382 176.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -63.52 -52.47 1.9 Allowed 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.465 2.11 . . . . 0.0 112.872 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 2.4 t -153.23 142.7 14.88 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 129.252 3.021 . . . . 0.0 108.482 175.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.33 -6.67 18.7 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.141 2.561 . . . . 0.0 114.187 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.1 -71.43 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 119.997 1.271 . . . . 0.0 113.996 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 27.6 p -94.07 -5.3 47.72 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 70.1 15.32 7.65 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 127.897 2.479 . . . . 0.0 115.397 175.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -74.69 132.96 77.14 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 119.309 0.958 . . . . 0.0 109.194 173.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.01 110.28 1.47 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.947 2.431 . . . . 0.0 114.486 -175.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.4 pp -64.27 155.33 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.536 1.534 . . . . 0.0 113.21 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -114.38 -46.59 2.97 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.798 2.039 . . . . 0.0 112.74 -176.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.12 170.09 21.35 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 14.9 mt -126.05 136.6 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 127.913 2.485 . . . . 0.0 107.492 176.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 12.7 p -123.68 148.02 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.344 1.057 . . . . 0.0 113.505 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.23 99.93 0.97 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.316 1.046 . . . . 0.0 108.193 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 26.6 m -96.13 103.7 15.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.004 1.722 . . . . 0.0 113.565 -173.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -89.66 75.74 7.4 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.585 1.183 . . . . 0.0 110.477 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -63.93 -29.92 4.5 Favored Pre-proline 0 CA--C 1.554 1.113 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo . . . . . 0 C--N 1.358 1.028 0 C-N-CA 123.265 2.644 . . . . 0.0 113.898 -179.582 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 73.6 p . . . . . 0 CA--C 1.54 0.584 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 7.4 tt -70.71 -59.68 3.57 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.836 1.654 . . . . 0.0 112.5 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -75.66 171.49 18.11 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.296 1.997 . . . . 0.0 112.443 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 4.3 pp -57.27 -18.73 17.76 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.173 1.389 . . . . 0.0 114.567 178.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -62.16 -5.71 2.51 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.515 1.926 . . . . 0.0 114.317 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -64.99 -27.73 69.03 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.172 1.389 . . . . 0.0 113.405 176.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 29.6 mm 41.12 88.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 129.32 3.048 . . . . 0.0 114.346 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -66.79 -35.18 8.82 Favored Pre-proline 0 CA--C 1.559 1.32 0 N-CA-C 116.985 2.217 . . . . 0.0 116.985 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -73.95 -104.11 0.01 OUTLIER 'Trans proline' 0 CA--C 1.556 1.607 0 C-N-CA 124.092 3.195 . . . . 0.0 114.149 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 23.8 t -63.65 148.06 49.95 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.704 1.593 . . . . 0.0 110.201 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 29.4 m -132.06 -0.46 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.001 0.921 . . . . 0.0 113.444 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 6.4 mt -134.86 -46.22 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 119.441 1.019 . . . . 0.0 112.981 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.2 m -68.8 -64.19 0.91 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -173.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -154.14 -10.32 0.14 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -175.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.26 14.36 76.84 Favored Glycine 0 CA--C 1.541 1.714 0 O-C-N 120.693 -1.254 . . . . 0.0 113.261 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -59.53 154.39 44.88 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 127.729 2.411 . . . . 0.0 112.867 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.79 68.89 7.05 Favored 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 124.081 3.187 . . . . 0.0 112.68 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -135.02 147.05 49.57 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.057 1.743 . . . . 0.0 111.457 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -128.27 141.54 51.41 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.011 1.324 . . . . 0.0 111.06 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -136.11 76.31 0.38 Allowed Glycine 0 CA--C 1.525 0.657 0 C-N-CA 126.839 2.161 . . . . 0.0 108.76 175.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 85.2 m -66.89 108.98 2.75 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.404 0.682 . . . . 0.0 110.918 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . 0.459 ' H ' HD12 ' A' ' 450' ' ' ILE . 0.8 OUTLIER -78.72 140.47 16.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 126.451 1.9 . . . . 0.0 109.993 -178.074 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 77.9 t -129.63 132.67 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.093 0.957 . . . . 0.0 110.707 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -124.61 98.31 5.67 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.691 2.796 . . . . 0.0 110.118 177.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 66.31 -95.07 0.24 Allowed Glycine 0 CA--C 1.534 1.272 0 C-N-CA 126.056 1.789 . . . . 0.0 114.057 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -113.85 1.19 14.7 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.288 1.835 . . . . 0.0 113.753 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 81.9 p -131.27 170.03 15.16 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.095 1.758 . . . . 0.0 111.258 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.4 174.26 34.2 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.023 -1.048 . . . . 0.0 113.716 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -120.32 145.0 47.54 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.026 1.331 . . . . 0.0 112.978 175.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.37 153.21 40.67 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.421 2.288 . . . . 0.0 111.263 177.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 52.0 mtt 97.5 48.96 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 130.148 3.379 . . . . 0.0 113.503 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -155.3 148.13 24.38 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.257 1.823 . . . . 0.0 109.68 176.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 7.7 p -83.3 175.18 10.08 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 122.672 1.225 . . . . 0.0 112.236 176.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -59.09 -46.8 87.36 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.02 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 88.7 m -69.13 -41.52 77.23 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 116.353 -1.784 . . . . 0.0 111.926 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 46.4 m -47.16 -59.4 3.18 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 121.522 1.965 . . . . 0.0 110.405 175.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.36 87.91 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.531 1.532 . . . . 0.0 113.689 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -60.19 -41.93 93.99 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.645 -1.284 . . . . 0.0 111.824 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -61.79 -56.6 17.8 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.26 1.824 . . . . 0.0 111.221 177.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 3.4 pp -60.48 -37.26 80.49 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.205 0.457 . . . . 0.0 111.271 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.18 -48.36 80.39 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.71 1.204 . . . . 0.0 111.753 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -58.54 -37.87 76.58 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.384 1.474 . . . . 0.0 111.636 176.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -74.98 6.08 4.49 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 127.322 2.249 . . . . 0.0 113.7 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 39.8 t30 73.41 9.81 5.06 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 129.662 3.185 . . . . 0.0 115.601 177.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -72.42 131.12 85.08 Favored Pre-proline 0 N--CA 1.474 0.768 0 O-C-N 120.791 -1.193 . . . . 0.0 109.19 175.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.07 -82.06 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.283 2.655 . . . . 0.0 109.682 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 32.3 t -123.16 130.76 24.45 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 126.672 1.989 . . . . 0.0 109.471 175.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.23 -1.39 10.52 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.328 2.685 . . . . 0.0 113.874 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 37.6 t -118.19 -78.28 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.754 1.222 . . . . 0.0 111.946 -177.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 18.5 p -89.98 0.15 57.25 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.389 1.476 . . . . 0.0 114.427 -177.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 12.4 mpt_? 62.46 6.97 2.15 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 127.883 2.473 . . . . 0.0 115.525 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -60.51 138.04 92.5 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-N 119.25 0.932 . . . . 0.0 111.172 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.23 114.28 3.37 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.196 2.597 . . . . 0.0 112.317 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 20.3 pt -76.76 158.85 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.096 1.358 . . . . 0.0 114.159 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -115.19 -43.4 3.08 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.142 1.777 . . . . 0.0 114.04 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.93 170.03 23.07 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -171.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.2 pt -141.97 145.57 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 129.923 3.289 . . . . 0.0 108.209 169.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 11.4 m -137.69 150.17 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.139 1.776 . . . . 0.0 109.619 177.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.15 99.87 0.94 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.88 142.31 27.9 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -172.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -128.48 179.63 5.55 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.231 2.212 . . . . 0.0 111.188 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -134.54 158.19 75.67 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.088 1.355 . . . . 0.0 111.407 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 C--N 1.352 0.743 0 C-N-CA 123.2 2.6 . . . . 0.0 111.381 -179.561 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 72.9 p . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 85.8 mt -145.94 161.64 39.02 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 129.579 3.152 . . . . 0.0 108.378 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -48.69 -41.36 38.03 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.228 2.619 . . . . 0.0 114.517 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 1.1 pp -67.88 -8.95 40.72 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -121.99 -10.88 8.58 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.771 2.028 . . . . 0.0 112.703 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.77 43.34 0.19 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 127.447 2.299 . . . . 0.0 113.549 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 71.3 mt -63.62 -39.82 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.948 1.699 . . . . 0.0 110.625 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 35.3 66.17 1.65 Allowed Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 128.294 2.638 . . . . 0.0 114.942 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -78.28 -105.67 0.01 OUTLIER 'Trans proline' 0 CA--C 1.553 1.437 0 C-N-CA 124.178 3.252 . . . . 0.0 110.889 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 35.3 t -65.22 153.3 41.39 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 120.466 1.484 . . . . 0.0 110.014 174.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 67.5 t -129.09 -14.59 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.656 1.582 . . . . 0.0 111.848 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 7.1 mt -133.24 -45.8 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.2 m -67.44 -65.19 0.72 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.465 1.506 . . . . 0.0 113.981 -173.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -146.8 -12.55 0.44 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 76.82 10.56 86.01 Favored Glycine 0 CA--C 1.545 1.949 0 CA-C-N 119.893 1.224 . . . . 0.0 112.418 -173.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -58.45 154.34 33.96 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 129.424 3.09 . . . . 0.0 112.866 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -77.32 68.69 7.41 Favored 'Trans proline' 0 CA--C 1.549 1.246 0 C-N-CA 124.146 3.231 . . . . 0.0 113.031 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -131.61 149.03 52.64 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.821 2.049 . . . . 0.0 110.681 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -128.03 149.99 50.13 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.166 1.387 . . . . 0.0 111.077 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -155.06 84.89 0.14 Allowed Glycine 0 CA--C 1.531 1.047 0 C-N-CA 127.038 2.256 . . . . 0.0 111.163 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 42.0 t -67.73 120.27 13.81 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.2 1.0 . . . . 0.0 110.148 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.68 139.7 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 125.561 1.544 . . . . 0.0 109.918 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 93.6 t -130.07 127.6 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.748 1.219 . . . . 0.0 108.748 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -125.2 95.09 4.35 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.886 2.074 . . . . 0.0 111.632 177.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 71.55 -87.28 0.43 Allowed Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.689 1.614 . . . . 0.0 115.172 178.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -122.52 -4.36 8.78 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.25 1.82 . . . . 0.0 113.765 -177.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 30.0 p -129.66 170.16 14.16 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.648 2.379 . . . . 0.0 110.056 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -158.69 171.27 35.37 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 120.981 -1.074 . . . . 0.0 113.505 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -120.02 137.43 54.1 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.936 1.694 . . . . 0.0 112.838 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 33.2 tp -121.63 153.16 38.47 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 129.023 2.929 . . . . 0.0 110.054 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 19.7 mmt 80.89 57.37 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.617 2.367 . . . . 0.0 112.959 177.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -154.0 153.56 32.18 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 128.222 2.609 . . . . 0.0 109.493 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 10.3 p -85.51 175.07 9.03 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 122.343 1.068 . . . . 0.0 111.926 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.24 -36.76 85.14 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.705 -0.664 . . . . 0.0 112.374 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 87.0 m -73.61 -42.11 61.95 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 117.074 -1.441 . . . . 0.0 111.142 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 55.3 m -48.57 -54.91 12.68 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 120.638 1.563 . . . . 0.0 109.548 172.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -60.72 -49.75 76.26 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.142 1.777 . . . . 0.0 113.262 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -58.97 -41.09 86.7 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.796 1.238 . . . . 0.0 111.734 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -58.9 -55.26 37.43 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.41 1.084 . . . . 0.0 110.552 176.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.73 -30.47 71.44 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -69.03 -47.81 64.49 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.213 1.405 . . . . 0.0 112.377 174.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -59.53 -40.49 87.35 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.811 1.244 . . . . 0.0 111.407 176.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -75.23 -7.89 55.12 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.721 1.609 . . . . 0.0 112.93 174.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 51.68 43.59 29.79 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 128.823 2.849 . . . . 0.0 112.091 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -70.05 117.64 55.97 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 125.238 1.415 . . . . 0.0 112.095 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -80.93 74.4 5.56 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 124.558 3.505 . . . . 0.0 111.193 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 30.7 t 22.4 105.13 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 130.561 3.544 . . . . 0.0 117.093 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.03 -19.5 8.78 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.79 2.993 . . . . 0.0 115.681 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 46.6 t -102.82 -63.68 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.52 1.928 . . . . 0.0 112.219 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 84.8 m -78.25 -18.75 54.95 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.288 1.835 . . . . 0.0 113.871 -176.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 63.24 7.01 2.61 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.878 2.471 . . . . 0.0 114.074 -176.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -83.84 149.59 57.02 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 124.302 1.041 . . . . 0.0 112.793 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.78 124.23 9.56 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.528 2.819 . . . . 0.0 112.212 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.99 117.23 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 126.671 1.988 . . . . 0.0 110.388 177.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -115.1 -46.32 2.91 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -174.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 1.1 ttp -143.18 155.1 44.47 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.699 1.136 . . . . 0.0 113.419 -174.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 12.8 mt -138.14 136.23 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 127.063 2.145 . . . . 0.0 109.506 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 16.2 m -138.65 150.18 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 125.5 1.52 . . . . 0.0 112.761 176.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 1.5 tt -74.95 99.95 3.99 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.313 1.045 . . . . 0.0 109.346 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 7.4 t -90.13 155.35 19.1 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -134.39 162.89 30.97 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.642 1.977 . . . . 0.0 112.703 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -93.4 167.64 13.63 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 125.277 1.431 . . . . 0.0 110.89 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo . . . . . 0 C--N 1.351 0.675 0 C-N-CA 124.1 3.2 . . . . 0.0 113.72 -179.854 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 37.8 m . . . . . 0 CA--C 1.541 0.602 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 92.8 mt -136.19 160.12 68.25 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 127.434 2.293 . . . . 0.0 110.756 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -60.36 -22.63 71.88 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.907 2.405 . . . . 0.0 113.557 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 79.0 mt -67.8 -35.25 78.31 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.746 1.218 . . . . 0.0 111.709 175.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -87.11 -19.43 28.55 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.469 1.508 . . . . 0.0 112.871 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -69.1 39.02 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.954 2.502 . . . . 0.0 115.619 -178.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 37.2 mm -57.44 -50.76 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 127.099 2.16 . . . . 0.0 110.858 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -150.53 154.59 35.67 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 128.013 2.525 . . . . 0.0 109.522 176.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -95.48 156.06 1.6 Allowed 'Trans proline' 0 CA--C 1.552 1.404 0 C-N-CA 123.529 2.819 . . . . 0.0 111.824 172.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 1.7 t -68.53 166.42 17.02 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 126.114 1.766 . . . . 0.0 109.966 169.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 99.3 t -127.03 -18.5 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 O-C-N 120.346 -1.471 . . . . 0.0 111.971 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 8.3 mt -133.03 -47.06 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 119.43 1.014 . . . . 0.0 113.707 -172.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.4 m -62.86 -54.83 32.73 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.163 1.385 . . . . 0.0 113.222 -175.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -160.46 -12.75 0.05 Allowed 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 85.8 1.22 87.3 Favored Glycine 0 CA--C 1.542 1.775 0 O-C-N 120.731 -1.231 . . . . 0.0 113.533 -176.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -59.16 154.98 37.39 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 129.301 3.04 . . . . 0.0 114.034 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.41 115.67 4.38 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.413 2.742 . . . . 0.0 111.685 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -171.12 146.14 2.36 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 129.162 2.985 . . . . 0.0 108.773 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -112.12 150.21 31.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 128.091 2.557 . . . . 0.0 113.216 -174.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 171.08 82.76 0.05 OUTLIER Glycine 0 CA--C 1.532 1.094 0 C-N-CA 126.263 1.887 . . . . 0.0 112.587 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.32 144.22 55.98 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.139 0.97 . . . . 0.0 110.776 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 3.0 mp -115.09 140.86 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.387 1.475 . . . . 0.0 110.371 -177.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 98.7 t -130.06 130.23 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.12 0.968 . . . . 0.0 109.256 175.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -124.97 95.14 4.39 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.521 2.328 . . . . 0.0 111.141 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.96 -88.17 0.38 Allowed Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.069 1.795 . . . . 0.0 114.197 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -123.4 -1.63 8.59 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 126.567 1.947 . . . . 0.0 113.465 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 16.4 p -127.04 170.1 12.68 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.423 2.289 . . . . 0.0 110.373 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -158.75 176.44 35.63 Favored Glycine 0 CA--C 1.531 1.085 0 O-C-N 120.992 -1.067 . . . . 0.0 114.046 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -120.19 142.39 49.04 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.884 1.674 . . . . 0.0 112.059 177.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 45.7 tp -129.66 150.49 50.96 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.476 2.31 . . . . 0.0 109.962 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 27.8 mtm 76.21 58.41 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 129.495 3.118 . . . . 0.0 112.18 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -148.83 153.96 38.84 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.033 2.133 . . . . 0.0 110.561 177.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 14.3 p -83.36 169.38 15.69 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 122.345 1.069 . . . . 0.0 112.79 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -65.49 -37.6 87.29 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.747 -0.595 . . . . 0.0 111.768 178.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 27.6 m -63.58 -46.26 86.67 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 117.388 -1.292 . . . . 0.0 111.787 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 46.2 m -48.52 -56.1 9.23 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 120.417 1.462 . . . . 0.0 110.453 174.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -60.64 -43.54 97.43 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.974 1.709 . . . . 0.0 113.08 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -62.55 -42.3 99.45 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.642 1.177 . . . . 0.0 111.616 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -59.73 -56.47 21.41 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.185 1.394 . . . . 0.0 111.083 176.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.2 pp -62.39 -35.3 78.76 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 119.23 -0.414 . . . . 0.0 111.793 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.6 -48.12 76.11 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.358 0.981 . . . . 0.0 112.047 175.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -56.4 -43.53 79.39 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.676 1.59 . . . . 0.0 111.554 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -76.58 -5.23 46.83 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.382 1.873 . . . . 0.0 113.59 176.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 54.7 36.69 26.78 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 127.68 2.392 . . . . 0.0 111.734 -176.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -81.31 114.88 52.72 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 126.642 1.977 . . . . 0.0 111.835 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.34 129.33 17.84 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.292 1.995 . . . . 0.0 108.121 172.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 42.6 t -12.88 117.78 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 129.739 3.216 . . . . 0.0 116.19 -177.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.3 -0.13 2.65 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 123.141 2.561 . . . . 0.0 114.694 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 53.1 t -123.21 -60.11 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.145 1.778 . . . . 0.0 111.216 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 82.1 m -79.17 -15.29 58.3 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.499 1.92 . . . . 0.0 113.557 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . 0.295 51.8 ptt85 53.52 17.05 1.05 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 128.175 2.59 . . . . 0.0 115.029 -174.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -85.26 150.13 53.99 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 124.226 1.011 . . . . 0.0 112.335 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.3 118.4 5.66 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.703 2.936 . . . . 0.0 112.167 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.64 129.01 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 125.354 1.461 . . . . 0.0 111.149 178.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -109.54 -41.52 4.56 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -177.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.04 166.97 31.19 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 5.4 mt -135.17 138.67 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 127.471 2.309 . . . . 0.0 108.943 177.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 17.0 m -139.8 150.0 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 64.8 mt -73.8 99.86 3.3 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 176.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 14.4 t -98.12 150.69 21.17 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.768 0.827 . . . . 0.0 112.844 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -144.4 172.79 12.46 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.3 1.84 . . . . 0.0 111.661 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -117.99 162.11 31.12 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.442 1.097 . . . . 0.0 111.878 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo . . . . . 0 C--N 1.353 0.785 0 C-N-CA 124.243 3.295 . . . . 0.0 114.054 179.796 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 45.4 m . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 95.3 mt -65.59 156.14 83.53 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 124.93 1.292 . . . . 0.0 111.862 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -46.25 -40.53 21.96 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 124.966 3.777 . . . . 0.0 117.174 -177.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -137.64 -26.56 0.97 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -72.61 -35.44 67.85 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.687 0.795 . . . . 0.0 112.874 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . 50.24 15.48 0.2 Allowed 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 127.421 2.288 . . . . 0.0 116.939 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 31.8 mm 69.76 -60.5 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 129.103 2.961 . . . . 0.0 112.514 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 30.24 76.07 0.37 Allowed Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 129.331 3.053 . . . . 0.0 114.837 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.96 -60.98 0.58 Allowed 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.445 3.43 . . . . 0.0 114.932 -178.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 1.5 t -50.69 142.7 10.74 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.563 1.545 . . . . 0.0 111.356 176.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.3 -1.22 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.934 1.294 . . . . 0.0 114.012 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 19.4 mt -123.21 -53.38 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.838 0.855 . . . . 0.0 112.027 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 2.4 m -71.88 -69.83 0.37 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.437 1.495 . . . . 0.0 114.355 -172.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -159.89 -1.16 0.07 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 -176.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 91.61 11.78 60.26 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-N 120.222 1.374 . . . . 0.0 113.998 -177.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -59.71 155.23 41.76 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 127.391 2.276 . . . . 0.0 112.76 176.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.11 146.55 37.95 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.468 2.779 . . . . 0.0 113.935 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.91 36.8 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -81.11 89.8 6.0 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.368 -1.457 . . . . 0.0 108.968 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 162.85 57.56 0.02 OUTLIER Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.762 1.649 . . . . 0.0 111.208 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 53.5 t -61.32 134.86 57.41 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.382 0.673 . . . . 0.0 110.254 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.23 137.23 37.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 126.248 1.819 . . . . 0.0 109.71 -176.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 86.0 t -130.06 129.06 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.011 0.924 . . . . 0.0 109.061 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -125.17 95.41 4.48 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.762 2.025 . . . . 0.0 111.701 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 73.19 -85.79 0.59 Allowed Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.844 1.688 . . . . 0.0 114.963 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 454' ' ' LYS . . . . . 0.435 ' HA ' ' HE2' ' B' ' 454' ' ' LYS . 0.6 OUTLIER -123.97 -7.66 7.79 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.188 1.795 . . . . 0.0 113.584 -177.418 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 28.1 p -125.51 170.1 11.77 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 127.179 2.192 . . . . 0.0 110.65 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -154.72 174.95 32.96 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 121.28 -0.888 . . . . 0.0 114.084 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -120.25 142.56 48.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.359 1.463 . . . . 0.0 113.446 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.5 pp -129.58 153.29 48.21 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.306 2.643 . . . . 0.0 110.625 177.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 28.9 tpp 93.8 -7.09 0.13 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 128.976 2.91 . . . . 0.0 113.442 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -99.99 144.9 28.5 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.394 1.078 . . . . 0.0 109.404 175.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 15.4 p -82.35 174.42 11.14 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 122.196 0.998 . . . . 0.0 112.591 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.08 -37.07 78.83 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.499 -0.75 . . . . 0.0 112.16 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 60.5 m -73.69 -41.85 62.08 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 117.751 -1.119 . . . . 0.0 110.767 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 27.6 m -53.07 -57.3 10.87 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.767 1.167 . . . . 0.0 109.172 171.174 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -50.56 -48.34 57.52 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.243 1.817 . . . . 0.0 112.967 176.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -61.21 -30.29 70.34 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.306 1.442 . . . . 0.0 112.635 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -61.26 -43.62 98.58 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.424 1.011 . . . . 0.0 111.55 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -57.55 -39.61 77.04 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.427 0.691 . . . . 0.0 110.219 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -68.65 -50.75 48.74 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.987 0.515 . . . . 0.0 111.841 176.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -53.97 -45.04 71.25 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.892 1.677 . . . . 0.0 112.156 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -82.93 -7.62 59.65 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 126.501 1.92 . . . . 0.0 113.584 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 50.33 50.72 18.17 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 127.813 2.445 . . . . 0.0 111.292 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -100.73 115.7 65.03 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 126.572 1.949 . . . . 0.0 113.323 -175.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.57 129.13 19.4 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 122.51 2.14 . . . . 0.0 107.823 171.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 48.3 t -17.02 118.97 0.06 OUTLIER Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 129.951 3.3 . . . . 0.0 116.447 -174.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -65.16 0.73 2.44 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.554 2.836 . . . . 0.0 114.277 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 43.3 t -127.61 -60.41 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.7 1.6 . . . . 0.0 111.283 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 63.2 m -77.5 -16.04 58.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.58 1.952 . . . . 0.0 113.637 -177.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 60.0 7.8 1.27 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 127.239 2.216 . . . . 0.0 114.401 -175.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -79.19 149.36 72.74 Favored Pre-proline 0 CA--C 1.547 0.842 0 O-C-N 121.461 -0.774 . . . . 0.0 112.117 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.3 123.28 10.1 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.027 2.485 . . . . 0.0 110.788 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.75 109.97 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 125.205 1.402 . . . . 0.0 109.761 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -96.55 -58.17 2.12 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.571 1.149 . . . . 0.0 113.541 -174.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.49 162.97 34.43 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -177.635 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 13.3 mt -137.41 136.64 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 127.316 2.246 . . . . 0.0 108.599 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 19.4 m -136.25 150.19 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.473 1.109 . . . . 0.0 113.5 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 5.1 tt -68.27 103.15 1.52 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.668 1.587 . . . . 0.0 107.654 175.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 5.7 t -98.02 161.75 13.57 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -175.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -129.77 130.59 45.57 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.457 1.903 . . . . 0.0 111.254 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 490' ' ' PHE . . . . . 0.429 ' H ' ' CD ' ' B' ' 491' ' ' PRO . 44.3 p90 -134.03 -27.36 0.02 OUTLIER Pre-proline 0 CA--C 1.551 1.011 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -178.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 491' ' ' PRO . . . . . 0.429 ' CD ' ' H ' ' B' ' 490' ' ' PHE . 89.2 Cg_exo . . . . . 0 C--N 1.359 1.121 0 C-N-CA 123.182 2.588 . . . . 0.0 114.321 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 4.4 t . . . . . 0 CA--C 1.541 0.611 0 CA-C-O 121.192 0.52 . . . . 0.0 112.266 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 9.8 mp -69.08 148.78 97.78 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.245 1.418 . . . . 0.0 110.615 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -63.46 -23.73 71.0 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.638 2.225 . . . . 0.0 113.175 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 72.2 mt -60.5 -44.71 95.7 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.262 1.425 . . . . 0.0 113.426 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -93.18 -15.9 25.45 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -87.67 -51.91 5.62 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.945 0.898 . . . . 0.0 112.929 -177.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 19.8 mm -84.01 73.49 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 122.152 0.977 . . . . 0.0 110.372 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -139.77 61.14 17.65 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 125.655 1.582 . . . . 0.0 110.967 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.38 -31.26 52.56 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.939 2.426 . . . . 0.0 116.187 -175.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 46.3 t -56.65 144.48 32.07 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 120.607 1.548 . . . . 0.0 111.153 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 32.1 m -123.1 -15.31 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 10.2 pt -137.52 -25.73 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.7 m -75.23 -65.3 0.9 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 120.72 1.6 . . . . 0.0 111.709 -177.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -145.98 -11.13 0.5 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 78.23 9.69 86.79 Favored Glycine 0 CA--C 1.546 1.978 0 CA-C-N 120.35 1.432 . . . . 0.0 112.824 -174.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 26.4 ptt180 -57.94 155.24 24.62 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 131.565 3.946 . . . . 0.0 114.164 178.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.6 -5.85 15.21 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 124.33 3.353 . . . . 0.0 115.495 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -54.58 139.77 37.18 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.503 1.921 . . . . 0.0 110.461 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.14 150.1 50.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.182 1.793 . . . . 0.0 112.855 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -157.39 88.14 0.12 Allowed Glycine 0 CA--C 1.532 1.119 0 C-N-CA 126.306 1.907 . . . . 0.0 112.32 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 48.9 t -65.16 133.06 50.74 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 117.765 0.782 . . . . 0.0 110.647 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -110.9 144.22 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.931 1.692 . . . . 0.0 110.948 -177.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 72.7 t -129.92 134.63 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.528 1.131 . . . . 0.0 111.624 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.23 97.35 5.19 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 128.894 2.877 . . . . 0.0 110.569 174.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 65.46 -99.31 0.38 Allowed Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.859 1.695 . . . . 0.0 114.349 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -103.68 -6.29 21.72 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.032 1.733 . . . . 0.0 113.582 -178.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 44.4 p -131.5 170.07 15.21 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.384 1.473 . . . . 0.0 111.422 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -151.55 173.42 30.89 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.313 1.435 . . . . 0.0 112.216 178.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -120.06 146.48 45.87 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.222 1.009 . . . . 0.0 113.451 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.15 153.16 27.42 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.34 2.656 . . . . 0.0 111.721 -177.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 6.8 tpt 71.69 65.01 0.15 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.275 2.23 . . . . 0.0 114.323 174.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -150.9 154.93 38.1 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.635 2.374 . . . . 0.0 109.374 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 1.8 p -90.28 171.1 9.72 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.218 0.917 . . . . 0.0 111.195 174.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -65.43 -36.6 84.42 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.325 -0.859 . . . . 0.0 111.345 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 32.6 m -70.02 -42.4 73.03 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 117.623 -1.18 . . . . 0.0 110.944 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 56.4 m -50.07 -61.16 2.31 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.693 1.197 . . . . 0.0 108.642 173.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.0 -45.29 75.07 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.783 1.633 . . . . 0.0 113.251 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -58.61 -37.21 75.38 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.661 1.185 . . . . 0.0 112.316 178.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -58.37 -44.12 88.71 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.271 1.028 . . . . 0.0 111.06 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 6.7 mp -65.62 -45.09 84.42 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.008 0.523 . . . . 0.0 109.924 174.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -56.27 -47.4 78.65 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.51 1.524 . . . . 0.0 113.972 -176.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -54.96 -27.71 45.83 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -120.04 8.89 11.07 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 127.561 2.345 . . . . 0.0 113.187 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 38.36 60.67 1.26 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 128.509 2.724 . . . . 0.0 112.879 -174.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -69.94 118.77 66.54 Favored Pre-proline 0 N--CA 1.473 0.68 0 C-N-CA 125.485 1.514 . . . . 0.0 113.225 -176.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -55.44 121.91 10.77 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.319 2.679 . . . . 0.0 109.088 170.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 53.2 t -29.68 121.12 0.3 Allowed Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 128.413 2.685 . . . . 0.0 115.32 -174.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -66.41 -3.97 9.86 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 122.901 2.4 . . . . 0.0 113.907 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 39.2 t -107.15 -64.75 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.472 1.509 . . . . 0.0 111.294 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 24.6 p -107.8 3.27 24.28 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -176.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 71.8 mtp85 63.64 8.66 3.81 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 128.182 2.593 . . . . 0.0 116.424 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -71.22 147.84 93.51 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 123.882 0.873 . . . . 0.0 111.853 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.7 106.83 2.34 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.609 2.872 . . . . 0.0 112.607 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 pp -59.65 135.82 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.704 1.202 . . . . 0.0 111.246 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -115.15 -30.74 6.24 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -177.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.29 165.62 34.34 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -175.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 6.9 mt -133.25 140.19 47.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 127.611 2.365 . . . . 0.0 108.269 176.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 9.5 m -126.83 146.92 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.032 0.933 . . . . 0.0 111.728 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.05 99.82 4.73 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 6.4 t -92.57 172.73 8.18 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.676 0.79 . . . . 0.0 113.095 -175.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -149.41 171.21 16.93 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.135 2.174 . . . . 0.0 111.217 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -138.73 154.13 72.77 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.507 1.523 . . . . 0.0 110.521 176.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 CA--C 1.538 0.718 0 C-N-CA 123.458 2.772 . . . . 0.0 112.497 -179.765 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 40.2 m . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 98.0 mt -135.62 160.17 68.72 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 127.361 2.265 . . . . 0.0 110.657 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -49.81 -34.73 37.27 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.97 3.113 . . . . 0.0 114.889 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 62.1 tp -62.33 -27.98 69.43 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.64 1.576 . . . . 0.0 113.114 177.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -108.91 -2.6 18.23 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.186 1.794 . . . . 0.0 113.227 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -70.47 5.3 1.86 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.87 2.068 . . . . 0.0 116.361 -178.037 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 30.8 mm 81.48 139.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 129.354 3.062 . . . . 0.0 111.696 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -47.12 122.54 7.78 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 127.331 2.252 . . . . 0.0 114.227 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -79.51 -171.99 1.4 Allowed 'Trans proline' 0 CA--C 1.549 1.273 0 C-N-CA 124.951 3.767 . . . . 0.0 112.522 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.26 166.71 0.54 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.549 1.539 . . . . 0.0 114.047 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 30.0 m -130.88 -3.66 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -175.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 32.9 mm -111.79 -61.29 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.464 1.106 . . . . 0.0 111.33 -177.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.2 m -62.96 -80.14 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 128.198 2.599 . . . . 0.0 114.626 -172.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -144.12 -5.59 0.77 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.092 1.357 . . . . 0.0 114.59 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 78.83 35.28 31.9 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 119.813 1.188 . . . . 0.0 111.281 -174.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 14.5 ptt180 -87.69 155.31 53.46 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 128.518 2.727 . . . . 0.0 111.843 179.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -43.47 125.99 5.01 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 124.06 3.173 . . . . 0.0 114.059 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 41.69 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 130.392 3.477 . . . . 0.0 117.06 -177.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -81.74 89.85 6.32 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.178 -1.576 . . . . 0.0 109.735 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 168.48 59.33 0.03 OUTLIER Glycine 0 CA--C 1.529 0.935 0 C-N-CA 123.96 0.791 . . . . 0.0 113.464 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 42.6 t -58.58 134.95 57.19 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.367 1.084 . . . . 0.0 110.205 178.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.1 mp -106.1 133.77 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 126.207 1.803 . . . . 0.0 108.211 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 92.6 t -120.46 130.39 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 121.656 0.741 . . . . 0.0 110.001 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.01 109.98 13.62 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 128.448 2.699 . . . . 0.0 110.757 177.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 68.22 -89.78 0.21 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.736 1.636 . . . . 0.0 112.938 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.41 4.04 4.3 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.604 1.962 . . . . 0.0 114.069 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 62.8 p -127.5 170.03 13.03 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.147 1.779 . . . . 0.0 110.742 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -150.5 171.41 30.35 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 121.075 -1.015 . . . . 0.0 114.626 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -120.35 143.49 48.37 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.428 1.491 . . . . 0.0 113.975 176.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 82.8 mt -125.11 153.24 43.27 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.958 2.903 . . . . 0.0 111.243 178.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 60.8 mtt 107.15 -2.68 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 1 C-N-CA 132.027 4.131 . . . . 0.0 113.551 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -108.24 145.63 34.02 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.73 1.212 . . . . 0.0 109.87 175.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 14.8 p -82.01 174.88 10.83 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 122.796 1.284 . . . . 0.0 112.103 178.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -59.68 -37.75 79.64 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.633 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 87.4 m -70.62 -44.63 66.83 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 117.326 -1.321 . . . . 0.0 110.979 179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 77.3 m -50.16 -53.25 29.03 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 120.462 1.483 . . . . 0.0 109.734 171.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -59.64 -43.33 93.91 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.794 1.638 . . . . 0.0 113.294 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -63.15 -42.66 99.48 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.913 1.285 . . . . 0.0 111.044 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -59.68 -56.55 20.45 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.687 1.195 . . . . 0.0 110.944 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.62 -33.23 72.46 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 122.691 0.396 . . . . 0.0 111.928 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -68.18 -48.02 66.41 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.841 1.257 . . . . 0.0 112.38 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -58.15 -40.79 82.26 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.862 1.265 . . . . 0.0 111.355 176.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 29.0 mmt85 -76.49 -7.79 55.85 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.203 1.801 . . . . 0.0 113.475 175.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 64.0 t30 52.63 40.33 29.92 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 128.012 2.525 . . . . 0.0 112.233 -177.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -74.55 131.37 80.09 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 125.647 1.579 . . . . 0.0 112.737 -177.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -71.9 123.54 9.41 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.732 2.288 . . . . 0.0 107.924 170.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 43.9 t -14.54 119.24 0.04 OUTLIER Pre-proline 0 CA--C 1.557 1.224 0 C-N-CA 130.062 3.345 . . . . 0.0 115.994 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -65.8 -1.13 4.58 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 123.202 2.601 . . . . 0.0 114.72 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 35.6 t -114.02 -60.79 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.281 1.432 . . . . 0.0 111.919 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 28.0 p -114.77 6.69 15.63 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -176.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . 0.31 13.8 ptm180 54.07 14.86 0.77 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 129.288 3.035 . . . . 0.0 117.56 177.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -68.02 152.32 96.52 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 123.852 0.861 . . . . 0.0 111.722 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -74.1 106.17 2.17 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 124.034 3.156 . . . . 0.0 113.344 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 pp -60.21 136.14 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.621 1.169 . . . . 0.0 111.494 177.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -115.07 -40.72 3.43 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.909 1.284 . . . . 0.0 113.678 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.21 167.46 30.3 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -176.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 6.0 mt -129.79 139.08 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 127.958 2.503 . . . . 0.0 107.587 175.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 14.1 p -131.54 146.42 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.137 0.975 . . . . 0.0 112.427 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.51 99.95 1.04 Allowed 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 1.8 m -102.27 95.54 6.37 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.244 1.418 . . . . 0.0 111.687 -174.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -83.22 159.78 21.91 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.46 1.104 . . . . 0.0 113.83 -178.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -78.71 158.85 75.17 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 125.643 1.577 . . . . 0.0 112.226 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo . . . . . 0 C--N 1.353 0.797 0 C-N-CA 124.39 3.393 . . . . 0.0 113.572 178.04 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 75.9 p . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 27.0 tp -46.49 -46.82 48.38 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 126.655 1.982 . . . . 0.0 115.961 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.52 -15.9 42.18 Favored 'Trans proline' 0 C--N 1.354 0.86 0 CA-C-N 122.163 1.808 . . . . 0.0 114.634 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 54.3 tp -81.47 80.23 7.9 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.875 1.216 . . . . 0.0 109.223 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 47.12 1.83 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 130.322 3.449 . . . . 0.0 118.929 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -72.09 33.71 0.06 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 127.403 2.281 . . . . 0.0 114.939 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 10.1 mm 56.52 64.55 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 127.565 2.346 . . . . 0.0 112.196 178.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -70.02 124.19 90.2 Favored Pre-proline 0 CA--C 1.559 1.309 0 C-N-CA 125.86 1.664 . . . . 0.0 111.514 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -75.77 -159.69 0.1 OUTLIER 'Trans proline' 0 CA--C 1.552 1.422 0 C-N-CA 125.093 3.862 . . . . 0.0 112.149 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 10.6 t -42.97 145.9 0.44 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.796 2.038 . . . . 0.0 111.972 174.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.13 -27.95 3.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 124.081 0.952 . . . . 0.0 112.613 -175.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 7.9 pt -141.39 -24.65 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 117.727 2.492 . . . . 0.0 117.727 -172.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.7 m -77.02 -64.61 1.09 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 120.617 1.553 . . . . 0.0 114.398 -174.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -153.03 -10.08 0.16 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -171.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 87.16 10.21 71.93 Favored Glycine 0 CA--C 1.541 1.691 0 CA-C-N 119.959 1.254 . . . . 0.0 113.13 -176.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -64.72 155.22 83.02 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 128.589 2.755 . . . . 0.0 113.43 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -46.72 139.51 13.7 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 124.396 3.398 . . . . 0.0 116.446 -177.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.33 13.44 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 131.436 3.894 . . . . 0.0 118.918 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.04 89.78 5.96 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.503 -1.373 . . . . 0.0 112.039 -177.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -178.59 44.58 0.09 OUTLIER Glycine 0 CA--C 1.529 0.906 0 CA-C-O 118.899 -0.945 . . . . 0.0 113.63 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 42.9 t -57.42 135.97 56.6 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.86 1.33 . . . . 0.0 110.689 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.4 mp -108.23 142.93 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 126.647 1.979 . . . . 0.0 109.037 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 95.1 t -129.76 133.41 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.419 0.628 . . . . 0.0 110.497 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -124.91 96.76 4.99 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.692 2.397 . . . . 0.0 111.087 176.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 71.54 -89.16 0.44 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 126.06 1.79 . . . . 0.0 114.075 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -124.07 0.79 8.53 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 126.238 1.815 . . . . 0.0 114.232 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 16.8 p -127.14 167.58 15.82 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.122 2.169 . . . . 0.0 109.922 178.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.51 172.18 34.23 Favored Glycine 0 CA--C 1.527 0.79 0 O-C-N 121.166 -0.959 . . . . 0.0 113.985 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -119.97 137.28 54.16 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.249 1.82 . . . . 0.0 111.192 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 60.0 tp -133.12 153.35 51.6 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.005 2.122 . . . . 0.0 111.601 -173.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 459' ' ' MET . . . . . . . . . . . . 0.256 29.4 mtt 81.89 56.7 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.204 2.202 . . . . 0.0 113.104 178.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -158.84 150.61 20.92 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 130.398 3.479 . . . . 0.0 106.824 176.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 16.1 p -78.08 171.22 15.34 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 123.164 1.459 . . . . 0.0 113.582 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.81 -36.92 77.77 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.835 175.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 11.4 m -66.66 -47.22 73.2 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 117.413 -1.279 . . . . 0.0 110.943 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 49.5 m -49.86 -52.79 30.01 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 120.53 1.514 . . . . 0.0 109.664 173.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -60.11 -43.03 95.9 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.665 1.586 . . . . 0.0 113.37 176.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -64.79 -40.68 95.63 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.63 -1.294 . . . . 0.0 111.43 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -61.95 -56.47 18.84 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.519 1.127 . . . . 0.0 110.835 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.2 pp -58.46 -33.49 69.81 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 118.461 0.573 . . . . 0.0 112.163 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -66.75 -50.38 62.94 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.216 1.406 . . . . 0.0 112.02 174.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -58.23 -38.39 76.75 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.434 1.094 . . . . 0.0 111.643 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -78.16 -1.67 33.83 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 127.051 2.14 . . . . 0.0 113.351 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.34 37.24 5.66 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 129.04 2.936 . . . . 0.0 113.922 -177.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -70.11 116.56 45.6 Favored Pre-proline 0 CA--C 1.539 0.519 0 C-N-CA 126.412 1.885 . . . . 0.0 113.734 -177.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.31 139.11 37.57 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 N-CA-C 106.799 -2.039 . . . . 0.0 106.799 169.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 53.2 t -38.63 121.91 1.15 Allowed Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 126.32 1.848 . . . . 0.0 114.37 -176.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.2 -1.24 7.66 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.063 2.509 . . . . 0.0 114.045 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 48.2 t -122.15 -60.57 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.711 1.604 . . . . 0.0 111.333 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 64.5 m -76.49 -17.84 59.07 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.731 2.012 . . . . 0.0 112.841 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 73.8 mtp85 64.52 5.38 2.64 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 127.635 2.374 . . . . 0.0 114.203 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -84.54 147.22 48.93 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.107 0.963 . . . . 0.0 113.386 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.1 120.08 5.89 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.485 2.79 . . . . 0.0 111.531 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.4 pp -59.0 141.14 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.541 1.137 . . . . 0.0 111.436 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -115.01 -38.25 3.93 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -177.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.44 167.05 31.64 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -176.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 14.2 mt -131.95 143.14 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 127.639 2.376 . . . . 0.0 108.7 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 8.4 m -134.12 150.16 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.336 1.455 . . . . 0.0 112.6 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -72.78 99.9 2.74 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 3.5 m -88.0 104.88 17.06 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -172.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -78.57 166.48 22.51 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.14 1.776 . . . . 0.0 110.701 173.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -123.15 170.45 8.23 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 126.095 1.758 . . . . 0.0 111.364 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo . . . . . 0 C--N 1.351 0.681 0 C-N-CA 123.92 3.08 . . . . 0.0 113.688 -178.713 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 43.6 m . . . . . 0 N--CA 1.467 0.386 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 56.0 tp -51.04 -46.95 88.33 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 124.565 1.146 . . . . 0.0 113.532 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.66 0.99 4.1 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 123.507 2.805 . . . . 0.0 114.821 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 8.8 tp 67.06 -70.86 0.11 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 129.849 3.26 . . . . 0.0 112.469 -176.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -64.03 4.69 0.29 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.885 2.074 . . . . 0.0 115.176 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -70.48 -6.74 38.23 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.107 1.763 . . . . 0.0 115.284 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 23.6 mm 48.7 73.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 127.023 2.129 . . . . 0.0 112.501 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 33.87 70.08 0.89 Allowed Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 127.693 2.397 . . . . 0.0 114.006 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -71.12 171.13 16.54 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.106 2.537 . . . . 0.0 114.186 -176.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 18.6 t -70.43 -175.23 0.98 Allowed 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 122.22 1.01 . . . . 0.0 112.601 175.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 3.6 p -144.4 2.75 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 126.446 1.898 . . . . 0.0 112.749 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 41.9 mt -113.97 -61.14 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.259 1.024 . . . . 0.0 111.408 -175.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 8.1 p -56.35 -83.23 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.593 1.557 . . . . 0.0 113.526 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -147.53 -7.68 0.44 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 129.867 3.267 . . . . 0.0 112.577 -177.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 85.49 39.23 8.41 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.011 0.823 . . . . 0.0 113.073 -177.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -66.1 152.33 94.02 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 124.957 1.303 . . . . 0.0 111.191 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.82 66.7 5.84 Favored 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 124.546 3.497 . . . . 0.0 113.667 -176.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -141.52 145.89 35.71 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.9 2.48 . . . . 0.0 110.374 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.29 144.74 51.16 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.103 1.761 . . . . 0.0 112.379 176.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -156.9 87.28 0.12 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 126.632 2.063 . . . . 0.0 110.781 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 45.4 t -62.09 137.16 58.21 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 117.606 0.703 . . . . 0.0 110.969 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -114.93 148.64 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 126.301 1.84 . . . . 0.0 110.174 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 38.7 t -117.69 140.97 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.071 1.348 . . . . 0.0 109.071 174.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -125.18 94.86 4.29 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.794 2.438 . . . . 0.0 107.569 175.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 62.25 -91.7 0.07 OUTLIER Glycine 0 CA--C 1.542 1.745 0 C-N-CA 124.648 1.118 . . . . 0.0 113.612 -176.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 50.4 mmtm -120.98 6.64 10.35 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 127.612 2.365 . . . . 0.0 113.296 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 30.3 p -120.73 170.22 9.65 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 128.172 2.589 . . . . 0.0 109.501 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.17 170.0 33.79 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 120.368 -1.458 . . . . 0.0 113.328 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.23 145.48 46.98 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.606 1.162 . . . . 0.0 114.135 177.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 3.6 pp -116.13 153.21 32.18 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.488 1.915 . . . . 0.0 112.421 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 21.6 ttt 70.55 66.14 0.19 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.611 2.364 . . . . 0.0 113.88 176.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -154.52 145.89 23.01 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 128.247 2.619 . . . . 0.0 107.802 175.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 29.1 p -79.54 164.96 23.46 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 120.71 1.595 . . . . 0.0 112.398 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -63.81 -34.75 78.6 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.138 177.054 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 37.3 m -62.55 -57.62 10.47 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.517 1.127 . . . . 0.0 110.51 176.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 33.1 m -54.12 -47.31 71.97 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 120.057 1.299 . . . . 0.0 112.469 176.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.64 -44.27 90.01 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.779 0.832 . . . . 0.0 112.554 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -64.98 -40.66 95.3 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.749 -1.22 . . . . 0.0 111.479 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -59.63 -56.61 19.76 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.927 1.291 . . . . 0.0 111.072 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.1 pp -61.84 -34.33 75.76 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -65.19 -48.97 71.56 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.402 1.081 . . . . 0.0 112.154 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -52.26 -43.69 64.5 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.739 1.616 . . . . 0.0 112.639 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -90.81 4.7 50.98 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.517 1.527 . . . . 0.0 114.141 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 65.4 t30 49.87 40.81 21.56 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.796 2.438 . . . . 0.0 113.366 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -71.04 117.23 54.43 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 126.215 1.806 . . . . 0.0 111.582 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.62 123.01 12.74 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.102 2.535 . . . . 0.0 108.571 171.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 42.7 t -22.98 122.14 0.16 Allowed Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 128.384 2.674 . . . . 0.0 115.887 -174.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -65.47 -2.37 6.03 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 122.817 2.345 . . . . 0.0 114.151 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 46.4 t -112.57 -61.68 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.595 1.558 . . . . 0.0 111.659 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 32.1 p -105.38 -6.86 19.2 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 61.94 11.07 3.94 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 127.693 2.397 . . . . 0.0 115.769 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -69.61 155.33 93.7 Favored Pre-proline 0 CA--C 1.554 1.118 0 O-C-N 121.22 -0.925 . . . . 0.0 111.861 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.85 116.95 4.91 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.703 2.935 . . . . 0.0 111.978 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 1.9 pp -65.31 147.91 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.452 1.101 . . . . 0.0 112.361 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -115.15 -62.8 1.55 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.201 1.8 . . . . 0.0 111.691 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.8 170.31 22.75 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.062 1.345 . . . . 0.0 113.431 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 7.3 mt -123.65 142.66 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 126.879 2.072 . . . . 0.0 109.038 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 9.4 m -138.27 150.14 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.788 1.235 . . . . 0.0 112.714 176.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 58.7 tp -69.85 99.9 1.46 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.003 1.321 . . . . 0.0 109.385 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 7.3 t -87.28 159.47 18.78 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -142.17 124.76 15.82 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.934 2.094 . . . . 0.0 111.212 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -84.28 -31.61 0.48 Allowed Pre-proline 0 CA--C 1.555 1.138 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 175.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 C--N 1.36 1.183 0 C-N-CA 122.995 2.464 . . . . 0.0 113.8 178.708 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 58.4 m . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 22.8 tp -143.2 138.23 15.47 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 126.586 1.954 . . . . 0.0 109.948 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -43.62 128.44 6.55 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 124.564 3.51 . . . . 0.0 114.009 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . 0.386 3.3 pp 54.42 -23.97 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.892 1 C-N-CA 132.152 4.181 . . . . 0.0 117.145 -174.734 . . . . . . . . 3 2 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -71.44 -17.6 62.37 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.912 2.085 . . . . 0.0 111.891 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -70.88 13.11 0.21 Allowed 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 127.648 2.379 . . . . 0.0 113.63 174.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 22.6 mm 72.11 78.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 129.071 2.948 . . . . 0.0 110.549 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -135.91 61.77 43.02 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 126.03 1.732 . . . . 0.0 110.315 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -64.61 -33.42 55.73 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.559 2.173 . . . . 0.0 116.002 -174.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 31.6 t -55.41 145.86 21.31 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 120.46 1.482 . . . . 0.0 111.645 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 15.8 m -134.85 -13.04 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.335 1.054 . . . . 0.0 113.251 177.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 24.1 mm -110.0 -43.98 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.91 1.284 . . . . 0.0 112.451 -177.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.1 m -79.89 -66.1 0.92 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -170.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -151.18 -14.31 0.21 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -174.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 84.75 12.41 74.86 Favored Glycine 0 CA--C 1.539 1.565 0 O-C-N 120.833 -1.167 . . . . 0.0 112.328 -174.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -61.52 155.11 61.17 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 127.883 2.473 . . . . 0.0 113.311 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.99 -6.38 7.76 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.32 3.347 . . . . 0.0 117.646 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -55.79 144.75 26.43 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.24 1.416 . . . . 0.0 111.161 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.12 141.11 51.58 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.545 1.938 . . . . 0.0 113.047 -176.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -163.43 82.57 0.12 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.853 1.692 . . . . 0.0 111.918 177.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 12.1 t -63.75 147.75 50.93 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.089 0.956 . . . . 0.0 110.899 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.4 mp -115.04 141.78 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 125.801 1.64 . . . . 0.0 109.376 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 80.7 t -123.35 137.21 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.489 1.116 . . . . 0.0 109.815 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -124.63 94.89 4.33 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.697 2.399 . . . . 0.0 108.044 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 60.86 -95.53 0.09 OUTLIER Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.327 1.442 . . . . 0.0 113.895 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -110.47 3.71 19.85 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.803 2.041 . . . . 0.0 113.359 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 22.1 p -126.52 170.12 12.34 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.167 1.787 . . . . 0.0 111.592 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.4 164.39 32.47 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 120.89 -1.131 . . . . 0.0 113.413 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -120.09 117.58 28.33 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.739 1.616 . . . . 0.0 111.869 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 7.3 tt -90.64 153.06 20.59 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.951 1.701 . . . . 0.0 110.863 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 3.4 tpt 86.19 64.95 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 128.274 2.63 . . . . 0.0 113.627 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -155.75 151.48 27.35 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.27 2.228 . . . . 0.0 108.987 175.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 14.1 p -89.21 175.0 7.54 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.834 0.826 . . . . 0.0 110.456 172.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.24 -38.58 91.74 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.342 -0.849 . . . . 0.0 110.972 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 38.1 m -67.66 -44.32 78.15 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 117.453 -1.26 . . . . 0.0 110.981 177.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 57.1 m -51.27 -60.22 3.36 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 120.288 1.404 . . . . 0.0 109.683 173.458 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -53.15 -40.5 64.34 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.197 1.799 . . . . 0.0 113.05 177.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -61.14 -31.37 71.09 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.467 1.107 . . . . 0.0 112.022 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -59.91 -51.03 71.42 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 120.106 1.321 . . . . 0.0 110.471 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -56.51 -45.07 81.25 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.088 0.955 . . . . 0.0 110.29 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -65.98 -51.94 53.96 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.632 1.173 . . . . 0.0 113.492 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -43.91 83.3 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.016 1.727 . . . . 0.0 111.673 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -79.21 -8.92 59.4 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.082 1.753 . . . . 0.0 112.962 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 48.02 47.13 19.1 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 128.058 2.543 . . . . 0.0 111.053 -175.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -87.2 123.5 69.89 Favored Pre-proline 0 N--CA 1.469 0.509 0 C-N-CA 124.711 1.205 . . . . 0.0 113.049 -174.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.47 90.69 1.1 Allowed 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 123.756 2.971 . . . . 0.0 109.599 175.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 33.7 t 18.85 113.95 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.141 1 C-N-CA 132.934 4.494 . . . . 0.0 118.115 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.98 -0.12 3.7 Favored 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 122.636 2.224 . . . . 0.0 113.759 176.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 35.2 t -110.12 -66.67 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.816 1.647 . . . . 0.0 111.616 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 28.3 p -95.68 -5.53 42.02 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 120.258 1.39 . . . . 0.0 114.604 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? 63.5 10.09 4.64 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.469 2.307 . . . . 0.0 115.172 178.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -74.81 153.66 87.06 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 124.503 1.121 . . . . 0.0 112.208 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -72.36 107.16 2.21 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.477 2.785 . . . . 0.0 111.384 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.0 pp -58.48 141.3 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.834 1.254 . . . . 0.0 111.107 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -115.09 -49.7 2.78 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -177.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.82 169.06 24.3 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -174.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 7.6 mt -131.94 139.57 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 128.496 2.719 . . . . 0.0 108.102 175.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 16.2 m -137.87 150.27 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.405 1.482 . . . . 0.0 111.615 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 60.4 tp -68.35 99.93 1.0 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.71 0.804 . . . . 0.0 108.939 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.67 90.72 3.59 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.985 1.314 . . . . 0.0 111.955 -173.045 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -59.8 124.48 20.3 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.349 1.46 . . . . 0.0 112.921 -179.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -68.74 159.05 83.92 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 124.609 1.164 . . . . 0.0 111.367 176.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo . . . . . 0 CA--C 1.538 0.702 0 C-N-CA 122.98 2.453 . . . . 0.0 112.412 179.184 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 43.2 m . . . . . 0 CA--C 1.54 0.587 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 49.0 tp -137.43 93.36 12.8 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.567 1.947 . . . . 0.0 110.579 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.43 -8.92 4.33 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.774 3.65 . . . . 0.0 117.455 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 38.3 tp -68.0 82.97 0.21 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.154 2.182 . . . . 0.0 112.618 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 18.3 m120 61.1 -12.51 0.05 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 129.228 3.011 . . . . 0.0 117.327 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -30.63 90.13 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 130.909 3.683 . . . . 0.0 116.101 -178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 4.4 mm 56.72 27.46 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 128.297 2.639 . . . . 0.0 113.285 177.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 23.72 76.37 0.24 Allowed Pre-proline 0 CA--C 1.555 1.159 0 C-N-CA 129.584 3.154 . . . . 0.0 115.227 178.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.25 174.83 7.53 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.923 3.082 . . . . 0.0 113.948 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 5.5 p -59.45 177.03 0.21 Allowed 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 115.961 1.838 . . . . 0.0 115.961 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 7.9 p -134.31 -9.19 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -172.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 6.9 mt -115.0 -62.56 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 119.937 1.244 . . . . 0.0 112.961 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 11.4 p -65.76 -59.31 4.03 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -174.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 18.1 tp60 -151.76 -18.27 0.19 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 -174.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 91.0 39.63 5.72 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -173.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -95.25 155.13 39.21 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 125.8 1.64 . . . . 0.0 112.787 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -48.31 126.68 14.17 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.686 2.924 . . . . 0.0 113.703 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -55.27 97.56 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 127.407 2.283 . . . . 0.0 114.635 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -128.05 89.86 2.99 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.041 1.336 . . . . 0.0 107.705 176.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 156.02 58.78 0.01 OUTLIER Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.687 1.137 . . . . 0.0 112.395 -177.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 44.3 t -57.1 115.47 2.66 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.906 1.283 . . . . 0.0 112.005 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.0 mp -88.73 122.4 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.736 1.614 . . . . 0.0 109.696 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 95.6 t -122.64 123.26 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.822 1.249 . . . . 0.0 110.483 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -108.02 101.59 10.83 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.099 2.56 . . . . 0.0 110.703 175.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.5 -88.25 0.35 Allowed Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.842 1.687 . . . . 0.0 113.759 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -129.49 6.95 5.27 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.335 1.854 . . . . 0.0 114.333 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 43.2 p -136.68 169.98 16.83 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.421 1.888 . . . . 0.0 110.367 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -161.44 169.85 37.05 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 120.618 -1.301 . . . . 0.0 114.527 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -120.21 99.94 6.89 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.992 1.717 . . . . 0.0 110.076 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.51 92.86 8.26 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 122.87 1.319 . . . . 0.0 110.709 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 28.1 ptm -156.39 1.45 0.14 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -176.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -143.84 174.67 10.62 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.085 1.354 . . . . 0.0 111.139 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 30.6 p -101.82 175.0 5.7 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 123.032 1.396 . . . . 0.0 113.734 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.02 -40.64 77.08 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.999 1.72 . . . . 0.0 112.535 -178.357 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 67.3 m -61.39 -53.56 55.0 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.089 0.956 . . . . 0.0 110.251 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 73.5 m -55.46 -49.12 73.32 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.387 1.075 . . . . 0.0 110.955 175.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.24 -54.91 37.47 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.708 1.203 . . . . 0.0 112.687 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -66.08 -33.83 76.68 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.025 -1.047 . . . . 0.0 112.73 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -59.75 -52.77 64.06 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.388 1.075 . . . . 0.0 110.379 176.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 22.6 mt -52.11 -51.22 59.15 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.7 1.2 . . . . 0.0 110.063 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -53.75 -49.02 69.1 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.948 1.299 . . . . 0.0 112.469 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -62.5 -40.57 97.14 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.075 1.35 . . . . 0.0 112.019 175.482 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 42.4 mmt180 -71.72 -6.35 40.62 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 126.401 1.88 . . . . 0.0 113.382 175.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 35.5 t30 83.87 4.14 0.81 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 130.928 3.691 . . . . 0.0 115.761 176.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -86.68 128.47 56.42 Favored Pre-proline 0 N--CA 1.475 0.775 0 CA-C-N 120.359 1.436 . . . . 0.0 109.799 176.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.16 -75.77 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.869 2.379 . . . . 0.0 111.701 178.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 41.6 t -109.26 133.3 20.83 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 126.554 1.942 . . . . 0.0 111.294 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.31 -5.39 16.14 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.337 2.691 . . . . 0.0 113.733 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 23.9 t -110.0 -76.99 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.472 1.109 . . . . 0.0 112.454 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 22.4 p -94.87 -4.99 45.97 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.862 1.665 . . . . 0.0 114.552 -176.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 65.2 13.43 8.74 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.487 2.315 . . . . 0.0 114.655 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -64.44 128.69 93.62 Favored Pre-proline 0 CA--C 1.552 1.035 0 O-C-N 121.34 -0.85 . . . . 0.0 110.793 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -49.19 113.72 1.02 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 124.536 3.49 . . . . 0.0 115.127 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.5 pp -71.7 142.58 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.776 1.231 . . . . 0.0 112.314 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -115.14 -34.87 4.88 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.733 1.613 . . . . 0.0 113.73 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 1.4 ttp -146.73 150.84 36.16 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 12.2 mt -139.07 130.81 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 128.363 2.665 . . . . 0.0 106.698 173.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 21.0 m -137.4 150.16 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 124.941 1.296 . . . . 0.0 113.573 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 5.7 tt -64.74 99.95 0.36 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.907 1.283 . . . . 0.0 109.019 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 45.6 m -95.35 113.32 24.98 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.527 1.531 . . . . 0.0 113.683 -173.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -75.46 100.85 4.62 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.07 1.348 . . . . 0.0 110.352 175.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -75.48 156.01 85.38 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 125.406 1.482 . . . . 0.0 111.585 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo . . . . . 0 C--N 1.351 0.695 0 C-N-CA 123.504 2.803 . . . . 0.0 111.566 -179.518 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo . . . . . 0 CA--C 1.545 1.049 0 N-CA-C 115.089 1.15 . . . . 0.0 115.089 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 7.6 t -51.33 156.87 1.09 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 128.317 2.647 . . . . 0.0 111.771 173.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 3.8 p -134.82 -2.4 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.847 0.859 . . . . 0.0 113.019 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 13.1 mt -131.11 -49.61 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.622 1.169 . . . . 0.0 112.591 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.7 m -65.99 -60.69 2.59 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.689 1.196 . . . . 0.0 113.957 -174.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -160.29 -9.21 0.05 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 85.57 16.36 64.15 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-N 119.963 1.256 . . . . 0.0 113.245 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -64.61 151.16 92.64 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 127.003 2.121 . . . . 0.0 112.982 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -54.48 -8.05 1.04 Allowed 'Trans proline' 0 CA--C 1.544 1.018 1 C-N-CA 125.526 4.151 . . . . 0.0 119.717 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -59.79 153.89 19.56 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 120.236 1.38 . . . . 0.0 112.459 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -128.12 150.2 50.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.887 2.475 . . . . 0.0 110.779 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -172.71 80.99 0.08 OUTLIER Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.665 1.126 . . . . 0.0 113.468 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 19.8 t -65.14 142.49 58.33 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.082 0.941 . . . . 0.0 110.245 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.88 142.47 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.854 1.662 . . . . 0.0 110.773 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 98.8 t -130.05 121.61 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.585 1.154 . . . . 0.0 111.303 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.3 125.43 43.51 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.949 2.9 . . . . 0.0 112.977 175.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 49.92 34.96 23.94 Favored Glycine 0 CA--C 1.54 1.618 0 N-CA-C 116.578 1.391 . . . . 0.0 116.578 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm 77.42 9.21 2.59 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 127.711 2.404 . . . . 0.0 114.351 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 78.5 p -118.58 161.7 19.62 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 127.405 2.282 . . . . 0.0 107.641 172.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -153.17 166.29 31.52 Favored Glycine 0 CA--C 1.523 0.571 0 O-C-N 119.891 -1.756 . . . . 0.0 115.668 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 9.2 m-70 -120.12 128.49 53.5 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 126.499 1.92 . . . . 0.0 112.022 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 55.3 tp -120.59 153.23 37.08 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.432 2.293 . . . . 0.0 111.364 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 34.2 mtm 90.72 54.27 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 129.44 3.096 . . . . 0.0 112.804 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -155.73 163.88 39.31 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 128.316 2.646 . . . . 0.0 108.992 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 15.3 p -91.54 175.02 7.06 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 122.896 1.332 . . . . 0.0 112.828 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -65.15 -36.08 83.11 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.049 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 25.2 m -67.39 -46.32 73.61 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 117.143 -1.408 . . . . 0.0 110.547 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 37.9 m -48.28 -56.46 7.96 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.442 1.474 . . . . 0.0 109.89 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.53 -52.59 65.0 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.43 1.492 . . . . 0.0 112.578 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -56.79 -42.05 78.8 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.459 1.503 . . . . 0.0 112.243 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -59.31 -54.02 51.61 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.012 1.725 . . . . 0.0 110.375 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . 0.254 0.4 OUTLIER -68.09 -31.14 70.55 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 179.233 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -62.88 -56.54 16.36 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.667 1.987 . . . . 0.0 112.226 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -62.86 -33.49 75.38 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -76.42 -3.16 35.6 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.633 1.573 . . . . 0.0 112.179 173.273 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 64.2 t30 48.24 42.12 17.11 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 128.066 2.546 . . . . 0.0 112.599 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -70.52 129.64 89.91 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 124.611 1.164 . . . . 0.0 112.949 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.33 123.74 8.44 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.616 2.211 . . . . 0.0 108.117 170.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 25.3 t -31.14 129.52 0.27 Allowed Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 128.311 2.645 . . . . 0.0 114.289 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -65.58 -3.86 8.6 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.286 2.658 . . . . 0.0 114.74 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 43.6 t -126.09 -59.59 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.281 1.432 . . . . 0.0 111.259 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 63.8 m -76.0 -19.83 58.35 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.351 1.861 . . . . 0.0 113.137 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 63.5 9.14 3.98 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 127.217 2.207 . . . . 0.0 114.028 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -82.81 137.95 43.69 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 125.007 1.323 . . . . 0.0 112.213 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.85 119.35 6.15 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.149 2.566 . . . . 0.0 108.704 174.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 6.2 pt -66.95 147.08 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -174.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -115.16 -35.77 4.59 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 -174.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 1.4 ttp -145.9 151.37 37.75 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -171.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 4.4 mt -137.04 136.75 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 127.62 2.368 . . . . 0.0 109.08 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 15.7 m -140.04 150.02 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 124.704 1.202 . . . . 0.0 112.953 177.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 55.5 mt -69.94 99.95 1.5 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.213 1.005 . . . . 0.0 108.612 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 26.2 m -101.26 94.89 6.18 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.119 1.768 . . . . 0.0 112.464 -174.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -83.7 164.11 19.84 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.401 1.48 . . . . 0.0 113.353 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -120.42 164.19 24.32 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.546 1.538 . . . . 0.0 112.555 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo . . . . . 0 C--N 1.353 0.815 0 C-N-CA 124.482 3.454 . . . . 0.0 113.915 -179.879 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 CA--C 1.541 0.865 0 CA-C-O 121.095 0.373 . . . . 0.0 112.978 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 438' ' ' CYS . . . . . 0.403 ' SG ' ' N ' ' B' ' 439' ' ' VAL . 40.1 t -54.59 178.06 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 127.583 2.353 . . . . 0.0 113.22 175.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 439' ' ' VAL . . . . . 0.403 ' N ' ' SG ' ' B' ' 438' ' ' CYS . 7.4 p -111.76 -11.47 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.39 1.876 . . . . 0.0 112.343 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 7.3 mt -113.91 -66.76 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.739 1.215 . . . . 0.0 111.341 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 17.0 p -73.57 -43.73 59.09 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 120.519 1.509 . . . . 0.0 108.869 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 57.87 13.5 2.13 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.936 2.894 . . . . 0.0 113.903 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . -85.22 -27.41 33.56 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 121.576 -0.703 . . . . 0.0 112.459 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -115.5 155.12 47.62 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 126.941 2.096 . . . . 0.0 115.384 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -56.84 155.17 28.56 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.094 3.196 . . . . 0.0 113.238 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -65.47 32.03 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 127.761 2.424 . . . . 0.0 116.148 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -81.78 89.96 6.34 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.061 -1.649 . . . . 0.0 109.822 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 165.93 58.8 0.03 OUTLIER Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.36 0.981 . . . . 0.0 112.401 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 43.3 t -59.3 126.29 27.06 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.394 1.097 . . . . 0.0 109.99 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 2.4 mp -102.07 142.81 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.187 1.395 . . . . 0.0 110.418 -176.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 88.5 t -130.01 132.88 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.856 0.862 . . . . 0.0 111.241 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -121.18 96.21 5.0 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 128.519 2.728 . . . . 0.0 110.047 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 71.21 -91.48 0.46 Allowed Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.716 1.627 . . . . 0.0 114.057 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -120.25 -2.19 10.16 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.169 1.788 . . . . 0.0 113.916 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 82.3 p -127.77 167.87 15.91 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.468 1.907 . . . . 0.0 109.882 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -150.67 177.52 28.67 Favored Glycine 0 CA--C 1.527 0.806 0 O-C-N 121.054 -1.029 . . . . 0.0 114.324 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -120.11 148.22 43.89 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.138 1.375 . . . . 0.0 114.524 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.8 tt -116.12 153.16 32.26 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 130.188 3.395 . . . . 0.0 110.388 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 29.1 tpp 78.48 30.72 0.38 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 116.65 2.092 . . . . 0.0 116.65 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -136.08 149.89 48.91 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.6 1.56 . . . . 0.0 108.88 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 29.3 p -88.1 172.14 9.74 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.674 1.226 . . . . 0.0 113.918 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.17 -36.11 78.95 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.736 175.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 63.4 m -62.53 -63.5 1.21 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.143 0.977 . . . . 0.0 109.964 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 77.5 m -53.79 -42.98 68.9 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.815 1.246 . . . . 0.0 112.754 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -60.67 -48.26 82.57 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.31 -0.869 . . . . 0.0 112.046 173.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -59.75 -43.22 94.37 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 120.771 -1.206 . . . . 0.0 111.205 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -57.79 -54.96 40.94 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.222 1.009 . . . . 0.0 111.09 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.32 -30.39 71.53 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -67.44 -48.14 68.1 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.337 1.455 . . . . 0.0 112.359 175.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -59.01 -37.49 77.04 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.381 1.072 . . . . 0.0 111.56 176.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 39.4 tpt85 -76.21 -10.54 59.49 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.872 2.469 . . . . 0.0 112.393 174.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 64.1 t30 52.76 42.62 31.83 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.323 2.249 . . . . 0.0 111.919 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 34.2 tttp -70.01 129.04 91.24 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.644 1.178 . . . . 0.0 113.401 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.61 124.44 8.82 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 122.638 2.225 . . . . 0.0 107.579 169.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 40.2 t -30.72 128.36 0.27 Allowed Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 128.294 2.638 . . . . 0.0 114.734 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -66.53 -3.04 8.35 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.172 2.581 . . . . 0.0 114.585 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 41.8 t -127.68 -58.49 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.172 1.389 . . . . 0.0 111.619 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 60.6 m -77.31 -17.57 58.2 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.43 1.892 . . . . 0.0 112.679 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 44.6 mtm105 62.76 7.85 2.75 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.527 2.331 . . . . 0.0 114.368 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -86.38 143.03 35.93 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 123.829 0.851 . . . . 0.0 112.914 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.38 126.46 10.38 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.359 2.706 . . . . 0.0 110.218 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 7.3 pt -72.19 153.8 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -115.05 -41.84 3.28 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.515 1.526 . . . . 0.0 114.019 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.98 167.16 30.09 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -174.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 7.9 mt -134.33 137.38 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 128.097 2.559 . . . . 0.0 107.728 177.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 3.7 t -127.01 147.78 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.627 1.171 . . . . 0.0 112.539 -178.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.52 106.86 2.28 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.565 1.546 . . . . 0.0 107.545 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 50.1 m -103.63 126.0 50.49 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.22 1.408 . . . . 0.0 114.214 -171.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -123.63 178.79 5.04 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.364 2.266 . . . . 0.0 111.823 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -127.79 163.48 42.9 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.509 1.524 . . . . 0.0 112.579 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo . . . . . 0 C--N 1.353 0.802 0 C-N-CA 123.931 3.088 . . . . 0.0 114.085 -179.175 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . 0.252 45.8 Cg_exo . . . . . 0 CA--C 1.552 1.382 0 N-CA-C 116.525 1.702 . . . . 0.0 116.525 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 14.1 t -65.32 151.5 46.08 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 121.508 1.958 . . . . 0.0 109.343 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 13.2 m -132.59 -3.23 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 6.6 mt -133.26 -46.34 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 119.4 1.0 . . . . 0.0 112.852 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.5 m -67.55 -60.05 2.87 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -173.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -153.89 -14.04 0.14 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -176.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 83.94 7.15 85.96 Favored Glycine 0 CA--C 1.539 1.532 0 O-C-N 120.948 -1.095 . . . . 0.0 112.453 -173.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -55.01 155.04 8.98 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 129.07 2.948 . . . . 0.0 113.255 178.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.31 -10.25 4.51 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 125.186 3.924 . . . . 0.0 118.795 -178.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -59.37 139.17 57.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.481 1.512 . . . . 0.0 112.8 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.2 150.04 50.19 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.27 1.828 . . . . 0.0 111.106 175.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -156.34 91.6 0.12 Allowed Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.667 1.603 . . . . 0.0 111.867 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 48.3 t -64.82 133.69 52.48 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.563 0.745 . . . . 0.0 110.89 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.16 144.73 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.424 1.889 . . . . 0.0 110.896 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 74.3 t -129.99 134.62 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.356 1.062 . . . . 0.0 111.198 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -125.07 94.96 4.32 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.497 2.319 . . . . 0.0 111.281 175.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 65.95 -93.32 0.18 Allowed Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.959 1.742 . . . . 0.0 114.709 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -111.0 -2.35 15.98 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.28 1.832 . . . . 0.0 114.362 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 6.5 p -130.65 170.0 14.88 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.229 2.212 . . . . 0.0 110.82 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -157.1 170.83 34.41 Favored Glycine 0 CA--C 1.533 1.176 0 O-C-N 120.902 -1.124 . . . . 0.0 113.854 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 1.9 m-70 -120.08 140.04 51.64 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.432 1.893 . . . . 0.0 111.799 179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 36.3 tp -134.67 153.26 52.07 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 127.553 2.341 . . . . 0.0 111.061 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 80.0 mtp 75.46 56.89 0.06 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 127.311 2.244 . . . . 0.0 112.054 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -151.53 148.52 28.12 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 129.391 3.076 . . . . 0.0 107.102 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 6.2 p -80.55 173.77 12.27 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 122.773 1.273 . . . . 0.0 112.321 177.009 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.38 -39.88 94.72 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.406 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 32.4 m -68.65 -44.52 73.98 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 116.505 -1.712 . . . . 0.0 110.918 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 53.8 m -46.64 -56.97 5.26 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 121.403 1.91 . . . . 0.0 110.926 175.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.72 -51.1 71.38 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.27 1.428 . . . . 0.0 112.778 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -58.77 -41.17 85.96 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.153 0.981 . . . . 0.0 112.667 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.37 -53.61 54.45 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.55 2.34 . . . . 0.0 110.768 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 15.0 mt -51.37 -54.42 26.66 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.658 1.183 . . . . 0.0 109.898 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -55.34 -48.03 74.8 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.486 1.114 . . . . 0.0 112.626 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -59.14 -40.99 87.21 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.555 1.542 . . . . 0.0 111.706 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -77.1 7.38 5.07 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 127.427 2.291 . . . . 0.0 113.569 175.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 75.76 0.85 3.45 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 130.387 3.475 . . . . 0.0 116.302 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -82.54 121.13 77.93 Favored Pre-proline 0 N--CA 1.473 0.702 0 CA-C-N 120.541 1.519 . . . . 0.0 109.555 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.51 -67.37 0.03 OUTLIER 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.149 2.566 . . . . 0.0 110.325 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 15.6 t -121.53 131.42 24.45 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 127.203 2.201 . . . . 0.0 110.346 176.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.72 -5.44 16.0 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.522 2.815 . . . . 0.0 114.589 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 36.7 t -131.46 -59.21 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 120.358 1.435 . . . . 0.0 113.414 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 21.6 m -71.56 -29.25 64.52 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.821 1.648 . . . . 0.0 110.613 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 64.89 7.49 3.99 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 128.172 2.589 . . . . 0.0 113.071 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -68.35 143.27 95.44 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 124.436 1.094 . . . . 0.0 110.765 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.05 110.08 2.53 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.563 2.842 . . . . 0.0 113.556 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 11.3 pt -66.06 153.58 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.496 0.665 . . . . 0.0 112.356 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -109.73 -47.53 3.34 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.071 1.348 . . . . 0.0 112.166 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.31 170.13 23.17 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.081 1.352 . . . . 0.0 112.676 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 13.0 mt -123.65 136.5 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 127.443 2.297 . . . . 0.0 106.435 175.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 14.3 m -131.89 150.11 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.68 99.92 2.21 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 6.3 t -87.71 150.12 23.81 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.887 -0.508 . . . . 0.0 111.606 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -139.28 156.84 46.78 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.638 1.575 . . . . 0.0 111.905 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -71.47 148.49 93.25 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.535 1.134 . . . . 0.0 113.002 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo . . . . . 0 CA--C 1.539 0.744 0 C-N-CA 123.75 2.967 . . . . 0.0 112.385 179.483 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo . . . . . 0 CA--C 1.545 1.025 0 N-CA-C 114.644 0.979 . . . . 0.0 114.644 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 2.2 p -63.02 -174.52 0.07 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.242 1.817 . . . . 0.0 114.865 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 5.6 p -138.65 -9.41 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 3.9 mt -119.59 -58.83 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 120.574 1.534 . . . . 0.0 112.996 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 13.7 p -67.82 -68.46 0.38 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -174.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -137.2 -13.54 1.58 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -169.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 77.53 35.38 36.93 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -172.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -86.52 151.2 52.82 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 124.557 1.143 . . . . 0.0 113.822 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -76.18 66.4 7.01 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 124.513 3.475 . . . . 0.0 113.543 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -131.98 165.58 23.62 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.65 1.98 . . . . 0.0 112.506 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -128.18 149.94 50.22 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 128.499 2.72 . . . . 0.0 111.791 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 168.01 75.95 0.04 OUTLIER Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.913 1.72 . . . . 0.0 112.303 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 35.7 t -62.61 141.27 58.57 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.759 0.779 . . . . 0.0 111.161 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 2.5 mp -105.07 139.12 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 C-N-CA 126.106 1.763 . . . . 0.0 109.654 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 88.9 t -130.0 131.7 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.197 0.999 . . . . 0.0 108.885 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.03 99.46 6.13 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.644 2.378 . . . . 0.0 110.516 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 65.33 -96.55 0.24 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 126.172 1.844 . . . . 0.0 113.792 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 38.6 mtmm -110.34 1.07 18.25 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.066 1.746 . . . . 0.0 113.693 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 44.7 p -130.1 170.05 14.53 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.434 1.494 . . . . 0.0 112.012 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -154.25 170.42 32.75 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 121.246 -0.909 . . . . 0.0 114.037 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 8.5 m-70 -120.22 112.7 19.39 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.295 1.838 . . . . 0.0 111.667 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -88.94 153.18 21.24 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 22.6 mmt 64.65 67.37 0.56 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.591 2.357 . . . . 0.0 114.54 175.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -148.97 157.87 43.75 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 129.253 3.021 . . . . 0.0 107.822 174.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 22.0 p -90.79 174.98 7.17 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 123.048 1.404 . . . . 0.0 114.13 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.44 -31.8 72.78 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.58 176.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 44.8 m -66.7 -50.25 63.44 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.64 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 36.3 m -47.87 -63.98 0.91 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.15 1.38 . . . . 0.0 109.868 174.025 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -52.74 -47.16 67.58 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.305 1.842 . . . . 0.0 113.654 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -60.68 -36.88 79.86 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.956 -1.09 . . . . 0.0 112.281 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -55.41 -48.16 74.81 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.607 1.163 . . . . 0.0 110.951 175.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 6.5 mp -62.63 -47.72 82.5 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.55 0.74 . . . . 0.0 110.001 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -57.09 -42.48 80.83 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -55.02 -28.36 51.48 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -119.59 8.84 11.33 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.856 2.062 . . . . 0.0 113.019 177.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 60.1 t30 42.29 56.39 3.69 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 127.252 2.221 . . . . 0.0 112.075 -174.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -70.0 133.04 88.14 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -174.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.95 115.16 4.14 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.52 2.147 . . . . 0.0 107.633 169.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 51.9 t -22.45 125.33 0.11 Allowed Pre-proline 0 CA--C 1.558 1.276 0 C-N-CA 130.146 3.378 . . . . 0.0 116.236 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -66.61 -3.94 10.06 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.139 2.56 . . . . 0.0 114.235 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 45.0 t -110.26 -64.02 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.327 1.451 . . . . 0.0 111.488 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 25.0 p -105.24 1.23 27.94 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 63.36 11.07 5.2 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 127.73 2.412 . . . . 0.0 115.945 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -75.35 144.92 78.97 Favored Pre-proline 0 CA--C 1.55 0.976 0 O-C-N 121.391 -0.818 . . . . 0.0 111.916 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.15 116.18 4.56 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.438 2.759 . . . . 0.0 111.461 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.5 pp -55.16 142.79 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.825 1.25 . . . . 0.0 111.929 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -115.04 -45.56 2.95 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.107 0.963 . . . . 0.0 113.361 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.28 166.98 30.11 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -177.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 4.0 mt -139.39 133.99 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 128.203 2.601 . . . . 0.0 107.943 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 27.8 m -140.02 150.24 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.76 1.224 . . . . 0.0 111.986 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 56.8 mt -66.91 99.82 0.67 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 42.1 m -99.79 136.0 40.37 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.624 1.17 . . . . 0.0 112.227 -173.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -128.57 160.77 31.34 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.521 1.128 . . . . 0.0 112.619 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -145.86 155.99 51.8 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.919 1.688 . . . . 0.0 111.749 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 CA--C 1.537 0.631 0 C-N-CA 123.533 2.822 . . . . 0.0 112.428 179.168 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo . . . . . 0 CA--C 1.543 0.947 0 CA-C-O 117.745 -1.023 . . . . 0.0 112.781 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 8.0 t -58.74 147.66 32.33 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 120.531 1.514 . . . . 0.0 109.594 172.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 15.9 m -130.92 -1.15 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 10.0 mt -132.12 -47.33 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.23 1.012 . . . . 0.0 112.237 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.8 m -68.93 -62.69 1.27 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -173.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -155.44 -12.02 0.11 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -174.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 81.53 7.89 87.66 Favored Glycine 0 CA--C 1.542 1.772 0 O-C-N 120.47 -1.394 . . . . 0.0 112.424 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -59.09 152.45 51.27 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 129.669 3.187 . . . . 0.0 113.256 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -74.91 73.12 4.37 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 124.329 3.353 . . . . 0.0 113.886 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -128.91 144.12 51.09 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 127.15 2.18 . . . . 0.0 110.411 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.26 116.16 19.42 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -173.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -138.59 83.2 0.25 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.441 1.496 . . . . 0.0 111.663 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 16.4 t -66.12 140.21 58.2 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.077 0.939 . . . . 0.0 112.309 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.3 mp -115.1 141.2 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 126.832 2.053 . . . . 0.0 110.441 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 67.4 t -126.49 134.02 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.627 1.171 . . . . 0.0 111.134 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -118.78 98.04 6.02 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.451 2.7 . . . . 0.0 110.651 175.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 73.55 -87.42 0.62 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.849 1.69 . . . . 0.0 114.068 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -129.85 1.92 4.87 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.265 1.826 . . . . 0.0 113.431 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 72.8 p -131.2 170.06 15.08 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.204 2.202 . . . . 0.0 109.197 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -152.56 174.6 31.4 Favored Glycine 0 N--CA 1.466 0.69 0 O-C-N 120.541 -1.349 . . . . 0.0 113.273 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -120.09 105.84 11.39 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.368 1.067 . . . . 0.0 111.788 177.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 15.2 tp -81.67 153.18 26.75 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.011 2.524 . . . . 0.0 110.211 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 48.7 mtt 85.54 66.35 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 128.008 2.523 . . . . 0.0 111.976 178.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -158.86 145.09 16.85 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 127.719 2.408 . . . . 0.0 108.537 175.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 19.9 p -83.78 173.69 11.08 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 122.28 1.038 . . . . 0.0 110.746 174.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -64.72 -37.44 87.59 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.502 -0.749 . . . . 0.0 111.191 178.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 27.8 m -65.15 -49.03 71.44 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 117.132 -1.413 . . . . 0.0 110.661 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 32.9 m -48.06 -55.77 9.37 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 120.555 1.525 . . . . 0.0 110.57 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.55 92.4 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.846 1.258 . . . . 0.0 113.002 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -61.52 -43.32 99.08 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.817 -1.177 . . . . 0.0 111.586 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -62.52 -54.03 45.93 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.996 1.318 . . . . 0.0 111.514 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 2.5 pp -60.49 -37.72 81.98 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.644 0.656 . . . . 0.0 111.25 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -59.95 -52.11 66.79 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.186 1.395 . . . . 0.0 111.378 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -58.68 -35.99 73.48 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.246 1.418 . . . . 0.0 112.684 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -78.5 2.93 17.42 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.534 1.934 . . . . 0.0 113.402 175.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 28.5 m120 64.13 19.18 11.66 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 128.713 2.805 . . . . 0.0 114.62 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -72.72 135.81 80.77 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.693 1.197 . . . . 0.0 109.383 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.8 -85.57 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.037 2.491 . . . . 0.0 109.804 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 36.1 t -118.45 132.76 23.67 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.921 1.688 . . . . 0.0 110.874 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.63 -6.86 20.02 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.397 2.731 . . . . 0.0 114.119 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 40.6 t -116.36 -72.3 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 119.732 1.151 . . . . 0.0 112.752 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 25.8 p -96.25 1.31 51.99 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 86.4 mmt-85 65.54 6.67 3.9 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 128.01 2.524 . . . . 0.0 115.665 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -62.16 140.98 96.09 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-N 119.593 1.088 . . . . 0.0 111.686 177.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -69.45 112.17 2.95 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.385 2.723 . . . . 0.0 113.725 -176.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 22.8 pt -73.73 160.14 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.709 1.603 . . . . 0.0 113.39 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -112.55 -48.13 3.03 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.48 1.512 . . . . 0.0 113.19 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.14 170.3 22.28 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -175.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 8.1 mt -117.2 135.38 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 126.523 1.929 . . . . 0.0 107.821 173.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 37.3 t -129.48 147.9 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.979 1.312 . . . . 0.0 110.334 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 487' ' ' LEU . . . . . 0.443 HD13 ' H ' ' A' ' 487' ' ' LEU 0.271 0.0 OUTLIER -81.59 116.79 21.51 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.298 1.047 . . . . 0.0 108.348 177.031 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 6.5 m -115.84 99.04 7.01 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.271 -1.331 . . . . 0.0 114.134 -169.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -68.78 171.2 8.17 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.044 1.738 . . . . 0.0 112.937 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -134.33 164.04 46.86 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.81 1.644 . . . . 0.0 111.121 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo . . . . . 0 C--N 1.353 0.774 0 C-N-CA 124.341 3.361 . . . . 0.0 113.855 179.551 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo . . . . . 0 CA--C 1.536 0.596 0 N-CA-C 115.5 1.308 . . . . 0.0 115.5 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 14.6 t -55.22 145.95 20.15 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 120.546 1.521 . . . . 0.0 111.333 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 29.8 m -132.22 0.1 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.93 1.692 . . . . 0.0 113.615 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 1.7 mt -134.69 -48.37 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 116.932 -1.509 . . . . 0.0 114.731 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 25.2 p -77.68 -60.53 2.33 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 121.457 1.935 . . . . 0.0 115.16 -173.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -139.86 -8.32 1.22 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 74.63 17.63 79.97 Favored Glycine 0 CA--C 1.541 1.672 0 CA-C-N 119.818 1.19 . . . . 0.0 111.356 -173.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -61.23 155.15 58.36 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 127.541 2.337 . . . . 0.0 113.858 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.8 -1.32 9.15 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.363 3.375 . . . . 0.0 116.141 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -60.17 156.77 14.52 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.941 1.696 . . . . 0.0 112.672 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -128.09 150.14 50.09 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.848 2.059 . . . . 0.0 110.489 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -163.87 67.76 0.22 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.258 1.409 . . . . 0.0 112.417 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 45.0 t -57.47 128.22 35.92 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.732 1.213 . . . . 0.0 110.176 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.98 144.06 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.06 1.344 . . . . 0.0 110.189 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 88.8 t -129.28 126.64 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.767 1.227 . . . . 0.0 109.697 176.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.18 122.52 37.29 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 128.813 2.845 . . . . 0.0 112.647 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 64.1 -77.54 0.05 OUTLIER Glycine 0 CA--C 1.539 1.552 0 C-N-CA 126.207 1.861 . . . . 0.0 114.872 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -146.61 2.46 0.83 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 127.453 2.301 . . . . 0.0 113.212 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 71.5 p -131.72 170.12 15.24 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 127.575 2.35 . . . . 0.0 110.54 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -144.58 171.93 25.73 Favored Glycine 0 N--CA 1.47 0.93 0 O-C-N 120.479 -1.388 . . . . 0.0 115.248 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.25 135.2 55.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.424 1.889 . . . . 0.0 113.223 175.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 4.0 pp -119.77 153.33 35.85 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.662 2.385 . . . . 0.0 110.942 174.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 11.5 tpt 94.65 53.87 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 129.304 3.042 . . . . 0.0 111.689 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -159.93 150.17 18.61 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.763 2.425 . . . . 0.0 108.4 175.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 31.2 p -90.03 174.29 7.73 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 122.377 1.084 . . . . 0.0 111.591 175.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.43 -37.93 88.38 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.634 -0.667 . . . . 0.0 110.991 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 43.7 m -60.25 -54.37 46.52 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 117.616 -1.183 . . . . 0.0 110.48 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 59.5 m -51.79 -61.98 1.91 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.923 1.238 . . . . 0.0 111.002 175.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -47.17 -52.37 15.79 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.037 -1.04 . . . . 0.0 112.578 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -62.21 -37.94 87.25 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.466 1.106 . . . . 0.0 112.965 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -60.47 -50.65 72.74 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.482 1.513 . . . . 0.0 110.625 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -58.25 -46.23 86.33 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.849 0.459 . . . . 0.0 110.242 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -55.99 -46.57 78.66 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.297 1.039 . . . . 0.0 112.276 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -62.05 -39.1 91.21 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.624 1.569 . . . . 0.0 111.506 174.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -79.7 16.47 1.11 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 128.066 2.546 . . . . 0.0 113.196 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . 0.303 0.2 OUTLIER 59.8 8.13 1.28 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 130.667 3.587 . . . . 0.0 117.849 179.802 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -84.59 127.41 65.65 Favored Pre-proline 0 N--CA 1.474 0.731 0 CA-C-N 120.045 1.293 . . . . 0.0 108.158 173.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.33 -81.8 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 123.069 2.513 . . . . 0.0 112.263 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 41.3 t -81.95 131.87 55.71 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 124.425 1.09 . . . . 0.0 110.887 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -70.32 -5.28 16.18 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.945 2.43 . . . . 0.0 114.487 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 28.9 t -119.68 -75.9 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.986 1.266 . . . . 0.0 113.084 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 23.7 p -91.91 -1.11 57.46 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 26.9 ttt-85 64.87 18.78 11.63 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 127.306 2.242 . . . . 0.0 115.107 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -65.98 156.09 85.02 Favored Pre-proline 0 CA--C 1.554 1.122 0 O-C-N 121.049 -1.032 . . . . 0.0 111.347 174.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.88 105.89 1.59 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.71 2.94 . . . . 0.0 113.522 -177.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.16 154.26 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.091 1.356 . . . . 0.0 113.512 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -115.2 -43.0 3.11 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.026 2.131 . . . . 0.0 111.687 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.91 167.55 27.79 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.977 1.311 . . . . 0.0 114.303 -176.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 18.6 mt -134.23 135.21 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 129.099 2.96 . . . . 0.0 105.919 173.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.48 150.14 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.428 1.091 . . . . 0.0 113.367 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.61 99.93 1.37 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.01 86.39 3.97 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.835 1.254 . . . . 0.0 112.704 -173.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -63.6 169.69 3.74 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.919 1.288 . . . . 0.0 111.88 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -130.51 167.28 21.75 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 125.167 1.387 . . . . 0.0 111.16 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo . . . . . 0 C--N 1.352 0.726 0 C-N-CA 124.068 3.178 . . . . 0.0 113.778 -179.786 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo . . . . . 0 CA--C 1.544 0.995 0 N-CA-C 115.303 1.232 . . . . 0.0 115.303 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 41.3 t -57.33 -167.91 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 130.408 3.483 . . . . 0.0 112.778 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 9.7 p -132.74 -12.86 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.135 1.774 . . . . 0.0 112.748 177.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 14.3 mm -93.3 -60.1 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.332 1.053 . . . . 0.0 108.566 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 26.5 p -87.55 -44.8 10.99 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.699 1.199 . . . . 0.0 109.768 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . 0.274 14.0 pt20 52.01 22.0 1.7 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 128.981 2.913 . . . . 0.0 114.777 -174.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -94.26 -24.66 18.56 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 112.213 -0.355 . . . . 0.0 112.213 176.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -115.42 155.08 47.57 Favored Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 125.979 1.712 . . . . 0.0 115.125 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -51.41 140.15 44.21 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.683 3.589 . . . . 0.0 114.54 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -67.6 28.14 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 127.564 2.345 . . . . 0.0 117.091 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -77.87 89.83 4.08 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.46 -1.4 . . . . 0.0 110.774 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 162.35 57.86 0.02 OUTLIER Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.065 -0.853 . . . . 0.0 113.523 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 78.3 m -63.14 142.91 58.2 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.687 1.243 . . . . 0.0 110.596 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.6 mp -115.06 144.53 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 126.033 1.733 . . . . 0.0 111.377 -172.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 67.0 t -127.24 131.48 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.72 1.208 . . . . 0.0 111.657 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -119.88 97.2 5.5 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.681 2.792 . . . . 0.0 110.786 174.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.72 -91.48 0.33 Allowed Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.906 1.717 . . . . 0.0 114.046 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -118.88 -0.27 11.24 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.297 1.839 . . . . 0.0 113.849 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 67.1 p -133.24 170.08 15.96 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.603 1.961 . . . . 0.0 110.337 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -153.53 171.61 32.36 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.911 1.243 . . . . 0.0 112.899 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -120.11 133.7 55.45 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.531 1.132 . . . . 0.0 113.275 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 25.7 tp -89.64 153.13 20.98 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 129.006 2.922 . . . . 0.0 113.882 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 459' ' ' MET . . . . . . . . . . . . 0.354 25.8 ptm 59.45 57.2 3.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 129.28 3.032 . . . . 0.0 118.535 172.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -136.76 147.9 46.94 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.259 1.824 . . . . 0.0 108.145 170.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 31.3 p -82.04 165.24 20.82 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 120.24 1.382 . . . . 0.0 112.874 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.32 -38.82 84.92 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.123 177.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 96.3 m -61.2 -59.42 5.34 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.693 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 54.6 m -53.93 -48.27 70.39 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.701 1.137 . . . . 0.0 112.4 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -56.36 -51.54 67.91 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.554 0.742 . . . . 0.0 112.613 175.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -62.78 -39.71 95.06 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.03 1.332 . . . . 0.0 112.437 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -61.85 -54.18 45.68 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.177 1.391 . . . . 0.0 110.457 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 27.2 mt -50.2 -53.05 30.72 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.426 1.091 . . . . 0.0 110.089 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -52.89 -51.12 62.33 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.871 1.268 . . . . 0.0 112.644 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -61.79 -38.9 89.8 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.345 1.458 . . . . 0.0 112.698 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -75.87 -1.67 26.44 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.782 2.033 . . . . 0.0 113.361 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 35.8 t30 77.88 7.27 2.66 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 130.111 3.365 . . . . 0.0 115.482 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -78.21 123.93 85.88 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 120.655 -1.278 . . . . 0.0 108.332 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.0 -76.45 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.58 2.853 . . . . 0.0 111.589 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 27.1 t -120.33 132.16 24.21 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.637 1.975 . . . . 0.0 110.114 178.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.12 -3.22 13.49 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.461 2.774 . . . . 0.0 113.428 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 39.2 t -113.44 -71.99 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.816 1.246 . . . . 0.0 112.272 -177.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 26.3 p -100.96 -2.61 31.36 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.44 1.496 . . . . 0.0 114.587 -176.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 65.89 8.67 5.51 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 128.067 2.547 . . . . 0.0 115.861 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -62.77 124.89 85.01 Favored Pre-proline 0 CA--C 1.553 1.092 0 CA-C-N 119.357 0.981 . . . . 0.0 111.287 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.38 114.49 1.46 Allowed 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.398 3.398 . . . . 0.0 114.882 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 16.4 pt -75.94 157.76 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.795 0.838 . . . . 0.0 113.233 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -115.1 -45.45 2.95 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.052 1.741 . . . . 0.0 112.749 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.68 170.09 22.82 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.208 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 13.9 mt -131.33 138.97 51.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 128.304 2.641 . . . . 0.0 107.37 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.22 150.04 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 CA-C-N 119.728 1.149 . . . . 0.0 113.843 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -62.78 99.92 0.18 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.518 1.927 . . . . 0.0 109.412 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 12.3 m -119.95 127.94 53.12 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.103 0.961 . . . . 0.0 112.242 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -118.93 161.73 19.7 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.183 1.393 . . . . 0.0 113.518 -176.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -74.92 163.61 67.05 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 125.333 1.453 . . . . 0.0 111.697 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo . . . . . 0 C--N 1.353 0.781 0 C-N-CA 123.925 3.083 . . . . 0.0 114.451 -178.565 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 CA--C 1.545 1.074 0 CA-C-O 116.771 -1.429 . . . . 0.0 114.705 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 32.7 t -55.99 142.92 34.14 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 121.502 1.956 . . . . 0.0 109.764 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.0 -0.36 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.399 1.079 . . . . 0.0 113.747 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 8.9 mt -132.94 -46.83 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.866 0.866 . . . . 0.0 112.299 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.3 m -72.13 -68.34 0.47 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -172.756 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -144.29 -10.45 0.65 Allowed 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -174.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 78.57 13.57 83.06 Favored Glycine 0 CA--C 1.542 1.766 0 CA-C-N 120.129 1.331 . . . . 0.0 112.668 -174.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -62.28 155.19 67.46 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 130.758 3.623 . . . . 0.0 113.952 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -67.71 -1.46 6.78 Favored 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 124.856 3.704 . . . . 0.0 116.211 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -60.93 135.14 57.7 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.007 1.723 . . . . 0.0 110.416 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.08 126.65 41.62 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.439 1.496 . . . . 0.0 113.31 -176.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -150.3 78.58 0.22 Allowed Glycine 0 CA--C 1.529 0.938 0 C-N-CA 125.405 1.479 . . . . 0.0 112.102 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 76.5 m -63.75 151.56 41.73 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 117.624 0.712 . . . . 0.0 110.987 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 4.6 mp -110.25 142.39 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 125.794 1.637 . . . . 0.0 111.216 -174.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 64.5 t -130.02 123.44 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.625 1.17 . . . . 0.0 108.234 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.24 106.24 9.72 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.843 2.057 . . . . 0.0 112.984 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 73.35 -83.75 0.64 Allowed Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.865 1.698 . . . . 0.0 114.746 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 454' ' ' LYS . . . . . 0.436 ' HA ' ' HE2' ' B' ' 454' ' ' LYS . 0.5 OUTLIER -127.57 -10.59 5.64 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.858 1.663 . . . . 0.0 114.021 -177.356 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 78.8 p -135.46 169.97 16.67 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.309 1.443 . . . . 0.0 111.078 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -144.32 168.8 26.56 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.192 0.901 . . . . 0.0 114.669 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -120.18 132.17 55.28 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.227 1.811 . . . . 0.0 112.649 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 4.4 pp -107.81 153.32 23.16 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.876 2.07 . . . . 0.0 111.872 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 44.0 ttm 86.19 69.16 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 128.531 2.732 . . . . 0.0 112.05 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -160.04 154.92 24.46 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 128.051 2.54 . . . . 0.0 108.538 176.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 14.3 p -90.05 174.99 7.34 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 122.354 1.073 . . . . 0.0 110.488 174.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -66.09 -31.72 72.76 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.425 -0.797 . . . . 0.0 111.616 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 40.8 m -72.25 -47.03 53.38 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 117.007 -1.473 . . . . 0.0 110.427 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 50.6 m -45.22 -57.6 3.85 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 120.306 1.412 . . . . 0.0 109.962 172.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.96 -49.89 76.16 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.234 1.814 . . . . 0.0 113.549 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -60.88 -37.5 82.41 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.091 1.356 . . . . 0.0 112.797 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -59.34 -52.15 66.88 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.966 1.306 . . . . 0.0 110.661 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 19.1 mt -57.33 -48.97 77.61 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.016 1.327 . . . . 0.0 109.978 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -56.21 -51.7 67.12 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.957 1.303 . . . . 0.0 113.244 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -52.26 -40.74 62.12 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.535 1.534 . . . . 0.0 113.426 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 32.3 ptt85 -97.45 5.99 48.88 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.684 1.594 . . . . 0.0 113.938 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 44.82 48.43 9.06 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.487 2.715 . . . . 0.0 112.332 -177.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -69.99 118.46 63.72 Favored Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 124.268 1.027 . . . . 0.0 111.896 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -62.58 123.33 12.18 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.294 1.996 . . . . 0.0 107.76 172.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 52.6 t -26.85 122.25 0.23 Allowed Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 128.72 2.808 . . . . 0.0 115.742 -173.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -65.5 -3.92 8.6 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 122.657 2.238 . . . . 0.0 113.931 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 33.9 t -107.47 -62.87 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.527 1.531 . . . . 0.0 111.347 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 26.6 p -110.09 0.97 18.58 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 63.55 11.32 5.57 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 127.84 2.456 . . . . 0.0 115.953 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -68.65 151.55 97.18 Favored Pre-proline 0 CA--C 1.551 1.01 0 O-C-N 121.373 -0.83 . . . . 0.0 111.534 176.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.84 111.26 2.98 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.594 2.863 . . . . 0.0 112.442 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.9 109.97 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 126.84 2.056 . . . . 0.0 109.982 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -107.3 -57.08 2.12 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -171.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.21 165.39 27.65 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -177.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 2.7 mt -134.96 141.41 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 127.399 2.28 . . . . 0.0 109.94 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.99 148.84 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.038 0.935 . . . . 0.0 111.826 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.0 99.8 0.91 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 17.3 m -109.23 86.87 2.37 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.221 1.008 . . . . 0.0 111.502 -174.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -77.18 159.32 29.81 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -176.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -74.12 156.28 87.77 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.617 1.567 . . . . 0.0 111.964 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo . . . . . 0 C--N 1.352 0.744 0 C-N-CA 124.156 3.237 . . . . 0.0 114.324 178.316 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 CA--C 1.542 0.909 0 N-CA-C 114.974 1.106 . . . . 0.0 114.974 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 8.4 t -58.44 178.38 0.1 Allowed 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 127.538 2.335 . . . . 0.0 114.25 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 33.6 m -134.83 -0.22 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 -173.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 6.8 mt -118.93 -56.58 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-N 121.106 1.775 . . . . 0.0 112.413 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 7.8 p -51.17 -84.85 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.116 2.166 . . . . 0.0 114.064 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -148.47 -15.8 0.33 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 131.516 3.926 . . . . 0.0 111.998 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 92.1 69.22 1.15 Allowed Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.082 1.325 . . . . 0.0 113.009 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -99.21 154.47 37.29 Favored Pre-proline 0 N--CA 1.48 1.026 0 C-N-CA 125.125 1.37 . . . . 0.0 110.888 175.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.71 125.05 15.83 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.648 2.899 . . . . 0.0 112.056 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.58 99.96 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -175.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -128.04 89.85 2.99 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.612 1.165 . . . . 0.0 107.912 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 151.96 58.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.845 0 C-N-CA 123.907 0.765 . . . . 0.0 112.459 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 35.7 t -59.57 138.31 57.75 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.34 1.07 . . . . 0.0 110.943 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.8 mp -114.96 140.62 35.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 C-N-CA 127.271 2.229 . . . . 0.0 110.772 -174.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 73.1 t -130.04 131.72 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.416 1.086 . . . . 0.0 111.641 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -111.42 100.96 9.45 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.755 2.422 . . . . 0.0 108.505 171.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 73.67 -85.0 0.65 Allowed Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.488 1.518 . . . . 0.0 112.939 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -137.08 4.86 2.75 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.338 1.855 . . . . 0.0 114.348 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 51.2 p -131.37 170.04 15.19 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.467 1.907 . . . . 0.0 110.248 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -160.08 175.56 36.87 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 120.804 -1.185 . . . . 0.0 114.561 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -120.03 100.02 6.96 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.083 1.753 . . . . 0.0 110.222 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 11.2 tp -76.69 92.75 3.56 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 128.212 2.605 . . . . 0.0 111.193 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -169.53 -27.41 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -103.35 164.06 11.88 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.085 1.311 . . . . 0.0 114.373 -174.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 32.0 p -85.92 168.34 14.29 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-O 122.123 0.963 . . . . 0.0 112.241 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.07 -42.35 90.16 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.224 -0.923 . . . . 0.0 111.678 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 86.9 m -54.98 -58.81 6.1 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.334 1.054 . . . . 0.0 109.628 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 84.0 m -57.51 -43.89 84.59 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.118 1.367 . . . . 0.0 112.629 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.71 -50.85 69.21 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.76 0.824 . . . . 0.0 111.775 174.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -65.49 -38.49 89.91 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.292 1.037 . . . . 0.0 112.089 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -60.57 -52.43 65.2 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.909 1.284 . . . . 0.0 110.845 177.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 19.6 mt -50.48 -49.81 54.37 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.764 1.226 . . . . 0.0 110.273 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 50.9 tttt -55.37 -51.64 66.15 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.942 1.297 . . . . 0.0 112.368 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -60.3 -42.47 95.57 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.555 1.542 . . . . 0.0 111.797 175.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -69.68 -3.96 17.49 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 127.372 2.269 . . . . 0.0 113.209 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 63.96 20.12 12.06 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 128.478 2.711 . . . . 0.0 114.291 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -70.05 127.7 92.16 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 173.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -64.18 -56.07 0.51 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.846 2.364 . . . . 0.0 112.057 -177.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 13.2 t -152.95 137.6 10.93 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 128.335 2.654 . . . . 0.0 108.412 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -70.08 -5.19 15.81 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.205 2.604 . . . . 0.0 114.179 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 24.7 t -120.16 -75.26 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 119.99 1.268 . . . . 0.0 113.197 -178.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 10.6 p -92.19 -1.57 57.06 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.978 1.711 . . . . 0.0 114.516 -176.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 61.54 24.74 14.79 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 127.635 2.374 . . . . 0.0 115.878 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -93.72 121.14 65.25 Favored Pre-proline 0 CA--C 1.558 1.279 0 CA-C-N 119.1 0.864 . . . . 0.0 109.912 174.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -42.87 112.09 0.25 Allowed 'Trans proline' 0 CA--C 1.547 1.139 1 C-N-CA 125.375 4.05 . . . . 0.0 119.727 -173.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 1.9 pp -70.59 128.69 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 126.466 1.906 . . . . 0.0 110.386 173.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -115.18 -16.59 11.54 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -174.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 484' ' ' MET . . . . . 0.495 ' SD ' HG13 ' A' ' 486' ' ' VAL . 5.7 tmm? -145.87 147.67 32.04 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.299 0.954 . . . . 0.0 112.953 -173.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 13.5 mt -137.2 133.27 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 126.736 2.014 . . . . 0.0 109.763 174.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 486' ' ' VAL . . . . . 0.495 HG13 ' SD ' ' A' ' 484' ' ' MET . 3.4 m -119.24 150.16 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 125.709 1.604 . . . . 0.0 112.4 176.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.55 99.88 3.74 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 175.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 24.8 m -88.63 143.81 26.7 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -174.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -123.6 152.32 42.04 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.107 2.163 . . . . 0.0 110.507 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 490' ' ' PHE . . . . . 0.54 ' H ' ' CD ' ' A' ' 491' ' ' PRO . 56.2 p90 -138.39 -29.53 0.01 OUTLIER Pre-proline 0 CA--C 1.552 1.033 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 491' ' ' PRO . . . . . 0.54 ' CD ' ' H ' ' A' ' 490' ' ' PHE . 87.5 Cg_exo . . . . . 0 C--N 1.359 1.12 0 C-N-CA 123.255 2.636 . . . . 0.0 114.218 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo . . . . . 0 CA--C 1.556 1.62 0 N-CA-C 110.2 -0.731 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 11.4 t -47.72 148.03 1.68 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.67 1.588 . . . . 0.0 111.722 175.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 25.7 t -117.93 -11.25 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.611 1.565 . . . . 0.0 112.093 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 10.0 mt -128.62 -53.26 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -174.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 2.1 m -69.82 -68.97 0.38 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.594 1.958 . . . . 0.0 115.371 -171.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -144.82 -10.24 0.6 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -173.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.51 11.38 82.04 Favored Glycine 0 CA--C 1.542 1.764 0 CA-C-N 119.638 1.108 . . . . 0.0 112.603 -174.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -67.48 155.04 92.0 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 127.738 2.415 . . . . 0.0 111.957 177.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.61 142.45 13.74 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.729 2.952 . . . . 0.0 115.112 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -63.82 34.98 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 129.305 3.042 . . . . 0.0 116.164 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -81.35 89.77 6.12 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.491 -1.381 . . . . 0.0 108.139 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 170.51 48.37 0.04 OUTLIER Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.993 0.806 . . . . 0.0 112.846 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 48.4 t -55.32 133.52 49.59 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.106 1.362 . . . . 0.0 109.732 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 2.1 mp -104.53 150.18 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 126.001 1.72 . . . . 0.0 109.736 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 40.2 t -124.68 140.12 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 122.362 1.077 . . . . 0.0 110.652 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -125.22 94.92 4.3 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 128.355 2.662 . . . . 0.0 109.106 175.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 66.63 -84.18 0.11 Allowed Glycine 0 CA--C 1.538 1.51 0 C-N-CA 124.796 1.189 . . . . 0.0 113.333 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -130.4 0.93 4.56 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 128.057 2.543 . . . . 0.0 113.81 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 27.7 p -112.39 170.15 8.37 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.978 2.111 . . . . 0.0 109.735 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -154.17 167.49 32.33 Favored Glycine 0 CA--C 1.528 0.879 0 O-C-N 120.692 -1.255 . . . . 0.0 114.844 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 8.4 m-70 -120.08 143.11 48.31 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.172 1.389 . . . . 0.0 113.11 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 9.9 tt -126.66 153.09 45.85 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 130.434 3.493 . . . . 0.0 108.985 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 9.5 ttt 100.22 19.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 128.796 2.838 . . . . 0.0 114.529 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -140.94 152.93 45.38 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.901 1.68 . . . . 0.0 110.368 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 13.1 p -82.2 174.51 11.11 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.619 1.2 . . . . 0.0 113.198 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.51 -46.31 86.97 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.406 177.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 49.0 m -65.86 -42.84 89.91 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 117.345 -1.312 . . . . 0.0 112.391 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 55.5 m -49.83 -55.36 14.49 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 120.382 1.447 . . . . 0.0 109.588 173.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -62.8 -40.75 98.31 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.622 1.569 . . . . 0.0 113.587 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -60.6 -44.02 96.75 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.554 1.542 . . . . 0.0 111.582 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -57.46 -58.37 8.6 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.108 1.363 . . . . 0.0 110.647 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.3 pp -64.03 -32.22 73.7 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -67.41 -47.39 70.41 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.906 1.682 . . . . 0.0 111.434 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -60.08 -38.7 83.66 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.234 1.014 . . . . 0.0 111.945 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -76.59 -6.41 51.83 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.7 1.6 . . . . 0.0 113.018 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 64.3 t30 52.7 39.31 28.27 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 128.135 2.574 . . . . 0.0 112.144 -177.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -73.92 132.3 80.35 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.328 1.451 . . . . 0.0 112.177 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -70.61 119.1 6.08 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.492 2.128 . . . . 0.0 107.612 170.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 42.9 t -20.75 125.7 0.08 OUTLIER Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 129.157 2.983 . . . . 0.0 116.44 -176.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -65.91 -1.8 5.67 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 122.845 2.363 . . . . 0.0 114.172 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 45.2 t -113.96 -69.51 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.671 1.588 . . . . 0.0 111.34 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 28.3 p -93.45 -7.57 44.08 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? 61.4 13.52 5.07 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 127.158 2.183 . . . . 0.0 114.67 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -74.1 159.19 84.52 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.418 1.087 . . . . 0.0 111.806 176.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -69.61 130.2 19.1 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.973 2.449 . . . . 0.0 112.087 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.59 110.4 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 126.161 1.784 . . . . 0.0 110.816 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -87.41 -61.14 1.79 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.542 1.137 . . . . 0.0 113.303 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.17 170.06 22.1 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.057 1.343 . . . . 0.0 113.922 -174.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 13.3 mt -133.03 140.69 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 127.714 2.405 . . . . 0.0 108.643 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 5.2 m -131.75 150.03 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 125.215 1.406 . . . . 0.0 112.956 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.51 99.93 3.14 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.78 95.8 6.05 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.306 1.442 . . . . 0.0 112.541 -173.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -68.55 161.71 27.33 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.306 1.442 . . . . 0.0 111.209 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -133.29 165.4 37.03 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 125.314 1.446 . . . . 0.0 111.59 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo . . . . . 0 C--N 1.352 0.752 0 C-N-CA 124.345 3.364 . . . . 0.0 114.124 -179.592 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo . . . . . 0 CA--C 1.544 1.01 0 N-CA-C 113.141 0.4 . . . . 0.0 113.141 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 8.0 p -68.47 -177.28 0.9 Allowed 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 16.8 m -139.09 -8.83 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 4.2 mt -110.74 -62.26 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 121.132 1.787 . . . . 0.0 112.539 -177.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 19.7 p -65.63 -64.32 0.89 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -176.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -143.64 -13.19 0.67 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 116.981 2.215 . . . . 0.0 116.981 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 81.94 28.07 43.25 Favored Glycine 0 CA--C 1.536 1.381 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -172.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -72.84 155.07 90.97 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 125.142 1.377 . . . . 0.0 111.534 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -70.07 1.82 4.29 Favored 'Trans proline' 0 CA--C 1.548 1.214 0 C-N-CA 124.03 3.153 . . . . 0.0 116.135 -178.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -63.56 156.71 25.67 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 127.016 2.126 . . . . 0.0 112.827 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -128.05 150.23 50.03 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 129.193 2.997 . . . . 0.0 111.956 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 176.77 84.29 0.06 OUTLIER Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.3 1.428 . . . . 0.0 113.671 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 42.2 t -62.36 139.58 58.54 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.978 0.911 . . . . 0.0 111.526 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.6 mp -115.11 148.75 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.95 1.7 . . . . 0.0 111.043 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 93.9 t -130.0 131.71 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.316 1.047 . . . . 0.0 111.517 177.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -125.04 100.15 6.44 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 128.097 2.559 . . . . 0.0 112.397 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.69 -89.6 0.38 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.579 1.562 . . . . 0.0 114.25 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -120.6 -4.5 9.78 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.955 1.702 . . . . 0.0 113.797 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 47.4 p -131.7 170.0 15.39 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.945 1.698 . . . . 0.0 111.176 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -141.81 176.12 22.17 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.546 1.07 . . . . 0.0 115.159 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -120.11 144.64 47.52 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.106 2.162 . . . . 0.0 112.784 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 34.0 tp -135.13 153.17 52.09 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.407 2.683 . . . . 0.0 110.904 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 47.3 mtt 82.97 29.77 0.09 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 128.748 2.819 . . . . 0.0 113.528 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -134.01 139.91 46.35 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 127.107 2.163 . . . . 0.0 107.563 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 30.6 p -79.42 175.04 10.97 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 122.883 1.325 . . . . 0.0 113.52 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.52 -36.08 81.45 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.46 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 53.8 m -63.94 -53.12 55.27 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 117.372 -1.299 . . . . 0.0 110.508 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 28.8 m -48.98 -54.24 16.44 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 120.394 1.452 . . . . 0.0 111.052 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.97 -49.48 76.67 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.806 1.242 . . . . 0.0 112.949 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -62.59 -41.66 99.1 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.559 1.144 . . . . 0.0 111.443 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -61.18 -57.96 10.28 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.0 1.72 . . . . 0.0 111.159 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 1.7 pp -59.51 -37.01 77.19 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.046 0.384 . . . . 0.0 111.495 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -61.9 -52.15 65.25 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.263 1.425 . . . . 0.0 111.827 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -59.94 -34.89 73.85 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.927 1.291 . . . . 0.0 112.599 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -78.34 2.92 16.99 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.625 1.97 . . . . 0.0 113.424 175.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 28.2 m120 64.16 21.01 12.42 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 128.582 2.753 . . . . 0.0 114.991 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -70.47 134.02 86.81 Favored Pre-proline 0 CA--C 1.544 0.732 0 O-C-N 121.102 -0.999 . . . . 0.0 108.606 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.38 -56.28 0.3 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.264 1.976 . . . . 0.0 111.223 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 1.8 t -155.2 145.26 15.72 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 129.858 3.263 . . . . 0.0 109.008 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.99 -12.47 32.53 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.018 2.478 . . . . 0.0 114.849 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 15.3 t -140.23 -56.16 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 120.707 1.594 . . . . 0.0 114.297 -177.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 16.8 m -71.5 -22.42 61.79 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.107 2.163 . . . . 0.0 112.207 -177.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 79.2 mtm-85 63.3 11.81 5.71 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.894 2.478 . . . . 0.0 113.527 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -75.94 132.85 73.46 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.503 1.121 . . . . 0.0 109.02 174.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.02 110.11 1.66 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.69 2.26 . . . . 0.0 114.412 -176.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.0 pp -65.28 141.38 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.519 1.528 . . . . 0.0 111.836 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -114.98 -28.04 7.16 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.89 1.276 . . . . 0.0 114.24 -176.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -154.63 162.57 41.07 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.274 1.03 . . . . 0.0 113.699 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 6.8 mt -129.19 137.71 56.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 127.725 2.41 . . . . 0.0 107.219 176.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 12.2 p -134.27 150.03 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.792 1.237 . . . . 0.0 112.312 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -75.21 99.74 4.1 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.489 0.716 . . . . 0.0 109.07 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.1 m -112.3 105.6 13.94 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.797 0.839 . . . . 0.0 109.599 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -87.04 161.54 18.11 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.177 1.391 . . . . 0.0 113.959 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -72.08 161.32 79.47 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 126.876 2.07 . . . . 0.0 112.387 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo . . . . . 0 C--N 1.353 0.766 0 C-N-CA 124.563 3.508 . . . . 0.0 114.422 178.775 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 CA--C 1.543 0.938 0 CA-C-O 117.977 -0.926 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 15.8 t -59.54 146.69 39.69 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.859 1.209 . . . . 0.0 109.295 173.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.98 -1.22 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.488 1.115 . . . . 0.0 113.723 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 4.1 mt -132.95 -45.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 119.431 1.014 . . . . 0.0 112.805 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 2.7 m -71.16 -60.55 2.17 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -152.17 -17.78 0.18 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -176.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 83.31 10.23 82.56 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-N 119.575 1.079 . . . . 0.0 112.439 -175.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -71.13 155.1 93.62 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 127.281 2.232 . . . . 0.0 113.237 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.96 7.7 0.04 OUTLIER 'Trans proline' 0 CA--C 1.553 1.449 1 C-N-CA 126.012 4.475 . . . . 0.0 120.103 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -61.47 151.28 33.18 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 120.652 1.569 . . . . 0.0 112.301 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -128.13 150.23 50.07 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.63 1.572 . . . . 0.0 112.336 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -167.88 79.9 0.1 Allowed Glycine 0 CA--C 1.531 1.083 0 C-N-CA 126.552 2.025 . . . . 0.0 111.523 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 49.1 t -68.04 135.36 52.16 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 117.719 0.76 . . . . 0.0 110.532 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.04 143.33 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.912 1.685 . . . . 0.0 111.855 -177.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 53.2 t -129.53 137.54 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.156 1.382 . . . . 0.0 110.681 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -124.0 104.07 8.68 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 129.6 3.16 . . . . 0.0 110.472 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.85 -87.42 0.29 Allowed Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.437 1.494 . . . . 0.0 113.62 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -131.22 5.04 4.43 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.47 1.908 . . . . 0.0 114.308 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 82.0 p -133.97 170.05 16.21 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.537 1.935 . . . . 0.0 110.693 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -159.08 174.44 36.03 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 120.781 -1.2 . . . . 0.0 113.309 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 42.8 m-70 -120.29 144.51 47.77 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.528 1.131 . . . . 0.0 113.38 175.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 4.1 pp -110.78 153.22 25.66 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.333 1.853 . . . . 0.0 112.792 178.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 22.8 ttt 85.33 67.89 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 129.084 2.954 . . . . 0.0 113.116 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -158.1 152.18 24.15 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.122 2.569 . . . . 0.0 108.675 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 13.3 p -91.61 171.56 9.09 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 122.074 0.94 . . . . 0.0 111.74 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.57 -36.75 85.25 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.641 -0.662 . . . . 0.0 111.467 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 38.4 m -68.76 -50.02 53.95 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 116.528 -1.701 . . . . 0.0 109.976 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 19.2 m -46.19 -57.77 4.24 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 121.237 1.835 . . . . 0.0 110.943 174.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.84 -51.3 67.97 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.787 1.235 . . . . 0.0 112.599 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -62.78 -37.94 88.64 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.236 -0.915 . . . . 0.0 112.778 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -61.22 -51.21 69.94 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.215 1.806 . . . . 0.0 110.96 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 20.9 mt -54.94 -53.63 53.14 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.858 1.263 . . . . 0.0 109.67 175.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -52.94 -48.07 67.59 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.431 1.492 . . . . 0.0 112.644 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -61.45 -41.67 97.58 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.462 1.505 . . . . 0.0 112.204 175.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -70.82 -16.74 62.75 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.189 1.396 . . . . 0.0 113.613 176.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 35.3 t30 105.13 -3.99 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.89 1 C-N-CA 132.428 4.291 . . . . 0.0 115.047 175.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -80.7 123.7 82.35 Favored Pre-proline 0 N--CA 1.472 0.663 0 CA-C-N 120.784 1.629 . . . . 0.0 109.882 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.77 -69.08 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.823 2.349 . . . . 0.0 111.655 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 7.1 t -111.12 135.18 20.9 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 126.346 1.859 . . . . 0.0 111.727 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -79.88 -7.55 14.41 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.351 2.7 . . . . 0.0 114.261 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 29.1 t -102.93 -72.87 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 119.748 1.158 . . . . 0.0 112.085 -177.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 26.5 p -100.65 -3.58 30.07 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.048 1.739 . . . . 0.0 113.647 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . 0.338 15.5 ptp180 53.85 23.6 3.95 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 128.797 2.839 . . . . 0.0 116.026 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -65.51 146.76 98.94 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 123.361 0.664 . . . . 0.0 109.579 173.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.02 112.2 2.66 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.337 2.691 . . . . 0.0 113.714 -175.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.5 pp -71.63 160.04 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.879 1.672 . . . . 0.0 113.209 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -111.38 -54.06 2.64 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.471 1.908 . . . . 0.0 110.818 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.33 170.21 21.21 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.83 1.252 . . . . 0.0 113.425 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 14.7 mt -121.14 137.94 53.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 127.302 2.241 . . . . 0.0 106.76 174.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 10.8 m -134.43 149.94 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 52.8 mt -73.34 99.94 3.05 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.704 1.202 . . . . 0.0 108.358 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 33.5 m -116.65 112.63 21.53 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.607 1.563 . . . . 0.0 112.29 -175.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -100.7 171.06 7.93 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.775 1.63 . . . . 0.0 112.692 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -139.05 156.09 72.51 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.331 1.452 . . . . 0.0 111.751 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 C--N 1.35 0.654 0 C-N-CA 123.599 2.866 . . . . 0.0 111.495 -179.828 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo . . . . . 0 CA--C 1.536 0.618 0 N-CA-C 115.683 1.378 . . . . 0.0 115.683 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 8.0 t -54.55 148.0 13.15 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.264 1.026 . . . . 0.0 111.752 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.35 -3.37 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 121.173 -0.955 . . . . 0.0 113.317 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 7.3 mt -129.65 -48.15 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.871 0.869 . . . . 0.0 112.774 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.2 m -68.0 -62.81 1.23 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -156.87 -15.01 0.09 Allowed 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 88.29 8.33 71.6 Favored Glycine 0 CA--C 1.54 1.629 0 O-C-N 120.652 -1.28 . . . . 0.0 112.657 -174.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -59.67 151.45 62.22 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 128.718 2.807 . . . . 0.0 114.336 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.8 88.39 1.31 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.448 3.432 . . . . 0.0 113.258 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -136.96 161.79 35.06 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 127.375 2.27 . . . . 0.0 111.023 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -125.61 150.08 47.85 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.668 1.587 . . . . 0.0 109.972 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -179.93 80.43 0.06 OUTLIER Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.309 1.909 . . . . 0.0 111.498 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 50.5 t -66.29 133.39 50.48 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.877 0.871 . . . . 0.0 110.008 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.03 141.21 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.878 1.271 . . . . 0.0 110.766 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 92.3 t -130.01 133.96 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.426 1.091 . . . . 0.0 111.8 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -124.92 107.88 11.32 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 128.693 2.797 . . . . 0.0 110.204 174.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 66.29 -93.6 0.2 Allowed Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.993 1.759 . . . . 0.0 113.625 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -126.16 7.19 7.18 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.72 2.008 . . . . 0.0 113.611 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 79.7 p -130.52 170.12 14.66 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.656 1.982 . . . . 0.0 110.541 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.33 -178.4 30.44 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.816 -1.177 . . . . 0.0 115.345 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -120.07 136.51 54.55 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.038 2.135 . . . . 0.0 110.404 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 26.4 tp -121.38 152.97 38.42 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.615 1.966 . . . . 0.0 111.206 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 41.4 mtm 64.97 68.34 0.51 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 127.62 2.368 . . . . 0.0 113.018 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -151.96 148.16 27.42 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 129.163 2.985 . . . . 0.0 107.252 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 17.2 p -77.92 165.89 23.55 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 122.472 1.13 . . . . 0.0 111.828 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.7 -38.67 91.34 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.698 -0.626 . . . . 0.0 111.165 177.316 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 23.8 m -62.16 -48.8 78.48 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 116.911 -1.519 . . . . 0.0 111.133 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 16.6 m -49.24 -51.66 31.96 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 120.809 1.64 . . . . 0.0 111.386 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.19 -47.06 84.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.42 1.088 . . . . 0.0 112.835 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -65.88 -40.57 91.73 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 121.216 -0.927 . . . . 0.0 111.937 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -61.43 -56.83 15.83 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.624 1.97 . . . . 0.0 111.471 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 2.8 pp -59.98 -35.89 75.97 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 118.133 0.424 . . . . 0.0 111.317 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -63.48 -48.63 76.86 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.886 1.274 . . . . 0.0 110.853 175.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -58.64 -39.36 80.32 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.314 1.446 . . . . 0.0 111.409 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -74.12 3.79 6.53 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 127.163 2.185 . . . . 0.0 113.746 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 67.51 15.82 9.86 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 128.949 2.9 . . . . 0.0 115.227 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 5.7 tppp? -70.17 129.96 90.09 Favored Pre-proline 0 N--CA 1.475 0.802 0 O-C-N 120.832 -1.168 . . . . 0.0 109.106 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.33 -49.48 1.26 Allowed 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.847 2.365 . . . . 0.0 111.38 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 1.7 t -158.36 142.28 11.27 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 131.576 3.95 . . . . 0.0 107.995 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.76 -11.32 29.35 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.081 2.521 . . . . 0.0 115.026 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 17.1 t -137.75 -55.93 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 120.54 1.518 . . . . 0.0 113.739 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 22.4 m -69.88 -25.47 63.72 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.739 1.616 . . . . 0.0 111.432 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 33.5 mtp-105 61.38 13.78 5.24 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 127.911 2.484 . . . . 0.0 113.244 -175.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -76.73 130.85 75.14 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.227 1.411 . . . . 0.0 108.484 174.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -64.46 109.61 1.24 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.549 2.166 . . . . 0.0 113.679 -176.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.1 pp -63.21 137.78 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.683 1.593 . . . . 0.0 111.861 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -115.18 -20.8 10.26 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 2.6 ttp -150.95 146.68 26.42 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.13 0.972 . . . . 0.0 112.763 -174.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 7.6 mt -130.78 131.47 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 127.478 2.311 . . . . 0.0 107.763 174.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.39 150.09 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 119.487 1.039 . . . . 0.0 113.707 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.18 99.87 3.52 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 10.2 t -89.41 156.19 18.85 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.372 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -135.7 170.33 16.14 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.161 2.185 . . . . 0.0 111.374 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -133.56 156.57 79.48 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 124.887 1.275 . . . . 0.0 111.706 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo . . . . . 0 CA--C 1.538 0.692 0 C-N-CA 123.434 2.756 . . . . 0.0 112.369 179.753 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo . . . . . 0 CA--C 1.54 0.786 0 CA-C-O 117.635 -1.069 . . . . 0.0 114.696 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 42.2 t -56.13 143.91 31.31 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 120.182 1.355 . . . . 0.0 111.029 177.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 28.5 m -123.68 -15.13 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 10.5 pt -137.12 -26.41 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.5 m -75.9 -64.47 1.08 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 120.64 1.563 . . . . 0.0 112.137 -177.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -145.39 -12.81 0.52 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 76.73 11.88 84.97 Favored Glycine 0 CA--C 1.544 1.886 0 CA-C-N 119.992 1.269 . . . . 0.0 112.487 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -59.54 155.11 40.7 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 129.997 3.319 . . . . 0.0 113.618 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.65 -1.69 10.21 Favored 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 124.354 3.37 . . . . 0.0 115.463 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -52.65 146.8 9.55 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 127.042 2.137 . . . . 0.0 111.577 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -116.21 150.16 37.97 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.757 2.023 . . . . 0.0 110.735 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -159.68 68.12 0.26 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 128.169 2.795 . . . . 0.0 109.349 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 33.8 t -63.8 133.28 53.15 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.063 0.945 . . . . 0.0 110.429 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -114.57 143.21 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.35 1.06 . . . . 0.0 112.057 -175.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 89.6 t -129.08 136.84 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.926 1.29 . . . . 0.0 110.629 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -125.04 95.05 4.36 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 129.456 3.102 . . . . 0.0 110.096 176.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.96 -91.5 0.35 Allowed Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.809 1.671 . . . . 0.0 114.227 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -121.49 4.34 10.18 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 126.318 1.847 . . . . 0.0 114.338 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 66.4 p -134.77 170.09 16.37 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.249 2.22 . . . . 0.0 109.903 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -160.18 174.45 36.93 Favored Glycine 0 CA--C 1.529 0.921 0 O-C-N 120.658 -1.276 . . . . 0.0 113.766 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -120.26 141.99 49.46 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.906 1.282 . . . . 0.0 113.072 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.41 153.26 36.8 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.152 2.581 . . . . 0.0 110.526 177.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 49.5 mtt 93.17 62.96 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 129.826 3.25 . . . . 0.0 111.486 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -160.01 149.59 17.97 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 127.205 2.202 . . . . 0.0 109.489 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 19.4 p -88.3 174.93 7.89 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.851 0.834 . . . . 0.0 110.232 172.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -39.81 94.77 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.397 -0.814 . . . . 0.0 112.416 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 68.9 m -68.13 -48.06 66.42 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 116.105 -1.902 . . . . 0.0 110.606 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 16.6 m -45.61 -59.07 2.95 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 121.601 2.001 . . . . 0.0 111.263 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.88 -43.95 86.35 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.028 1.331 . . . . 0.0 114.062 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -68.92 -42.51 76.73 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.354 -0.841 . . . . 0.0 111.777 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -62.35 -53.91 48.19 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.006 2.122 . . . . 0.0 112.358 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.3 pp -57.54 -36.49 71.69 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.319 0.509 . . . . 0.0 111.197 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -66.68 -46.21 76.39 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.452 0.701 . . . . 0.0 111.767 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -59.23 -35.11 73.07 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.853 1.261 . . . . 0.0 111.704 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -76.3 3.77 10.21 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 127.322 2.249 . . . . 0.0 113.457 175.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 39.3 t30 76.38 8.49 3.28 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 130.013 3.325 . . . . 0.0 115.649 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -70.14 129.46 90.64 Favored Pre-proline 0 N--CA 1.475 0.818 0 O-C-N 120.755 -1.216 . . . . 0.0 109.242 175.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -69.76 -43.23 2.78 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.072 2.515 . . . . 0.0 114.695 -176.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.56 149.3 36.65 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 128.251 2.62 . . . . 0.0 110.313 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.24 -17.69 61.32 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.361 2.707 . . . . 0.0 115.369 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.09 -63.31 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 -172.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 28.8 p -89.16 -19.47 25.44 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -172.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . 0.259 3.9 ptm180 94.15 4.8 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 131.252 3.821 . . . . 0.0 116.182 174.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -67.67 111.99 9.12 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 125.08 1.352 . . . . 0.0 110.387 178.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -46.64 107.84 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 124.269 3.313 . . . . 0.0 116.099 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 pp -62.86 146.95 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.178 1.391 . . . . 0.0 113.45 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -112.1 -29.76 7.48 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.781 1.632 . . . . 0.0 114.187 -173.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.03 161.34 33.97 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.63 1.172 . . . . 0.0 113.468 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 14.1 mt -129.51 136.48 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 127.518 2.327 . . . . 0.0 108.231 175.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 16.9 m -137.61 150.16 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.726 1.21 . . . . 0.0 113.479 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.22 99.85 4.86 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 177.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 1.9 t -93.79 157.61 16.06 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -129.27 143.3 50.8 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.32 1.448 . . . . 0.0 112.403 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -73.39 164.53 60.37 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 125.137 1.375 . . . . 0.0 111.56 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo . . . . . 0 CA--C 1.539 0.726 0 C-N-CA 124.226 3.284 . . . . 0.0 114.272 179.718 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo . . . . . 0 CA--C 1.546 1.102 0 N-CA-C 114.447 0.903 . . . . 0.0 114.447 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 10.0 t -61.01 159.21 11.94 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 128.228 2.611 . . . . 0.0 111.029 171.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.71 -0.63 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.378 1.071 . . . . 0.0 113.442 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 10.4 mt -133.94 -48.86 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 119.735 1.152 . . . . 0.0 112.866 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.5 m -67.61 -60.16 2.77 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.439 1.496 . . . . 0.0 114.228 -173.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -151.53 -16.13 0.2 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -174.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.62 10.69 82.95 Favored Glycine 0 CA--C 1.542 1.755 0 O-C-N 120.812 -1.18 . . . . 0.0 113.173 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -61.96 155.04 65.46 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 128.39 2.676 . . . . 0.0 112.339 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -66.27 1.66 2.35 Favored 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.459 3.439 . . . . 0.0 117.3 -177.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -60.96 144.9 52.3 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.871 1.214 . . . . 0.0 110.62 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -128.19 150.07 50.17 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.68 1.992 . . . . 0.0 111.683 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -162.69 98.92 0.17 Allowed Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.742 1.639 . . . . 0.0 112.51 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 46.4 t -68.21 133.2 48.47 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.517 0.727 . . . . 0.0 110.638 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.2 mp -113.0 135.4 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.181 1.392 . . . . 0.0 110.463 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 45.4 t -130.04 130.32 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.422 1.089 . . . . 0.0 109.65 176.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.2 99.09 5.93 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.908 2.083 . . . . 0.0 112.206 178.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 75.9 -84.36 0.91 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.732 1.634 . . . . 0.0 114.711 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -124.99 -11.53 7.09 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.761 1.624 . . . . 0.0 114.3 -176.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 72.9 p -135.33 168.89 18.37 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.455 1.502 . . . . 0.0 110.573 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -142.96 178.44 21.24 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.35 0.976 . . . . 0.0 113.829 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -120.27 147.03 45.49 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.866 1.266 . . . . 0.0 113.839 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 12.2 tp -111.4 153.27 26.3 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 128.84 2.856 . . . . 0.0 113.551 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 16.7 mtt 69.47 59.74 0.31 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.68 2.392 . . . . 0.0 115.835 173.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -149.56 163.04 38.96 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.286 1.434 . . . . 0.0 111.046 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 11.6 p -87.25 174.49 8.56 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 122.393 1.092 . . . . 0.0 112.484 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -67.04 -40.15 87.13 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.72 -0.612 . . . . 0.0 111.197 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 27.8 m -64.73 -41.98 95.55 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 117.528 -1.225 . . . . 0.0 111.651 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 34.6 m -49.29 -63.61 1.05 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.242 1.417 . . . . 0.0 109.187 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -53.92 -45.17 71.11 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.021 1.728 . . . . 0.0 113.109 176.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -60.11 -37.26 79.47 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.756 1.222 . . . . 0.0 112.352 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -59.85 -49.34 78.1 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.446 1.099 . . . . 0.0 110.922 175.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 5.9 mp -58.75 -46.7 86.84 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 122.847 0.459 . . . . 0.0 109.882 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -57.39 -48.06 80.07 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.132 0.973 . . . . 0.0 112.906 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -56.83 -28.05 60.98 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.183 1.393 . . . . 0.0 113.911 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -107.45 -0.55 22.17 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.708 2.003 . . . . 0.0 112.979 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 60.3 t30 45.49 50.59 10.21 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.943 2.497 . . . . 0.0 111.319 -174.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -73.33 130.6 84.08 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.601 0.761 . . . . 0.0 112.876 -174.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -70.43 115.35 4.15 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.51 2.14 . . . . 0.0 107.568 170.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 53.8 t -23.07 123.35 0.15 Allowed Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 129.211 3.005 . . . . 0.0 115.682 -176.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -65.34 -3.62 7.87 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.127 2.551 . . . . 0.0 114.531 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 47.0 t -109.08 -65.5 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.346 1.458 . . . . 0.0 111.31 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 24.5 p -104.63 0.74 28.82 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 62.84 10.29 4.2 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 127.795 2.438 . . . . 0.0 115.898 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -68.68 149.28 97.99 Favored Pre-proline 0 CA--C 1.552 1.058 0 C-N-CA 123.87 0.868 . . . . 0.0 111.732 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.39 112.96 3.47 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.662 2.908 . . . . 0.0 112.009 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.92 109.97 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 126.547 1.939 . . . . 0.0 110.463 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -103.65 -55.79 2.33 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -172.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.31 161.87 37.18 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -177.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 4.6 mt -135.02 136.53 51.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 126.998 2.119 . . . . 0.0 108.847 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 16.9 m -133.21 150.01 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.935 0.894 . . . . 0.0 112.555 176.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 3.8 tt -82.53 99.75 9.69 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 5.1 t -90.87 162.66 14.7 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.157 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -131.68 148.44 52.59 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.451 1.5 . . . . 0.0 112.038 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -78.06 160.6 73.28 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 125.444 1.498 . . . . 0.0 110.969 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo . . . . . 0 C--N 1.351 0.683 0 C-N-CA 123.322 2.682 . . . . 0.0 111.784 -177.796 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 CA--C 1.537 0.659 0 N-CA-C 113.235 0.437 . . . . 0.0 113.235 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 1.9 p -67.85 175.54 2.98 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 34.8 m -135.94 -3.32 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -176.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 7.7 mt -114.77 -64.43 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 120.319 1.418 . . . . 0.0 112.588 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 21.5 p -68.85 -59.19 3.25 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -147.35 -17.8 0.39 Allowed 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.531 2.049 . . . . 0.0 116.531 -172.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 90.65 30.65 11.35 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.035 1.303 . . . . 0.0 110.778 -174.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 35.0 mtt-85 -62.65 149.38 89.09 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 124.929 1.292 . . . . 0.0 111.595 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.96 -10.49 29.01 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.448 2.765 . . . . 0.0 114.297 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -58.99 153.56 17.32 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 129.593 3.157 . . . . 0.0 113.002 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -128.2 150.16 50.14 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.319 2.248 . . . . 0.0 110.625 176.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -167.06 75.11 0.14 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 127.047 2.26 . . . . 0.0 110.291 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 33.1 t -59.89 122.4 14.17 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.643 0.777 . . . . 0.0 111.854 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 450' ' ' ILE . . . . . 0.423 HD12 ' H ' ' B' ' 450' ' ' ILE . 1.2 mp -95.66 134.09 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.966 1.306 . . . . 0.0 109.794 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 95.5 t -127.97 130.38 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.279 1.032 . . . . 0.0 111.353 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -115.06 94.92 4.95 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 128.597 2.759 . . . . 0.0 110.12 174.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.83 -94.92 0.31 Allowed Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.856 1.693 . . . . 0.0 114.372 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -111.97 -1.19 15.51 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.02 1.728 . . . . 0.0 113.648 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 70.1 p -132.28 170.01 15.66 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.655 1.582 . . . . 0.0 111.351 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -157.69 174.64 35.08 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 121.114 -0.991 . . . . 0.0 113.655 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -120.22 110.8 17.03 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.259 1.424 . . . . 0.0 111.411 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 9.8 tp -81.22 153.31 27.24 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.339 2.655 . . . . 0.0 113.033 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 23.7 mtt 79.58 57.99 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 127.786 2.435 . . . . 0.0 114.663 172.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -148.8 150.27 32.77 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.992 2.117 . . . . 0.0 108.319 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 31.7 p -86.47 175.0 8.6 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 122.649 1.214 . . . . 0.0 112.798 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.98 -33.78 76.87 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.2 174.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 37.4 m -63.86 -54.25 37.89 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 117.284 -1.341 . . . . 0.0 109.88 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 21.5 m -47.58 -59.71 3.06 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.126 1.33 . . . . 0.0 111.234 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.95 -48.02 76.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.679 1.192 . . . . 0.0 113.767 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -66.05 -41.72 90.48 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.209 -0.932 . . . . 0.0 111.722 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -63.39 -54.86 30.11 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.785 1.634 . . . . 0.0 112.101 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.5 pp -59.07 -37.89 78.15 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.238 0.472 . . . . 0.0 110.926 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -65.68 -42.99 90.62 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.74 0.816 . . . . 0.0 112.174 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -59.23 -37.86 78.54 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.031 1.332 . . . . 0.0 111.043 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 48.1 mtm105 -77.04 9.67 2.84 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 127.031 2.133 . . . . 0.0 113.646 174.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . 0.313 0.0 OUTLIER 72.56 3.4 4.67 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 130.742 3.617 . . . . 0.0 116.823 178.415 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -72.08 131.12 85.65 Favored Pre-proline 0 CA--C 1.545 0.752 0 O-C-N 121.091 -1.006 . . . . 0.0 109.947 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.51 -72.47 0.02 OUTLIER 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.152 2.568 . . . . 0.0 109.651 176.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 9.3 t -120.92 136.26 25.43 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 127.897 2.479 . . . . 0.0 109.674 175.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.87 -8.18 19.97 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.343 2.696 . . . . 0.0 114.902 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 41.6 t -111.36 -74.84 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 119.877 1.217 . . . . 0.0 112.613 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 16.7 p -92.5 -5.4 51.9 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.57 1.548 . . . . 0.0 113.694 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 61.94 16.22 7.89 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.743 2.417 . . . . 0.0 114.761 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -64.36 139.4 97.7 Favored Pre-proline 0 CA--C 1.549 0.938 0 O-C-N 121.477 -0.764 . . . . 0.0 109.796 175.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.54 113.64 2.79 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.162 2.574 . . . . 0.0 112.612 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 16.5 pt -70.93 157.55 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.54 1.136 . . . . 0.0 113.528 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -115.02 -40.7 3.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.324 1.849 . . . . 0.0 112.978 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.63 167.22 31.11 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -176.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 6.9 mt -135.99 129.03 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 129.169 2.987 . . . . 0.0 106.369 174.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.68 150.15 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.9 107.22 2.57 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 174.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 23.3 m -103.18 88.23 3.09 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.212 1.805 . . . . 0.0 110.086 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -60.78 153.64 23.85 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.772 2.029 . . . . 0.0 115.1 -176.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -61.88 156.12 58.51 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 126.276 1.831 . . . . 0.0 112.531 176.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 CA--C 1.538 0.709 0 C-N-CA 123.308 2.672 . . . . 0.0 112.591 179.869 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo . . . . . 0 CA--C 1.541 0.837 0 N-CA-C 117.253 1.982 . . . . 0.0 117.253 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 30.5 t -51.27 148.12 5.06 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 120.166 1.348 . . . . 0.0 112.663 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.8 -14.9 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 9.4 pt -136.36 -26.55 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.5 m -76.28 -60.12 2.47 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 120.719 1.599 . . . . 0.0 112.064 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -154.17 -13.76 0.13 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -176.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.51 11.55 81.75 Favored Glycine 0 CA--C 1.541 1.687 0 CA-C-N 120.011 1.278 . . . . 0.0 112.198 -173.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 9.4 ptm85 -55.97 155.05 12.69 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 129.592 3.157 . . . . 0.0 114.024 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.7 4.9 4.18 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 124.551 3.501 . . . . 0.0 115.762 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -58.52 157.98 8.26 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.182 1.793 . . . . 0.0 112.586 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -119.66 150.04 40.99 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 128.423 2.689 . . . . 0.0 111.898 -175.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 176.84 82.66 0.06 OUTLIER Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.575 1.56 . . . . 0.0 113.015 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 48.0 t -71.33 138.82 49.57 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 118.152 0.976 . . . . 0.0 109.864 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.6 mp -115.01 144.11 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.651 1.58 . . . . 0.0 110.44 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 97.1 t -129.91 131.34 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.242 1.017 . . . . 0.0 109.527 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -125.05 94.98 4.33 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.91 2.484 . . . . 0.0 111.281 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.49 -89.64 0.36 Allowed Glycine 0 CA--C 1.534 1.281 0 C-N-CA 125.689 1.614 . . . . 0.0 114.386 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -121.56 -0.85 9.65 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 126.348 1.859 . . . . 0.0 113.868 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 16.8 p -130.66 170.12 14.74 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 128.223 2.609 . . . . 0.0 109.787 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -157.79 177.06 34.73 Favored Glycine 0 CA--C 1.529 0.932 0 O-C-N 120.688 -1.258 . . . . 0.0 113.947 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 4.6 m-70 -120.34 135.91 54.87 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.715 1.606 . . . . 0.0 113.842 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 4.0 pp -119.9 153.35 36.0 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.294 2.638 . . . . 0.0 109.451 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 25.0 ttt 78.26 66.3 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.762 2.025 . . . . 0.0 111.094 -177.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -160.03 154.5 23.84 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 128.898 2.879 . . . . 0.0 108.314 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 22.7 p -86.91 172.21 10.23 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.113 0.959 . . . . 0.0 111.21 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -64.94 -35.39 81.01 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.435 -0.79 . . . . 0.0 111.223 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 25.2 m -64.44 -49.2 72.39 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 117.212 -1.375 . . . . 0.0 111.152 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 29.4 m -46.93 -55.58 7.83 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 120.469 1.486 . . . . 0.0 109.924 174.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -59.99 -45.39 92.89 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.923 1.689 . . . . 0.0 113.52 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -60.1 -44.5 94.78 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.228 1.411 . . . . 0.0 111.523 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -62.35 -54.09 45.51 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.341 1.057 . . . . 0.0 111.473 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.4 pp -60.87 -32.05 71.49 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 118.579 0.627 . . . . 0.0 111.958 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -68.24 -48.56 64.79 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.269 1.428 . . . . 0.0 111.734 174.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -55.8 -43.67 77.07 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.632 1.573 . . . . 0.0 111.02 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -75.31 -6.94 52.45 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 127.067 2.147 . . . . 0.0 113.642 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 64.0 t30 50.79 41.13 26.04 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 128.074 2.55 . . . . 0.0 112.173 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -78.15 126.58 83.31 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 125.519 1.528 . . . . 0.0 113.367 -176.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -74.56 129.03 12.35 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.813 2.342 . . . . 0.0 107.526 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 48.2 t -27.01 123.79 0.23 Allowed Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 128.195 2.598 . . . . 0.0 115.493 -176.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.76 -1.66 6.31 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 122.959 2.439 . . . . 0.0 114.33 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 49.1 t -123.64 -59.55 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.686 1.594 . . . . 0.0 111.233 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 69.7 m -78.12 -19.78 53.4 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.682 1.993 . . . . 0.0 112.84 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 61.62 11.79 4.12 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 127.339 2.255 . . . . 0.0 114.198 -177.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -87.17 148.19 44.36 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 123.975 0.91 . . . . 0.0 112.95 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.25 124.55 7.9 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.863 3.042 . . . . 0.0 111.97 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.98 143.04 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.643 1.177 . . . . 0.0 112.859 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -115.17 -40.25 3.49 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.51 1.524 . . . . 0.0 113.656 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.5 166.58 31.82 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -176.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 8.0 mt -133.07 139.22 49.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 127.534 2.333 . . . . 0.0 108.732 176.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.06 150.11 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.944 1.297 . . . . 0.0 113.329 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 55.8 mt -73.29 99.87 3.0 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.294 1.037 . . . . 0.0 109.182 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 6.3 t -95.44 151.53 19.21 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -141.91 158.72 43.44 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.325 1.45 . . . . 0.0 112.558 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -80.54 158.44 71.23 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 123.842 0.857 . . . . 0.0 112.947 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo . . . . . 0 C--N 1.355 0.886 0 C-N-CA 124.565 3.51 . . . . 0.0 113.853 179.386 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo . . . . . 0 CA--C 1.54 0.776 0 N-CA-C 115.923 1.47 . . . . 0.0 115.923 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 44.3 t -46.91 138.67 6.18 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 121.178 1.808 . . . . 0.0 112.45 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.61 -28.74 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 125.173 1.389 . . . . 0.0 112.258 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 8.3 pt -138.01 -24.86 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 -173.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.5 m -73.21 -57.67 3.86 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.731 1.605 . . . . 0.0 112.083 -176.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -154.94 -14.85 0.12 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 81.16 11.06 84.03 Favored Glycine 0 CA--C 1.542 1.766 0 CA-C-N 119.993 1.27 . . . . 0.0 112.513 -174.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -64.7 155.18 83.06 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 129.785 3.234 . . . . 0.0 113.122 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -69.12 4.48 1.89 Allowed 'Trans proline' 0 CA--C 1.548 1.224 0 C-N-CA 124.569 3.512 . . . . 0.0 117.055 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -56.74 139.7 49.86 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 120.166 1.348 . . . . 0.0 110.59 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -128.17 113.86 16.26 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.192 1.797 . . . . 0.0 114.646 -170.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -144.62 82.79 0.2 Allowed Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.55 1.548 . . . . 0.0 112.527 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 49.3 t -65.0 142.17 58.53 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 117.872 0.836 . . . . 0.0 110.565 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 2.2 mp -107.17 141.64 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 125.816 1.646 . . . . 0.0 110.121 -177.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 96.9 t -130.09 132.79 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.277 1.031 . . . . 0.0 110.398 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -125.01 94.98 4.34 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.313 2.245 . . . . 0.0 110.841 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.74 -92.44 0.24 Allowed Glycine 0 CA--C 1.534 1.275 0 C-N-CA 126.259 1.885 . . . . 0.0 114.648 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -111.88 -7.89 14.14 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.334 1.854 . . . . 0.0 113.345 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 19.7 p -124.24 170.01 11.19 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.618 1.967 . . . . 0.0 111.125 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -160.8 174.9 37.51 Favored Glycine 0 CA--C 1.532 1.099 0 O-C-N 121.088 -1.007 . . . . 0.0 113.999 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 7.6 m-70 -120.28 113.46 20.43 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.319 1.848 . . . . 0.0 113.333 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -97.37 153.18 18.24 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.923 1.289 . . . . 0.0 112.023 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 40.1 tpp 75.58 68.51 0.07 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.86 2.064 . . . . 0.0 111.244 177.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -157.25 150.22 23.54 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 129.293 3.037 . . . . 0.0 108.616 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 17.1 p -86.46 170.46 11.93 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.616 1.198 . . . . 0.0 111.781 176.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.49 -30.28 70.58 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.095 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 25.0 m -69.96 -50.5 41.22 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 117.303 -1.332 . . . . 0.0 109.9 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 35.0 m -47.65 -56.84 6.38 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 120.371 1.441 . . . . 0.0 110.105 173.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.15 -46.47 82.71 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.938 1.695 . . . . 0.0 113.403 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -65.86 -37.43 86.15 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.561 -1.337 . . . . 0.0 111.822 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 21.2 tptp -63.49 -52.36 61.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.122 0.969 . . . . 0.0 111.105 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.59 -30.32 70.6 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.073 0.397 . . . . 0.0 111.704 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -68.58 -46.06 70.38 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.033 1.333 . . . . 0.0 111.829 173.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -57.64 -42.44 83.41 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.864 1.265 . . . . 0.0 110.982 174.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -72.78 -11.05 60.46 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.459 1.904 . . . . 0.0 113.528 175.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 63.8 t30 52.41 40.45 29.49 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.814 2.446 . . . . 0.0 111.754 -175.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -74.2 116.13 49.69 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 126.357 1.863 . . . . 0.0 113.781 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.1 132.49 22.89 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.41 2.073 . . . . 0.0 107.671 170.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 47.1 t -32.58 125.11 0.39 Allowed Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 127.656 2.382 . . . . 0.0 115.214 -175.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.94 -3.18 10.94 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.146 2.564 . . . . 0.0 114.381 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 42.6 t -124.74 -60.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.076 1.35 . . . . 0.0 111.726 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 58.6 m -75.01 -18.78 60.29 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.635 1.974 . . . . 0.0 112.432 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 64.6 5.12 2.56 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.554 2.342 . . . . 0.0 114.081 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -83.8 148.99 55.78 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 124.204 1.002 . . . . 0.0 113.144 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.11 124.04 8.77 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.037 2.491 . . . . 0.0 110.405 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.2 pp -60.95 128.61 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.526 1.13 . . . . 0.0 110.932 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -115.08 -26.82 7.55 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -175.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 1.7 ttp -149.86 150.35 31.8 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.241 1.016 . . . . 0.0 112.624 -175.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 10.4 mt -137.24 130.05 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 127.138 2.175 . . . . 0.0 107.941 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 27.0 m -140.07 150.23 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 124.378 1.071 . . . . 0.0 112.913 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 66.6 tp -63.7 99.89 0.25 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.065 1.746 . . . . 0.0 108.683 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 41.4 m -110.8 108.48 18.33 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -170.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -85.72 178.41 7.35 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.239 1.816 . . . . 0.0 112.997 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -129.84 168.64 15.78 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 125.953 1.701 . . . . 0.0 111.552 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo . . . . . 0 C--N 1.353 0.798 0 C-N-CA 124.249 3.299 . . . . 0.0 113.887 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 CA--C 1.549 1.233 0 N-CA-C 113.036 0.36 . . . . 0.0 113.036 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 6.7 p -60.29 173.04 0.72 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.646 1.579 . . . . 0.0 114.579 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 28.6 m -130.75 -3.61 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -175.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 4.5 mt -117.88 -59.99 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 120.529 1.513 . . . . 0.0 112.796 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 7.0 p -69.39 -68.75 0.38 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -174.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -144.56 -13.95 0.57 Allowed 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 -171.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 88.92 40.86 6.09 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.426 1.012 . . . . 0.0 110.859 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -97.83 155.31 37.26 Favored Pre-proline 0 N--CA 1.481 1.107 0 C-N-CA 125.854 1.662 . . . . 0.0 112.406 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -44.08 121.44 2.98 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.949 3.1 . . . . 0.0 114.461 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.14 31.86 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 131.127 3.771 . . . . 0.0 118.944 -176.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -76.58 89.85 3.32 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 119.952 -1.718 . . . . 0.0 109.541 -178.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 164.97 57.21 0.02 OUTLIER Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.049 -0.862 . . . . 0.0 114.085 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 52.5 t -57.24 138.58 54.54 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.899 1.35 . . . . 0.0 110.91 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.4 mp -115.13 136.18 52.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 C-N-CA 126.687 1.995 . . . . 0.0 109.216 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 90.1 t -127.28 132.42 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.634 0.774 . . . . 0.0 110.924 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -124.35 106.14 10.0 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.011 2.525 . . . . 0.0 111.471 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 68.46 -89.92 0.23 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.703 1.621 . . . . 0.0 114.177 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -124.69 -0.97 7.99 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.152 1.781 . . . . 0.0 113.997 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 54.9 p -133.25 170.02 16.04 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.898 1.679 . . . . 0.0 110.296 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -152.01 175.12 30.87 Favored Glycine 0 CA--C 1.526 0.771 0 O-C-N 120.88 -1.138 . . . . 0.0 113.512 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -120.28 145.64 46.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.045 1.338 . . . . 0.0 114.181 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 94.8 mt -123.35 153.48 40.25 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 129.504 3.122 . . . . 0.0 110.686 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 50.5 mtt 90.7 31.39 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 128.757 2.823 . . . . 0.0 113.37 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -139.42 134.9 33.01 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.739 2.016 . . . . 0.0 107.583 173.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 22.1 p -80.98 175.11 10.97 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 122.667 1.222 . . . . 0.0 112.842 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.9 -36.93 70.73 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.731 0.812 . . . . 0.0 112.254 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 87.7 m -66.38 -52.56 45.57 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.197 0.999 . . . . 0.0 110.748 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 98.5 m -52.41 -50.54 62.32 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.31 1.044 . . . . 0.0 110.747 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.9 -44.54 91.23 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.177 1.391 . . . . 0.0 112.769 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -61.92 -43.26 99.21 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.785 1.234 . . . . 0.0 111.099 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -61.58 -57.11 13.39 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.117 0.967 . . . . 0.0 111.255 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.0 pp -59.11 -33.44 70.85 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 118.373 0.533 . . . . 0.0 112.227 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -68.05 -50.71 53.56 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.393 1.477 . . . . 0.0 112.217 175.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -56.81 -40.39 75.9 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.698 1.599 . . . . 0.0 111.502 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -79.93 -0.97 37.31 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.409 2.284 . . . . 0.0 113.403 176.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 46.24 39.22 5.9 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 128.866 2.866 . . . . 0.0 113.752 -177.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -69.98 127.93 92.06 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.478 1.511 . . . . 0.0 114.01 -176.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.09 128.19 11.22 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 122.834 2.356 . . . . 0.0 107.864 169.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 32.3 t -29.72 128.99 0.24 Allowed Pre-proline 0 CA--C 1.558 1.26 0 C-N-CA 128.07 2.548 . . . . 0.0 115.106 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -66.74 -2.56 7.81 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.181 2.588 . . . . 0.0 114.617 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 53.5 t -127.07 -59.48 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.393 1.477 . . . . 0.0 111.476 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 65.0 m -77.14 -24.59 51.61 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.595 1.958 . . . . 0.0 112.671 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 62.44 9.91 3.66 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 127.128 2.171 . . . . 0.0 113.81 -175.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -81.81 151.33 67.48 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.134 0.973 . . . . 0.0 113.068 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -77.46 121.09 5.47 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 123.978 3.119 . . . . 0.0 111.919 177.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.55 153.35 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.988 1.315 . . . . 0.0 112.231 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 18.7 tp60 -115.01 -48.6 2.82 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.1 170.27 20.36 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -176.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 7.9 mt -127.21 138.57 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.087 2.155 . . . . 0.0 108.396 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 16.8 m -133.87 150.09 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.52 1.128 . . . . 0.0 112.215 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 74.6 mt -68.56 99.85 1.04 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.849 0.86 . . . . 0.0 109.57 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 12.1 m -99.4 116.52 31.74 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.059 1.344 . . . . 0.0 114.271 -173.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -102.65 170.45 8.01 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.437 1.895 . . . . 0.0 111.921 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -136.25 157.91 74.63 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.793 1.637 . . . . 0.0 112.132 -176.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 CA--C 1.538 0.69 0 C-N-CA 123.347 2.698 . . . . 0.0 112.478 179.789 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo . . . . . 0 CA--C 1.543 0.959 0 N-CA-C 114.857 1.061 . . . . 0.0 114.857 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.69 -179.74 0.4 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.131 1.372 . . . . 0.0 114.359 176.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 19.3 m -131.06 -4.56 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 3.5 mt -121.63 -62.65 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 120.947 1.703 . . . . 0.0 113.677 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 31.4 p -70.61 -67.83 0.47 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 -174.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -140.98 -10.05 1.0 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 116.825 2.158 . . . . 0.0 116.825 -172.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 85.16 33.93 16.15 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 119.64 1.109 . . . . 0.0 110.759 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 44.0 mtt-85 -65.61 136.39 96.02 Favored Pre-proline 0 N--CA 1.477 0.882 0 CA-C-O 117.272 -1.347 . . . . 0.0 110.763 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -73.87 67.12 4.91 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 124.538 3.492 . . . . 0.0 111.235 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -141.75 153.4 44.57 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 128.508 2.723 . . . . 0.0 111.423 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -128.09 120.57 27.69 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.9 1.68 . . . . 0.0 111.8 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -136.04 70.8 0.49 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.652 1.596 . . . . 0.0 111.176 178.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 51.0 t -54.65 123.09 12.13 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.196 1.398 . . . . 0.0 110.49 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.32 138.16 20.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 124.937 1.295 . . . . 0.0 109.801 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 96.0 t -129.97 130.48 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.78 0.832 . . . . 0.0 110.254 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.13 105.03 8.85 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 128.603 2.761 . . . . 0.0 110.76 176.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 65.84 -93.75 0.19 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.868 1.699 . . . . 0.0 114.147 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -120.69 -0.14 10.27 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.457 1.903 . . . . 0.0 113.529 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 36.1 p -124.42 165.23 18.11 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.71 2.004 . . . . 0.0 110.638 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -158.81 169.57 35.17 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 120.985 -1.072 . . . . 0.0 113.908 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 19.1 m-70 -120.33 138.67 53.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.619 1.968 . . . . 0.0 113.227 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.7 pp -120.74 153.32 37.15 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.813 2.045 . . . . 0.0 112.352 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 30.1 ttm 108.66 -7.35 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 131.08 3.752 . . . . 0.0 114.441 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -99.96 154.63 18.23 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.903 -1.123 . . . . 0.0 111.557 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 30.4 p -84.6 175.1 9.47 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 123.344 1.545 . . . . 0.0 113.594 178.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.41 -28.35 69.72 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.791 174.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 83.7 m -72.2 -51.02 23.06 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.567 1.076 . . . . 0.0 110.253 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 67.9 m -49.66 -54.8 16.5 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.662 1.185 . . . . 0.0 110.386 173.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.37 -49.46 76.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.209 1.403 . . . . 0.0 112.931 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -60.0 -40.07 87.95 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.952 1.301 . . . . 0.0 112.168 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -61.72 -52.98 62.06 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.38 1.072 . . . . 0.0 110.978 176.194 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 44.9 mt -52.22 -49.93 62.98 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.184 0.993 . . . . 0.0 110.107 175.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -54.14 49.54 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.988 1.315 . . . . 0.0 112.681 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -54.86 -43.54 73.18 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.903 1.681 . . . . 0.0 112.281 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -78.88 -6.93 57.35 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.835 2.054 . . . . 0.0 113.366 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 62.4 t30 49.4 42.55 22.5 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 128.521 2.729 . . . . 0.0 112.082 -175.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -75.47 117.04 60.32 Favored Pre-proline 0 N--CA 1.47 0.539 0 C-N-CA 125.552 1.541 . . . . 0.0 113.116 -176.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.9 130.93 21.34 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.106 1.871 . . . . 0.0 108.834 171.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 41.5 t -33.0 125.53 0.41 Allowed Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 128.298 2.639 . . . . 0.0 114.168 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -66.88 -1.45 6.05 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 123.112 2.541 . . . . 0.0 114.307 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.67 -59.14 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.698 1.599 . . . . 0.0 111.346 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 81.8 m -76.83 -14.39 59.91 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.364 1.866 . . . . 0.0 113.027 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . 0.304 14.7 ptm180 55.23 13.43 0.85 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 128.496 2.718 . . . . 0.0 115.108 -175.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -89.53 144.33 31.89 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 123.938 0.895 . . . . 0.0 112.294 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -68.71 122.32 9.26 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.158 2.572 . . . . 0.0 109.442 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 1.8 pt -64.89 137.76 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 O-C-N 121.661 -0.649 . . . . 0.0 112.132 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -115.2 -33.74 5.24 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 117.234 2.309 . . . . 0.0 117.234 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -143.27 152.18 41.4 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.82 0.848 . . . . 0.0 113.236 -171.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 5.1 mt -141.03 131.04 26.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 127.649 2.38 . . . . 0.0 109.038 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 27.7 m -140.12 150.13 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.985 1.314 . . . . 0.0 111.928 176.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 2.2 tt -66.1 105.9 1.49 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.569 1.148 . . . . 0.0 108.273 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.2 96.58 7.3 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -171.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -74.02 171.47 13.43 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.086 1.754 . . . . 0.0 113.295 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -132.78 168.19 19.11 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 127.554 2.342 . . . . 0.0 110.474 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo . . . . . 0 C--N 1.352 0.758 0 C-N-CA 124.425 3.417 . . . . 0.0 113.983 -178.84 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . 0.278 87.9 Cg_exo . . . . . 0 CA--C 1.553 1.462 0 N-CA-C 117.477 2.068 . . . . 0.0 117.477 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 28.4 t -67.06 150.67 48.88 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 121.899 2.136 . . . . 0.0 109.342 174.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 4.1 p -134.52 -1.68 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 121.221 -0.925 . . . . 0.0 113.301 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 7.2 mt -135.55 -45.66 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.057 0.943 . . . . 0.0 112.974 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.3 m -69.45 -59.49 2.95 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -173.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -152.02 -16.37 0.18 Allowed 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -175.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 80.34 17.01 74.88 Favored Glycine 0 CA--C 1.539 1.591 0 O-C-N 120.973 -1.079 . . . . 0.0 111.865 -174.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 -72.21 155.06 91.96 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 127.549 2.34 . . . . 0.0 112.607 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.0 71.05 5.14 Favored 'Trans proline' 0 CA--C 1.55 1.29 0 C-N-CA 123.929 3.086 . . . . 0.0 113.363 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -129.32 143.17 50.74 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 127.959 2.504 . . . . 0.0 108.842 176.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -128.02 150.27 50.0 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.115 1.366 . . . . 0.0 112.593 -176.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -151.12 80.39 0.19 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 128.076 2.751 . . . . 0.0 109.201 178.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 42.2 t -63.55 119.09 9.15 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.505 1.122 . . . . 0.0 110.794 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.419 ' H ' HD12 ' A' ' 450' ' ' ILE . 0.3 OUTLIER -102.07 141.71 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.768 1.227 . . . . 0.0 111.745 -177.48 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 90.0 t -130.08 133.53 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.778 1.231 . . . . 0.0 111.931 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -124.99 95.03 4.35 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.53 2.732 . . . . 0.0 110.685 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.4 -97.74 0.41 Allowed Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.73 1.633 . . . . 0.0 114.561 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -107.86 -2.71 19.63 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 126.224 1.81 . . . . 0.0 113.168 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 51.0 p -132.25 170.01 15.64 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.124 1.77 . . . . 0.0 110.808 -178.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -161.26 175.99 37.84 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.201 1.381 . . . . 0.0 112.233 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -120.29 142.58 48.96 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.754 1.222 . . . . 0.0 113.927 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 4.6 pp -111.32 153.25 26.23 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.522 1.929 . . . . 0.0 112.0 175.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 459' ' ' MET . . . . . . . . . . . . 0.253 25.2 mmt 70.42 68.94 0.2 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 128.08 2.552 . . . . 0.0 114.996 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -154.23 138.52 16.63 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 128.659 2.784 . . . . 0.0 106.757 171.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 6.3 p -77.57 172.33 13.53 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 120.224 1.375 . . . . 0.0 112.127 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.36 -44.95 95.28 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.648 -0.657 . . . . 0.0 111.117 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 29.2 m -62.67 -44.37 96.42 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 116.664 -1.636 . . . . 0.0 111.375 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 35.5 m -48.1 -69.97 0.11 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 120.704 1.593 . . . . 0.0 110.541 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -50.33 -49.12 54.77 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.526 1.53 . . . . 0.0 112.539 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -57.13 -42.5 81.03 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.602 0.761 . . . . 0.0 112.49 177.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -61.51 -45.49 93.97 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.815 1.246 . . . . 0.0 111.746 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.1 -46.92 84.71 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 174.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 43.5 tptt -57.35 -46.21 83.55 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.004 0.922 . . . . 0.0 112.204 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -61.07 -34.01 74.23 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.001 1.32 . . . . 0.0 112.326 174.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -81.82 0.72 38.11 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.663 1.985 . . . . 0.0 113.407 175.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 84.11 -2.28 1.05 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 131.242 3.817 . . . . 0.0 115.516 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 5.8 tppp? -79.55 130.26 68.68 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 119.815 1.189 . . . . 0.0 109.366 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.34 -92.74 0.01 OUTLIER 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 123.375 2.717 . . . . 0.0 112.22 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 43.7 t -65.8 130.36 94.47 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 124.477 1.111 . . . . 0.0 112.532 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.55 -1.67 11.38 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 123.255 2.636 . . . . 0.0 114.062 177.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 32.8 t -122.01 -72.1 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 119.972 1.26 . . . . 0.0 113.359 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 29.8 p -92.87 -9.27 40.85 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -175.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 77.55 12.85 1.95 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 128.518 2.727 . . . . 0.0 115.138 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -64.9 156.93 78.15 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 124.606 1.163 . . . . 0.0 112.049 175.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.99 100.34 1.2 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.035 3.157 . . . . 0.0 113.284 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 pp -79.09 155.76 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.651 1.181 . . . . 0.0 112.355 179.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -115.02 -26.92 7.53 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.845 1.258 . . . . 0.0 113.756 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.95 164.81 33.08 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.473 1.109 . . . . 0.0 113.914 -177.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 14.2 mt -132.6 132.43 59.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 128.444 2.698 . . . . 0.0 106.359 173.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 24.0 m -134.74 150.2 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 64.3 tp -73.05 99.91 2.87 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.19 1.796 . . . . 0.0 108.624 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 2.5 t -93.21 163.94 13.43 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -135.59 177.76 7.57 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.671 2.388 . . . . 0.0 110.942 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -124.34 157.97 62.86 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 125.306 1.443 . . . . 0.0 111.387 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 C--N 1.351 0.675 0 C-N-CA 123.111 2.541 . . . . 0.0 111.455 -179.646 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo . . . . . 0 CA--C 1.539 0.759 0 CA-C-O 117.175 -1.261 . . . . 0.0 113.668 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 27.5 t -55.25 143.33 28.35 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 120.876 1.671 . . . . 0.0 110.18 173.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 32.6 m -121.23 -14.69 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 9.9 pt -137.09 -26.17 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 -178.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.2 m -77.67 -59.64 2.7 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 120.549 1.522 . . . . 0.0 112.512 -176.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -151.88 -15.53 0.19 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -176.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.89 9.47 84.39 Favored Glycine 0 CA--C 1.541 1.714 0 CA-C-N 119.946 1.248 . . . . 0.0 112.544 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -56.56 155.07 14.93 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 129.427 3.091 . . . . 0.0 113.616 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -72.43 2.93 4.58 Favored 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 124.91 3.74 . . . . 0.0 115.817 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -59.05 142.95 49.97 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.887 2.075 . . . . 0.0 111.62 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -128.1 122.45 32.07 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.371 1.469 . . . . 0.0 112.73 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -138.97 75.21 0.38 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.46 1.981 . . . . 0.0 110.516 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 31.4 t -62.85 138.29 58.49 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.017 0.909 . . . . 0.0 110.282 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 1.4 mp -109.09 142.03 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 125.317 1.447 . . . . 0.0 109.928 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 96.0 t -124.12 131.92 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.293 1.037 . . . . 0.0 110.288 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -123.08 100.06 6.68 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 129.02 2.928 . . . . 0.0 110.725 177.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.97 -93.5 0.27 Allowed Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.914 1.721 . . . . 0.0 113.783 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -120.63 4.71 10.6 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.463 1.905 . . . . 0.0 114.061 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 60.5 p -132.58 170.12 15.63 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.701 2.0 . . . . 0.0 110.417 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -151.24 174.19 30.51 Favored Glycine 0 CA--C 1.528 0.845 0 O-C-N 120.925 -1.109 . . . . 0.0 113.799 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.28 108.14 13.81 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.982 1.713 . . . . 0.0 111.741 174.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 48.3 tp -92.01 153.07 19.67 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.075 2.15 . . . . 0.0 110.153 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 21.9 ttt 80.31 67.58 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.588 2.355 . . . . 0.0 111.778 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -159.87 147.67 16.88 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 129.705 3.202 . . . . 0.0 107.353 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 17.9 p -84.33 173.64 10.78 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 122.447 1.118 . . . . 0.0 111.457 175.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -34.19 77.32 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.134 177.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 22.2 m -70.4 -45.87 65.12 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 117.086 -1.435 . . . . 0.0 110.687 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 41.1 m -50.79 -53.76 29.23 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 120.946 1.703 . . . . 0.0 110.143 173.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -59.77 -40.29 87.75 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.412 1.485 . . . . 0.0 113.065 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -68.09 -40.98 82.54 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.85 -1.156 . . . . 0.0 111.182 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -60.23 -54.15 49.19 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.352 1.461 . . . . 0.0 112.135 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.1 pp -58.18 -36.63 73.35 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 118.923 0.783 . . . . 0.0 111.309 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -65.24 -49.96 67.63 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.768 1.627 . . . . 0.0 111.35 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -58.88 -39.57 81.8 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.956 1.302 . . . . 0.0 111.967 177.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -73.5 0.15 13.31 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 126.468 1.907 . . . . 0.0 113.506 175.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 55.5 t30 61.46 24.01 14.18 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 128.298 2.639 . . . . 0.0 113.949 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -79.42 133.64 59.64 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.455 1.102 . . . . 0.0 108.904 177.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -65.41 -68.25 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.586 2.191 . . . . 0.0 108.927 176.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 34.1 t -143.01 125.13 8.68 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 127.511 2.325 . . . . 0.0 109.315 174.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.54 -2.26 11.89 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.105 2.537 . . . . 0.0 113.382 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 25.4 t -111.18 -64.41 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.978 1.311 . . . . 0.0 112.234 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 27.9 p -109.89 2.5 19.87 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.244 1.418 . . . . 0.0 114.786 -177.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 63.48 7.98 3.3 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 128.061 2.544 . . . . 0.0 116.518 175.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -67.28 135.73 93.5 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-N 119.097 0.862 . . . . 0.0 110.649 176.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.73 115.56 4.14 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.409 2.739 . . . . 0.0 113.423 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.9 pp -70.61 151.38 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 125.286 1.434 . . . . 0.0 114.047 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -115.0 -44.2 3.05 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.842 2.057 . . . . 0.0 113.448 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.41 166.79 31.55 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -175.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 10.1 mt -133.76 136.37 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 128.646 2.778 . . . . 0.0 107.789 176.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 19.5 m -140.02 150.16 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.64 102.56 0.93 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.178 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 7.1 m -94.73 95.65 8.87 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -173.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -75.0 156.68 36.0 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.977 1.311 . . . . 0.0 112.685 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -86.06 164.89 37.03 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 125.708 1.603 . . . . 0.0 111.819 177.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo . . . . . 0 C--N 1.353 0.801 0 C-N-CA 124.2 3.267 . . . . 0.0 114.598 -179.61 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo . . . . . 0 CA--C 1.542 0.887 0 N-CA-C 117.379 2.03 . . . . 0.0 117.379 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 16.2 t -55.99 161.85 2.14 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 128.951 2.9 . . . . 0.0 111.319 172.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 18.8 m -129.65 -14.98 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 10.5 pt -137.29 -26.74 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.7 m -76.17 -57.8 3.66 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 120.646 1.566 . . . . 0.0 111.936 -178.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -149.0 -18.98 0.3 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 80.69 11.14 84.33 Favored Glycine 0 CA--C 1.54 1.603 0 O-C-N 120.959 -1.088 . . . . 0.0 113.366 -176.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -69.53 155.1 94.15 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 127.976 2.51 . . . . 0.0 113.548 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -52.54 -9.03 0.48 Allowed 'Trans proline' 0 CA--C 1.545 1.043 1 C-N-CA 125.965 4.443 . . . . 0.0 119.309 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -58.41 141.43 51.52 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 120.227 1.376 . . . . 0.0 111.569 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.18 150.14 50.14 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.021 2.128 . . . . 0.0 111.777 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -159.94 85.19 0.12 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 126.262 1.887 . . . . 0.0 110.046 176.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 42.3 t -58.54 139.11 56.26 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 117.839 0.819 . . . . 0.0 111.467 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.8 mp -115.13 140.87 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.074 1.749 . . . . 0.0 109.596 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 60.0 t -127.38 136.04 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.767 0.827 . . . . 0.0 109.47 175.309 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -125.11 94.85 4.29 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.752 2.421 . . . . 0.0 109.818 175.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 58.78 -99.61 0.13 Allowed Glycine 0 CA--C 1.534 1.273 0 C-N-CA 126.175 1.845 . . . . 0.0 114.71 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -86.55 -19.86 28.83 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.881 1.673 . . . . 0.0 114.636 -176.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 67.6 p -133.07 170.06 15.93 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.856 1.262 . . . . 0.0 112.729 -176.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -142.36 169.19 25.54 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.575 1.083 . . . . 0.0 113.968 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.6 m-70 -120.18 134.0 55.36 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.95 1.7 . . . . 0.0 112.047 178.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.51 153.43 31.17 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 128.999 2.92 . . . . 0.0 111.473 -179.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 459' ' ' MET . . . . . . . . . . . . 0.424 19.1 ptp 70.4 69.36 0.21 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 128.714 2.806 . . . . 0.0 113.881 -178.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -158.31 143.24 16.35 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 130.25 3.42 . . . . 0.0 105.864 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 21.8 p -79.64 174.99 11.02 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 119.787 1.176 . . . . 0.0 111.846 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -63.38 -31.39 72.53 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.421 -0.799 . . . . 0.0 110.735 176.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 25.6 m -70.46 -44.63 67.37 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 117.542 -1.218 . . . . 0.0 110.987 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 60.1 m -51.37 -53.9 31.76 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 120.426 1.466 . . . . 0.0 109.433 172.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.62 -47.12 83.08 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.566 1.547 . . . . 0.0 112.648 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.14 -40.54 94.19 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.096 1.358 . . . . 0.0 111.718 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -59.29 -55.02 40.19 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.607 1.163 . . . . 0.0 110.591 176.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 23.9 mt -51.62 -50.36 60.41 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.704 1.202 . . . . 0.0 110.109 177.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.44 -54.79 42.61 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.755 1.222 . . . . 0.0 114.153 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -60.17 -38.45 83.25 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.149 1.38 . . . . 0.0 112.584 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -82.19 -4.22 56.57 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.537 1.535 . . . . 0.0 112.902 175.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 49.07 50.71 17.48 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 129.055 2.942 . . . . 0.0 112.151 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -70.02 148.98 96.33 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.514 0.726 . . . . 0.0 112.642 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -81.95 11.86 2.99 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 124.016 3.144 . . . . 0.0 113.435 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 34.6 t 73.24 88.66 0.08 OUTLIER Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 128.493 2.717 . . . . 0.0 108.585 -173.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.75 -23.19 25.69 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.27 2.646 . . . . 0.0 114.869 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 20.1 t -73.32 -51.71 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 126.567 1.947 . . . . 0.0 113.213 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 26.1 p -128.59 0.39 5.54 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 -174.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 66.56 30.12 8.61 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 127.485 2.314 . . . . 0.0 114.841 175.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -107.48 102.87 46.47 Favored Pre-proline 0 CA--C 1.554 1.135 0 C-N-CA 126.695 1.998 . . . . 0.0 111.112 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.45 124.53 10.86 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.06 3.173 . . . . 0.0 115.235 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.4 pp -57.52 151.48 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.716 2.007 . . . . 0.0 113.327 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -115.03 -57.27 2.28 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.057 1.343 . . . . 0.0 112.018 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.64 170.22 20.78 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 4.4 mt -121.47 148.24 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.867 2.067 . . . . 0.0 108.603 175.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 6.2 m -134.48 150.18 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.808 1.643 . . . . 0.0 111.189 176.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.91 99.9 4.66 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 56.9 m -79.27 156.02 28.28 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.952 0.901 . . . . 0.0 112.545 -176.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -138.53 164.09 30.33 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.981 2.112 . . . . 0.0 110.257 178.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -124.05 168.82 11.81 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 125.944 1.698 . . . . 0.0 110.907 -178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo . . . . . 0 C--N 1.348 0.547 0 C-N-CA 123.14 2.56 . . . . 0.0 110.895 178.3 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo . . . . . 0 CA--C 1.541 0.864 0 N-CA-C 115.085 1.148 . . . . 0.0 115.085 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 438' ' ' CYS . . . . . 0.406 ' SG ' ' N ' ' B' ' 439' ' ' VAL . 21.3 t -68.17 -175.95 0.66 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.969 1.708 . . . . 0.0 112.506 174.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 439' ' ' VAL . . . . . 0.406 ' N ' ' SG ' ' B' ' 438' ' ' CYS . 6.0 p -141.84 -1.66 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.481 1.513 . . . . 0.0 114.193 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 19.4 mt -118.74 -65.78 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 120.072 1.305 . . . . 0.0 113.393 -176.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 22.8 p -52.67 -74.69 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -141.0 -11.34 0.98 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.571 2.348 . . . . 0.0 113.311 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 79.61 30.69 43.39 Favored Glycine 0 CA--C 1.536 1.364 0 O-C-N 121.556 -0.715 . . . . 0.0 112.634 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -69.73 155.05 94.19 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.737 1.615 . . . . 0.0 111.95 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.89 -2.19 0.32 Allowed 'Trans proline' 0 CA--C 1.549 1.257 1 C-N-CA 125.778 4.319 . . . . 0.0 118.982 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -73.26 142.43 47.23 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.5 1.52 . . . . 0.0 111.861 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.31 149.98 50.27 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.335 1.854 . . . . 0.0 111.692 174.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -160.14 84.73 0.12 Allowed Glycine 0 CA--C 1.53 0.978 0 C-N-CA 126.453 1.977 . . . . 0.0 111.295 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 33.3 t -61.26 137.09 58.24 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.914 0.886 . . . . 0.0 111.402 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.07 147.19 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 126.215 1.806 . . . . 0.0 110.427 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 33.7 t -127.51 138.48 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.151 0.98 . . . . 0.0 110.527 175.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -125.05 95.02 4.34 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 128.868 2.867 . . . . 0.0 109.935 175.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.53 -93.36 0.37 Allowed Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.824 1.678 . . . . 0.0 113.804 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -117.48 -0.31 11.96 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 126.408 1.883 . . . . 0.0 113.532 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 47.4 p -127.13 170.06 12.77 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.469 1.908 . . . . 0.0 110.15 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -159.09 170.93 35.55 Favored Glycine 0 N--CA 1.468 0.772 0 O-C-N 120.592 -1.317 . . . . 0.0 114.062 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.02 139.15 52.94 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.264 1.425 . . . . 0.0 112.01 178.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 56.0 tp -130.02 153.2 48.66 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.737 2.415 . . . . 0.0 110.995 -176.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 28.1 ttm 95.21 29.16 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 129.061 2.944 . . . . 0.0 113.783 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -133.14 151.38 51.99 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.629 1.972 . . . . 0.0 109.556 176.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 22.3 p -75.43 168.86 19.19 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 122.881 1.324 . . . . 0.0 113.312 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.21 -35.18 80.27 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.919 177.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 19.7 m -64.14 -52.9 56.9 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.89 176.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 18.1 m -53.51 -52.89 58.16 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.727 1.149 . . . . 0.0 111.239 175.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -51.85 -41.39 61.8 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.267 1.427 . . . . 0.0 112.669 173.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -69.93 -27.35 64.69 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.045 1.338 . . . . 0.0 113.266 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -57.54 -42.28 82.65 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 120.18 1.355 . . . . 0.0 111.202 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -54.56 -44.54 73.01 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.957 1.303 . . . . 0.0 110.099 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -66.06 -50.29 64.67 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.451 0.7 . . . . 0.0 111.444 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -53.45 -41.63 66.31 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.419 1.488 . . . . 0.0 113.758 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -99.33 11.32 39.43 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.424 1.49 . . . . 0.0 114.845 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 63.3 t30 47.89 60.66 3.41 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.212 2.205 . . . . 0.0 113.803 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -121.58 143.35 37.78 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 128.693 2.797 . . . . 0.0 108.985 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.92 -85.23 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.19 0 C-N-CA 122.798 2.332 . . . . 0.0 112.853 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 5.7 t -127.02 140.37 37.63 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 127.01 2.124 . . . . 0.0 111.328 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.54 -5.56 16.69 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.514 2.809 . . . . 0.0 114.412 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 55.1 t -119.32 -74.22 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.736 1.153 . . . . 0.0 112.602 -177.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 24.6 p -93.85 0.6 56.3 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.611 1.564 . . . . 0.0 114.007 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 58.71 14.62 3.25 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 128.193 2.597 . . . . 0.0 115.892 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -68.58 138.99 91.28 Favored Pre-proline 0 CA--C 1.552 1.034 0 CA-C-N 119.244 0.929 . . . . 0.0 110.645 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.75 113.05 2.61 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.562 2.842 . . . . 0.0 113.757 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.6 pp -69.16 159.34 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.357 1.463 . . . . 0.0 113.758 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -115.12 -56.83 2.33 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.991 2.116 . . . . 0.0 111.243 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.96 170.21 19.9 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.568 1.147 . . . . 0.0 113.51 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 10.5 mt -118.25 138.11 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 127.62 2.368 . . . . 0.0 106.191 174.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 14.7 p -129.02 147.19 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 119.382 0.992 . . . . 0.0 113.497 -177.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.3 99.92 1.63 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.979 1.311 . . . . 0.0 107.876 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 6.0 t -98.87 155.17 17.52 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -144.56 167.17 23.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.395 1.878 . . . . 0.0 111.269 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -123.36 153.34 65.4 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 125.333 1.453 . . . . 0.0 111.689 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 C--N 1.351 0.693 0 C-N-CA 123.592 2.861 . . . . 0.0 111.546 -179.063 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo . . . . . 0 CA--C 1.552 1.415 0 CA-C-O 119.175 -0.427 . . . . 0.0 112.042 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 23.0 t -63.59 154.86 31.4 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 119.747 1.158 . . . . 0.0 110.154 174.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 31.0 m -129.43 -14.61 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 10.4 pt -137.08 -26.4 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.4 m -73.68 -60.76 2.1 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 120.921 1.691 . . . . 0.0 112.051 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -153.54 -13.85 0.15 Allowed 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -176.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 80.08 8.9 87.23 Favored Glycine 0 CA--C 1.541 1.682 0 O-C-N 120.747 -1.221 . . . . 0.0 112.853 -175.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -62.17 155.01 67.55 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 128.175 2.59 . . . . 0.0 113.415 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.03 75.22 3.78 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 124.143 3.229 . . . . 0.0 113.611 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -135.02 148.01 49.81 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.994 2.518 . . . . 0.0 109.218 176.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -128.05 148.09 50.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.013 0.925 . . . . 0.0 111.367 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -159.1 86.62 0.12 Allowed Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.872 1.701 . . . . 0.0 112.822 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 49.3 t -68.63 136.2 52.62 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.896 0.848 . . . . 0.0 110.115 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.0 140.32 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.811 1.244 . . . . 0.0 111.448 -178.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 93.3 t -126.89 131.4 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.138 1.375 . . . . 0.0 111.742 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -114.23 94.98 5.05 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 128.608 2.763 . . . . 0.0 109.727 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.82 -91.41 0.42 Allowed Glycine 0 CA--C 1.535 1.29 0 C-N-CA 126.218 1.866 . . . . 0.0 113.97 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -121.93 5.11 9.91 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 126.506 1.922 . . . . 0.0 113.494 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 74.6 p -135.6 170.06 16.55 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.018 2.127 . . . . 0.0 109.823 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -160.14 179.18 35.84 Favored Glycine 0 N--CA 1.47 0.908 0 O-C-N 120.538 -1.351 . . . . 0.0 114.45 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -120.41 133.87 55.36 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.239 1.415 . . . . 0.0 113.849 174.352 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -110.16 153.26 24.99 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.596 1.558 . . . . 0.0 111.487 173.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 41.8 ttm 99.73 60.0 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 129.825 3.25 . . . . 0.0 112.487 177.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -160.05 158.31 30.22 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.306 1.842 . . . . 0.0 110.936 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 13.7 p -88.71 175.07 7.67 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 122.441 1.115 . . . . 0.0 111.63 173.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -37.16 84.3 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.028 -1.045 . . . . 0.0 110.672 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 26.6 m -63.21 -49.69 73.19 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 117.18 -1.391 . . . . 0.0 109.847 176.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 60.0 m -47.12 -56.23 6.95 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 120.35 1.432 . . . . 0.0 110.291 173.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -56.85 -47.3 80.69 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.905 1.682 . . . . 0.0 114.398 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -74.4 -31.64 62.4 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 120.055 1.298 . . . . 0.0 112.682 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -62.63 -55.5 26.49 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.897 1.679 . . . . 0.0 110.942 177.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 2.3 pp -59.0 -37.88 77.89 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 117.8 0.273 . . . . 0.0 111.131 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -63.11 -49.3 74.96 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.121 1.368 . . . . 0.0 111.759 176.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -58.0 -39.6 78.66 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.598 1.559 . . . . 0.0 111.561 176.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -76.0 5.56 6.45 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 127.078 2.151 . . . . 0.0 113.866 175.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 45.3 t30 65.21 18.72 11.53 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 128.771 2.828 . . . . 0.0 115.438 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -70.13 130.04 90.07 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 120.821 -1.174 . . . . 0.0 108.82 175.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.77 -51.3 0.93 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.772 2.315 . . . . 0.0 111.695 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 3.4 t -153.85 140.08 12.6 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 129.375 3.07 . . . . 0.0 108.019 174.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -71.29 -6.37 19.03 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.261 2.641 . . . . 0.0 114.583 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 46.4 t -125.08 -70.86 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 119.829 1.195 . . . . 0.0 113.404 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 24.6 p -97.13 3.62 51.58 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.803 1.641 . . . . 0.0 114.797 -175.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 59.62 20.21 8.81 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 127.763 2.425 . . . . 0.0 116.054 175.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -81.04 115.99 59.65 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 124.544 1.138 . . . . 0.0 109.376 175.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -47.32 108.32 0.16 Allowed 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 124.373 3.382 . . . . 0.0 117.264 -175.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.0 pp -66.41 134.52 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 126.124 1.77 . . . . 0.0 112.14 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -115.24 -16.61 11.5 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.55 1.54 . . . . 0.0 115.026 -176.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 1.8 ttp -150.32 148.17 28.51 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.122 0.969 . . . . 0.0 113.021 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 14.4 mt -131.99 139.42 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 127.363 2.265 . . . . 0.0 107.936 173.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 10.0 m -134.68 150.23 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.565 1.146 . . . . 0.0 113.403 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 63.5 tp -70.13 99.87 1.56 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 173.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 4.8 t -98.98 159.1 15.2 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -172.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -142.6 171.18 14.4 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.392 2.277 . . . . 0.0 111.606 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -138.54 156.63 73.15 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.98 1.712 . . . . 0.0 111.028 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo . . . . . 0 C--N 1.351 0.674 0 C-N-CA 123.627 2.884 . . . . 0.0 111.482 -179.61 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo . . . . . 0 CA--C 1.55 1.318 0 N-CA-C 117.361 2.024 . . . . 0.0 117.361 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 40.0 t -61.26 145.82 49.99 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 121.838 2.108 . . . . 0.0 109.684 175.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 35.3 m -123.15 -15.17 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 8.4 pt -137.66 -25.32 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.8 m -77.28 -63.64 1.32 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.656 1.571 . . . . 0.0 112.211 -176.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -144.16 -11.74 0.64 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -177.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 75.84 16.16 80.84 Favored Glycine 0 CA--C 1.545 1.914 0 CA-C-N 120.117 1.326 . . . . 0.0 112.42 -174.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -65.58 155.2 86.4 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 130.484 3.513 . . . . 0.0 113.021 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -68.96 -3.61 11.82 Favored 'Trans proline' 0 CA--C 1.546 1.089 0 C-N-CA 124.161 3.241 . . . . 0.0 115.956 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -59.35 134.7 57.25 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.341 1.456 . . . . 0.0 110.17 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -128.24 138.68 52.54 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.22 1.808 . . . . 0.0 110.344 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -139.25 83.58 0.24 Allowed Glycine 0 CA--C 1.526 0.779 0 C-N-CA 127.482 2.467 . . . . 0.0 109.761 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 50.7 t -59.4 138.52 57.63 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.01 0.924 . . . . 0.0 111.013 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.05 142.4 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 125.647 1.579 . . . . 0.0 109.478 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 14.5 t -116.81 142.31 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.325 1.05 . . . . 0.0 109.463 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -125.11 94.83 4.28 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 128.016 2.527 . . . . 0.0 107.165 175.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 60.87 -91.85 0.06 OUTLIER Glycine 0 CA--C 1.541 1.706 0 C-N-CA 124.759 1.171 . . . . 0.0 113.829 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -118.71 6.17 11.56 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 127.441 2.297 . . . . 0.0 113.514 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 41.5 p -121.74 170.21 9.97 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.629 2.372 . . . . 0.0 110.441 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -162.6 167.48 37.11 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 120.598 -1.313 . . . . 0.0 114.688 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -120.12 141.31 49.94 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.552 1.541 . . . . 0.0 113.034 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 79.8 mt -119.26 153.21 35.37 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.268 2.627 . . . . 0.0 110.959 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 20.2 mmt 76.44 65.25 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.588 2.355 . . . . 0.0 113.19 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -155.81 135.02 12.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 129.749 3.22 . . . . 0.0 105.438 172.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 13.1 p -77.22 174.72 10.42 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 120.958 1.708 . . . . 0.0 111.96 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.47 -37.22 82.82 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.59 -0.694 . . . . 0.0 111.827 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 84.7 m -72.49 -44.21 62.58 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 116.194 -1.86 . . . . 0.0 110.684 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 53.0 m -46.36 -57.33 4.72 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 121.596 1.998 . . . . 0.0 110.474 173.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.03 -52.42 65.34 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.482 1.513 . . . . 0.0 112.663 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -59.82 -38.58 82.4 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 121.091 -1.006 . . . . 0.0 113.083 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -62.19 -48.05 81.76 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.153 1.781 . . . . 0.0 111.416 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 14.5 mt -54.88 -50.73 68.02 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.894 0.878 . . . . 0.0 109.631 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -55.86 -46.5 78.2 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.155 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -58.59 -42.23 87.58 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.244 1.417 . . . . 0.0 111.725 175.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -76.35 0.45 19.45 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 127.407 2.283 . . . . 0.0 113.713 175.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 71.73 6.92 5.81 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 129.71 3.204 . . . . 0.0 115.508 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.11 135.88 47.48 Favored Pre-proline 0 CA--C 1.544 0.75 0 O-C-N 120.664 -1.272 . . . . 0.0 109.342 175.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -78.06 -110.22 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.286 0 C-N-CA 123.212 2.608 . . . . 0.0 108.78 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 15.2 t -70.7 139.64 86.22 Favored Pre-proline 0 CA--C 1.556 1.183 0 O-C-N 120.76 -1.213 . . . . 0.0 112.65 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.17 -4.23 14.57 Favored 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 123.612 2.875 . . . . 0.0 114.115 175.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 61.3 t -129.02 -68.29 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 29.6 p -88.08 -6.37 57.96 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 120.393 1.451 . . . . 0.0 113.575 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 61.27 9.18 2.39 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 128.487 2.715 . . . . 0.0 115.12 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -66.39 153.38 92.91 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-N 118.763 0.71 . . . . 0.0 111.925 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.48 119.88 6.98 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.357 2.705 . . . . 0.0 113.01 -177.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.65 159.5 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.567 1.547 . . . . 0.0 112.91 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.08 -60.72 1.85 Allowed 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.036 1.735 . . . . 0.0 110.893 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.99 170.32 21.57 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.679 1.992 . . . . 0.0 112.581 -177.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 13.2 mt -115.98 135.47 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 126.388 1.875 . . . . 0.0 108.036 174.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 15.0 m -134.3 150.0 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.578 1.151 . . . . 0.0 112.595 177.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.58 99.94 5.93 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 56.1 m -101.03 104.03 15.16 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.199 0.6 . . . . 0.0 111.313 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -78.63 172.48 13.63 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.811 2.444 . . . . 0.0 112.45 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -115.6 167.03 10.79 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 126.254 1.822 . . . . 0.0 111.787 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo . . . . . 0 C--N 1.351 0.702 0 C-N-CA 124.104 3.203 . . . . 0.0 113.785 179.352 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo . . . . . 0 CA--C 1.546 1.109 0 N-CA-C 112.672 0.22 . . . . 0.0 112.672 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 15.0 p -70.19 -179.02 1.82 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.921 1.288 . . . . 0.0 112.7 177.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.08 -3.81 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -177.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 4.7 mt -121.88 -62.42 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 120.147 1.339 . . . . 0.0 113.498 -178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . 0.256 3.6 p -66.69 -61.95 1.7 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 -173.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -154.61 -15.47 0.12 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -175.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 100.44 51.19 1.24 Allowed Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.878 1.704 . . . . 0.0 110.585 -176.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -105.75 155.0 38.93 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 125.291 1.436 . . . . 0.0 112.526 -176.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -46.62 118.8 2.8 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.252 2.635 . . . . 0.0 113.877 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 29.13 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 129.375 3.07 . . . . 0.0 118.818 -175.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.77 89.84 2.32 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 120.288 -1.507 . . . . 0.0 109.207 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 170.09 42.01 0.03 OUTLIER Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.034 1.302 . . . . 0.0 112.118 -177.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 45.4 t -49.96 121.35 5.28 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.673 1.589 . . . . 0.0 111.846 -178.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.403 HD12 ' H ' ' A' ' 450' ' ' ILE . 4.4 mp -83.45 123.85 39.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 125.689 1.595 . . . . 0.0 107.718 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 96.5 t -127.08 123.15 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 121.679 0.752 . . . . 0.0 111.061 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -120.3 106.81 12.24 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 128.113 2.565 . . . . 0.0 111.393 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.65 -92.22 0.43 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.749 1.642 . . . . 0.0 113.934 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -127.06 4.44 6.47 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.574 1.95 . . . . 0.0 113.183 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 60.1 p -133.53 170.15 15.94 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.32 1.848 . . . . 0.0 110.668 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -159.26 173.91 36.13 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.326 0.965 . . . . 0.0 113.301 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 25.8 m-70 -120.11 131.82 55.19 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.899 1.28 . . . . 0.0 112.784 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 458' ' ' LEU . . . . . 0.437 HD23 ' N ' ' A' ' 459' ' ' MET . 1.9 tt -92.85 153.27 18.93 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 129.487 3.115 . . . . 0.0 112.133 -178.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 459' ' ' MET . . . . . 0.437 ' N ' HD23 ' A' ' 458' ' ' LEU . 16.0 ttp 86.5 31.07 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.964 2.506 . . . . 0.0 117.213 169.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -139.28 135.01 33.39 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.018 1.327 . . . . 0.0 108.801 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 26.3 p -79.59 175.01 11.0 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 123.051 1.405 . . . . 0.0 114.317 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.24 -41.06 78.84 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.678 1.191 . . . . 0.0 111.869 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 78.8 m -60.8 -53.0 62.66 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.721 1.208 . . . . 0.0 110.358 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 90.5 m -52.08 -53.7 39.22 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.561 1.144 . . . . 0.0 111.056 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -56.02 -50.16 71.66 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.363 1.065 . . . . 0.0 112.671 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -64.91 -38.17 90.07 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.212 1.005 . . . . 0.0 112.414 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -61.02 -52.99 62.65 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.359 1.464 . . . . 0.0 110.573 177.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 29.8 mt -51.77 -51.47 56.07 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.397 1.079 . . . . 0.0 109.782 175.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -54.22 -48.63 70.85 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.175 0.99 . . . . 0.0 112.342 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -59.86 -41.55 91.7 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.326 1.45 . . . . 0.0 111.983 175.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -75.72 -0.99 22.78 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 127.065 2.146 . . . . 0.0 113.44 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 38.9 t30 75.44 7.1 4.02 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 130.086 3.354 . . . . 0.0 115.425 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -80.89 128.7 70.56 Favored Pre-proline 0 CA--C 1.543 0.697 0 O-C-N 120.612 -1.305 . . . . 0.0 109.154 175.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.11 -87.82 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 123.326 2.684 . . . . 0.0 110.415 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 37.4 t -96.78 132.44 26.07 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.67 1.588 . . . . 0.0 111.031 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.56 -4.7 14.89 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.272 2.648 . . . . 0.0 113.794 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 24.4 t -112.46 -74.19 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 119.772 1.169 . . . . 0.0 112.634 -177.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 25.4 p -95.82 -3.64 45.23 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.422 1.489 . . . . 0.0 114.318 -177.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 67.12 10.58 7.81 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 127.75 2.42 . . . . 0.0 115.162 176.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -62.97 149.68 89.81 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 124.0 0.92 . . . . 0.0 111.663 177.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -68.77 106.89 1.56 Allowed 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.892 3.061 . . . . 0.0 113.682 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 1.5 pp -71.86 145.77 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.352 1.461 . . . . 0.0 111.405 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -115.22 -24.25 8.57 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.2 168.13 27.88 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -176.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 10.0 mt -139.29 132.49 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 128.784 2.833 . . . . 0.0 106.731 174.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.11 150.08 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 125.003 1.321 . . . . 0.0 112.153 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 64.5 mt -69.54 99.84 1.33 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.632 0.729 . . . . 0.0 109.295 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.15 112.67 25.88 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.89 1.676 . . . . 0.0 113.601 -174.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -127.83 169.05 14.33 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.903 1.281 . . . . 0.0 113.854 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -73.55 159.67 84.07 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 127.098 2.159 . . . . 0.0 112.821 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo . . . . . 0 C--N 1.351 0.698 0 C-N-CA 123.562 2.842 . . . . 0.0 111.501 178.787 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo . . . . . 0 CA--C 1.544 0.989 0 N-CA-C 113.255 0.444 . . . . 0.0 113.255 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 8.5 p -66.98 -163.32 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 126.832 2.053 . . . . 0.0 115.021 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 96.4 t -125.67 -22.72 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -174.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 2.5 mt -129.4 -56.8 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 -171.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 27.8 p -69.19 -61.97 1.57 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 -172.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -148.75 -9.09 0.36 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 116.716 2.117 . . . . 0.0 116.716 -173.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 86.59 30.56 21.14 Favored Glycine 0 CA--C 1.534 1.248 0 O-C-N 120.693 -1.254 . . . . 0.0 111.196 -175.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 44.6 mtt-85 -65.44 135.98 96.08 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 125.526 1.53 . . . . 0.0 111.388 -177.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.78 77.88 1.79 Allowed 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 123.815 3.01 . . . . 0.0 110.328 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -150.05 160.67 43.46 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.024 2.13 . . . . 0.0 113.188 -170.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -128.21 150.11 50.17 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 128.967 2.907 . . . . 0.0 111.104 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 176.45 76.92 0.05 OUTLIER Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.825 1.678 . . . . 0.0 112.323 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 19.7 t -61.55 140.69 58.08 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.934 0.894 . . . . 0.0 111.869 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 2.0 mp -109.96 140.8 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 126.257 1.823 . . . . 0.0 109.281 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 94.6 t -130.06 135.39 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.659 0.742 . . . . 0.0 110.891 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.04 100.09 6.42 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 128.192 2.597 . . . . 0.0 110.728 174.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.55 -94.14 0.27 Allowed Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.005 1.764 . . . . 0.0 114.323 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -116.9 -0.33 12.26 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.274 1.83 . . . . 0.0 113.457 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 16.5 p -129.88 166.06 20.76 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.512 1.125 . . . . 0.0 110.793 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.11 166.82 33.19 Favored Glycine 0 CA--C 1.528 0.871 0 O-C-N 121.015 -1.053 . . . . 0.0 113.976 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 13.8 m-70 -115.65 116.69 28.54 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.768 2.027 . . . . 0.0 110.682 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 43.2 tp -107.97 153.1 23.56 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.516 2.327 . . . . 0.0 110.63 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 62.5 mtt 105.73 -5.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 130.92 3.688 . . . . 0.0 115.686 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -99.87 160.5 14.26 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.432 1.014 . . . . 0.0 111.305 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 21.7 p -79.64 173.45 12.58 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 123.198 1.475 . . . . 0.0 113.874 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.63 -23.62 65.37 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.612 174.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 51.4 m -73.94 -50.76 18.59 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 117.823 -1.084 . . . . 0.0 110.145 178.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 60.7 m -49.0 -53.2 21.0 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.777 1.231 . . . . 0.0 110.476 173.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.72 -49.58 76.06 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.861 1.664 . . . . 0.0 112.927 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -61.42 -40.67 95.27 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.826 -1.171 . . . . 0.0 111.655 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -62.31 -54.53 39.29 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.98 1.712 . . . . 0.0 111.328 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.3 pp -62.91 -31.84 73.0 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.71 -0.619 . . . . 0.0 112.034 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -68.29 -46.65 69.78 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.052 1.341 . . . . 0.0 112.226 175.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -58.45 -40.97 84.05 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.464 1.105 . . . . 0.0 111.503 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -74.88 -8.43 56.44 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.566 1.546 . . . . 0.0 113.118 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 50.45 41.05 24.5 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.47 2.708 . . . . 0.0 111.74 -176.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -71.73 127.56 90.72 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.385 1.474 . . . . 0.0 114.053 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.76 127.55 10.95 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.808 2.338 . . . . 0.0 107.333 169.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 40.9 t -30.62 125.44 0.3 Allowed Pre-proline 0 CA--C 1.555 1.159 0 C-N-CA 127.914 2.486 . . . . 0.0 115.2 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.1 -1.78 6.83 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.072 2.515 . . . . 0.0 114.328 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 58.4 t -124.04 -59.8 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.796 1.638 . . . . 0.0 111.17 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 85.7 m -75.11 -22.54 58.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.089 1.756 . . . . 0.0 112.766 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? 62.5 9.12 3.22 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 127.161 2.184 . . . . 0.0 113.419 -175.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -83.1 146.72 52.22 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.769 1.227 . . . . 0.0 112.266 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.67 121.94 7.44 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.18 2.587 . . . . 0.0 110.375 175.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.4 pp -61.05 144.12 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.22 1.008 . . . . 0.0 111.369 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -115.02 -38.87 3.77 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.75 165.85 35.3 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 8.2 mt -135.36 135.83 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.674 2.389 . . . . 0.0 108.475 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 20.0 m -140.01 150.05 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.126 0.97 . . . . 0.0 113.312 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.95 100.0 1.89 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 36.5 m -96.64 88.95 4.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.794 1.237 . . . . 0.0 111.483 -174.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -61.81 129.05 39.16 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.946 1.698 . . . . 0.0 112.892 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -47.71 -40.48 30.68 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 118.817 2.895 . . . . 0.0 118.817 -176.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo . . . . . 0 C--N 1.355 0.896 0 C-N-CA 123.979 3.119 . . . . 0.0 115.028 -178.256 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 CA--C 1.544 1.02 0 N-CA-C 117.417 2.045 . . . . 0.0 117.417 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 11.2 t -50.53 153.21 1.68 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 128.323 2.649 . . . . 0.0 111.892 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 22.0 m -135.35 -0.37 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.656 1.183 . . . . 0.0 113.708 178.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 8.2 mt -128.73 -48.18 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 119.565 1.075 . . . . 0.0 112.255 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 1.9 m -71.2 -68.93 0.41 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -173.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -146.55 -11.39 0.46 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.313 1.598 . . . . 0.0 115.313 -173.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.5 16.78 70.19 Favored Glycine 0 CA--C 1.541 1.717 0 CA-C-N 119.836 1.198 . . . . 0.0 113.051 -175.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 11.8 ptp85 -57.47 154.3 24.49 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 127.22 2.208 . . . . 0.0 112.499 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.18 -10.23 26.53 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 123.807 3.005 . . . . 0.0 116.388 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -59.39 147.52 35.97 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.201 1.4 . . . . 0.0 112.05 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -128.33 150.16 50.2 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.21 2.604 . . . . 0.0 111.667 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -168.44 86.35 0.09 OUTLIER Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.252 1.882 . . . . 0.0 112.517 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 47.7 t -60.4 142.94 54.3 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.686 1.194 . . . . 0.0 110.862 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 mp -115.0 132.21 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.578 1.551 . . . . 0.0 109.595 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 69.6 t -115.56 129.05 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.337 1.055 . . . . 0.0 108.591 176.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -125.08 94.95 4.32 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.184 2.194 . . . . 0.0 112.74 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 77.06 -77.77 1.48 Allowed Glycine 0 CA--C 1.535 1.284 0 C-N-CA 126.048 1.785 . . . . 0.0 113.899 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -135.22 -10.17 2.24 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.36 1.864 . . . . 0.0 113.754 -178.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 42.1 p -122.61 170.07 10.39 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.418 2.287 . . . . 0.0 110.084 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -157.33 170.19 34.45 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.893 -1.129 . . . . 0.0 114.186 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -119.99 145.19 47.02 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.619 1.968 . . . . 0.0 112.231 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 35.3 tp -121.71 153.07 38.69 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.832 2.053 . . . . 0.0 109.962 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 25.1 ttt 82.44 68.97 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 128.483 2.713 . . . . 0.0 112.42 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -160.12 151.08 19.09 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 129.169 2.987 . . . . 0.0 107.192 175.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 23.0 p -85.89 174.99 8.89 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 122.397 1.094 . . . . 0.0 111.195 175.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -63.37 -33.68 76.07 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.482 -0.761 . . . . 0.0 110.726 177.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 21.3 m -68.28 -48.52 64.78 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 117.39 -1.29 . . . . 0.0 110.655 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 31.4 m -48.33 -54.72 12.82 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 120.373 1.442 . . . . 0.0 110.007 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -59.8 -43.31 94.53 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.633 1.573 . . . . 0.0 113.12 177.543 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -64.61 -40.97 96.43 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.752 -1.217 . . . . 0.0 111.631 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -59.67 -55.41 34.75 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.151 1.38 . . . . 0.0 110.921 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.4 pp -62.46 -32.75 73.67 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -69.58 -43.66 72.38 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.826 1.25 . . . . 0.0 113.069 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -54.8 -38.79 67.76 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.713 1.605 . . . . 0.0 111.868 177.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -91.76 -0.2 57.53 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.566 1.946 . . . . 0.0 113.331 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 64.8 t30 47.74 45.84 18.27 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 128.429 2.692 . . . . 0.0 112.627 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm -70.12 126.39 92.38 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.159 1.384 . . . . 0.0 113.148 -177.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.89 129.29 12.3 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 122.843 2.362 . . . . 0.0 107.91 170.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 53.6 t -31.94 123.89 0.37 Allowed Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 127.337 2.255 . . . . 0.0 114.655 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.51 -1.68 7.0 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.2 2.6 . . . . 0.0 114.136 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 48.2 t -122.6 -60.96 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.913 1.685 . . . . 0.0 111.002 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 86.0 m -76.54 -19.13 58.25 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.468 1.907 . . . . 0.0 113.319 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 62.29 6.78 1.99 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 127.18 2.192 . . . . 0.0 113.81 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -75.67 146.27 79.88 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 125.843 1.657 . . . . 0.0 113.382 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -78.02 120.19 4.93 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 124.159 3.239 . . . . 0.0 111.656 177.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.5 pp -63.09 141.48 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.055 0.942 . . . . 0.0 112.785 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -115.1 -45.64 2.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.462 1.505 . . . . 0.0 114.495 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.52 169.1 25.43 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -173.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 4.7 mt -133.65 143.43 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 128.453 2.701 . . . . 0.0 108.451 175.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 15.4 m -139.95 150.17 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.957 1.703 . . . . 0.0 111.214 177.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.33 99.95 2.05 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 176.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.94 102.39 14.75 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.364 1.066 . . . . 0.0 110.757 -176.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -72.53 143.13 48.44 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.656 1.182 . . . . 0.0 112.41 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -66.42 166.81 15.28 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 126.126 1.77 . . . . 0.0 112.201 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo . . . . . 0 C--N 1.354 0.819 0 C-N-CA 124.136 3.224 . . . . 0.0 114.398 -179.302 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 CA--C 1.549 1.24 0 N-CA-C 113.09 0.381 . . . . 0.0 113.09 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 12.5 t -56.41 173.03 0.19 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.002 1.721 . . . . 0.0 113.607 177.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.37 1.82 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 -175.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 15.0 mt -121.73 -60.99 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 120.39 1.45 . . . . 0.0 113.016 -177.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 12.9 p -54.34 -78.49 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.528 1.531 . . . . 0.0 114.607 -177.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -150.63 -12.86 0.24 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 127.34 2.256 . . . . 0.0 113.19 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 96.73 45.74 2.63 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.388 0.995 . . . . 0.0 113.187 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -84.33 155.34 63.18 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 126.095 1.758 . . . . 0.0 111.265 175.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -39.96 125.37 1.65 Allowed 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.716 3.611 . . . . 0.0 114.541 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -67.37 63.97 0.07 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.977 2.911 . . . . 0.0 113.5 -177.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -109.09 89.82 3.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.585 1.154 . . . . 0.0 108.034 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 164.66 51.58 0.02 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.155 0.884 . . . . 0.0 112.85 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 42.5 t -61.32 141.45 57.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.31 1.055 . . . . 0.0 109.887 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.11 137.79 47.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 125.717 1.607 . . . . 0.0 110.104 -174.78 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 83.0 t -126.52 128.81 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.006 0.923 . . . . 0.0 112.116 -177.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -111.31 94.89 5.2 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.713 2.805 . . . . 0.0 109.318 173.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.31 -96.02 0.32 Allowed Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.657 1.599 . . . . 0.0 114.186 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -112.51 0.93 15.67 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.374 1.87 . . . . 0.0 113.565 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 49.4 p -132.15 170.04 15.56 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.959 1.704 . . . . 0.0 110.515 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -161.18 177.19 37.62 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 120.615 -1.303 . . . . 0.0 113.573 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 12.7 m-70 -120.29 140.19 51.61 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.479 1.512 . . . . 0.0 112.333 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.9 92.87 3.89 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.925 1.29 . . . . 0.0 112.13 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.58 -13.59 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 119.073 2.99 . . . . 0.0 119.073 -178.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -129.52 165.42 21.7 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 119.799 1.181 . . . . 0.0 114.041 -174.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 29.8 p -78.78 168.8 19.21 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 122.541 1.162 . . . . 0.0 111.376 175.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.4 -39.4 79.6 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.36 -0.838 . . . . 0.0 112.069 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 62.6 m -60.55 -55.94 27.37 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.108 0.963 . . . . 0.0 110.025 178.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 62.8 m -57.41 -45.15 84.91 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.191 0.996 . . . . 0.0 112.087 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.55 -39.88 81.46 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.024 1.329 . . . . 0.0 112.99 174.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -71.97 -39.35 69.38 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.101 1.36 . . . . 0.0 111.16 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -56.52 -54.49 45.27 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.582 1.153 . . . . 0.0 111.965 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . 0.315 0.0 OUTLIER -63.19 -27.25 69.23 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.547 1.067 . . . . 0.0 113.317 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -70.1 -45.11 67.62 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.413 1.485 . . . . 0.0 110.275 175.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -61.31 -35.76 78.27 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.929 1.292 . . . . 0.0 111.672 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -76.93 -1.17 27.23 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 126.451 1.9 . . . . 0.0 113.338 174.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 51.8 t30 65.18 22.01 12.18 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 128.918 2.887 . . . . 0.0 114.966 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -72.56 137.22 80.58 Favored Pre-proline 0 CA--C 1.544 0.735 0 O-C-N 120.969 -1.082 . . . . 0.0 109.382 176.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -63.52 -52.47 1.9 Allowed 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.465 2.11 . . . . 0.0 112.872 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 2.4 t -153.23 142.7 14.88 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 129.252 3.021 . . . . 0.0 108.482 175.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.33 -6.67 18.7 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.141 2.561 . . . . 0.0 114.187 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.1 -71.43 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 119.997 1.271 . . . . 0.0 113.996 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 27.6 p -94.07 -5.3 47.72 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 70.1 15.32 7.65 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 127.897 2.479 . . . . 0.0 115.397 175.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -74.69 132.96 77.14 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 119.309 0.958 . . . . 0.0 109.194 173.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.01 110.28 1.47 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.947 2.431 . . . . 0.0 114.486 -175.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.4 pp -64.27 155.33 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.536 1.534 . . . . 0.0 113.21 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -114.38 -46.59 2.97 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.798 2.039 . . . . 0.0 112.74 -176.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.12 170.09 21.35 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 14.9 mt -126.05 136.6 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 127.913 2.485 . . . . 0.0 107.492 176.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 12.7 p -123.68 148.02 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.344 1.057 . . . . 0.0 113.505 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.23 99.93 0.97 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.316 1.046 . . . . 0.0 108.193 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 26.6 m -96.13 103.7 15.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.004 1.722 . . . . 0.0 113.565 -173.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -89.66 75.74 7.4 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.585 1.183 . . . . 0.0 110.477 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -63.93 -29.92 4.5 Favored Pre-proline 0 CA--C 1.554 1.113 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo . . . . . 0 C--N 1.358 1.028 0 C-N-CA 123.265 2.644 . . . . 0.0 113.898 -179.582 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo . . . . . 0 CA--C 1.556 1.607 0 N-CA-C 114.149 0.788 . . . . 0.0 114.149 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 23.8 t -63.65 148.06 49.95 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.704 1.593 . . . . 0.0 110.201 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 29.4 m -132.06 -0.46 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.001 0.921 . . . . 0.0 113.444 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 6.4 mt -134.86 -46.22 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 119.441 1.019 . . . . 0.0 112.981 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.2 m -68.8 -64.19 0.91 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -173.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -154.14 -10.32 0.14 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -175.652 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.26 14.36 76.84 Favored Glycine 0 CA--C 1.541 1.714 0 O-C-N 120.693 -1.254 . . . . 0.0 113.261 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -59.53 154.39 44.88 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 127.729 2.411 . . . . 0.0 112.867 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.79 68.89 7.05 Favored 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 124.081 3.187 . . . . 0.0 112.68 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -135.02 147.05 49.57 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.057 1.743 . . . . 0.0 111.457 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -128.27 141.54 51.41 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.011 1.324 . . . . 0.0 111.06 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -136.11 76.31 0.38 Allowed Glycine 0 CA--C 1.525 0.657 0 C-N-CA 126.839 2.161 . . . . 0.0 108.76 175.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 85.2 m -66.89 108.98 2.75 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.404 0.682 . . . . 0.0 110.918 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 450' ' ' ILE . . . . . 0.564 ' H ' HD12 ' A' ' 450' ' ' ILE . 0.8 OUTLIER -78.72 140.47 16.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 126.451 1.9 . . . . 0.0 109.993 -178.074 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 77.9 t -129.63 132.67 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.093 0.957 . . . . 0.0 110.707 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -124.61 98.31 5.67 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.691 2.796 . . . . 0.0 110.118 177.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 66.31 -95.07 0.24 Allowed Glycine 0 CA--C 1.534 1.272 0 C-N-CA 126.056 1.789 . . . . 0.0 114.057 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -113.85 1.19 14.7 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.288 1.835 . . . . 0.0 113.753 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 81.9 p -131.27 170.03 15.16 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.095 1.758 . . . . 0.0 111.258 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.4 174.26 34.2 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.023 -1.048 . . . . 0.0 113.716 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -120.32 145.0 47.54 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.026 1.331 . . . . 0.0 112.978 175.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.37 153.21 40.67 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.421 2.288 . . . . 0.0 111.263 177.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 52.0 mtt 97.5 48.96 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 130.148 3.379 . . . . 0.0 113.503 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -155.3 148.13 24.38 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.257 1.823 . . . . 0.0 109.68 176.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 7.7 p -83.3 175.18 10.08 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 122.672 1.225 . . . . 0.0 112.236 176.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -59.09 -46.8 87.36 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.02 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 88.7 m -69.13 -41.52 77.23 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 116.353 -1.784 . . . . 0.0 111.926 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 46.4 m -47.16 -59.4 3.18 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 121.522 1.965 . . . . 0.0 110.405 175.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.36 87.91 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.531 1.532 . . . . 0.0 113.689 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -60.19 -41.93 93.99 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.645 -1.284 . . . . 0.0 111.824 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -61.79 -56.6 17.8 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.26 1.824 . . . . 0.0 111.221 177.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 3.4 pp -60.48 -37.26 80.49 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.205 0.457 . . . . 0.0 111.271 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.18 -48.36 80.39 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.71 1.204 . . . . 0.0 111.753 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -58.54 -37.87 76.58 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.384 1.474 . . . . 0.0 111.636 176.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -74.98 6.08 4.49 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 127.322 2.249 . . . . 0.0 113.7 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 39.8 t30 73.41 9.81 5.06 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 129.662 3.185 . . . . 0.0 115.601 177.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -72.42 131.12 85.08 Favored Pre-proline 0 N--CA 1.474 0.768 0 O-C-N 120.791 -1.193 . . . . 0.0 109.19 175.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.07 -82.06 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.283 2.655 . . . . 0.0 109.682 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 32.3 t -123.16 130.76 24.45 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 126.672 1.989 . . . . 0.0 109.471 175.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.23 -1.39 10.52 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.328 2.685 . . . . 0.0 113.874 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 37.6 t -118.19 -78.28 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.754 1.222 . . . . 0.0 111.946 -177.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 18.5 p -89.98 0.15 57.25 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.389 1.476 . . . . 0.0 114.427 -177.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 12.4 mpt_? 62.46 6.97 2.15 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 127.883 2.473 . . . . 0.0 115.525 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -60.51 138.04 92.5 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-N 119.25 0.932 . . . . 0.0 111.172 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.23 114.28 3.37 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.196 2.597 . . . . 0.0 112.317 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 20.3 pt -76.76 158.85 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.096 1.358 . . . . 0.0 114.159 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -115.19 -43.4 3.08 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.142 1.777 . . . . 0.0 114.04 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.93 170.03 23.07 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -171.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.2 pt -141.97 145.57 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 129.923 3.289 . . . . 0.0 108.209 169.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 11.4 m -137.69 150.17 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.139 1.776 . . . . 0.0 109.619 177.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.15 99.87 0.94 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.88 142.31 27.9 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -172.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -128.48 179.63 5.55 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.231 2.212 . . . . 0.0 111.188 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -134.54 158.19 75.67 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.088 1.355 . . . . 0.0 111.407 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 C--N 1.352 0.743 0 C-N-CA 123.2 2.6 . . . . 0.0 111.381 -179.561 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 CA--C 1.553 1.437 0 CA-C-O 118.805 -0.581 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 35.3 t -65.22 153.3 41.39 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 120.466 1.484 . . . . 0.0 110.014 174.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 67.5 t -129.09 -14.59 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.656 1.582 . . . . 0.0 111.848 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 7.1 mt -133.24 -45.8 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.2 m -67.44 -65.19 0.72 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.465 1.506 . . . . 0.0 113.981 -173.036 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -146.8 -12.55 0.44 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 76.82 10.56 86.01 Favored Glycine 0 CA--C 1.545 1.949 0 CA-C-N 119.893 1.224 . . . . 0.0 112.418 -173.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -58.45 154.34 33.96 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 129.424 3.09 . . . . 0.0 112.866 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -77.32 68.69 7.41 Favored 'Trans proline' 0 CA--C 1.549 1.246 0 C-N-CA 124.146 3.231 . . . . 0.0 113.031 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -131.61 149.03 52.64 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.821 2.049 . . . . 0.0 110.681 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -128.03 149.99 50.13 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.166 1.387 . . . . 0.0 111.077 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -155.06 84.89 0.14 Allowed Glycine 0 CA--C 1.531 1.047 0 C-N-CA 127.038 2.256 . . . . 0.0 111.163 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 42.0 t -67.73 120.27 13.81 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.2 1.0 . . . . 0.0 110.148 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.68 139.7 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 125.561 1.544 . . . . 0.0 109.918 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 93.6 t -130.07 127.6 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.748 1.219 . . . . 0.0 108.748 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -125.2 95.09 4.35 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.886 2.074 . . . . 0.0 111.632 177.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 71.55 -87.28 0.43 Allowed Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.689 1.614 . . . . 0.0 115.172 178.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -122.52 -4.36 8.78 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.25 1.82 . . . . 0.0 113.765 -177.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 30.0 p -129.66 170.16 14.16 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.648 2.379 . . . . 0.0 110.056 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -158.69 171.27 35.37 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 120.981 -1.074 . . . . 0.0 113.505 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 6.5 m-70 -120.02 137.43 54.1 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.936 1.694 . . . . 0.0 112.838 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 33.2 tp -121.63 153.16 38.47 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 129.023 2.929 . . . . 0.0 110.054 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 19.7 mmt 80.89 57.37 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.617 2.367 . . . . 0.0 112.959 177.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -154.0 153.56 32.18 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 128.222 2.609 . . . . 0.0 109.493 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 10.3 p -85.51 175.07 9.03 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 122.343 1.068 . . . . 0.0 111.926 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.24 -36.76 85.14 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.705 -0.664 . . . . 0.0 112.374 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 87.0 m -73.61 -42.11 61.95 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 117.074 -1.441 . . . . 0.0 111.142 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 55.3 m -48.57 -54.91 12.68 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 120.638 1.563 . . . . 0.0 109.548 172.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -60.72 -49.75 76.26 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.142 1.777 . . . . 0.0 113.262 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -58.97 -41.09 86.7 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.796 1.238 . . . . 0.0 111.734 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -58.9 -55.26 37.43 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.41 1.084 . . . . 0.0 110.552 176.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.73 -30.47 71.44 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -69.03 -47.81 64.49 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.213 1.405 . . . . 0.0 112.377 174.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -59.53 -40.49 87.35 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.811 1.244 . . . . 0.0 111.407 176.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -75.23 -7.89 55.12 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.721 1.609 . . . . 0.0 112.93 174.046 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 51.68 43.59 29.79 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 128.823 2.849 . . . . 0.0 112.091 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -70.05 117.64 55.97 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 125.238 1.415 . . . . 0.0 112.095 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -80.93 74.4 5.56 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 124.558 3.505 . . . . 0.0 111.193 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 30.7 t 22.4 105.13 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 130.561 3.544 . . . . 0.0 117.093 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.03 -19.5 8.78 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.79 2.993 . . . . 0.0 115.681 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 46.6 t -102.82 -63.68 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.52 1.928 . . . . 0.0 112.219 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 84.8 m -78.25 -18.75 54.95 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.288 1.835 . . . . 0.0 113.871 -176.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 63.24 7.01 2.61 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.878 2.471 . . . . 0.0 114.074 -176.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -83.84 149.59 57.02 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 124.302 1.041 . . . . 0.0 112.793 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.78 124.23 9.56 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.528 2.819 . . . . 0.0 112.212 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.99 117.23 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 126.671 1.988 . . . . 0.0 110.388 177.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -115.1 -46.32 2.91 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -174.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 1.1 ttp -143.18 155.1 44.47 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.699 1.136 . . . . 0.0 113.419 -174.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 12.8 mt -138.14 136.23 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 127.063 2.145 . . . . 0.0 109.506 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 16.2 m -138.65 150.18 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 125.5 1.52 . . . . 0.0 112.761 176.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 1.5 tt -74.95 99.95 3.99 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.313 1.045 . . . . 0.0 109.346 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 7.4 t -90.13 155.35 19.1 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -134.39 162.89 30.97 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.642 1.977 . . . . 0.0 112.703 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -93.4 167.64 13.63 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 125.277 1.431 . . . . 0.0 110.89 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo . . . . . 0 C--N 1.351 0.675 0 C-N-CA 124.1 3.2 . . . . 0.0 113.72 -179.854 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo . . . . . 0 CA--C 1.552 1.404 0 CA-C-O 121.024 0.343 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 1.7 t -68.53 166.42 17.02 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 126.114 1.766 . . . . 0.0 109.966 169.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 99.3 t -127.03 -18.5 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 O-C-N 120.346 -1.471 . . . . 0.0 111.971 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 8.3 mt -133.03 -47.06 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 119.43 1.014 . . . . 0.0 113.707 -172.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.4 m -62.86 -54.83 32.73 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.163 1.385 . . . . 0.0 113.222 -175.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -160.46 -12.75 0.05 Allowed 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 85.8 1.22 87.3 Favored Glycine 0 CA--C 1.542 1.775 0 O-C-N 120.731 -1.231 . . . . 0.0 113.533 -176.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -59.16 154.98 37.39 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 129.301 3.04 . . . . 0.0 114.034 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.41 115.67 4.38 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.413 2.742 . . . . 0.0 111.685 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -171.12 146.14 2.36 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 129.162 2.985 . . . . 0.0 108.773 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -112.12 150.21 31.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 128.091 2.557 . . . . 0.0 113.216 -174.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 171.08 82.76 0.05 OUTLIER Glycine 0 CA--C 1.532 1.094 0 C-N-CA 126.263 1.887 . . . . 0.0 112.587 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.32 144.22 55.98 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.139 0.97 . . . . 0.0 110.776 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 3.0 mp -115.09 140.86 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.387 1.475 . . . . 0.0 110.371 -177.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 98.7 t -130.06 130.23 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.12 0.968 . . . . 0.0 109.256 175.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -124.97 95.14 4.39 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.521 2.328 . . . . 0.0 111.141 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.96 -88.17 0.38 Allowed Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.069 1.795 . . . . 0.0 114.197 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -123.4 -1.63 8.59 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 126.567 1.947 . . . . 0.0 113.465 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 16.4 p -127.04 170.1 12.68 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.423 2.289 . . . . 0.0 110.373 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -158.75 176.44 35.63 Favored Glycine 0 CA--C 1.531 1.085 0 O-C-N 120.992 -1.067 . . . . 0.0 114.046 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -120.19 142.39 49.04 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.884 1.674 . . . . 0.0 112.059 177.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 45.7 tp -129.66 150.49 50.96 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.476 2.31 . . . . 0.0 109.962 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 27.8 mtm 76.21 58.41 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 129.495 3.118 . . . . 0.0 112.18 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -148.83 153.96 38.84 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.033 2.133 . . . . 0.0 110.561 177.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 14.3 p -83.36 169.38 15.69 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 122.345 1.069 . . . . 0.0 112.79 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -65.49 -37.6 87.29 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.747 -0.595 . . . . 0.0 111.768 178.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 27.6 m -63.58 -46.26 86.67 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 117.388 -1.292 . . . . 0.0 111.787 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 46.2 m -48.52 -56.1 9.23 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 120.417 1.462 . . . . 0.0 110.453 174.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -60.64 -43.54 97.43 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.974 1.709 . . . . 0.0 113.08 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -62.55 -42.3 99.45 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.642 1.177 . . . . 0.0 111.616 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -59.73 -56.47 21.41 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.185 1.394 . . . . 0.0 111.083 176.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.2 pp -62.39 -35.3 78.76 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 119.23 -0.414 . . . . 0.0 111.793 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.6 -48.12 76.11 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.358 0.981 . . . . 0.0 112.047 175.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -56.4 -43.53 79.39 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.676 1.59 . . . . 0.0 111.554 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -76.58 -5.23 46.83 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.382 1.873 . . . . 0.0 113.59 176.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 54.7 36.69 26.78 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 127.68 2.392 . . . . 0.0 111.734 -176.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -81.31 114.88 52.72 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 126.642 1.977 . . . . 0.0 111.835 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.34 129.33 17.84 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.292 1.995 . . . . 0.0 108.121 172.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 42.6 t -12.88 117.78 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 129.739 3.216 . . . . 0.0 116.19 -177.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.3 -0.13 2.65 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 123.141 2.561 . . . . 0.0 114.694 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 53.1 t -123.21 -60.11 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.145 1.778 . . . . 0.0 111.216 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 82.1 m -79.17 -15.29 58.3 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.499 1.92 . . . . 0.0 113.557 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . 0.295 51.8 ptt85 53.52 17.05 1.05 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 128.175 2.59 . . . . 0.0 115.029 -174.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -85.26 150.13 53.99 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 124.226 1.011 . . . . 0.0 112.335 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.3 118.4 5.66 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.703 2.936 . . . . 0.0 112.167 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.64 129.01 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 125.354 1.461 . . . . 0.0 111.149 178.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -109.54 -41.52 4.56 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -177.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.04 166.97 31.19 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 5.4 mt -135.17 138.67 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 127.471 2.309 . . . . 0.0 108.943 177.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 17.0 m -139.8 150.0 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 64.8 mt -73.8 99.86 3.3 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 176.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 14.4 t -98.12 150.69 21.17 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.768 0.827 . . . . 0.0 112.844 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -144.4 172.79 12.46 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.3 1.84 . . . . 0.0 111.661 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -117.99 162.11 31.12 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.442 1.097 . . . . 0.0 111.878 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo . . . . . 0 C--N 1.353 0.785 0 C-N-CA 124.243 3.295 . . . . 0.0 114.054 179.796 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo . . . . . 0 CA--C 1.544 0.993 0 N-CA-C 114.932 1.089 . . . . 0.0 114.932 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 1.5 t -50.69 142.7 10.74 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.563 1.545 . . . . 0.0 111.356 176.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.3 -1.22 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.934 1.294 . . . . 0.0 114.012 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 19.4 mt -123.21 -53.38 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.838 0.855 . . . . 0.0 112.027 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 2.4 m -71.88 -69.83 0.37 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.437 1.495 . . . . 0.0 114.355 -172.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -159.89 -1.16 0.07 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 -176.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 91.61 11.78 60.26 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-N 120.222 1.374 . . . . 0.0 113.998 -177.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -59.71 155.23 41.76 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 127.391 2.276 . . . . 0.0 112.76 176.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.11 146.55 37.95 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.468 2.779 . . . . 0.0 113.935 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.91 36.8 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -81.11 89.8 6.0 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.368 -1.457 . . . . 0.0 108.968 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 162.85 57.56 0.02 OUTLIER Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.762 1.649 . . . . 0.0 111.208 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 53.5 t -61.32 134.86 57.41 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.382 0.673 . . . . 0.0 110.254 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.23 137.23 37.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 126.248 1.819 . . . . 0.0 109.71 -176.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 86.0 t -130.06 129.06 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.011 0.924 . . . . 0.0 109.061 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -125.17 95.41 4.48 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.762 2.025 . . . . 0.0 111.701 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 73.19 -85.79 0.59 Allowed Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.844 1.688 . . . . 0.0 114.963 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 454' ' ' LYS . . . . . 0.452 ' HA ' ' HE2' ' B' ' 454' ' ' LYS . 0.6 OUTLIER -123.97 -7.66 7.79 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.188 1.795 . . . . 0.0 113.584 -177.418 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 28.1 p -125.51 170.1 11.77 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 127.179 2.192 . . . . 0.0 110.65 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -154.72 174.95 32.96 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 121.28 -0.888 . . . . 0.0 114.084 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 3.9 m-70 -120.25 142.56 48.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.359 1.463 . . . . 0.0 113.446 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.5 pp -129.58 153.29 48.21 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.306 2.643 . . . . 0.0 110.625 177.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 28.9 tpp 93.8 -7.09 0.13 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 128.976 2.91 . . . . 0.0 113.442 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -99.99 144.9 28.5 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.394 1.078 . . . . 0.0 109.404 175.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 15.4 p -82.35 174.42 11.14 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 122.196 0.998 . . . . 0.0 112.591 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.08 -37.07 78.83 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.499 -0.75 . . . . 0.0 112.16 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 60.5 m -73.69 -41.85 62.08 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 117.751 -1.119 . . . . 0.0 110.767 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 27.6 m -53.07 -57.3 10.87 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.767 1.167 . . . . 0.0 109.172 171.174 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -50.56 -48.34 57.52 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.243 1.817 . . . . 0.0 112.967 176.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -61.21 -30.29 70.34 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.306 1.442 . . . . 0.0 112.635 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -61.26 -43.62 98.58 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.424 1.011 . . . . 0.0 111.55 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -57.55 -39.61 77.04 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.427 0.691 . . . . 0.0 110.219 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -68.65 -50.75 48.74 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.987 0.515 . . . . 0.0 111.841 176.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -53.97 -45.04 71.25 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.892 1.677 . . . . 0.0 112.156 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -82.93 -7.62 59.65 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 126.501 1.92 . . . . 0.0 113.584 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 50.33 50.72 18.17 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 127.813 2.445 . . . . 0.0 111.292 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -100.73 115.7 65.03 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 126.572 1.949 . . . . 0.0 113.323 -175.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.57 129.13 19.4 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 122.51 2.14 . . . . 0.0 107.823 171.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 48.3 t -17.02 118.97 0.06 OUTLIER Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 129.951 3.3 . . . . 0.0 116.447 -174.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -65.16 0.73 2.44 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.554 2.836 . . . . 0.0 114.277 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 43.3 t -127.61 -60.41 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.7 1.6 . . . . 0.0 111.283 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 63.2 m -77.5 -16.04 58.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.58 1.952 . . . . 0.0 113.637 -177.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 60.0 7.8 1.27 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 127.239 2.216 . . . . 0.0 114.401 -175.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -79.19 149.36 72.74 Favored Pre-proline 0 CA--C 1.547 0.842 0 O-C-N 121.461 -0.774 . . . . 0.0 112.117 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.3 123.28 10.1 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.027 2.485 . . . . 0.0 110.788 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.75 109.97 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 125.205 1.402 . . . . 0.0 109.761 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -96.55 -58.17 2.12 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.571 1.149 . . . . 0.0 113.541 -174.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.49 162.97 34.43 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -177.635 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 13.3 mt -137.41 136.64 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 127.316 2.246 . . . . 0.0 108.599 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 19.4 m -136.25 150.19 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.473 1.109 . . . . 0.0 113.5 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 5.1 tt -68.27 103.15 1.52 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.668 1.587 . . . . 0.0 107.654 175.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 5.7 t -98.02 161.75 13.57 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -175.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -129.77 130.59 45.57 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.457 1.903 . . . . 0.0 111.254 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 490' ' ' PHE . . . . . 0.509 ' H ' ' CD ' ' B' ' 491' ' ' PRO . 44.3 p90 -134.03 -27.36 0.02 OUTLIER Pre-proline 0 CA--C 1.551 1.011 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -178.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 491' ' ' PRO . . . . . 0.509 ' CD ' ' H ' ' B' ' 490' ' ' PHE . 89.2 Cg_exo . . . . . 0 C--N 1.359 1.121 0 C-N-CA 123.182 2.588 . . . . 0.0 114.321 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo . . . . . 0 CA--C 1.536 0.584 0 N-CA-C 116.187 1.572 . . . . 0.0 116.187 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 46.3 t -56.65 144.48 32.07 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 120.607 1.548 . . . . 0.0 111.153 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 32.1 m -123.1 -15.31 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 10.2 pt -137.52 -25.73 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 441' ' ' CYS . . . . . 0.419 ' CB ' HH21 ' A' ' 444' ' ' ARG . 3.7 m -75.23 -65.3 0.9 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 120.72 1.6 . . . . 0.0 111.709 -177.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -145.98 -11.13 0.5 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 78.23 9.69 86.79 Favored Glycine 0 CA--C 1.546 1.978 0 CA-C-N 120.35 1.432 . . . . 0.0 112.824 -174.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 444' ' ' ARG . . . . . 0.419 HH21 ' CB ' ' A' ' 441' ' ' CYS . 26.4 ptt180 -57.94 155.24 24.62 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 131.565 3.946 . . . . 0.0 114.164 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.6 -5.85 15.21 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 124.33 3.353 . . . . 0.0 115.495 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -54.58 139.77 37.18 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.503 1.921 . . . . 0.0 110.461 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.14 150.1 50.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.182 1.793 . . . . 0.0 112.855 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -157.39 88.14 0.12 Allowed Glycine 0 CA--C 1.532 1.119 0 C-N-CA 126.306 1.907 . . . . 0.0 112.32 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 48.9 t -65.16 133.06 50.74 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 117.765 0.782 . . . . 0.0 110.647 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -110.9 144.22 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.931 1.692 . . . . 0.0 110.948 -177.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 72.7 t -129.92 134.63 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.528 1.131 . . . . 0.0 111.624 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.23 97.35 5.19 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 128.894 2.877 . . . . 0.0 110.569 174.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 65.46 -99.31 0.38 Allowed Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.859 1.695 . . . . 0.0 114.349 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -103.68 -6.29 21.72 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.032 1.733 . . . . 0.0 113.582 -178.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 44.4 p -131.5 170.07 15.21 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.384 1.473 . . . . 0.0 111.422 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -151.55 173.42 30.89 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.313 1.435 . . . . 0.0 112.216 178.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -120.06 146.48 45.87 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.222 1.009 . . . . 0.0 113.451 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.15 153.16 27.42 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.34 2.656 . . . . 0.0 111.721 -177.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 6.8 tpt 71.69 65.01 0.15 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.275 2.23 . . . . 0.0 114.323 174.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -150.9 154.93 38.1 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.635 2.374 . . . . 0.0 109.374 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 1.8 p -90.28 171.1 9.72 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.218 0.917 . . . . 0.0 111.195 174.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -65.43 -36.6 84.42 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.325 -0.859 . . . . 0.0 111.345 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 32.6 m -70.02 -42.4 73.03 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 117.623 -1.18 . . . . 0.0 110.944 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 56.4 m -50.07 -61.16 2.31 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.693 1.197 . . . . 0.0 108.642 173.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.0 -45.29 75.07 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.783 1.633 . . . . 0.0 113.251 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -58.61 -37.21 75.38 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.661 1.185 . . . . 0.0 112.316 178.419 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -58.37 -44.12 88.71 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.271 1.028 . . . . 0.0 111.06 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 6.7 mp -65.62 -45.09 84.42 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.008 0.523 . . . . 0.0 109.924 174.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -56.27 -47.4 78.65 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.51 1.524 . . . . 0.0 113.972 -176.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -54.96 -27.71 45.83 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -120.04 8.89 11.07 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 127.561 2.345 . . . . 0.0 113.187 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 38.36 60.67 1.26 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 128.509 2.724 . . . . 0.0 112.879 -174.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -69.94 118.77 66.54 Favored Pre-proline 0 N--CA 1.473 0.68 0 C-N-CA 125.485 1.514 . . . . 0.0 113.225 -176.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -55.44 121.91 10.77 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.319 2.679 . . . . 0.0 109.088 170.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 53.2 t -29.68 121.12 0.3 Allowed Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 128.413 2.685 . . . . 0.0 115.32 -174.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -66.41 -3.97 9.86 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 122.901 2.4 . . . . 0.0 113.907 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 39.2 t -107.15 -64.75 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.472 1.509 . . . . 0.0 111.294 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 24.6 p -107.8 3.27 24.28 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -176.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 71.8 mtp85 63.64 8.66 3.81 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 128.182 2.593 . . . . 0.0 116.424 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -71.22 147.84 93.51 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 123.882 0.873 . . . . 0.0 111.853 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.7 106.83 2.34 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.609 2.872 . . . . 0.0 112.607 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 pp -59.65 135.82 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.704 1.202 . . . . 0.0 111.246 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -115.15 -30.74 6.24 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -177.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.29 165.62 34.34 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -175.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 6.9 mt -133.25 140.19 47.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 127.611 2.365 . . . . 0.0 108.269 176.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 9.5 m -126.83 146.92 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.032 0.933 . . . . 0.0 111.728 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.05 99.82 4.73 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 6.4 t -92.57 172.73 8.18 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.676 0.79 . . . . 0.0 113.095 -175.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -149.41 171.21 16.93 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.135 2.174 . . . . 0.0 111.217 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -138.73 154.13 72.77 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.507 1.523 . . . . 0.0 110.521 176.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 CA--C 1.538 0.718 0 C-N-CA 123.458 2.772 . . . . 0.0 112.497 -179.765 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo . . . . . 0 CA--C 1.549 1.273 0 N-CA-C 112.522 0.162 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.26 166.71 0.54 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.549 1.539 . . . . 0.0 114.047 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 30.0 m -130.88 -3.66 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -175.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 32.9 mm -111.79 -61.29 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.464 1.106 . . . . 0.0 111.33 -177.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.2 m -62.96 -80.14 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 128.198 2.599 . . . . 0.0 114.626 -172.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -144.12 -5.59 0.77 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.092 1.357 . . . . 0.0 114.59 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 78.83 35.28 31.9 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 119.813 1.188 . . . . 0.0 111.281 -174.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 444' ' ' ARG . . . . . 0.419 ' NH2' ' H ' ' B' ' 463' ' ' THR . 14.5 ptt180 -87.69 155.31 53.46 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 128.518 2.727 . . . . 0.0 111.843 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -43.47 125.99 5.01 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 124.06 3.173 . . . . 0.0 114.059 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 41.69 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 130.392 3.477 . . . . 0.0 117.06 -177.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -81.74 89.85 6.32 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.178 -1.576 . . . . 0.0 109.735 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 168.48 59.33 0.03 OUTLIER Glycine 0 CA--C 1.529 0.935 0 C-N-CA 123.96 0.791 . . . . 0.0 113.464 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 42.6 t -58.58 134.95 57.19 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.367 1.084 . . . . 0.0 110.205 178.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.1 mp -106.1 133.77 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 126.207 1.803 . . . . 0.0 108.211 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 92.6 t -120.46 130.39 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 121.656 0.741 . . . . 0.0 110.001 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.01 109.98 13.62 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 128.448 2.699 . . . . 0.0 110.757 177.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 68.22 -89.78 0.21 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.736 1.636 . . . . 0.0 112.938 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.41 4.04 4.3 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.604 1.962 . . . . 0.0 114.069 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 62.8 p -127.5 170.03 13.03 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.147 1.779 . . . . 0.0 110.742 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -150.5 171.41 30.35 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 121.075 -1.015 . . . . 0.0 114.626 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -120.35 143.49 48.37 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.428 1.491 . . . . 0.0 113.975 176.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 82.8 mt -125.11 153.24 43.27 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.958 2.903 . . . . 0.0 111.243 178.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 60.8 mtt 107.15 -2.68 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 1 C-N-CA 132.027 4.131 . . . . 0.0 113.551 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -108.24 145.63 34.02 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.73 1.212 . . . . 0.0 109.87 175.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 14.8 p -82.01 174.88 10.83 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 122.796 1.284 . . . . 0.0 112.103 178.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -59.68 -37.75 79.64 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.633 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 463' ' ' THR . . . . . 0.419 ' H ' ' NH2' ' B' ' 444' ' ' ARG . 87.4 m -70.62 -44.63 66.83 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 117.326 -1.321 . . . . 0.0 110.979 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 77.3 m -50.16 -53.25 29.03 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 120.462 1.483 . . . . 0.0 109.734 171.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -59.64 -43.33 93.91 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.794 1.638 . . . . 0.0 113.294 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -63.15 -42.66 99.48 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.913 1.285 . . . . 0.0 111.044 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -59.68 -56.55 20.45 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.687 1.195 . . . . 0.0 110.944 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.62 -33.23 72.46 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 122.691 0.396 . . . . 0.0 111.928 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -68.18 -48.02 66.41 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.841 1.257 . . . . 0.0 112.38 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -58.15 -40.79 82.26 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.862 1.265 . . . . 0.0 111.355 176.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 29.0 mmt85 -76.49 -7.79 55.85 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.203 1.801 . . . . 0.0 113.475 175.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 64.0 t30 52.63 40.33 29.92 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 128.012 2.525 . . . . 0.0 112.233 -177.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -74.55 131.37 80.09 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 125.647 1.579 . . . . 0.0 112.737 -177.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -71.9 123.54 9.41 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.732 2.288 . . . . 0.0 107.924 170.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 43.9 t -14.54 119.24 0.04 OUTLIER Pre-proline 0 CA--C 1.557 1.224 0 C-N-CA 130.062 3.345 . . . . 0.0 115.994 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -65.8 -1.13 4.58 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 123.202 2.601 . . . . 0.0 114.72 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 35.6 t -114.02 -60.79 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.281 1.432 . . . . 0.0 111.919 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 28.0 p -114.77 6.69 15.63 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -176.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . 0.31 13.8 ptm180 54.07 14.86 0.77 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 129.288 3.035 . . . . 0.0 117.56 177.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -68.02 152.32 96.52 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 123.852 0.861 . . . . 0.0 111.722 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -74.1 106.17 2.17 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 124.034 3.156 . . . . 0.0 113.344 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 pp -60.21 136.14 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.621 1.169 . . . . 0.0 111.494 177.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -115.07 -40.72 3.43 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.909 1.284 . . . . 0.0 113.678 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.21 167.46 30.3 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -176.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 6.0 mt -129.79 139.08 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 127.958 2.503 . . . . 0.0 107.587 175.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 14.1 p -131.54 146.42 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.137 0.975 . . . . 0.0 112.427 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.51 99.95 1.04 Allowed 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 1.8 m -102.27 95.54 6.37 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.244 1.418 . . . . 0.0 111.687 -174.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -83.22 159.78 21.91 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.46 1.104 . . . . 0.0 113.83 -178.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -78.71 158.85 75.17 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 125.643 1.577 . . . . 0.0 112.226 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo . . . . . 0 C--N 1.353 0.797 0 C-N-CA 124.39 3.393 . . . . 0.0 113.572 178.04 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo . . . . . 0 CA--C 1.552 1.422 0 CA-C-O 120.682 0.201 . . . . 0.0 112.149 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 10.6 t -42.97 145.9 0.44 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.796 2.038 . . . . 0.0 111.972 174.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.13 -27.95 3.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 124.081 0.952 . . . . 0.0 112.613 -175.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 7.9 pt -141.39 -24.65 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 117.727 2.492 . . . . 0.0 117.727 -172.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.7 m -77.02 -64.61 1.09 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 120.617 1.553 . . . . 0.0 114.398 -174.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -153.03 -10.08 0.16 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -171.057 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 87.16 10.21 71.93 Favored Glycine 0 CA--C 1.541 1.691 0 CA-C-N 119.959 1.254 . . . . 0.0 113.13 -176.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -64.72 155.22 83.02 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 128.589 2.755 . . . . 0.0 113.43 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -46.72 139.51 13.7 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 124.396 3.398 . . . . 0.0 116.446 -177.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.33 13.44 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 131.436 3.894 . . . . 0.0 118.918 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.04 89.78 5.96 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.503 -1.373 . . . . 0.0 112.039 -177.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -178.59 44.58 0.09 OUTLIER Glycine 0 CA--C 1.529 0.906 0 CA-C-O 118.899 -0.945 . . . . 0.0 113.63 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 42.9 t -57.42 135.97 56.6 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.86 1.33 . . . . 0.0 110.689 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.4 mp -108.23 142.93 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 126.647 1.979 . . . . 0.0 109.037 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 95.1 t -129.76 133.41 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.419 0.628 . . . . 0.0 110.497 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -124.91 96.76 4.99 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.692 2.397 . . . . 0.0 111.087 176.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 71.54 -89.16 0.44 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 126.06 1.79 . . . . 0.0 114.075 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -124.07 0.79 8.53 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 126.238 1.815 . . . . 0.0 114.232 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 16.8 p -127.14 167.58 15.82 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.122 2.169 . . . . 0.0 109.922 178.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.51 172.18 34.23 Favored Glycine 0 CA--C 1.527 0.79 0 O-C-N 121.166 -0.959 . . . . 0.0 113.985 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -119.97 137.28 54.16 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.249 1.82 . . . . 0.0 111.192 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 60.0 tp -133.12 153.35 51.6 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.005 2.122 . . . . 0.0 111.601 -173.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 459' ' ' MET . . . . . . . . . . . . 0.256 29.4 mtt 81.89 56.7 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.204 2.202 . . . . 0.0 113.104 178.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -158.84 150.61 20.92 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 130.398 3.479 . . . . 0.0 106.824 176.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 16.1 p -78.08 171.22 15.34 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 123.164 1.459 . . . . 0.0 113.582 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.81 -36.92 77.77 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.835 175.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 11.4 m -66.66 -47.22 73.2 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 117.413 -1.279 . . . . 0.0 110.943 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 49.5 m -49.86 -52.79 30.01 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 120.53 1.514 . . . . 0.0 109.664 173.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -60.11 -43.03 95.9 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.665 1.586 . . . . 0.0 113.37 176.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -64.79 -40.68 95.63 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.63 -1.294 . . . . 0.0 111.43 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -61.95 -56.47 18.84 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.519 1.127 . . . . 0.0 110.835 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.2 pp -58.46 -33.49 69.81 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 118.461 0.573 . . . . 0.0 112.163 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -66.75 -50.38 62.94 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.216 1.406 . . . . 0.0 112.02 174.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -58.23 -38.39 76.75 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.434 1.094 . . . . 0.0 111.643 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -78.16 -1.67 33.83 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 127.051 2.14 . . . . 0.0 113.351 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.34 37.24 5.66 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 129.04 2.936 . . . . 0.0 113.922 -177.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -70.11 116.56 45.6 Favored Pre-proline 0 CA--C 1.539 0.519 0 C-N-CA 126.412 1.885 . . . . 0.0 113.734 -177.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.31 139.11 37.57 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 N-CA-C 106.799 -2.039 . . . . 0.0 106.799 169.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 53.2 t -38.63 121.91 1.15 Allowed Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 126.32 1.848 . . . . 0.0 114.37 -176.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.2 -1.24 7.66 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.063 2.509 . . . . 0.0 114.045 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 48.2 t -122.15 -60.57 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.711 1.604 . . . . 0.0 111.333 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 64.5 m -76.49 -17.84 59.07 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.731 2.012 . . . . 0.0 112.841 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 73.8 mtp85 64.52 5.38 2.64 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 127.635 2.374 . . . . 0.0 114.203 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -84.54 147.22 48.93 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.107 0.963 . . . . 0.0 113.386 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.1 120.08 5.89 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.485 2.79 . . . . 0.0 111.531 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.4 pp -59.0 141.14 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.541 1.137 . . . . 0.0 111.436 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -115.01 -38.25 3.93 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -177.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.44 167.05 31.64 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -176.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 14.2 mt -131.95 143.14 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 127.639 2.376 . . . . 0.0 108.7 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 8.4 m -134.12 150.16 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.336 1.455 . . . . 0.0 112.6 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -72.78 99.9 2.74 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 3.5 m -88.0 104.88 17.06 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -172.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -78.57 166.48 22.51 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.14 1.776 . . . . 0.0 110.701 173.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -123.15 170.45 8.23 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 126.095 1.758 . . . . 0.0 111.364 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo . . . . . 0 C--N 1.351 0.681 0 C-N-CA 123.92 3.08 . . . . 0.0 113.688 -178.713 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo . . . . . 0 CA--C 1.538 0.709 0 N-CA-C 114.186 0.802 . . . . 0.0 114.186 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 438' ' ' CYS . . . . . 0.414 ' SG ' ' N ' ' B' ' 439' ' ' VAL . 18.6 t -70.43 -175.23 0.98 Allowed 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 122.22 1.01 . . . . 0.0 112.601 175.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 439' ' ' VAL . . . . . 0.414 ' N ' ' SG ' ' B' ' 438' ' ' CYS . 3.6 p -144.4 2.75 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 126.446 1.898 . . . . 0.0 112.749 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 41.9 mt -113.97 -61.14 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.259 1.024 . . . . 0.0 111.408 -175.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 8.1 p -56.35 -83.23 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.593 1.557 . . . . 0.0 113.526 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -147.53 -7.68 0.44 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 129.867 3.267 . . . . 0.0 112.577 -177.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 85.49 39.23 8.41 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.011 0.823 . . . . 0.0 113.073 -177.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -66.1 152.33 94.02 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 124.957 1.303 . . . . 0.0 111.191 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.82 66.7 5.84 Favored 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 124.546 3.497 . . . . 0.0 113.667 -176.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -141.52 145.89 35.71 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.9 2.48 . . . . 0.0 110.374 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.29 144.74 51.16 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.103 1.761 . . . . 0.0 112.379 176.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -156.9 87.28 0.12 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 126.632 2.063 . . . . 0.0 110.781 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 45.4 t -62.09 137.16 58.21 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 117.606 0.703 . . . . 0.0 110.969 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -114.93 148.64 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 126.301 1.84 . . . . 0.0 110.174 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 38.7 t -117.69 140.97 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.071 1.348 . . . . 0.0 109.071 174.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -125.18 94.86 4.29 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.794 2.438 . . . . 0.0 107.569 175.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 62.25 -91.7 0.07 OUTLIER Glycine 0 CA--C 1.542 1.745 0 C-N-CA 124.648 1.118 . . . . 0.0 113.612 -176.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 50.4 mmtm -120.98 6.64 10.35 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 127.612 2.365 . . . . 0.0 113.296 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 30.3 p -120.73 170.22 9.65 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 128.172 2.589 . . . . 0.0 109.501 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.17 170.0 33.79 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 120.368 -1.458 . . . . 0.0 113.328 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.23 145.48 46.98 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.606 1.162 . . . . 0.0 114.135 177.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 3.6 pp -116.13 153.21 32.18 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.488 1.915 . . . . 0.0 112.421 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 21.6 ttt 70.55 66.14 0.19 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.611 2.364 . . . . 0.0 113.88 176.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -154.52 145.89 23.01 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 128.247 2.619 . . . . 0.0 107.802 175.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 29.1 p -79.54 164.96 23.46 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 120.71 1.595 . . . . 0.0 112.398 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -63.81 -34.75 78.6 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.138 177.054 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 37.3 m -62.55 -57.62 10.47 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.517 1.127 . . . . 0.0 110.51 176.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 33.1 m -54.12 -47.31 71.97 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 120.057 1.299 . . . . 0.0 112.469 176.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.64 -44.27 90.01 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.779 0.832 . . . . 0.0 112.554 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -64.98 -40.66 95.3 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.749 -1.22 . . . . 0.0 111.479 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -59.63 -56.61 19.76 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.927 1.291 . . . . 0.0 111.072 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.1 pp -61.84 -34.33 75.76 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -65.19 -48.97 71.56 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.402 1.081 . . . . 0.0 112.154 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -52.26 -43.69 64.5 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.739 1.616 . . . . 0.0 112.639 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -90.81 4.7 50.98 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.517 1.527 . . . . 0.0 114.141 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 65.4 t30 49.87 40.81 21.56 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.796 2.438 . . . . 0.0 113.366 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -71.04 117.23 54.43 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 126.215 1.806 . . . . 0.0 111.582 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.62 123.01 12.74 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.102 2.535 . . . . 0.0 108.571 171.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 42.7 t -22.98 122.14 0.16 Allowed Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 128.384 2.674 . . . . 0.0 115.887 -174.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -65.47 -2.37 6.03 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 122.817 2.345 . . . . 0.0 114.151 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 46.4 t -112.57 -61.68 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.595 1.558 . . . . 0.0 111.659 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 32.1 p -105.38 -6.86 19.2 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 61.94 11.07 3.94 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 127.693 2.397 . . . . 0.0 115.769 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -69.61 155.33 93.7 Favored Pre-proline 0 CA--C 1.554 1.118 0 O-C-N 121.22 -0.925 . . . . 0.0 111.861 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.85 116.95 4.91 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.703 2.935 . . . . 0.0 111.978 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 1.9 pp -65.31 147.91 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.452 1.101 . . . . 0.0 112.361 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -115.15 -62.8 1.55 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.201 1.8 . . . . 0.0 111.691 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.8 170.31 22.75 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.062 1.345 . . . . 0.0 113.431 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 7.3 mt -123.65 142.66 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 126.879 2.072 . . . . 0.0 109.038 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 9.4 m -138.27 150.14 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.788 1.235 . . . . 0.0 112.714 176.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 58.7 tp -69.85 99.9 1.46 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.003 1.321 . . . . 0.0 109.385 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 7.3 t -87.28 159.47 18.78 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -142.17 124.76 15.82 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.934 2.094 . . . . 0.0 111.212 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -84.28 -31.61 0.48 Allowed Pre-proline 0 CA--C 1.555 1.138 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 175.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 C--N 1.36 1.183 0 C-N-CA 122.995 2.464 . . . . 0.0 113.8 178.708 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo . . . . . 0 CA--C 1.537 0.643 0 N-CA-C 116.002 1.501 . . . . 0.0 116.002 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 31.6 t -55.41 145.86 21.31 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 120.46 1.482 . . . . 0.0 111.645 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 15.8 m -134.85 -13.04 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.335 1.054 . . . . 0.0 113.251 177.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 24.1 mm -110.0 -43.98 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.91 1.284 . . . . 0.0 112.451 -177.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.1 m -79.89 -66.1 0.92 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -170.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -151.18 -14.31 0.21 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -174.812 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 84.75 12.41 74.86 Favored Glycine 0 CA--C 1.539 1.565 0 O-C-N 120.833 -1.167 . . . . 0.0 112.328 -174.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -61.52 155.11 61.17 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 127.883 2.473 . . . . 0.0 113.311 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.99 -6.38 7.76 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.32 3.347 . . . . 0.0 117.646 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -55.79 144.75 26.43 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.24 1.416 . . . . 0.0 111.161 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.12 141.11 51.58 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.545 1.938 . . . . 0.0 113.047 -176.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -163.43 82.57 0.12 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.853 1.692 . . . . 0.0 111.918 177.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 12.1 t -63.75 147.75 50.93 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.089 0.956 . . . . 0.0 110.899 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.4 mp -115.04 141.78 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 125.801 1.64 . . . . 0.0 109.376 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 80.7 t -123.35 137.21 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.489 1.116 . . . . 0.0 109.815 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -124.63 94.89 4.33 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.697 2.399 . . . . 0.0 108.044 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 60.86 -95.53 0.09 OUTLIER Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.327 1.442 . . . . 0.0 113.895 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -110.47 3.71 19.85 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.803 2.041 . . . . 0.0 113.359 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 22.1 p -126.52 170.12 12.34 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.167 1.787 . . . . 0.0 111.592 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.4 164.39 32.47 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 120.89 -1.131 . . . . 0.0 113.413 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -120.09 117.58 28.33 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.739 1.616 . . . . 0.0 111.869 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 7.3 tt -90.64 153.06 20.59 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.951 1.701 . . . . 0.0 110.863 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 3.4 tpt 86.19 64.95 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 128.274 2.63 . . . . 0.0 113.627 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -155.75 151.48 27.35 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.27 2.228 . . . . 0.0 108.987 175.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 14.1 p -89.21 175.0 7.54 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.834 0.826 . . . . 0.0 110.456 172.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.24 -38.58 91.74 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.342 -0.849 . . . . 0.0 110.972 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 38.1 m -67.66 -44.32 78.15 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 117.453 -1.26 . . . . 0.0 110.981 177.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 57.1 m -51.27 -60.22 3.36 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 120.288 1.404 . . . . 0.0 109.683 173.458 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -53.15 -40.5 64.34 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.197 1.799 . . . . 0.0 113.05 177.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -61.14 -31.37 71.09 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.467 1.107 . . . . 0.0 112.022 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -59.91 -51.03 71.42 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 120.106 1.321 . . . . 0.0 110.471 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -56.51 -45.07 81.25 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.088 0.955 . . . . 0.0 110.29 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -65.98 -51.94 53.96 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.632 1.173 . . . . 0.0 113.492 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -43.91 83.3 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.016 1.727 . . . . 0.0 111.673 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -79.21 -8.92 59.4 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.082 1.753 . . . . 0.0 112.962 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 48.02 47.13 19.1 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 128.058 2.543 . . . . 0.0 111.053 -175.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -87.2 123.5 69.89 Favored Pre-proline 0 N--CA 1.469 0.509 0 C-N-CA 124.711 1.205 . . . . 0.0 113.049 -174.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.47 90.69 1.1 Allowed 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 123.756 2.971 . . . . 0.0 109.599 175.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 33.7 t 18.85 113.95 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.141 1 C-N-CA 132.934 4.494 . . . . 0.0 118.115 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.98 -0.12 3.7 Favored 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 122.636 2.224 . . . . 0.0 113.759 176.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 35.2 t -110.12 -66.67 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.816 1.647 . . . . 0.0 111.616 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 28.3 p -95.68 -5.53 42.02 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 120.258 1.39 . . . . 0.0 114.604 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? 63.5 10.09 4.64 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.469 2.307 . . . . 0.0 115.172 178.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -74.81 153.66 87.06 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 124.503 1.121 . . . . 0.0 112.208 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -72.36 107.16 2.21 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.477 2.785 . . . . 0.0 111.384 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.0 pp -58.48 141.3 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.834 1.254 . . . . 0.0 111.107 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -115.09 -49.7 2.78 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -177.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.82 169.06 24.3 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -174.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 7.6 mt -131.94 139.57 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 128.496 2.719 . . . . 0.0 108.102 175.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 16.2 m -137.87 150.27 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.405 1.482 . . . . 0.0 111.615 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 60.4 tp -68.35 99.93 1.0 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.71 0.804 . . . . 0.0 108.939 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.67 90.72 3.59 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.985 1.314 . . . . 0.0 111.955 -173.045 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -59.8 124.48 20.3 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.349 1.46 . . . . 0.0 112.921 -179.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -68.74 159.05 83.92 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 124.609 1.164 . . . . 0.0 111.367 176.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo . . . . . 0 CA--C 1.538 0.702 0 C-N-CA 122.98 2.453 . . . . 0.0 112.412 179.184 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 CA--C 1.545 1.055 0 N-CA-C 113.948 0.711 . . . . 0.0 113.948 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 5.5 p -59.45 177.03 0.21 Allowed 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 115.961 1.838 . . . . 0.0 115.961 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 7.9 p -134.31 -9.19 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -172.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 6.9 mt -115.0 -62.56 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 119.937 1.244 . . . . 0.0 112.961 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 11.4 p -65.76 -59.31 4.03 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -174.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 18.1 tp60 -151.76 -18.27 0.19 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 -174.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 91.0 39.63 5.72 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -173.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -95.25 155.13 39.21 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 125.8 1.64 . . . . 0.0 112.787 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -48.31 126.68 14.17 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.686 2.924 . . . . 0.0 113.703 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -55.27 97.56 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 127.407 2.283 . . . . 0.0 114.635 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -128.05 89.86 2.99 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.041 1.336 . . . . 0.0 107.705 176.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 156.02 58.78 0.01 OUTLIER Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.687 1.137 . . . . 0.0 112.395 -177.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 44.3 t -57.1 115.47 2.66 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.906 1.283 . . . . 0.0 112.005 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 450' ' ' ILE . . . . . 0.431 HD12 ' H ' ' B' ' 450' ' ' ILE . 3.0 mp -88.73 122.4 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.736 1.614 . . . . 0.0 109.696 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 95.6 t -122.64 123.26 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.822 1.249 . . . . 0.0 110.483 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -108.02 101.59 10.83 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.099 2.56 . . . . 0.0 110.703 175.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.5 -88.25 0.35 Allowed Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.842 1.687 . . . . 0.0 113.759 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -129.49 6.95 5.27 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.335 1.854 . . . . 0.0 114.333 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 43.2 p -136.68 169.98 16.83 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.421 1.888 . . . . 0.0 110.367 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -161.44 169.85 37.05 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 120.618 -1.301 . . . . 0.0 114.527 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 45.6 m-70 -120.21 99.94 6.89 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.992 1.717 . . . . 0.0 110.076 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.51 92.86 8.26 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 122.87 1.319 . . . . 0.0 110.709 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 28.1 ptm -156.39 1.45 0.14 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -176.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -143.84 174.67 10.62 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.085 1.354 . . . . 0.0 111.139 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 30.6 p -101.82 175.0 5.7 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 123.032 1.396 . . . . 0.0 113.734 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.02 -40.64 77.08 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.999 1.72 . . . . 0.0 112.535 -178.357 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 67.3 m -61.39 -53.56 55.0 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.089 0.956 . . . . 0.0 110.251 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 73.5 m -55.46 -49.12 73.32 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.387 1.075 . . . . 0.0 110.955 175.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.24 -54.91 37.47 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.708 1.203 . . . . 0.0 112.687 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -66.08 -33.83 76.68 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.025 -1.047 . . . . 0.0 112.73 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -59.75 -52.77 64.06 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.388 1.075 . . . . 0.0 110.379 176.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 22.6 mt -52.11 -51.22 59.15 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.7 1.2 . . . . 0.0 110.063 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -53.75 -49.02 69.1 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.948 1.299 . . . . 0.0 112.469 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -62.5 -40.57 97.14 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.075 1.35 . . . . 0.0 112.019 175.482 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 42.4 mmt180 -71.72 -6.35 40.62 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 126.401 1.88 . . . . 0.0 113.382 175.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 35.5 t30 83.87 4.14 0.81 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 130.928 3.691 . . . . 0.0 115.761 176.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -86.68 128.47 56.42 Favored Pre-proline 0 N--CA 1.475 0.775 0 CA-C-N 120.359 1.436 . . . . 0.0 109.799 176.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.16 -75.77 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.869 2.379 . . . . 0.0 111.701 178.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 41.6 t -109.26 133.3 20.83 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 126.554 1.942 . . . . 0.0 111.294 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.31 -5.39 16.14 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.337 2.691 . . . . 0.0 113.733 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 23.9 t -110.0 -76.99 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.472 1.109 . . . . 0.0 112.454 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 22.4 p -94.87 -4.99 45.97 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.862 1.665 . . . . 0.0 114.552 -176.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 65.2 13.43 8.74 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.487 2.315 . . . . 0.0 114.655 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -64.44 128.69 93.62 Favored Pre-proline 0 CA--C 1.552 1.035 0 O-C-N 121.34 -0.85 . . . . 0.0 110.793 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -49.19 113.72 1.02 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 124.536 3.49 . . . . 0.0 115.127 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.5 pp -71.7 142.58 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.776 1.231 . . . . 0.0 112.314 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -115.14 -34.87 4.88 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.733 1.613 . . . . 0.0 113.73 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 1.4 ttp -146.73 150.84 36.16 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 12.2 mt -139.07 130.81 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 128.363 2.665 . . . . 0.0 106.698 173.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 21.0 m -137.4 150.16 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 124.941 1.296 . . . . 0.0 113.573 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 5.7 tt -64.74 99.95 0.36 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.907 1.283 . . . . 0.0 109.019 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 45.6 m -95.35 113.32 24.98 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.527 1.531 . . . . 0.0 113.683 -173.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -75.46 100.85 4.62 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.07 1.348 . . . . 0.0 110.352 175.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -75.48 156.01 85.38 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 125.406 1.482 . . . . 0.0 111.585 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo . . . . . 0 C--N 1.351 0.695 0 C-N-CA 123.504 2.803 . . . . 0.0 111.566 -179.518 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 64.5 m . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.598 ' H ' ' HD2' ' A' ' 431' ' ' PRO . 58.5 tp -124.8 -47.81 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 126.869 2.067 . . . . 0.0 114.49 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.598 ' HD2' ' H ' ' A' ' 430' ' ' LEU . 73.3 Cg_endo -74.42 -173.74 1.58 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.555 2.17 . . . . 0.0 112.643 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 59.6 tp -53.4 -22.31 7.41 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.657 1.983 . . . . 0.0 114.709 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -63.59 29.71 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 128.882 2.873 . . . . 0.0 115.79 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -135.81 25.06 3.37 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 126.842 2.057 . . . . 0.0 114.012 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 88.4 mt -54.45 -50.45 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.607 1.163 . . . . 0.0 113.61 -177.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 50.76 70.43 2.01 Favored Pre-proline 0 CA--C 1.559 1.315 0 C-N-CA 126.096 1.758 . . . . 0.0 111.915 -176.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -76.63 -169.79 0.78 Allowed 'Trans proline' 0 CA--C 1.545 1.049 1 C-N-CA 125.931 4.42 . . . . 0.0 115.089 -175.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 7.6 t -51.33 156.87 1.09 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 128.317 2.647 . . . . 0.0 111.771 173.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 3.8 p -134.82 -2.4 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.847 0.859 . . . . 0.0 113.019 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 13.1 mt -131.11 -49.61 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.622 1.169 . . . . 0.0 112.591 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.7 m -65.99 -60.69 2.59 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.689 1.196 . . . . 0.0 113.957 -174.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -160.29 -9.21 0.05 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 85.57 16.36 64.15 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-N 119.963 1.256 . . . . 0.0 113.245 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -64.61 151.16 92.64 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 127.003 2.121 . . . . 0.0 112.982 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -54.48 -8.05 1.04 Allowed 'Trans proline' 0 CA--C 1.544 1.018 1 C-N-CA 125.526 4.151 . . . . 0.0 119.717 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -59.79 153.89 19.56 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 120.236 1.38 . . . . 0.0 112.459 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -128.12 150.2 50.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.887 2.475 . . . . 0.0 110.779 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -172.71 80.99 0.08 OUTLIER Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.665 1.126 . . . . 0.0 113.468 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 19.8 t -65.14 142.49 58.33 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.082 0.941 . . . . 0.0 110.245 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.88 142.47 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.854 1.662 . . . . 0.0 110.773 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 98.8 t -130.05 121.61 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.585 1.154 . . . . 0.0 111.303 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.3 125.43 43.51 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.949 2.9 . . . . 0.0 112.977 175.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 49.92 34.96 23.94 Favored Glycine 0 CA--C 1.54 1.618 0 N-CA-C 116.578 1.391 . . . . 0.0 116.578 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm 77.42 9.21 2.59 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 127.711 2.404 . . . . 0.0 114.351 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 78.5 p -118.58 161.7 19.62 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 127.405 2.282 . . . . 0.0 107.641 172.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -153.17 166.29 31.52 Favored Glycine 0 CA--C 1.523 0.571 0 O-C-N 119.891 -1.756 . . . . 0.0 115.668 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -120.12 128.49 53.5 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 126.499 1.92 . . . . 0.0 112.022 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 55.3 tp -120.59 153.23 37.08 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.432 2.293 . . . . 0.0 111.364 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 34.2 mtm 90.72 54.27 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 129.44 3.096 . . . . 0.0 112.804 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -155.73 163.88 39.31 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 128.316 2.646 . . . . 0.0 108.992 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 15.3 p -91.54 175.02 7.06 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 122.896 1.332 . . . . 0.0 112.828 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -65.15 -36.08 83.11 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.049 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 25.2 m -67.39 -46.32 73.61 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 117.143 -1.408 . . . . 0.0 110.547 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 37.9 m -48.28 -56.46 7.96 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.442 1.474 . . . . 0.0 109.89 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.53 -52.59 65.0 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.43 1.492 . . . . 0.0 112.578 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -56.79 -42.05 78.8 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.459 1.503 . . . . 0.0 112.243 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -59.31 -54.02 51.61 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.012 1.725 . . . . 0.0 110.375 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . 0.254 0.4 OUTLIER -68.09 -31.14 70.55 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 179.233 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -62.88 -56.54 16.36 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.667 1.987 . . . . 0.0 112.226 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -62.86 -33.49 75.38 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -76.42 -3.16 35.6 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.633 1.573 . . . . 0.0 112.179 173.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 64.2 t30 48.24 42.12 17.11 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 128.066 2.546 . . . . 0.0 112.599 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -70.52 129.64 89.91 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 124.611 1.164 . . . . 0.0 112.949 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.33 123.74 8.44 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.616 2.211 . . . . 0.0 108.117 170.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 25.3 t -31.14 129.52 0.27 Allowed Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 128.311 2.645 . . . . 0.0 114.289 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -65.58 -3.86 8.6 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.286 2.658 . . . . 0.0 114.74 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 43.6 t -126.09 -59.59 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.281 1.432 . . . . 0.0 111.259 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 63.8 m -76.0 -19.83 58.35 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.351 1.861 . . . . 0.0 113.137 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 63.5 9.14 3.98 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 127.217 2.207 . . . . 0.0 114.028 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -82.81 137.95 43.69 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 125.007 1.323 . . . . 0.0 112.213 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.85 119.35 6.15 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.149 2.566 . . . . 0.0 108.704 174.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 6.2 pt -66.95 147.08 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -174.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -115.16 -35.77 4.59 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 -174.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 1.4 ttp -145.9 151.37 37.75 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -171.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 4.4 mt -137.04 136.75 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 127.62 2.368 . . . . 0.0 109.08 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 15.7 m -140.04 150.02 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 124.704 1.202 . . . . 0.0 112.953 177.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 55.5 mt -69.94 99.95 1.5 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.213 1.005 . . . . 0.0 108.612 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 26.2 m -101.26 94.89 6.18 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.119 1.768 . . . . 0.0 112.464 -174.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -83.7 164.11 19.84 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.401 1.48 . . . . 0.0 113.353 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -120.42 164.19 24.32 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.546 1.538 . . . . 0.0 112.555 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo . . . . . 0 C--N 1.353 0.815 0 C-N-CA 124.482 3.454 . . . . 0.0 113.915 -179.879 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 98.5 mt -62.6 148.51 90.68 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.32 1.048 . . . . 0.0 113.605 -177.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -76.93 -3.68 14.05 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 123.899 3.066 . . . . 0.0 113.668 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 22.3 mt -141.76 159.92 41.24 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 128.013 2.525 . . . . 0.0 108.53 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 57.12 -10.61 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 129.76 3.224 . . . . 0.0 116.88 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -73.74 49.02 0.3 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 127.205 2.202 . . . . 0.0 113.551 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 13.1 mm -78.46 62.21 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.971 1.708 . . . . 0.0 110.034 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -73.87 158.71 85.63 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 126.746 2.018 . . . . 0.0 113.25 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -79.61 178.93 6.79 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.446 2.764 . . . . 0.0 112.978 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 438' ' ' CYS . . . . . 0.403 ' SG ' ' N ' ' B' ' 439' ' ' VAL . 40.1 t -54.59 178.06 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 127.583 2.353 . . . . 0.0 113.22 175.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 439' ' ' VAL . . . . . 0.403 ' N ' ' SG ' ' B' ' 438' ' ' CYS . 7.4 p -111.76 -11.47 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.39 1.876 . . . . 0.0 112.343 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 7.3 mt -113.91 -66.76 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.739 1.215 . . . . 0.0 111.341 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 17.0 p -73.57 -43.73 59.09 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 120.519 1.509 . . . . 0.0 108.869 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 57.87 13.5 2.13 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.936 2.894 . . . . 0.0 113.903 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . -85.22 -27.41 33.56 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 121.576 -0.703 . . . . 0.0 112.459 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -115.5 155.12 47.62 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 126.941 2.096 . . . . 0.0 115.384 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -56.84 155.17 28.56 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.094 3.196 . . . . 0.0 113.238 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -65.47 32.03 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 127.761 2.424 . . . . 0.0 116.148 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -81.78 89.96 6.34 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.061 -1.649 . . . . 0.0 109.822 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 165.93 58.8 0.03 OUTLIER Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.36 0.981 . . . . 0.0 112.401 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 43.3 t -59.3 126.29 27.06 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.394 1.097 . . . . 0.0 109.99 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 2.4 mp -102.07 142.81 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.187 1.395 . . . . 0.0 110.418 -176.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 88.5 t -130.01 132.88 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.856 0.862 . . . . 0.0 111.241 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -121.18 96.21 5.0 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 128.519 2.728 . . . . 0.0 110.047 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 71.21 -91.48 0.46 Allowed Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.716 1.627 . . . . 0.0 114.057 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -120.25 -2.19 10.16 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.169 1.788 . . . . 0.0 113.916 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 82.3 p -127.77 167.87 15.91 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.468 1.907 . . . . 0.0 109.882 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -150.67 177.52 28.67 Favored Glycine 0 CA--C 1.527 0.806 0 O-C-N 121.054 -1.029 . . . . 0.0 114.324 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.11 148.22 43.89 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.138 1.375 . . . . 0.0 114.524 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.8 tt -116.12 153.16 32.26 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 130.188 3.395 . . . . 0.0 110.388 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 29.1 tpp 78.48 30.72 0.38 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 116.65 2.092 . . . . 0.0 116.65 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -136.08 149.89 48.91 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.6 1.56 . . . . 0.0 108.88 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 29.3 p -88.1 172.14 9.74 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.674 1.226 . . . . 0.0 113.918 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.17 -36.11 78.95 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.736 175.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 63.4 m -62.53 -63.5 1.21 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.143 0.977 . . . . 0.0 109.964 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 77.5 m -53.79 -42.98 68.9 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.815 1.246 . . . . 0.0 112.754 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -60.67 -48.26 82.57 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.31 -0.869 . . . . 0.0 112.046 173.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -59.75 -43.22 94.37 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 120.771 -1.206 . . . . 0.0 111.205 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -57.79 -54.96 40.94 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.222 1.009 . . . . 0.0 111.09 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.32 -30.39 71.53 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -67.44 -48.14 68.1 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.337 1.455 . . . . 0.0 112.359 175.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -59.01 -37.49 77.04 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.381 1.072 . . . . 0.0 111.56 176.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 39.4 tpt85 -76.21 -10.54 59.49 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.872 2.469 . . . . 0.0 112.393 174.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 64.1 t30 52.76 42.62 31.83 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.323 2.249 . . . . 0.0 111.919 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 34.2 tttp -70.01 129.04 91.24 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.644 1.178 . . . . 0.0 113.401 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.61 124.44 8.82 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 122.638 2.225 . . . . 0.0 107.579 169.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 40.2 t -30.72 128.36 0.27 Allowed Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 128.294 2.638 . . . . 0.0 114.734 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -66.53 -3.04 8.35 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.172 2.581 . . . . 0.0 114.585 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 41.8 t -127.68 -58.49 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.172 1.389 . . . . 0.0 111.619 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 60.6 m -77.31 -17.57 58.2 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.43 1.892 . . . . 0.0 112.679 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 44.6 mtm105 62.76 7.85 2.75 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.527 2.331 . . . . 0.0 114.368 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -86.38 143.03 35.93 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 123.829 0.851 . . . . 0.0 112.914 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.38 126.46 10.38 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.359 2.706 . . . . 0.0 110.218 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 7.3 pt -72.19 153.8 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -115.05 -41.84 3.28 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.515 1.526 . . . . 0.0 114.019 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.98 167.16 30.09 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -174.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 7.9 mt -134.33 137.38 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 128.097 2.559 . . . . 0.0 107.728 177.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 3.7 t -127.01 147.78 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.627 1.171 . . . . 0.0 112.539 -178.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.52 106.86 2.28 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.565 1.546 . . . . 0.0 107.545 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 50.1 m -103.63 126.0 50.49 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.22 1.408 . . . . 0.0 114.214 -171.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -123.63 178.79 5.04 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.364 2.266 . . . . 0.0 111.823 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -127.79 163.48 42.9 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.509 1.524 . . . . 0.0 112.579 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo . . . . . 0 C--N 1.353 0.802 0 C-N-CA 123.931 3.088 . . . . 0.0 114.085 -179.175 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -136.01 62.4 45.91 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 126.601 1.96 . . . . 0.0 112.788 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -56.49 -34.3 94.57 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.288 2.658 . . . . 0.0 113.38 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -63.83 -15.07 57.92 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.25 -12.87 8.97 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.766 1.626 . . . . 0.0 111.789 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -96.61 -30.77 13.08 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.922 1.289 . . . . 0.0 113.169 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 3.9 mp -129.92 -53.94 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.72 1.608 . . . . 0.0 109.415 176.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . 0.268 38.8 mt-10 113.86 -53.38 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.335 1 C-N-CA 131.743 4.017 . . . . 0.0 117.333 174.523 . . . . . . . . 3 2 . 1 . 002 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . 0.252 45.8 Cg_exo -55.25 -82.2 0.01 OUTLIER 'Trans proline' 0 CA--C 1.552 1.382 0 C-N-CA 124.913 3.742 . . . . 0.0 116.525 -174.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 14.1 t -65.32 151.5 46.08 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 121.508 1.958 . . . . 0.0 109.343 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 13.2 m -132.59 -3.23 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 6.6 mt -133.26 -46.34 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 119.4 1.0 . . . . 0.0 112.852 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.5 m -67.55 -60.05 2.87 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -173.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -153.89 -14.04 0.14 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -176.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 83.94 7.15 85.96 Favored Glycine 0 CA--C 1.539 1.532 0 O-C-N 120.948 -1.095 . . . . 0.0 112.453 -173.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -55.01 155.04 8.98 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 129.07 2.948 . . . . 0.0 113.255 178.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.31 -10.25 4.51 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 125.186 3.924 . . . . 0.0 118.795 -178.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -59.37 139.17 57.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.481 1.512 . . . . 0.0 112.8 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.2 150.04 50.19 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.27 1.828 . . . . 0.0 111.106 175.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -156.34 91.6 0.12 Allowed Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.667 1.603 . . . . 0.0 111.867 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 48.3 t -64.82 133.69 52.48 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.563 0.745 . . . . 0.0 110.89 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.16 144.73 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.424 1.889 . . . . 0.0 110.896 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 74.3 t -129.99 134.62 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.356 1.062 . . . . 0.0 111.198 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -125.07 94.96 4.32 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.497 2.319 . . . . 0.0 111.281 175.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 65.95 -93.32 0.18 Allowed Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.959 1.742 . . . . 0.0 114.709 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -111.0 -2.35 15.98 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.28 1.832 . . . . 0.0 114.362 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 6.5 p -130.65 170.0 14.88 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.229 2.212 . . . . 0.0 110.82 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -157.1 170.83 34.41 Favored Glycine 0 CA--C 1.533 1.176 0 O-C-N 120.902 -1.124 . . . . 0.0 113.854 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -120.08 140.04 51.64 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.432 1.893 . . . . 0.0 111.799 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 36.3 tp -134.67 153.26 52.07 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 127.553 2.341 . . . . 0.0 111.061 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 80.0 mtp 75.46 56.89 0.06 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 127.311 2.244 . . . . 0.0 112.054 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -151.53 148.52 28.12 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 129.391 3.076 . . . . 0.0 107.102 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 6.2 p -80.55 173.77 12.27 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 122.773 1.273 . . . . 0.0 112.321 177.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.38 -39.88 94.72 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.406 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 32.4 m -68.65 -44.52 73.98 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 116.505 -1.712 . . . . 0.0 110.918 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 53.8 m -46.64 -56.97 5.26 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 121.403 1.91 . . . . 0.0 110.926 175.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.72 -51.1 71.38 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.27 1.428 . . . . 0.0 112.778 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -58.77 -41.17 85.96 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.153 0.981 . . . . 0.0 112.667 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.37 -53.61 54.45 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.55 2.34 . . . . 0.0 110.768 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 15.0 mt -51.37 -54.42 26.66 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.658 1.183 . . . . 0.0 109.898 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -55.34 -48.03 74.8 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.486 1.114 . . . . 0.0 112.626 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -59.14 -40.99 87.21 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.555 1.542 . . . . 0.0 111.706 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -77.1 7.38 5.07 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 127.427 2.291 . . . . 0.0 113.569 175.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 75.76 0.85 3.45 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 130.387 3.475 . . . . 0.0 116.302 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -82.54 121.13 77.93 Favored Pre-proline 0 N--CA 1.473 0.702 0 CA-C-N 120.541 1.519 . . . . 0.0 109.555 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.51 -67.37 0.03 OUTLIER 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.149 2.566 . . . . 0.0 110.325 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 15.6 t -121.53 131.42 24.45 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 127.203 2.201 . . . . 0.0 110.346 176.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.72 -5.44 16.0 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.522 2.815 . . . . 0.0 114.589 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 36.7 t -131.46 -59.21 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 120.358 1.435 . . . . 0.0 113.414 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 21.6 m -71.56 -29.25 64.52 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.821 1.648 . . . . 0.0 110.613 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 64.89 7.49 3.99 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 128.172 2.589 . . . . 0.0 113.071 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -68.35 143.27 95.44 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 124.436 1.094 . . . . 0.0 110.765 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.05 110.08 2.53 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.563 2.842 . . . . 0.0 113.556 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 11.3 pt -66.06 153.58 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.496 0.665 . . . . 0.0 112.356 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -109.73 -47.53 3.34 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.071 1.348 . . . . 0.0 112.166 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.31 170.13 23.17 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.081 1.352 . . . . 0.0 112.676 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 13.0 mt -123.65 136.5 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 127.443 2.297 . . . . 0.0 106.435 175.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 14.3 m -131.89 150.11 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.68 99.92 2.21 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 6.3 t -87.71 150.12 23.81 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.887 -0.508 . . . . 0.0 111.606 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -139.28 156.84 46.78 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.638 1.575 . . . . 0.0 111.905 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -71.47 148.49 93.25 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.535 1.134 . . . . 0.0 113.002 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo . . . . . 0 CA--C 1.539 0.744 0 C-N-CA 123.75 2.967 . . . . 0.0 112.385 179.483 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 40.9 m . . . . . 0 CA--C 1.539 0.556 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 430' ' ' LEU . . . . . 0.582 ' H ' ' HD2' ' B' ' 431' ' ' PRO . 62.2 tp -144.75 -53.32 0.02 OUTLIER Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 126.0 1.72 . . . . 0.0 114.639 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 431' ' ' PRO . . . . . 0.582 ' HD2' ' H ' ' B' ' 430' ' ' LEU . 80.1 Cg_endo -71.12 159.92 50.71 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.973 1.782 . . . . 0.0 113.147 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 67.1 mt -54.31 -33.93 59.85 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.783 1.633 . . . . 0.0 113.453 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -66.27 -21.55 66.28 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.371 1.468 . . . . 0.0 113.493 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -109.31 -44.68 3.87 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.635 1.574 . . . . 0.0 112.539 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 45.4 mm -119.55 92.45 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 126.992 2.117 . . . . 0.0 107.914 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -60.41 145.96 85.54 Favored Pre-proline 0 CA--C 1.553 1.09 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -79.07 179.56 6.36 Favored 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 124.2 3.267 . . . . 0.0 114.644 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 2.2 p -63.02 -174.52 0.07 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.242 1.817 . . . . 0.0 114.865 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 5.6 p -138.65 -9.41 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 3.9 mt -119.59 -58.83 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 120.574 1.534 . . . . 0.0 112.996 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 13.7 p -67.82 -68.46 0.38 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -174.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -137.2 -13.54 1.58 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -169.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 77.53 35.38 36.93 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -172.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -86.52 151.2 52.82 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 124.557 1.143 . . . . 0.0 113.822 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -76.18 66.4 7.01 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 124.513 3.475 . . . . 0.0 113.543 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -131.98 165.58 23.62 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.65 1.98 . . . . 0.0 112.506 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -128.18 149.94 50.22 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 128.499 2.72 . . . . 0.0 111.791 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 168.01 75.95 0.04 OUTLIER Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.913 1.72 . . . . 0.0 112.303 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 35.7 t -62.61 141.27 58.57 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.759 0.779 . . . . 0.0 111.161 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 2.5 mp -105.07 139.12 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 C-N-CA 126.106 1.763 . . . . 0.0 109.654 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 88.9 t -130.0 131.7 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.197 0.999 . . . . 0.0 108.885 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.03 99.46 6.13 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.644 2.378 . . . . 0.0 110.516 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 65.33 -96.55 0.24 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 126.172 1.844 . . . . 0.0 113.792 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 38.6 mtmm -110.34 1.07 18.25 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.066 1.746 . . . . 0.0 113.693 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 44.7 p -130.1 170.05 14.53 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.434 1.494 . . . . 0.0 112.012 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -154.25 170.42 32.75 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 121.246 -0.909 . . . . 0.0 114.037 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -120.22 112.7 19.39 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.295 1.838 . . . . 0.0 111.667 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -88.94 153.18 21.24 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 22.6 mmt 64.65 67.37 0.56 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.591 2.357 . . . . 0.0 114.54 175.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -148.97 157.87 43.75 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 129.253 3.021 . . . . 0.0 107.822 174.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 22.0 p -90.79 174.98 7.17 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 123.048 1.404 . . . . 0.0 114.13 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.44 -31.8 72.78 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.58 176.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 44.8 m -66.7 -50.25 63.44 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.64 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 36.3 m -47.87 -63.98 0.91 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.15 1.38 . . . . 0.0 109.868 174.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -52.74 -47.16 67.58 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.305 1.842 . . . . 0.0 113.654 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -60.68 -36.88 79.86 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.956 -1.09 . . . . 0.0 112.281 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -55.41 -48.16 74.81 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.607 1.163 . . . . 0.0 110.951 175.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 6.5 mp -62.63 -47.72 82.5 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.55 0.74 . . . . 0.0 110.001 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -57.09 -42.48 80.83 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -55.02 -28.36 51.48 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -119.59 8.84 11.33 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.856 2.062 . . . . 0.0 113.019 177.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 60.1 t30 42.29 56.39 3.69 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 127.252 2.221 . . . . 0.0 112.075 -174.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -70.0 133.04 88.14 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -174.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.95 115.16 4.14 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.52 2.147 . . . . 0.0 107.633 169.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 51.9 t -22.45 125.33 0.11 Allowed Pre-proline 0 CA--C 1.558 1.276 0 C-N-CA 130.146 3.378 . . . . 0.0 116.236 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -66.61 -3.94 10.06 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.139 2.56 . . . . 0.0 114.235 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 45.0 t -110.26 -64.02 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.327 1.451 . . . . 0.0 111.488 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 25.0 p -105.24 1.23 27.94 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 63.36 11.07 5.2 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 127.73 2.412 . . . . 0.0 115.945 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -75.35 144.92 78.97 Favored Pre-proline 0 CA--C 1.55 0.976 0 O-C-N 121.391 -0.818 . . . . 0.0 111.916 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.15 116.18 4.56 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.438 2.759 . . . . 0.0 111.461 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.5 pp -55.16 142.79 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.825 1.25 . . . . 0.0 111.929 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -115.04 -45.56 2.95 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.107 0.963 . . . . 0.0 113.361 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.28 166.98 30.11 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -177.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 4.0 mt -139.39 133.99 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 128.203 2.601 . . . . 0.0 107.943 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 27.8 m -140.02 150.24 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.76 1.224 . . . . 0.0 111.986 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 56.8 mt -66.91 99.82 0.67 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 42.1 m -99.79 136.0 40.37 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.624 1.17 . . . . 0.0 112.227 -173.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -128.57 160.77 31.34 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.521 1.128 . . . . 0.0 112.619 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -145.86 155.99 51.8 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.919 1.688 . . . . 0.0 111.749 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 CA--C 1.537 0.631 0 C-N-CA 123.533 2.822 . . . . 0.0 112.428 179.168 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 48.3 m . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 430' ' ' LEU . . . . . 0.518 ' H ' ' HD2' ' A' ' 431' ' ' PRO . 10.3 tt -129.96 -59.88 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 126.976 2.11 . . . . 0.0 111.861 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 431' ' ' PRO . . . . . 0.518 ' HD2' ' H ' ' A' ' 430' ' ' LEU . 72.1 Cg_endo -69.77 161.05 47.41 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.834 1.69 . . . . 0.0 111.119 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 60.0 tp -53.37 -39.44 64.19 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.153 1.381 . . . . 0.0 113.628 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -80.4 -3.66 50.58 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.903 1.281 . . . . 0.0 114.033 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . 56.96 12.93 1.33 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 127.848 2.459 . . . . 0.0 116.506 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 65.2 mt -61.86 -44.77 99.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.407 1.483 . . . . 0.0 111.4 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 38.29 64.2 3.5 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 127.69 2.396 . . . . 0.0 115.007 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -72.93 -45.15 0.5 Allowed 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.722 2.282 . . . . 0.0 112.781 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 8.0 t -58.74 147.66 32.33 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 120.531 1.514 . . . . 0.0 109.594 172.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 15.9 m -130.92 -1.15 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 10.0 mt -132.12 -47.33 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.23 1.012 . . . . 0.0 112.237 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.8 m -68.93 -62.69 1.27 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -173.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -155.44 -12.02 0.11 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -174.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 81.53 7.89 87.66 Favored Glycine 0 CA--C 1.542 1.772 0 O-C-N 120.47 -1.394 . . . . 0.0 112.424 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -59.09 152.45 51.27 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 129.669 3.187 . . . . 0.0 113.256 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -74.91 73.12 4.37 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 124.329 3.353 . . . . 0.0 113.886 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -128.91 144.12 51.09 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 127.15 2.18 . . . . 0.0 110.411 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.26 116.16 19.42 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -173.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -138.59 83.2 0.25 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.441 1.496 . . . . 0.0 111.663 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 16.4 t -66.12 140.21 58.2 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.077 0.939 . . . . 0.0 112.309 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.3 mp -115.1 141.2 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 126.832 2.053 . . . . 0.0 110.441 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 67.4 t -126.49 134.02 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.627 1.171 . . . . 0.0 111.134 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -118.78 98.04 6.02 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.451 2.7 . . . . 0.0 110.651 175.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 73.55 -87.42 0.62 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.849 1.69 . . . . 0.0 114.068 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -129.85 1.92 4.87 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.265 1.826 . . . . 0.0 113.431 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 72.8 p -131.2 170.06 15.08 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.204 2.202 . . . . 0.0 109.197 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -152.56 174.6 31.4 Favored Glycine 0 N--CA 1.466 0.69 0 O-C-N 120.541 -1.349 . . . . 0.0 113.273 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -120.09 105.84 11.39 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.368 1.067 . . . . 0.0 111.788 177.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 15.2 tp -81.67 153.18 26.75 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.011 2.524 . . . . 0.0 110.211 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 48.7 mtt 85.54 66.35 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 128.008 2.523 . . . . 0.0 111.976 178.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -158.86 145.09 16.85 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 127.719 2.408 . . . . 0.0 108.537 175.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 19.9 p -83.78 173.69 11.08 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 122.28 1.038 . . . . 0.0 110.746 174.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -64.72 -37.44 87.59 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.502 -0.749 . . . . 0.0 111.191 178.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 27.8 m -65.15 -49.03 71.44 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 117.132 -1.413 . . . . 0.0 110.661 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 32.9 m -48.06 -55.77 9.37 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 120.555 1.525 . . . . 0.0 110.57 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.55 92.4 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.846 1.258 . . . . 0.0 113.002 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -61.52 -43.32 99.08 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.817 -1.177 . . . . 0.0 111.586 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -62.52 -54.03 45.93 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.996 1.318 . . . . 0.0 111.514 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 2.5 pp -60.49 -37.72 81.98 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.644 0.656 . . . . 0.0 111.25 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -59.95 -52.11 66.79 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.186 1.395 . . . . 0.0 111.378 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -58.68 -35.99 73.48 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.246 1.418 . . . . 0.0 112.684 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -78.5 2.93 17.42 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.534 1.934 . . . . 0.0 113.402 175.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 28.5 m120 64.13 19.18 11.66 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 128.713 2.805 . . . . 0.0 114.62 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -72.72 135.81 80.77 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.693 1.197 . . . . 0.0 109.383 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.8 -85.57 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.037 2.491 . . . . 0.0 109.804 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 36.1 t -118.45 132.76 23.67 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.921 1.688 . . . . 0.0 110.874 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.63 -6.86 20.02 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.397 2.731 . . . . 0.0 114.119 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 40.6 t -116.36 -72.3 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 119.732 1.151 . . . . 0.0 112.752 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 25.8 p -96.25 1.31 51.99 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 86.4 mmt-85 65.54 6.67 3.9 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 128.01 2.524 . . . . 0.0 115.665 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -62.16 140.98 96.09 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-N 119.593 1.088 . . . . 0.0 111.686 177.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -69.45 112.17 2.95 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.385 2.723 . . . . 0.0 113.725 -176.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 22.8 pt -73.73 160.14 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.709 1.603 . . . . 0.0 113.39 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -112.55 -48.13 3.03 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.48 1.512 . . . . 0.0 113.19 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.14 170.3 22.28 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -175.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 8.1 mt -117.2 135.38 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 126.523 1.929 . . . . 0.0 107.821 173.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 37.3 t -129.48 147.9 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.979 1.312 . . . . 0.0 110.334 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 487' ' ' LEU . . . . . 0.443 HD13 ' H ' ' A' ' 487' ' ' LEU 0.271 0.0 OUTLIER -81.59 116.79 21.51 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.298 1.047 . . . . 0.0 108.348 177.031 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 6.5 m -115.84 99.04 7.01 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.271 -1.331 . . . . 0.0 114.134 -169.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -68.78 171.2 8.17 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.044 1.738 . . . . 0.0 112.937 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -134.33 164.04 46.86 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.81 1.644 . . . . 0.0 111.121 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo . . . . . 0 C--N 1.353 0.774 0 C-N-CA 124.341 3.361 . . . . 0.0 113.855 179.551 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 96.7 mt -68.39 156.68 89.84 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.293 1.437 . . . . 0.0 110.731 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -42.82 -51.0 5.67 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 124.262 3.308 . . . . 0.0 115.827 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -64.94 -16.66 63.59 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 35.9 t30 -103.21 -25.76 13.24 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.984 1.714 . . . . 0.0 111.441 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -79.6 -48.66 13.41 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.737 1.615 . . . . 0.0 111.858 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 26.5 mm -83.27 68.58 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.583 1.153 . . . . 0.0 109.97 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -140.52 66.04 27.76 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 126.134 1.774 . . . . 0.0 109.512 176.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.15 -32.34 52.61 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.347 2.698 . . . . 0.0 115.5 -175.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 14.6 t -55.22 145.95 20.15 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 120.546 1.521 . . . . 0.0 111.333 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 29.8 m -132.22 0.1 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.93 1.692 . . . . 0.0 113.615 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 1.7 mt -134.69 -48.37 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 116.932 -1.509 . . . . 0.0 114.731 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 25.2 p -77.68 -60.53 2.33 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 121.457 1.935 . . . . 0.0 115.16 -173.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -139.86 -8.32 1.22 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 74.63 17.63 79.97 Favored Glycine 0 CA--C 1.541 1.672 0 CA-C-N 119.818 1.19 . . . . 0.0 111.356 -173.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -61.23 155.15 58.36 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 127.541 2.337 . . . . 0.0 113.858 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.8 -1.32 9.15 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.363 3.375 . . . . 0.0 116.141 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -60.17 156.77 14.52 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.941 1.696 . . . . 0.0 112.672 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -128.09 150.14 50.09 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.848 2.059 . . . . 0.0 110.489 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -163.87 67.76 0.22 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.258 1.409 . . . . 0.0 112.417 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 45.0 t -57.47 128.22 35.92 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.732 1.213 . . . . 0.0 110.176 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.98 144.06 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.06 1.344 . . . . 0.0 110.189 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 88.8 t -129.28 126.64 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.767 1.227 . . . . 0.0 109.697 176.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.18 122.52 37.29 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 128.813 2.845 . . . . 0.0 112.647 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 64.1 -77.54 0.05 OUTLIER Glycine 0 CA--C 1.539 1.552 0 C-N-CA 126.207 1.861 . . . . 0.0 114.872 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -146.61 2.46 0.83 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 127.453 2.301 . . . . 0.0 113.212 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 71.5 p -131.72 170.12 15.24 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 127.575 2.35 . . . . 0.0 110.54 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -144.58 171.93 25.73 Favored Glycine 0 N--CA 1.47 0.93 0 O-C-N 120.479 -1.388 . . . . 0.0 115.248 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.25 135.2 55.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.424 1.889 . . . . 0.0 113.223 175.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 4.0 pp -119.77 153.33 35.85 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.662 2.385 . . . . 0.0 110.942 174.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 11.5 tpt 94.65 53.87 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 129.304 3.042 . . . . 0.0 111.689 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -159.93 150.17 18.61 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.763 2.425 . . . . 0.0 108.4 175.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 31.2 p -90.03 174.29 7.73 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 122.377 1.084 . . . . 0.0 111.591 175.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.43 -37.93 88.38 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.634 -0.667 . . . . 0.0 110.991 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 43.7 m -60.25 -54.37 46.52 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 117.616 -1.183 . . . . 0.0 110.48 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 59.5 m -51.79 -61.98 1.91 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.923 1.238 . . . . 0.0 111.002 175.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -47.17 -52.37 15.79 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.037 -1.04 . . . . 0.0 112.578 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -62.21 -37.94 87.25 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.466 1.106 . . . . 0.0 112.965 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -60.47 -50.65 72.74 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.482 1.513 . . . . 0.0 110.625 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -58.25 -46.23 86.33 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.849 0.459 . . . . 0.0 110.242 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -55.99 -46.57 78.66 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.297 1.039 . . . . 0.0 112.276 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -62.05 -39.1 91.21 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.624 1.569 . . . . 0.0 111.506 174.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -79.7 16.47 1.11 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 128.066 2.546 . . . . 0.0 113.196 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . 0.303 0.2 OUTLIER 59.8 8.13 1.28 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 130.667 3.587 . . . . 0.0 117.849 179.802 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -84.59 127.41 65.65 Favored Pre-proline 0 N--CA 1.474 0.731 0 CA-C-N 120.045 1.293 . . . . 0.0 108.158 173.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.33 -81.8 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 123.069 2.513 . . . . 0.0 112.263 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 41.3 t -81.95 131.87 55.71 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 124.425 1.09 . . . . 0.0 110.887 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -70.32 -5.28 16.18 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.945 2.43 . . . . 0.0 114.487 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 28.9 t -119.68 -75.9 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.986 1.266 . . . . 0.0 113.084 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 23.7 p -91.91 -1.11 57.46 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 26.9 ttt-85 64.87 18.78 11.63 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 127.306 2.242 . . . . 0.0 115.107 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -65.98 156.09 85.02 Favored Pre-proline 0 CA--C 1.554 1.122 0 O-C-N 121.049 -1.032 . . . . 0.0 111.347 174.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.88 105.89 1.59 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.71 2.94 . . . . 0.0 113.522 -177.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.16 154.26 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.091 1.356 . . . . 0.0 113.512 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -115.2 -43.0 3.11 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.026 2.131 . . . . 0.0 111.687 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.91 167.55 27.79 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.977 1.311 . . . . 0.0 114.303 -176.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 18.6 mt -134.23 135.21 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 129.099 2.96 . . . . 0.0 105.919 173.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.48 150.14 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.428 1.091 . . . . 0.0 113.367 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.61 99.93 1.37 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.01 86.39 3.97 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.835 1.254 . . . . 0.0 112.704 -173.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -63.6 169.69 3.74 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.919 1.288 . . . . 0.0 111.88 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -130.51 167.28 21.75 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 125.167 1.387 . . . . 0.0 111.16 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo . . . . . 0 C--N 1.352 0.726 0 C-N-CA 124.068 3.178 . . . . 0.0 113.778 -179.786 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 39.2 m . . . . . 0 CA--C 1.539 0.527 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 96.2 mt -128.45 156.99 76.16 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.937 1.695 . . . . 0.0 112.121 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -52.72 -35.65 69.58 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.602 2.868 . . . . 0.0 114.881 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 45.7 tp -62.43 -49.36 75.75 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.594 1.158 . . . . 0.0 112.86 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -75.32 -21.77 58.17 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.561 -0.712 . . . . 0.0 112.542 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.36 -52.18 12.93 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.107 0.963 . . . . 0.0 110.574 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 23.8 mm -101.91 75.5 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 126.958 2.103 . . . . 0.0 107.245 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -45.33 129.43 6.01 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 126.213 1.805 . . . . 0.0 114.926 -173.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -86.78 -179.01 2.8 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.872 3.048 . . . . 0.0 115.303 -177.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 41.3 t -57.33 -167.91 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 130.408 3.483 . . . . 0.0 112.778 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 9.7 p -132.74 -12.86 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.135 1.774 . . . . 0.0 112.748 177.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 14.3 mm -93.3 -60.1 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.332 1.053 . . . . 0.0 108.566 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 26.5 p -87.55 -44.8 10.99 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.699 1.199 . . . . 0.0 109.768 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . 0.274 14.0 pt20 52.01 22.0 1.7 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 128.981 2.913 . . . . 0.0 114.777 -174.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -94.26 -24.66 18.56 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 112.213 -0.355 . . . . 0.0 112.213 176.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -115.42 155.08 47.57 Favored Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 125.979 1.712 . . . . 0.0 115.125 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -51.41 140.15 44.21 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.683 3.589 . . . . 0.0 114.54 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -67.6 28.14 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 127.564 2.345 . . . . 0.0 117.091 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -77.87 89.83 4.08 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.46 -1.4 . . . . 0.0 110.774 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 162.35 57.86 0.02 OUTLIER Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.065 -0.853 . . . . 0.0 113.523 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 78.3 m -63.14 142.91 58.2 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.687 1.243 . . . . 0.0 110.596 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.6 mp -115.06 144.53 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 126.033 1.733 . . . . 0.0 111.377 -172.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 67.0 t -127.24 131.48 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.72 1.208 . . . . 0.0 111.657 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -119.88 97.2 5.5 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.681 2.792 . . . . 0.0 110.786 174.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.72 -91.48 0.33 Allowed Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.906 1.717 . . . . 0.0 114.046 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -118.88 -0.27 11.24 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.297 1.839 . . . . 0.0 113.849 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 67.1 p -133.24 170.08 15.96 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.603 1.961 . . . . 0.0 110.337 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -153.53 171.61 32.36 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.911 1.243 . . . . 0.0 112.899 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -120.11 133.7 55.45 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.531 1.132 . . . . 0.0 113.275 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 25.7 tp -89.64 153.13 20.98 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 129.006 2.922 . . . . 0.0 113.882 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 459' ' ' MET . . . . . . . . . . . . 0.354 25.8 ptm 59.45 57.2 3.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 129.28 3.032 . . . . 0.0 118.535 172.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -136.76 147.9 46.94 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.259 1.824 . . . . 0.0 108.145 170.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 31.3 p -82.04 165.24 20.82 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 120.24 1.382 . . . . 0.0 112.874 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.32 -38.82 84.92 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.123 177.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 96.3 m -61.2 -59.42 5.34 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.693 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 54.6 m -53.93 -48.27 70.39 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.701 1.137 . . . . 0.0 112.4 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -56.36 -51.54 67.91 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.554 0.742 . . . . 0.0 112.613 175.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -62.78 -39.71 95.06 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.03 1.332 . . . . 0.0 112.437 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -61.85 -54.18 45.68 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.177 1.391 . . . . 0.0 110.457 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 27.2 mt -50.2 -53.05 30.72 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.426 1.091 . . . . 0.0 110.089 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -52.89 -51.12 62.33 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.871 1.268 . . . . 0.0 112.644 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -61.79 -38.9 89.8 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.345 1.458 . . . . 0.0 112.698 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -75.87 -1.67 26.44 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.782 2.033 . . . . 0.0 113.361 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 35.8 t30 77.88 7.27 2.66 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 130.111 3.365 . . . . 0.0 115.482 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -78.21 123.93 85.88 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 120.655 -1.278 . . . . 0.0 108.332 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.0 -76.45 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.58 2.853 . . . . 0.0 111.589 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 27.1 t -120.33 132.16 24.21 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.637 1.975 . . . . 0.0 110.114 178.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.12 -3.22 13.49 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.461 2.774 . . . . 0.0 113.428 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 39.2 t -113.44 -71.99 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.816 1.246 . . . . 0.0 112.272 -177.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 26.3 p -100.96 -2.61 31.36 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.44 1.496 . . . . 0.0 114.587 -176.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 65.89 8.67 5.51 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 128.067 2.547 . . . . 0.0 115.861 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -62.77 124.89 85.01 Favored Pre-proline 0 CA--C 1.553 1.092 0 CA-C-N 119.357 0.981 . . . . 0.0 111.287 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.38 114.49 1.46 Allowed 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.398 3.398 . . . . 0.0 114.882 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 16.4 pt -75.94 157.76 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.795 0.838 . . . . 0.0 113.233 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -115.1 -45.45 2.95 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.052 1.741 . . . . 0.0 112.749 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.68 170.09 22.82 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.208 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 13.9 mt -131.33 138.97 51.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 128.304 2.641 . . . . 0.0 107.37 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.22 150.04 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 CA-C-N 119.728 1.149 . . . . 0.0 113.843 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -62.78 99.92 0.18 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.518 1.927 . . . . 0.0 109.412 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 12.3 m -119.95 127.94 53.12 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.103 0.961 . . . . 0.0 112.242 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -118.93 161.73 19.7 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.183 1.393 . . . . 0.0 113.518 -176.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -74.92 163.61 67.05 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 125.333 1.453 . . . . 0.0 111.697 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo . . . . . 0 C--N 1.353 0.781 0 C-N-CA 123.925 3.083 . . . . 0.0 114.451 -178.565 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 42.0 m . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 10.0 mp -68.76 157.89 87.37 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.563 1.545 . . . . 0.0 110.173 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -46.38 -41.62 22.81 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.772 2.981 . . . . 0.0 114.897 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 2.5 pp -67.31 -21.83 65.65 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -98.74 -26.28 14.39 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.352 1.461 . . . . 0.0 111.348 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -85.78 -26.92 25.51 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.934 1.694 . . . . 0.0 114.192 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 30.1 mm 57.99 85.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 127.484 2.314 . . . . 0.0 111.055 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -120.18 58.91 6.08 Favored Pre-proline 0 CA--C 1.557 1.212 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.08 -42.1 38.83 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 124.853 3.702 . . . . 0.0 114.705 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 32.7 t -55.99 142.92 34.14 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 121.502 1.956 . . . . 0.0 109.764 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.0 -0.36 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.399 1.079 . . . . 0.0 113.747 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 8.9 mt -132.94 -46.83 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.866 0.866 . . . . 0.0 112.299 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.3 m -72.13 -68.34 0.47 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -172.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -144.29 -10.45 0.65 Allowed 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -174.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 78.57 13.57 83.06 Favored Glycine 0 CA--C 1.542 1.766 0 CA-C-N 120.129 1.331 . . . . 0.0 112.668 -174.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -62.28 155.19 67.46 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 130.758 3.623 . . . . 0.0 113.952 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -67.71 -1.46 6.78 Favored 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 124.856 3.704 . . . . 0.0 116.211 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -60.93 135.14 57.7 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.007 1.723 . . . . 0.0 110.416 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.08 126.65 41.62 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.439 1.496 . . . . 0.0 113.31 -176.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -150.3 78.58 0.22 Allowed Glycine 0 CA--C 1.529 0.938 0 C-N-CA 125.405 1.479 . . . . 0.0 112.102 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 76.5 m -63.75 151.56 41.73 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 117.624 0.712 . . . . 0.0 110.987 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 4.6 mp -110.25 142.39 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 125.794 1.637 . . . . 0.0 111.216 -174.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 64.5 t -130.02 123.44 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.625 1.17 . . . . 0.0 108.234 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.24 106.24 9.72 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.843 2.057 . . . . 0.0 112.984 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 73.35 -83.75 0.64 Allowed Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.865 1.698 . . . . 0.0 114.746 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 454' ' ' LYS . . . . . 0.436 ' HA ' ' HE2' ' B' ' 454' ' ' LYS . 0.5 OUTLIER -127.57 -10.59 5.64 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.858 1.663 . . . . 0.0 114.021 -177.356 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 78.8 p -135.46 169.97 16.67 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.309 1.443 . . . . 0.0 111.078 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -144.32 168.8 26.56 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.192 0.901 . . . . 0.0 114.669 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -120.18 132.17 55.28 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.227 1.811 . . . . 0.0 112.649 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 4.4 pp -107.81 153.32 23.16 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.876 2.07 . . . . 0.0 111.872 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 44.0 ttm 86.19 69.16 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 128.531 2.732 . . . . 0.0 112.05 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -160.04 154.92 24.46 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 128.051 2.54 . . . . 0.0 108.538 176.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 14.3 p -90.05 174.99 7.34 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 122.354 1.073 . . . . 0.0 110.488 174.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -66.09 -31.72 72.76 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.425 -0.797 . . . . 0.0 111.616 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 40.8 m -72.25 -47.03 53.38 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 117.007 -1.473 . . . . 0.0 110.427 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 50.6 m -45.22 -57.6 3.85 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 120.306 1.412 . . . . 0.0 109.962 172.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.96 -49.89 76.16 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.234 1.814 . . . . 0.0 113.549 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -60.88 -37.5 82.41 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.091 1.356 . . . . 0.0 112.797 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -59.34 -52.15 66.88 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.966 1.306 . . . . 0.0 110.661 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 19.1 mt -57.33 -48.97 77.61 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.016 1.327 . . . . 0.0 109.978 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -56.21 -51.7 67.12 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.957 1.303 . . . . 0.0 113.244 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -52.26 -40.74 62.12 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.535 1.534 . . . . 0.0 113.426 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 32.3 ptt85 -97.45 5.99 48.88 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.684 1.594 . . . . 0.0 113.938 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 44.82 48.43 9.06 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.487 2.715 . . . . 0.0 112.332 -177.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -69.99 118.46 63.72 Favored Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 124.268 1.027 . . . . 0.0 111.896 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -62.58 123.33 12.18 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.294 1.996 . . . . 0.0 107.76 172.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 52.6 t -26.85 122.25 0.23 Allowed Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 128.72 2.808 . . . . 0.0 115.742 -173.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -65.5 -3.92 8.6 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 122.657 2.238 . . . . 0.0 113.931 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 33.9 t -107.47 -62.87 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.527 1.531 . . . . 0.0 111.347 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 26.6 p -110.09 0.97 18.58 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 63.55 11.32 5.57 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 127.84 2.456 . . . . 0.0 115.953 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -68.65 151.55 97.18 Favored Pre-proline 0 CA--C 1.551 1.01 0 O-C-N 121.373 -0.83 . . . . 0.0 111.534 176.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.84 111.26 2.98 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.594 2.863 . . . . 0.0 112.442 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.9 109.97 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 126.84 2.056 . . . . 0.0 109.982 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -107.3 -57.08 2.12 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -171.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.21 165.39 27.65 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -177.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 2.7 mt -134.96 141.41 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 127.399 2.28 . . . . 0.0 109.94 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.99 148.84 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.038 0.935 . . . . 0.0 111.826 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.0 99.8 0.91 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 17.3 m -109.23 86.87 2.37 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.221 1.008 . . . . 0.0 111.502 -174.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -77.18 159.32 29.81 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -176.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -74.12 156.28 87.77 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.617 1.567 . . . . 0.0 111.964 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo . . . . . 0 C--N 1.352 0.744 0 C-N-CA 124.156 3.237 . . . . 0.0 114.324 178.316 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 429' ' ' SER . . . . . 0.485 ' N ' HD21 ' A' ' 433' ' ' ASN . 33.2 m . . . . . 0 CA--C 1.54 0.572 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 10.9 mp -69.29 156.18 92.1 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.377 1.471 . . . . 0.0 110.901 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -45.35 -42.98 17.48 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 124.07 3.18 . . . . 0.0 115.957 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -66.21 -14.83 62.52 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 433' ' ' ASN . . . . . 0.485 HD21 ' N ' ' A' ' 429' ' ' SER . 1.7 p-10 -127.23 -7.15 5.91 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.562 1.145 . . . . 0.0 113.143 177.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -61.39 -38.26 86.42 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.638 1.175 . . . . 0.0 112.943 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.31 7.45 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.978 1.711 . . . . 0.0 113.474 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 48.55 57.41 18.17 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 126.989 2.116 . . . . 0.0 113.015 -176.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.31 167.52 23.6 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.718 2.279 . . . . 0.0 114.974 -177.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 8.4 t -58.44 178.38 0.1 Allowed 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 127.538 2.335 . . . . 0.0 114.25 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 33.6 m -134.83 -0.22 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 -173.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 6.8 mt -118.93 -56.58 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-N 121.106 1.775 . . . . 0.0 112.413 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 7.8 p -51.17 -84.85 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.116 2.166 . . . . 0.0 114.064 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -148.47 -15.8 0.33 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 131.516 3.926 . . . . 0.0 111.998 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 92.1 69.22 1.15 Allowed Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.082 1.325 . . . . 0.0 113.009 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -99.21 154.47 37.29 Favored Pre-proline 0 N--CA 1.48 1.026 0 C-N-CA 125.125 1.37 . . . . 0.0 110.888 175.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.71 125.05 15.83 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.648 2.899 . . . . 0.0 112.056 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.58 99.96 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -175.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -128.04 89.85 2.99 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.612 1.165 . . . . 0.0 107.912 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 151.96 58.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.845 0 C-N-CA 123.907 0.765 . . . . 0.0 112.459 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 35.7 t -59.57 138.31 57.75 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.34 1.07 . . . . 0.0 110.943 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.8 mp -114.96 140.62 35.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 C-N-CA 127.271 2.229 . . . . 0.0 110.772 -174.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 73.1 t -130.04 131.72 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.416 1.086 . . . . 0.0 111.641 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -111.42 100.96 9.45 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.755 2.422 . . . . 0.0 108.505 171.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 73.67 -85.0 0.65 Allowed Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.488 1.518 . . . . 0.0 112.939 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -137.08 4.86 2.75 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.338 1.855 . . . . 0.0 114.348 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 51.2 p -131.37 170.04 15.19 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.467 1.907 . . . . 0.0 110.248 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -160.08 175.56 36.87 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 120.804 -1.185 . . . . 0.0 114.561 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -120.03 100.02 6.96 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.083 1.753 . . . . 0.0 110.222 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 11.2 tp -76.69 92.75 3.56 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 128.212 2.605 . . . . 0.0 111.193 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -169.53 -27.41 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -103.35 164.06 11.88 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.085 1.311 . . . . 0.0 114.373 -174.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 32.0 p -85.92 168.34 14.29 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-O 122.123 0.963 . . . . 0.0 112.241 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.07 -42.35 90.16 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.224 -0.923 . . . . 0.0 111.678 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 86.9 m -54.98 -58.81 6.1 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.334 1.054 . . . . 0.0 109.628 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 84.0 m -57.51 -43.89 84.59 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.118 1.367 . . . . 0.0 112.629 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.71 -50.85 69.21 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.76 0.824 . . . . 0.0 111.775 174.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -65.49 -38.49 89.91 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.292 1.037 . . . . 0.0 112.089 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -60.57 -52.43 65.2 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.909 1.284 . . . . 0.0 110.845 177.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 19.6 mt -50.48 -49.81 54.37 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.764 1.226 . . . . 0.0 110.273 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 50.9 tttt -55.37 -51.64 66.15 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.942 1.297 . . . . 0.0 112.368 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -60.3 -42.47 95.57 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.555 1.542 . . . . 0.0 111.797 175.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -69.68 -3.96 17.49 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 127.372 2.269 . . . . 0.0 113.209 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 63.96 20.12 12.06 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 128.478 2.711 . . . . 0.0 114.291 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -70.05 127.7 92.16 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 173.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -64.18 -56.07 0.51 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.846 2.364 . . . . 0.0 112.057 -177.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 13.2 t -152.95 137.6 10.93 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 128.335 2.654 . . . . 0.0 108.412 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -70.08 -5.19 15.81 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.205 2.604 . . . . 0.0 114.179 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 24.7 t -120.16 -75.26 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 119.99 1.268 . . . . 0.0 113.197 -178.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 10.6 p -92.19 -1.57 57.06 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.978 1.711 . . . . 0.0 114.516 -176.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 61.54 24.74 14.79 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 127.635 2.374 . . . . 0.0 115.878 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -93.72 121.14 65.25 Favored Pre-proline 0 CA--C 1.558 1.279 0 CA-C-N 119.1 0.864 . . . . 0.0 109.912 174.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -42.87 112.09 0.25 Allowed 'Trans proline' 0 CA--C 1.547 1.139 1 C-N-CA 125.375 4.05 . . . . 0.0 119.727 -173.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 1.9 pp -70.59 128.69 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 126.466 1.906 . . . . 0.0 110.386 173.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -115.18 -16.59 11.54 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -174.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 484' ' ' MET . . . . . 0.495 ' SD ' HG13 ' A' ' 486' ' ' VAL . 5.7 tmm? -145.87 147.67 32.04 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.299 0.954 . . . . 0.0 112.953 -173.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 13.5 mt -137.2 133.27 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 126.736 2.014 . . . . 0.0 109.763 174.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 486' ' ' VAL . . . . . 0.495 HG13 ' SD ' ' A' ' 484' ' ' MET . 3.4 m -119.24 150.16 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 125.709 1.604 . . . . 0.0 112.4 176.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.55 99.88 3.74 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 175.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 24.8 m -88.63 143.81 26.7 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -174.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -123.6 152.32 42.04 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.107 2.163 . . . . 0.0 110.507 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 490' ' ' PHE . . . . . 0.54 ' H ' ' CD ' ' A' ' 491' ' ' PRO . 56.2 p90 -138.39 -29.53 0.01 OUTLIER Pre-proline 0 CA--C 1.552 1.033 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 491' ' ' PRO . . . . . 0.54 ' CD ' ' H ' ' A' ' 490' ' ' PHE . 87.5 Cg_exo . . . . . 0 C--N 1.359 1.12 0 C-N-CA 123.255 2.636 . . . . 0.0 114.218 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 41.3 p . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 23.0 tp -63.97 136.76 96.87 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.34 1.456 . . . . 0.0 109.244 176.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -44.23 -43.98 12.96 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.855 3.037 . . . . 0.0 115.498 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 71.7 mt -58.93 -36.68 75.17 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.473 1.109 . . . . 0.0 113.066 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -89.12 -19.01 26.06 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.599 1.56 . . . . 0.0 112.852 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -76.69 1.91 15.73 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.384 1.873 . . . . 0.0 115.192 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 15.4 mm 55.5 80.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 127.672 2.389 . . . . 0.0 112.554 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.13 156.31 59.75 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.839 1.656 . . . . 0.0 114.771 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -78.63 -155.4 0.05 OUTLIER 'Trans proline' 0 CA--C 1.556 1.62 0 C-N-CA 125.004 3.803 . . . . 0.0 110.2 174.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 11.4 t -47.72 148.03 1.68 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.67 1.588 . . . . 0.0 111.722 175.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 25.7 t -117.93 -11.25 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.611 1.565 . . . . 0.0 112.093 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 10.0 mt -128.62 -53.26 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -174.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 2.1 m -69.82 -68.97 0.38 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.594 1.958 . . . . 0.0 115.371 -171.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -144.82 -10.24 0.6 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -173.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.51 11.38 82.04 Favored Glycine 0 CA--C 1.542 1.764 0 CA-C-N 119.638 1.108 . . . . 0.0 112.603 -174.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -67.48 155.04 92.0 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 127.738 2.415 . . . . 0.0 111.957 177.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.61 142.45 13.74 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.729 2.952 . . . . 0.0 115.112 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -63.82 34.98 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 129.305 3.042 . . . . 0.0 116.164 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -81.35 89.77 6.12 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.491 -1.381 . . . . 0.0 108.139 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 170.51 48.37 0.04 OUTLIER Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.993 0.806 . . . . 0.0 112.846 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 48.4 t -55.32 133.52 49.59 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.106 1.362 . . . . 0.0 109.732 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 2.1 mp -104.53 150.18 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 126.001 1.72 . . . . 0.0 109.736 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 40.2 t -124.68 140.12 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 122.362 1.077 . . . . 0.0 110.652 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -125.22 94.92 4.3 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 128.355 2.662 . . . . 0.0 109.106 175.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 66.63 -84.18 0.11 Allowed Glycine 0 CA--C 1.538 1.51 0 C-N-CA 124.796 1.189 . . . . 0.0 113.333 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -130.4 0.93 4.56 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 128.057 2.543 . . . . 0.0 113.81 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 27.7 p -112.39 170.15 8.37 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.978 2.111 . . . . 0.0 109.735 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -154.17 167.49 32.33 Favored Glycine 0 CA--C 1.528 0.879 0 O-C-N 120.692 -1.255 . . . . 0.0 114.844 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -120.08 143.11 48.31 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.172 1.389 . . . . 0.0 113.11 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 9.9 tt -126.66 153.09 45.85 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 130.434 3.493 . . . . 0.0 108.985 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 9.5 ttt 100.22 19.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 128.796 2.838 . . . . 0.0 114.529 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -140.94 152.93 45.38 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.901 1.68 . . . . 0.0 110.368 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 13.1 p -82.2 174.51 11.11 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.619 1.2 . . . . 0.0 113.198 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.51 -46.31 86.97 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.406 177.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 49.0 m -65.86 -42.84 89.91 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 117.345 -1.312 . . . . 0.0 112.391 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 55.5 m -49.83 -55.36 14.49 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 120.382 1.447 . . . . 0.0 109.588 173.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -62.8 -40.75 98.31 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.622 1.569 . . . . 0.0 113.587 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -60.6 -44.02 96.75 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.554 1.542 . . . . 0.0 111.582 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -57.46 -58.37 8.6 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.108 1.363 . . . . 0.0 110.647 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.3 pp -64.03 -32.22 73.7 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -67.41 -47.39 70.41 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.906 1.682 . . . . 0.0 111.434 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -60.08 -38.7 83.66 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.234 1.014 . . . . 0.0 111.945 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -76.59 -6.41 51.83 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.7 1.6 . . . . 0.0 113.018 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 64.3 t30 52.7 39.31 28.27 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 128.135 2.574 . . . . 0.0 112.144 -177.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -73.92 132.3 80.35 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.328 1.451 . . . . 0.0 112.177 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -70.61 119.1 6.08 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.492 2.128 . . . . 0.0 107.612 170.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 42.9 t -20.75 125.7 0.08 OUTLIER Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 129.157 2.983 . . . . 0.0 116.44 -176.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -65.91 -1.8 5.67 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 122.845 2.363 . . . . 0.0 114.172 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 45.2 t -113.96 -69.51 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.671 1.588 . . . . 0.0 111.34 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 28.3 p -93.45 -7.57 44.08 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? 61.4 13.52 5.07 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 127.158 2.183 . . . . 0.0 114.67 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -74.1 159.19 84.52 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.418 1.087 . . . . 0.0 111.806 176.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -69.61 130.2 19.1 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.973 2.449 . . . . 0.0 112.087 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.59 110.4 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 126.161 1.784 . . . . 0.0 110.816 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -87.41 -61.14 1.79 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.542 1.137 . . . . 0.0 113.303 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.17 170.06 22.1 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.057 1.343 . . . . 0.0 113.922 -174.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 13.3 mt -133.03 140.69 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 127.714 2.405 . . . . 0.0 108.643 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 5.2 m -131.75 150.03 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 125.215 1.406 . . . . 0.0 112.956 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.51 99.93 3.14 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.78 95.8 6.05 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.306 1.442 . . . . 0.0 112.541 -173.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -68.55 161.71 27.33 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.306 1.442 . . . . 0.0 111.209 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -133.29 165.4 37.03 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 125.314 1.446 . . . . 0.0 111.59 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo . . . . . 0 C--N 1.352 0.752 0 C-N-CA 124.345 3.364 . . . . 0.0 114.124 -179.592 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 43.7 m . . . . . 0 CA--C 1.54 0.572 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 52.3 tp -135.1 97.38 13.58 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 126.601 1.96 . . . . 0.0 109.622 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -62.39 -27.89 77.87 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.676 2.25 . . . . 0.0 114.099 -176.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 63.4 tp -65.45 -36.0 82.6 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.189 0.904 . . . . 0.0 112.316 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -73.45 -33.71 65.03 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.844 0.858 . . . . 0.0 111.28 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -72.55 -59.29 2.79 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.34 1.056 . . . . 0.0 110.833 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 19.5 mm -84.97 62.11 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 126.723 2.009 . . . . 0.0 108.447 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -56.27 114.18 7.22 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 125.283 1.433 . . . . 0.0 114.067 -176.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -79.02 171.24 16.7 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.565 2.844 . . . . 0.0 113.141 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 8.0 p -68.47 -177.28 0.9 Allowed 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 16.8 m -139.09 -8.83 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 4.2 mt -110.74 -62.26 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 121.132 1.787 . . . . 0.0 112.539 -177.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 19.7 p -65.63 -64.32 0.89 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -176.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 -143.64 -13.19 0.67 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 116.981 2.215 . . . . 0.0 116.981 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 81.94 28.07 43.25 Favored Glycine 0 CA--C 1.536 1.381 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -172.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -72.84 155.07 90.97 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 125.142 1.377 . . . . 0.0 111.534 -179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -70.07 1.82 4.29 Favored 'Trans proline' 0 CA--C 1.548 1.214 0 C-N-CA 124.03 3.153 . . . . 0.0 116.135 -178.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -63.56 156.71 25.67 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 127.016 2.126 . . . . 0.0 112.827 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -128.05 150.23 50.03 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 129.193 2.997 . . . . 0.0 111.956 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 176.77 84.29 0.06 OUTLIER Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.3 1.428 . . . . 0.0 113.671 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 42.2 t -62.36 139.58 58.54 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.978 0.911 . . . . 0.0 111.526 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.6 mp -115.11 148.75 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.95 1.7 . . . . 0.0 111.043 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 93.9 t -130.0 131.71 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.316 1.047 . . . . 0.0 111.517 177.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -125.04 100.15 6.44 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 128.097 2.559 . . . . 0.0 112.397 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.69 -89.6 0.38 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.579 1.562 . . . . 0.0 114.25 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -120.6 -4.5 9.78 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.955 1.702 . . . . 0.0 113.797 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 47.4 p -131.7 170.0 15.39 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.945 1.698 . . . . 0.0 111.176 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -141.81 176.12 22.17 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.546 1.07 . . . . 0.0 115.159 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.11 144.64 47.52 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.106 2.162 . . . . 0.0 112.784 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 34.0 tp -135.13 153.17 52.09 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.407 2.683 . . . . 0.0 110.904 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 47.3 mtt 82.97 29.77 0.09 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 128.748 2.819 . . . . 0.0 113.528 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -134.01 139.91 46.35 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 127.107 2.163 . . . . 0.0 107.563 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 30.6 p -79.42 175.04 10.97 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 122.883 1.325 . . . . 0.0 113.52 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.52 -36.08 81.45 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.46 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 53.8 m -63.94 -53.12 55.27 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 117.372 -1.299 . . . . 0.0 110.508 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 28.8 m -48.98 -54.24 16.44 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 120.394 1.452 . . . . 0.0 111.052 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.97 -49.48 76.67 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.806 1.242 . . . . 0.0 112.949 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -62.59 -41.66 99.1 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.559 1.144 . . . . 0.0 111.443 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -61.18 -57.96 10.28 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.0 1.72 . . . . 0.0 111.159 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 1.7 pp -59.51 -37.01 77.19 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.046 0.384 . . . . 0.0 111.495 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -61.9 -52.15 65.25 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.263 1.425 . . . . 0.0 111.827 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -59.94 -34.89 73.85 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.927 1.291 . . . . 0.0 112.599 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -78.34 2.92 16.99 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.625 1.97 . . . . 0.0 113.424 175.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 28.2 m120 64.16 21.01 12.42 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 128.582 2.753 . . . . 0.0 114.991 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -70.47 134.02 86.81 Favored Pre-proline 0 CA--C 1.544 0.732 0 O-C-N 121.102 -0.999 . . . . 0.0 108.606 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.38 -56.28 0.3 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.264 1.976 . . . . 0.0 111.223 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 1.8 t -155.2 145.26 15.72 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 129.858 3.263 . . . . 0.0 109.008 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.99 -12.47 32.53 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.018 2.478 . . . . 0.0 114.849 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 15.3 t -140.23 -56.16 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 120.707 1.594 . . . . 0.0 114.297 -177.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 16.8 m -71.5 -22.42 61.79 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.107 2.163 . . . . 0.0 112.207 -177.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 79.2 mtm-85 63.3 11.81 5.71 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.894 2.478 . . . . 0.0 113.527 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -75.94 132.85 73.46 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.503 1.121 . . . . 0.0 109.02 174.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.02 110.11 1.66 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.69 2.26 . . . . 0.0 114.412 -176.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.0 pp -65.28 141.38 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.519 1.528 . . . . 0.0 111.836 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -114.98 -28.04 7.16 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.89 1.276 . . . . 0.0 114.24 -176.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -154.63 162.57 41.07 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.274 1.03 . . . . 0.0 113.699 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 6.8 mt -129.19 137.71 56.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 127.725 2.41 . . . . 0.0 107.219 176.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 12.2 p -134.27 150.03 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.792 1.237 . . . . 0.0 112.312 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -75.21 99.74 4.1 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.489 0.716 . . . . 0.0 109.07 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.1 m -112.3 105.6 13.94 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.797 0.839 . . . . 0.0 109.599 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -87.04 161.54 18.11 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.177 1.391 . . . . 0.0 113.959 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -72.08 161.32 79.47 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 126.876 2.07 . . . . 0.0 112.387 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo . . . . . 0 C--N 1.353 0.766 0 C-N-CA 124.563 3.508 . . . . 0.0 114.422 178.775 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 97.2 mt -69.15 158.81 85.6 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 125.389 1.476 . . . . 0.0 112.429 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -58.57 165.19 8.15 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.728 2.952 . . . . 0.0 113.68 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 7.2 tt -49.5 -39.26 33.35 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.294 1.438 . . . . 0.0 113.254 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -54.61 -24.73 22.61 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.84 1.656 . . . . 0.0 114.263 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -69.28 -22.49 63.81 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.36 -0.837 . . . . 0.0 112.737 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 35.1 mm -84.07 81.29 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 125.913 1.685 . . . . 0.0 107.421 176.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -109.48 60.79 0.3 Allowed Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 127.3 2.24 . . . . 0.0 115.07 -173.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.39 -45.35 1.82 Allowed 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.523 2.815 . . . . 0.0 112.563 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 15.8 t -59.54 146.69 39.69 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.859 1.209 . . . . 0.0 109.295 173.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.98 -1.22 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.488 1.115 . . . . 0.0 113.723 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 4.1 mt -132.95 -45.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 119.431 1.014 . . . . 0.0 112.805 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 2.7 m -71.16 -60.55 2.17 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -152.17 -17.78 0.18 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -176.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 83.31 10.23 82.56 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-N 119.575 1.079 . . . . 0.0 112.439 -175.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -71.13 155.1 93.62 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 127.281 2.232 . . . . 0.0 113.237 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.96 7.7 0.04 OUTLIER 'Trans proline' 0 CA--C 1.553 1.449 1 C-N-CA 126.012 4.475 . . . . 0.0 120.103 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -61.47 151.28 33.18 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 120.652 1.569 . . . . 0.0 112.301 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -128.13 150.23 50.07 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.63 1.572 . . . . 0.0 112.336 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -167.88 79.9 0.1 Allowed Glycine 0 CA--C 1.531 1.083 0 C-N-CA 126.552 2.025 . . . . 0.0 111.523 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 49.1 t -68.04 135.36 52.16 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 117.719 0.76 . . . . 0.0 110.532 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.04 143.33 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.912 1.685 . . . . 0.0 111.855 -177.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 53.2 t -129.53 137.54 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.156 1.382 . . . . 0.0 110.681 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -124.0 104.07 8.68 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 129.6 3.16 . . . . 0.0 110.472 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.85 -87.42 0.29 Allowed Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.437 1.494 . . . . 0.0 113.62 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -131.22 5.04 4.43 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.47 1.908 . . . . 0.0 114.308 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 82.0 p -133.97 170.05 16.21 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.537 1.935 . . . . 0.0 110.693 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -159.08 174.44 36.03 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 120.781 -1.2 . . . . 0.0 113.309 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -120.29 144.51 47.77 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.528 1.131 . . . . 0.0 113.38 175.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 4.1 pp -110.78 153.22 25.66 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.333 1.853 . . . . 0.0 112.792 178.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 22.8 ttt 85.33 67.89 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 129.084 2.954 . . . . 0.0 113.116 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -158.1 152.18 24.15 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.122 2.569 . . . . 0.0 108.675 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 13.3 p -91.61 171.56 9.09 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 122.074 0.94 . . . . 0.0 111.74 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.57 -36.75 85.25 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.641 -0.662 . . . . 0.0 111.467 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 38.4 m -68.76 -50.02 53.95 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 116.528 -1.701 . . . . 0.0 109.976 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 19.2 m -46.19 -57.77 4.24 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 121.237 1.835 . . . . 0.0 110.943 174.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.84 -51.3 67.97 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.787 1.235 . . . . 0.0 112.599 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -62.78 -37.94 88.64 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.236 -0.915 . . . . 0.0 112.778 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -61.22 -51.21 69.94 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.215 1.806 . . . . 0.0 110.96 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 20.9 mt -54.94 -53.63 53.14 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.858 1.263 . . . . 0.0 109.67 175.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -52.94 -48.07 67.59 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.431 1.492 . . . . 0.0 112.644 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -61.45 -41.67 97.58 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.462 1.505 . . . . 0.0 112.204 175.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -70.82 -16.74 62.75 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.189 1.396 . . . . 0.0 113.613 176.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 35.3 t30 105.13 -3.99 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.89 1 C-N-CA 132.428 4.291 . . . . 0.0 115.047 175.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -80.7 123.7 82.35 Favored Pre-proline 0 N--CA 1.472 0.663 0 CA-C-N 120.784 1.629 . . . . 0.0 109.882 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.77 -69.08 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.823 2.349 . . . . 0.0 111.655 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 7.1 t -111.12 135.18 20.9 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 126.346 1.859 . . . . 0.0 111.727 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -79.88 -7.55 14.41 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.351 2.7 . . . . 0.0 114.261 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 29.1 t -102.93 -72.87 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 119.748 1.158 . . . . 0.0 112.085 -177.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 26.5 p -100.65 -3.58 30.07 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.048 1.739 . . . . 0.0 113.647 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . 0.338 15.5 ptp180 53.85 23.6 3.95 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 128.797 2.839 . . . . 0.0 116.026 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -65.51 146.76 98.94 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 123.361 0.664 . . . . 0.0 109.579 173.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.02 112.2 2.66 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.337 2.691 . . . . 0.0 113.714 -175.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.5 pp -71.63 160.04 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.879 1.672 . . . . 0.0 113.209 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -111.38 -54.06 2.64 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.471 1.908 . . . . 0.0 110.818 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.33 170.21 21.21 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.83 1.252 . . . . 0.0 113.425 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 14.7 mt -121.14 137.94 53.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 127.302 2.241 . . . . 0.0 106.76 174.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 10.8 m -134.43 149.94 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 52.8 mt -73.34 99.94 3.05 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.704 1.202 . . . . 0.0 108.358 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 33.5 m -116.65 112.63 21.53 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.607 1.563 . . . . 0.0 112.29 -175.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -100.7 171.06 7.93 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.775 1.63 . . . . 0.0 112.692 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -139.05 156.09 72.51 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.331 1.452 . . . . 0.0 111.751 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 C--N 1.35 0.654 0 C-N-CA 123.599 2.866 . . . . 0.0 111.495 -179.828 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 41.1 m . . . . . 0 CA--C 1.54 0.573 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 54.1 tp -126.18 105.75 25.07 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 126.583 1.953 . . . . 0.0 110.735 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -48.89 152.52 4.52 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 124.106 3.204 . . . . 0.0 114.135 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 85.4 mt 63.97 -56.52 0.22 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 129.947 3.299 . . . . 0.0 113.042 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -55.14 -31.97 61.74 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.864 2.466 . . . . 0.0 113.48 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -96.14 -7.04 36.98 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 49.4 mm -66.57 -51.34 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.123 0.969 . . . . 0.0 110.961 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 31.43 73.29 0.51 Allowed Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 128.532 2.733 . . . . 0.0 113.962 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.44 -57.62 2.1 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 124.423 3.416 . . . . 0.0 115.683 -177.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 8.0 t -54.55 148.0 13.15 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.264 1.026 . . . . 0.0 111.752 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.35 -3.37 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 121.173 -0.955 . . . . 0.0 113.317 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 7.3 mt -129.65 -48.15 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.871 0.869 . . . . 0.0 112.774 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.2 m -68.0 -62.81 1.23 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -156.87 -15.01 0.09 Allowed 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 88.29 8.33 71.6 Favored Glycine 0 CA--C 1.54 1.629 0 O-C-N 120.652 -1.28 . . . . 0.0 112.657 -174.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -59.67 151.45 62.22 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 128.718 2.807 . . . . 0.0 114.336 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.8 88.39 1.31 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.448 3.432 . . . . 0.0 113.258 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -136.96 161.79 35.06 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 127.375 2.27 . . . . 0.0 111.023 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -125.61 150.08 47.85 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.668 1.587 . . . . 0.0 109.972 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -179.93 80.43 0.06 OUTLIER Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.309 1.909 . . . . 0.0 111.498 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 50.5 t -66.29 133.39 50.48 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.877 0.871 . . . . 0.0 110.008 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.03 141.21 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.878 1.271 . . . . 0.0 110.766 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 92.3 t -130.01 133.96 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.426 1.091 . . . . 0.0 111.8 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -124.92 107.88 11.32 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 128.693 2.797 . . . . 0.0 110.204 174.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 66.29 -93.6 0.2 Allowed Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.993 1.759 . . . . 0.0 113.625 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -126.16 7.19 7.18 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.72 2.008 . . . . 0.0 113.611 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 79.7 p -130.52 170.12 14.66 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.656 1.982 . . . . 0.0 110.541 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.33 -178.4 30.44 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.816 -1.177 . . . . 0.0 115.345 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -120.07 136.51 54.55 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.038 2.135 . . . . 0.0 110.404 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 26.4 tp -121.38 152.97 38.42 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.615 1.966 . . . . 0.0 111.206 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 41.4 mtm 64.97 68.34 0.51 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 127.62 2.368 . . . . 0.0 113.018 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -151.96 148.16 27.42 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 129.163 2.985 . . . . 0.0 107.252 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 17.2 p -77.92 165.89 23.55 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 122.472 1.13 . . . . 0.0 111.828 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.7 -38.67 91.34 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.698 -0.626 . . . . 0.0 111.165 177.316 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 23.8 m -62.16 -48.8 78.48 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 116.911 -1.519 . . . . 0.0 111.133 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 16.6 m -49.24 -51.66 31.96 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 120.809 1.64 . . . . 0.0 111.386 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.19 -47.06 84.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.42 1.088 . . . . 0.0 112.835 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -65.88 -40.57 91.73 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 121.216 -0.927 . . . . 0.0 111.937 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -61.43 -56.83 15.83 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.624 1.97 . . . . 0.0 111.471 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 2.8 pp -59.98 -35.89 75.97 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 118.133 0.424 . . . . 0.0 111.317 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -63.48 -48.63 76.86 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.886 1.274 . . . . 0.0 110.853 175.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -58.64 -39.36 80.32 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.314 1.446 . . . . 0.0 111.409 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -74.12 3.79 6.53 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 127.163 2.185 . . . . 0.0 113.746 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 67.51 15.82 9.86 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 128.949 2.9 . . . . 0.0 115.227 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 5.7 tppp? -70.17 129.96 90.09 Favored Pre-proline 0 N--CA 1.475 0.802 0 O-C-N 120.832 -1.168 . . . . 0.0 109.106 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.33 -49.48 1.26 Allowed 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.847 2.365 . . . . 0.0 111.38 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 1.7 t -158.36 142.28 11.27 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 131.576 3.95 . . . . 0.0 107.995 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.76 -11.32 29.35 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.081 2.521 . . . . 0.0 115.026 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 17.1 t -137.75 -55.93 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 120.54 1.518 . . . . 0.0 113.739 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 22.4 m -69.88 -25.47 63.72 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.739 1.616 . . . . 0.0 111.432 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 33.5 mtp-105 61.38 13.78 5.24 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 127.911 2.484 . . . . 0.0 113.244 -175.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -76.73 130.85 75.14 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.227 1.411 . . . . 0.0 108.484 174.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -64.46 109.61 1.24 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.549 2.166 . . . . 0.0 113.679 -176.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.1 pp -63.21 137.78 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.683 1.593 . . . . 0.0 111.861 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -115.18 -20.8 10.26 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 2.6 ttp -150.95 146.68 26.42 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.13 0.972 . . . . 0.0 112.763 -174.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 7.6 mt -130.78 131.47 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 127.478 2.311 . . . . 0.0 107.763 174.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.39 150.09 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 119.487 1.039 . . . . 0.0 113.707 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.18 99.87 3.52 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 10.2 t -89.41 156.19 18.85 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.372 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -135.7 170.33 16.14 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.161 2.185 . . . . 0.0 111.374 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -133.56 156.57 79.48 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 124.887 1.275 . . . . 0.0 111.706 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo . . . . . 0 CA--C 1.538 0.692 0 C-N-CA 123.434 2.756 . . . . 0.0 112.369 179.753 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 41.2 m . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.52 90.46 20.13 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.324 1.85 . . . . 0.0 111.669 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -47.45 -31.38 13.31 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.705 3.603 . . . . 0.0 115.599 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 1.6 pp -58.05 -20.18 37.31 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.064 1.745 . . . . 0.0 114.907 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -121.32 -2.45 9.54 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.189 1.796 . . . . 0.0 112.64 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -78.41 64.96 3.61 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.414 1.486 . . . . 0.0 112.756 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 28.8 mm -77.46 73.21 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.777 1.231 . . . . 0.0 109.838 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -138.04 67.86 48.67 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 126.454 1.902 . . . . 0.0 110.143 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.13 -38.89 63.67 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.092 2.528 . . . . 0.0 114.696 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 42.2 t -56.13 143.91 31.31 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 120.182 1.355 . . . . 0.0 111.029 177.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 28.5 m -123.68 -15.13 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 10.5 pt -137.12 -26.41 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.5 m -75.9 -64.47 1.08 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 120.64 1.563 . . . . 0.0 112.137 -177.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -145.39 -12.81 0.52 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 76.73 11.88 84.97 Favored Glycine 0 CA--C 1.544 1.886 0 CA-C-N 119.992 1.269 . . . . 0.0 112.487 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -59.54 155.11 40.7 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 129.997 3.319 . . . . 0.0 113.618 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.65 -1.69 10.21 Favored 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 124.354 3.37 . . . . 0.0 115.463 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -52.65 146.8 9.55 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 127.042 2.137 . . . . 0.0 111.577 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -116.21 150.16 37.97 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.757 2.023 . . . . 0.0 110.735 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -159.68 68.12 0.26 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 128.169 2.795 . . . . 0.0 109.349 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 33.8 t -63.8 133.28 53.15 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.063 0.945 . . . . 0.0 110.429 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -114.57 143.21 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.35 1.06 . . . . 0.0 112.057 -175.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 89.6 t -129.08 136.84 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.926 1.29 . . . . 0.0 110.629 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -125.04 95.05 4.36 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 129.456 3.102 . . . . 0.0 110.096 176.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.96 -91.5 0.35 Allowed Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.809 1.671 . . . . 0.0 114.227 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -121.49 4.34 10.18 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 126.318 1.847 . . . . 0.0 114.338 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 66.4 p -134.77 170.09 16.37 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.249 2.22 . . . . 0.0 109.903 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -160.18 174.45 36.93 Favored Glycine 0 CA--C 1.529 0.921 0 O-C-N 120.658 -1.276 . . . . 0.0 113.766 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -120.26 141.99 49.46 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.906 1.282 . . . . 0.0 113.072 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.41 153.26 36.8 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.152 2.581 . . . . 0.0 110.526 177.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 49.5 mtt 93.17 62.96 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 129.826 3.25 . . . . 0.0 111.486 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -160.01 149.59 17.97 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 127.205 2.202 . . . . 0.0 109.489 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 19.4 p -88.3 174.93 7.89 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.851 0.834 . . . . 0.0 110.232 172.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -39.81 94.77 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.397 -0.814 . . . . 0.0 112.416 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 68.9 m -68.13 -48.06 66.42 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 116.105 -1.902 . . . . 0.0 110.606 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 16.6 m -45.61 -59.07 2.95 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 121.601 2.001 . . . . 0.0 111.263 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.88 -43.95 86.35 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.028 1.331 . . . . 0.0 114.062 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -68.92 -42.51 76.73 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.354 -0.841 . . . . 0.0 111.777 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -62.35 -53.91 48.19 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.006 2.122 . . . . 0.0 112.358 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.3 pp -57.54 -36.49 71.69 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.319 0.509 . . . . 0.0 111.197 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -66.68 -46.21 76.39 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.452 0.701 . . . . 0.0 111.767 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -59.23 -35.11 73.07 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.853 1.261 . . . . 0.0 111.704 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -76.3 3.77 10.21 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 127.322 2.249 . . . . 0.0 113.457 175.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 39.3 t30 76.38 8.49 3.28 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 130.013 3.325 . . . . 0.0 115.649 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -70.14 129.46 90.64 Favored Pre-proline 0 N--CA 1.475 0.818 0 O-C-N 120.755 -1.216 . . . . 0.0 109.242 175.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -69.76 -43.23 2.78 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.072 2.515 . . . . 0.0 114.695 -176.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.56 149.3 36.65 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 128.251 2.62 . . . . 0.0 110.313 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.24 -17.69 61.32 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.361 2.707 . . . . 0.0 115.369 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.09 -63.31 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 -172.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 28.8 p -89.16 -19.47 25.44 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -172.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . 0.259 3.9 ptm180 94.15 4.8 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 131.252 3.821 . . . . 0.0 116.182 174.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -67.67 111.99 9.12 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 125.08 1.352 . . . . 0.0 110.387 178.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -46.64 107.84 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 124.269 3.313 . . . . 0.0 116.099 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 pp -62.86 146.95 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.178 1.391 . . . . 0.0 113.45 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -112.1 -29.76 7.48 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.781 1.632 . . . . 0.0 114.187 -173.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.03 161.34 33.97 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.63 1.172 . . . . 0.0 113.468 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 14.1 mt -129.51 136.48 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 127.518 2.327 . . . . 0.0 108.231 175.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 16.9 m -137.61 150.16 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.726 1.21 . . . . 0.0 113.479 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.22 99.85 4.86 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 177.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 1.9 t -93.79 157.61 16.06 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -129.27 143.3 50.8 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.32 1.448 . . . . 0.0 112.403 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -73.39 164.53 60.37 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 125.137 1.375 . . . . 0.0 111.56 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo . . . . . 0 CA--C 1.539 0.726 0 C-N-CA 124.226 3.284 . . . . 0.0 114.272 179.718 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -153.96 150.08 22.03 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 126.727 2.011 . . . . 0.0 111.037 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.17 149.59 90.97 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.052 1.834 . . . . 0.0 112.728 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 5.1 tp 62.04 -60.76 0.11 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 130.1 3.36 . . . . 0.0 115.205 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -65.25 -16.49 63.6 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -63.53 -37.81 88.73 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 27.3 mm 39.01 65.97 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 127.325 2.25 . . . . 0.0 111.645 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -40.55 102.84 0.27 Allowed Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 128.892 2.877 . . . . 0.0 114.311 -175.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -88.82 -179.1 2.09 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 124.53 3.487 . . . . 0.0 114.447 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 10.0 t -61.01 159.21 11.94 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 128.228 2.611 . . . . 0.0 111.029 171.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.71 -0.63 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.378 1.071 . . . . 0.0 113.442 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 10.4 mt -133.94 -48.86 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 119.735 1.152 . . . . 0.0 112.866 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.5 m -67.61 -60.16 2.77 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.439 1.496 . . . . 0.0 114.228 -173.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -151.53 -16.13 0.2 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -174.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.62 10.69 82.95 Favored Glycine 0 CA--C 1.542 1.755 0 O-C-N 120.812 -1.18 . . . . 0.0 113.173 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -61.96 155.04 65.46 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 128.39 2.676 . . . . 0.0 112.339 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -66.27 1.66 2.35 Favored 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.459 3.439 . . . . 0.0 117.3 -177.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -60.96 144.9 52.3 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.871 1.214 . . . . 0.0 110.62 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -128.19 150.07 50.17 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.68 1.992 . . . . 0.0 111.683 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -162.69 98.92 0.17 Allowed Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.742 1.639 . . . . 0.0 112.51 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 46.4 t -68.21 133.2 48.47 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.517 0.727 . . . . 0.0 110.638 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.2 mp -113.0 135.4 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.181 1.392 . . . . 0.0 110.463 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 45.4 t -130.04 130.32 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.422 1.089 . . . . 0.0 109.65 176.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.2 99.09 5.93 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.908 2.083 . . . . 0.0 112.206 178.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 75.9 -84.36 0.91 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.732 1.634 . . . . 0.0 114.711 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -124.99 -11.53 7.09 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.761 1.624 . . . . 0.0 114.3 -176.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 72.9 p -135.33 168.89 18.37 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.455 1.502 . . . . 0.0 110.573 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -142.96 178.44 21.24 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.35 0.976 . . . . 0.0 113.829 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -120.27 147.03 45.49 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.866 1.266 . . . . 0.0 113.839 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 12.2 tp -111.4 153.27 26.3 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 128.84 2.856 . . . . 0.0 113.551 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 16.7 mtt 69.47 59.74 0.31 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.68 2.392 . . . . 0.0 115.835 173.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -149.56 163.04 38.96 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.286 1.434 . . . . 0.0 111.046 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 11.6 p -87.25 174.49 8.56 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 122.393 1.092 . . . . 0.0 112.484 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -67.04 -40.15 87.13 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.72 -0.612 . . . . 0.0 111.197 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 27.8 m -64.73 -41.98 95.55 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 117.528 -1.225 . . . . 0.0 111.651 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 34.6 m -49.29 -63.61 1.05 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.242 1.417 . . . . 0.0 109.187 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -53.92 -45.17 71.11 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.021 1.728 . . . . 0.0 113.109 176.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -60.11 -37.26 79.47 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.756 1.222 . . . . 0.0 112.352 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -59.85 -49.34 78.1 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.446 1.099 . . . . 0.0 110.922 175.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 5.9 mp -58.75 -46.7 86.84 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 122.847 0.459 . . . . 0.0 109.882 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -57.39 -48.06 80.07 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.132 0.973 . . . . 0.0 112.906 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -56.83 -28.05 60.98 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.183 1.393 . . . . 0.0 113.911 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -107.45 -0.55 22.17 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.708 2.003 . . . . 0.0 112.979 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 60.3 t30 45.49 50.59 10.21 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.943 2.497 . . . . 0.0 111.319 -174.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -73.33 130.6 84.08 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.601 0.761 . . . . 0.0 112.876 -174.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -70.43 115.35 4.15 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.51 2.14 . . . . 0.0 107.568 170.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 53.8 t -23.07 123.35 0.15 Allowed Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 129.211 3.005 . . . . 0.0 115.682 -176.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -65.34 -3.62 7.87 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.127 2.551 . . . . 0.0 114.531 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 47.0 t -109.08 -65.5 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.346 1.458 . . . . 0.0 111.31 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 24.5 p -104.63 0.74 28.82 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 62.84 10.29 4.2 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 127.795 2.438 . . . . 0.0 115.898 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -68.68 149.28 97.99 Favored Pre-proline 0 CA--C 1.552 1.058 0 C-N-CA 123.87 0.868 . . . . 0.0 111.732 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.39 112.96 3.47 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.662 2.908 . . . . 0.0 112.009 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.92 109.97 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 126.547 1.939 . . . . 0.0 110.463 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -103.65 -55.79 2.33 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -172.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.31 161.87 37.18 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -177.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 4.6 mt -135.02 136.53 51.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 126.998 2.119 . . . . 0.0 108.847 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 16.9 m -133.21 150.01 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.935 0.894 . . . . 0.0 112.555 176.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 3.8 tt -82.53 99.75 9.69 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 5.1 t -90.87 162.66 14.7 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.157 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -131.68 148.44 52.59 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.451 1.5 . . . . 0.0 112.038 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -78.06 160.6 73.28 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 125.444 1.498 . . . . 0.0 110.969 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo . . . . . 0 C--N 1.351 0.683 0 C-N-CA 123.322 2.682 . . . . 0.0 111.784 -177.796 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.52 157.91 69.98 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.829 1.652 . . . . 0.0 111.456 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -60.17 -30.91 92.36 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.833 2.355 . . . . 0.0 113.579 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 62.8 tp -78.01 -43.01 30.74 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.83 0.852 . . . . 0.0 111.47 175.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -62.21 -33.97 75.57 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.987 1.315 . . . . 0.0 112.37 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -123.24 60.59 1.06 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.809 2.043 . . . . 0.0 109.857 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 435' ' ' ILE . . . . . 0.451 HG23 ' H ' ' B' ' 436' ' ' GLU . 9.6 tp -44.22 -63.54 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 129.806 3.242 . . . . 0.0 114.7 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 436' ' ' GLU . . . . . 0.451 ' H ' HG23 ' B' ' 435' ' ' ILE . 64.3 mm-40 -148.85 88.82 5.1 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 126.532 1.933 . . . . 0.0 107.672 176.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.93 164.77 32.35 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.584 2.19 . . . . 0.0 113.235 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 1.9 p -67.85 175.54 2.98 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 34.8 m -135.94 -3.32 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -176.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 7.7 mt -114.77 -64.43 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 120.319 1.418 . . . . 0.0 112.588 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 21.5 p -68.85 -59.19 3.25 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -147.35 -17.8 0.39 Allowed 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.531 2.049 . . . . 0.0 116.531 -172.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 90.65 30.65 11.35 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.035 1.303 . . . . 0.0 110.778 -174.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 35.0 mtt-85 -62.65 149.38 89.09 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 124.929 1.292 . . . . 0.0 111.595 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.96 -10.49 29.01 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.448 2.765 . . . . 0.0 114.297 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -58.99 153.56 17.32 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 129.593 3.157 . . . . 0.0 113.002 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -128.2 150.16 50.14 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.319 2.248 . . . . 0.0 110.625 176.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -167.06 75.11 0.14 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 127.047 2.26 . . . . 0.0 110.291 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 33.1 t -59.89 122.4 14.17 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.643 0.777 . . . . 0.0 111.854 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 450' ' ' ILE . . . . . 0.423 HD12 ' H ' ' B' ' 450' ' ' ILE . 1.2 mp -95.66 134.09 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.966 1.306 . . . . 0.0 109.794 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 95.5 t -127.97 130.38 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.279 1.032 . . . . 0.0 111.353 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -115.06 94.92 4.95 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 128.597 2.759 . . . . 0.0 110.12 174.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.83 -94.92 0.31 Allowed Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.856 1.693 . . . . 0.0 114.372 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -111.97 -1.19 15.51 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.02 1.728 . . . . 0.0 113.648 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 70.1 p -132.28 170.01 15.66 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.655 1.582 . . . . 0.0 111.351 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -157.69 174.64 35.08 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 121.114 -0.991 . . . . 0.0 113.655 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -120.22 110.8 17.03 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.259 1.424 . . . . 0.0 111.411 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 9.8 tp -81.22 153.31 27.24 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.339 2.655 . . . . 0.0 113.033 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 23.7 mtt 79.58 57.99 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 127.786 2.435 . . . . 0.0 114.663 172.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -148.8 150.27 32.77 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.992 2.117 . . . . 0.0 108.319 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 31.7 p -86.47 175.0 8.6 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 122.649 1.214 . . . . 0.0 112.798 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.98 -33.78 76.87 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.2 174.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 37.4 m -63.86 -54.25 37.89 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 117.284 -1.341 . . . . 0.0 109.88 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 21.5 m -47.58 -59.71 3.06 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.126 1.33 . . . . 0.0 111.234 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.95 -48.02 76.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.679 1.192 . . . . 0.0 113.767 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -66.05 -41.72 90.48 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.209 -0.932 . . . . 0.0 111.722 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -63.39 -54.86 30.11 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.785 1.634 . . . . 0.0 112.101 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.5 pp -59.07 -37.89 78.15 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.238 0.472 . . . . 0.0 110.926 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -65.68 -42.99 90.62 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.74 0.816 . . . . 0.0 112.174 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -59.23 -37.86 78.54 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.031 1.332 . . . . 0.0 111.043 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 48.1 mtm105 -77.04 9.67 2.84 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 127.031 2.133 . . . . 0.0 113.646 174.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . 0.313 0.0 OUTLIER 72.56 3.4 4.67 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 130.742 3.617 . . . . 0.0 116.823 178.415 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -72.08 131.12 85.65 Favored Pre-proline 0 CA--C 1.545 0.752 0 O-C-N 121.091 -1.006 . . . . 0.0 109.947 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.51 -72.47 0.02 OUTLIER 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.152 2.568 . . . . 0.0 109.651 176.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 9.3 t -120.92 136.26 25.43 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 127.897 2.479 . . . . 0.0 109.674 175.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.87 -8.18 19.97 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.343 2.696 . . . . 0.0 114.902 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 41.6 t -111.36 -74.84 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 119.877 1.217 . . . . 0.0 112.613 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 16.7 p -92.5 -5.4 51.9 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.57 1.548 . . . . 0.0 113.694 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 61.94 16.22 7.89 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.743 2.417 . . . . 0.0 114.761 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -64.36 139.4 97.7 Favored Pre-proline 0 CA--C 1.549 0.938 0 O-C-N 121.477 -0.764 . . . . 0.0 109.796 175.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.54 113.64 2.79 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.162 2.574 . . . . 0.0 112.612 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 16.5 pt -70.93 157.55 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.54 1.136 . . . . 0.0 113.528 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -115.02 -40.7 3.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.324 1.849 . . . . 0.0 112.978 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.63 167.22 31.11 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -176.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 6.9 mt -135.99 129.03 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 129.169 2.987 . . . . 0.0 106.369 174.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.68 150.15 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.9 107.22 2.57 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 174.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 23.3 m -103.18 88.23 3.09 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.212 1.805 . . . . 0.0 110.086 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -60.78 153.64 23.85 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.772 2.029 . . . . 0.0 115.1 -176.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -61.88 156.12 58.51 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 126.276 1.831 . . . . 0.0 112.531 176.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 CA--C 1.538 0.709 0 C-N-CA 123.308 2.672 . . . . 0.0 112.591 179.869 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 78.4 p . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 95.8 mt -69.17 157.28 89.71 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.358 1.463 . . . . 0.0 111.279 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_exo -44.31 -50.38 7.92 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 124.295 3.33 . . . . 0.0 115.323 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -64.58 -9.69 20.99 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -112.72 -21.23 11.33 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.122 1.769 . . . . 0.0 111.794 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -87.65 1.73 52.91 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.88 2.072 . . . . 0.0 114.431 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.2 pp -65.52 69.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 128.095 2.558 . . . . 0.0 113.266 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 436' ' ' GLU . . . . . 0.48 ' H ' ' CD ' ' A' ' 437' ' ' PRO . 48.7 mt-10 -133.67 -42.43 0.03 OUTLIER Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 126.302 1.841 . . . . 0.0 115.667 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 437' ' ' PRO . . . . . 0.48 ' CD ' ' H ' ' A' ' 436' ' ' GLU . 82.5 Cg_exo -49.23 -69.32 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 124.969 3.78 . . . . 0.0 117.253 -178.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 30.5 t -51.27 148.12 5.06 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 120.166 1.348 . . . . 0.0 112.663 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.8 -14.9 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 9.4 pt -136.36 -26.55 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.5 m -76.28 -60.12 2.47 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 120.719 1.599 . . . . 0.0 112.064 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -154.17 -13.76 0.13 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -176.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.51 11.55 81.75 Favored Glycine 0 CA--C 1.541 1.687 0 CA-C-N 120.011 1.278 . . . . 0.0 112.198 -173.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 9.4 ptm85 -55.97 155.05 12.69 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 129.592 3.157 . . . . 0.0 114.024 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.7 4.9 4.18 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 124.551 3.501 . . . . 0.0 115.762 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -58.52 157.98 8.26 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.182 1.793 . . . . 0.0 112.586 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -119.66 150.04 40.99 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 128.423 2.689 . . . . 0.0 111.898 -175.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 176.84 82.66 0.06 OUTLIER Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.575 1.56 . . . . 0.0 113.015 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 48.0 t -71.33 138.82 49.57 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 118.152 0.976 . . . . 0.0 109.864 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.6 mp -115.01 144.11 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.651 1.58 . . . . 0.0 110.44 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 97.1 t -129.91 131.34 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.242 1.017 . . . . 0.0 109.527 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -125.05 94.98 4.33 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.91 2.484 . . . . 0.0 111.281 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.49 -89.64 0.36 Allowed Glycine 0 CA--C 1.534 1.281 0 C-N-CA 125.689 1.614 . . . . 0.0 114.386 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -121.56 -0.85 9.65 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 126.348 1.859 . . . . 0.0 113.868 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 16.8 p -130.66 170.12 14.74 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 128.223 2.609 . . . . 0.0 109.787 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -157.79 177.06 34.73 Favored Glycine 0 CA--C 1.529 0.932 0 O-C-N 120.688 -1.258 . . . . 0.0 113.947 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -120.34 135.91 54.87 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.715 1.606 . . . . 0.0 113.842 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 4.0 pp -119.9 153.35 36.0 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.294 2.638 . . . . 0.0 109.451 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 25.0 ttt 78.26 66.3 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.762 2.025 . . . . 0.0 111.094 -177.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -160.03 154.5 23.84 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 128.898 2.879 . . . . 0.0 108.314 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 22.7 p -86.91 172.21 10.23 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.113 0.959 . . . . 0.0 111.21 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -64.94 -35.39 81.01 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.435 -0.79 . . . . 0.0 111.223 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 25.2 m -64.44 -49.2 72.39 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 117.212 -1.375 . . . . 0.0 111.152 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 29.4 m -46.93 -55.58 7.83 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 120.469 1.486 . . . . 0.0 109.924 174.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -59.99 -45.39 92.89 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.923 1.689 . . . . 0.0 113.52 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -60.1 -44.5 94.78 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.228 1.411 . . . . 0.0 111.523 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -62.35 -54.09 45.51 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.341 1.057 . . . . 0.0 111.473 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.4 pp -60.87 -32.05 71.49 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 118.579 0.627 . . . . 0.0 111.958 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -68.24 -48.56 64.79 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.269 1.428 . . . . 0.0 111.734 174.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -55.8 -43.67 77.07 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.632 1.573 . . . . 0.0 111.02 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -75.31 -6.94 52.45 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 127.067 2.147 . . . . 0.0 113.642 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 64.0 t30 50.79 41.13 26.04 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 128.074 2.55 . . . . 0.0 112.173 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -78.15 126.58 83.31 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 125.519 1.528 . . . . 0.0 113.367 -176.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -74.56 129.03 12.35 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.813 2.342 . . . . 0.0 107.526 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 48.2 t -27.01 123.79 0.23 Allowed Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 128.195 2.598 . . . . 0.0 115.493 -176.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.76 -1.66 6.31 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 122.959 2.439 . . . . 0.0 114.33 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 49.1 t -123.64 -59.55 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.686 1.594 . . . . 0.0 111.233 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 69.7 m -78.12 -19.78 53.4 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.682 1.993 . . . . 0.0 112.84 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 61.62 11.79 4.12 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 127.339 2.255 . . . . 0.0 114.198 -177.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -87.17 148.19 44.36 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 123.975 0.91 . . . . 0.0 112.95 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.25 124.55 7.9 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.863 3.042 . . . . 0.0 111.97 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.98 143.04 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.643 1.177 . . . . 0.0 112.859 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -115.17 -40.25 3.49 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.51 1.524 . . . . 0.0 113.656 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.5 166.58 31.82 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -176.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 8.0 mt -133.07 139.22 49.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 127.534 2.333 . . . . 0.0 108.732 176.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.06 150.11 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.944 1.297 . . . . 0.0 113.329 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 55.8 mt -73.29 99.87 3.0 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.294 1.037 . . . . 0.0 109.182 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 6.3 t -95.44 151.53 19.21 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -141.91 158.72 43.44 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.325 1.45 . . . . 0.0 112.558 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -80.54 158.44 71.23 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 123.842 0.857 . . . . 0.0 112.947 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo . . . . . 0 C--N 1.355 0.886 0 C-N-CA 124.565 3.51 . . . . 0.0 113.853 179.386 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 57.3 tp -62.02 -49.22 86.17 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 126.472 1.909 . . . . 0.0 115.29 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.19 160.05 48.25 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.071 1.847 . . . . 0.0 113.333 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.16 -34.02 71.59 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.992 1.317 . . . . 0.0 111.891 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -58.0 -16.98 14.45 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.151 1.78 . . . . 0.0 114.003 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -71.34 -17.4 62.44 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 176.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 32.8 mm 46.45 83.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 127.959 2.503 . . . . 0.0 113.069 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -126.25 62.02 44.36 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 125.764 1.625 . . . . 0.0 111.336 176.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -62.74 -64.07 0.08 OUTLIER 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 124.823 3.682 . . . . 0.0 115.923 -175.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 44.3 t -46.91 138.67 6.18 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 121.178 1.808 . . . . 0.0 112.45 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.61 -28.74 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 125.173 1.389 . . . . 0.0 112.258 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 8.3 pt -138.01 -24.86 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 -173.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.5 m -73.21 -57.67 3.86 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.731 1.605 . . . . 0.0 112.083 -176.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -154.94 -14.85 0.12 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 81.16 11.06 84.03 Favored Glycine 0 CA--C 1.542 1.766 0 CA-C-N 119.993 1.27 . . . . 0.0 112.513 -174.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -64.7 155.18 83.06 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 129.785 3.234 . . . . 0.0 113.122 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -69.12 4.48 1.89 Allowed 'Trans proline' 0 CA--C 1.548 1.224 0 C-N-CA 124.569 3.512 . . . . 0.0 117.055 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -56.74 139.7 49.86 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 120.166 1.348 . . . . 0.0 110.59 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -128.17 113.86 16.26 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.192 1.797 . . . . 0.0 114.646 -170.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -144.62 82.79 0.2 Allowed Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.55 1.548 . . . . 0.0 112.527 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 49.3 t -65.0 142.17 58.53 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 117.872 0.836 . . . . 0.0 110.565 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 2.2 mp -107.17 141.64 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 125.816 1.646 . . . . 0.0 110.121 -177.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 96.9 t -130.09 132.79 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.277 1.031 . . . . 0.0 110.398 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -125.01 94.98 4.34 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.313 2.245 . . . . 0.0 110.841 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.74 -92.44 0.24 Allowed Glycine 0 CA--C 1.534 1.275 0 C-N-CA 126.259 1.885 . . . . 0.0 114.648 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -111.88 -7.89 14.14 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.334 1.854 . . . . 0.0 113.345 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 19.7 p -124.24 170.01 11.19 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.618 1.967 . . . . 0.0 111.125 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -160.8 174.9 37.51 Favored Glycine 0 CA--C 1.532 1.099 0 O-C-N 121.088 -1.007 . . . . 0.0 113.999 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -120.28 113.46 20.43 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.319 1.848 . . . . 0.0 113.333 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -97.37 153.18 18.24 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.923 1.289 . . . . 0.0 112.023 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 40.1 tpp 75.58 68.51 0.07 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.86 2.064 . . . . 0.0 111.244 177.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -157.25 150.22 23.54 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 129.293 3.037 . . . . 0.0 108.616 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 17.1 p -86.46 170.46 11.93 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.616 1.198 . . . . 0.0 111.781 176.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.49 -30.28 70.58 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.095 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 25.0 m -69.96 -50.5 41.22 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 117.303 -1.332 . . . . 0.0 109.9 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 35.0 m -47.65 -56.84 6.38 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 120.371 1.441 . . . . 0.0 110.105 173.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.15 -46.47 82.71 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.938 1.695 . . . . 0.0 113.403 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -65.86 -37.43 86.15 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.561 -1.337 . . . . 0.0 111.822 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 21.2 tptp -63.49 -52.36 61.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.122 0.969 . . . . 0.0 111.105 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.59 -30.32 70.6 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.073 0.397 . . . . 0.0 111.704 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -68.58 -46.06 70.38 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.033 1.333 . . . . 0.0 111.829 173.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -57.64 -42.44 83.41 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.864 1.265 . . . . 0.0 110.982 174.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -72.78 -11.05 60.46 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.459 1.904 . . . . 0.0 113.528 175.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 63.8 t30 52.41 40.45 29.49 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.814 2.446 . . . . 0.0 111.754 -175.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -74.2 116.13 49.69 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 126.357 1.863 . . . . 0.0 113.781 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.1 132.49 22.89 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.41 2.073 . . . . 0.0 107.671 170.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 47.1 t -32.58 125.11 0.39 Allowed Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 127.656 2.382 . . . . 0.0 115.214 -175.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.94 -3.18 10.94 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.146 2.564 . . . . 0.0 114.381 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 42.6 t -124.74 -60.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.076 1.35 . . . . 0.0 111.726 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 58.6 m -75.01 -18.78 60.29 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.635 1.974 . . . . 0.0 112.432 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 64.6 5.12 2.56 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.554 2.342 . . . . 0.0 114.081 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -83.8 148.99 55.78 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 124.204 1.002 . . . . 0.0 113.144 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.11 124.04 8.77 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.037 2.491 . . . . 0.0 110.405 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.2 pp -60.95 128.61 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.526 1.13 . . . . 0.0 110.932 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -115.08 -26.82 7.55 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -175.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 1.7 ttp -149.86 150.35 31.8 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.241 1.016 . . . . 0.0 112.624 -175.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 10.4 mt -137.24 130.05 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 127.138 2.175 . . . . 0.0 107.941 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 27.0 m -140.07 150.23 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 124.378 1.071 . . . . 0.0 112.913 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 66.6 tp -63.7 99.89 0.25 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.065 1.746 . . . . 0.0 108.683 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 41.4 m -110.8 108.48 18.33 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -170.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -85.72 178.41 7.35 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.239 1.816 . . . . 0.0 112.997 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -129.84 168.64 15.78 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 125.953 1.701 . . . . 0.0 111.552 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo . . . . . 0 C--N 1.353 0.798 0 C-N-CA 124.249 3.299 . . . . 0.0 113.887 179.968 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 43.2 m . . . . . 0 CA--C 1.54 0.584 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 46.3 tp -133.65 89.89 29.73 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.546 1.939 . . . . 0.0 109.829 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -58.42 -37.87 92.86 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.881 2.387 . . . . 0.0 114.057 -175.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 4.4 pp -63.37 -13.55 40.59 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -106.1 -25.07 12.19 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.435 1.494 . . . . 0.0 111.689 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -83.61 -43.77 15.29 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.977 1.311 . . . . 0.0 113.045 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.1 mp -82.17 85.82 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.79 1.636 . . . . 0.0 107.223 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -53.44 126.63 47.41 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 126.817 2.047 . . . . 0.0 113.793 -176.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -76.47 -172.07 1.28 Allowed 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 124.471 3.448 . . . . 0.0 113.036 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 6.7 p -60.29 173.04 0.72 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.646 1.579 . . . . 0.0 114.579 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 28.6 m -130.75 -3.61 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -175.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 4.5 mt -117.88 -59.99 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 120.529 1.513 . . . . 0.0 112.796 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 7.0 p -69.39 -68.75 0.38 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -174.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -144.56 -13.95 0.57 Allowed 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 -171.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 88.92 40.86 6.09 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.426 1.012 . . . . 0.0 110.859 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -97.83 155.31 37.26 Favored Pre-proline 0 N--CA 1.481 1.107 0 C-N-CA 125.854 1.662 . . . . 0.0 112.406 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -44.08 121.44 2.98 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.949 3.1 . . . . 0.0 114.461 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.14 31.86 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 131.127 3.771 . . . . 0.0 118.944 -176.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -76.58 89.85 3.32 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 119.952 -1.718 . . . . 0.0 109.541 -178.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 164.97 57.21 0.02 OUTLIER Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.049 -0.862 . . . . 0.0 114.085 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 52.5 t -57.24 138.58 54.54 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.899 1.35 . . . . 0.0 110.91 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.4 mp -115.13 136.18 52.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 C-N-CA 126.687 1.995 . . . . 0.0 109.216 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 90.1 t -127.28 132.42 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.634 0.774 . . . . 0.0 110.924 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -124.35 106.14 10.0 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.011 2.525 . . . . 0.0 111.471 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 68.46 -89.92 0.23 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.703 1.621 . . . . 0.0 114.177 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -124.69 -0.97 7.99 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.152 1.781 . . . . 0.0 113.997 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 54.9 p -133.25 170.02 16.04 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.898 1.679 . . . . 0.0 110.296 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -152.01 175.12 30.87 Favored Glycine 0 CA--C 1.526 0.771 0 O-C-N 120.88 -1.138 . . . . 0.0 113.512 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -120.28 145.64 46.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.045 1.338 . . . . 0.0 114.181 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 94.8 mt -123.35 153.48 40.25 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 129.504 3.122 . . . . 0.0 110.686 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 50.5 mtt 90.7 31.39 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 128.757 2.823 . . . . 0.0 113.37 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -139.42 134.9 33.01 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.739 2.016 . . . . 0.0 107.583 173.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 22.1 p -80.98 175.11 10.97 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 122.667 1.222 . . . . 0.0 112.842 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.9 -36.93 70.73 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.731 0.812 . . . . 0.0 112.254 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 87.7 m -66.38 -52.56 45.57 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.197 0.999 . . . . 0.0 110.748 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 98.5 m -52.41 -50.54 62.32 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.31 1.044 . . . . 0.0 110.747 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.9 -44.54 91.23 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.177 1.391 . . . . 0.0 112.769 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -61.92 -43.26 99.21 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.785 1.234 . . . . 0.0 111.099 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -61.58 -57.11 13.39 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.117 0.967 . . . . 0.0 111.255 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.0 pp -59.11 -33.44 70.85 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 118.373 0.533 . . . . 0.0 112.227 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -68.05 -50.71 53.56 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.393 1.477 . . . . 0.0 112.217 175.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -56.81 -40.39 75.9 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.698 1.599 . . . . 0.0 111.502 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -79.93 -0.97 37.31 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.409 2.284 . . . . 0.0 113.403 176.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 46.24 39.22 5.9 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 128.866 2.866 . . . . 0.0 113.752 -177.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -69.98 127.93 92.06 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.478 1.511 . . . . 0.0 114.01 -176.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.09 128.19 11.22 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 122.834 2.356 . . . . 0.0 107.864 169.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 32.3 t -29.72 128.99 0.24 Allowed Pre-proline 0 CA--C 1.558 1.26 0 C-N-CA 128.07 2.548 . . . . 0.0 115.106 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -66.74 -2.56 7.81 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.181 2.588 . . . . 0.0 114.617 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 53.5 t -127.07 -59.48 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.393 1.477 . . . . 0.0 111.476 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 65.0 m -77.14 -24.59 51.61 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.595 1.958 . . . . 0.0 112.671 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 62.44 9.91 3.66 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 127.128 2.171 . . . . 0.0 113.81 -175.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -81.81 151.33 67.48 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.134 0.973 . . . . 0.0 113.068 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -77.46 121.09 5.47 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 123.978 3.119 . . . . 0.0 111.919 177.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.55 153.35 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.988 1.315 . . . . 0.0 112.231 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 18.7 tp60 -115.01 -48.6 2.82 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.1 170.27 20.36 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -176.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 7.9 mt -127.21 138.57 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.087 2.155 . . . . 0.0 108.396 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 16.8 m -133.87 150.09 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.52 1.128 . . . . 0.0 112.215 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 74.6 mt -68.56 99.85 1.04 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.849 0.86 . . . . 0.0 109.57 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 12.1 m -99.4 116.52 31.74 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.059 1.344 . . . . 0.0 114.271 -173.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -102.65 170.45 8.01 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.437 1.895 . . . . 0.0 111.921 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -136.25 157.91 74.63 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.793 1.637 . . . . 0.0 112.132 -176.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 CA--C 1.538 0.69 0 C-N-CA 123.347 2.698 . . . . 0.0 112.478 179.789 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 81.2 p . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.43 -59.72 12.05 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 125.901 1.68 . . . . 0.0 113.689 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -73.59 156.72 49.31 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.137 1.891 . . . . 0.0 111.894 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 63.8 tp -48.91 -47.34 43.47 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.566 1.546 . . . . 0.0 113.678 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -63.0 -7.55 5.51 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -112.44 -9.14 13.85 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.818 1.647 . . . . 0.0 113.058 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 74.7 mt -71.56 -46.93 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.074 0.852 . . . . 0.0 109.065 175.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 39.19 67.67 2.31 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 127.717 2.407 . . . . 0.0 113.606 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -77.82 163.11 29.12 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.317 2.678 . . . . 0.0 114.857 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.69 -179.74 0.4 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.131 1.372 . . . . 0.0 114.359 176.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 19.3 m -131.06 -4.56 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 3.5 mt -121.63 -62.65 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 120.947 1.703 . . . . 0.0 113.677 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 31.4 p -70.61 -67.83 0.47 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 -174.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -140.98 -10.05 1.0 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 116.825 2.158 . . . . 0.0 116.825 -172.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 85.16 33.93 16.15 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 119.64 1.109 . . . . 0.0 110.759 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 44.0 mtt-85 -65.61 136.39 96.02 Favored Pre-proline 0 N--CA 1.477 0.882 0 CA-C-O 117.272 -1.347 . . . . 0.0 110.763 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -73.87 67.12 4.91 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 124.538 3.492 . . . . 0.0 111.235 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -141.75 153.4 44.57 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 128.508 2.723 . . . . 0.0 111.423 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -128.09 120.57 27.69 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.9 1.68 . . . . 0.0 111.8 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -136.04 70.8 0.49 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.652 1.596 . . . . 0.0 111.176 178.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 51.0 t -54.65 123.09 12.13 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.196 1.398 . . . . 0.0 110.49 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.32 138.16 20.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 124.937 1.295 . . . . 0.0 109.801 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 96.0 t -129.97 130.48 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.78 0.832 . . . . 0.0 110.254 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.13 105.03 8.85 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 128.603 2.761 . . . . 0.0 110.76 176.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 65.84 -93.75 0.19 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.868 1.699 . . . . 0.0 114.147 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -120.69 -0.14 10.27 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.457 1.903 . . . . 0.0 113.529 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 36.1 p -124.42 165.23 18.11 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.71 2.004 . . . . 0.0 110.638 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -158.81 169.57 35.17 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 120.985 -1.072 . . . . 0.0 113.908 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -120.33 138.67 53.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.619 1.968 . . . . 0.0 113.227 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.7 pp -120.74 153.32 37.15 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.813 2.045 . . . . 0.0 112.352 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 30.1 ttm 108.66 -7.35 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 131.08 3.752 . . . . 0.0 114.441 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -99.96 154.63 18.23 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.903 -1.123 . . . . 0.0 111.557 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 30.4 p -84.6 175.1 9.47 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 123.344 1.545 . . . . 0.0 113.594 178.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.41 -28.35 69.72 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.791 174.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 83.7 m -72.2 -51.02 23.06 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.567 1.076 . . . . 0.0 110.253 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 67.9 m -49.66 -54.8 16.5 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.662 1.185 . . . . 0.0 110.386 173.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.37 -49.46 76.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.209 1.403 . . . . 0.0 112.931 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -60.0 -40.07 87.95 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.952 1.301 . . . . 0.0 112.168 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -61.72 -52.98 62.06 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.38 1.072 . . . . 0.0 110.978 176.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 44.9 mt -52.22 -49.93 62.98 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.184 0.993 . . . . 0.0 110.107 175.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -54.14 49.54 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.988 1.315 . . . . 0.0 112.681 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -54.86 -43.54 73.18 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.903 1.681 . . . . 0.0 112.281 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -78.88 -6.93 57.35 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.835 2.054 . . . . 0.0 113.366 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 62.4 t30 49.4 42.55 22.5 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 128.521 2.729 . . . . 0.0 112.082 -175.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -75.47 117.04 60.32 Favored Pre-proline 0 N--CA 1.47 0.539 0 C-N-CA 125.552 1.541 . . . . 0.0 113.116 -176.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.9 130.93 21.34 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.106 1.871 . . . . 0.0 108.834 171.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 41.5 t -33.0 125.53 0.41 Allowed Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 128.298 2.639 . . . . 0.0 114.168 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -66.88 -1.45 6.05 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 123.112 2.541 . . . . 0.0 114.307 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.67 -59.14 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.698 1.599 . . . . 0.0 111.346 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 81.8 m -76.83 -14.39 59.91 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.364 1.866 . . . . 0.0 113.027 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . 0.304 14.7 ptm180 55.23 13.43 0.85 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 128.496 2.718 . . . . 0.0 115.108 -175.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -89.53 144.33 31.89 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 123.938 0.895 . . . . 0.0 112.294 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -68.71 122.32 9.26 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.158 2.572 . . . . 0.0 109.442 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 1.8 pt -64.89 137.76 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 O-C-N 121.661 -0.649 . . . . 0.0 112.132 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -115.2 -33.74 5.24 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 117.234 2.309 . . . . 0.0 117.234 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -143.27 152.18 41.4 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.82 0.848 . . . . 0.0 113.236 -171.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 5.1 mt -141.03 131.04 26.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 127.649 2.38 . . . . 0.0 109.038 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 27.7 m -140.12 150.13 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.985 1.314 . . . . 0.0 111.928 176.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 2.2 tt -66.1 105.9 1.49 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.569 1.148 . . . . 0.0 108.273 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.2 96.58 7.3 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -171.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -74.02 171.47 13.43 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.086 1.754 . . . . 0.0 113.295 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -132.78 168.19 19.11 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 127.554 2.342 . . . . 0.0 110.474 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo . . . . . 0 C--N 1.352 0.758 0 C-N-CA 124.425 3.417 . . . . 0.0 113.983 -178.84 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 79.5 p . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 10.4 mp -67.42 156.81 87.58 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 125.554 1.541 . . . . 0.0 112.114 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -71.24 176.56 7.71 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.522 2.815 . . . . 0.0 112.126 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -52.84 -19.57 2.62 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -59.76 -23.4 63.2 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.826 1.25 . . . . 0.0 112.602 175.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -72.34 -10.19 59.47 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.279 1.432 . . . . 0.0 113.972 177.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 42.5 mm -82.84 84.52 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 125.206 1.402 . . . . 0.0 108.089 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -56.03 -34.23 23.94 Favored Pre-proline 0 CA--C 1.555 1.137 0 N-CA-C 118.8 2.889 . . . . 0.0 118.8 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . 0.278 87.9 Cg_exo -43.25 -80.33 0.02 OUTLIER 'Trans proline' 0 CA--C 1.553 1.462 0 C-N-CA 125.173 3.916 . . . . 0.0 117.477 -175.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 28.4 t -67.06 150.67 48.88 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 121.899 2.136 . . . . 0.0 109.342 174.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 4.1 p -134.52 -1.68 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 121.221 -0.925 . . . . 0.0 113.301 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 7.2 mt -135.55 -45.66 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.057 0.943 . . . . 0.0 112.974 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.3 m -69.45 -59.49 2.95 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -173.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -152.02 -16.37 0.18 Allowed 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -175.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 80.34 17.01 74.88 Favored Glycine 0 CA--C 1.539 1.591 0 O-C-N 120.973 -1.079 . . . . 0.0 111.865 -174.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 -72.21 155.06 91.96 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 127.549 2.34 . . . . 0.0 112.607 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.0 71.05 5.14 Favored 'Trans proline' 0 CA--C 1.55 1.29 0 C-N-CA 123.929 3.086 . . . . 0.0 113.363 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -129.32 143.17 50.74 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 127.959 2.504 . . . . 0.0 108.842 176.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -128.02 150.27 50.0 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.115 1.366 . . . . 0.0 112.593 -176.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -151.12 80.39 0.19 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 128.076 2.751 . . . . 0.0 109.201 178.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 42.2 t -63.55 119.09 9.15 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.505 1.122 . . . . 0.0 110.794 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.419 ' H ' HD12 ' A' ' 450' ' ' ILE . 0.3 OUTLIER -102.07 141.71 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.768 1.227 . . . . 0.0 111.745 -177.48 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 90.0 t -130.08 133.53 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.778 1.231 . . . . 0.0 111.931 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -124.99 95.03 4.35 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.53 2.732 . . . . 0.0 110.685 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.4 -97.74 0.41 Allowed Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.73 1.633 . . . . 0.0 114.561 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -107.86 -2.71 19.63 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 126.224 1.81 . . . . 0.0 113.168 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 51.0 p -132.25 170.01 15.64 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.124 1.77 . . . . 0.0 110.808 -178.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -161.26 175.99 37.84 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.201 1.381 . . . . 0.0 112.233 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -120.29 142.58 48.96 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.754 1.222 . . . . 0.0 113.927 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 4.6 pp -111.32 153.25 26.23 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.522 1.929 . . . . 0.0 112.0 175.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 459' ' ' MET . . . . . . . . . . . . 0.253 25.2 mmt 70.42 68.94 0.2 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 128.08 2.552 . . . . 0.0 114.996 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -154.23 138.52 16.63 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 128.659 2.784 . . . . 0.0 106.757 171.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 6.3 p -77.57 172.33 13.53 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 120.224 1.375 . . . . 0.0 112.127 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.36 -44.95 95.28 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.648 -0.657 . . . . 0.0 111.117 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 29.2 m -62.67 -44.37 96.42 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 116.664 -1.636 . . . . 0.0 111.375 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 35.5 m -48.1 -69.97 0.11 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 120.704 1.593 . . . . 0.0 110.541 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -50.33 -49.12 54.77 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.526 1.53 . . . . 0.0 112.539 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -57.13 -42.5 81.03 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.602 0.761 . . . . 0.0 112.49 177.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -61.51 -45.49 93.97 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.815 1.246 . . . . 0.0 111.746 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.1 -46.92 84.71 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 174.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 43.5 tptt -57.35 -46.21 83.55 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.004 0.922 . . . . 0.0 112.204 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -61.07 -34.01 74.23 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.001 1.32 . . . . 0.0 112.326 174.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -81.82 0.72 38.11 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.663 1.985 . . . . 0.0 113.407 175.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 84.11 -2.28 1.05 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 131.242 3.817 . . . . 0.0 115.516 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 5.8 tppp? -79.55 130.26 68.68 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 119.815 1.189 . . . . 0.0 109.366 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.34 -92.74 0.01 OUTLIER 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 123.375 2.717 . . . . 0.0 112.22 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 43.7 t -65.8 130.36 94.47 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 124.477 1.111 . . . . 0.0 112.532 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.55 -1.67 11.38 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 123.255 2.636 . . . . 0.0 114.062 177.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 32.8 t -122.01 -72.1 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 119.972 1.26 . . . . 0.0 113.359 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 29.8 p -92.87 -9.27 40.85 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -175.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 77.55 12.85 1.95 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 128.518 2.727 . . . . 0.0 115.138 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -64.9 156.93 78.15 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 124.606 1.163 . . . . 0.0 112.049 175.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.99 100.34 1.2 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.035 3.157 . . . . 0.0 113.284 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 pp -79.09 155.76 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.651 1.181 . . . . 0.0 112.355 179.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -115.02 -26.92 7.53 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.845 1.258 . . . . 0.0 113.756 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.95 164.81 33.08 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.473 1.109 . . . . 0.0 113.914 -177.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 14.2 mt -132.6 132.43 59.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 128.444 2.698 . . . . 0.0 106.359 173.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 24.0 m -134.74 150.2 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 64.3 tp -73.05 99.91 2.87 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.19 1.796 . . . . 0.0 108.624 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 2.5 t -93.21 163.94 13.43 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -135.59 177.76 7.57 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.671 2.388 . . . . 0.0 110.942 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -124.34 157.97 62.86 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 125.306 1.443 . . . . 0.0 111.387 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 C--N 1.351 0.675 0 C-N-CA 123.111 2.541 . . . . 0.0 111.455 -179.646 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 39.9 m . . . . . 0 CA--C 1.54 0.585 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 91.1 mt -135.8 156.24 77.46 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 127.172 2.189 . . . . 0.0 110.79 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -62.1 -22.33 74.03 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.057 2.505 . . . . 0.0 113.466 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.9 -63.86 0.98 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.486 1.514 . . . . 0.0 109.004 174.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -54.23 -29.59 47.03 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.727 1.611 . . . . 0.0 113.245 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -62.65 -20.01 64.38 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.612 1.165 . . . . 0.0 113.983 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 24.0 mm -81.93 71.14 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 122.413 1.101 . . . . 0.0 108.8 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -131.39 60.78 54.94 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 125.843 1.657 . . . . 0.0 112.595 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -60.81 -49.1 9.14 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.922 3.082 . . . . 0.0 113.668 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 27.5 t -55.25 143.33 28.35 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 120.876 1.671 . . . . 0.0 110.18 173.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 32.6 m -121.23 -14.69 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 9.9 pt -137.09 -26.17 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 -178.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.2 m -77.67 -59.64 2.7 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 120.549 1.522 . . . . 0.0 112.512 -176.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -151.88 -15.53 0.19 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -176.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.89 9.47 84.39 Favored Glycine 0 CA--C 1.541 1.714 0 CA-C-N 119.946 1.248 . . . . 0.0 112.544 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -56.56 155.07 14.93 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 129.427 3.091 . . . . 0.0 113.616 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -72.43 2.93 4.58 Favored 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 124.91 3.74 . . . . 0.0 115.817 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -59.05 142.95 49.97 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.887 2.075 . . . . 0.0 111.62 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -128.1 122.45 32.07 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.371 1.469 . . . . 0.0 112.73 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -138.97 75.21 0.38 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.46 1.981 . . . . 0.0 110.516 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 31.4 t -62.85 138.29 58.49 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.017 0.909 . . . . 0.0 110.282 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 1.4 mp -109.09 142.03 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 125.317 1.447 . . . . 0.0 109.928 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 96.0 t -124.12 131.92 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.293 1.037 . . . . 0.0 110.288 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -123.08 100.06 6.68 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 129.02 2.928 . . . . 0.0 110.725 177.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.97 -93.5 0.27 Allowed Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.914 1.721 . . . . 0.0 113.783 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -120.63 4.71 10.6 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.463 1.905 . . . . 0.0 114.061 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 60.5 p -132.58 170.12 15.63 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.701 2.0 . . . . 0.0 110.417 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -151.24 174.19 30.51 Favored Glycine 0 CA--C 1.528 0.845 0 O-C-N 120.925 -1.109 . . . . 0.0 113.799 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.28 108.14 13.81 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.982 1.713 . . . . 0.0 111.741 174.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 48.3 tp -92.01 153.07 19.67 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.075 2.15 . . . . 0.0 110.153 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 21.9 ttt 80.31 67.58 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.588 2.355 . . . . 0.0 111.778 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -159.87 147.67 16.88 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 129.705 3.202 . . . . 0.0 107.353 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 17.9 p -84.33 173.64 10.78 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 122.447 1.118 . . . . 0.0 111.457 175.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -34.19 77.32 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.134 177.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 22.2 m -70.4 -45.87 65.12 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 117.086 -1.435 . . . . 0.0 110.687 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 41.1 m -50.79 -53.76 29.23 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 120.946 1.703 . . . . 0.0 110.143 173.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -59.77 -40.29 87.75 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.412 1.485 . . . . 0.0 113.065 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -68.09 -40.98 82.54 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.85 -1.156 . . . . 0.0 111.182 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -60.23 -54.15 49.19 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.352 1.461 . . . . 0.0 112.135 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.1 pp -58.18 -36.63 73.35 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 118.923 0.783 . . . . 0.0 111.309 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -65.24 -49.96 67.63 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.768 1.627 . . . . 0.0 111.35 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -58.88 -39.57 81.8 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.956 1.302 . . . . 0.0 111.967 177.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -73.5 0.15 13.31 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 126.468 1.907 . . . . 0.0 113.506 175.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 55.5 t30 61.46 24.01 14.18 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 128.298 2.639 . . . . 0.0 113.949 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -79.42 133.64 59.64 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.455 1.102 . . . . 0.0 108.904 177.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -65.41 -68.25 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.586 2.191 . . . . 0.0 108.927 176.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 34.1 t -143.01 125.13 8.68 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 127.511 2.325 . . . . 0.0 109.315 174.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.54 -2.26 11.89 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.105 2.537 . . . . 0.0 113.382 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 25.4 t -111.18 -64.41 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.978 1.311 . . . . 0.0 112.234 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 27.9 p -109.89 2.5 19.87 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.244 1.418 . . . . 0.0 114.786 -177.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 63.48 7.98 3.3 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 128.061 2.544 . . . . 0.0 116.518 175.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -67.28 135.73 93.5 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-N 119.097 0.862 . . . . 0.0 110.649 176.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.73 115.56 4.14 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.409 2.739 . . . . 0.0 113.423 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.9 pp -70.61 151.38 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 125.286 1.434 . . . . 0.0 114.047 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -115.0 -44.2 3.05 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.842 2.057 . . . . 0.0 113.448 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.41 166.79 31.55 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -175.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 10.1 mt -133.76 136.37 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 128.646 2.778 . . . . 0.0 107.789 176.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 19.5 m -140.02 150.16 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.64 102.56 0.93 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.178 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 7.1 m -94.73 95.65 8.87 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -173.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -75.0 156.68 36.0 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.977 1.311 . . . . 0.0 112.685 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -86.06 164.89 37.03 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 125.708 1.603 . . . . 0.0 111.819 177.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo . . . . . 0 C--N 1.353 0.801 0 C-N-CA 124.2 3.267 . . . . 0.0 114.598 -179.61 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 17.8 tp -54.82 136.1 65.29 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.597 1.559 . . . . 0.0 111.112 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -37.67 -46.2 1.84 Allowed 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 124.96 3.773 . . . . 0.0 115.905 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 47.8 tp -53.41 -29.47 35.15 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.091 1.757 . . . . 0.0 115.014 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 18.9 p30 -112.46 -7.69 13.91 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.874 1.27 . . . . 0.0 112.969 175.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -82.2 -33.6 29.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.374 1.07 . . . . 0.0 112.35 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 5.3 mm 66.01 18.87 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 126.32 1.848 . . . . 0.0 112.801 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 52.98 73.34 0.95 Allowed Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 126.199 1.799 . . . . 0.0 111.226 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -74.4 178.86 6.48 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 125.261 3.974 . . . . 0.0 117.379 -171.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 16.2 t -55.99 161.85 2.14 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 128.951 2.9 . . . . 0.0 111.319 172.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 18.8 m -129.65 -14.98 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 10.5 pt -137.29 -26.74 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.7 m -76.17 -57.8 3.66 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 120.646 1.566 . . . . 0.0 111.936 -178.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -149.0 -18.98 0.3 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 80.69 11.14 84.33 Favored Glycine 0 CA--C 1.54 1.603 0 O-C-N 120.959 -1.088 . . . . 0.0 113.366 -176.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -69.53 155.1 94.15 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 127.976 2.51 . . . . 0.0 113.548 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -52.54 -9.03 0.48 Allowed 'Trans proline' 0 CA--C 1.545 1.043 1 C-N-CA 125.965 4.443 . . . . 0.0 119.309 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -58.41 141.43 51.52 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 120.227 1.376 . . . . 0.0 111.569 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.18 150.14 50.14 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.021 2.128 . . . . 0.0 111.777 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -159.94 85.19 0.12 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 126.262 1.887 . . . . 0.0 110.046 176.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 42.3 t -58.54 139.11 56.26 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 117.839 0.819 . . . . 0.0 111.467 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.8 mp -115.13 140.87 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.074 1.749 . . . . 0.0 109.596 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 60.0 t -127.38 136.04 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.767 0.827 . . . . 0.0 109.47 175.309 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -125.11 94.85 4.29 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.752 2.421 . . . . 0.0 109.818 175.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 58.78 -99.61 0.13 Allowed Glycine 0 CA--C 1.534 1.273 0 C-N-CA 126.175 1.845 . . . . 0.0 114.71 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -86.55 -19.86 28.83 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.881 1.673 . . . . 0.0 114.636 -176.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 67.6 p -133.07 170.06 15.93 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.856 1.262 . . . . 0.0 112.729 -176.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -142.36 169.19 25.54 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.575 1.083 . . . . 0.0 113.968 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.18 134.0 55.36 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.95 1.7 . . . . 0.0 112.047 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.51 153.43 31.17 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 128.999 2.92 . . . . 0.0 111.473 -179.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 459' ' ' MET . . . . . . . . . . . . 0.424 19.1 ptp 70.4 69.36 0.21 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 128.714 2.806 . . . . 0.0 113.881 -178.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -158.31 143.24 16.35 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 130.25 3.42 . . . . 0.0 105.864 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 21.8 p -79.64 174.99 11.02 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 119.787 1.176 . . . . 0.0 111.846 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -63.38 -31.39 72.53 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.421 -0.799 . . . . 0.0 110.735 176.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 25.6 m -70.46 -44.63 67.37 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 117.542 -1.218 . . . . 0.0 110.987 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 60.1 m -51.37 -53.9 31.76 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 120.426 1.466 . . . . 0.0 109.433 172.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.62 -47.12 83.08 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.566 1.547 . . . . 0.0 112.648 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.14 -40.54 94.19 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.096 1.358 . . . . 0.0 111.718 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -59.29 -55.02 40.19 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.607 1.163 . . . . 0.0 110.591 176.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 23.9 mt -51.62 -50.36 60.41 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.704 1.202 . . . . 0.0 110.109 177.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.44 -54.79 42.61 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.755 1.222 . . . . 0.0 114.153 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -60.17 -38.45 83.25 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.149 1.38 . . . . 0.0 112.584 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -82.19 -4.22 56.57 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.537 1.535 . . . . 0.0 112.902 175.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 49.07 50.71 17.48 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 129.055 2.942 . . . . 0.0 112.151 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -70.02 148.98 96.33 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.514 0.726 . . . . 0.0 112.642 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -81.95 11.86 2.99 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 124.016 3.144 . . . . 0.0 113.435 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 34.6 t 73.24 88.66 0.08 OUTLIER Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 128.493 2.717 . . . . 0.0 108.585 -173.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.75 -23.19 25.69 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.27 2.646 . . . . 0.0 114.869 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 20.1 t -73.32 -51.71 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 126.567 1.947 . . . . 0.0 113.213 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 26.1 p -128.59 0.39 5.54 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 -174.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 66.56 30.12 8.61 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 127.485 2.314 . . . . 0.0 114.841 175.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -107.48 102.87 46.47 Favored Pre-proline 0 CA--C 1.554 1.135 0 C-N-CA 126.695 1.998 . . . . 0.0 111.112 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.45 124.53 10.86 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.06 3.173 . . . . 0.0 115.235 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.4 pp -57.52 151.48 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.716 2.007 . . . . 0.0 113.327 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -115.03 -57.27 2.28 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.057 1.343 . . . . 0.0 112.018 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.64 170.22 20.78 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 4.4 mt -121.47 148.24 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.867 2.067 . . . . 0.0 108.603 175.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 6.2 m -134.48 150.18 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.808 1.643 . . . . 0.0 111.189 176.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.91 99.9 4.66 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 56.9 m -79.27 156.02 28.28 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.952 0.901 . . . . 0.0 112.545 -176.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -138.53 164.09 30.33 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.981 2.112 . . . . 0.0 110.257 178.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -124.05 168.82 11.81 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 125.944 1.698 . . . . 0.0 110.907 -178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo . . . . . 0 C--N 1.348 0.547 0 C-N-CA 123.14 2.56 . . . . 0.0 110.895 178.3 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -51.62 119.57 13.64 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 127.248 2.219 . . . . 0.0 110.364 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -43.26 -44.86 10.07 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 124.985 3.79 . . . . 0.0 117.11 -175.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 63.4 mt -62.51 -34.91 77.82 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.781 0.832 . . . . 0.0 112.79 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -86.59 -21.4 26.86 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.121 1.368 . . . . 0.0 112.518 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -76.07 -13.09 60.22 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.452 1.501 . . . . 0.0 113.928 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 8.4 mm 52.14 59.46 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 127.265 2.226 . . . . 0.0 111.928 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 5.08 78.32 0.04 OUTLIER Pre-proline 0 N--CA 1.482 1.147 0 C-N-CA 130.124 3.37 . . . . 0.0 116.239 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -79.93 170.85 16.14 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.312 2.675 . . . . 0.0 115.085 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 438' ' ' CYS . . . . . 0.406 ' SG ' ' N ' ' B' ' 439' ' ' VAL . 21.3 t -68.17 -175.95 0.66 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.969 1.708 . . . . 0.0 112.506 174.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 439' ' ' VAL . . . . . 0.406 ' N ' ' SG ' ' B' ' 438' ' ' CYS . 6.0 p -141.84 -1.66 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.481 1.513 . . . . 0.0 114.193 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 19.4 mt -118.74 -65.78 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 120.072 1.305 . . . . 0.0 113.393 -176.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 22.8 p -52.67 -74.69 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -141.0 -11.34 0.98 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.571 2.348 . . . . 0.0 113.311 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 79.61 30.69 43.39 Favored Glycine 0 CA--C 1.536 1.364 0 O-C-N 121.556 -0.715 . . . . 0.0 112.634 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -69.73 155.05 94.19 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.737 1.615 . . . . 0.0 111.95 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.89 -2.19 0.32 Allowed 'Trans proline' 0 CA--C 1.549 1.257 1 C-N-CA 125.778 4.319 . . . . 0.0 118.982 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -73.26 142.43 47.23 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.5 1.52 . . . . 0.0 111.861 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.31 149.98 50.27 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.335 1.854 . . . . 0.0 111.692 174.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -160.14 84.73 0.12 Allowed Glycine 0 CA--C 1.53 0.978 0 C-N-CA 126.453 1.977 . . . . 0.0 111.295 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 33.3 t -61.26 137.09 58.24 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.914 0.886 . . . . 0.0 111.402 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.07 147.19 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 126.215 1.806 . . . . 0.0 110.427 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 33.7 t -127.51 138.48 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.151 0.98 . . . . 0.0 110.527 175.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -125.05 95.02 4.34 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 128.868 2.867 . . . . 0.0 109.935 175.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.53 -93.36 0.37 Allowed Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.824 1.678 . . . . 0.0 113.804 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -117.48 -0.31 11.96 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 126.408 1.883 . . . . 0.0 113.532 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 47.4 p -127.13 170.06 12.77 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.469 1.908 . . . . 0.0 110.15 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -159.09 170.93 35.55 Favored Glycine 0 N--CA 1.468 0.772 0 O-C-N 120.592 -1.317 . . . . 0.0 114.062 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.02 139.15 52.94 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.264 1.425 . . . . 0.0 112.01 178.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 56.0 tp -130.02 153.2 48.66 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.737 2.415 . . . . 0.0 110.995 -176.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 28.1 ttm 95.21 29.16 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 129.061 2.944 . . . . 0.0 113.783 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -133.14 151.38 51.99 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.629 1.972 . . . . 0.0 109.556 176.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 22.3 p -75.43 168.86 19.19 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 122.881 1.324 . . . . 0.0 113.312 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.21 -35.18 80.27 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.919 177.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 19.7 m -64.14 -52.9 56.9 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.89 176.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 18.1 m -53.51 -52.89 58.16 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.727 1.149 . . . . 0.0 111.239 175.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -51.85 -41.39 61.8 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.267 1.427 . . . . 0.0 112.669 173.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -69.93 -27.35 64.69 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.045 1.338 . . . . 0.0 113.266 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -57.54 -42.28 82.65 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 120.18 1.355 . . . . 0.0 111.202 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -54.56 -44.54 73.01 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.957 1.303 . . . . 0.0 110.099 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -66.06 -50.29 64.67 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.451 0.7 . . . . 0.0 111.444 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -53.45 -41.63 66.31 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.419 1.488 . . . . 0.0 113.758 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -99.33 11.32 39.43 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.424 1.49 . . . . 0.0 114.845 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 63.3 t30 47.89 60.66 3.41 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.212 2.205 . . . . 0.0 113.803 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -121.58 143.35 37.78 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 128.693 2.797 . . . . 0.0 108.985 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.92 -85.23 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.19 0 C-N-CA 122.798 2.332 . . . . 0.0 112.853 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 5.7 t -127.02 140.37 37.63 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 127.01 2.124 . . . . 0.0 111.328 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.54 -5.56 16.69 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.514 2.809 . . . . 0.0 114.412 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 55.1 t -119.32 -74.22 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.736 1.153 . . . . 0.0 112.602 -177.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 24.6 p -93.85 0.6 56.3 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.611 1.564 . . . . 0.0 114.007 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 58.71 14.62 3.25 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 128.193 2.597 . . . . 0.0 115.892 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -68.58 138.99 91.28 Favored Pre-proline 0 CA--C 1.552 1.034 0 CA-C-N 119.244 0.929 . . . . 0.0 110.645 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.75 113.05 2.61 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.562 2.842 . . . . 0.0 113.757 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.6 pp -69.16 159.34 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.357 1.463 . . . . 0.0 113.758 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -115.12 -56.83 2.33 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.991 2.116 . . . . 0.0 111.243 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.96 170.21 19.9 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.568 1.147 . . . . 0.0 113.51 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 10.5 mt -118.25 138.11 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 127.62 2.368 . . . . 0.0 106.191 174.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 14.7 p -129.02 147.19 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 119.382 0.992 . . . . 0.0 113.497 -177.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.3 99.92 1.63 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.979 1.311 . . . . 0.0 107.876 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 6.0 t -98.87 155.17 17.52 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -144.56 167.17 23.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.395 1.878 . . . . 0.0 111.269 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -123.36 153.34 65.4 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 125.333 1.453 . . . . 0.0 111.689 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 C--N 1.351 0.693 0 C-N-CA 123.592 2.861 . . . . 0.0 111.546 -179.063 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 63.7 m . . . . . 0 CA--C 1.538 0.513 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 91.1 mt -41.48 -51.31 8.79 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 126.581 1.952 . . . . 0.0 115.804 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -59.97 -8.12 7.39 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.428 2.085 . . . . 0.0 114.762 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 26.0 mt -117.5 -61.38 1.71 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.402 1.881 . . . . 0.0 111.464 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -77.78 -9.38 58.99 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 -177.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -119.9 -49.98 2.3 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.131 0.972 . . . . 0.0 111.919 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.44 -28.59 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 124.751 1.221 . . . . 0.0 110.95 176.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 47.84 72.9 1.11 Allowed Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 127.301 2.24 . . . . 0.0 113.121 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.33 -102.47 0.01 OUTLIER 'Trans proline' 0 CA--C 1.552 1.415 1 C-N-CA 125.379 4.053 . . . . 0.0 112.042 -178.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 23.0 t -63.59 154.86 31.4 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 119.747 1.158 . . . . 0.0 110.154 174.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 31.0 m -129.43 -14.61 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 10.4 pt -137.08 -26.4 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.4 m -73.68 -60.76 2.1 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 120.921 1.691 . . . . 0.0 112.051 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -153.54 -13.85 0.15 Allowed 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -176.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 80.08 8.9 87.23 Favored Glycine 0 CA--C 1.541 1.682 0 O-C-N 120.747 -1.221 . . . . 0.0 112.853 -175.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -62.17 155.01 67.55 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 128.175 2.59 . . . . 0.0 113.415 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.03 75.22 3.78 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 124.143 3.229 . . . . 0.0 113.611 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -135.02 148.01 49.81 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.994 2.518 . . . . 0.0 109.218 176.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -128.05 148.09 50.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.013 0.925 . . . . 0.0 111.367 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -159.1 86.62 0.12 Allowed Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.872 1.701 . . . . 0.0 112.822 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 49.3 t -68.63 136.2 52.62 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.896 0.848 . . . . 0.0 110.115 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.0 140.32 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.811 1.244 . . . . 0.0 111.448 -178.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 93.3 t -126.89 131.4 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.138 1.375 . . . . 0.0 111.742 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -114.23 94.98 5.05 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 128.608 2.763 . . . . 0.0 109.727 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.82 -91.41 0.42 Allowed Glycine 0 CA--C 1.535 1.29 0 C-N-CA 126.218 1.866 . . . . 0.0 113.97 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -121.93 5.11 9.91 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 126.506 1.922 . . . . 0.0 113.494 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 74.6 p -135.6 170.06 16.55 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.018 2.127 . . . . 0.0 109.823 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -160.14 179.18 35.84 Favored Glycine 0 N--CA 1.47 0.908 0 O-C-N 120.538 -1.351 . . . . 0.0 114.45 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -120.41 133.87 55.36 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.239 1.415 . . . . 0.0 113.849 174.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -110.16 153.26 24.99 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.596 1.558 . . . . 0.0 111.487 173.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 41.8 ttm 99.73 60.0 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 129.825 3.25 . . . . 0.0 112.487 177.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -160.05 158.31 30.22 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.306 1.842 . . . . 0.0 110.936 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 13.7 p -88.71 175.07 7.67 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 122.441 1.115 . . . . 0.0 111.63 173.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -37.16 84.3 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.028 -1.045 . . . . 0.0 110.672 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 26.6 m -63.21 -49.69 73.19 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 117.18 -1.391 . . . . 0.0 109.847 176.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 60.0 m -47.12 -56.23 6.95 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 120.35 1.432 . . . . 0.0 110.291 173.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -56.85 -47.3 80.69 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.905 1.682 . . . . 0.0 114.398 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -74.4 -31.64 62.4 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 120.055 1.298 . . . . 0.0 112.682 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -62.63 -55.5 26.49 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.897 1.679 . . . . 0.0 110.942 177.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 2.3 pp -59.0 -37.88 77.89 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 117.8 0.273 . . . . 0.0 111.131 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -63.11 -49.3 74.96 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.121 1.368 . . . . 0.0 111.759 176.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -58.0 -39.6 78.66 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.598 1.559 . . . . 0.0 111.561 176.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -76.0 5.56 6.45 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 127.078 2.151 . . . . 0.0 113.866 175.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 45.3 t30 65.21 18.72 11.53 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 128.771 2.828 . . . . 0.0 115.438 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -70.13 130.04 90.07 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 120.821 -1.174 . . . . 0.0 108.82 175.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.77 -51.3 0.93 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.772 2.315 . . . . 0.0 111.695 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 3.4 t -153.85 140.08 12.6 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 129.375 3.07 . . . . 0.0 108.019 174.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -71.29 -6.37 19.03 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.261 2.641 . . . . 0.0 114.583 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 46.4 t -125.08 -70.86 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 119.829 1.195 . . . . 0.0 113.404 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 24.6 p -97.13 3.62 51.58 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.803 1.641 . . . . 0.0 114.797 -175.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 59.62 20.21 8.81 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 127.763 2.425 . . . . 0.0 116.054 175.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -81.04 115.99 59.65 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 124.544 1.138 . . . . 0.0 109.376 175.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -47.32 108.32 0.16 Allowed 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 124.373 3.382 . . . . 0.0 117.264 -175.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.0 pp -66.41 134.52 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 126.124 1.77 . . . . 0.0 112.14 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -115.24 -16.61 11.5 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.55 1.54 . . . . 0.0 115.026 -176.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 1.8 ttp -150.32 148.17 28.51 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.122 0.969 . . . . 0.0 113.021 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 14.4 mt -131.99 139.42 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 127.363 2.265 . . . . 0.0 107.936 173.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 10.0 m -134.68 150.23 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.565 1.146 . . . . 0.0 113.403 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 63.5 tp -70.13 99.87 1.56 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 173.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 4.8 t -98.98 159.1 15.2 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -172.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -142.6 171.18 14.4 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.392 2.277 . . . . 0.0 111.606 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -138.54 156.63 73.15 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.98 1.712 . . . . 0.0 111.028 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo . . . . . 0 C--N 1.351 0.674 0 C-N-CA 123.627 2.884 . . . . 0.0 111.482 -179.61 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 CA--C 1.541 0.61 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 96.6 mt -71.97 165.86 46.11 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 125.742 1.617 . . . . 0.0 111.913 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -58.54 164.05 9.81 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.266 2.644 . . . . 0.0 113.713 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -56.19 -22.19 27.57 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -65.24 -34.28 77.99 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.112 0.965 . . . . 0.0 111.3 175.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -90.28 -52.76 4.77 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.764 1.625 . . . . 0.0 110.192 175.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 28.6 mm -83.89 72.42 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 125.134 1.373 . . . . 0.0 109.559 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -82.03 -14.14 0.21 Allowed Pre-proline 0 CA--C 1.562 1.429 0 N-CA-C 118.856 2.909 . . . . 0.0 118.856 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -43.44 -78.62 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.318 0 C-N-CA 124.78 3.653 . . . . 0.0 117.361 -177.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 40.0 t -61.26 145.82 49.99 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 121.838 2.108 . . . . 0.0 109.684 175.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 35.3 m -123.15 -15.17 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 8.4 pt -137.66 -25.32 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.8 m -77.28 -63.64 1.32 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.656 1.571 . . . . 0.0 112.211 -176.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -144.16 -11.74 0.64 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -177.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 75.84 16.16 80.84 Favored Glycine 0 CA--C 1.545 1.914 0 CA-C-N 120.117 1.326 . . . . 0.0 112.42 -174.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -65.58 155.2 86.4 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 130.484 3.513 . . . . 0.0 113.021 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -68.96 -3.61 11.82 Favored 'Trans proline' 0 CA--C 1.546 1.089 0 C-N-CA 124.161 3.241 . . . . 0.0 115.956 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -59.35 134.7 57.25 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.341 1.456 . . . . 0.0 110.17 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -128.24 138.68 52.54 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.22 1.808 . . . . 0.0 110.344 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -139.25 83.58 0.24 Allowed Glycine 0 CA--C 1.526 0.779 0 C-N-CA 127.482 2.467 . . . . 0.0 109.761 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 50.7 t -59.4 138.52 57.63 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.01 0.924 . . . . 0.0 111.013 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.05 142.4 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 125.647 1.579 . . . . 0.0 109.478 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 14.5 t -116.81 142.31 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.325 1.05 . . . . 0.0 109.463 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -125.11 94.83 4.28 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 128.016 2.527 . . . . 0.0 107.165 175.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 60.87 -91.85 0.06 OUTLIER Glycine 0 CA--C 1.541 1.706 0 C-N-CA 124.759 1.171 . . . . 0.0 113.829 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -118.71 6.17 11.56 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 127.441 2.297 . . . . 0.0 113.514 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 41.5 p -121.74 170.21 9.97 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.629 2.372 . . . . 0.0 110.441 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -162.6 167.48 37.11 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 120.598 -1.313 . . . . 0.0 114.688 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -120.12 141.31 49.94 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.552 1.541 . . . . 0.0 113.034 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 79.8 mt -119.26 153.21 35.37 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.268 2.627 . . . . 0.0 110.959 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 20.2 mmt 76.44 65.25 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.588 2.355 . . . . 0.0 113.19 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -155.81 135.02 12.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 129.749 3.22 . . . . 0.0 105.438 172.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 13.1 p -77.22 174.72 10.42 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 120.958 1.708 . . . . 0.0 111.96 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.47 -37.22 82.82 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.59 -0.694 . . . . 0.0 111.827 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 84.7 m -72.49 -44.21 62.58 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 116.194 -1.86 . . . . 0.0 110.684 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 53.0 m -46.36 -57.33 4.72 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 121.596 1.998 . . . . 0.0 110.474 173.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.03 -52.42 65.34 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.482 1.513 . . . . 0.0 112.663 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -59.82 -38.58 82.4 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 121.091 -1.006 . . . . 0.0 113.083 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -62.19 -48.05 81.76 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.153 1.781 . . . . 0.0 111.416 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 14.5 mt -54.88 -50.73 68.02 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.894 0.878 . . . . 0.0 109.631 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -55.86 -46.5 78.2 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.155 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -58.59 -42.23 87.58 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.244 1.417 . . . . 0.0 111.725 175.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -76.35 0.45 19.45 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 127.407 2.283 . . . . 0.0 113.713 175.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 71.73 6.92 5.81 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 129.71 3.204 . . . . 0.0 115.508 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.11 135.88 47.48 Favored Pre-proline 0 CA--C 1.544 0.75 0 O-C-N 120.664 -1.272 . . . . 0.0 109.342 175.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -78.06 -110.22 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.286 0 C-N-CA 123.212 2.608 . . . . 0.0 108.78 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 15.2 t -70.7 139.64 86.22 Favored Pre-proline 0 CA--C 1.556 1.183 0 O-C-N 120.76 -1.213 . . . . 0.0 112.65 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.17 -4.23 14.57 Favored 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 123.612 2.875 . . . . 0.0 114.115 175.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 61.3 t -129.02 -68.29 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 29.6 p -88.08 -6.37 57.96 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 120.393 1.451 . . . . 0.0 113.575 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 61.27 9.18 2.39 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 128.487 2.715 . . . . 0.0 115.12 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -66.39 153.38 92.91 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-N 118.763 0.71 . . . . 0.0 111.925 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.48 119.88 6.98 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.357 2.705 . . . . 0.0 113.01 -177.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.65 159.5 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.567 1.547 . . . . 0.0 112.91 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.08 -60.72 1.85 Allowed 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.036 1.735 . . . . 0.0 110.893 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.99 170.32 21.57 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.679 1.992 . . . . 0.0 112.581 -177.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 13.2 mt -115.98 135.47 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 126.388 1.875 . . . . 0.0 108.036 174.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 15.0 m -134.3 150.0 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.578 1.151 . . . . 0.0 112.595 177.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.58 99.94 5.93 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 56.1 m -101.03 104.03 15.16 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.199 0.6 . . . . 0.0 111.313 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -78.63 172.48 13.63 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.811 2.444 . . . . 0.0 112.45 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -115.6 167.03 10.79 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 126.254 1.822 . . . . 0.0 111.787 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo . . . . . 0 C--N 1.351 0.702 0 C-N-CA 124.104 3.203 . . . . 0.0 113.785 179.352 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 77.8 p . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.66 156.44 88.97 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.367 1.467 . . . . 0.0 110.319 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -45.78 -50.93 8.93 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.798 2.998 . . . . 0.0 114.413 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 3.9 pp -64.56 -22.33 66.94 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -93.08 -23.8 18.51 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.022 1.329 . . . . 0.0 112.283 178.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -89.06 -1.94 58.33 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.596 1.959 . . . . 0.0 115.253 -177.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 51.5 mm -51.23 -69.74 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 126.254 1.822 . . . . 0.0 112.55 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -146.57 97.88 4.27 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.927 1.691 . . . . 0.0 110.216 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -77.55 160.97 31.51 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.147 2.564 . . . . 0.0 112.672 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 15.0 p -70.19 -179.02 1.82 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.921 1.288 . . . . 0.0 112.7 177.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.08 -3.81 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -177.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 4.7 mt -121.88 -62.42 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 120.147 1.339 . . . . 0.0 113.498 -178.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . 0.256 3.6 p -66.69 -61.95 1.7 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 -173.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -154.61 -15.47 0.12 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -175.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 100.44 51.19 1.24 Allowed Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.878 1.704 . . . . 0.0 110.585 -176.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -105.75 155.0 38.93 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 125.291 1.436 . . . . 0.0 112.526 -176.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -46.62 118.8 2.8 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.252 2.635 . . . . 0.0 113.877 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 29.13 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 129.375 3.07 . . . . 0.0 118.818 -175.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.77 89.84 2.32 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 120.288 -1.507 . . . . 0.0 109.207 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 170.09 42.01 0.03 OUTLIER Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.034 1.302 . . . . 0.0 112.118 -177.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 45.4 t -49.96 121.35 5.28 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.673 1.589 . . . . 0.0 111.846 -178.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.403 HD12 ' H ' ' A' ' 450' ' ' ILE . 4.4 mp -83.45 123.85 39.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 125.689 1.595 . . . . 0.0 107.718 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 96.5 t -127.08 123.15 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 121.679 0.752 . . . . 0.0 111.061 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -120.3 106.81 12.24 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 128.113 2.565 . . . . 0.0 111.393 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.65 -92.22 0.43 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.749 1.642 . . . . 0.0 113.934 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -127.06 4.44 6.47 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.574 1.95 . . . . 0.0 113.183 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 60.1 p -133.53 170.15 15.94 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.32 1.848 . . . . 0.0 110.668 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -159.26 173.91 36.13 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.326 0.965 . . . . 0.0 113.301 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -120.11 131.82 55.19 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.899 1.28 . . . . 0.0 112.784 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 458' ' ' LEU . . . . . 0.437 HD23 ' N ' ' A' ' 459' ' ' MET . 1.9 tt -92.85 153.27 18.93 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 129.487 3.115 . . . . 0.0 112.133 -178.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 459' ' ' MET . . . . . 0.437 ' N ' HD23 ' A' ' 458' ' ' LEU . 16.0 ttp 86.5 31.07 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.964 2.506 . . . . 0.0 117.213 169.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -139.28 135.01 33.39 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.018 1.327 . . . . 0.0 108.801 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 26.3 p -79.59 175.01 11.0 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 123.051 1.405 . . . . 0.0 114.317 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.24 -41.06 78.84 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.678 1.191 . . . . 0.0 111.869 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 78.8 m -60.8 -53.0 62.66 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.721 1.208 . . . . 0.0 110.358 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 90.5 m -52.08 -53.7 39.22 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.561 1.144 . . . . 0.0 111.056 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -56.02 -50.16 71.66 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.363 1.065 . . . . 0.0 112.671 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -64.91 -38.17 90.07 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.212 1.005 . . . . 0.0 112.414 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -61.02 -52.99 62.65 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.359 1.464 . . . . 0.0 110.573 177.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 29.8 mt -51.77 -51.47 56.07 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.397 1.079 . . . . 0.0 109.782 175.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -54.22 -48.63 70.85 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.175 0.99 . . . . 0.0 112.342 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -59.86 -41.55 91.7 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.326 1.45 . . . . 0.0 111.983 175.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -75.72 -0.99 22.78 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 127.065 2.146 . . . . 0.0 113.44 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 38.9 t30 75.44 7.1 4.02 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 130.086 3.354 . . . . 0.0 115.425 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -80.89 128.7 70.56 Favored Pre-proline 0 CA--C 1.543 0.697 0 O-C-N 120.612 -1.305 . . . . 0.0 109.154 175.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.11 -87.82 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 123.326 2.684 . . . . 0.0 110.415 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 37.4 t -96.78 132.44 26.07 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.67 1.588 . . . . 0.0 111.031 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.56 -4.7 14.89 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.272 2.648 . . . . 0.0 113.794 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 24.4 t -112.46 -74.19 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 119.772 1.169 . . . . 0.0 112.634 -177.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 25.4 p -95.82 -3.64 45.23 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.422 1.489 . . . . 0.0 114.318 -177.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 67.12 10.58 7.81 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 127.75 2.42 . . . . 0.0 115.162 176.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -62.97 149.68 89.81 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 124.0 0.92 . . . . 0.0 111.663 177.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -68.77 106.89 1.56 Allowed 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.892 3.061 . . . . 0.0 113.682 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 1.5 pp -71.86 145.77 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.352 1.461 . . . . 0.0 111.405 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -115.22 -24.25 8.57 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.2 168.13 27.88 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -176.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 10.0 mt -139.29 132.49 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 128.784 2.833 . . . . 0.0 106.731 174.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.11 150.08 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 125.003 1.321 . . . . 0.0 112.153 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 64.5 mt -69.54 99.84 1.33 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.632 0.729 . . . . 0.0 109.295 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.15 112.67 25.88 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.89 1.676 . . . . 0.0 113.601 -174.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -127.83 169.05 14.33 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.903 1.281 . . . . 0.0 113.854 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -73.55 159.67 84.07 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 127.098 2.159 . . . . 0.0 112.821 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo . . . . . 0 C--N 1.351 0.698 0 C-N-CA 123.562 2.842 . . . . 0.0 111.501 178.787 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 41.8 m . . . . . 0 CA--C 1.54 0.583 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 96.1 mt -137.68 161.27 61.21 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 127.601 2.36 . . . . 0.0 110.363 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -49.98 -34.12 36.56 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.683 2.922 . . . . 0.0 114.279 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 57.1 mt -57.26 -32.36 66.51 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.276 1.83 . . . . 0.0 113.106 177.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -103.29 -12.38 17.31 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.403 1.481 . . . . 0.0 112.65 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -73.81 -47.36 39.23 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.732 0.813 . . . . 0.0 110.07 176.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 21.5 mm -85.44 83.37 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 122.269 1.033 . . . . 0.0 108.942 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -116.52 -68.55 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.606 0 CA-C-O 117.251 -1.357 . . . . 0.0 110.469 176.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -73.32 155.09 51.38 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.207 1.938 . . . . 0.0 113.255 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 8.5 p -66.98 -163.32 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 126.832 2.053 . . . . 0.0 115.021 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 96.4 t -125.67 -22.72 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -174.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 2.5 mt -129.4 -56.8 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 -171.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 27.8 p -69.19 -61.97 1.57 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 -172.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -148.75 -9.09 0.36 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 116.716 2.117 . . . . 0.0 116.716 -173.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 86.59 30.56 21.14 Favored Glycine 0 CA--C 1.534 1.248 0 O-C-N 120.693 -1.254 . . . . 0.0 111.196 -175.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 44.6 mtt-85 -65.44 135.98 96.08 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 125.526 1.53 . . . . 0.0 111.388 -177.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.78 77.88 1.79 Allowed 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 123.815 3.01 . . . . 0.0 110.328 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -150.05 160.67 43.46 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.024 2.13 . . . . 0.0 113.188 -170.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -128.21 150.11 50.17 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 128.967 2.907 . . . . 0.0 111.104 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 176.45 76.92 0.05 OUTLIER Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.825 1.678 . . . . 0.0 112.323 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 19.7 t -61.55 140.69 58.08 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.934 0.894 . . . . 0.0 111.869 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 2.0 mp -109.96 140.8 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 126.257 1.823 . . . . 0.0 109.281 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 94.6 t -130.06 135.39 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.659 0.742 . . . . 0.0 110.891 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.04 100.09 6.42 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 128.192 2.597 . . . . 0.0 110.728 174.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.55 -94.14 0.27 Allowed Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.005 1.764 . . . . 0.0 114.323 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -116.9 -0.33 12.26 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.274 1.83 . . . . 0.0 113.457 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 16.5 p -129.88 166.06 20.76 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.512 1.125 . . . . 0.0 110.793 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.11 166.82 33.19 Favored Glycine 0 CA--C 1.528 0.871 0 O-C-N 121.015 -1.053 . . . . 0.0 113.976 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -115.65 116.69 28.54 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.768 2.027 . . . . 0.0 110.682 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 43.2 tp -107.97 153.1 23.56 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.516 2.327 . . . . 0.0 110.63 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 62.5 mtt 105.73 -5.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 130.92 3.688 . . . . 0.0 115.686 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -99.87 160.5 14.26 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.432 1.014 . . . . 0.0 111.305 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 21.7 p -79.64 173.45 12.58 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 123.198 1.475 . . . . 0.0 113.874 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.63 -23.62 65.37 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.612 174.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 51.4 m -73.94 -50.76 18.59 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 117.823 -1.084 . . . . 0.0 110.145 178.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 60.7 m -49.0 -53.2 21.0 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.777 1.231 . . . . 0.0 110.476 173.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.72 -49.58 76.06 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.861 1.664 . . . . 0.0 112.927 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -61.42 -40.67 95.27 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.826 -1.171 . . . . 0.0 111.655 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -62.31 -54.53 39.29 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.98 1.712 . . . . 0.0 111.328 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.3 pp -62.91 -31.84 73.0 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.71 -0.619 . . . . 0.0 112.034 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -68.29 -46.65 69.78 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.052 1.341 . . . . 0.0 112.226 175.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -58.45 -40.97 84.05 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.464 1.105 . . . . 0.0 111.503 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -74.88 -8.43 56.44 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.566 1.546 . . . . 0.0 113.118 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 50.45 41.05 24.5 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.47 2.708 . . . . 0.0 111.74 -176.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -71.73 127.56 90.72 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.385 1.474 . . . . 0.0 114.053 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.76 127.55 10.95 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.808 2.338 . . . . 0.0 107.333 169.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 40.9 t -30.62 125.44 0.3 Allowed Pre-proline 0 CA--C 1.555 1.159 0 C-N-CA 127.914 2.486 . . . . 0.0 115.2 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.1 -1.78 6.83 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.072 2.515 . . . . 0.0 114.328 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 58.4 t -124.04 -59.8 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.796 1.638 . . . . 0.0 111.17 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 85.7 m -75.11 -22.54 58.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.089 1.756 . . . . 0.0 112.766 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? 62.5 9.12 3.22 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 127.161 2.184 . . . . 0.0 113.419 -175.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -83.1 146.72 52.22 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.769 1.227 . . . . 0.0 112.266 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.67 121.94 7.44 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.18 2.587 . . . . 0.0 110.375 175.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.4 pp -61.05 144.12 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.22 1.008 . . . . 0.0 111.369 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -115.02 -38.87 3.77 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.75 165.85 35.3 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 8.2 mt -135.36 135.83 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.674 2.389 . . . . 0.0 108.475 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 20.0 m -140.01 150.05 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.126 0.97 . . . . 0.0 113.312 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.95 100.0 1.89 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 36.5 m -96.64 88.95 4.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.794 1.237 . . . . 0.0 111.483 -174.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -61.81 129.05 39.16 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.946 1.698 . . . . 0.0 112.892 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -47.71 -40.48 30.68 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 118.817 2.895 . . . . 0.0 118.817 -176.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo . . . . . 0 C--N 1.355 0.896 0 C-N-CA 123.979 3.119 . . . . 0.0 115.028 -178.256 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 CA--C 1.541 0.597 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 91.0 mt -140.74 156.92 68.75 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 128.276 2.63 . . . . 0.0 109.341 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -47.87 -45.97 22.99 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.536 2.824 . . . . 0.0 113.973 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 2.3 pp -66.1 -14.29 61.51 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -101.79 -26.9 13.3 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.686 1.594 . . . . 0.0 110.672 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -79.45 26.92 0.28 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 127.517 2.327 . . . . 0.0 113.181 176.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -60.23 -25.58 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 127.38 2.272 . . . . 0.0 115.017 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 49.55 68.41 3.51 Favored Pre-proline 0 CA--C 1.558 1.276 0 C-N-CA 126.205 1.802 . . . . 0.0 111.285 -174.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.62 -179.55 2.93 Favored 'Trans proline' 0 CA--C 1.544 1.02 1 C-N-CA 126.129 4.552 . . . . 0.0 117.417 -173.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 11.2 t -50.53 153.21 1.68 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 128.323 2.649 . . . . 0.0 111.892 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 22.0 m -135.35 -0.37 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.656 1.183 . . . . 0.0 113.708 178.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 8.2 mt -128.73 -48.18 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 119.565 1.075 . . . . 0.0 112.255 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 1.9 m -71.2 -68.93 0.41 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -173.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -146.55 -11.39 0.46 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.313 1.598 . . . . 0.0 115.313 -173.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.5 16.78 70.19 Favored Glycine 0 CA--C 1.541 1.717 0 CA-C-N 119.836 1.198 . . . . 0.0 113.051 -175.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 11.8 ptp85 -57.47 154.3 24.49 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 127.22 2.208 . . . . 0.0 112.499 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.18 -10.23 26.53 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 123.807 3.005 . . . . 0.0 116.388 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -59.39 147.52 35.97 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.201 1.4 . . . . 0.0 112.05 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -128.33 150.16 50.2 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.21 2.604 . . . . 0.0 111.667 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -168.44 86.35 0.09 OUTLIER Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.252 1.882 . . . . 0.0 112.517 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 47.7 t -60.4 142.94 54.3 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.686 1.194 . . . . 0.0 110.862 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 mp -115.0 132.21 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.578 1.551 . . . . 0.0 109.595 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 69.6 t -115.56 129.05 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.337 1.055 . . . . 0.0 108.591 176.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -125.08 94.95 4.32 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.184 2.194 . . . . 0.0 112.74 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 77.06 -77.77 1.48 Allowed Glycine 0 CA--C 1.535 1.284 0 C-N-CA 126.048 1.785 . . . . 0.0 113.899 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -135.22 -10.17 2.24 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.36 1.864 . . . . 0.0 113.754 -178.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 42.1 p -122.61 170.07 10.39 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.418 2.287 . . . . 0.0 110.084 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -157.33 170.19 34.45 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.893 -1.129 . . . . 0.0 114.186 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -119.99 145.19 47.02 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.619 1.968 . . . . 0.0 112.231 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 35.3 tp -121.71 153.07 38.69 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.832 2.053 . . . . 0.0 109.962 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 25.1 ttt 82.44 68.97 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 128.483 2.713 . . . . 0.0 112.42 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -160.12 151.08 19.09 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 129.169 2.987 . . . . 0.0 107.192 175.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 23.0 p -85.89 174.99 8.89 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 122.397 1.094 . . . . 0.0 111.195 175.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -63.37 -33.68 76.07 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.482 -0.761 . . . . 0.0 110.726 177.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 21.3 m -68.28 -48.52 64.78 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 117.39 -1.29 . . . . 0.0 110.655 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 31.4 m -48.33 -54.72 12.82 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 120.373 1.442 . . . . 0.0 110.007 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -59.8 -43.31 94.53 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.633 1.573 . . . . 0.0 113.12 177.543 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -64.61 -40.97 96.43 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.752 -1.217 . . . . 0.0 111.631 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -59.67 -55.41 34.75 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.151 1.38 . . . . 0.0 110.921 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.4 pp -62.46 -32.75 73.67 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -69.58 -43.66 72.38 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.826 1.25 . . . . 0.0 113.069 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -54.8 -38.79 67.76 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.713 1.605 . . . . 0.0 111.868 177.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -91.76 -0.2 57.53 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.566 1.946 . . . . 0.0 113.331 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 64.8 t30 47.74 45.84 18.27 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 128.429 2.692 . . . . 0.0 112.627 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm -70.12 126.39 92.38 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.159 1.384 . . . . 0.0 113.148 -177.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.89 129.29 12.3 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 122.843 2.362 . . . . 0.0 107.91 170.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 53.6 t -31.94 123.89 0.37 Allowed Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 127.337 2.255 . . . . 0.0 114.655 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.51 -1.68 7.0 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.2 2.6 . . . . 0.0 114.136 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 48.2 t -122.6 -60.96 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.913 1.685 . . . . 0.0 111.002 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 86.0 m -76.54 -19.13 58.25 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.468 1.907 . . . . 0.0 113.319 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 62.29 6.78 1.99 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 127.18 2.192 . . . . 0.0 113.81 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -75.67 146.27 79.88 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 125.843 1.657 . . . . 0.0 113.382 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -78.02 120.19 4.93 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 124.159 3.239 . . . . 0.0 111.656 177.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.5 pp -63.09 141.48 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.055 0.942 . . . . 0.0 112.785 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -115.1 -45.64 2.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.462 1.505 . . . . 0.0 114.495 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.52 169.1 25.43 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -173.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 4.7 mt -133.65 143.43 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 128.453 2.701 . . . . 0.0 108.451 175.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 15.4 m -139.95 150.17 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.957 1.703 . . . . 0.0 111.214 177.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.33 99.95 2.05 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 176.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.94 102.39 14.75 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.364 1.066 . . . . 0.0 110.757 -176.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -72.53 143.13 48.44 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.656 1.182 . . . . 0.0 112.41 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -66.42 166.81 15.28 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 126.126 1.77 . . . . 0.0 112.201 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo . . . . . 0 C--N 1.354 0.819 0 C-N-CA 124.136 3.224 . . . . 0.0 114.398 -179.302 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 43.3 m . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 22.4 tp -144.6 139.91 15.99 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 126.974 2.11 . . . . 0.0 109.224 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -42.48 -66.29 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 124.47 3.447 . . . . 0.0 116.134 -177.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -61.04 -30.31 70.24 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -67.12 -38.73 86.13 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.912 0.885 . . . . 0.0 111.263 176.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -78.35 -46.48 19.93 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.783 1.233 . . . . 0.0 112.604 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 70.1 mt -70.74 -38.71 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.73 1.612 . . . . 0.0 112.385 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 55.0 61.67 8.67 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 125.986 1.714 . . . . 0.0 111.696 -174.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -77.27 -171.08 1.06 Allowed 'Trans proline' 0 CA--C 1.549 1.24 0 C-N-CA 124.666 3.577 . . . . 0.0 113.09 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 12.5 t -56.41 173.03 0.19 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.002 1.721 . . . . 0.0 113.607 177.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.37 1.82 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 -175.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 15.0 mt -121.73 -60.99 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 120.39 1.45 . . . . 0.0 113.016 -177.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 12.9 p -54.34 -78.49 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.528 1.531 . . . . 0.0 114.607 -177.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -150.63 -12.86 0.24 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 127.34 2.256 . . . . 0.0 113.19 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 96.73 45.74 2.63 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.388 0.995 . . . . 0.0 113.187 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -84.33 155.34 63.18 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 126.095 1.758 . . . . 0.0 111.265 175.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -39.96 125.37 1.65 Allowed 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.716 3.611 . . . . 0.0 114.541 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -67.37 63.97 0.07 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.977 2.911 . . . . 0.0 113.5 -177.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -109.09 89.82 3.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.585 1.154 . . . . 0.0 108.034 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 164.66 51.58 0.02 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.155 0.884 . . . . 0.0 112.85 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 42.5 t -61.32 141.45 57.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.31 1.055 . . . . 0.0 109.887 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.11 137.79 47.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 125.717 1.607 . . . . 0.0 110.104 -174.78 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 83.0 t -126.52 128.81 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.006 0.923 . . . . 0.0 112.116 -177.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -111.31 94.89 5.2 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.713 2.805 . . . . 0.0 109.318 173.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.31 -96.02 0.32 Allowed Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.657 1.599 . . . . 0.0 114.186 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -112.51 0.93 15.67 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.374 1.87 . . . . 0.0 113.565 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 49.4 p -132.15 170.04 15.56 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.959 1.704 . . . . 0.0 110.515 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -161.18 177.19 37.62 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 120.615 -1.303 . . . . 0.0 113.573 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -120.29 140.19 51.61 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.479 1.512 . . . . 0.0 112.333 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.9 92.87 3.89 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.925 1.29 . . . . 0.0 112.13 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.58 -13.59 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 119.073 2.99 . . . . 0.0 119.073 -178.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -129.52 165.42 21.7 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 119.799 1.181 . . . . 0.0 114.041 -174.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 29.8 p -78.78 168.8 19.21 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 122.541 1.162 . . . . 0.0 111.376 175.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.4 -39.4 79.6 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.36 -0.838 . . . . 0.0 112.069 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 62.6 m -60.55 -55.94 27.37 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.108 0.963 . . . . 0.0 110.025 178.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 62.8 m -57.41 -45.15 84.91 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.191 0.996 . . . . 0.0 112.087 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.55 -39.88 81.46 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.024 1.329 . . . . 0.0 112.99 174.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -71.97 -39.35 69.38 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.101 1.36 . . . . 0.0 111.16 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -56.52 -54.49 45.27 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.582 1.153 . . . . 0.0 111.965 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . 0.315 0.0 OUTLIER -63.19 -27.25 69.23 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.547 1.067 . . . . 0.0 113.317 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -70.1 -45.11 67.62 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.413 1.485 . . . . 0.0 110.275 175.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -61.31 -35.76 78.27 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.929 1.292 . . . . 0.0 111.672 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -76.93 -1.17 27.23 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 126.451 1.9 . . . . 0.0 113.338 174.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 51.8 t30 65.18 22.01 12.18 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 128.918 2.887 . . . . 0.0 114.966 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -72.56 137.22 80.58 Favored Pre-proline 0 CA--C 1.544 0.735 0 O-C-N 120.969 -1.082 . . . . 0.0 109.382 176.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -63.52 -52.47 1.9 Allowed 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.465 2.11 . . . . 0.0 112.872 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 2.4 t -153.23 142.7 14.88 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 129.252 3.021 . . . . 0.0 108.482 175.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.33 -6.67 18.7 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.141 2.561 . . . . 0.0 114.187 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.1 -71.43 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 119.997 1.271 . . . . 0.0 113.996 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 27.6 p -94.07 -5.3 47.72 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 70.1 15.32 7.65 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 127.897 2.479 . . . . 0.0 115.397 175.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -74.69 132.96 77.14 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 119.309 0.958 . . . . 0.0 109.194 173.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.01 110.28 1.47 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.947 2.431 . . . . 0.0 114.486 -175.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.4 pp -64.27 155.33 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.536 1.534 . . . . 0.0 113.21 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -114.38 -46.59 2.97 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.798 2.039 . . . . 0.0 112.74 -176.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.12 170.09 21.35 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 14.9 mt -126.05 136.6 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 127.913 2.485 . . . . 0.0 107.492 176.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 12.7 p -123.68 148.02 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.344 1.057 . . . . 0.0 113.505 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.23 99.93 0.97 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.316 1.046 . . . . 0.0 108.193 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 26.6 m -96.13 103.7 15.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.004 1.722 . . . . 0.0 113.565 -173.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -89.66 75.74 7.4 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.585 1.183 . . . . 0.0 110.477 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -63.93 -29.92 4.5 Favored Pre-proline 0 CA--C 1.554 1.113 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo . . . . . 0 C--N 1.358 1.028 0 C-N-CA 123.265 2.644 . . . . 0.0 113.898 -179.582 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 73.6 p . . . . . 0 CA--C 1.54 0.584 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 7.4 tt -70.71 -59.68 3.57 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.836 1.654 . . . . 0.0 112.5 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -75.66 171.49 18.11 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.296 1.997 . . . . 0.0 112.443 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 4.3 pp -57.27 -18.73 17.76 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.173 1.389 . . . . 0.0 114.567 178.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -62.16 -5.71 2.51 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.515 1.926 . . . . 0.0 114.317 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -64.99 -27.73 69.03 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.172 1.389 . . . . 0.0 113.405 176.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 29.6 mm 41.12 88.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 129.32 3.048 . . . . 0.0 114.346 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -66.79 -35.18 8.82 Favored Pre-proline 0 CA--C 1.559 1.32 0 N-CA-C 116.985 2.217 . . . . 0.0 116.985 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -73.95 -104.11 0.01 OUTLIER 'Trans proline' 0 CA--C 1.556 1.607 0 C-N-CA 124.092 3.195 . . . . 0.0 114.149 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 23.8 t -63.65 148.06 49.95 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.704 1.593 . . . . 0.0 110.201 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 29.4 m -132.06 -0.46 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.001 0.921 . . . . 0.0 113.444 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 6.4 mt -134.86 -46.22 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 119.441 1.019 . . . . 0.0 112.981 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.2 m -68.8 -64.19 0.91 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -173.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -154.14 -10.32 0.14 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -175.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.26 14.36 76.84 Favored Glycine 0 CA--C 1.541 1.714 0 O-C-N 120.693 -1.254 . . . . 0.0 113.261 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -59.53 154.39 44.88 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 127.729 2.411 . . . . 0.0 112.867 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.79 68.89 7.05 Favored 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 124.081 3.187 . . . . 0.0 112.68 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -135.02 147.05 49.57 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.057 1.743 . . . . 0.0 111.457 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -128.27 141.54 51.41 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.011 1.324 . . . . 0.0 111.06 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -136.11 76.31 0.38 Allowed Glycine 0 CA--C 1.525 0.657 0 C-N-CA 126.839 2.161 . . . . 0.0 108.76 175.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 85.2 m -66.89 108.98 2.75 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.404 0.682 . . . . 0.0 110.918 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 450' ' ' ILE . . . . . 0.564 ' H ' HD12 ' A' ' 450' ' ' ILE . 0.8 OUTLIER -78.72 140.47 16.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 126.451 1.9 . . . . 0.0 109.993 -178.074 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 77.9 t -129.63 132.67 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.093 0.957 . . . . 0.0 110.707 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -124.61 98.31 5.67 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.691 2.796 . . . . 0.0 110.118 177.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 66.31 -95.07 0.24 Allowed Glycine 0 CA--C 1.534 1.272 0 C-N-CA 126.056 1.789 . . . . 0.0 114.057 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -113.85 1.19 14.7 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.288 1.835 . . . . 0.0 113.753 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 81.9 p -131.27 170.03 15.16 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.095 1.758 . . . . 0.0 111.258 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.4 174.26 34.2 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.023 -1.048 . . . . 0.0 113.716 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -120.32 145.0 47.54 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.026 1.331 . . . . 0.0 112.978 175.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.37 153.21 40.67 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.421 2.288 . . . . 0.0 111.263 177.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 52.0 mtt 97.5 48.96 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 130.148 3.379 . . . . 0.0 113.503 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -155.3 148.13 24.38 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.257 1.823 . . . . 0.0 109.68 176.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 7.7 p -83.3 175.18 10.08 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 122.672 1.225 . . . . 0.0 112.236 176.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -59.09 -46.8 87.36 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.02 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 88.7 m -69.13 -41.52 77.23 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 116.353 -1.784 . . . . 0.0 111.926 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 46.4 m -47.16 -59.4 3.18 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 121.522 1.965 . . . . 0.0 110.405 175.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.36 87.91 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.531 1.532 . . . . 0.0 113.689 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -60.19 -41.93 93.99 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.645 -1.284 . . . . 0.0 111.824 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -61.79 -56.6 17.8 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.26 1.824 . . . . 0.0 111.221 177.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 3.4 pp -60.48 -37.26 80.49 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.205 0.457 . . . . 0.0 111.271 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.18 -48.36 80.39 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.71 1.204 . . . . 0.0 111.753 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -58.54 -37.87 76.58 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.384 1.474 . . . . 0.0 111.636 176.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -74.98 6.08 4.49 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 127.322 2.249 . . . . 0.0 113.7 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 39.8 t30 73.41 9.81 5.06 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 129.662 3.185 . . . . 0.0 115.601 177.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -72.42 131.12 85.08 Favored Pre-proline 0 N--CA 1.474 0.768 0 O-C-N 120.791 -1.193 . . . . 0.0 109.19 175.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.07 -82.06 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.283 2.655 . . . . 0.0 109.682 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 32.3 t -123.16 130.76 24.45 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 126.672 1.989 . . . . 0.0 109.471 175.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.23 -1.39 10.52 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.328 2.685 . . . . 0.0 113.874 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 37.6 t -118.19 -78.28 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.754 1.222 . . . . 0.0 111.946 -177.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 18.5 p -89.98 0.15 57.25 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.389 1.476 . . . . 0.0 114.427 -177.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 12.4 mpt_? 62.46 6.97 2.15 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 127.883 2.473 . . . . 0.0 115.525 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -60.51 138.04 92.5 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-N 119.25 0.932 . . . . 0.0 111.172 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.23 114.28 3.37 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.196 2.597 . . . . 0.0 112.317 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 20.3 pt -76.76 158.85 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.096 1.358 . . . . 0.0 114.159 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -115.19 -43.4 3.08 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.142 1.777 . . . . 0.0 114.04 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.93 170.03 23.07 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -171.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.2 pt -141.97 145.57 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 129.923 3.289 . . . . 0.0 108.209 169.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 11.4 m -137.69 150.17 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.139 1.776 . . . . 0.0 109.619 177.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.15 99.87 0.94 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.88 142.31 27.9 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -172.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -128.48 179.63 5.55 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.231 2.212 . . . . 0.0 111.188 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -134.54 158.19 75.67 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.088 1.355 . . . . 0.0 111.407 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 C--N 1.352 0.743 0 C-N-CA 123.2 2.6 . . . . 0.0 111.381 -179.561 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 72.9 p . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 85.8 mt -145.94 161.64 39.02 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 129.579 3.152 . . . . 0.0 108.378 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -48.69 -41.36 38.03 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.228 2.619 . . . . 0.0 114.517 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 1.1 pp -67.88 -8.95 40.72 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -121.99 -10.88 8.58 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.771 2.028 . . . . 0.0 112.703 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.77 43.34 0.19 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 127.447 2.299 . . . . 0.0 113.549 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 71.3 mt -63.62 -39.82 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.948 1.699 . . . . 0.0 110.625 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 35.3 66.17 1.65 Allowed Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 128.294 2.638 . . . . 0.0 114.942 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -78.28 -105.67 0.01 OUTLIER 'Trans proline' 0 CA--C 1.553 1.437 0 C-N-CA 124.178 3.252 . . . . 0.0 110.889 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 35.3 t -65.22 153.3 41.39 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 120.466 1.484 . . . . 0.0 110.014 174.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 67.5 t -129.09 -14.59 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.656 1.582 . . . . 0.0 111.848 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 7.1 mt -133.24 -45.8 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.2 m -67.44 -65.19 0.72 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.465 1.506 . . . . 0.0 113.981 -173.036 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -146.8 -12.55 0.44 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 76.82 10.56 86.01 Favored Glycine 0 CA--C 1.545 1.949 0 CA-C-N 119.893 1.224 . . . . 0.0 112.418 -173.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -58.45 154.34 33.96 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 129.424 3.09 . . . . 0.0 112.866 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -77.32 68.69 7.41 Favored 'Trans proline' 0 CA--C 1.549 1.246 0 C-N-CA 124.146 3.231 . . . . 0.0 113.031 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -131.61 149.03 52.64 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.821 2.049 . . . . 0.0 110.681 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -128.03 149.99 50.13 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.166 1.387 . . . . 0.0 111.077 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -155.06 84.89 0.14 Allowed Glycine 0 CA--C 1.531 1.047 0 C-N-CA 127.038 2.256 . . . . 0.0 111.163 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 42.0 t -67.73 120.27 13.81 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.2 1.0 . . . . 0.0 110.148 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.68 139.7 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 125.561 1.544 . . . . 0.0 109.918 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 93.6 t -130.07 127.6 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.748 1.219 . . . . 0.0 108.748 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -125.2 95.09 4.35 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.886 2.074 . . . . 0.0 111.632 177.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 71.55 -87.28 0.43 Allowed Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.689 1.614 . . . . 0.0 115.172 178.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -122.52 -4.36 8.78 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.25 1.82 . . . . 0.0 113.765 -177.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 30.0 p -129.66 170.16 14.16 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.648 2.379 . . . . 0.0 110.056 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -158.69 171.27 35.37 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 120.981 -1.074 . . . . 0.0 113.505 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -120.02 137.43 54.1 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.936 1.694 . . . . 0.0 112.838 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 33.2 tp -121.63 153.16 38.47 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 129.023 2.929 . . . . 0.0 110.054 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 19.7 mmt 80.89 57.37 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.617 2.367 . . . . 0.0 112.959 177.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -154.0 153.56 32.18 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 128.222 2.609 . . . . 0.0 109.493 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 10.3 p -85.51 175.07 9.03 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 122.343 1.068 . . . . 0.0 111.926 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.24 -36.76 85.14 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.705 -0.664 . . . . 0.0 112.374 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 87.0 m -73.61 -42.11 61.95 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 117.074 -1.441 . . . . 0.0 111.142 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 55.3 m -48.57 -54.91 12.68 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 120.638 1.563 . . . . 0.0 109.548 172.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -60.72 -49.75 76.26 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.142 1.777 . . . . 0.0 113.262 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -58.97 -41.09 86.7 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.796 1.238 . . . . 0.0 111.734 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -58.9 -55.26 37.43 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.41 1.084 . . . . 0.0 110.552 176.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.73 -30.47 71.44 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -69.03 -47.81 64.49 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.213 1.405 . . . . 0.0 112.377 174.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -59.53 -40.49 87.35 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.811 1.244 . . . . 0.0 111.407 176.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -75.23 -7.89 55.12 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.721 1.609 . . . . 0.0 112.93 174.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 51.68 43.59 29.79 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 128.823 2.849 . . . . 0.0 112.091 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -70.05 117.64 55.97 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 125.238 1.415 . . . . 0.0 112.095 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -80.93 74.4 5.56 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 124.558 3.505 . . . . 0.0 111.193 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 30.7 t 22.4 105.13 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 130.561 3.544 . . . . 0.0 117.093 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.03 -19.5 8.78 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.79 2.993 . . . . 0.0 115.681 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 46.6 t -102.82 -63.68 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.52 1.928 . . . . 0.0 112.219 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 84.8 m -78.25 -18.75 54.95 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.288 1.835 . . . . 0.0 113.871 -176.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 63.24 7.01 2.61 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.878 2.471 . . . . 0.0 114.074 -176.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -83.84 149.59 57.02 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 124.302 1.041 . . . . 0.0 112.793 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.78 124.23 9.56 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.528 2.819 . . . . 0.0 112.212 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.99 117.23 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 126.671 1.988 . . . . 0.0 110.388 177.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -115.1 -46.32 2.91 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -174.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 1.1 ttp -143.18 155.1 44.47 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.699 1.136 . . . . 0.0 113.419 -174.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 12.8 mt -138.14 136.23 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 127.063 2.145 . . . . 0.0 109.506 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 16.2 m -138.65 150.18 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 125.5 1.52 . . . . 0.0 112.761 176.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 1.5 tt -74.95 99.95 3.99 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.313 1.045 . . . . 0.0 109.346 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 7.4 t -90.13 155.35 19.1 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -134.39 162.89 30.97 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.642 1.977 . . . . 0.0 112.703 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -93.4 167.64 13.63 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 125.277 1.431 . . . . 0.0 110.89 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo . . . . . 0 C--N 1.351 0.675 0 C-N-CA 124.1 3.2 . . . . 0.0 113.72 -179.854 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 37.8 m . . . . . 0 CA--C 1.541 0.602 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 92.8 mt -136.19 160.12 68.25 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 127.434 2.293 . . . . 0.0 110.756 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -60.36 -22.63 71.88 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.907 2.405 . . . . 0.0 113.557 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 79.0 mt -67.8 -35.25 78.31 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.746 1.218 . . . . 0.0 111.709 175.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -87.11 -19.43 28.55 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.469 1.508 . . . . 0.0 112.871 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -69.1 39.02 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.954 2.502 . . . . 0.0 115.619 -178.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 37.2 mm -57.44 -50.76 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 127.099 2.16 . . . . 0.0 110.858 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -150.53 154.59 35.67 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 128.013 2.525 . . . . 0.0 109.522 176.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -95.48 156.06 1.6 Allowed 'Trans proline' 0 CA--C 1.552 1.404 0 C-N-CA 123.529 2.819 . . . . 0.0 111.824 172.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 1.7 t -68.53 166.42 17.02 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 126.114 1.766 . . . . 0.0 109.966 169.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 99.3 t -127.03 -18.5 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 O-C-N 120.346 -1.471 . . . . 0.0 111.971 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 8.3 mt -133.03 -47.06 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 119.43 1.014 . . . . 0.0 113.707 -172.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.4 m -62.86 -54.83 32.73 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.163 1.385 . . . . 0.0 113.222 -175.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -160.46 -12.75 0.05 Allowed 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 85.8 1.22 87.3 Favored Glycine 0 CA--C 1.542 1.775 0 O-C-N 120.731 -1.231 . . . . 0.0 113.533 -176.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -59.16 154.98 37.39 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 129.301 3.04 . . . . 0.0 114.034 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.41 115.67 4.38 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.413 2.742 . . . . 0.0 111.685 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -171.12 146.14 2.36 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 129.162 2.985 . . . . 0.0 108.773 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -112.12 150.21 31.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 128.091 2.557 . . . . 0.0 113.216 -174.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 171.08 82.76 0.05 OUTLIER Glycine 0 CA--C 1.532 1.094 0 C-N-CA 126.263 1.887 . . . . 0.0 112.587 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.32 144.22 55.98 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.139 0.97 . . . . 0.0 110.776 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 3.0 mp -115.09 140.86 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.387 1.475 . . . . 0.0 110.371 -177.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 98.7 t -130.06 130.23 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.12 0.968 . . . . 0.0 109.256 175.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -124.97 95.14 4.39 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.521 2.328 . . . . 0.0 111.141 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.96 -88.17 0.38 Allowed Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.069 1.795 . . . . 0.0 114.197 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -123.4 -1.63 8.59 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 126.567 1.947 . . . . 0.0 113.465 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 16.4 p -127.04 170.1 12.68 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.423 2.289 . . . . 0.0 110.373 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -158.75 176.44 35.63 Favored Glycine 0 CA--C 1.531 1.085 0 O-C-N 120.992 -1.067 . . . . 0.0 114.046 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -120.19 142.39 49.04 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.884 1.674 . . . . 0.0 112.059 177.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 45.7 tp -129.66 150.49 50.96 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.476 2.31 . . . . 0.0 109.962 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 27.8 mtm 76.21 58.41 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 129.495 3.118 . . . . 0.0 112.18 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -148.83 153.96 38.84 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.033 2.133 . . . . 0.0 110.561 177.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 14.3 p -83.36 169.38 15.69 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 122.345 1.069 . . . . 0.0 112.79 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -65.49 -37.6 87.29 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.747 -0.595 . . . . 0.0 111.768 178.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 27.6 m -63.58 -46.26 86.67 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 117.388 -1.292 . . . . 0.0 111.787 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 46.2 m -48.52 -56.1 9.23 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 120.417 1.462 . . . . 0.0 110.453 174.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -60.64 -43.54 97.43 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.974 1.709 . . . . 0.0 113.08 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -62.55 -42.3 99.45 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.642 1.177 . . . . 0.0 111.616 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -59.73 -56.47 21.41 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.185 1.394 . . . . 0.0 111.083 176.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.2 pp -62.39 -35.3 78.76 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 119.23 -0.414 . . . . 0.0 111.793 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.6 -48.12 76.11 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.358 0.981 . . . . 0.0 112.047 175.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -56.4 -43.53 79.39 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.676 1.59 . . . . 0.0 111.554 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -76.58 -5.23 46.83 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.382 1.873 . . . . 0.0 113.59 176.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 54.7 36.69 26.78 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 127.68 2.392 . . . . 0.0 111.734 -176.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -81.31 114.88 52.72 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 126.642 1.977 . . . . 0.0 111.835 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.34 129.33 17.84 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.292 1.995 . . . . 0.0 108.121 172.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 42.6 t -12.88 117.78 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 129.739 3.216 . . . . 0.0 116.19 -177.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.3 -0.13 2.65 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 123.141 2.561 . . . . 0.0 114.694 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 53.1 t -123.21 -60.11 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.145 1.778 . . . . 0.0 111.216 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 82.1 m -79.17 -15.29 58.3 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.499 1.92 . . . . 0.0 113.557 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . 0.295 51.8 ptt85 53.52 17.05 1.05 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 128.175 2.59 . . . . 0.0 115.029 -174.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -85.26 150.13 53.99 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 124.226 1.011 . . . . 0.0 112.335 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.3 118.4 5.66 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.703 2.936 . . . . 0.0 112.167 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.64 129.01 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 125.354 1.461 . . . . 0.0 111.149 178.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -109.54 -41.52 4.56 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -177.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.04 166.97 31.19 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 5.4 mt -135.17 138.67 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 127.471 2.309 . . . . 0.0 108.943 177.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 17.0 m -139.8 150.0 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 64.8 mt -73.8 99.86 3.3 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 176.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 14.4 t -98.12 150.69 21.17 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.768 0.827 . . . . 0.0 112.844 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -144.4 172.79 12.46 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.3 1.84 . . . . 0.0 111.661 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -117.99 162.11 31.12 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.442 1.097 . . . . 0.0 111.878 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo . . . . . 0 C--N 1.353 0.785 0 C-N-CA 124.243 3.295 . . . . 0.0 114.054 179.796 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 45.4 m . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 95.3 mt -65.59 156.14 83.53 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 124.93 1.292 . . . . 0.0 111.862 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -46.25 -40.53 21.96 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 124.966 3.777 . . . . 0.0 117.174 -177.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -137.64 -26.56 0.97 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -72.61 -35.44 67.85 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.687 0.795 . . . . 0.0 112.874 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . 50.24 15.48 0.2 Allowed 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 127.421 2.288 . . . . 0.0 116.939 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 31.8 mm 69.76 -60.5 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 129.103 2.961 . . . . 0.0 112.514 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 30.24 76.07 0.37 Allowed Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 129.331 3.053 . . . . 0.0 114.837 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.96 -60.98 0.58 Allowed 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.445 3.43 . . . . 0.0 114.932 -178.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 1.5 t -50.69 142.7 10.74 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.563 1.545 . . . . 0.0 111.356 176.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.3 -1.22 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.934 1.294 . . . . 0.0 114.012 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 19.4 mt -123.21 -53.38 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.838 0.855 . . . . 0.0 112.027 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 2.4 m -71.88 -69.83 0.37 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.437 1.495 . . . . 0.0 114.355 -172.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -159.89 -1.16 0.07 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 -176.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 91.61 11.78 60.26 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-N 120.222 1.374 . . . . 0.0 113.998 -177.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -59.71 155.23 41.76 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 127.391 2.276 . . . . 0.0 112.76 176.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.11 146.55 37.95 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.468 2.779 . . . . 0.0 113.935 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.91 36.8 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -81.11 89.8 6.0 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.368 -1.457 . . . . 0.0 108.968 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 162.85 57.56 0.02 OUTLIER Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.762 1.649 . . . . 0.0 111.208 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 53.5 t -61.32 134.86 57.41 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.382 0.673 . . . . 0.0 110.254 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.23 137.23 37.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 126.248 1.819 . . . . 0.0 109.71 -176.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 86.0 t -130.06 129.06 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.011 0.924 . . . . 0.0 109.061 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -125.17 95.41 4.48 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.762 2.025 . . . . 0.0 111.701 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 73.19 -85.79 0.59 Allowed Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.844 1.688 . . . . 0.0 114.963 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 454' ' ' LYS . . . . . 0.452 ' HA ' ' HE2' ' B' ' 454' ' ' LYS . 0.6 OUTLIER -123.97 -7.66 7.79 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.188 1.795 . . . . 0.0 113.584 -177.418 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 28.1 p -125.51 170.1 11.77 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 127.179 2.192 . . . . 0.0 110.65 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -154.72 174.95 32.96 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 121.28 -0.888 . . . . 0.0 114.084 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -120.25 142.56 48.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.359 1.463 . . . . 0.0 113.446 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.5 pp -129.58 153.29 48.21 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.306 2.643 . . . . 0.0 110.625 177.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 28.9 tpp 93.8 -7.09 0.13 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 128.976 2.91 . . . . 0.0 113.442 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -99.99 144.9 28.5 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.394 1.078 . . . . 0.0 109.404 175.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 15.4 p -82.35 174.42 11.14 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 122.196 0.998 . . . . 0.0 112.591 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.08 -37.07 78.83 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.499 -0.75 . . . . 0.0 112.16 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 60.5 m -73.69 -41.85 62.08 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 117.751 -1.119 . . . . 0.0 110.767 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 27.6 m -53.07 -57.3 10.87 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.767 1.167 . . . . 0.0 109.172 171.174 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -50.56 -48.34 57.52 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.243 1.817 . . . . 0.0 112.967 176.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -61.21 -30.29 70.34 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.306 1.442 . . . . 0.0 112.635 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -61.26 -43.62 98.58 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.424 1.011 . . . . 0.0 111.55 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -57.55 -39.61 77.04 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.427 0.691 . . . . 0.0 110.219 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -68.65 -50.75 48.74 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.987 0.515 . . . . 0.0 111.841 176.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -53.97 -45.04 71.25 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.892 1.677 . . . . 0.0 112.156 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -82.93 -7.62 59.65 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 126.501 1.92 . . . . 0.0 113.584 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 50.33 50.72 18.17 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 127.813 2.445 . . . . 0.0 111.292 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -100.73 115.7 65.03 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 126.572 1.949 . . . . 0.0 113.323 -175.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.57 129.13 19.4 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 122.51 2.14 . . . . 0.0 107.823 171.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 48.3 t -17.02 118.97 0.06 OUTLIER Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 129.951 3.3 . . . . 0.0 116.447 -174.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -65.16 0.73 2.44 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.554 2.836 . . . . 0.0 114.277 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 43.3 t -127.61 -60.41 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.7 1.6 . . . . 0.0 111.283 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 63.2 m -77.5 -16.04 58.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.58 1.952 . . . . 0.0 113.637 -177.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 60.0 7.8 1.27 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 127.239 2.216 . . . . 0.0 114.401 -175.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -79.19 149.36 72.74 Favored Pre-proline 0 CA--C 1.547 0.842 0 O-C-N 121.461 -0.774 . . . . 0.0 112.117 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.3 123.28 10.1 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.027 2.485 . . . . 0.0 110.788 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.75 109.97 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 125.205 1.402 . . . . 0.0 109.761 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -96.55 -58.17 2.12 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.571 1.149 . . . . 0.0 113.541 -174.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.49 162.97 34.43 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -177.635 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 13.3 mt -137.41 136.64 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 127.316 2.246 . . . . 0.0 108.599 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 19.4 m -136.25 150.19 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.473 1.109 . . . . 0.0 113.5 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 5.1 tt -68.27 103.15 1.52 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.668 1.587 . . . . 0.0 107.654 175.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 5.7 t -98.02 161.75 13.57 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -175.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -129.77 130.59 45.57 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.457 1.903 . . . . 0.0 111.254 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 490' ' ' PHE . . . . . 0.509 ' H ' ' CD ' ' B' ' 491' ' ' PRO . 44.3 p90 -134.03 -27.36 0.02 OUTLIER Pre-proline 0 CA--C 1.551 1.011 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -178.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 491' ' ' PRO . . . . . 0.509 ' CD ' ' H ' ' B' ' 490' ' ' PHE . 89.2 Cg_exo . . . . . 0 C--N 1.359 1.121 0 C-N-CA 123.182 2.588 . . . . 0.0 114.321 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 4.4 t . . . . . 0 CA--C 1.541 0.611 0 CA-C-O 121.192 0.52 . . . . 0.0 112.266 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 9.8 mp -69.08 148.78 97.78 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.245 1.418 . . . . 0.0 110.615 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -63.46 -23.73 71.0 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.638 2.225 . . . . 0.0 113.175 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 72.2 mt -60.5 -44.71 95.7 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.262 1.425 . . . . 0.0 113.426 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -93.18 -15.9 25.45 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -87.67 -51.91 5.62 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.945 0.898 . . . . 0.0 112.929 -177.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 19.8 mm -84.01 73.49 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 122.152 0.977 . . . . 0.0 110.372 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -139.77 61.14 17.65 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 125.655 1.582 . . . . 0.0 110.967 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.38 -31.26 52.56 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.939 2.426 . . . . 0.0 116.187 -175.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 46.3 t -56.65 144.48 32.07 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 120.607 1.548 . . . . 0.0 111.153 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 32.1 m -123.1 -15.31 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 10.2 pt -137.52 -25.73 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 441' ' ' CYS . . . . . 0.419 ' CB ' HH21 ' A' ' 444' ' ' ARG . 3.7 m -75.23 -65.3 0.9 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 120.72 1.6 . . . . 0.0 111.709 -177.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -145.98 -11.13 0.5 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 78.23 9.69 86.79 Favored Glycine 0 CA--C 1.546 1.978 0 CA-C-N 120.35 1.432 . . . . 0.0 112.824 -174.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 444' ' ' ARG . . . . . 0.419 HH21 ' CB ' ' A' ' 441' ' ' CYS . 26.4 ptt180 -57.94 155.24 24.62 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 131.565 3.946 . . . . 0.0 114.164 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.6 -5.85 15.21 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 124.33 3.353 . . . . 0.0 115.495 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -54.58 139.77 37.18 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.503 1.921 . . . . 0.0 110.461 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.14 150.1 50.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.182 1.793 . . . . 0.0 112.855 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -157.39 88.14 0.12 Allowed Glycine 0 CA--C 1.532 1.119 0 C-N-CA 126.306 1.907 . . . . 0.0 112.32 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 48.9 t -65.16 133.06 50.74 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 117.765 0.782 . . . . 0.0 110.647 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -110.9 144.22 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.931 1.692 . . . . 0.0 110.948 -177.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 72.7 t -129.92 134.63 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.528 1.131 . . . . 0.0 111.624 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.23 97.35 5.19 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 128.894 2.877 . . . . 0.0 110.569 174.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 65.46 -99.31 0.38 Allowed Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.859 1.695 . . . . 0.0 114.349 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -103.68 -6.29 21.72 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.032 1.733 . . . . 0.0 113.582 -178.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 44.4 p -131.5 170.07 15.21 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.384 1.473 . . . . 0.0 111.422 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -151.55 173.42 30.89 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.313 1.435 . . . . 0.0 112.216 178.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -120.06 146.48 45.87 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.222 1.009 . . . . 0.0 113.451 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.15 153.16 27.42 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.34 2.656 . . . . 0.0 111.721 -177.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 6.8 tpt 71.69 65.01 0.15 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.275 2.23 . . . . 0.0 114.323 174.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -150.9 154.93 38.1 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.635 2.374 . . . . 0.0 109.374 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 1.8 p -90.28 171.1 9.72 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.218 0.917 . . . . 0.0 111.195 174.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -65.43 -36.6 84.42 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.325 -0.859 . . . . 0.0 111.345 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 32.6 m -70.02 -42.4 73.03 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 117.623 -1.18 . . . . 0.0 110.944 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 56.4 m -50.07 -61.16 2.31 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.693 1.197 . . . . 0.0 108.642 173.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.0 -45.29 75.07 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.783 1.633 . . . . 0.0 113.251 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -58.61 -37.21 75.38 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.661 1.185 . . . . 0.0 112.316 178.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -58.37 -44.12 88.71 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.271 1.028 . . . . 0.0 111.06 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 6.7 mp -65.62 -45.09 84.42 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.008 0.523 . . . . 0.0 109.924 174.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -56.27 -47.4 78.65 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.51 1.524 . . . . 0.0 113.972 -176.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -54.96 -27.71 45.83 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -120.04 8.89 11.07 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 127.561 2.345 . . . . 0.0 113.187 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 38.36 60.67 1.26 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 128.509 2.724 . . . . 0.0 112.879 -174.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -69.94 118.77 66.54 Favored Pre-proline 0 N--CA 1.473 0.68 0 C-N-CA 125.485 1.514 . . . . 0.0 113.225 -176.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -55.44 121.91 10.77 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.319 2.679 . . . . 0.0 109.088 170.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 53.2 t -29.68 121.12 0.3 Allowed Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 128.413 2.685 . . . . 0.0 115.32 -174.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -66.41 -3.97 9.86 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 122.901 2.4 . . . . 0.0 113.907 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 39.2 t -107.15 -64.75 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.472 1.509 . . . . 0.0 111.294 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 24.6 p -107.8 3.27 24.28 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -176.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 71.8 mtp85 63.64 8.66 3.81 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 128.182 2.593 . . . . 0.0 116.424 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -71.22 147.84 93.51 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 123.882 0.873 . . . . 0.0 111.853 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.7 106.83 2.34 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.609 2.872 . . . . 0.0 112.607 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 pp -59.65 135.82 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.704 1.202 . . . . 0.0 111.246 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -115.15 -30.74 6.24 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -177.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.29 165.62 34.34 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -175.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 6.9 mt -133.25 140.19 47.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 127.611 2.365 . . . . 0.0 108.269 176.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 9.5 m -126.83 146.92 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.032 0.933 . . . . 0.0 111.728 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.05 99.82 4.73 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 6.4 t -92.57 172.73 8.18 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.676 0.79 . . . . 0.0 113.095 -175.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -149.41 171.21 16.93 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.135 2.174 . . . . 0.0 111.217 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -138.73 154.13 72.77 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.507 1.523 . . . . 0.0 110.521 176.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 CA--C 1.538 0.718 0 C-N-CA 123.458 2.772 . . . . 0.0 112.497 -179.765 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 40.2 m . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 98.0 mt -135.62 160.17 68.72 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 127.361 2.265 . . . . 0.0 110.657 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -49.81 -34.73 37.27 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.97 3.113 . . . . 0.0 114.889 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 62.1 tp -62.33 -27.98 69.43 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.64 1.576 . . . . 0.0 113.114 177.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -108.91 -2.6 18.23 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.186 1.794 . . . . 0.0 113.227 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -70.47 5.3 1.86 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.87 2.068 . . . . 0.0 116.361 -178.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 30.8 mm 81.48 139.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 129.354 3.062 . . . . 0.0 111.696 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -47.12 122.54 7.78 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 127.331 2.252 . . . . 0.0 114.227 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -79.51 -171.99 1.4 Allowed 'Trans proline' 0 CA--C 1.549 1.273 0 C-N-CA 124.951 3.767 . . . . 0.0 112.522 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.26 166.71 0.54 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.549 1.539 . . . . 0.0 114.047 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 30.0 m -130.88 -3.66 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -175.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 32.9 mm -111.79 -61.29 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.464 1.106 . . . . 0.0 111.33 -177.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.2 m -62.96 -80.14 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 128.198 2.599 . . . . 0.0 114.626 -172.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -144.12 -5.59 0.77 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.092 1.357 . . . . 0.0 114.59 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 78.83 35.28 31.9 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 119.813 1.188 . . . . 0.0 111.281 -174.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 444' ' ' ARG . . . . . 0.419 ' NH2' ' H ' ' B' ' 463' ' ' THR . 14.5 ptt180 -87.69 155.31 53.46 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 128.518 2.727 . . . . 0.0 111.843 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -43.47 125.99 5.01 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 124.06 3.173 . . . . 0.0 114.059 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 41.69 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 130.392 3.477 . . . . 0.0 117.06 -177.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -81.74 89.85 6.32 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.178 -1.576 . . . . 0.0 109.735 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 168.48 59.33 0.03 OUTLIER Glycine 0 CA--C 1.529 0.935 0 C-N-CA 123.96 0.791 . . . . 0.0 113.464 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 42.6 t -58.58 134.95 57.19 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.367 1.084 . . . . 0.0 110.205 178.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.1 mp -106.1 133.77 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 126.207 1.803 . . . . 0.0 108.211 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 92.6 t -120.46 130.39 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 121.656 0.741 . . . . 0.0 110.001 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.01 109.98 13.62 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 128.448 2.699 . . . . 0.0 110.757 177.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 68.22 -89.78 0.21 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.736 1.636 . . . . 0.0 112.938 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.41 4.04 4.3 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.604 1.962 . . . . 0.0 114.069 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 62.8 p -127.5 170.03 13.03 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.147 1.779 . . . . 0.0 110.742 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -150.5 171.41 30.35 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 121.075 -1.015 . . . . 0.0 114.626 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -120.35 143.49 48.37 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.428 1.491 . . . . 0.0 113.975 176.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 82.8 mt -125.11 153.24 43.27 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.958 2.903 . . . . 0.0 111.243 178.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 60.8 mtt 107.15 -2.68 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 1 C-N-CA 132.027 4.131 . . . . 0.0 113.551 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -108.24 145.63 34.02 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.73 1.212 . . . . 0.0 109.87 175.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 14.8 p -82.01 174.88 10.83 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 122.796 1.284 . . . . 0.0 112.103 178.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -59.68 -37.75 79.64 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.633 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 463' ' ' THR . . . . . 0.419 ' H ' ' NH2' ' B' ' 444' ' ' ARG . 87.4 m -70.62 -44.63 66.83 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 117.326 -1.321 . . . . 0.0 110.979 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 77.3 m -50.16 -53.25 29.03 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 120.462 1.483 . . . . 0.0 109.734 171.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -59.64 -43.33 93.91 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.794 1.638 . . . . 0.0 113.294 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -63.15 -42.66 99.48 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.913 1.285 . . . . 0.0 111.044 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -59.68 -56.55 20.45 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.687 1.195 . . . . 0.0 110.944 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.62 -33.23 72.46 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 122.691 0.396 . . . . 0.0 111.928 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -68.18 -48.02 66.41 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.841 1.257 . . . . 0.0 112.38 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -58.15 -40.79 82.26 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.862 1.265 . . . . 0.0 111.355 176.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 29.0 mmt85 -76.49 -7.79 55.85 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.203 1.801 . . . . 0.0 113.475 175.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 64.0 t30 52.63 40.33 29.92 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 128.012 2.525 . . . . 0.0 112.233 -177.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -74.55 131.37 80.09 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 125.647 1.579 . . . . 0.0 112.737 -177.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -71.9 123.54 9.41 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.732 2.288 . . . . 0.0 107.924 170.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 43.9 t -14.54 119.24 0.04 OUTLIER Pre-proline 0 CA--C 1.557 1.224 0 C-N-CA 130.062 3.345 . . . . 0.0 115.994 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -65.8 -1.13 4.58 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 123.202 2.601 . . . . 0.0 114.72 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 35.6 t -114.02 -60.79 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.281 1.432 . . . . 0.0 111.919 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 28.0 p -114.77 6.69 15.63 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -176.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . 0.31 13.8 ptm180 54.07 14.86 0.77 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 129.288 3.035 . . . . 0.0 117.56 177.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -68.02 152.32 96.52 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 123.852 0.861 . . . . 0.0 111.722 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -74.1 106.17 2.17 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 124.034 3.156 . . . . 0.0 113.344 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 pp -60.21 136.14 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.621 1.169 . . . . 0.0 111.494 177.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -115.07 -40.72 3.43 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.909 1.284 . . . . 0.0 113.678 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.21 167.46 30.3 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -176.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 6.0 mt -129.79 139.08 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 127.958 2.503 . . . . 0.0 107.587 175.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 14.1 p -131.54 146.42 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.137 0.975 . . . . 0.0 112.427 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.51 99.95 1.04 Allowed 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 1.8 m -102.27 95.54 6.37 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.244 1.418 . . . . 0.0 111.687 -174.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -83.22 159.78 21.91 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.46 1.104 . . . . 0.0 113.83 -178.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -78.71 158.85 75.17 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 125.643 1.577 . . . . 0.0 112.226 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo . . . . . 0 C--N 1.353 0.797 0 C-N-CA 124.39 3.393 . . . . 0.0 113.572 178.04 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 75.9 p . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 27.0 tp -46.49 -46.82 48.38 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 126.655 1.982 . . . . 0.0 115.961 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.52 -15.9 42.18 Favored 'Trans proline' 0 C--N 1.354 0.86 0 CA-C-N 122.163 1.808 . . . . 0.0 114.634 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 54.3 tp -81.47 80.23 7.9 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.875 1.216 . . . . 0.0 109.223 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 47.12 1.83 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 130.322 3.449 . . . . 0.0 118.929 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -72.09 33.71 0.06 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 127.403 2.281 . . . . 0.0 114.939 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 10.1 mm 56.52 64.55 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 127.565 2.346 . . . . 0.0 112.196 178.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -70.02 124.19 90.2 Favored Pre-proline 0 CA--C 1.559 1.309 0 C-N-CA 125.86 1.664 . . . . 0.0 111.514 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -75.77 -159.69 0.1 OUTLIER 'Trans proline' 0 CA--C 1.552 1.422 0 C-N-CA 125.093 3.862 . . . . 0.0 112.149 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 10.6 t -42.97 145.9 0.44 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.796 2.038 . . . . 0.0 111.972 174.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.13 -27.95 3.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 124.081 0.952 . . . . 0.0 112.613 -175.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 7.9 pt -141.39 -24.65 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 117.727 2.492 . . . . 0.0 117.727 -172.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.7 m -77.02 -64.61 1.09 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 120.617 1.553 . . . . 0.0 114.398 -174.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -153.03 -10.08 0.16 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -171.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 87.16 10.21 71.93 Favored Glycine 0 CA--C 1.541 1.691 0 CA-C-N 119.959 1.254 . . . . 0.0 113.13 -176.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -64.72 155.22 83.02 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 128.589 2.755 . . . . 0.0 113.43 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -46.72 139.51 13.7 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 124.396 3.398 . . . . 0.0 116.446 -177.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.33 13.44 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 131.436 3.894 . . . . 0.0 118.918 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.04 89.78 5.96 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.503 -1.373 . . . . 0.0 112.039 -177.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -178.59 44.58 0.09 OUTLIER Glycine 0 CA--C 1.529 0.906 0 CA-C-O 118.899 -0.945 . . . . 0.0 113.63 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 42.9 t -57.42 135.97 56.6 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.86 1.33 . . . . 0.0 110.689 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.4 mp -108.23 142.93 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 126.647 1.979 . . . . 0.0 109.037 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 95.1 t -129.76 133.41 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.419 0.628 . . . . 0.0 110.497 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -124.91 96.76 4.99 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.692 2.397 . . . . 0.0 111.087 176.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 71.54 -89.16 0.44 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 126.06 1.79 . . . . 0.0 114.075 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -124.07 0.79 8.53 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 126.238 1.815 . . . . 0.0 114.232 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 16.8 p -127.14 167.58 15.82 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.122 2.169 . . . . 0.0 109.922 178.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.51 172.18 34.23 Favored Glycine 0 CA--C 1.527 0.79 0 O-C-N 121.166 -0.959 . . . . 0.0 113.985 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -119.97 137.28 54.16 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.249 1.82 . . . . 0.0 111.192 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 60.0 tp -133.12 153.35 51.6 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.005 2.122 . . . . 0.0 111.601 -173.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 459' ' ' MET . . . . . . . . . . . . 0.256 29.4 mtt 81.89 56.7 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.204 2.202 . . . . 0.0 113.104 178.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -158.84 150.61 20.92 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 130.398 3.479 . . . . 0.0 106.824 176.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 16.1 p -78.08 171.22 15.34 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 123.164 1.459 . . . . 0.0 113.582 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.81 -36.92 77.77 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.835 175.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 11.4 m -66.66 -47.22 73.2 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 117.413 -1.279 . . . . 0.0 110.943 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 49.5 m -49.86 -52.79 30.01 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 120.53 1.514 . . . . 0.0 109.664 173.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -60.11 -43.03 95.9 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.665 1.586 . . . . 0.0 113.37 176.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -64.79 -40.68 95.63 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.63 -1.294 . . . . 0.0 111.43 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -61.95 -56.47 18.84 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.519 1.127 . . . . 0.0 110.835 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.2 pp -58.46 -33.49 69.81 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 118.461 0.573 . . . . 0.0 112.163 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -66.75 -50.38 62.94 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.216 1.406 . . . . 0.0 112.02 174.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -58.23 -38.39 76.75 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.434 1.094 . . . . 0.0 111.643 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -78.16 -1.67 33.83 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 127.051 2.14 . . . . 0.0 113.351 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.34 37.24 5.66 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 129.04 2.936 . . . . 0.0 113.922 -177.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -70.11 116.56 45.6 Favored Pre-proline 0 CA--C 1.539 0.519 0 C-N-CA 126.412 1.885 . . . . 0.0 113.734 -177.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.31 139.11 37.57 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 N-CA-C 106.799 -2.039 . . . . 0.0 106.799 169.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 53.2 t -38.63 121.91 1.15 Allowed Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 126.32 1.848 . . . . 0.0 114.37 -176.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.2 -1.24 7.66 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.063 2.509 . . . . 0.0 114.045 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 48.2 t -122.15 -60.57 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.711 1.604 . . . . 0.0 111.333 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 64.5 m -76.49 -17.84 59.07 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.731 2.012 . . . . 0.0 112.841 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 73.8 mtp85 64.52 5.38 2.64 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 127.635 2.374 . . . . 0.0 114.203 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -84.54 147.22 48.93 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.107 0.963 . . . . 0.0 113.386 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.1 120.08 5.89 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.485 2.79 . . . . 0.0 111.531 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.4 pp -59.0 141.14 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.541 1.137 . . . . 0.0 111.436 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -115.01 -38.25 3.93 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -177.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.44 167.05 31.64 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -176.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 14.2 mt -131.95 143.14 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 127.639 2.376 . . . . 0.0 108.7 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 8.4 m -134.12 150.16 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.336 1.455 . . . . 0.0 112.6 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -72.78 99.9 2.74 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 3.5 m -88.0 104.88 17.06 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -172.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -78.57 166.48 22.51 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.14 1.776 . . . . 0.0 110.701 173.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -123.15 170.45 8.23 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 126.095 1.758 . . . . 0.0 111.364 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo . . . . . 0 C--N 1.351 0.681 0 C-N-CA 123.92 3.08 . . . . 0.0 113.688 -178.713 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 43.6 m . . . . . 0 N--CA 1.467 0.386 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 56.0 tp -51.04 -46.95 88.33 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 124.565 1.146 . . . . 0.0 113.532 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.66 0.99 4.1 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 123.507 2.805 . . . . 0.0 114.821 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 8.8 tp 67.06 -70.86 0.11 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 129.849 3.26 . . . . 0.0 112.469 -176.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -64.03 4.69 0.29 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.885 2.074 . . . . 0.0 115.176 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -70.48 -6.74 38.23 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.107 1.763 . . . . 0.0 115.284 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 23.6 mm 48.7 73.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 127.023 2.129 . . . . 0.0 112.501 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 33.87 70.08 0.89 Allowed Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 127.693 2.397 . . . . 0.0 114.006 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -71.12 171.13 16.54 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.106 2.537 . . . . 0.0 114.186 -176.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 438' ' ' CYS . . . . . 0.414 ' SG ' ' N ' ' B' ' 439' ' ' VAL . 18.6 t -70.43 -175.23 0.98 Allowed 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 122.22 1.01 . . . . 0.0 112.601 175.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 439' ' ' VAL . . . . . 0.414 ' N ' ' SG ' ' B' ' 438' ' ' CYS . 3.6 p -144.4 2.75 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 126.446 1.898 . . . . 0.0 112.749 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 41.9 mt -113.97 -61.14 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.259 1.024 . . . . 0.0 111.408 -175.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 8.1 p -56.35 -83.23 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.593 1.557 . . . . 0.0 113.526 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -147.53 -7.68 0.44 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 129.867 3.267 . . . . 0.0 112.577 -177.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 85.49 39.23 8.41 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.011 0.823 . . . . 0.0 113.073 -177.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -66.1 152.33 94.02 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 124.957 1.303 . . . . 0.0 111.191 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.82 66.7 5.84 Favored 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 124.546 3.497 . . . . 0.0 113.667 -176.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -141.52 145.89 35.71 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.9 2.48 . . . . 0.0 110.374 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.29 144.74 51.16 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.103 1.761 . . . . 0.0 112.379 176.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -156.9 87.28 0.12 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 126.632 2.063 . . . . 0.0 110.781 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 45.4 t -62.09 137.16 58.21 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 117.606 0.703 . . . . 0.0 110.969 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -114.93 148.64 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 126.301 1.84 . . . . 0.0 110.174 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 38.7 t -117.69 140.97 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.071 1.348 . . . . 0.0 109.071 174.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -125.18 94.86 4.29 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.794 2.438 . . . . 0.0 107.569 175.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 62.25 -91.7 0.07 OUTLIER Glycine 0 CA--C 1.542 1.745 0 C-N-CA 124.648 1.118 . . . . 0.0 113.612 -176.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 50.4 mmtm -120.98 6.64 10.35 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 127.612 2.365 . . . . 0.0 113.296 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 30.3 p -120.73 170.22 9.65 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 128.172 2.589 . . . . 0.0 109.501 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.17 170.0 33.79 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 120.368 -1.458 . . . . 0.0 113.328 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.23 145.48 46.98 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.606 1.162 . . . . 0.0 114.135 177.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 3.6 pp -116.13 153.21 32.18 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.488 1.915 . . . . 0.0 112.421 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 21.6 ttt 70.55 66.14 0.19 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.611 2.364 . . . . 0.0 113.88 176.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -154.52 145.89 23.01 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 128.247 2.619 . . . . 0.0 107.802 175.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 29.1 p -79.54 164.96 23.46 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 120.71 1.595 . . . . 0.0 112.398 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -63.81 -34.75 78.6 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.138 177.054 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 37.3 m -62.55 -57.62 10.47 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.517 1.127 . . . . 0.0 110.51 176.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 33.1 m -54.12 -47.31 71.97 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 120.057 1.299 . . . . 0.0 112.469 176.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.64 -44.27 90.01 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.779 0.832 . . . . 0.0 112.554 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -64.98 -40.66 95.3 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.749 -1.22 . . . . 0.0 111.479 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -59.63 -56.61 19.76 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.927 1.291 . . . . 0.0 111.072 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.1 pp -61.84 -34.33 75.76 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -65.19 -48.97 71.56 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.402 1.081 . . . . 0.0 112.154 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -52.26 -43.69 64.5 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.739 1.616 . . . . 0.0 112.639 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -90.81 4.7 50.98 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.517 1.527 . . . . 0.0 114.141 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 65.4 t30 49.87 40.81 21.56 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.796 2.438 . . . . 0.0 113.366 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -71.04 117.23 54.43 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 126.215 1.806 . . . . 0.0 111.582 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.62 123.01 12.74 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.102 2.535 . . . . 0.0 108.571 171.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 42.7 t -22.98 122.14 0.16 Allowed Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 128.384 2.674 . . . . 0.0 115.887 -174.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -65.47 -2.37 6.03 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 122.817 2.345 . . . . 0.0 114.151 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 46.4 t -112.57 -61.68 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.595 1.558 . . . . 0.0 111.659 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 32.1 p -105.38 -6.86 19.2 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 61.94 11.07 3.94 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 127.693 2.397 . . . . 0.0 115.769 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -69.61 155.33 93.7 Favored Pre-proline 0 CA--C 1.554 1.118 0 O-C-N 121.22 -0.925 . . . . 0.0 111.861 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.85 116.95 4.91 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.703 2.935 . . . . 0.0 111.978 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 1.9 pp -65.31 147.91 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.452 1.101 . . . . 0.0 112.361 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -115.15 -62.8 1.55 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.201 1.8 . . . . 0.0 111.691 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.8 170.31 22.75 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.062 1.345 . . . . 0.0 113.431 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 7.3 mt -123.65 142.66 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 126.879 2.072 . . . . 0.0 109.038 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 9.4 m -138.27 150.14 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.788 1.235 . . . . 0.0 112.714 176.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 58.7 tp -69.85 99.9 1.46 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.003 1.321 . . . . 0.0 109.385 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 7.3 t -87.28 159.47 18.78 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -142.17 124.76 15.82 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.934 2.094 . . . . 0.0 111.212 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -84.28 -31.61 0.48 Allowed Pre-proline 0 CA--C 1.555 1.138 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 175.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 C--N 1.36 1.183 0 C-N-CA 122.995 2.464 . . . . 0.0 113.8 178.708 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 58.4 m . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 22.8 tp -143.2 138.23 15.47 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 126.586 1.954 . . . . 0.0 109.948 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -43.62 128.44 6.55 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 124.564 3.51 . . . . 0.0 114.009 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . 0.386 3.3 pp 54.42 -23.97 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.892 1 C-N-CA 132.152 4.181 . . . . 0.0 117.145 -174.734 . . . . . . . . 3 2 . 1 . 020 nuclear build full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -71.44 -17.6 62.37 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.912 2.085 . . . . 0.0 111.891 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -70.88 13.11 0.21 Allowed 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 127.648 2.379 . . . . 0.0 113.63 174.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 22.6 mm 72.11 78.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 129.071 2.948 . . . . 0.0 110.549 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -135.91 61.77 43.02 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 126.03 1.732 . . . . 0.0 110.315 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -64.61 -33.42 55.73 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.559 2.173 . . . . 0.0 116.002 -174.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 31.6 t -55.41 145.86 21.31 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 120.46 1.482 . . . . 0.0 111.645 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 15.8 m -134.85 -13.04 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.335 1.054 . . . . 0.0 113.251 177.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 24.1 mm -110.0 -43.98 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.91 1.284 . . . . 0.0 112.451 -177.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.1 m -79.89 -66.1 0.92 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -170.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -151.18 -14.31 0.21 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -174.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 84.75 12.41 74.86 Favored Glycine 0 CA--C 1.539 1.565 0 O-C-N 120.833 -1.167 . . . . 0.0 112.328 -174.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -61.52 155.11 61.17 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 127.883 2.473 . . . . 0.0 113.311 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.99 -6.38 7.76 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.32 3.347 . . . . 0.0 117.646 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -55.79 144.75 26.43 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.24 1.416 . . . . 0.0 111.161 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.12 141.11 51.58 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.545 1.938 . . . . 0.0 113.047 -176.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -163.43 82.57 0.12 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.853 1.692 . . . . 0.0 111.918 177.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 12.1 t -63.75 147.75 50.93 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.089 0.956 . . . . 0.0 110.899 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.4 mp -115.04 141.78 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 125.801 1.64 . . . . 0.0 109.376 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 80.7 t -123.35 137.21 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.489 1.116 . . . . 0.0 109.815 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -124.63 94.89 4.33 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.697 2.399 . . . . 0.0 108.044 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 60.86 -95.53 0.09 OUTLIER Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.327 1.442 . . . . 0.0 113.895 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -110.47 3.71 19.85 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.803 2.041 . . . . 0.0 113.359 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 22.1 p -126.52 170.12 12.34 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.167 1.787 . . . . 0.0 111.592 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.4 164.39 32.47 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 120.89 -1.131 . . . . 0.0 113.413 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -120.09 117.58 28.33 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.739 1.616 . . . . 0.0 111.869 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 7.3 tt -90.64 153.06 20.59 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.951 1.701 . . . . 0.0 110.863 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 3.4 tpt 86.19 64.95 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 128.274 2.63 . . . . 0.0 113.627 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -155.75 151.48 27.35 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.27 2.228 . . . . 0.0 108.987 175.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 14.1 p -89.21 175.0 7.54 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.834 0.826 . . . . 0.0 110.456 172.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.24 -38.58 91.74 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.342 -0.849 . . . . 0.0 110.972 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 38.1 m -67.66 -44.32 78.15 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 117.453 -1.26 . . . . 0.0 110.981 177.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 57.1 m -51.27 -60.22 3.36 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 120.288 1.404 . . . . 0.0 109.683 173.458 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -53.15 -40.5 64.34 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.197 1.799 . . . . 0.0 113.05 177.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -61.14 -31.37 71.09 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.467 1.107 . . . . 0.0 112.022 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -59.91 -51.03 71.42 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 120.106 1.321 . . . . 0.0 110.471 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -56.51 -45.07 81.25 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.088 0.955 . . . . 0.0 110.29 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -65.98 -51.94 53.96 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.632 1.173 . . . . 0.0 113.492 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -43.91 83.3 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.016 1.727 . . . . 0.0 111.673 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -79.21 -8.92 59.4 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.082 1.753 . . . . 0.0 112.962 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 48.02 47.13 19.1 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 128.058 2.543 . . . . 0.0 111.053 -175.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -87.2 123.5 69.89 Favored Pre-proline 0 N--CA 1.469 0.509 0 C-N-CA 124.711 1.205 . . . . 0.0 113.049 -174.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.47 90.69 1.1 Allowed 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 123.756 2.971 . . . . 0.0 109.599 175.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 33.7 t 18.85 113.95 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.141 1 C-N-CA 132.934 4.494 . . . . 0.0 118.115 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.98 -0.12 3.7 Favored 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 122.636 2.224 . . . . 0.0 113.759 176.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 35.2 t -110.12 -66.67 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.816 1.647 . . . . 0.0 111.616 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 28.3 p -95.68 -5.53 42.02 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 120.258 1.39 . . . . 0.0 114.604 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? 63.5 10.09 4.64 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.469 2.307 . . . . 0.0 115.172 178.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -74.81 153.66 87.06 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 124.503 1.121 . . . . 0.0 112.208 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -72.36 107.16 2.21 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.477 2.785 . . . . 0.0 111.384 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.0 pp -58.48 141.3 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.834 1.254 . . . . 0.0 111.107 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -115.09 -49.7 2.78 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -177.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.82 169.06 24.3 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -174.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 7.6 mt -131.94 139.57 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 128.496 2.719 . . . . 0.0 108.102 175.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 16.2 m -137.87 150.27 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.405 1.482 . . . . 0.0 111.615 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 60.4 tp -68.35 99.93 1.0 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.71 0.804 . . . . 0.0 108.939 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.67 90.72 3.59 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.985 1.314 . . . . 0.0 111.955 -173.045 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -59.8 124.48 20.3 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.349 1.46 . . . . 0.0 112.921 -179.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -68.74 159.05 83.92 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 124.609 1.164 . . . . 0.0 111.367 176.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo . . . . . 0 CA--C 1.538 0.702 0 C-N-CA 122.98 2.453 . . . . 0.0 112.412 179.184 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 43.2 m . . . . . 0 CA--C 1.54 0.587 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 49.0 tp -137.43 93.36 12.8 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.567 1.947 . . . . 0.0 110.579 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.43 -8.92 4.33 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.774 3.65 . . . . 0.0 117.455 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 38.3 tp -68.0 82.97 0.21 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.154 2.182 . . . . 0.0 112.618 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 18.3 m120 61.1 -12.51 0.05 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 129.228 3.011 . . . . 0.0 117.327 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -30.63 90.13 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 130.909 3.683 . . . . 0.0 116.101 -178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 4.4 mm 56.72 27.46 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 128.297 2.639 . . . . 0.0 113.285 177.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 23.72 76.37 0.24 Allowed Pre-proline 0 CA--C 1.555 1.159 0 C-N-CA 129.584 3.154 . . . . 0.0 115.227 178.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.25 174.83 7.53 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.923 3.082 . . . . 0.0 113.948 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 5.5 p -59.45 177.03 0.21 Allowed 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 115.961 1.838 . . . . 0.0 115.961 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 7.9 p -134.31 -9.19 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -172.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 6.9 mt -115.0 -62.56 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 119.937 1.244 . . . . 0.0 112.961 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 11.4 p -65.76 -59.31 4.03 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -174.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 18.1 tp60 -151.76 -18.27 0.19 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 -174.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 91.0 39.63 5.72 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -173.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -95.25 155.13 39.21 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 125.8 1.64 . . . . 0.0 112.787 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -48.31 126.68 14.17 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.686 2.924 . . . . 0.0 113.703 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -55.27 97.56 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 127.407 2.283 . . . . 0.0 114.635 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -128.05 89.86 2.99 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.041 1.336 . . . . 0.0 107.705 176.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 156.02 58.78 0.01 OUTLIER Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.687 1.137 . . . . 0.0 112.395 -177.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 44.3 t -57.1 115.47 2.66 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.906 1.283 . . . . 0.0 112.005 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 450' ' ' ILE . . . . . 0.431 HD12 ' H ' ' B' ' 450' ' ' ILE . 3.0 mp -88.73 122.4 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.736 1.614 . . . . 0.0 109.696 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 95.6 t -122.64 123.26 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.822 1.249 . . . . 0.0 110.483 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -108.02 101.59 10.83 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.099 2.56 . . . . 0.0 110.703 175.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.5 -88.25 0.35 Allowed Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.842 1.687 . . . . 0.0 113.759 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -129.49 6.95 5.27 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.335 1.854 . . . . 0.0 114.333 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 43.2 p -136.68 169.98 16.83 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.421 1.888 . . . . 0.0 110.367 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -161.44 169.85 37.05 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 120.618 -1.301 . . . . 0.0 114.527 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -120.21 99.94 6.89 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.992 1.717 . . . . 0.0 110.076 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.51 92.86 8.26 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 122.87 1.319 . . . . 0.0 110.709 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 28.1 ptm -156.39 1.45 0.14 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -176.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -143.84 174.67 10.62 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.085 1.354 . . . . 0.0 111.139 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 30.6 p -101.82 175.0 5.7 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 123.032 1.396 . . . . 0.0 113.734 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.02 -40.64 77.08 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.999 1.72 . . . . 0.0 112.535 -178.357 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 67.3 m -61.39 -53.56 55.0 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.089 0.956 . . . . 0.0 110.251 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 73.5 m -55.46 -49.12 73.32 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.387 1.075 . . . . 0.0 110.955 175.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.24 -54.91 37.47 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.708 1.203 . . . . 0.0 112.687 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -66.08 -33.83 76.68 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.025 -1.047 . . . . 0.0 112.73 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -59.75 -52.77 64.06 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.388 1.075 . . . . 0.0 110.379 176.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 22.6 mt -52.11 -51.22 59.15 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.7 1.2 . . . . 0.0 110.063 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -53.75 -49.02 69.1 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.948 1.299 . . . . 0.0 112.469 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -62.5 -40.57 97.14 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.075 1.35 . . . . 0.0 112.019 175.482 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 42.4 mmt180 -71.72 -6.35 40.62 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 126.401 1.88 . . . . 0.0 113.382 175.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 35.5 t30 83.87 4.14 0.81 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 130.928 3.691 . . . . 0.0 115.761 176.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -86.68 128.47 56.42 Favored Pre-proline 0 N--CA 1.475 0.775 0 CA-C-N 120.359 1.436 . . . . 0.0 109.799 176.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.16 -75.77 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.869 2.379 . . . . 0.0 111.701 178.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 41.6 t -109.26 133.3 20.83 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 126.554 1.942 . . . . 0.0 111.294 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.31 -5.39 16.14 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.337 2.691 . . . . 0.0 113.733 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 23.9 t -110.0 -76.99 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.472 1.109 . . . . 0.0 112.454 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 22.4 p -94.87 -4.99 45.97 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.862 1.665 . . . . 0.0 114.552 -176.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 65.2 13.43 8.74 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.487 2.315 . . . . 0.0 114.655 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -64.44 128.69 93.62 Favored Pre-proline 0 CA--C 1.552 1.035 0 O-C-N 121.34 -0.85 . . . . 0.0 110.793 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -49.19 113.72 1.02 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 124.536 3.49 . . . . 0.0 115.127 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.5 pp -71.7 142.58 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.776 1.231 . . . . 0.0 112.314 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -115.14 -34.87 4.88 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.733 1.613 . . . . 0.0 113.73 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 1.4 ttp -146.73 150.84 36.16 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 12.2 mt -139.07 130.81 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 128.363 2.665 . . . . 0.0 106.698 173.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 21.0 m -137.4 150.16 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 124.941 1.296 . . . . 0.0 113.573 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 5.7 tt -64.74 99.95 0.36 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.907 1.283 . . . . 0.0 109.019 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 45.6 m -95.35 113.32 24.98 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.527 1.531 . . . . 0.0 113.683 -173.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -75.46 100.85 4.62 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.07 1.348 . . . . 0.0 110.352 175.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -75.48 156.01 85.38 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 125.406 1.482 . . . . 0.0 111.585 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo . . . . . 0 C--N 1.351 0.695 0 C-N-CA 123.504 2.803 . . . . 0.0 111.566 -179.518 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo . . . . . 0 CA--C 1.545 1.049 0 N-CA-C 115.089 1.15 . . . . 0.0 115.089 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 7.6 t -51.33 156.87 1.09 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 128.317 2.647 . . . . 0.0 111.771 173.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 3.8 p -134.82 -2.4 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.847 0.859 . . . . 0.0 113.019 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 13.1 mt -131.11 -49.61 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.622 1.169 . . . . 0.0 112.591 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.7 m -65.99 -60.69 2.59 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.689 1.196 . . . . 0.0 113.957 -174.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -160.29 -9.21 0.05 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 85.57 16.36 64.15 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-N 119.963 1.256 . . . . 0.0 113.245 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -64.61 151.16 92.64 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 127.003 2.121 . . . . 0.0 112.982 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -54.48 -8.05 1.04 Allowed 'Trans proline' 0 CA--C 1.544 1.018 1 C-N-CA 125.526 4.151 . . . . 0.0 119.717 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -59.79 153.89 19.56 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 120.236 1.38 . . . . 0.0 112.459 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -128.12 150.2 50.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.887 2.475 . . . . 0.0 110.779 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -172.71 80.99 0.08 OUTLIER Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.665 1.126 . . . . 0.0 113.468 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 19.8 t -65.14 142.49 58.33 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.082 0.941 . . . . 0.0 110.245 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.88 142.47 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.854 1.662 . . . . 0.0 110.773 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 98.8 t -130.05 121.61 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.585 1.154 . . . . 0.0 111.303 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.3 125.43 43.51 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.949 2.9 . . . . 0.0 112.977 175.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 49.92 34.96 23.94 Favored Glycine 0 CA--C 1.54 1.618 0 N-CA-C 116.578 1.391 . . . . 0.0 116.578 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm 77.42 9.21 2.59 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 127.711 2.404 . . . . 0.0 114.351 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 78.5 p -118.58 161.7 19.62 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 127.405 2.282 . . . . 0.0 107.641 172.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -153.17 166.29 31.52 Favored Glycine 0 CA--C 1.523 0.571 0 O-C-N 119.891 -1.756 . . . . 0.0 115.668 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -120.12 128.49 53.5 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 126.499 1.92 . . . . 0.0 112.022 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 55.3 tp -120.59 153.23 37.08 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.432 2.293 . . . . 0.0 111.364 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 34.2 mtm 90.72 54.27 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 129.44 3.096 . . . . 0.0 112.804 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -155.73 163.88 39.31 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 128.316 2.646 . . . . 0.0 108.992 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 15.3 p -91.54 175.02 7.06 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 122.896 1.332 . . . . 0.0 112.828 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -65.15 -36.08 83.11 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.049 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 25.2 m -67.39 -46.32 73.61 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 117.143 -1.408 . . . . 0.0 110.547 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 37.9 m -48.28 -56.46 7.96 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.442 1.474 . . . . 0.0 109.89 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.53 -52.59 65.0 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.43 1.492 . . . . 0.0 112.578 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -56.79 -42.05 78.8 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.459 1.503 . . . . 0.0 112.243 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -59.31 -54.02 51.61 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.012 1.725 . . . . 0.0 110.375 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . 0.254 0.4 OUTLIER -68.09 -31.14 70.55 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 179.233 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -62.88 -56.54 16.36 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.667 1.987 . . . . 0.0 112.226 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -62.86 -33.49 75.38 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -76.42 -3.16 35.6 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.633 1.573 . . . . 0.0 112.179 173.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 64.2 t30 48.24 42.12 17.11 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 128.066 2.546 . . . . 0.0 112.599 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -70.52 129.64 89.91 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 124.611 1.164 . . . . 0.0 112.949 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.33 123.74 8.44 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.616 2.211 . . . . 0.0 108.117 170.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 25.3 t -31.14 129.52 0.27 Allowed Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 128.311 2.645 . . . . 0.0 114.289 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -65.58 -3.86 8.6 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.286 2.658 . . . . 0.0 114.74 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 43.6 t -126.09 -59.59 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.281 1.432 . . . . 0.0 111.259 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 63.8 m -76.0 -19.83 58.35 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.351 1.861 . . . . 0.0 113.137 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 63.5 9.14 3.98 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 127.217 2.207 . . . . 0.0 114.028 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -82.81 137.95 43.69 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 125.007 1.323 . . . . 0.0 112.213 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.85 119.35 6.15 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.149 2.566 . . . . 0.0 108.704 174.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 6.2 pt -66.95 147.08 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -174.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -115.16 -35.77 4.59 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 -174.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 1.4 ttp -145.9 151.37 37.75 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -171.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 4.4 mt -137.04 136.75 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 127.62 2.368 . . . . 0.0 109.08 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 15.7 m -140.04 150.02 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 124.704 1.202 . . . . 0.0 112.953 177.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 55.5 mt -69.94 99.95 1.5 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.213 1.005 . . . . 0.0 108.612 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 26.2 m -101.26 94.89 6.18 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.119 1.768 . . . . 0.0 112.464 -174.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -83.7 164.11 19.84 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.401 1.48 . . . . 0.0 113.353 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -120.42 164.19 24.32 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.546 1.538 . . . . 0.0 112.555 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo . . . . . 0 C--N 1.353 0.815 0 C-N-CA 124.482 3.454 . . . . 0.0 113.915 -179.879 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo . . . . . 0 CA--C 1.541 0.865 0 CA-C-O 121.095 0.373 . . . . 0.0 112.978 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 438' ' ' CYS . . . . . 0.403 ' SG ' ' N ' ' B' ' 439' ' ' VAL . 40.1 t -54.59 178.06 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 127.583 2.353 . . . . 0.0 113.22 175.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 439' ' ' VAL . . . . . 0.403 ' N ' ' SG ' ' B' ' 438' ' ' CYS . 7.4 p -111.76 -11.47 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.39 1.876 . . . . 0.0 112.343 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 7.3 mt -113.91 -66.76 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.739 1.215 . . . . 0.0 111.341 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 17.0 p -73.57 -43.73 59.09 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 120.519 1.509 . . . . 0.0 108.869 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 57.87 13.5 2.13 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.936 2.894 . . . . 0.0 113.903 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . -85.22 -27.41 33.56 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 121.576 -0.703 . . . . 0.0 112.459 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -115.5 155.12 47.62 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 126.941 2.096 . . . . 0.0 115.384 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -56.84 155.17 28.56 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.094 3.196 . . . . 0.0 113.238 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -65.47 32.03 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 127.761 2.424 . . . . 0.0 116.148 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -81.78 89.96 6.34 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.061 -1.649 . . . . 0.0 109.822 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 165.93 58.8 0.03 OUTLIER Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.36 0.981 . . . . 0.0 112.401 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 43.3 t -59.3 126.29 27.06 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.394 1.097 . . . . 0.0 109.99 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 2.4 mp -102.07 142.81 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.187 1.395 . . . . 0.0 110.418 -176.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 88.5 t -130.01 132.88 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.856 0.862 . . . . 0.0 111.241 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -121.18 96.21 5.0 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 128.519 2.728 . . . . 0.0 110.047 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 71.21 -91.48 0.46 Allowed Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.716 1.627 . . . . 0.0 114.057 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -120.25 -2.19 10.16 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.169 1.788 . . . . 0.0 113.916 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 82.3 p -127.77 167.87 15.91 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.468 1.907 . . . . 0.0 109.882 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -150.67 177.52 28.67 Favored Glycine 0 CA--C 1.527 0.806 0 O-C-N 121.054 -1.029 . . . . 0.0 114.324 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.11 148.22 43.89 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.138 1.375 . . . . 0.0 114.524 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.8 tt -116.12 153.16 32.26 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 130.188 3.395 . . . . 0.0 110.388 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 29.1 tpp 78.48 30.72 0.38 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 116.65 2.092 . . . . 0.0 116.65 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -136.08 149.89 48.91 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.6 1.56 . . . . 0.0 108.88 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 29.3 p -88.1 172.14 9.74 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.674 1.226 . . . . 0.0 113.918 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.17 -36.11 78.95 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.736 175.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 63.4 m -62.53 -63.5 1.21 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.143 0.977 . . . . 0.0 109.964 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 77.5 m -53.79 -42.98 68.9 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.815 1.246 . . . . 0.0 112.754 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -60.67 -48.26 82.57 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.31 -0.869 . . . . 0.0 112.046 173.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -59.75 -43.22 94.37 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 120.771 -1.206 . . . . 0.0 111.205 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -57.79 -54.96 40.94 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.222 1.009 . . . . 0.0 111.09 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.32 -30.39 71.53 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -67.44 -48.14 68.1 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.337 1.455 . . . . 0.0 112.359 175.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -59.01 -37.49 77.04 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.381 1.072 . . . . 0.0 111.56 176.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 39.4 tpt85 -76.21 -10.54 59.49 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.872 2.469 . . . . 0.0 112.393 174.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 64.1 t30 52.76 42.62 31.83 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.323 2.249 . . . . 0.0 111.919 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 34.2 tttp -70.01 129.04 91.24 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.644 1.178 . . . . 0.0 113.401 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.61 124.44 8.82 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 122.638 2.225 . . . . 0.0 107.579 169.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 40.2 t -30.72 128.36 0.27 Allowed Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 128.294 2.638 . . . . 0.0 114.734 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -66.53 -3.04 8.35 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.172 2.581 . . . . 0.0 114.585 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 41.8 t -127.68 -58.49 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.172 1.389 . . . . 0.0 111.619 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 60.6 m -77.31 -17.57 58.2 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.43 1.892 . . . . 0.0 112.679 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 44.6 mtm105 62.76 7.85 2.75 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.527 2.331 . . . . 0.0 114.368 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -86.38 143.03 35.93 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 123.829 0.851 . . . . 0.0 112.914 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.38 126.46 10.38 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.359 2.706 . . . . 0.0 110.218 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 7.3 pt -72.19 153.8 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -115.05 -41.84 3.28 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.515 1.526 . . . . 0.0 114.019 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.98 167.16 30.09 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -174.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 7.9 mt -134.33 137.38 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 128.097 2.559 . . . . 0.0 107.728 177.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 3.7 t -127.01 147.78 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.627 1.171 . . . . 0.0 112.539 -178.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.52 106.86 2.28 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.565 1.546 . . . . 0.0 107.545 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 50.1 m -103.63 126.0 50.49 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.22 1.408 . . . . 0.0 114.214 -171.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -123.63 178.79 5.04 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.364 2.266 . . . . 0.0 111.823 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -127.79 163.48 42.9 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.509 1.524 . . . . 0.0 112.579 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo . . . . . 0 C--N 1.353 0.802 0 C-N-CA 123.931 3.088 . . . . 0.0 114.085 -179.175 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . 0.252 45.8 Cg_exo . . . . . 0 CA--C 1.552 1.382 0 N-CA-C 116.525 1.702 . . . . 0.0 116.525 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 14.1 t -65.32 151.5 46.08 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 121.508 1.958 . . . . 0.0 109.343 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 13.2 m -132.59 -3.23 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 6.6 mt -133.26 -46.34 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 119.4 1.0 . . . . 0.0 112.852 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.5 m -67.55 -60.05 2.87 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -173.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -153.89 -14.04 0.14 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -176.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 83.94 7.15 85.96 Favored Glycine 0 CA--C 1.539 1.532 0 O-C-N 120.948 -1.095 . . . . 0.0 112.453 -173.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -55.01 155.04 8.98 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 129.07 2.948 . . . . 0.0 113.255 178.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.31 -10.25 4.51 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 125.186 3.924 . . . . 0.0 118.795 -178.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -59.37 139.17 57.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.481 1.512 . . . . 0.0 112.8 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.2 150.04 50.19 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.27 1.828 . . . . 0.0 111.106 175.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -156.34 91.6 0.12 Allowed Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.667 1.603 . . . . 0.0 111.867 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 48.3 t -64.82 133.69 52.48 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.563 0.745 . . . . 0.0 110.89 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.16 144.73 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.424 1.889 . . . . 0.0 110.896 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 74.3 t -129.99 134.62 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.356 1.062 . . . . 0.0 111.198 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -125.07 94.96 4.32 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.497 2.319 . . . . 0.0 111.281 175.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 65.95 -93.32 0.18 Allowed Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.959 1.742 . . . . 0.0 114.709 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -111.0 -2.35 15.98 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.28 1.832 . . . . 0.0 114.362 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 6.5 p -130.65 170.0 14.88 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.229 2.212 . . . . 0.0 110.82 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -157.1 170.83 34.41 Favored Glycine 0 CA--C 1.533 1.176 0 O-C-N 120.902 -1.124 . . . . 0.0 113.854 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -120.08 140.04 51.64 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.432 1.893 . . . . 0.0 111.799 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 36.3 tp -134.67 153.26 52.07 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 127.553 2.341 . . . . 0.0 111.061 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 80.0 mtp 75.46 56.89 0.06 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 127.311 2.244 . . . . 0.0 112.054 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -151.53 148.52 28.12 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 129.391 3.076 . . . . 0.0 107.102 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 6.2 p -80.55 173.77 12.27 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 122.773 1.273 . . . . 0.0 112.321 177.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.38 -39.88 94.72 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.406 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 32.4 m -68.65 -44.52 73.98 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 116.505 -1.712 . . . . 0.0 110.918 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 53.8 m -46.64 -56.97 5.26 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 121.403 1.91 . . . . 0.0 110.926 175.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.72 -51.1 71.38 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.27 1.428 . . . . 0.0 112.778 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -58.77 -41.17 85.96 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.153 0.981 . . . . 0.0 112.667 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.37 -53.61 54.45 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.55 2.34 . . . . 0.0 110.768 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 15.0 mt -51.37 -54.42 26.66 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.658 1.183 . . . . 0.0 109.898 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -55.34 -48.03 74.8 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.486 1.114 . . . . 0.0 112.626 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -59.14 -40.99 87.21 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.555 1.542 . . . . 0.0 111.706 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -77.1 7.38 5.07 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 127.427 2.291 . . . . 0.0 113.569 175.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 75.76 0.85 3.45 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 130.387 3.475 . . . . 0.0 116.302 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -82.54 121.13 77.93 Favored Pre-proline 0 N--CA 1.473 0.702 0 CA-C-N 120.541 1.519 . . . . 0.0 109.555 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.51 -67.37 0.03 OUTLIER 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.149 2.566 . . . . 0.0 110.325 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 15.6 t -121.53 131.42 24.45 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 127.203 2.201 . . . . 0.0 110.346 176.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.72 -5.44 16.0 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.522 2.815 . . . . 0.0 114.589 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 36.7 t -131.46 -59.21 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 120.358 1.435 . . . . 0.0 113.414 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 21.6 m -71.56 -29.25 64.52 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.821 1.648 . . . . 0.0 110.613 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 64.89 7.49 3.99 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 128.172 2.589 . . . . 0.0 113.071 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -68.35 143.27 95.44 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 124.436 1.094 . . . . 0.0 110.765 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.05 110.08 2.53 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.563 2.842 . . . . 0.0 113.556 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 11.3 pt -66.06 153.58 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.496 0.665 . . . . 0.0 112.356 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -109.73 -47.53 3.34 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.071 1.348 . . . . 0.0 112.166 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.31 170.13 23.17 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.081 1.352 . . . . 0.0 112.676 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 13.0 mt -123.65 136.5 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 127.443 2.297 . . . . 0.0 106.435 175.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 14.3 m -131.89 150.11 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.68 99.92 2.21 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 6.3 t -87.71 150.12 23.81 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.887 -0.508 . . . . 0.0 111.606 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -139.28 156.84 46.78 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.638 1.575 . . . . 0.0 111.905 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -71.47 148.49 93.25 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.535 1.134 . . . . 0.0 113.002 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo . . . . . 0 CA--C 1.539 0.744 0 C-N-CA 123.75 2.967 . . . . 0.0 112.385 179.483 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo . . . . . 0 CA--C 1.545 1.025 0 N-CA-C 114.644 0.979 . . . . 0.0 114.644 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 2.2 p -63.02 -174.52 0.07 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.242 1.817 . . . . 0.0 114.865 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 5.6 p -138.65 -9.41 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 3.9 mt -119.59 -58.83 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 120.574 1.534 . . . . 0.0 112.996 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 13.7 p -67.82 -68.46 0.38 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -174.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -137.2 -13.54 1.58 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -169.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 77.53 35.38 36.93 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -172.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -86.52 151.2 52.82 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 124.557 1.143 . . . . 0.0 113.822 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -76.18 66.4 7.01 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 124.513 3.475 . . . . 0.0 113.543 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -131.98 165.58 23.62 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.65 1.98 . . . . 0.0 112.506 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -128.18 149.94 50.22 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 128.499 2.72 . . . . 0.0 111.791 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 168.01 75.95 0.04 OUTLIER Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.913 1.72 . . . . 0.0 112.303 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 35.7 t -62.61 141.27 58.57 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.759 0.779 . . . . 0.0 111.161 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 2.5 mp -105.07 139.12 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 C-N-CA 126.106 1.763 . . . . 0.0 109.654 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 88.9 t -130.0 131.7 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.197 0.999 . . . . 0.0 108.885 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.03 99.46 6.13 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.644 2.378 . . . . 0.0 110.516 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 65.33 -96.55 0.24 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 126.172 1.844 . . . . 0.0 113.792 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 38.6 mtmm -110.34 1.07 18.25 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.066 1.746 . . . . 0.0 113.693 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 44.7 p -130.1 170.05 14.53 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.434 1.494 . . . . 0.0 112.012 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -154.25 170.42 32.75 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 121.246 -0.909 . . . . 0.0 114.037 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -120.22 112.7 19.39 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.295 1.838 . . . . 0.0 111.667 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -88.94 153.18 21.24 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 22.6 mmt 64.65 67.37 0.56 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.591 2.357 . . . . 0.0 114.54 175.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -148.97 157.87 43.75 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 129.253 3.021 . . . . 0.0 107.822 174.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 22.0 p -90.79 174.98 7.17 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 123.048 1.404 . . . . 0.0 114.13 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.44 -31.8 72.78 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.58 176.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 44.8 m -66.7 -50.25 63.44 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.64 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 36.3 m -47.87 -63.98 0.91 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.15 1.38 . . . . 0.0 109.868 174.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -52.74 -47.16 67.58 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.305 1.842 . . . . 0.0 113.654 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -60.68 -36.88 79.86 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.956 -1.09 . . . . 0.0 112.281 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -55.41 -48.16 74.81 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.607 1.163 . . . . 0.0 110.951 175.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 6.5 mp -62.63 -47.72 82.5 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.55 0.74 . . . . 0.0 110.001 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -57.09 -42.48 80.83 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -55.02 -28.36 51.48 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -119.59 8.84 11.33 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.856 2.062 . . . . 0.0 113.019 177.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 60.1 t30 42.29 56.39 3.69 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 127.252 2.221 . . . . 0.0 112.075 -174.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -70.0 133.04 88.14 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -174.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.95 115.16 4.14 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.52 2.147 . . . . 0.0 107.633 169.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 51.9 t -22.45 125.33 0.11 Allowed Pre-proline 0 CA--C 1.558 1.276 0 C-N-CA 130.146 3.378 . . . . 0.0 116.236 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -66.61 -3.94 10.06 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.139 2.56 . . . . 0.0 114.235 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 45.0 t -110.26 -64.02 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.327 1.451 . . . . 0.0 111.488 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 25.0 p -105.24 1.23 27.94 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 63.36 11.07 5.2 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 127.73 2.412 . . . . 0.0 115.945 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -75.35 144.92 78.97 Favored Pre-proline 0 CA--C 1.55 0.976 0 O-C-N 121.391 -0.818 . . . . 0.0 111.916 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.15 116.18 4.56 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.438 2.759 . . . . 0.0 111.461 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.5 pp -55.16 142.79 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.825 1.25 . . . . 0.0 111.929 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -115.04 -45.56 2.95 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.107 0.963 . . . . 0.0 113.361 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.28 166.98 30.11 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -177.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 4.0 mt -139.39 133.99 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 128.203 2.601 . . . . 0.0 107.943 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 27.8 m -140.02 150.24 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.76 1.224 . . . . 0.0 111.986 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 56.8 mt -66.91 99.82 0.67 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 42.1 m -99.79 136.0 40.37 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.624 1.17 . . . . 0.0 112.227 -173.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -128.57 160.77 31.34 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.521 1.128 . . . . 0.0 112.619 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -145.86 155.99 51.8 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.919 1.688 . . . . 0.0 111.749 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 CA--C 1.537 0.631 0 C-N-CA 123.533 2.822 . . . . 0.0 112.428 179.168 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo . . . . . 0 CA--C 1.543 0.947 0 CA-C-O 117.745 -1.023 . . . . 0.0 112.781 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 8.0 t -58.74 147.66 32.33 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 120.531 1.514 . . . . 0.0 109.594 172.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 15.9 m -130.92 -1.15 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 10.0 mt -132.12 -47.33 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.23 1.012 . . . . 0.0 112.237 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.8 m -68.93 -62.69 1.27 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -173.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -155.44 -12.02 0.11 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -174.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 81.53 7.89 87.66 Favored Glycine 0 CA--C 1.542 1.772 0 O-C-N 120.47 -1.394 . . . . 0.0 112.424 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -59.09 152.45 51.27 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 129.669 3.187 . . . . 0.0 113.256 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -74.91 73.12 4.37 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 124.329 3.353 . . . . 0.0 113.886 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -128.91 144.12 51.09 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 127.15 2.18 . . . . 0.0 110.411 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.26 116.16 19.42 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -173.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -138.59 83.2 0.25 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.441 1.496 . . . . 0.0 111.663 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 16.4 t -66.12 140.21 58.2 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.077 0.939 . . . . 0.0 112.309 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.3 mp -115.1 141.2 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 126.832 2.053 . . . . 0.0 110.441 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 67.4 t -126.49 134.02 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.627 1.171 . . . . 0.0 111.134 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -118.78 98.04 6.02 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.451 2.7 . . . . 0.0 110.651 175.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 73.55 -87.42 0.62 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.849 1.69 . . . . 0.0 114.068 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -129.85 1.92 4.87 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.265 1.826 . . . . 0.0 113.431 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 72.8 p -131.2 170.06 15.08 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.204 2.202 . . . . 0.0 109.197 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -152.56 174.6 31.4 Favored Glycine 0 N--CA 1.466 0.69 0 O-C-N 120.541 -1.349 . . . . 0.0 113.273 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -120.09 105.84 11.39 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.368 1.067 . . . . 0.0 111.788 177.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 15.2 tp -81.67 153.18 26.75 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.011 2.524 . . . . 0.0 110.211 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 48.7 mtt 85.54 66.35 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 128.008 2.523 . . . . 0.0 111.976 178.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -158.86 145.09 16.85 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 127.719 2.408 . . . . 0.0 108.537 175.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 19.9 p -83.78 173.69 11.08 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 122.28 1.038 . . . . 0.0 110.746 174.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -64.72 -37.44 87.59 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.502 -0.749 . . . . 0.0 111.191 178.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 27.8 m -65.15 -49.03 71.44 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 117.132 -1.413 . . . . 0.0 110.661 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 32.9 m -48.06 -55.77 9.37 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 120.555 1.525 . . . . 0.0 110.57 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.55 92.4 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.846 1.258 . . . . 0.0 113.002 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -61.52 -43.32 99.08 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.817 -1.177 . . . . 0.0 111.586 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -62.52 -54.03 45.93 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.996 1.318 . . . . 0.0 111.514 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 2.5 pp -60.49 -37.72 81.98 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.644 0.656 . . . . 0.0 111.25 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -59.95 -52.11 66.79 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.186 1.395 . . . . 0.0 111.378 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -58.68 -35.99 73.48 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.246 1.418 . . . . 0.0 112.684 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -78.5 2.93 17.42 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.534 1.934 . . . . 0.0 113.402 175.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 28.5 m120 64.13 19.18 11.66 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 128.713 2.805 . . . . 0.0 114.62 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -72.72 135.81 80.77 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.693 1.197 . . . . 0.0 109.383 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.8 -85.57 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.037 2.491 . . . . 0.0 109.804 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 36.1 t -118.45 132.76 23.67 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.921 1.688 . . . . 0.0 110.874 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.63 -6.86 20.02 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.397 2.731 . . . . 0.0 114.119 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 40.6 t -116.36 -72.3 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 119.732 1.151 . . . . 0.0 112.752 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 25.8 p -96.25 1.31 51.99 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 86.4 mmt-85 65.54 6.67 3.9 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 128.01 2.524 . . . . 0.0 115.665 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -62.16 140.98 96.09 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-N 119.593 1.088 . . . . 0.0 111.686 177.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -69.45 112.17 2.95 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.385 2.723 . . . . 0.0 113.725 -176.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 22.8 pt -73.73 160.14 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.709 1.603 . . . . 0.0 113.39 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -112.55 -48.13 3.03 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.48 1.512 . . . . 0.0 113.19 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.14 170.3 22.28 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -175.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 8.1 mt -117.2 135.38 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 126.523 1.929 . . . . 0.0 107.821 173.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 37.3 t -129.48 147.9 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.979 1.312 . . . . 0.0 110.334 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 487' ' ' LEU . . . . . 0.443 HD13 ' H ' ' A' ' 487' ' ' LEU 0.271 0.0 OUTLIER -81.59 116.79 21.51 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.298 1.047 . . . . 0.0 108.348 177.031 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 6.5 m -115.84 99.04 7.01 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.271 -1.331 . . . . 0.0 114.134 -169.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -68.78 171.2 8.17 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.044 1.738 . . . . 0.0 112.937 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -134.33 164.04 46.86 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.81 1.644 . . . . 0.0 111.121 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo . . . . . 0 C--N 1.353 0.774 0 C-N-CA 124.341 3.361 . . . . 0.0 113.855 179.551 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo . . . . . 0 CA--C 1.536 0.596 0 N-CA-C 115.5 1.308 . . . . 0.0 115.5 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 14.6 t -55.22 145.95 20.15 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 120.546 1.521 . . . . 0.0 111.333 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 29.8 m -132.22 0.1 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.93 1.692 . . . . 0.0 113.615 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 1.7 mt -134.69 -48.37 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 116.932 -1.509 . . . . 0.0 114.731 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 25.2 p -77.68 -60.53 2.33 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 121.457 1.935 . . . . 0.0 115.16 -173.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -139.86 -8.32 1.22 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 74.63 17.63 79.97 Favored Glycine 0 CA--C 1.541 1.672 0 CA-C-N 119.818 1.19 . . . . 0.0 111.356 -173.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -61.23 155.15 58.36 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 127.541 2.337 . . . . 0.0 113.858 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.8 -1.32 9.15 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.363 3.375 . . . . 0.0 116.141 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -60.17 156.77 14.52 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.941 1.696 . . . . 0.0 112.672 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -128.09 150.14 50.09 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.848 2.059 . . . . 0.0 110.489 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -163.87 67.76 0.22 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.258 1.409 . . . . 0.0 112.417 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 45.0 t -57.47 128.22 35.92 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.732 1.213 . . . . 0.0 110.176 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.98 144.06 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.06 1.344 . . . . 0.0 110.189 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 88.8 t -129.28 126.64 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.767 1.227 . . . . 0.0 109.697 176.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.18 122.52 37.29 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 128.813 2.845 . . . . 0.0 112.647 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 64.1 -77.54 0.05 OUTLIER Glycine 0 CA--C 1.539 1.552 0 C-N-CA 126.207 1.861 . . . . 0.0 114.872 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -146.61 2.46 0.83 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 127.453 2.301 . . . . 0.0 113.212 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 71.5 p -131.72 170.12 15.24 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 127.575 2.35 . . . . 0.0 110.54 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -144.58 171.93 25.73 Favored Glycine 0 N--CA 1.47 0.93 0 O-C-N 120.479 -1.388 . . . . 0.0 115.248 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.25 135.2 55.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.424 1.889 . . . . 0.0 113.223 175.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 4.0 pp -119.77 153.33 35.85 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.662 2.385 . . . . 0.0 110.942 174.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 11.5 tpt 94.65 53.87 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 129.304 3.042 . . . . 0.0 111.689 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -159.93 150.17 18.61 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.763 2.425 . . . . 0.0 108.4 175.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 31.2 p -90.03 174.29 7.73 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 122.377 1.084 . . . . 0.0 111.591 175.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.43 -37.93 88.38 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.634 -0.667 . . . . 0.0 110.991 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 43.7 m -60.25 -54.37 46.52 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 117.616 -1.183 . . . . 0.0 110.48 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 59.5 m -51.79 -61.98 1.91 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.923 1.238 . . . . 0.0 111.002 175.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -47.17 -52.37 15.79 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.037 -1.04 . . . . 0.0 112.578 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -62.21 -37.94 87.25 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.466 1.106 . . . . 0.0 112.965 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -60.47 -50.65 72.74 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.482 1.513 . . . . 0.0 110.625 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -58.25 -46.23 86.33 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.849 0.459 . . . . 0.0 110.242 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -55.99 -46.57 78.66 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.297 1.039 . . . . 0.0 112.276 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -62.05 -39.1 91.21 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.624 1.569 . . . . 0.0 111.506 174.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -79.7 16.47 1.11 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 128.066 2.546 . . . . 0.0 113.196 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . 0.303 0.2 OUTLIER 59.8 8.13 1.28 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 130.667 3.587 . . . . 0.0 117.849 179.802 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -84.59 127.41 65.65 Favored Pre-proline 0 N--CA 1.474 0.731 0 CA-C-N 120.045 1.293 . . . . 0.0 108.158 173.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.33 -81.8 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 123.069 2.513 . . . . 0.0 112.263 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 41.3 t -81.95 131.87 55.71 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 124.425 1.09 . . . . 0.0 110.887 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -70.32 -5.28 16.18 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.945 2.43 . . . . 0.0 114.487 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 28.9 t -119.68 -75.9 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.986 1.266 . . . . 0.0 113.084 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 23.7 p -91.91 -1.11 57.46 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 26.9 ttt-85 64.87 18.78 11.63 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 127.306 2.242 . . . . 0.0 115.107 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -65.98 156.09 85.02 Favored Pre-proline 0 CA--C 1.554 1.122 0 O-C-N 121.049 -1.032 . . . . 0.0 111.347 174.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.88 105.89 1.59 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.71 2.94 . . . . 0.0 113.522 -177.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.16 154.26 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.091 1.356 . . . . 0.0 113.512 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -115.2 -43.0 3.11 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.026 2.131 . . . . 0.0 111.687 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.91 167.55 27.79 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.977 1.311 . . . . 0.0 114.303 -176.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 18.6 mt -134.23 135.21 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 129.099 2.96 . . . . 0.0 105.919 173.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.48 150.14 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.428 1.091 . . . . 0.0 113.367 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.61 99.93 1.37 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.01 86.39 3.97 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.835 1.254 . . . . 0.0 112.704 -173.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -63.6 169.69 3.74 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.919 1.288 . . . . 0.0 111.88 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -130.51 167.28 21.75 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 125.167 1.387 . . . . 0.0 111.16 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo . . . . . 0 C--N 1.352 0.726 0 C-N-CA 124.068 3.178 . . . . 0.0 113.778 -179.786 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo . . . . . 0 CA--C 1.544 0.995 0 N-CA-C 115.303 1.232 . . . . 0.0 115.303 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 41.3 t -57.33 -167.91 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 130.408 3.483 . . . . 0.0 112.778 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 9.7 p -132.74 -12.86 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.135 1.774 . . . . 0.0 112.748 177.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 14.3 mm -93.3 -60.1 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.332 1.053 . . . . 0.0 108.566 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 26.5 p -87.55 -44.8 10.99 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.699 1.199 . . . . 0.0 109.768 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . 0.274 14.0 pt20 52.01 22.0 1.7 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 128.981 2.913 . . . . 0.0 114.777 -174.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -94.26 -24.66 18.56 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 112.213 -0.355 . . . . 0.0 112.213 176.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -115.42 155.08 47.57 Favored Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 125.979 1.712 . . . . 0.0 115.125 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -51.41 140.15 44.21 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.683 3.589 . . . . 0.0 114.54 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -67.6 28.14 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 127.564 2.345 . . . . 0.0 117.091 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -77.87 89.83 4.08 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.46 -1.4 . . . . 0.0 110.774 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 162.35 57.86 0.02 OUTLIER Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.065 -0.853 . . . . 0.0 113.523 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 78.3 m -63.14 142.91 58.2 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.687 1.243 . . . . 0.0 110.596 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.6 mp -115.06 144.53 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 126.033 1.733 . . . . 0.0 111.377 -172.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 67.0 t -127.24 131.48 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.72 1.208 . . . . 0.0 111.657 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -119.88 97.2 5.5 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.681 2.792 . . . . 0.0 110.786 174.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.72 -91.48 0.33 Allowed Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.906 1.717 . . . . 0.0 114.046 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -118.88 -0.27 11.24 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.297 1.839 . . . . 0.0 113.849 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 67.1 p -133.24 170.08 15.96 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.603 1.961 . . . . 0.0 110.337 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -153.53 171.61 32.36 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.911 1.243 . . . . 0.0 112.899 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -120.11 133.7 55.45 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.531 1.132 . . . . 0.0 113.275 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 25.7 tp -89.64 153.13 20.98 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 129.006 2.922 . . . . 0.0 113.882 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 459' ' ' MET . . . . . . . . . . . . 0.354 25.8 ptm 59.45 57.2 3.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 129.28 3.032 . . . . 0.0 118.535 172.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -136.76 147.9 46.94 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.259 1.824 . . . . 0.0 108.145 170.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 31.3 p -82.04 165.24 20.82 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 120.24 1.382 . . . . 0.0 112.874 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.32 -38.82 84.92 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.123 177.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 96.3 m -61.2 -59.42 5.34 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.693 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 54.6 m -53.93 -48.27 70.39 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.701 1.137 . . . . 0.0 112.4 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -56.36 -51.54 67.91 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.554 0.742 . . . . 0.0 112.613 175.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -62.78 -39.71 95.06 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.03 1.332 . . . . 0.0 112.437 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -61.85 -54.18 45.68 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.177 1.391 . . . . 0.0 110.457 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 27.2 mt -50.2 -53.05 30.72 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.426 1.091 . . . . 0.0 110.089 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -52.89 -51.12 62.33 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.871 1.268 . . . . 0.0 112.644 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -61.79 -38.9 89.8 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.345 1.458 . . . . 0.0 112.698 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -75.87 -1.67 26.44 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.782 2.033 . . . . 0.0 113.361 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 35.8 t30 77.88 7.27 2.66 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 130.111 3.365 . . . . 0.0 115.482 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -78.21 123.93 85.88 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 120.655 -1.278 . . . . 0.0 108.332 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.0 -76.45 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.58 2.853 . . . . 0.0 111.589 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 27.1 t -120.33 132.16 24.21 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.637 1.975 . . . . 0.0 110.114 178.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.12 -3.22 13.49 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.461 2.774 . . . . 0.0 113.428 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 39.2 t -113.44 -71.99 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.816 1.246 . . . . 0.0 112.272 -177.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 26.3 p -100.96 -2.61 31.36 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.44 1.496 . . . . 0.0 114.587 -176.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 65.89 8.67 5.51 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 128.067 2.547 . . . . 0.0 115.861 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -62.77 124.89 85.01 Favored Pre-proline 0 CA--C 1.553 1.092 0 CA-C-N 119.357 0.981 . . . . 0.0 111.287 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.38 114.49 1.46 Allowed 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.398 3.398 . . . . 0.0 114.882 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 16.4 pt -75.94 157.76 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.795 0.838 . . . . 0.0 113.233 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -115.1 -45.45 2.95 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.052 1.741 . . . . 0.0 112.749 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.68 170.09 22.82 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 13.9 mt -131.33 138.97 51.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 128.304 2.641 . . . . 0.0 107.37 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.22 150.04 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 CA-C-N 119.728 1.149 . . . . 0.0 113.843 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -62.78 99.92 0.18 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.518 1.927 . . . . 0.0 109.412 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 12.3 m -119.95 127.94 53.12 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.103 0.961 . . . . 0.0 112.242 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -118.93 161.73 19.7 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.183 1.393 . . . . 0.0 113.518 -176.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -74.92 163.61 67.05 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 125.333 1.453 . . . . 0.0 111.697 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo . . . . . 0 C--N 1.353 0.781 0 C-N-CA 123.925 3.083 . . . . 0.0 114.451 -178.565 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo . . . . . 0 CA--C 1.545 1.074 0 CA-C-O 116.771 -1.429 . . . . 0.0 114.705 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 32.7 t -55.99 142.92 34.14 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 121.502 1.956 . . . . 0.0 109.764 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.0 -0.36 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.399 1.079 . . . . 0.0 113.747 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 8.9 mt -132.94 -46.83 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.866 0.866 . . . . 0.0 112.299 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.3 m -72.13 -68.34 0.47 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -172.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -144.29 -10.45 0.65 Allowed 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -174.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 78.57 13.57 83.06 Favored Glycine 0 CA--C 1.542 1.766 0 CA-C-N 120.129 1.331 . . . . 0.0 112.668 -174.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -62.28 155.19 67.46 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 130.758 3.623 . . . . 0.0 113.952 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -67.71 -1.46 6.78 Favored 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 124.856 3.704 . . . . 0.0 116.211 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -60.93 135.14 57.7 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.007 1.723 . . . . 0.0 110.416 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.08 126.65 41.62 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.439 1.496 . . . . 0.0 113.31 -176.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -150.3 78.58 0.22 Allowed Glycine 0 CA--C 1.529 0.938 0 C-N-CA 125.405 1.479 . . . . 0.0 112.102 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 76.5 m -63.75 151.56 41.73 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 117.624 0.712 . . . . 0.0 110.987 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 4.6 mp -110.25 142.39 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 125.794 1.637 . . . . 0.0 111.216 -174.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 64.5 t -130.02 123.44 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.625 1.17 . . . . 0.0 108.234 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.24 106.24 9.72 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.843 2.057 . . . . 0.0 112.984 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 73.35 -83.75 0.64 Allowed Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.865 1.698 . . . . 0.0 114.746 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 454' ' ' LYS . . . . . 0.436 ' HA ' ' HE2' ' B' ' 454' ' ' LYS . 0.5 OUTLIER -127.57 -10.59 5.64 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.858 1.663 . . . . 0.0 114.021 -177.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 78.8 p -135.46 169.97 16.67 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.309 1.443 . . . . 0.0 111.078 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -144.32 168.8 26.56 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.192 0.901 . . . . 0.0 114.669 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -120.18 132.17 55.28 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.227 1.811 . . . . 0.0 112.649 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 4.4 pp -107.81 153.32 23.16 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.876 2.07 . . . . 0.0 111.872 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 44.0 ttm 86.19 69.16 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 128.531 2.732 . . . . 0.0 112.05 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -160.04 154.92 24.46 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 128.051 2.54 . . . . 0.0 108.538 176.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 14.3 p -90.05 174.99 7.34 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 122.354 1.073 . . . . 0.0 110.488 174.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -66.09 -31.72 72.76 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.425 -0.797 . . . . 0.0 111.616 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 40.8 m -72.25 -47.03 53.38 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 117.007 -1.473 . . . . 0.0 110.427 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 50.6 m -45.22 -57.6 3.85 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 120.306 1.412 . . . . 0.0 109.962 172.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.96 -49.89 76.16 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.234 1.814 . . . . 0.0 113.549 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -60.88 -37.5 82.41 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.091 1.356 . . . . 0.0 112.797 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -59.34 -52.15 66.88 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.966 1.306 . . . . 0.0 110.661 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 19.1 mt -57.33 -48.97 77.61 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.016 1.327 . . . . 0.0 109.978 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -56.21 -51.7 67.12 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.957 1.303 . . . . 0.0 113.244 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -52.26 -40.74 62.12 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.535 1.534 . . . . 0.0 113.426 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 32.3 ptt85 -97.45 5.99 48.88 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.684 1.594 . . . . 0.0 113.938 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 44.82 48.43 9.06 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.487 2.715 . . . . 0.0 112.332 -177.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -69.99 118.46 63.72 Favored Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 124.268 1.027 . . . . 0.0 111.896 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -62.58 123.33 12.18 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.294 1.996 . . . . 0.0 107.76 172.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 52.6 t -26.85 122.25 0.23 Allowed Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 128.72 2.808 . . . . 0.0 115.742 -173.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -65.5 -3.92 8.6 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 122.657 2.238 . . . . 0.0 113.931 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 33.9 t -107.47 -62.87 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.527 1.531 . . . . 0.0 111.347 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 26.6 p -110.09 0.97 18.58 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 63.55 11.32 5.57 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 127.84 2.456 . . . . 0.0 115.953 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -68.65 151.55 97.18 Favored Pre-proline 0 CA--C 1.551 1.01 0 O-C-N 121.373 -0.83 . . . . 0.0 111.534 176.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.84 111.26 2.98 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.594 2.863 . . . . 0.0 112.442 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.9 109.97 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 126.84 2.056 . . . . 0.0 109.982 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -107.3 -57.08 2.12 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -171.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.21 165.39 27.65 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -177.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 2.7 mt -134.96 141.41 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 127.399 2.28 . . . . 0.0 109.94 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.99 148.84 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.038 0.935 . . . . 0.0 111.826 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.0 99.8 0.91 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 17.3 m -109.23 86.87 2.37 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.221 1.008 . . . . 0.0 111.502 -174.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -77.18 159.32 29.81 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -176.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -74.12 156.28 87.77 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.617 1.567 . . . . 0.0 111.964 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo . . . . . 0 C--N 1.352 0.744 0 C-N-CA 124.156 3.237 . . . . 0.0 114.324 178.316 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 CA--C 1.542 0.909 0 N-CA-C 114.974 1.106 . . . . 0.0 114.974 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 8.4 t -58.44 178.38 0.1 Allowed 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 127.538 2.335 . . . . 0.0 114.25 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 33.6 m -134.83 -0.22 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 -173.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 6.8 mt -118.93 -56.58 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-N 121.106 1.775 . . . . 0.0 112.413 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 7.8 p -51.17 -84.85 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.116 2.166 . . . . 0.0 114.064 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -148.47 -15.8 0.33 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 131.516 3.926 . . . . 0.0 111.998 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 92.1 69.22 1.15 Allowed Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.082 1.325 . . . . 0.0 113.009 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -99.21 154.47 37.29 Favored Pre-proline 0 N--CA 1.48 1.026 0 C-N-CA 125.125 1.37 . . . . 0.0 110.888 175.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.71 125.05 15.83 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.648 2.899 . . . . 0.0 112.056 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.58 99.96 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -175.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -128.04 89.85 2.99 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.612 1.165 . . . . 0.0 107.912 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 151.96 58.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.845 0 C-N-CA 123.907 0.765 . . . . 0.0 112.459 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 35.7 t -59.57 138.31 57.75 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.34 1.07 . . . . 0.0 110.943 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.8 mp -114.96 140.62 35.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 C-N-CA 127.271 2.229 . . . . 0.0 110.772 -174.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 73.1 t -130.04 131.72 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.416 1.086 . . . . 0.0 111.641 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -111.42 100.96 9.45 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.755 2.422 . . . . 0.0 108.505 171.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 73.67 -85.0 0.65 Allowed Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.488 1.518 . . . . 0.0 112.939 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -137.08 4.86 2.75 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.338 1.855 . . . . 0.0 114.348 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 51.2 p -131.37 170.04 15.19 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.467 1.907 . . . . 0.0 110.248 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -160.08 175.56 36.87 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 120.804 -1.185 . . . . 0.0 114.561 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -120.03 100.02 6.96 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.083 1.753 . . . . 0.0 110.222 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 11.2 tp -76.69 92.75 3.56 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 128.212 2.605 . . . . 0.0 111.193 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -169.53 -27.41 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -103.35 164.06 11.88 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.085 1.311 . . . . 0.0 114.373 -174.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 32.0 p -85.92 168.34 14.29 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-O 122.123 0.963 . . . . 0.0 112.241 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.07 -42.35 90.16 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.224 -0.923 . . . . 0.0 111.678 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 86.9 m -54.98 -58.81 6.1 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.334 1.054 . . . . 0.0 109.628 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 84.0 m -57.51 -43.89 84.59 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.118 1.367 . . . . 0.0 112.629 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.71 -50.85 69.21 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.76 0.824 . . . . 0.0 111.775 174.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -65.49 -38.49 89.91 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.292 1.037 . . . . 0.0 112.089 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -60.57 -52.43 65.2 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.909 1.284 . . . . 0.0 110.845 177.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 19.6 mt -50.48 -49.81 54.37 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.764 1.226 . . . . 0.0 110.273 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 50.9 tttt -55.37 -51.64 66.15 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.942 1.297 . . . . 0.0 112.368 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -60.3 -42.47 95.57 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.555 1.542 . . . . 0.0 111.797 175.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -69.68 -3.96 17.49 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 127.372 2.269 . . . . 0.0 113.209 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 63.96 20.12 12.06 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 128.478 2.711 . . . . 0.0 114.291 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -70.05 127.7 92.16 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 173.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -64.18 -56.07 0.51 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.846 2.364 . . . . 0.0 112.057 -177.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 13.2 t -152.95 137.6 10.93 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 128.335 2.654 . . . . 0.0 108.412 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -70.08 -5.19 15.81 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.205 2.604 . . . . 0.0 114.179 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 24.7 t -120.16 -75.26 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 119.99 1.268 . . . . 0.0 113.197 -178.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 10.6 p -92.19 -1.57 57.06 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.978 1.711 . . . . 0.0 114.516 -176.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 61.54 24.74 14.79 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 127.635 2.374 . . . . 0.0 115.878 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -93.72 121.14 65.25 Favored Pre-proline 0 CA--C 1.558 1.279 0 CA-C-N 119.1 0.864 . . . . 0.0 109.912 174.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -42.87 112.09 0.25 Allowed 'Trans proline' 0 CA--C 1.547 1.139 1 C-N-CA 125.375 4.05 . . . . 0.0 119.727 -173.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 1.9 pp -70.59 128.69 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 126.466 1.906 . . . . 0.0 110.386 173.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -115.18 -16.59 11.54 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -174.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . 0.495 ' SD ' HG13 ' A' ' 486' ' ' VAL . 5.7 tmm? -145.87 147.67 32.04 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.299 0.954 . . . . 0.0 112.953 -173.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 13.5 mt -137.2 133.27 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 126.736 2.014 . . . . 0.0 109.763 174.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 486' ' ' VAL . . . . . 0.495 HG13 ' SD ' ' A' ' 484' ' ' MET . 3.4 m -119.24 150.16 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 125.709 1.604 . . . . 0.0 112.4 176.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.55 99.88 3.74 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 175.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 24.8 m -88.63 143.81 26.7 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -174.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -123.6 152.32 42.04 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.107 2.163 . . . . 0.0 110.507 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . 0.54 ' H ' ' CD ' ' A' ' 491' ' ' PRO . 56.2 p90 -138.39 -29.53 0.01 OUTLIER Pre-proline 0 CA--C 1.552 1.033 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 491' ' ' PRO . . . . . 0.54 ' CD ' ' H ' ' A' ' 490' ' ' PHE . 87.5 Cg_exo . . . . . 0 C--N 1.359 1.12 0 C-N-CA 123.255 2.636 . . . . 0.0 114.218 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo . . . . . 0 CA--C 1.556 1.62 0 N-CA-C 110.2 -0.731 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 11.4 t -47.72 148.03 1.68 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.67 1.588 . . . . 0.0 111.722 175.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 25.7 t -117.93 -11.25 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.611 1.565 . . . . 0.0 112.093 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 10.0 mt -128.62 -53.26 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -174.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 2.1 m -69.82 -68.97 0.38 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.594 1.958 . . . . 0.0 115.371 -171.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -144.82 -10.24 0.6 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -173.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.51 11.38 82.04 Favored Glycine 0 CA--C 1.542 1.764 0 CA-C-N 119.638 1.108 . . . . 0.0 112.603 -174.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -67.48 155.04 92.0 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 127.738 2.415 . . . . 0.0 111.957 177.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.61 142.45 13.74 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.729 2.952 . . . . 0.0 115.112 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -63.82 34.98 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 129.305 3.042 . . . . 0.0 116.164 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -81.35 89.77 6.12 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.491 -1.381 . . . . 0.0 108.139 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 170.51 48.37 0.04 OUTLIER Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.993 0.806 . . . . 0.0 112.846 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 48.4 t -55.32 133.52 49.59 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.106 1.362 . . . . 0.0 109.732 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 2.1 mp -104.53 150.18 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 126.001 1.72 . . . . 0.0 109.736 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 40.2 t -124.68 140.12 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 122.362 1.077 . . . . 0.0 110.652 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -125.22 94.92 4.3 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 128.355 2.662 . . . . 0.0 109.106 175.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 66.63 -84.18 0.11 Allowed Glycine 0 CA--C 1.538 1.51 0 C-N-CA 124.796 1.189 . . . . 0.0 113.333 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -130.4 0.93 4.56 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 128.057 2.543 . . . . 0.0 113.81 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 27.7 p -112.39 170.15 8.37 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.978 2.111 . . . . 0.0 109.735 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -154.17 167.49 32.33 Favored Glycine 0 CA--C 1.528 0.879 0 O-C-N 120.692 -1.255 . . . . 0.0 114.844 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -120.08 143.11 48.31 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.172 1.389 . . . . 0.0 113.11 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 9.9 tt -126.66 153.09 45.85 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 130.434 3.493 . . . . 0.0 108.985 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 9.5 ttt 100.22 19.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 128.796 2.838 . . . . 0.0 114.529 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -140.94 152.93 45.38 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.901 1.68 . . . . 0.0 110.368 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 13.1 p -82.2 174.51 11.11 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.619 1.2 . . . . 0.0 113.198 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.51 -46.31 86.97 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.406 177.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 49.0 m -65.86 -42.84 89.91 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 117.345 -1.312 . . . . 0.0 112.391 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 55.5 m -49.83 -55.36 14.49 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 120.382 1.447 . . . . 0.0 109.588 173.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -62.8 -40.75 98.31 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.622 1.569 . . . . 0.0 113.587 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -60.6 -44.02 96.75 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.554 1.542 . . . . 0.0 111.582 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -57.46 -58.37 8.6 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.108 1.363 . . . . 0.0 110.647 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.3 pp -64.03 -32.22 73.7 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -67.41 -47.39 70.41 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.906 1.682 . . . . 0.0 111.434 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -60.08 -38.7 83.66 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.234 1.014 . . . . 0.0 111.945 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -76.59 -6.41 51.83 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.7 1.6 . . . . 0.0 113.018 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 64.3 t30 52.7 39.31 28.27 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 128.135 2.574 . . . . 0.0 112.144 -177.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -73.92 132.3 80.35 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.328 1.451 . . . . 0.0 112.177 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -70.61 119.1 6.08 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.492 2.128 . . . . 0.0 107.612 170.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 42.9 t -20.75 125.7 0.08 OUTLIER Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 129.157 2.983 . . . . 0.0 116.44 -176.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -65.91 -1.8 5.67 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 122.845 2.363 . . . . 0.0 114.172 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 45.2 t -113.96 -69.51 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.671 1.588 . . . . 0.0 111.34 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 28.3 p -93.45 -7.57 44.08 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? 61.4 13.52 5.07 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 127.158 2.183 . . . . 0.0 114.67 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -74.1 159.19 84.52 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.418 1.087 . . . . 0.0 111.806 176.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -69.61 130.2 19.1 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.973 2.449 . . . . 0.0 112.087 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.59 110.4 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 126.161 1.784 . . . . 0.0 110.816 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -87.41 -61.14 1.79 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.542 1.137 . . . . 0.0 113.303 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.17 170.06 22.1 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.057 1.343 . . . . 0.0 113.922 -174.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 13.3 mt -133.03 140.69 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 127.714 2.405 . . . . 0.0 108.643 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 5.2 m -131.75 150.03 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 125.215 1.406 . . . . 0.0 112.956 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.51 99.93 3.14 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.78 95.8 6.05 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.306 1.442 . . . . 0.0 112.541 -173.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -68.55 161.71 27.33 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.306 1.442 . . . . 0.0 111.209 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -133.29 165.4 37.03 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 125.314 1.446 . . . . 0.0 111.59 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo . . . . . 0 C--N 1.352 0.752 0 C-N-CA 124.345 3.364 . . . . 0.0 114.124 -179.592 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo . . . . . 0 CA--C 1.544 1.01 0 N-CA-C 113.141 0.4 . . . . 0.0 113.141 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 8.0 p -68.47 -177.28 0.9 Allowed 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 16.8 m -139.09 -8.83 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 4.2 mt -110.74 -62.26 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 121.132 1.787 . . . . 0.0 112.539 -177.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 19.7 p -65.63 -64.32 0.89 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -176.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . 0.51 HE21 ' NH2' ' A' ' 444' ' ' ARG . 43.4 mt-30 -143.64 -13.19 0.67 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 116.981 2.215 . . . . 0.0 116.981 -173.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 81.94 28.07 43.25 Favored Glycine 0 CA--C 1.536 1.381 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -172.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . 0.51 ' NH2' HE21 ' A' ' 442' ' ' GLN . 12.8 ptp180 -72.84 155.07 90.97 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 125.142 1.377 . . . . 0.0 111.534 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -70.07 1.82 4.29 Favored 'Trans proline' 0 CA--C 1.548 1.214 0 C-N-CA 124.03 3.153 . . . . 0.0 116.135 -178.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -63.56 156.71 25.67 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 127.016 2.126 . . . . 0.0 112.827 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -128.05 150.23 50.03 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 129.193 2.997 . . . . 0.0 111.956 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 176.77 84.29 0.06 OUTLIER Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.3 1.428 . . . . 0.0 113.671 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 42.2 t -62.36 139.58 58.54 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.978 0.911 . . . . 0.0 111.526 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.6 mp -115.11 148.75 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.95 1.7 . . . . 0.0 111.043 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 93.9 t -130.0 131.71 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.316 1.047 . . . . 0.0 111.517 177.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -125.04 100.15 6.44 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 128.097 2.559 . . . . 0.0 112.397 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.69 -89.6 0.38 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.579 1.562 . . . . 0.0 114.25 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -120.6 -4.5 9.78 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.955 1.702 . . . . 0.0 113.797 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 47.4 p -131.7 170.0 15.39 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.945 1.698 . . . . 0.0 111.176 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -141.81 176.12 22.17 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.546 1.07 . . . . 0.0 115.159 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.11 144.64 47.52 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.106 2.162 . . . . 0.0 112.784 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 34.0 tp -135.13 153.17 52.09 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.407 2.683 . . . . 0.0 110.904 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 47.3 mtt 82.97 29.77 0.09 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 128.748 2.819 . . . . 0.0 113.528 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -134.01 139.91 46.35 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 127.107 2.163 . . . . 0.0 107.563 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 30.6 p -79.42 175.04 10.97 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 122.883 1.325 . . . . 0.0 113.52 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.52 -36.08 81.45 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.46 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 53.8 m -63.94 -53.12 55.27 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 117.372 -1.299 . . . . 0.0 110.508 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 28.8 m -48.98 -54.24 16.44 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 120.394 1.452 . . . . 0.0 111.052 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.97 -49.48 76.67 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.806 1.242 . . . . 0.0 112.949 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -62.59 -41.66 99.1 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.559 1.144 . . . . 0.0 111.443 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -61.18 -57.96 10.28 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.0 1.72 . . . . 0.0 111.159 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 1.7 pp -59.51 -37.01 77.19 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.046 0.384 . . . . 0.0 111.495 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -61.9 -52.15 65.25 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.263 1.425 . . . . 0.0 111.827 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -59.94 -34.89 73.85 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.927 1.291 . . . . 0.0 112.599 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -78.34 2.92 16.99 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.625 1.97 . . . . 0.0 113.424 175.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 28.2 m120 64.16 21.01 12.42 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 128.582 2.753 . . . . 0.0 114.991 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -70.47 134.02 86.81 Favored Pre-proline 0 CA--C 1.544 0.732 0 O-C-N 121.102 -0.999 . . . . 0.0 108.606 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.38 -56.28 0.3 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.264 1.976 . . . . 0.0 111.223 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 1.8 t -155.2 145.26 15.72 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 129.858 3.263 . . . . 0.0 109.008 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.99 -12.47 32.53 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.018 2.478 . . . . 0.0 114.849 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 15.3 t -140.23 -56.16 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 120.707 1.594 . . . . 0.0 114.297 -177.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 16.8 m -71.5 -22.42 61.79 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.107 2.163 . . . . 0.0 112.207 -177.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 79.2 mtm-85 63.3 11.81 5.71 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.894 2.478 . . . . 0.0 113.527 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -75.94 132.85 73.46 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.503 1.121 . . . . 0.0 109.02 174.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.02 110.11 1.66 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.69 2.26 . . . . 0.0 114.412 -176.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.0 pp -65.28 141.38 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.519 1.528 . . . . 0.0 111.836 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -114.98 -28.04 7.16 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.89 1.276 . . . . 0.0 114.24 -176.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -154.63 162.57 41.07 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.274 1.03 . . . . 0.0 113.699 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 6.8 mt -129.19 137.71 56.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 127.725 2.41 . . . . 0.0 107.219 176.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 12.2 p -134.27 150.03 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.792 1.237 . . . . 0.0 112.312 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -75.21 99.74 4.1 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.489 0.716 . . . . 0.0 109.07 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.1 m -112.3 105.6 13.94 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.797 0.839 . . . . 0.0 109.599 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -87.04 161.54 18.11 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.177 1.391 . . . . 0.0 113.959 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -72.08 161.32 79.47 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 126.876 2.07 . . . . 0.0 112.387 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo . . . . . 0 C--N 1.353 0.766 0 C-N-CA 124.563 3.508 . . . . 0.0 114.422 178.775 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 CA--C 1.543 0.938 0 CA-C-O 117.977 -0.926 . . . . 0.0 112.563 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 15.8 t -59.54 146.69 39.69 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.859 1.209 . . . . 0.0 109.295 173.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.98 -1.22 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.488 1.115 . . . . 0.0 113.723 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 4.1 mt -132.95 -45.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 119.431 1.014 . . . . 0.0 112.805 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 2.7 m -71.16 -60.55 2.17 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -152.17 -17.78 0.18 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -176.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 83.31 10.23 82.56 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-N 119.575 1.079 . . . . 0.0 112.439 -175.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -71.13 155.1 93.62 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 127.281 2.232 . . . . 0.0 113.237 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.96 7.7 0.04 OUTLIER 'Trans proline' 0 CA--C 1.553 1.449 1 C-N-CA 126.012 4.475 . . . . 0.0 120.103 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -61.47 151.28 33.18 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 120.652 1.569 . . . . 0.0 112.301 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -128.13 150.23 50.07 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.63 1.572 . . . . 0.0 112.336 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -167.88 79.9 0.1 Allowed Glycine 0 CA--C 1.531 1.083 0 C-N-CA 126.552 2.025 . . . . 0.0 111.523 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 49.1 t -68.04 135.36 52.16 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 117.719 0.76 . . . . 0.0 110.532 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.04 143.33 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.912 1.685 . . . . 0.0 111.855 -177.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 53.2 t -129.53 137.54 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.156 1.382 . . . . 0.0 110.681 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -124.0 104.07 8.68 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 129.6 3.16 . . . . 0.0 110.472 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.85 -87.42 0.29 Allowed Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.437 1.494 . . . . 0.0 113.62 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -131.22 5.04 4.43 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.47 1.908 . . . . 0.0 114.308 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 82.0 p -133.97 170.05 16.21 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.537 1.935 . . . . 0.0 110.693 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -159.08 174.44 36.03 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 120.781 -1.2 . . . . 0.0 113.309 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -120.29 144.51 47.77 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.528 1.131 . . . . 0.0 113.38 175.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 4.1 pp -110.78 153.22 25.66 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.333 1.853 . . . . 0.0 112.792 178.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 22.8 ttt 85.33 67.89 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 129.084 2.954 . . . . 0.0 113.116 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -158.1 152.18 24.15 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.122 2.569 . . . . 0.0 108.675 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 13.3 p -91.61 171.56 9.09 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 122.074 0.94 . . . . 0.0 111.74 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.57 -36.75 85.25 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.641 -0.662 . . . . 0.0 111.467 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 38.4 m -68.76 -50.02 53.95 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 116.528 -1.701 . . . . 0.0 109.976 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 19.2 m -46.19 -57.77 4.24 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 121.237 1.835 . . . . 0.0 110.943 174.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.84 -51.3 67.97 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.787 1.235 . . . . 0.0 112.599 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -62.78 -37.94 88.64 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.236 -0.915 . . . . 0.0 112.778 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -61.22 -51.21 69.94 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.215 1.806 . . . . 0.0 110.96 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 20.9 mt -54.94 -53.63 53.14 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.858 1.263 . . . . 0.0 109.67 175.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -52.94 -48.07 67.59 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.431 1.492 . . . . 0.0 112.644 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -61.45 -41.67 97.58 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.462 1.505 . . . . 0.0 112.204 175.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -70.82 -16.74 62.75 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.189 1.396 . . . . 0.0 113.613 176.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 35.3 t30 105.13 -3.99 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.89 1 C-N-CA 132.428 4.291 . . . . 0.0 115.047 175.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -80.7 123.7 82.35 Favored Pre-proline 0 N--CA 1.472 0.663 0 CA-C-N 120.784 1.629 . . . . 0.0 109.882 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.77 -69.08 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.823 2.349 . . . . 0.0 111.655 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 7.1 t -111.12 135.18 20.9 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 126.346 1.859 . . . . 0.0 111.727 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -79.88 -7.55 14.41 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.351 2.7 . . . . 0.0 114.261 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 29.1 t -102.93 -72.87 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 119.748 1.158 . . . . 0.0 112.085 -177.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 26.5 p -100.65 -3.58 30.07 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.048 1.739 . . . . 0.0 113.647 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . 0.338 15.5 ptp180 53.85 23.6 3.95 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 128.797 2.839 . . . . 0.0 116.026 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -65.51 146.76 98.94 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 123.361 0.664 . . . . 0.0 109.579 173.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.02 112.2 2.66 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.337 2.691 . . . . 0.0 113.714 -175.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.5 pp -71.63 160.04 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.879 1.672 . . . . 0.0 113.209 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -111.38 -54.06 2.64 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.471 1.908 . . . . 0.0 110.818 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.33 170.21 21.21 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.83 1.252 . . . . 0.0 113.425 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 14.7 mt -121.14 137.94 53.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 127.302 2.241 . . . . 0.0 106.76 174.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 10.8 m -134.43 149.94 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 52.8 mt -73.34 99.94 3.05 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.704 1.202 . . . . 0.0 108.358 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 33.5 m -116.65 112.63 21.53 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.607 1.563 . . . . 0.0 112.29 -175.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -100.7 171.06 7.93 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.775 1.63 . . . . 0.0 112.692 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -139.05 156.09 72.51 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.331 1.452 . . . . 0.0 111.751 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 C--N 1.35 0.654 0 C-N-CA 123.599 2.866 . . . . 0.0 111.495 -179.828 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo . . . . . 0 CA--C 1.536 0.618 0 N-CA-C 115.683 1.378 . . . . 0.0 115.683 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 8.0 t -54.55 148.0 13.15 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.264 1.026 . . . . 0.0 111.752 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.35 -3.37 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 121.173 -0.955 . . . . 0.0 113.317 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 7.3 mt -129.65 -48.15 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.871 0.869 . . . . 0.0 112.774 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.2 m -68.0 -62.81 1.23 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -156.87 -15.01 0.09 Allowed 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 88.29 8.33 71.6 Favored Glycine 0 CA--C 1.54 1.629 0 O-C-N 120.652 -1.28 . . . . 0.0 112.657 -174.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -59.67 151.45 62.22 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 128.718 2.807 . . . . 0.0 114.336 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.8 88.39 1.31 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.448 3.432 . . . . 0.0 113.258 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -136.96 161.79 35.06 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 127.375 2.27 . . . . 0.0 111.023 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -125.61 150.08 47.85 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.668 1.587 . . . . 0.0 109.972 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -179.93 80.43 0.06 OUTLIER Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.309 1.909 . . . . 0.0 111.498 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 50.5 t -66.29 133.39 50.48 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.877 0.871 . . . . 0.0 110.008 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.03 141.21 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.878 1.271 . . . . 0.0 110.766 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 92.3 t -130.01 133.96 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.426 1.091 . . . . 0.0 111.8 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -124.92 107.88 11.32 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 128.693 2.797 . . . . 0.0 110.204 174.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 66.29 -93.6 0.2 Allowed Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.993 1.759 . . . . 0.0 113.625 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -126.16 7.19 7.18 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.72 2.008 . . . . 0.0 113.611 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 79.7 p -130.52 170.12 14.66 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.656 1.982 . . . . 0.0 110.541 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.33 -178.4 30.44 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.816 -1.177 . . . . 0.0 115.345 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -120.07 136.51 54.55 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.038 2.135 . . . . 0.0 110.404 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 26.4 tp -121.38 152.97 38.42 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.615 1.966 . . . . 0.0 111.206 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 41.4 mtm 64.97 68.34 0.51 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 127.62 2.368 . . . . 0.0 113.018 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -151.96 148.16 27.42 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 129.163 2.985 . . . . 0.0 107.252 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 17.2 p -77.92 165.89 23.55 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 122.472 1.13 . . . . 0.0 111.828 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.7 -38.67 91.34 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.698 -0.626 . . . . 0.0 111.165 177.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 23.8 m -62.16 -48.8 78.48 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 116.911 -1.519 . . . . 0.0 111.133 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 16.6 m -49.24 -51.66 31.96 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 120.809 1.64 . . . . 0.0 111.386 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.19 -47.06 84.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.42 1.088 . . . . 0.0 112.835 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -65.88 -40.57 91.73 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 121.216 -0.927 . . . . 0.0 111.937 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -61.43 -56.83 15.83 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.624 1.97 . . . . 0.0 111.471 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 2.8 pp -59.98 -35.89 75.97 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 118.133 0.424 . . . . 0.0 111.317 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -63.48 -48.63 76.86 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.886 1.274 . . . . 0.0 110.853 175.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -58.64 -39.36 80.32 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.314 1.446 . . . . 0.0 111.409 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -74.12 3.79 6.53 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 127.163 2.185 . . . . 0.0 113.746 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 67.51 15.82 9.86 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 128.949 2.9 . . . . 0.0 115.227 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 5.7 tppp? -70.17 129.96 90.09 Favored Pre-proline 0 N--CA 1.475 0.802 0 O-C-N 120.832 -1.168 . . . . 0.0 109.106 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.33 -49.48 1.26 Allowed 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.847 2.365 . . . . 0.0 111.38 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 1.7 t -158.36 142.28 11.27 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 131.576 3.95 . . . . 0.0 107.995 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.76 -11.32 29.35 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.081 2.521 . . . . 0.0 115.026 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 17.1 t -137.75 -55.93 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 120.54 1.518 . . . . 0.0 113.739 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 22.4 m -69.88 -25.47 63.72 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.739 1.616 . . . . 0.0 111.432 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 33.5 mtp-105 61.38 13.78 5.24 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 127.911 2.484 . . . . 0.0 113.244 -175.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -76.73 130.85 75.14 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.227 1.411 . . . . 0.0 108.484 174.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -64.46 109.61 1.24 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.549 2.166 . . . . 0.0 113.679 -176.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.1 pp -63.21 137.78 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.683 1.593 . . . . 0.0 111.861 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -115.18 -20.8 10.26 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 2.6 ttp -150.95 146.68 26.42 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.13 0.972 . . . . 0.0 112.763 -174.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 7.6 mt -130.78 131.47 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 127.478 2.311 . . . . 0.0 107.763 174.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.39 150.09 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 119.487 1.039 . . . . 0.0 113.707 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.18 99.87 3.52 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 10.2 t -89.41 156.19 18.85 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.372 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -135.7 170.33 16.14 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.161 2.185 . . . . 0.0 111.374 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -133.56 156.57 79.48 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 124.887 1.275 . . . . 0.0 111.706 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo . . . . . 0 CA--C 1.538 0.692 0 C-N-CA 123.434 2.756 . . . . 0.0 112.369 179.753 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo . . . . . 0 CA--C 1.54 0.786 0 CA-C-O 117.635 -1.069 . . . . 0.0 114.696 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 42.2 t -56.13 143.91 31.31 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 120.182 1.355 . . . . 0.0 111.029 177.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 28.5 m -123.68 -15.13 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 10.5 pt -137.12 -26.41 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.5 m -75.9 -64.47 1.08 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 120.64 1.563 . . . . 0.0 112.137 -177.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -145.39 -12.81 0.52 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 76.73 11.88 84.97 Favored Glycine 0 CA--C 1.544 1.886 0 CA-C-N 119.992 1.269 . . . . 0.0 112.487 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -59.54 155.11 40.7 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 129.997 3.319 . . . . 0.0 113.618 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.65 -1.69 10.21 Favored 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 124.354 3.37 . . . . 0.0 115.463 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -52.65 146.8 9.55 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 127.042 2.137 . . . . 0.0 111.577 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -116.21 150.16 37.97 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.757 2.023 . . . . 0.0 110.735 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -159.68 68.12 0.26 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 128.169 2.795 . . . . 0.0 109.349 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 33.8 t -63.8 133.28 53.15 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.063 0.945 . . . . 0.0 110.429 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -114.57 143.21 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.35 1.06 . . . . 0.0 112.057 -175.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 89.6 t -129.08 136.84 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.926 1.29 . . . . 0.0 110.629 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -125.04 95.05 4.36 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 129.456 3.102 . . . . 0.0 110.096 176.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.96 -91.5 0.35 Allowed Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.809 1.671 . . . . 0.0 114.227 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -121.49 4.34 10.18 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 126.318 1.847 . . . . 0.0 114.338 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 66.4 p -134.77 170.09 16.37 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.249 2.22 . . . . 0.0 109.903 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -160.18 174.45 36.93 Favored Glycine 0 CA--C 1.529 0.921 0 O-C-N 120.658 -1.276 . . . . 0.0 113.766 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -120.26 141.99 49.46 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.906 1.282 . . . . 0.0 113.072 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.41 153.26 36.8 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.152 2.581 . . . . 0.0 110.526 177.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 49.5 mtt 93.17 62.96 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 129.826 3.25 . . . . 0.0 111.486 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -160.01 149.59 17.97 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 127.205 2.202 . . . . 0.0 109.489 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 19.4 p -88.3 174.93 7.89 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.851 0.834 . . . . 0.0 110.232 172.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -39.81 94.77 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.397 -0.814 . . . . 0.0 112.416 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 68.9 m -68.13 -48.06 66.42 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 116.105 -1.902 . . . . 0.0 110.606 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 16.6 m -45.61 -59.07 2.95 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 121.601 2.001 . . . . 0.0 111.263 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.88 -43.95 86.35 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.028 1.331 . . . . 0.0 114.062 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -68.92 -42.51 76.73 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.354 -0.841 . . . . 0.0 111.777 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -62.35 -53.91 48.19 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.006 2.122 . . . . 0.0 112.358 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.3 pp -57.54 -36.49 71.69 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.319 0.509 . . . . 0.0 111.197 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -66.68 -46.21 76.39 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.452 0.701 . . . . 0.0 111.767 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -59.23 -35.11 73.07 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.853 1.261 . . . . 0.0 111.704 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -76.3 3.77 10.21 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 127.322 2.249 . . . . 0.0 113.457 175.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 39.3 t30 76.38 8.49 3.28 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 130.013 3.325 . . . . 0.0 115.649 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -70.14 129.46 90.64 Favored Pre-proline 0 N--CA 1.475 0.818 0 O-C-N 120.755 -1.216 . . . . 0.0 109.242 175.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -69.76 -43.23 2.78 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.072 2.515 . . . . 0.0 114.695 -176.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.56 149.3 36.65 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 128.251 2.62 . . . . 0.0 110.313 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.24 -17.69 61.32 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.361 2.707 . . . . 0.0 115.369 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.09 -63.31 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 -172.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 28.8 p -89.16 -19.47 25.44 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -172.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . 0.259 3.9 ptm180 94.15 4.8 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 131.252 3.821 . . . . 0.0 116.182 174.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -67.67 111.99 9.12 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 125.08 1.352 . . . . 0.0 110.387 178.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -46.64 107.84 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 124.269 3.313 . . . . 0.0 116.099 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 pp -62.86 146.95 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.178 1.391 . . . . 0.0 113.45 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -112.1 -29.76 7.48 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.781 1.632 . . . . 0.0 114.187 -173.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.03 161.34 33.97 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.63 1.172 . . . . 0.0 113.468 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 14.1 mt -129.51 136.48 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 127.518 2.327 . . . . 0.0 108.231 175.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 16.9 m -137.61 150.16 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.726 1.21 . . . . 0.0 113.479 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.22 99.85 4.86 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 177.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 1.9 t -93.79 157.61 16.06 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -129.27 143.3 50.8 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.32 1.448 . . . . 0.0 112.403 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -73.39 164.53 60.37 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 125.137 1.375 . . . . 0.0 111.56 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo . . . . . 0 CA--C 1.539 0.726 0 C-N-CA 124.226 3.284 . . . . 0.0 114.272 179.718 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo . . . . . 0 CA--C 1.546 1.102 0 N-CA-C 114.447 0.903 . . . . 0.0 114.447 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 10.0 t -61.01 159.21 11.94 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 128.228 2.611 . . . . 0.0 111.029 171.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.71 -0.63 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.378 1.071 . . . . 0.0 113.442 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 10.4 mt -133.94 -48.86 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 119.735 1.152 . . . . 0.0 112.866 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.5 m -67.61 -60.16 2.77 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.439 1.496 . . . . 0.0 114.228 -173.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -151.53 -16.13 0.2 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -174.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.62 10.69 82.95 Favored Glycine 0 CA--C 1.542 1.755 0 O-C-N 120.812 -1.18 . . . . 0.0 113.173 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -61.96 155.04 65.46 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 128.39 2.676 . . . . 0.0 112.339 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -66.27 1.66 2.35 Favored 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.459 3.439 . . . . 0.0 117.3 -177.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -60.96 144.9 52.3 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.871 1.214 . . . . 0.0 110.62 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -128.19 150.07 50.17 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.68 1.992 . . . . 0.0 111.683 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -162.69 98.92 0.17 Allowed Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.742 1.639 . . . . 0.0 112.51 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 46.4 t -68.21 133.2 48.47 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.517 0.727 . . . . 0.0 110.638 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.2 mp -113.0 135.4 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.181 1.392 . . . . 0.0 110.463 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 45.4 t -130.04 130.32 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.422 1.089 . . . . 0.0 109.65 176.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.2 99.09 5.93 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.908 2.083 . . . . 0.0 112.206 178.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 75.9 -84.36 0.91 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.732 1.634 . . . . 0.0 114.711 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -124.99 -11.53 7.09 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.761 1.624 . . . . 0.0 114.3 -176.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 72.9 p -135.33 168.89 18.37 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.455 1.502 . . . . 0.0 110.573 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -142.96 178.44 21.24 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.35 0.976 . . . . 0.0 113.829 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -120.27 147.03 45.49 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.866 1.266 . . . . 0.0 113.839 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 12.2 tp -111.4 153.27 26.3 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 128.84 2.856 . . . . 0.0 113.551 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 16.7 mtt 69.47 59.74 0.31 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.68 2.392 . . . . 0.0 115.835 173.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -149.56 163.04 38.96 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.286 1.434 . . . . 0.0 111.046 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 11.6 p -87.25 174.49 8.56 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 122.393 1.092 . . . . 0.0 112.484 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -67.04 -40.15 87.13 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.72 -0.612 . . . . 0.0 111.197 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 27.8 m -64.73 -41.98 95.55 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 117.528 -1.225 . . . . 0.0 111.651 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 34.6 m -49.29 -63.61 1.05 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.242 1.417 . . . . 0.0 109.187 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -53.92 -45.17 71.11 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.021 1.728 . . . . 0.0 113.109 176.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -60.11 -37.26 79.47 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.756 1.222 . . . . 0.0 112.352 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -59.85 -49.34 78.1 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.446 1.099 . . . . 0.0 110.922 175.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 5.9 mp -58.75 -46.7 86.84 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 122.847 0.459 . . . . 0.0 109.882 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -57.39 -48.06 80.07 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.132 0.973 . . . . 0.0 112.906 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -56.83 -28.05 60.98 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.183 1.393 . . . . 0.0 113.911 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -107.45 -0.55 22.17 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.708 2.003 . . . . 0.0 112.979 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 60.3 t30 45.49 50.59 10.21 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.943 2.497 . . . . 0.0 111.319 -174.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -73.33 130.6 84.08 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.601 0.761 . . . . 0.0 112.876 -174.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -70.43 115.35 4.15 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.51 2.14 . . . . 0.0 107.568 170.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 53.8 t -23.07 123.35 0.15 Allowed Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 129.211 3.005 . . . . 0.0 115.682 -176.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -65.34 -3.62 7.87 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.127 2.551 . . . . 0.0 114.531 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 47.0 t -109.08 -65.5 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.346 1.458 . . . . 0.0 111.31 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 24.5 p -104.63 0.74 28.82 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 62.84 10.29 4.2 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 127.795 2.438 . . . . 0.0 115.898 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -68.68 149.28 97.99 Favored Pre-proline 0 CA--C 1.552 1.058 0 C-N-CA 123.87 0.868 . . . . 0.0 111.732 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.39 112.96 3.47 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.662 2.908 . . . . 0.0 112.009 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.92 109.97 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 126.547 1.939 . . . . 0.0 110.463 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -103.65 -55.79 2.33 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -172.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.31 161.87 37.18 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -177.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 4.6 mt -135.02 136.53 51.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 126.998 2.119 . . . . 0.0 108.847 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 16.9 m -133.21 150.01 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.935 0.894 . . . . 0.0 112.555 176.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 3.8 tt -82.53 99.75 9.69 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 5.1 t -90.87 162.66 14.7 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.157 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -131.68 148.44 52.59 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.451 1.5 . . . . 0.0 112.038 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -78.06 160.6 73.28 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 125.444 1.498 . . . . 0.0 110.969 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo . . . . . 0 C--N 1.351 0.683 0 C-N-CA 123.322 2.682 . . . . 0.0 111.784 -177.796 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 CA--C 1.537 0.659 0 N-CA-C 113.235 0.437 . . . . 0.0 113.235 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 1.9 p -67.85 175.54 2.98 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 34.8 m -135.94 -3.32 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -176.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 7.7 mt -114.77 -64.43 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 120.319 1.418 . . . . 0.0 112.588 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 21.5 p -68.85 -59.19 3.25 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -147.35 -17.8 0.39 Allowed 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.531 2.049 . . . . 0.0 116.531 -172.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 90.65 30.65 11.35 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.035 1.303 . . . . 0.0 110.778 -174.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 35.0 mtt-85 -62.65 149.38 89.09 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 124.929 1.292 . . . . 0.0 111.595 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.96 -10.49 29.01 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.448 2.765 . . . . 0.0 114.297 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -58.99 153.56 17.32 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 129.593 3.157 . . . . 0.0 113.002 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -128.2 150.16 50.14 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.319 2.248 . . . . 0.0 110.625 176.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -167.06 75.11 0.14 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 127.047 2.26 . . . . 0.0 110.291 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 33.1 t -59.89 122.4 14.17 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.643 0.777 . . . . 0.0 111.854 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 450' ' ' ILE . . . . . 0.423 HD12 ' H ' ' B' ' 450' ' ' ILE . 1.2 mp -95.66 134.09 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.966 1.306 . . . . 0.0 109.794 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 95.5 t -127.97 130.38 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.279 1.032 . . . . 0.0 111.353 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -115.06 94.92 4.95 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 128.597 2.759 . . . . 0.0 110.12 174.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.83 -94.92 0.31 Allowed Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.856 1.693 . . . . 0.0 114.372 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -111.97 -1.19 15.51 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.02 1.728 . . . . 0.0 113.648 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 70.1 p -132.28 170.01 15.66 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.655 1.582 . . . . 0.0 111.351 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -157.69 174.64 35.08 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 121.114 -0.991 . . . . 0.0 113.655 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -120.22 110.8 17.03 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.259 1.424 . . . . 0.0 111.411 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 9.8 tp -81.22 153.31 27.24 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.339 2.655 . . . . 0.0 113.033 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 23.7 mtt 79.58 57.99 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 127.786 2.435 . . . . 0.0 114.663 172.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -148.8 150.27 32.77 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.992 2.117 . . . . 0.0 108.319 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 31.7 p -86.47 175.0 8.6 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 122.649 1.214 . . . . 0.0 112.798 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.98 -33.78 76.87 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.2 174.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 37.4 m -63.86 -54.25 37.89 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 117.284 -1.341 . . . . 0.0 109.88 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 21.5 m -47.58 -59.71 3.06 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.126 1.33 . . . . 0.0 111.234 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.95 -48.02 76.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.679 1.192 . . . . 0.0 113.767 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -66.05 -41.72 90.48 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.209 -0.932 . . . . 0.0 111.722 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -63.39 -54.86 30.11 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.785 1.634 . . . . 0.0 112.101 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.5 pp -59.07 -37.89 78.15 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.238 0.472 . . . . 0.0 110.926 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -65.68 -42.99 90.62 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.74 0.816 . . . . 0.0 112.174 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -59.23 -37.86 78.54 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.031 1.332 . . . . 0.0 111.043 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 48.1 mtm105 -77.04 9.67 2.84 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 127.031 2.133 . . . . 0.0 113.646 174.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . 0.313 0.0 OUTLIER 72.56 3.4 4.67 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 130.742 3.617 . . . . 0.0 116.823 178.415 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -72.08 131.12 85.65 Favored Pre-proline 0 CA--C 1.545 0.752 0 O-C-N 121.091 -1.006 . . . . 0.0 109.947 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.51 -72.47 0.02 OUTLIER 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.152 2.568 . . . . 0.0 109.651 176.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 9.3 t -120.92 136.26 25.43 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 127.897 2.479 . . . . 0.0 109.674 175.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.87 -8.18 19.97 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.343 2.696 . . . . 0.0 114.902 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 41.6 t -111.36 -74.84 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 119.877 1.217 . . . . 0.0 112.613 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 16.7 p -92.5 -5.4 51.9 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.57 1.548 . . . . 0.0 113.694 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 61.94 16.22 7.89 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.743 2.417 . . . . 0.0 114.761 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -64.36 139.4 97.7 Favored Pre-proline 0 CA--C 1.549 0.938 0 O-C-N 121.477 -0.764 . . . . 0.0 109.796 175.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.54 113.64 2.79 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.162 2.574 . . . . 0.0 112.612 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 16.5 pt -70.93 157.55 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.54 1.136 . . . . 0.0 113.528 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -115.02 -40.7 3.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.324 1.849 . . . . 0.0 112.978 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.63 167.22 31.11 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -176.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 6.9 mt -135.99 129.03 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 129.169 2.987 . . . . 0.0 106.369 174.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.68 150.15 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.9 107.22 2.57 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 174.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 23.3 m -103.18 88.23 3.09 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.212 1.805 . . . . 0.0 110.086 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -60.78 153.64 23.85 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.772 2.029 . . . . 0.0 115.1 -176.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -61.88 156.12 58.51 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 126.276 1.831 . . . . 0.0 112.531 176.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 CA--C 1.538 0.709 0 C-N-CA 123.308 2.672 . . . . 0.0 112.591 179.869 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo . . . . . 0 CA--C 1.541 0.837 0 N-CA-C 117.253 1.982 . . . . 0.0 117.253 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 30.5 t -51.27 148.12 5.06 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 120.166 1.348 . . . . 0.0 112.663 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.8 -14.9 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 9.4 pt -136.36 -26.55 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.5 m -76.28 -60.12 2.47 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 120.719 1.599 . . . . 0.0 112.064 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -154.17 -13.76 0.13 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -176.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.51 11.55 81.75 Favored Glycine 0 CA--C 1.541 1.687 0 CA-C-N 120.011 1.278 . . . . 0.0 112.198 -173.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 9.4 ptm85 -55.97 155.05 12.69 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 129.592 3.157 . . . . 0.0 114.024 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.7 4.9 4.18 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 124.551 3.501 . . . . 0.0 115.762 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -58.52 157.98 8.26 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.182 1.793 . . . . 0.0 112.586 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -119.66 150.04 40.99 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 128.423 2.689 . . . . 0.0 111.898 -175.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 176.84 82.66 0.06 OUTLIER Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.575 1.56 . . . . 0.0 113.015 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 48.0 t -71.33 138.82 49.57 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 118.152 0.976 . . . . 0.0 109.864 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.6 mp -115.01 144.11 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.651 1.58 . . . . 0.0 110.44 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 97.1 t -129.91 131.34 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.242 1.017 . . . . 0.0 109.527 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -125.05 94.98 4.33 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.91 2.484 . . . . 0.0 111.281 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.49 -89.64 0.36 Allowed Glycine 0 CA--C 1.534 1.281 0 C-N-CA 125.689 1.614 . . . . 0.0 114.386 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -121.56 -0.85 9.65 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 126.348 1.859 . . . . 0.0 113.868 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 16.8 p -130.66 170.12 14.74 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 128.223 2.609 . . . . 0.0 109.787 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -157.79 177.06 34.73 Favored Glycine 0 CA--C 1.529 0.932 0 O-C-N 120.688 -1.258 . . . . 0.0 113.947 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -120.34 135.91 54.87 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.715 1.606 . . . . 0.0 113.842 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 4.0 pp -119.9 153.35 36.0 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.294 2.638 . . . . 0.0 109.451 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 25.0 ttt 78.26 66.3 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.762 2.025 . . . . 0.0 111.094 -177.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -160.03 154.5 23.84 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 128.898 2.879 . . . . 0.0 108.314 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 22.7 p -86.91 172.21 10.23 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.113 0.959 . . . . 0.0 111.21 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -64.94 -35.39 81.01 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.435 -0.79 . . . . 0.0 111.223 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 25.2 m -64.44 -49.2 72.39 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 117.212 -1.375 . . . . 0.0 111.152 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 29.4 m -46.93 -55.58 7.83 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 120.469 1.486 . . . . 0.0 109.924 174.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -59.99 -45.39 92.89 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.923 1.689 . . . . 0.0 113.52 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -60.1 -44.5 94.78 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.228 1.411 . . . . 0.0 111.523 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -62.35 -54.09 45.51 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.341 1.057 . . . . 0.0 111.473 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.4 pp -60.87 -32.05 71.49 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 118.579 0.627 . . . . 0.0 111.958 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -68.24 -48.56 64.79 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.269 1.428 . . . . 0.0 111.734 174.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -55.8 -43.67 77.07 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.632 1.573 . . . . 0.0 111.02 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -75.31 -6.94 52.45 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 127.067 2.147 . . . . 0.0 113.642 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 64.0 t30 50.79 41.13 26.04 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 128.074 2.55 . . . . 0.0 112.173 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -78.15 126.58 83.31 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 125.519 1.528 . . . . 0.0 113.367 -176.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -74.56 129.03 12.35 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.813 2.342 . . . . 0.0 107.526 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 48.2 t -27.01 123.79 0.23 Allowed Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 128.195 2.598 . . . . 0.0 115.493 -176.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.76 -1.66 6.31 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 122.959 2.439 . . . . 0.0 114.33 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 49.1 t -123.64 -59.55 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.686 1.594 . . . . 0.0 111.233 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 69.7 m -78.12 -19.78 53.4 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.682 1.993 . . . . 0.0 112.84 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 61.62 11.79 4.12 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 127.339 2.255 . . . . 0.0 114.198 -177.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -87.17 148.19 44.36 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 123.975 0.91 . . . . 0.0 112.95 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.25 124.55 7.9 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.863 3.042 . . . . 0.0 111.97 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.98 143.04 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.643 1.177 . . . . 0.0 112.859 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -115.17 -40.25 3.49 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.51 1.524 . . . . 0.0 113.656 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.5 166.58 31.82 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -176.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 8.0 mt -133.07 139.22 49.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 127.534 2.333 . . . . 0.0 108.732 176.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.06 150.11 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.944 1.297 . . . . 0.0 113.329 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 55.8 mt -73.29 99.87 3.0 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.294 1.037 . . . . 0.0 109.182 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 6.3 t -95.44 151.53 19.21 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -141.91 158.72 43.44 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.325 1.45 . . . . 0.0 112.558 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -80.54 158.44 71.23 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 123.842 0.857 . . . . 0.0 112.947 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo . . . . . 0 C--N 1.355 0.886 0 C-N-CA 124.565 3.51 . . . . 0.0 113.853 179.386 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo . . . . . 0 CA--C 1.54 0.776 0 N-CA-C 115.923 1.47 . . . . 0.0 115.923 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 44.3 t -46.91 138.67 6.18 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 121.178 1.808 . . . . 0.0 112.45 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.61 -28.74 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 125.173 1.389 . . . . 0.0 112.258 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 8.3 pt -138.01 -24.86 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 -173.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.5 m -73.21 -57.67 3.86 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.731 1.605 . . . . 0.0 112.083 -176.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -154.94 -14.85 0.12 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 81.16 11.06 84.03 Favored Glycine 0 CA--C 1.542 1.766 0 CA-C-N 119.993 1.27 . . . . 0.0 112.513 -174.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -64.7 155.18 83.06 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 129.785 3.234 . . . . 0.0 113.122 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -69.12 4.48 1.89 Allowed 'Trans proline' 0 CA--C 1.548 1.224 0 C-N-CA 124.569 3.512 . . . . 0.0 117.055 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -56.74 139.7 49.86 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 120.166 1.348 . . . . 0.0 110.59 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -128.17 113.86 16.26 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.192 1.797 . . . . 0.0 114.646 -170.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -144.62 82.79 0.2 Allowed Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.55 1.548 . . . . 0.0 112.527 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 49.3 t -65.0 142.17 58.53 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 117.872 0.836 . . . . 0.0 110.565 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 2.2 mp -107.17 141.64 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 125.816 1.646 . . . . 0.0 110.121 -177.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 96.9 t -130.09 132.79 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.277 1.031 . . . . 0.0 110.398 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -125.01 94.98 4.34 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.313 2.245 . . . . 0.0 110.841 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.74 -92.44 0.24 Allowed Glycine 0 CA--C 1.534 1.275 0 C-N-CA 126.259 1.885 . . . . 0.0 114.648 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -111.88 -7.89 14.14 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.334 1.854 . . . . 0.0 113.345 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 19.7 p -124.24 170.01 11.19 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.618 1.967 . . . . 0.0 111.125 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -160.8 174.9 37.51 Favored Glycine 0 CA--C 1.532 1.099 0 O-C-N 121.088 -1.007 . . . . 0.0 113.999 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -120.28 113.46 20.43 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.319 1.848 . . . . 0.0 113.333 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -97.37 153.18 18.24 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.923 1.289 . . . . 0.0 112.023 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 40.1 tpp 75.58 68.51 0.07 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.86 2.064 . . . . 0.0 111.244 177.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -157.25 150.22 23.54 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 129.293 3.037 . . . . 0.0 108.616 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 17.1 p -86.46 170.46 11.93 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.616 1.198 . . . . 0.0 111.781 176.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.49 -30.28 70.58 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.095 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 25.0 m -69.96 -50.5 41.22 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 117.303 -1.332 . . . . 0.0 109.9 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 35.0 m -47.65 -56.84 6.38 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 120.371 1.441 . . . . 0.0 110.105 173.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.15 -46.47 82.71 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.938 1.695 . . . . 0.0 113.403 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -65.86 -37.43 86.15 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.561 -1.337 . . . . 0.0 111.822 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 21.2 tptp -63.49 -52.36 61.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.122 0.969 . . . . 0.0 111.105 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.59 -30.32 70.6 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.073 0.397 . . . . 0.0 111.704 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -68.58 -46.06 70.38 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.033 1.333 . . . . 0.0 111.829 173.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -57.64 -42.44 83.41 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.864 1.265 . . . . 0.0 110.982 174.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -72.78 -11.05 60.46 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.459 1.904 . . . . 0.0 113.528 175.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 63.8 t30 52.41 40.45 29.49 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.814 2.446 . . . . 0.0 111.754 -175.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -74.2 116.13 49.69 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 126.357 1.863 . . . . 0.0 113.781 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.1 132.49 22.89 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.41 2.073 . . . . 0.0 107.671 170.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 47.1 t -32.58 125.11 0.39 Allowed Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 127.656 2.382 . . . . 0.0 115.214 -175.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.94 -3.18 10.94 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.146 2.564 . . . . 0.0 114.381 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 42.6 t -124.74 -60.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.076 1.35 . . . . 0.0 111.726 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 58.6 m -75.01 -18.78 60.29 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.635 1.974 . . . . 0.0 112.432 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 64.6 5.12 2.56 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.554 2.342 . . . . 0.0 114.081 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -83.8 148.99 55.78 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 124.204 1.002 . . . . 0.0 113.144 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.11 124.04 8.77 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.037 2.491 . . . . 0.0 110.405 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.2 pp -60.95 128.61 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.526 1.13 . . . . 0.0 110.932 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -115.08 -26.82 7.55 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -175.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 1.7 ttp -149.86 150.35 31.8 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.241 1.016 . . . . 0.0 112.624 -175.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 10.4 mt -137.24 130.05 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 127.138 2.175 . . . . 0.0 107.941 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 27.0 m -140.07 150.23 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 124.378 1.071 . . . . 0.0 112.913 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 66.6 tp -63.7 99.89 0.25 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.065 1.746 . . . . 0.0 108.683 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 41.4 m -110.8 108.48 18.33 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -170.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -85.72 178.41 7.35 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.239 1.816 . . . . 0.0 112.997 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -129.84 168.64 15.78 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 125.953 1.701 . . . . 0.0 111.552 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo . . . . . 0 C--N 1.353 0.798 0 C-N-CA 124.249 3.299 . . . . 0.0 113.887 179.968 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo . . . . . 0 CA--C 1.549 1.233 0 N-CA-C 113.036 0.36 . . . . 0.0 113.036 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 6.7 p -60.29 173.04 0.72 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.646 1.579 . . . . 0.0 114.579 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 28.6 m -130.75 -3.61 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -175.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 4.5 mt -117.88 -59.99 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 120.529 1.513 . . . . 0.0 112.796 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 7.0 p -69.39 -68.75 0.38 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -174.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -144.56 -13.95 0.57 Allowed 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 -171.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 88.92 40.86 6.09 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.426 1.012 . . . . 0.0 110.859 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -97.83 155.31 37.26 Favored Pre-proline 0 N--CA 1.481 1.107 0 C-N-CA 125.854 1.662 . . . . 0.0 112.406 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -44.08 121.44 2.98 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.949 3.1 . . . . 0.0 114.461 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.14 31.86 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 131.127 3.771 . . . . 0.0 118.944 -176.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -76.58 89.85 3.32 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 119.952 -1.718 . . . . 0.0 109.541 -178.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 164.97 57.21 0.02 OUTLIER Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.049 -0.862 . . . . 0.0 114.085 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 52.5 t -57.24 138.58 54.54 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.899 1.35 . . . . 0.0 110.91 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.4 mp -115.13 136.18 52.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 C-N-CA 126.687 1.995 . . . . 0.0 109.216 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 90.1 t -127.28 132.42 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.634 0.774 . . . . 0.0 110.924 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -124.35 106.14 10.0 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.011 2.525 . . . . 0.0 111.471 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 68.46 -89.92 0.23 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.703 1.621 . . . . 0.0 114.177 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -124.69 -0.97 7.99 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.152 1.781 . . . . 0.0 113.997 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 54.9 p -133.25 170.02 16.04 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.898 1.679 . . . . 0.0 110.296 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -152.01 175.12 30.87 Favored Glycine 0 CA--C 1.526 0.771 0 O-C-N 120.88 -1.138 . . . . 0.0 113.512 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -120.28 145.64 46.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.045 1.338 . . . . 0.0 114.181 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 94.8 mt -123.35 153.48 40.25 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 129.504 3.122 . . . . 0.0 110.686 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 50.5 mtt 90.7 31.39 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 128.757 2.823 . . . . 0.0 113.37 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -139.42 134.9 33.01 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.739 2.016 . . . . 0.0 107.583 173.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 22.1 p -80.98 175.11 10.97 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 122.667 1.222 . . . . 0.0 112.842 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.9 -36.93 70.73 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.731 0.812 . . . . 0.0 112.254 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 87.7 m -66.38 -52.56 45.57 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.197 0.999 . . . . 0.0 110.748 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 98.5 m -52.41 -50.54 62.32 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.31 1.044 . . . . 0.0 110.747 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.9 -44.54 91.23 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.177 1.391 . . . . 0.0 112.769 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -61.92 -43.26 99.21 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.785 1.234 . . . . 0.0 111.099 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -61.58 -57.11 13.39 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.117 0.967 . . . . 0.0 111.255 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.0 pp -59.11 -33.44 70.85 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 118.373 0.533 . . . . 0.0 112.227 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -68.05 -50.71 53.56 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.393 1.477 . . . . 0.0 112.217 175.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -56.81 -40.39 75.9 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.698 1.599 . . . . 0.0 111.502 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -79.93 -0.97 37.31 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.409 2.284 . . . . 0.0 113.403 176.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 46.24 39.22 5.9 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 128.866 2.866 . . . . 0.0 113.752 -177.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -69.98 127.93 92.06 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.478 1.511 . . . . 0.0 114.01 -176.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.09 128.19 11.22 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 122.834 2.356 . . . . 0.0 107.864 169.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 32.3 t -29.72 128.99 0.24 Allowed Pre-proline 0 CA--C 1.558 1.26 0 C-N-CA 128.07 2.548 . . . . 0.0 115.106 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -66.74 -2.56 7.81 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.181 2.588 . . . . 0.0 114.617 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 53.5 t -127.07 -59.48 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.393 1.477 . . . . 0.0 111.476 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 65.0 m -77.14 -24.59 51.61 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.595 1.958 . . . . 0.0 112.671 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 62.44 9.91 3.66 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 127.128 2.171 . . . . 0.0 113.81 -175.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -81.81 151.33 67.48 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.134 0.973 . . . . 0.0 113.068 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -77.46 121.09 5.47 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 123.978 3.119 . . . . 0.0 111.919 177.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.55 153.35 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.988 1.315 . . . . 0.0 112.231 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 18.7 tp60 -115.01 -48.6 2.82 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.1 170.27 20.36 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -176.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 7.9 mt -127.21 138.57 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.087 2.155 . . . . 0.0 108.396 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 16.8 m -133.87 150.09 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.52 1.128 . . . . 0.0 112.215 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 74.6 mt -68.56 99.85 1.04 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.849 0.86 . . . . 0.0 109.57 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 12.1 m -99.4 116.52 31.74 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.059 1.344 . . . . 0.0 114.271 -173.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -102.65 170.45 8.01 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.437 1.895 . . . . 0.0 111.921 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -136.25 157.91 74.63 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.793 1.637 . . . . 0.0 112.132 -176.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 CA--C 1.538 0.69 0 C-N-CA 123.347 2.698 . . . . 0.0 112.478 179.789 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo . . . . . 0 CA--C 1.543 0.959 0 N-CA-C 114.857 1.061 . . . . 0.0 114.857 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.69 -179.74 0.4 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.131 1.372 . . . . 0.0 114.359 176.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 19.3 m -131.06 -4.56 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 3.5 mt -121.63 -62.65 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 120.947 1.703 . . . . 0.0 113.677 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 31.4 p -70.61 -67.83 0.47 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 -174.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -140.98 -10.05 1.0 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 116.825 2.158 . . . . 0.0 116.825 -172.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 85.16 33.93 16.15 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 119.64 1.109 . . . . 0.0 110.759 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 44.0 mtt-85 -65.61 136.39 96.02 Favored Pre-proline 0 N--CA 1.477 0.882 0 CA-C-O 117.272 -1.347 . . . . 0.0 110.763 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -73.87 67.12 4.91 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 124.538 3.492 . . . . 0.0 111.235 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -141.75 153.4 44.57 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 128.508 2.723 . . . . 0.0 111.423 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -128.09 120.57 27.69 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.9 1.68 . . . . 0.0 111.8 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -136.04 70.8 0.49 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.652 1.596 . . . . 0.0 111.176 178.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 51.0 t -54.65 123.09 12.13 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.196 1.398 . . . . 0.0 110.49 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.32 138.16 20.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 124.937 1.295 . . . . 0.0 109.801 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 96.0 t -129.97 130.48 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.78 0.832 . . . . 0.0 110.254 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.13 105.03 8.85 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 128.603 2.761 . . . . 0.0 110.76 176.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 65.84 -93.75 0.19 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.868 1.699 . . . . 0.0 114.147 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -120.69 -0.14 10.27 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.457 1.903 . . . . 0.0 113.529 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 36.1 p -124.42 165.23 18.11 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.71 2.004 . . . . 0.0 110.638 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -158.81 169.57 35.17 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 120.985 -1.072 . . . . 0.0 113.908 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -120.33 138.67 53.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.619 1.968 . . . . 0.0 113.227 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.7 pp -120.74 153.32 37.15 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.813 2.045 . . . . 0.0 112.352 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 30.1 ttm 108.66 -7.35 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 131.08 3.752 . . . . 0.0 114.441 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -99.96 154.63 18.23 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.903 -1.123 . . . . 0.0 111.557 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 30.4 p -84.6 175.1 9.47 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 123.344 1.545 . . . . 0.0 113.594 178.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.41 -28.35 69.72 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.791 174.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 83.7 m -72.2 -51.02 23.06 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.567 1.076 . . . . 0.0 110.253 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 67.9 m -49.66 -54.8 16.5 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.662 1.185 . . . . 0.0 110.386 173.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.37 -49.46 76.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.209 1.403 . . . . 0.0 112.931 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -60.0 -40.07 87.95 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.952 1.301 . . . . 0.0 112.168 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -61.72 -52.98 62.06 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.38 1.072 . . . . 0.0 110.978 176.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 44.9 mt -52.22 -49.93 62.98 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.184 0.993 . . . . 0.0 110.107 175.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -54.14 49.54 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.988 1.315 . . . . 0.0 112.681 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -54.86 -43.54 73.18 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.903 1.681 . . . . 0.0 112.281 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -78.88 -6.93 57.35 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.835 2.054 . . . . 0.0 113.366 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 62.4 t30 49.4 42.55 22.5 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 128.521 2.729 . . . . 0.0 112.082 -175.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -75.47 117.04 60.32 Favored Pre-proline 0 N--CA 1.47 0.539 0 C-N-CA 125.552 1.541 . . . . 0.0 113.116 -176.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.9 130.93 21.34 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.106 1.871 . . . . 0.0 108.834 171.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 41.5 t -33.0 125.53 0.41 Allowed Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 128.298 2.639 . . . . 0.0 114.168 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -66.88 -1.45 6.05 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 123.112 2.541 . . . . 0.0 114.307 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.67 -59.14 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.698 1.599 . . . . 0.0 111.346 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 81.8 m -76.83 -14.39 59.91 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.364 1.866 . . . . 0.0 113.027 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . 0.304 14.7 ptm180 55.23 13.43 0.85 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 128.496 2.718 . . . . 0.0 115.108 -175.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -89.53 144.33 31.89 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 123.938 0.895 . . . . 0.0 112.294 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -68.71 122.32 9.26 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.158 2.572 . . . . 0.0 109.442 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 1.8 pt -64.89 137.76 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 O-C-N 121.661 -0.649 . . . . 0.0 112.132 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -115.2 -33.74 5.24 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 117.234 2.309 . . . . 0.0 117.234 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -143.27 152.18 41.4 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.82 0.848 . . . . 0.0 113.236 -171.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 5.1 mt -141.03 131.04 26.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 127.649 2.38 . . . . 0.0 109.038 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 27.7 m -140.12 150.13 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.985 1.314 . . . . 0.0 111.928 176.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 2.2 tt -66.1 105.9 1.49 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.569 1.148 . . . . 0.0 108.273 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.2 96.58 7.3 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -171.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -74.02 171.47 13.43 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.086 1.754 . . . . 0.0 113.295 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -132.78 168.19 19.11 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 127.554 2.342 . . . . 0.0 110.474 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo . . . . . 0 C--N 1.352 0.758 0 C-N-CA 124.425 3.417 . . . . 0.0 113.983 -178.84 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . 0.278 87.9 Cg_exo . . . . . 0 CA--C 1.553 1.462 0 N-CA-C 117.477 2.068 . . . . 0.0 117.477 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 28.4 t -67.06 150.67 48.88 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 121.899 2.136 . . . . 0.0 109.342 174.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 4.1 p -134.52 -1.68 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 121.221 -0.925 . . . . 0.0 113.301 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 7.2 mt -135.55 -45.66 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.057 0.943 . . . . 0.0 112.974 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.3 m -69.45 -59.49 2.95 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -173.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -152.02 -16.37 0.18 Allowed 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -175.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 80.34 17.01 74.88 Favored Glycine 0 CA--C 1.539 1.591 0 O-C-N 120.973 -1.079 . . . . 0.0 111.865 -174.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 -72.21 155.06 91.96 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 127.549 2.34 . . . . 0.0 112.607 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.0 71.05 5.14 Favored 'Trans proline' 0 CA--C 1.55 1.29 0 C-N-CA 123.929 3.086 . . . . 0.0 113.363 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -129.32 143.17 50.74 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 127.959 2.504 . . . . 0.0 108.842 176.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -128.02 150.27 50.0 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.115 1.366 . . . . 0.0 112.593 -176.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -151.12 80.39 0.19 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 128.076 2.751 . . . . 0.0 109.201 178.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 42.2 t -63.55 119.09 9.15 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.505 1.122 . . . . 0.0 110.794 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.419 ' H ' HD12 ' A' ' 450' ' ' ILE . 0.3 OUTLIER -102.07 141.71 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.768 1.227 . . . . 0.0 111.745 -177.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 90.0 t -130.08 133.53 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.778 1.231 . . . . 0.0 111.931 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -124.99 95.03 4.35 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.53 2.732 . . . . 0.0 110.685 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.4 -97.74 0.41 Allowed Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.73 1.633 . . . . 0.0 114.561 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -107.86 -2.71 19.63 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 126.224 1.81 . . . . 0.0 113.168 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 51.0 p -132.25 170.01 15.64 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.124 1.77 . . . . 0.0 110.808 -178.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -161.26 175.99 37.84 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.201 1.381 . . . . 0.0 112.233 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -120.29 142.58 48.96 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.754 1.222 . . . . 0.0 113.927 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 4.6 pp -111.32 153.25 26.23 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.522 1.929 . . . . 0.0 112.0 175.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 459' ' ' MET . . . . . . . . . . . . 0.253 25.2 mmt 70.42 68.94 0.2 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 128.08 2.552 . . . . 0.0 114.996 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -154.23 138.52 16.63 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 128.659 2.784 . . . . 0.0 106.757 171.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 6.3 p -77.57 172.33 13.53 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 120.224 1.375 . . . . 0.0 112.127 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.36 -44.95 95.28 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.648 -0.657 . . . . 0.0 111.117 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 29.2 m -62.67 -44.37 96.42 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 116.664 -1.636 . . . . 0.0 111.375 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 35.5 m -48.1 -69.97 0.11 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 120.704 1.593 . . . . 0.0 110.541 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -50.33 -49.12 54.77 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.526 1.53 . . . . 0.0 112.539 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -57.13 -42.5 81.03 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.602 0.761 . . . . 0.0 112.49 177.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -61.51 -45.49 93.97 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.815 1.246 . . . . 0.0 111.746 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.1 -46.92 84.71 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 174.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 43.5 tptt -57.35 -46.21 83.55 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.004 0.922 . . . . 0.0 112.204 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -61.07 -34.01 74.23 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.001 1.32 . . . . 0.0 112.326 174.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -81.82 0.72 38.11 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.663 1.985 . . . . 0.0 113.407 175.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 84.11 -2.28 1.05 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 131.242 3.817 . . . . 0.0 115.516 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 5.8 tppp? -79.55 130.26 68.68 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 119.815 1.189 . . . . 0.0 109.366 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.34 -92.74 0.01 OUTLIER 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 123.375 2.717 . . . . 0.0 112.22 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 43.7 t -65.8 130.36 94.47 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 124.477 1.111 . . . . 0.0 112.532 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.55 -1.67 11.38 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 123.255 2.636 . . . . 0.0 114.062 177.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 32.8 t -122.01 -72.1 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 119.972 1.26 . . . . 0.0 113.359 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 29.8 p -92.87 -9.27 40.85 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -175.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 77.55 12.85 1.95 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 128.518 2.727 . . . . 0.0 115.138 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -64.9 156.93 78.15 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 124.606 1.163 . . . . 0.0 112.049 175.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.99 100.34 1.2 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.035 3.157 . . . . 0.0 113.284 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 pp -79.09 155.76 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.651 1.181 . . . . 0.0 112.355 179.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -115.02 -26.92 7.53 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.845 1.258 . . . . 0.0 113.756 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.95 164.81 33.08 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.473 1.109 . . . . 0.0 113.914 -177.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 14.2 mt -132.6 132.43 59.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 128.444 2.698 . . . . 0.0 106.359 173.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 24.0 m -134.74 150.2 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 64.3 tp -73.05 99.91 2.87 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.19 1.796 . . . . 0.0 108.624 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 2.5 t -93.21 163.94 13.43 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -135.59 177.76 7.57 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.671 2.388 . . . . 0.0 110.942 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -124.34 157.97 62.86 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 125.306 1.443 . . . . 0.0 111.387 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 C--N 1.351 0.675 0 C-N-CA 123.111 2.541 . . . . 0.0 111.455 -179.646 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo . . . . . 0 CA--C 1.539 0.759 0 CA-C-O 117.175 -1.261 . . . . 0.0 113.668 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 27.5 t -55.25 143.33 28.35 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 120.876 1.671 . . . . 0.0 110.18 173.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 32.6 m -121.23 -14.69 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 9.9 pt -137.09 -26.17 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 -178.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.2 m -77.67 -59.64 2.7 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 120.549 1.522 . . . . 0.0 112.512 -176.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -151.88 -15.53 0.19 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -176.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.89 9.47 84.39 Favored Glycine 0 CA--C 1.541 1.714 0 CA-C-N 119.946 1.248 . . . . 0.0 112.544 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -56.56 155.07 14.93 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 129.427 3.091 . . . . 0.0 113.616 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -72.43 2.93 4.58 Favored 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 124.91 3.74 . . . . 0.0 115.817 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -59.05 142.95 49.97 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.887 2.075 . . . . 0.0 111.62 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -128.1 122.45 32.07 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.371 1.469 . . . . 0.0 112.73 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -138.97 75.21 0.38 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.46 1.981 . . . . 0.0 110.516 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 31.4 t -62.85 138.29 58.49 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.017 0.909 . . . . 0.0 110.282 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 1.4 mp -109.09 142.03 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 125.317 1.447 . . . . 0.0 109.928 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 96.0 t -124.12 131.92 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.293 1.037 . . . . 0.0 110.288 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -123.08 100.06 6.68 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 129.02 2.928 . . . . 0.0 110.725 177.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.97 -93.5 0.27 Allowed Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.914 1.721 . . . . 0.0 113.783 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -120.63 4.71 10.6 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.463 1.905 . . . . 0.0 114.061 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 60.5 p -132.58 170.12 15.63 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.701 2.0 . . . . 0.0 110.417 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -151.24 174.19 30.51 Favored Glycine 0 CA--C 1.528 0.845 0 O-C-N 120.925 -1.109 . . . . 0.0 113.799 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.28 108.14 13.81 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.982 1.713 . . . . 0.0 111.741 174.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 48.3 tp -92.01 153.07 19.67 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.075 2.15 . . . . 0.0 110.153 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 21.9 ttt 80.31 67.58 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.588 2.355 . . . . 0.0 111.778 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -159.87 147.67 16.88 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 129.705 3.202 . . . . 0.0 107.353 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 17.9 p -84.33 173.64 10.78 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 122.447 1.118 . . . . 0.0 111.457 175.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -34.19 77.32 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.134 177.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 22.2 m -70.4 -45.87 65.12 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 117.086 -1.435 . . . . 0.0 110.687 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 41.1 m -50.79 -53.76 29.23 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 120.946 1.703 . . . . 0.0 110.143 173.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -59.77 -40.29 87.75 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.412 1.485 . . . . 0.0 113.065 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -68.09 -40.98 82.54 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.85 -1.156 . . . . 0.0 111.182 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -60.23 -54.15 49.19 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.352 1.461 . . . . 0.0 112.135 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.1 pp -58.18 -36.63 73.35 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 118.923 0.783 . . . . 0.0 111.309 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -65.24 -49.96 67.63 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.768 1.627 . . . . 0.0 111.35 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -58.88 -39.57 81.8 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.956 1.302 . . . . 0.0 111.967 177.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -73.5 0.15 13.31 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 126.468 1.907 . . . . 0.0 113.506 175.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 55.5 t30 61.46 24.01 14.18 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 128.298 2.639 . . . . 0.0 113.949 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -79.42 133.64 59.64 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.455 1.102 . . . . 0.0 108.904 177.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -65.41 -68.25 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.586 2.191 . . . . 0.0 108.927 176.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 34.1 t -143.01 125.13 8.68 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 127.511 2.325 . . . . 0.0 109.315 174.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.54 -2.26 11.89 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.105 2.537 . . . . 0.0 113.382 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 25.4 t -111.18 -64.41 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.978 1.311 . . . . 0.0 112.234 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 27.9 p -109.89 2.5 19.87 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.244 1.418 . . . . 0.0 114.786 -177.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 63.48 7.98 3.3 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 128.061 2.544 . . . . 0.0 116.518 175.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -67.28 135.73 93.5 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-N 119.097 0.862 . . . . 0.0 110.649 176.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.73 115.56 4.14 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.409 2.739 . . . . 0.0 113.423 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.9 pp -70.61 151.38 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 125.286 1.434 . . . . 0.0 114.047 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -115.0 -44.2 3.05 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.842 2.057 . . . . 0.0 113.448 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.41 166.79 31.55 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -175.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 10.1 mt -133.76 136.37 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 128.646 2.778 . . . . 0.0 107.789 176.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 19.5 m -140.02 150.16 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.64 102.56 0.93 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 7.1 m -94.73 95.65 8.87 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -173.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -75.0 156.68 36.0 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.977 1.311 . . . . 0.0 112.685 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -86.06 164.89 37.03 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 125.708 1.603 . . . . 0.0 111.819 177.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo . . . . . 0 C--N 1.353 0.801 0 C-N-CA 124.2 3.267 . . . . 0.0 114.598 -179.61 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo . . . . . 0 CA--C 1.542 0.887 0 N-CA-C 117.379 2.03 . . . . 0.0 117.379 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 16.2 t -55.99 161.85 2.14 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 128.951 2.9 . . . . 0.0 111.319 172.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 18.8 m -129.65 -14.98 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 10.5 pt -137.29 -26.74 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.7 m -76.17 -57.8 3.66 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 120.646 1.566 . . . . 0.0 111.936 -178.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -149.0 -18.98 0.3 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 80.69 11.14 84.33 Favored Glycine 0 CA--C 1.54 1.603 0 O-C-N 120.959 -1.088 . . . . 0.0 113.366 -176.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -69.53 155.1 94.15 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 127.976 2.51 . . . . 0.0 113.548 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -52.54 -9.03 0.48 Allowed 'Trans proline' 0 CA--C 1.545 1.043 1 C-N-CA 125.965 4.443 . . . . 0.0 119.309 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -58.41 141.43 51.52 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 120.227 1.376 . . . . 0.0 111.569 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.18 150.14 50.14 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.021 2.128 . . . . 0.0 111.777 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -159.94 85.19 0.12 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 126.262 1.887 . . . . 0.0 110.046 176.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 42.3 t -58.54 139.11 56.26 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 117.839 0.819 . . . . 0.0 111.467 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.8 mp -115.13 140.87 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.074 1.749 . . . . 0.0 109.596 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 60.0 t -127.38 136.04 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.767 0.827 . . . . 0.0 109.47 175.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -125.11 94.85 4.29 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.752 2.421 . . . . 0.0 109.818 175.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 58.78 -99.61 0.13 Allowed Glycine 0 CA--C 1.534 1.273 0 C-N-CA 126.175 1.845 . . . . 0.0 114.71 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -86.55 -19.86 28.83 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.881 1.673 . . . . 0.0 114.636 -176.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 67.6 p -133.07 170.06 15.93 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.856 1.262 . . . . 0.0 112.729 -176.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -142.36 169.19 25.54 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.575 1.083 . . . . 0.0 113.968 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.18 134.0 55.36 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.95 1.7 . . . . 0.0 112.047 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.51 153.43 31.17 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 128.999 2.92 . . . . 0.0 111.473 -179.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 459' ' ' MET . . . . . . . . . . . . 0.424 19.1 ptp 70.4 69.36 0.21 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 128.714 2.806 . . . . 0.0 113.881 -178.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -158.31 143.24 16.35 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 130.25 3.42 . . . . 0.0 105.864 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 21.8 p -79.64 174.99 11.02 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 119.787 1.176 . . . . 0.0 111.846 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -63.38 -31.39 72.53 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.421 -0.799 . . . . 0.0 110.735 176.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 25.6 m -70.46 -44.63 67.37 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 117.542 -1.218 . . . . 0.0 110.987 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 60.1 m -51.37 -53.9 31.76 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 120.426 1.466 . . . . 0.0 109.433 172.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.62 -47.12 83.08 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.566 1.547 . . . . 0.0 112.648 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.14 -40.54 94.19 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.096 1.358 . . . . 0.0 111.718 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -59.29 -55.02 40.19 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.607 1.163 . . . . 0.0 110.591 176.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 23.9 mt -51.62 -50.36 60.41 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.704 1.202 . . . . 0.0 110.109 177.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.44 -54.79 42.61 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.755 1.222 . . . . 0.0 114.153 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -60.17 -38.45 83.25 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.149 1.38 . . . . 0.0 112.584 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -82.19 -4.22 56.57 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.537 1.535 . . . . 0.0 112.902 175.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 49.07 50.71 17.48 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 129.055 2.942 . . . . 0.0 112.151 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -70.02 148.98 96.33 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.514 0.726 . . . . 0.0 112.642 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -81.95 11.86 2.99 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 124.016 3.144 . . . . 0.0 113.435 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 34.6 t 73.24 88.66 0.08 OUTLIER Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 128.493 2.717 . . . . 0.0 108.585 -173.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.75 -23.19 25.69 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.27 2.646 . . . . 0.0 114.869 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 20.1 t -73.32 -51.71 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 126.567 1.947 . . . . 0.0 113.213 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 26.1 p -128.59 0.39 5.54 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 -174.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 66.56 30.12 8.61 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 127.485 2.314 . . . . 0.0 114.841 175.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -107.48 102.87 46.47 Favored Pre-proline 0 CA--C 1.554 1.135 0 C-N-CA 126.695 1.998 . . . . 0.0 111.112 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.45 124.53 10.86 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.06 3.173 . . . . 0.0 115.235 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.4 pp -57.52 151.48 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.716 2.007 . . . . 0.0 113.327 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -115.03 -57.27 2.28 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.057 1.343 . . . . 0.0 112.018 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.64 170.22 20.78 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 4.4 mt -121.47 148.24 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.867 2.067 . . . . 0.0 108.603 175.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 6.2 m -134.48 150.18 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.808 1.643 . . . . 0.0 111.189 176.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.91 99.9 4.66 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 56.9 m -79.27 156.02 28.28 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.952 0.901 . . . . 0.0 112.545 -176.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -138.53 164.09 30.33 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.981 2.112 . . . . 0.0 110.257 178.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -124.05 168.82 11.81 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 125.944 1.698 . . . . 0.0 110.907 -178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo . . . . . 0 C--N 1.348 0.547 0 C-N-CA 123.14 2.56 . . . . 0.0 110.895 178.3 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo . . . . . 0 CA--C 1.541 0.864 0 N-CA-C 115.085 1.148 . . . . 0.0 115.085 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 438' ' ' CYS . . . . . 0.406 ' SG ' ' N ' ' B' ' 439' ' ' VAL . 21.3 t -68.17 -175.95 0.66 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.969 1.708 . . . . 0.0 112.506 174.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 439' ' ' VAL . . . . . 0.406 ' N ' ' SG ' ' B' ' 438' ' ' CYS . 6.0 p -141.84 -1.66 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.481 1.513 . . . . 0.0 114.193 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 19.4 mt -118.74 -65.78 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 120.072 1.305 . . . . 0.0 113.393 -176.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 22.8 p -52.67 -74.69 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -141.0 -11.34 0.98 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.571 2.348 . . . . 0.0 113.311 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 79.61 30.69 43.39 Favored Glycine 0 CA--C 1.536 1.364 0 O-C-N 121.556 -0.715 . . . . 0.0 112.634 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -69.73 155.05 94.19 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.737 1.615 . . . . 0.0 111.95 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.89 -2.19 0.32 Allowed 'Trans proline' 0 CA--C 1.549 1.257 1 C-N-CA 125.778 4.319 . . . . 0.0 118.982 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -73.26 142.43 47.23 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.5 1.52 . . . . 0.0 111.861 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.31 149.98 50.27 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.335 1.854 . . . . 0.0 111.692 174.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -160.14 84.73 0.12 Allowed Glycine 0 CA--C 1.53 0.978 0 C-N-CA 126.453 1.977 . . . . 0.0 111.295 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 33.3 t -61.26 137.09 58.24 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.914 0.886 . . . . 0.0 111.402 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.07 147.19 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 126.215 1.806 . . . . 0.0 110.427 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 33.7 t -127.51 138.48 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.151 0.98 . . . . 0.0 110.527 175.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -125.05 95.02 4.34 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 128.868 2.867 . . . . 0.0 109.935 175.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.53 -93.36 0.37 Allowed Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.824 1.678 . . . . 0.0 113.804 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -117.48 -0.31 11.96 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 126.408 1.883 . . . . 0.0 113.532 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 47.4 p -127.13 170.06 12.77 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.469 1.908 . . . . 0.0 110.15 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -159.09 170.93 35.55 Favored Glycine 0 N--CA 1.468 0.772 0 O-C-N 120.592 -1.317 . . . . 0.0 114.062 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.02 139.15 52.94 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.264 1.425 . . . . 0.0 112.01 178.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 56.0 tp -130.02 153.2 48.66 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.737 2.415 . . . . 0.0 110.995 -176.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 28.1 ttm 95.21 29.16 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 129.061 2.944 . . . . 0.0 113.783 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -133.14 151.38 51.99 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.629 1.972 . . . . 0.0 109.556 176.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 22.3 p -75.43 168.86 19.19 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 122.881 1.324 . . . . 0.0 113.312 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.21 -35.18 80.27 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.919 177.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 19.7 m -64.14 -52.9 56.9 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.89 176.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 18.1 m -53.51 -52.89 58.16 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.727 1.149 . . . . 0.0 111.239 175.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -51.85 -41.39 61.8 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.267 1.427 . . . . 0.0 112.669 173.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -69.93 -27.35 64.69 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.045 1.338 . . . . 0.0 113.266 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -57.54 -42.28 82.65 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 120.18 1.355 . . . . 0.0 111.202 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -54.56 -44.54 73.01 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.957 1.303 . . . . 0.0 110.099 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -66.06 -50.29 64.67 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.451 0.7 . . . . 0.0 111.444 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -53.45 -41.63 66.31 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.419 1.488 . . . . 0.0 113.758 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -99.33 11.32 39.43 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.424 1.49 . . . . 0.0 114.845 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 63.3 t30 47.89 60.66 3.41 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.212 2.205 . . . . 0.0 113.803 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -121.58 143.35 37.78 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 128.693 2.797 . . . . 0.0 108.985 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.92 -85.23 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.19 0 C-N-CA 122.798 2.332 . . . . 0.0 112.853 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 5.7 t -127.02 140.37 37.63 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 127.01 2.124 . . . . 0.0 111.328 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.54 -5.56 16.69 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.514 2.809 . . . . 0.0 114.412 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 55.1 t -119.32 -74.22 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.736 1.153 . . . . 0.0 112.602 -177.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 24.6 p -93.85 0.6 56.3 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.611 1.564 . . . . 0.0 114.007 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 58.71 14.62 3.25 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 128.193 2.597 . . . . 0.0 115.892 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -68.58 138.99 91.28 Favored Pre-proline 0 CA--C 1.552 1.034 0 CA-C-N 119.244 0.929 . . . . 0.0 110.645 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.75 113.05 2.61 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.562 2.842 . . . . 0.0 113.757 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.6 pp -69.16 159.34 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.357 1.463 . . . . 0.0 113.758 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -115.12 -56.83 2.33 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.991 2.116 . . . . 0.0 111.243 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.96 170.21 19.9 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.568 1.147 . . . . 0.0 113.51 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 10.5 mt -118.25 138.11 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 127.62 2.368 . . . . 0.0 106.191 174.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 14.7 p -129.02 147.19 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 119.382 0.992 . . . . 0.0 113.497 -177.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.3 99.92 1.63 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.979 1.311 . . . . 0.0 107.876 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 6.0 t -98.87 155.17 17.52 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -144.56 167.17 23.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.395 1.878 . . . . 0.0 111.269 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -123.36 153.34 65.4 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 125.333 1.453 . . . . 0.0 111.689 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 C--N 1.351 0.693 0 C-N-CA 123.592 2.861 . . . . 0.0 111.546 -179.063 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo . . . . . 0 CA--C 1.552 1.415 0 CA-C-O 119.175 -0.427 . . . . 0.0 112.042 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 23.0 t -63.59 154.86 31.4 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 119.747 1.158 . . . . 0.0 110.154 174.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 31.0 m -129.43 -14.61 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 10.4 pt -137.08 -26.4 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.4 m -73.68 -60.76 2.1 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 120.921 1.691 . . . . 0.0 112.051 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -153.54 -13.85 0.15 Allowed 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -176.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 80.08 8.9 87.23 Favored Glycine 0 CA--C 1.541 1.682 0 O-C-N 120.747 -1.221 . . . . 0.0 112.853 -175.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -62.17 155.01 67.55 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 128.175 2.59 . . . . 0.0 113.415 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.03 75.22 3.78 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 124.143 3.229 . . . . 0.0 113.611 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -135.02 148.01 49.81 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.994 2.518 . . . . 0.0 109.218 176.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -128.05 148.09 50.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.013 0.925 . . . . 0.0 111.367 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -159.1 86.62 0.12 Allowed Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.872 1.701 . . . . 0.0 112.822 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 49.3 t -68.63 136.2 52.62 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.896 0.848 . . . . 0.0 110.115 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.0 140.32 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.811 1.244 . . . . 0.0 111.448 -178.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 93.3 t -126.89 131.4 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.138 1.375 . . . . 0.0 111.742 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -114.23 94.98 5.05 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 128.608 2.763 . . . . 0.0 109.727 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.82 -91.41 0.42 Allowed Glycine 0 CA--C 1.535 1.29 0 C-N-CA 126.218 1.866 . . . . 0.0 113.97 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -121.93 5.11 9.91 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 126.506 1.922 . . . . 0.0 113.494 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 74.6 p -135.6 170.06 16.55 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.018 2.127 . . . . 0.0 109.823 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -160.14 179.18 35.84 Favored Glycine 0 N--CA 1.47 0.908 0 O-C-N 120.538 -1.351 . . . . 0.0 114.45 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -120.41 133.87 55.36 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.239 1.415 . . . . 0.0 113.849 174.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -110.16 153.26 24.99 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.596 1.558 . . . . 0.0 111.487 173.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 41.8 ttm 99.73 60.0 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 129.825 3.25 . . . . 0.0 112.487 177.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -160.05 158.31 30.22 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.306 1.842 . . . . 0.0 110.936 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 13.7 p -88.71 175.07 7.67 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 122.441 1.115 . . . . 0.0 111.63 173.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -37.16 84.3 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.028 -1.045 . . . . 0.0 110.672 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 26.6 m -63.21 -49.69 73.19 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 117.18 -1.391 . . . . 0.0 109.847 176.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 60.0 m -47.12 -56.23 6.95 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 120.35 1.432 . . . . 0.0 110.291 173.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -56.85 -47.3 80.69 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.905 1.682 . . . . 0.0 114.398 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -74.4 -31.64 62.4 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 120.055 1.298 . . . . 0.0 112.682 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -62.63 -55.5 26.49 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.897 1.679 . . . . 0.0 110.942 177.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 2.3 pp -59.0 -37.88 77.89 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 117.8 0.273 . . . . 0.0 111.131 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -63.11 -49.3 74.96 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.121 1.368 . . . . 0.0 111.759 176.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -58.0 -39.6 78.66 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.598 1.559 . . . . 0.0 111.561 176.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -76.0 5.56 6.45 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 127.078 2.151 . . . . 0.0 113.866 175.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 45.3 t30 65.21 18.72 11.53 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 128.771 2.828 . . . . 0.0 115.438 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -70.13 130.04 90.07 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 120.821 -1.174 . . . . 0.0 108.82 175.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.77 -51.3 0.93 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.772 2.315 . . . . 0.0 111.695 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 3.4 t -153.85 140.08 12.6 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 129.375 3.07 . . . . 0.0 108.019 174.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -71.29 -6.37 19.03 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.261 2.641 . . . . 0.0 114.583 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 46.4 t -125.08 -70.86 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 119.829 1.195 . . . . 0.0 113.404 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 24.6 p -97.13 3.62 51.58 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.803 1.641 . . . . 0.0 114.797 -175.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 59.62 20.21 8.81 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 127.763 2.425 . . . . 0.0 116.054 175.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -81.04 115.99 59.65 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 124.544 1.138 . . . . 0.0 109.376 175.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -47.32 108.32 0.16 Allowed 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 124.373 3.382 . . . . 0.0 117.264 -175.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.0 pp -66.41 134.52 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 126.124 1.77 . . . . 0.0 112.14 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -115.24 -16.61 11.5 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.55 1.54 . . . . 0.0 115.026 -176.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 1.8 ttp -150.32 148.17 28.51 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.122 0.969 . . . . 0.0 113.021 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 14.4 mt -131.99 139.42 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 127.363 2.265 . . . . 0.0 107.936 173.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 10.0 m -134.68 150.23 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.565 1.146 . . . . 0.0 113.403 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 63.5 tp -70.13 99.87 1.56 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 173.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 4.8 t -98.98 159.1 15.2 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -172.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -142.6 171.18 14.4 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.392 2.277 . . . . 0.0 111.606 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -138.54 156.63 73.15 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.98 1.712 . . . . 0.0 111.028 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo . . . . . 0 C--N 1.351 0.674 0 C-N-CA 123.627 2.884 . . . . 0.0 111.482 -179.61 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo . . . . . 0 CA--C 1.55 1.318 0 N-CA-C 117.361 2.024 . . . . 0.0 117.361 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 40.0 t -61.26 145.82 49.99 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 121.838 2.108 . . . . 0.0 109.684 175.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 35.3 m -123.15 -15.17 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 8.4 pt -137.66 -25.32 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.8 m -77.28 -63.64 1.32 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.656 1.571 . . . . 0.0 112.211 -176.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -144.16 -11.74 0.64 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -177.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 75.84 16.16 80.84 Favored Glycine 0 CA--C 1.545 1.914 0 CA-C-N 120.117 1.326 . . . . 0.0 112.42 -174.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -65.58 155.2 86.4 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 130.484 3.513 . . . . 0.0 113.021 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -68.96 -3.61 11.82 Favored 'Trans proline' 0 CA--C 1.546 1.089 0 C-N-CA 124.161 3.241 . . . . 0.0 115.956 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -59.35 134.7 57.25 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.341 1.456 . . . . 0.0 110.17 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -128.24 138.68 52.54 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.22 1.808 . . . . 0.0 110.344 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -139.25 83.58 0.24 Allowed Glycine 0 CA--C 1.526 0.779 0 C-N-CA 127.482 2.467 . . . . 0.0 109.761 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 50.7 t -59.4 138.52 57.63 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.01 0.924 . . . . 0.0 111.013 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.05 142.4 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 125.647 1.579 . . . . 0.0 109.478 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 14.5 t -116.81 142.31 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.325 1.05 . . . . 0.0 109.463 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -125.11 94.83 4.28 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 128.016 2.527 . . . . 0.0 107.165 175.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 60.87 -91.85 0.06 OUTLIER Glycine 0 CA--C 1.541 1.706 0 C-N-CA 124.759 1.171 . . . . 0.0 113.829 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -118.71 6.17 11.56 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 127.441 2.297 . . . . 0.0 113.514 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 41.5 p -121.74 170.21 9.97 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.629 2.372 . . . . 0.0 110.441 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -162.6 167.48 37.11 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 120.598 -1.313 . . . . 0.0 114.688 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -120.12 141.31 49.94 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.552 1.541 . . . . 0.0 113.034 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 79.8 mt -119.26 153.21 35.37 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.268 2.627 . . . . 0.0 110.959 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 20.2 mmt 76.44 65.25 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.588 2.355 . . . . 0.0 113.19 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -155.81 135.02 12.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 129.749 3.22 . . . . 0.0 105.438 172.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 13.1 p -77.22 174.72 10.42 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 120.958 1.708 . . . . 0.0 111.96 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.47 -37.22 82.82 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.59 -0.694 . . . . 0.0 111.827 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 84.7 m -72.49 -44.21 62.58 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 116.194 -1.86 . . . . 0.0 110.684 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 53.0 m -46.36 -57.33 4.72 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 121.596 1.998 . . . . 0.0 110.474 173.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.03 -52.42 65.34 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.482 1.513 . . . . 0.0 112.663 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -59.82 -38.58 82.4 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 121.091 -1.006 . . . . 0.0 113.083 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -62.19 -48.05 81.76 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.153 1.781 . . . . 0.0 111.416 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 14.5 mt -54.88 -50.73 68.02 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.894 0.878 . . . . 0.0 109.631 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -55.86 -46.5 78.2 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.155 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -58.59 -42.23 87.58 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.244 1.417 . . . . 0.0 111.725 175.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -76.35 0.45 19.45 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 127.407 2.283 . . . . 0.0 113.713 175.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 71.73 6.92 5.81 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 129.71 3.204 . . . . 0.0 115.508 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.11 135.88 47.48 Favored Pre-proline 0 CA--C 1.544 0.75 0 O-C-N 120.664 -1.272 . . . . 0.0 109.342 175.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -78.06 -110.22 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.286 0 C-N-CA 123.212 2.608 . . . . 0.0 108.78 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 15.2 t -70.7 139.64 86.22 Favored Pre-proline 0 CA--C 1.556 1.183 0 O-C-N 120.76 -1.213 . . . . 0.0 112.65 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.17 -4.23 14.57 Favored 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 123.612 2.875 . . . . 0.0 114.115 175.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 61.3 t -129.02 -68.29 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 29.6 p -88.08 -6.37 57.96 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 120.393 1.451 . . . . 0.0 113.575 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 61.27 9.18 2.39 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 128.487 2.715 . . . . 0.0 115.12 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -66.39 153.38 92.91 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-N 118.763 0.71 . . . . 0.0 111.925 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.48 119.88 6.98 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.357 2.705 . . . . 0.0 113.01 -177.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.65 159.5 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.567 1.547 . . . . 0.0 112.91 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.08 -60.72 1.85 Allowed 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.036 1.735 . . . . 0.0 110.893 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.99 170.32 21.57 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.679 1.992 . . . . 0.0 112.581 -177.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 13.2 mt -115.98 135.47 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 126.388 1.875 . . . . 0.0 108.036 174.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 15.0 m -134.3 150.0 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.578 1.151 . . . . 0.0 112.595 177.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.58 99.94 5.93 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 56.1 m -101.03 104.03 15.16 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.199 0.6 . . . . 0.0 111.313 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -78.63 172.48 13.63 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.811 2.444 . . . . 0.0 112.45 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -115.6 167.03 10.79 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 126.254 1.822 . . . . 0.0 111.787 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo . . . . . 0 C--N 1.351 0.702 0 C-N-CA 124.104 3.203 . . . . 0.0 113.785 179.352 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo . . . . . 0 CA--C 1.546 1.109 0 N-CA-C 112.672 0.22 . . . . 0.0 112.672 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 15.0 p -70.19 -179.02 1.82 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.921 1.288 . . . . 0.0 112.7 177.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.08 -3.81 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -177.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 4.7 mt -121.88 -62.42 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 120.147 1.339 . . . . 0.0 113.498 -178.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . 0.256 3.6 p -66.69 -61.95 1.7 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 -173.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -154.61 -15.47 0.12 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -175.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 100.44 51.19 1.24 Allowed Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.878 1.704 . . . . 0.0 110.585 -176.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -105.75 155.0 38.93 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 125.291 1.436 . . . . 0.0 112.526 -176.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -46.62 118.8 2.8 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.252 2.635 . . . . 0.0 113.877 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 29.13 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 129.375 3.07 . . . . 0.0 118.818 -175.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.77 89.84 2.32 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 120.288 -1.507 . . . . 0.0 109.207 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 170.09 42.01 0.03 OUTLIER Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.034 1.302 . . . . 0.0 112.118 -177.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 45.4 t -49.96 121.35 5.28 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.673 1.589 . . . . 0.0 111.846 -178.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.403 HD12 ' H ' ' A' ' 450' ' ' ILE . 4.4 mp -83.45 123.85 39.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 125.689 1.595 . . . . 0.0 107.718 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 96.5 t -127.08 123.15 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 121.679 0.752 . . . . 0.0 111.061 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -120.3 106.81 12.24 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 128.113 2.565 . . . . 0.0 111.393 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.65 -92.22 0.43 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.749 1.642 . . . . 0.0 113.934 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -127.06 4.44 6.47 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.574 1.95 . . . . 0.0 113.183 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 60.1 p -133.53 170.15 15.94 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.32 1.848 . . . . 0.0 110.668 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -159.26 173.91 36.13 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.326 0.965 . . . . 0.0 113.301 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -120.11 131.82 55.19 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.899 1.28 . . . . 0.0 112.784 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . 0.437 HD23 ' N ' ' A' ' 459' ' ' MET . 1.9 tt -92.85 153.27 18.93 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 129.487 3.115 . . . . 0.0 112.133 -178.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 459' ' ' MET . . . . . 0.437 ' N ' HD23 ' A' ' 458' ' ' LEU . 16.0 ttp 86.5 31.07 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.964 2.506 . . . . 0.0 117.213 169.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -139.28 135.01 33.39 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.018 1.327 . . . . 0.0 108.801 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 26.3 p -79.59 175.01 11.0 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 123.051 1.405 . . . . 0.0 114.317 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.24 -41.06 78.84 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.678 1.191 . . . . 0.0 111.869 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 78.8 m -60.8 -53.0 62.66 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.721 1.208 . . . . 0.0 110.358 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 90.5 m -52.08 -53.7 39.22 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.561 1.144 . . . . 0.0 111.056 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -56.02 -50.16 71.66 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.363 1.065 . . . . 0.0 112.671 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -64.91 -38.17 90.07 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.212 1.005 . . . . 0.0 112.414 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -61.02 -52.99 62.65 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.359 1.464 . . . . 0.0 110.573 177.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 29.8 mt -51.77 -51.47 56.07 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.397 1.079 . . . . 0.0 109.782 175.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -54.22 -48.63 70.85 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.175 0.99 . . . . 0.0 112.342 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -59.86 -41.55 91.7 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.326 1.45 . . . . 0.0 111.983 175.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -75.72 -0.99 22.78 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 127.065 2.146 . . . . 0.0 113.44 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 38.9 t30 75.44 7.1 4.02 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 130.086 3.354 . . . . 0.0 115.425 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -80.89 128.7 70.56 Favored Pre-proline 0 CA--C 1.543 0.697 0 O-C-N 120.612 -1.305 . . . . 0.0 109.154 175.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.11 -87.82 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 123.326 2.684 . . . . 0.0 110.415 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 37.4 t -96.78 132.44 26.07 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.67 1.588 . . . . 0.0 111.031 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.56 -4.7 14.89 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.272 2.648 . . . . 0.0 113.794 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 24.4 t -112.46 -74.19 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 119.772 1.169 . . . . 0.0 112.634 -177.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 25.4 p -95.82 -3.64 45.23 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.422 1.489 . . . . 0.0 114.318 -177.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 67.12 10.58 7.81 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 127.75 2.42 . . . . 0.0 115.162 176.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -62.97 149.68 89.81 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 124.0 0.92 . . . . 0.0 111.663 177.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -68.77 106.89 1.56 Allowed 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.892 3.061 . . . . 0.0 113.682 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 1.5 pp -71.86 145.77 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.352 1.461 . . . . 0.0 111.405 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -115.22 -24.25 8.57 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.2 168.13 27.88 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -176.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 10.0 mt -139.29 132.49 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 128.784 2.833 . . . . 0.0 106.731 174.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.11 150.08 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 125.003 1.321 . . . . 0.0 112.153 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 64.5 mt -69.54 99.84 1.33 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.632 0.729 . . . . 0.0 109.295 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.15 112.67 25.88 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.89 1.676 . . . . 0.0 113.601 -174.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -127.83 169.05 14.33 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.903 1.281 . . . . 0.0 113.854 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -73.55 159.67 84.07 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 127.098 2.159 . . . . 0.0 112.821 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo . . . . . 0 C--N 1.351 0.698 0 C-N-CA 123.562 2.842 . . . . 0.0 111.501 178.787 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo . . . . . 0 CA--C 1.544 0.989 0 N-CA-C 113.255 0.444 . . . . 0.0 113.255 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 8.5 p -66.98 -163.32 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 126.832 2.053 . . . . 0.0 115.021 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 96.4 t -125.67 -22.72 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -174.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 2.5 mt -129.4 -56.8 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 -171.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 27.8 p -69.19 -61.97 1.57 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 -172.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -148.75 -9.09 0.36 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 116.716 2.117 . . . . 0.0 116.716 -173.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 86.59 30.56 21.14 Favored Glycine 0 CA--C 1.534 1.248 0 O-C-N 120.693 -1.254 . . . . 0.0 111.196 -175.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 44.6 mtt-85 -65.44 135.98 96.08 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 125.526 1.53 . . . . 0.0 111.388 -177.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.78 77.88 1.79 Allowed 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 123.815 3.01 . . . . 0.0 110.328 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -150.05 160.67 43.46 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.024 2.13 . . . . 0.0 113.188 -170.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -128.21 150.11 50.17 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 128.967 2.907 . . . . 0.0 111.104 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 176.45 76.92 0.05 OUTLIER Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.825 1.678 . . . . 0.0 112.323 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 19.7 t -61.55 140.69 58.08 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.934 0.894 . . . . 0.0 111.869 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 2.0 mp -109.96 140.8 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 126.257 1.823 . . . . 0.0 109.281 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 94.6 t -130.06 135.39 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.659 0.742 . . . . 0.0 110.891 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.04 100.09 6.42 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 128.192 2.597 . . . . 0.0 110.728 174.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.55 -94.14 0.27 Allowed Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.005 1.764 . . . . 0.0 114.323 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -116.9 -0.33 12.26 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.274 1.83 . . . . 0.0 113.457 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 16.5 p -129.88 166.06 20.76 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.512 1.125 . . . . 0.0 110.793 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.11 166.82 33.19 Favored Glycine 0 CA--C 1.528 0.871 0 O-C-N 121.015 -1.053 . . . . 0.0 113.976 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -115.65 116.69 28.54 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.768 2.027 . . . . 0.0 110.682 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 43.2 tp -107.97 153.1 23.56 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.516 2.327 . . . . 0.0 110.63 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 62.5 mtt 105.73 -5.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 130.92 3.688 . . . . 0.0 115.686 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -99.87 160.5 14.26 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.432 1.014 . . . . 0.0 111.305 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 21.7 p -79.64 173.45 12.58 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 123.198 1.475 . . . . 0.0 113.874 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.63 -23.62 65.37 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.612 174.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 51.4 m -73.94 -50.76 18.59 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 117.823 -1.084 . . . . 0.0 110.145 178.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 60.7 m -49.0 -53.2 21.0 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.777 1.231 . . . . 0.0 110.476 173.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.72 -49.58 76.06 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.861 1.664 . . . . 0.0 112.927 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -61.42 -40.67 95.27 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.826 -1.171 . . . . 0.0 111.655 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -62.31 -54.53 39.29 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.98 1.712 . . . . 0.0 111.328 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.3 pp -62.91 -31.84 73.0 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.71 -0.619 . . . . 0.0 112.034 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -68.29 -46.65 69.78 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.052 1.341 . . . . 0.0 112.226 175.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -58.45 -40.97 84.05 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.464 1.105 . . . . 0.0 111.503 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -74.88 -8.43 56.44 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.566 1.546 . . . . 0.0 113.118 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 50.45 41.05 24.5 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.47 2.708 . . . . 0.0 111.74 -176.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -71.73 127.56 90.72 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.385 1.474 . . . . 0.0 114.053 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.76 127.55 10.95 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.808 2.338 . . . . 0.0 107.333 169.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 40.9 t -30.62 125.44 0.3 Allowed Pre-proline 0 CA--C 1.555 1.159 0 C-N-CA 127.914 2.486 . . . . 0.0 115.2 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.1 -1.78 6.83 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.072 2.515 . . . . 0.0 114.328 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 58.4 t -124.04 -59.8 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.796 1.638 . . . . 0.0 111.17 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 85.7 m -75.11 -22.54 58.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.089 1.756 . . . . 0.0 112.766 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? 62.5 9.12 3.22 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 127.161 2.184 . . . . 0.0 113.419 -175.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -83.1 146.72 52.22 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.769 1.227 . . . . 0.0 112.266 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.67 121.94 7.44 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.18 2.587 . . . . 0.0 110.375 175.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.4 pp -61.05 144.12 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.22 1.008 . . . . 0.0 111.369 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -115.02 -38.87 3.77 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.75 165.85 35.3 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 8.2 mt -135.36 135.83 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.674 2.389 . . . . 0.0 108.475 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 20.0 m -140.01 150.05 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.126 0.97 . . . . 0.0 113.312 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.95 100.0 1.89 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 36.5 m -96.64 88.95 4.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.794 1.237 . . . . 0.0 111.483 -174.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -61.81 129.05 39.16 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.946 1.698 . . . . 0.0 112.892 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -47.71 -40.48 30.68 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 118.817 2.895 . . . . 0.0 118.817 -176.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo . . . . . 0 C--N 1.355 0.896 0 C-N-CA 123.979 3.119 . . . . 0.0 115.028 -178.256 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo . . . . . 0 CA--C 1.544 1.02 0 N-CA-C 117.417 2.045 . . . . 0.0 117.417 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 11.2 t -50.53 153.21 1.68 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 128.323 2.649 . . . . 0.0 111.892 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 22.0 m -135.35 -0.37 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.656 1.183 . . . . 0.0 113.708 178.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 8.2 mt -128.73 -48.18 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 119.565 1.075 . . . . 0.0 112.255 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 1.9 m -71.2 -68.93 0.41 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -173.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -146.55 -11.39 0.46 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.313 1.598 . . . . 0.0 115.313 -173.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.5 16.78 70.19 Favored Glycine 0 CA--C 1.541 1.717 0 CA-C-N 119.836 1.198 . . . . 0.0 113.051 -175.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 11.8 ptp85 -57.47 154.3 24.49 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 127.22 2.208 . . . . 0.0 112.499 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.18 -10.23 26.53 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 123.807 3.005 . . . . 0.0 116.388 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -59.39 147.52 35.97 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.201 1.4 . . . . 0.0 112.05 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -128.33 150.16 50.2 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.21 2.604 . . . . 0.0 111.667 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -168.44 86.35 0.09 OUTLIER Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.252 1.882 . . . . 0.0 112.517 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 47.7 t -60.4 142.94 54.3 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.686 1.194 . . . . 0.0 110.862 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 mp -115.0 132.21 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.578 1.551 . . . . 0.0 109.595 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 69.6 t -115.56 129.05 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.337 1.055 . . . . 0.0 108.591 176.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -125.08 94.95 4.32 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.184 2.194 . . . . 0.0 112.74 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 77.06 -77.77 1.48 Allowed Glycine 0 CA--C 1.535 1.284 0 C-N-CA 126.048 1.785 . . . . 0.0 113.899 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -135.22 -10.17 2.24 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.36 1.864 . . . . 0.0 113.754 -178.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 42.1 p -122.61 170.07 10.39 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.418 2.287 . . . . 0.0 110.084 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -157.33 170.19 34.45 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.893 -1.129 . . . . 0.0 114.186 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -119.99 145.19 47.02 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.619 1.968 . . . . 0.0 112.231 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 35.3 tp -121.71 153.07 38.69 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.832 2.053 . . . . 0.0 109.962 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 25.1 ttt 82.44 68.97 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 128.483 2.713 . . . . 0.0 112.42 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -160.12 151.08 19.09 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 129.169 2.987 . . . . 0.0 107.192 175.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 23.0 p -85.89 174.99 8.89 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 122.397 1.094 . . . . 0.0 111.195 175.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -63.37 -33.68 76.07 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.482 -0.761 . . . . 0.0 110.726 177.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 21.3 m -68.28 -48.52 64.78 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 117.39 -1.29 . . . . 0.0 110.655 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 31.4 m -48.33 -54.72 12.82 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 120.373 1.442 . . . . 0.0 110.007 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -59.8 -43.31 94.53 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.633 1.573 . . . . 0.0 113.12 177.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -64.61 -40.97 96.43 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.752 -1.217 . . . . 0.0 111.631 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -59.67 -55.41 34.75 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.151 1.38 . . . . 0.0 110.921 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.4 pp -62.46 -32.75 73.67 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -69.58 -43.66 72.38 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.826 1.25 . . . . 0.0 113.069 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -54.8 -38.79 67.76 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.713 1.605 . . . . 0.0 111.868 177.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -91.76 -0.2 57.53 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.566 1.946 . . . . 0.0 113.331 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 64.8 t30 47.74 45.84 18.27 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 128.429 2.692 . . . . 0.0 112.627 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm -70.12 126.39 92.38 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.159 1.384 . . . . 0.0 113.148 -177.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.89 129.29 12.3 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 122.843 2.362 . . . . 0.0 107.91 170.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 53.6 t -31.94 123.89 0.37 Allowed Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 127.337 2.255 . . . . 0.0 114.655 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.51 -1.68 7.0 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.2 2.6 . . . . 0.0 114.136 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 48.2 t -122.6 -60.96 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.913 1.685 . . . . 0.0 111.002 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 86.0 m -76.54 -19.13 58.25 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.468 1.907 . . . . 0.0 113.319 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 62.29 6.78 1.99 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 127.18 2.192 . . . . 0.0 113.81 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -75.67 146.27 79.88 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 125.843 1.657 . . . . 0.0 113.382 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -78.02 120.19 4.93 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 124.159 3.239 . . . . 0.0 111.656 177.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.5 pp -63.09 141.48 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.055 0.942 . . . . 0.0 112.785 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -115.1 -45.64 2.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.462 1.505 . . . . 0.0 114.495 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.52 169.1 25.43 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -173.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 4.7 mt -133.65 143.43 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 128.453 2.701 . . . . 0.0 108.451 175.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 15.4 m -139.95 150.17 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.957 1.703 . . . . 0.0 111.214 177.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.33 99.95 2.05 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 176.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.94 102.39 14.75 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.364 1.066 . . . . 0.0 110.757 -176.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -72.53 143.13 48.44 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.656 1.182 . . . . 0.0 112.41 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -66.42 166.81 15.28 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 126.126 1.77 . . . . 0.0 112.201 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo . . . . . 0 C--N 1.354 0.819 0 C-N-CA 124.136 3.224 . . . . 0.0 114.398 -179.302 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 CA--C 1.549 1.24 0 N-CA-C 113.09 0.381 . . . . 0.0 113.09 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 12.5 t -56.41 173.03 0.19 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.002 1.721 . . . . 0.0 113.607 177.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.37 1.82 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 -175.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 15.0 mt -121.73 -60.99 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 120.39 1.45 . . . . 0.0 113.016 -177.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 12.9 p -54.34 -78.49 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.528 1.531 . . . . 0.0 114.607 -177.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -150.63 -12.86 0.24 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 127.34 2.256 . . . . 0.0 113.19 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 96.73 45.74 2.63 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.388 0.995 . . . . 0.0 113.187 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -84.33 155.34 63.18 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 126.095 1.758 . . . . 0.0 111.265 175.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -39.96 125.37 1.65 Allowed 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.716 3.611 . . . . 0.0 114.541 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -67.37 63.97 0.07 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.977 2.911 . . . . 0.0 113.5 -177.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -109.09 89.82 3.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.585 1.154 . . . . 0.0 108.034 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 164.66 51.58 0.02 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.155 0.884 . . . . 0.0 112.85 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 42.5 t -61.32 141.45 57.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.31 1.055 . . . . 0.0 109.887 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.11 137.79 47.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 125.717 1.607 . . . . 0.0 110.104 -174.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 83.0 t -126.52 128.81 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.006 0.923 . . . . 0.0 112.116 -177.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -111.31 94.89 5.2 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.713 2.805 . . . . 0.0 109.318 173.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.31 -96.02 0.32 Allowed Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.657 1.599 . . . . 0.0 114.186 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -112.51 0.93 15.67 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.374 1.87 . . . . 0.0 113.565 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 49.4 p -132.15 170.04 15.56 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.959 1.704 . . . . 0.0 110.515 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -161.18 177.19 37.62 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 120.615 -1.303 . . . . 0.0 113.573 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -120.29 140.19 51.61 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.479 1.512 . . . . 0.0 112.333 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.9 92.87 3.89 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.925 1.29 . . . . 0.0 112.13 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.58 -13.59 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 119.073 2.99 . . . . 0.0 119.073 -178.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -129.52 165.42 21.7 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 119.799 1.181 . . . . 0.0 114.041 -174.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 29.8 p -78.78 168.8 19.21 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 122.541 1.162 . . . . 0.0 111.376 175.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.4 -39.4 79.6 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.36 -0.838 . . . . 0.0 112.069 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 62.6 m -60.55 -55.94 27.37 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.108 0.963 . . . . 0.0 110.025 178.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 62.8 m -57.41 -45.15 84.91 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.191 0.996 . . . . 0.0 112.087 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.55 -39.88 81.46 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.024 1.329 . . . . 0.0 112.99 174.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -71.97 -39.35 69.38 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.101 1.36 . . . . 0.0 111.16 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -56.52 -54.49 45.27 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.582 1.153 . . . . 0.0 111.965 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . 0.315 0.0 OUTLIER -63.19 -27.25 69.23 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.547 1.067 . . . . 0.0 113.317 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -70.1 -45.11 67.62 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.413 1.485 . . . . 0.0 110.275 175.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -61.31 -35.76 78.27 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.929 1.292 . . . . 0.0 111.672 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -76.93 -1.17 27.23 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 126.451 1.9 . . . . 0.0 113.338 174.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 51.8 t30 65.18 22.01 12.18 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 128.918 2.887 . . . . 0.0 114.966 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -72.56 137.22 80.58 Favored Pre-proline 0 CA--C 1.544 0.735 0 O-C-N 120.969 -1.082 . . . . 0.0 109.382 176.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -63.52 -52.47 1.9 Allowed 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.465 2.11 . . . . 0.0 112.872 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 2.4 t -153.23 142.7 14.88 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 129.252 3.021 . . . . 0.0 108.482 175.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.33 -6.67 18.7 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.141 2.561 . . . . 0.0 114.187 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.1 -71.43 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 119.997 1.271 . . . . 0.0 113.996 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 27.6 p -94.07 -5.3 47.72 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 70.1 15.32 7.65 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 127.897 2.479 . . . . 0.0 115.397 175.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -74.69 132.96 77.14 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 119.309 0.958 . . . . 0.0 109.194 173.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.01 110.28 1.47 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.947 2.431 . . . . 0.0 114.486 -175.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.4 pp -64.27 155.33 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.536 1.534 . . . . 0.0 113.21 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -114.38 -46.59 2.97 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.798 2.039 . . . . 0.0 112.74 -176.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.12 170.09 21.35 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 14.9 mt -126.05 136.6 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 127.913 2.485 . . . . 0.0 107.492 176.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 12.7 p -123.68 148.02 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.344 1.057 . . . . 0.0 113.505 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.23 99.93 0.97 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.316 1.046 . . . . 0.0 108.193 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 26.6 m -96.13 103.7 15.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.004 1.722 . . . . 0.0 113.565 -173.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -89.66 75.74 7.4 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.585 1.183 . . . . 0.0 110.477 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -63.93 -29.92 4.5 Favored Pre-proline 0 CA--C 1.554 1.113 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo . . . . . 0 C--N 1.358 1.028 0 C-N-CA 123.265 2.644 . . . . 0.0 113.898 -179.582 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo . . . . . 0 CA--C 1.556 1.607 0 N-CA-C 114.149 0.788 . . . . 0.0 114.149 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 23.8 t -63.65 148.06 49.95 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.704 1.593 . . . . 0.0 110.201 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 29.4 m -132.06 -0.46 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.001 0.921 . . . . 0.0 113.444 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 6.4 mt -134.86 -46.22 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 119.441 1.019 . . . . 0.0 112.981 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.2 m -68.8 -64.19 0.91 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -173.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -154.14 -10.32 0.14 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -175.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.26 14.36 76.84 Favored Glycine 0 CA--C 1.541 1.714 0 O-C-N 120.693 -1.254 . . . . 0.0 113.261 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -59.53 154.39 44.88 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 127.729 2.411 . . . . 0.0 112.867 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.79 68.89 7.05 Favored 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 124.081 3.187 . . . . 0.0 112.68 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -135.02 147.05 49.57 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.057 1.743 . . . . 0.0 111.457 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -128.27 141.54 51.41 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.011 1.324 . . . . 0.0 111.06 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -136.11 76.31 0.38 Allowed Glycine 0 CA--C 1.525 0.657 0 C-N-CA 126.839 2.161 . . . . 0.0 108.76 175.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 85.2 m -66.89 108.98 2.75 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.404 0.682 . . . . 0.0 110.918 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . 0.564 ' H ' HD12 ' A' ' 450' ' ' ILE . 0.8 OUTLIER -78.72 140.47 16.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 126.451 1.9 . . . . 0.0 109.993 -178.074 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 77.9 t -129.63 132.67 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.093 0.957 . . . . 0.0 110.707 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -124.61 98.31 5.67 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.691 2.796 . . . . 0.0 110.118 177.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 66.31 -95.07 0.24 Allowed Glycine 0 CA--C 1.534 1.272 0 C-N-CA 126.056 1.789 . . . . 0.0 114.057 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -113.85 1.19 14.7 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.288 1.835 . . . . 0.0 113.753 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 81.9 p -131.27 170.03 15.16 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.095 1.758 . . . . 0.0 111.258 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.4 174.26 34.2 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.023 -1.048 . . . . 0.0 113.716 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -120.32 145.0 47.54 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.026 1.331 . . . . 0.0 112.978 175.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.37 153.21 40.67 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.421 2.288 . . . . 0.0 111.263 177.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 52.0 mtt 97.5 48.96 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 130.148 3.379 . . . . 0.0 113.503 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -155.3 148.13 24.38 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.257 1.823 . . . . 0.0 109.68 176.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 7.7 p -83.3 175.18 10.08 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 122.672 1.225 . . . . 0.0 112.236 176.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -59.09 -46.8 87.36 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.02 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 88.7 m -69.13 -41.52 77.23 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 116.353 -1.784 . . . . 0.0 111.926 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 46.4 m -47.16 -59.4 3.18 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 121.522 1.965 . . . . 0.0 110.405 175.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.36 87.91 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.531 1.532 . . . . 0.0 113.689 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -60.19 -41.93 93.99 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.645 -1.284 . . . . 0.0 111.824 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -61.79 -56.6 17.8 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.26 1.824 . . . . 0.0 111.221 177.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 3.4 pp -60.48 -37.26 80.49 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.205 0.457 . . . . 0.0 111.271 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.18 -48.36 80.39 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.71 1.204 . . . . 0.0 111.753 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -58.54 -37.87 76.58 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.384 1.474 . . . . 0.0 111.636 176.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -74.98 6.08 4.49 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 127.322 2.249 . . . . 0.0 113.7 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 39.8 t30 73.41 9.81 5.06 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 129.662 3.185 . . . . 0.0 115.601 177.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -72.42 131.12 85.08 Favored Pre-proline 0 N--CA 1.474 0.768 0 O-C-N 120.791 -1.193 . . . . 0.0 109.19 175.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.07 -82.06 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.283 2.655 . . . . 0.0 109.682 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 32.3 t -123.16 130.76 24.45 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 126.672 1.989 . . . . 0.0 109.471 175.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.23 -1.39 10.52 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.328 2.685 . . . . 0.0 113.874 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 37.6 t -118.19 -78.28 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.754 1.222 . . . . 0.0 111.946 -177.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 18.5 p -89.98 0.15 57.25 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.389 1.476 . . . . 0.0 114.427 -177.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 12.4 mpt_? 62.46 6.97 2.15 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 127.883 2.473 . . . . 0.0 115.525 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -60.51 138.04 92.5 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-N 119.25 0.932 . . . . 0.0 111.172 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.23 114.28 3.37 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.196 2.597 . . . . 0.0 112.317 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 20.3 pt -76.76 158.85 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.096 1.358 . . . . 0.0 114.159 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -115.19 -43.4 3.08 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.142 1.777 . . . . 0.0 114.04 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.93 170.03 23.07 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -171.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.2 pt -141.97 145.57 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 129.923 3.289 . . . . 0.0 108.209 169.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 11.4 m -137.69 150.17 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.139 1.776 . . . . 0.0 109.619 177.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.15 99.87 0.94 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.88 142.31 27.9 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -172.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -128.48 179.63 5.55 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.231 2.212 . . . . 0.0 111.188 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -134.54 158.19 75.67 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.088 1.355 . . . . 0.0 111.407 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 C--N 1.352 0.743 0 C-N-CA 123.2 2.6 . . . . 0.0 111.381 -179.561 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo . . . . . 0 CA--C 1.553 1.437 0 CA-C-O 118.805 -0.581 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 35.3 t -65.22 153.3 41.39 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 120.466 1.484 . . . . 0.0 110.014 174.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 67.5 t -129.09 -14.59 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.656 1.582 . . . . 0.0 111.848 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 7.1 mt -133.24 -45.8 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.2 m -67.44 -65.19 0.72 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.465 1.506 . . . . 0.0 113.981 -173.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -146.8 -12.55 0.44 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 76.82 10.56 86.01 Favored Glycine 0 CA--C 1.545 1.949 0 CA-C-N 119.893 1.224 . . . . 0.0 112.418 -173.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -58.45 154.34 33.96 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 129.424 3.09 . . . . 0.0 112.866 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -77.32 68.69 7.41 Favored 'Trans proline' 0 CA--C 1.549 1.246 0 C-N-CA 124.146 3.231 . . . . 0.0 113.031 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -131.61 149.03 52.64 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.821 2.049 . . . . 0.0 110.681 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -128.03 149.99 50.13 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.166 1.387 . . . . 0.0 111.077 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -155.06 84.89 0.14 Allowed Glycine 0 CA--C 1.531 1.047 0 C-N-CA 127.038 2.256 . . . . 0.0 111.163 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 42.0 t -67.73 120.27 13.81 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.2 1.0 . . . . 0.0 110.148 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.68 139.7 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 125.561 1.544 . . . . 0.0 109.918 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 93.6 t -130.07 127.6 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.748 1.219 . . . . 0.0 108.748 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -125.2 95.09 4.35 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.886 2.074 . . . . 0.0 111.632 177.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 71.55 -87.28 0.43 Allowed Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.689 1.614 . . . . 0.0 115.172 178.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -122.52 -4.36 8.78 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.25 1.82 . . . . 0.0 113.765 -177.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 30.0 p -129.66 170.16 14.16 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.648 2.379 . . . . 0.0 110.056 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -158.69 171.27 35.37 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 120.981 -1.074 . . . . 0.0 113.505 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -120.02 137.43 54.1 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.936 1.694 . . . . 0.0 112.838 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 33.2 tp -121.63 153.16 38.47 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 129.023 2.929 . . . . 0.0 110.054 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 19.7 mmt 80.89 57.37 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.617 2.367 . . . . 0.0 112.959 177.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -154.0 153.56 32.18 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 128.222 2.609 . . . . 0.0 109.493 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 10.3 p -85.51 175.07 9.03 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 122.343 1.068 . . . . 0.0 111.926 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.24 -36.76 85.14 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.705 -0.664 . . . . 0.0 112.374 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 87.0 m -73.61 -42.11 61.95 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 117.074 -1.441 . . . . 0.0 111.142 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 55.3 m -48.57 -54.91 12.68 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 120.638 1.563 . . . . 0.0 109.548 172.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -60.72 -49.75 76.26 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.142 1.777 . . . . 0.0 113.262 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -58.97 -41.09 86.7 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.796 1.238 . . . . 0.0 111.734 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -58.9 -55.26 37.43 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.41 1.084 . . . . 0.0 110.552 176.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.73 -30.47 71.44 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -69.03 -47.81 64.49 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.213 1.405 . . . . 0.0 112.377 174.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -59.53 -40.49 87.35 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.811 1.244 . . . . 0.0 111.407 176.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -75.23 -7.89 55.12 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.721 1.609 . . . . 0.0 112.93 174.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 51.68 43.59 29.79 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 128.823 2.849 . . . . 0.0 112.091 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -70.05 117.64 55.97 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 125.238 1.415 . . . . 0.0 112.095 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -80.93 74.4 5.56 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 124.558 3.505 . . . . 0.0 111.193 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 30.7 t 22.4 105.13 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 130.561 3.544 . . . . 0.0 117.093 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.03 -19.5 8.78 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.79 2.993 . . . . 0.0 115.681 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 46.6 t -102.82 -63.68 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.52 1.928 . . . . 0.0 112.219 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 84.8 m -78.25 -18.75 54.95 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.288 1.835 . . . . 0.0 113.871 -176.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 63.24 7.01 2.61 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.878 2.471 . . . . 0.0 114.074 -176.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -83.84 149.59 57.02 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 124.302 1.041 . . . . 0.0 112.793 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.78 124.23 9.56 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.528 2.819 . . . . 0.0 112.212 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.99 117.23 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 126.671 1.988 . . . . 0.0 110.388 177.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -115.1 -46.32 2.91 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -174.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 1.1 ttp -143.18 155.1 44.47 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.699 1.136 . . . . 0.0 113.419 -174.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 12.8 mt -138.14 136.23 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 127.063 2.145 . . . . 0.0 109.506 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 16.2 m -138.65 150.18 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 125.5 1.52 . . . . 0.0 112.761 176.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 1.5 tt -74.95 99.95 3.99 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.313 1.045 . . . . 0.0 109.346 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 7.4 t -90.13 155.35 19.1 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -134.39 162.89 30.97 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.642 1.977 . . . . 0.0 112.703 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -93.4 167.64 13.63 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 125.277 1.431 . . . . 0.0 110.89 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo . . . . . 0 C--N 1.351 0.675 0 C-N-CA 124.1 3.2 . . . . 0.0 113.72 -179.854 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo . . . . . 0 CA--C 1.552 1.404 0 CA-C-O 121.024 0.343 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 1.7 t -68.53 166.42 17.02 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 126.114 1.766 . . . . 0.0 109.966 169.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 99.3 t -127.03 -18.5 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 O-C-N 120.346 -1.471 . . . . 0.0 111.971 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 8.3 mt -133.03 -47.06 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 119.43 1.014 . . . . 0.0 113.707 -172.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.4 m -62.86 -54.83 32.73 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.163 1.385 . . . . 0.0 113.222 -175.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -160.46 -12.75 0.05 Allowed 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 85.8 1.22 87.3 Favored Glycine 0 CA--C 1.542 1.775 0 O-C-N 120.731 -1.231 . . . . 0.0 113.533 -176.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -59.16 154.98 37.39 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 129.301 3.04 . . . . 0.0 114.034 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.41 115.67 4.38 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.413 2.742 . . . . 0.0 111.685 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -171.12 146.14 2.36 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 129.162 2.985 . . . . 0.0 108.773 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -112.12 150.21 31.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 128.091 2.557 . . . . 0.0 113.216 -174.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 171.08 82.76 0.05 OUTLIER Glycine 0 CA--C 1.532 1.094 0 C-N-CA 126.263 1.887 . . . . 0.0 112.587 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.32 144.22 55.98 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.139 0.97 . . . . 0.0 110.776 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 3.0 mp -115.09 140.86 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.387 1.475 . . . . 0.0 110.371 -177.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 98.7 t -130.06 130.23 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.12 0.968 . . . . 0.0 109.256 175.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -124.97 95.14 4.39 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.521 2.328 . . . . 0.0 111.141 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.96 -88.17 0.38 Allowed Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.069 1.795 . . . . 0.0 114.197 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -123.4 -1.63 8.59 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 126.567 1.947 . . . . 0.0 113.465 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 16.4 p -127.04 170.1 12.68 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.423 2.289 . . . . 0.0 110.373 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -158.75 176.44 35.63 Favored Glycine 0 CA--C 1.531 1.085 0 O-C-N 120.992 -1.067 . . . . 0.0 114.046 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -120.19 142.39 49.04 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.884 1.674 . . . . 0.0 112.059 177.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 45.7 tp -129.66 150.49 50.96 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.476 2.31 . . . . 0.0 109.962 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 27.8 mtm 76.21 58.41 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 129.495 3.118 . . . . 0.0 112.18 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -148.83 153.96 38.84 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.033 2.133 . . . . 0.0 110.561 177.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 14.3 p -83.36 169.38 15.69 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 122.345 1.069 . . . . 0.0 112.79 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -65.49 -37.6 87.29 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.747 -0.595 . . . . 0.0 111.768 178.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 27.6 m -63.58 -46.26 86.67 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 117.388 -1.292 . . . . 0.0 111.787 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 46.2 m -48.52 -56.1 9.23 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 120.417 1.462 . . . . 0.0 110.453 174.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -60.64 -43.54 97.43 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.974 1.709 . . . . 0.0 113.08 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -62.55 -42.3 99.45 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.642 1.177 . . . . 0.0 111.616 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -59.73 -56.47 21.41 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.185 1.394 . . . . 0.0 111.083 176.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.2 pp -62.39 -35.3 78.76 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 119.23 -0.414 . . . . 0.0 111.793 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.6 -48.12 76.11 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.358 0.981 . . . . 0.0 112.047 175.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -56.4 -43.53 79.39 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.676 1.59 . . . . 0.0 111.554 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -76.58 -5.23 46.83 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.382 1.873 . . . . 0.0 113.59 176.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 54.7 36.69 26.78 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 127.68 2.392 . . . . 0.0 111.734 -176.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -81.31 114.88 52.72 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 126.642 1.977 . . . . 0.0 111.835 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.34 129.33 17.84 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.292 1.995 . . . . 0.0 108.121 172.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 42.6 t -12.88 117.78 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 129.739 3.216 . . . . 0.0 116.19 -177.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.3 -0.13 2.65 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 123.141 2.561 . . . . 0.0 114.694 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 53.1 t -123.21 -60.11 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.145 1.778 . . . . 0.0 111.216 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 82.1 m -79.17 -15.29 58.3 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.499 1.92 . . . . 0.0 113.557 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . 0.295 51.8 ptt85 53.52 17.05 1.05 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 128.175 2.59 . . . . 0.0 115.029 -174.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -85.26 150.13 53.99 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 124.226 1.011 . . . . 0.0 112.335 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.3 118.4 5.66 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.703 2.936 . . . . 0.0 112.167 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.64 129.01 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 125.354 1.461 . . . . 0.0 111.149 178.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -109.54 -41.52 4.56 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -177.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.04 166.97 31.19 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 5.4 mt -135.17 138.67 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 127.471 2.309 . . . . 0.0 108.943 177.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 17.0 m -139.8 150.0 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 64.8 mt -73.8 99.86 3.3 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 176.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 14.4 t -98.12 150.69 21.17 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.768 0.827 . . . . 0.0 112.844 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -144.4 172.79 12.46 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.3 1.84 . . . . 0.0 111.661 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -117.99 162.11 31.12 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.442 1.097 . . . . 0.0 111.878 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo . . . . . 0 C--N 1.353 0.785 0 C-N-CA 124.243 3.295 . . . . 0.0 114.054 179.796 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo . . . . . 0 CA--C 1.544 0.993 0 N-CA-C 114.932 1.089 . . . . 0.0 114.932 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 1.5 t -50.69 142.7 10.74 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.563 1.545 . . . . 0.0 111.356 176.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.3 -1.22 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.934 1.294 . . . . 0.0 114.012 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 19.4 mt -123.21 -53.38 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.838 0.855 . . . . 0.0 112.027 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 2.4 m -71.88 -69.83 0.37 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.437 1.495 . . . . 0.0 114.355 -172.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -159.89 -1.16 0.07 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 -176.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 91.61 11.78 60.26 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-N 120.222 1.374 . . . . 0.0 113.998 -177.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -59.71 155.23 41.76 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 127.391 2.276 . . . . 0.0 112.76 176.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.11 146.55 37.95 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.468 2.779 . . . . 0.0 113.935 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.91 36.8 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -81.11 89.8 6.0 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.368 -1.457 . . . . 0.0 108.968 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 162.85 57.56 0.02 OUTLIER Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.762 1.649 . . . . 0.0 111.208 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 53.5 t -61.32 134.86 57.41 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.382 0.673 . . . . 0.0 110.254 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.23 137.23 37.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 126.248 1.819 . . . . 0.0 109.71 -176.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 86.0 t -130.06 129.06 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.011 0.924 . . . . 0.0 109.061 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -125.17 95.41 4.48 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.762 2.025 . . . . 0.0 111.701 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 73.19 -85.79 0.59 Allowed Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.844 1.688 . . . . 0.0 114.963 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 454' ' ' LYS . . . . . 0.452 ' HA ' ' HE2' ' B' ' 454' ' ' LYS . 0.6 OUTLIER -123.97 -7.66 7.79 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.188 1.795 . . . . 0.0 113.584 -177.418 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 28.1 p -125.51 170.1 11.77 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 127.179 2.192 . . . . 0.0 110.65 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -154.72 174.95 32.96 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 121.28 -0.888 . . . . 0.0 114.084 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -120.25 142.56 48.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.359 1.463 . . . . 0.0 113.446 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.5 pp -129.58 153.29 48.21 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.306 2.643 . . . . 0.0 110.625 177.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 28.9 tpp 93.8 -7.09 0.13 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 128.976 2.91 . . . . 0.0 113.442 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -99.99 144.9 28.5 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.394 1.078 . . . . 0.0 109.404 175.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 15.4 p -82.35 174.42 11.14 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 122.196 0.998 . . . . 0.0 112.591 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.08 -37.07 78.83 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.499 -0.75 . . . . 0.0 112.16 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 60.5 m -73.69 -41.85 62.08 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 117.751 -1.119 . . . . 0.0 110.767 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 27.6 m -53.07 -57.3 10.87 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.767 1.167 . . . . 0.0 109.172 171.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -50.56 -48.34 57.52 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.243 1.817 . . . . 0.0 112.967 176.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -61.21 -30.29 70.34 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.306 1.442 . . . . 0.0 112.635 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -61.26 -43.62 98.58 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.424 1.011 . . . . 0.0 111.55 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -57.55 -39.61 77.04 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.427 0.691 . . . . 0.0 110.219 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -68.65 -50.75 48.74 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.987 0.515 . . . . 0.0 111.841 176.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -53.97 -45.04 71.25 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.892 1.677 . . . . 0.0 112.156 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -82.93 -7.62 59.65 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 126.501 1.92 . . . . 0.0 113.584 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 50.33 50.72 18.17 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 127.813 2.445 . . . . 0.0 111.292 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -100.73 115.7 65.03 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 126.572 1.949 . . . . 0.0 113.323 -175.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.57 129.13 19.4 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 122.51 2.14 . . . . 0.0 107.823 171.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 48.3 t -17.02 118.97 0.06 OUTLIER Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 129.951 3.3 . . . . 0.0 116.447 -174.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -65.16 0.73 2.44 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.554 2.836 . . . . 0.0 114.277 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 43.3 t -127.61 -60.41 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.7 1.6 . . . . 0.0 111.283 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 63.2 m -77.5 -16.04 58.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.58 1.952 . . . . 0.0 113.637 -177.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 60.0 7.8 1.27 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 127.239 2.216 . . . . 0.0 114.401 -175.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -79.19 149.36 72.74 Favored Pre-proline 0 CA--C 1.547 0.842 0 O-C-N 121.461 -0.774 . . . . 0.0 112.117 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.3 123.28 10.1 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.027 2.485 . . . . 0.0 110.788 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.75 109.97 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 125.205 1.402 . . . . 0.0 109.761 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -96.55 -58.17 2.12 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.571 1.149 . . . . 0.0 113.541 -174.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.49 162.97 34.43 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -177.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 13.3 mt -137.41 136.64 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 127.316 2.246 . . . . 0.0 108.599 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 19.4 m -136.25 150.19 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.473 1.109 . . . . 0.0 113.5 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 5.1 tt -68.27 103.15 1.52 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.668 1.587 . . . . 0.0 107.654 175.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 5.7 t -98.02 161.75 13.57 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -175.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -129.77 130.59 45.57 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.457 1.903 . . . . 0.0 111.254 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 490' ' ' PHE . . . . . 0.509 ' H ' ' CD ' ' B' ' 491' ' ' PRO . 44.3 p90 -134.03 -27.36 0.02 OUTLIER Pre-proline 0 CA--C 1.551 1.011 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -178.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 491' ' ' PRO . . . . . 0.509 ' CD ' ' H ' ' B' ' 490' ' ' PHE . 89.2 Cg_exo . . . . . 0 C--N 1.359 1.121 0 C-N-CA 123.182 2.588 . . . . 0.0 114.321 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo . . . . . 0 CA--C 1.536 0.584 0 N-CA-C 116.187 1.572 . . . . 0.0 116.187 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 46.3 t -56.65 144.48 32.07 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 120.607 1.548 . . . . 0.0 111.153 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 32.1 m -123.1 -15.31 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 10.2 pt -137.52 -25.73 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 441' ' ' CYS . . . . . 0.419 ' CB ' HH21 ' A' ' 444' ' ' ARG . 3.7 m -75.23 -65.3 0.9 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 120.72 1.6 . . . . 0.0 111.709 -177.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -145.98 -11.13 0.5 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 78.23 9.69 86.79 Favored Glycine 0 CA--C 1.546 1.978 0 CA-C-N 120.35 1.432 . . . . 0.0 112.824 -174.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . 0.419 HH21 ' CB ' ' A' ' 441' ' ' CYS . 26.4 ptt180 -57.94 155.24 24.62 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 131.565 3.946 . . . . 0.0 114.164 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.6 -5.85 15.21 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 124.33 3.353 . . . . 0.0 115.495 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -54.58 139.77 37.18 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.503 1.921 . . . . 0.0 110.461 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.14 150.1 50.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.182 1.793 . . . . 0.0 112.855 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -157.39 88.14 0.12 Allowed Glycine 0 CA--C 1.532 1.119 0 C-N-CA 126.306 1.907 . . . . 0.0 112.32 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 48.9 t -65.16 133.06 50.74 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 117.765 0.782 . . . . 0.0 110.647 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -110.9 144.22 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.931 1.692 . . . . 0.0 110.948 -177.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 72.7 t -129.92 134.63 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.528 1.131 . . . . 0.0 111.624 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.23 97.35 5.19 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 128.894 2.877 . . . . 0.0 110.569 174.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 65.46 -99.31 0.38 Allowed Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.859 1.695 . . . . 0.0 114.349 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -103.68 -6.29 21.72 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.032 1.733 . . . . 0.0 113.582 -178.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 44.4 p -131.5 170.07 15.21 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.384 1.473 . . . . 0.0 111.422 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -151.55 173.42 30.89 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.313 1.435 . . . . 0.0 112.216 178.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -120.06 146.48 45.87 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.222 1.009 . . . . 0.0 113.451 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.15 153.16 27.42 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.34 2.656 . . . . 0.0 111.721 -177.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 6.8 tpt 71.69 65.01 0.15 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.275 2.23 . . . . 0.0 114.323 174.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -150.9 154.93 38.1 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.635 2.374 . . . . 0.0 109.374 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 1.8 p -90.28 171.1 9.72 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.218 0.917 . . . . 0.0 111.195 174.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -65.43 -36.6 84.42 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.325 -0.859 . . . . 0.0 111.345 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 32.6 m -70.02 -42.4 73.03 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 117.623 -1.18 . . . . 0.0 110.944 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 56.4 m -50.07 -61.16 2.31 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.693 1.197 . . . . 0.0 108.642 173.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.0 -45.29 75.07 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.783 1.633 . . . . 0.0 113.251 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -58.61 -37.21 75.38 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.661 1.185 . . . . 0.0 112.316 178.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -58.37 -44.12 88.71 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.271 1.028 . . . . 0.0 111.06 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 6.7 mp -65.62 -45.09 84.42 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.008 0.523 . . . . 0.0 109.924 174.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -56.27 -47.4 78.65 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.51 1.524 . . . . 0.0 113.972 -176.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -54.96 -27.71 45.83 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -120.04 8.89 11.07 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 127.561 2.345 . . . . 0.0 113.187 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 38.36 60.67 1.26 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 128.509 2.724 . . . . 0.0 112.879 -174.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -69.94 118.77 66.54 Favored Pre-proline 0 N--CA 1.473 0.68 0 C-N-CA 125.485 1.514 . . . . 0.0 113.225 -176.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -55.44 121.91 10.77 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.319 2.679 . . . . 0.0 109.088 170.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 53.2 t -29.68 121.12 0.3 Allowed Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 128.413 2.685 . . . . 0.0 115.32 -174.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -66.41 -3.97 9.86 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 122.901 2.4 . . . . 0.0 113.907 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 39.2 t -107.15 -64.75 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.472 1.509 . . . . 0.0 111.294 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 24.6 p -107.8 3.27 24.28 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -176.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 71.8 mtp85 63.64 8.66 3.81 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 128.182 2.593 . . . . 0.0 116.424 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -71.22 147.84 93.51 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 123.882 0.873 . . . . 0.0 111.853 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.7 106.83 2.34 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.609 2.872 . . . . 0.0 112.607 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 pp -59.65 135.82 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.704 1.202 . . . . 0.0 111.246 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -115.15 -30.74 6.24 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -177.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.29 165.62 34.34 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -175.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 6.9 mt -133.25 140.19 47.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 127.611 2.365 . . . . 0.0 108.269 176.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 9.5 m -126.83 146.92 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.032 0.933 . . . . 0.0 111.728 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.05 99.82 4.73 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 6.4 t -92.57 172.73 8.18 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.676 0.79 . . . . 0.0 113.095 -175.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -149.41 171.21 16.93 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.135 2.174 . . . . 0.0 111.217 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -138.73 154.13 72.77 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.507 1.523 . . . . 0.0 110.521 176.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 CA--C 1.538 0.718 0 C-N-CA 123.458 2.772 . . . . 0.0 112.497 -179.765 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo . . . . . 0 CA--C 1.549 1.273 0 N-CA-C 112.522 0.162 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.26 166.71 0.54 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.549 1.539 . . . . 0.0 114.047 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 30.0 m -130.88 -3.66 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -175.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 32.9 mm -111.79 -61.29 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.464 1.106 . . . . 0.0 111.33 -177.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.2 m -62.96 -80.14 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 128.198 2.599 . . . . 0.0 114.626 -172.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -144.12 -5.59 0.77 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.092 1.357 . . . . 0.0 114.59 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 78.83 35.28 31.9 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 119.813 1.188 . . . . 0.0 111.281 -174.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 444' ' ' ARG . . . . . 0.419 ' NH2' ' H ' ' B' ' 463' ' ' THR . 14.5 ptt180 -87.69 155.31 53.46 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 128.518 2.727 . . . . 0.0 111.843 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -43.47 125.99 5.01 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 124.06 3.173 . . . . 0.0 114.059 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 41.69 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 130.392 3.477 . . . . 0.0 117.06 -177.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -81.74 89.85 6.32 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.178 -1.576 . . . . 0.0 109.735 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 168.48 59.33 0.03 OUTLIER Glycine 0 CA--C 1.529 0.935 0 C-N-CA 123.96 0.791 . . . . 0.0 113.464 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 42.6 t -58.58 134.95 57.19 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.367 1.084 . . . . 0.0 110.205 178.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.1 mp -106.1 133.77 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 126.207 1.803 . . . . 0.0 108.211 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 92.6 t -120.46 130.39 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 121.656 0.741 . . . . 0.0 110.001 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.01 109.98 13.62 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 128.448 2.699 . . . . 0.0 110.757 177.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 68.22 -89.78 0.21 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.736 1.636 . . . . 0.0 112.938 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.41 4.04 4.3 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.604 1.962 . . . . 0.0 114.069 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 62.8 p -127.5 170.03 13.03 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.147 1.779 . . . . 0.0 110.742 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -150.5 171.41 30.35 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 121.075 -1.015 . . . . 0.0 114.626 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -120.35 143.49 48.37 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.428 1.491 . . . . 0.0 113.975 176.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 82.8 mt -125.11 153.24 43.27 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.958 2.903 . . . . 0.0 111.243 178.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 60.8 mtt 107.15 -2.68 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 1 C-N-CA 132.027 4.131 . . . . 0.0 113.551 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -108.24 145.63 34.02 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.73 1.212 . . . . 0.0 109.87 175.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 14.8 p -82.01 174.88 10.83 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 122.796 1.284 . . . . 0.0 112.103 178.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -59.68 -37.75 79.64 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.633 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 463' ' ' THR . . . . . 0.419 ' H ' ' NH2' ' B' ' 444' ' ' ARG . 87.4 m -70.62 -44.63 66.83 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 117.326 -1.321 . . . . 0.0 110.979 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 77.3 m -50.16 -53.25 29.03 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 120.462 1.483 . . . . 0.0 109.734 171.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -59.64 -43.33 93.91 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.794 1.638 . . . . 0.0 113.294 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -63.15 -42.66 99.48 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.913 1.285 . . . . 0.0 111.044 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -59.68 -56.55 20.45 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.687 1.195 . . . . 0.0 110.944 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.62 -33.23 72.46 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 122.691 0.396 . . . . 0.0 111.928 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -68.18 -48.02 66.41 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.841 1.257 . . . . 0.0 112.38 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -58.15 -40.79 82.26 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.862 1.265 . . . . 0.0 111.355 176.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 29.0 mmt85 -76.49 -7.79 55.85 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.203 1.801 . . . . 0.0 113.475 175.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 64.0 t30 52.63 40.33 29.92 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 128.012 2.525 . . . . 0.0 112.233 -177.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -74.55 131.37 80.09 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 125.647 1.579 . . . . 0.0 112.737 -177.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -71.9 123.54 9.41 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.732 2.288 . . . . 0.0 107.924 170.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 43.9 t -14.54 119.24 0.04 OUTLIER Pre-proline 0 CA--C 1.557 1.224 0 C-N-CA 130.062 3.345 . . . . 0.0 115.994 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -65.8 -1.13 4.58 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 123.202 2.601 . . . . 0.0 114.72 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 35.6 t -114.02 -60.79 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.281 1.432 . . . . 0.0 111.919 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 28.0 p -114.77 6.69 15.63 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -176.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . 0.31 13.8 ptm180 54.07 14.86 0.77 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 129.288 3.035 . . . . 0.0 117.56 177.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -68.02 152.32 96.52 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 123.852 0.861 . . . . 0.0 111.722 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -74.1 106.17 2.17 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 124.034 3.156 . . . . 0.0 113.344 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 pp -60.21 136.14 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.621 1.169 . . . . 0.0 111.494 177.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -115.07 -40.72 3.43 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.909 1.284 . . . . 0.0 113.678 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.21 167.46 30.3 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -176.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 6.0 mt -129.79 139.08 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 127.958 2.503 . . . . 0.0 107.587 175.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 14.1 p -131.54 146.42 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.137 0.975 . . . . 0.0 112.427 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.51 99.95 1.04 Allowed 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 1.8 m -102.27 95.54 6.37 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.244 1.418 . . . . 0.0 111.687 -174.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -83.22 159.78 21.91 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.46 1.104 . . . . 0.0 113.83 -178.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -78.71 158.85 75.17 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 125.643 1.577 . . . . 0.0 112.226 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo . . . . . 0 C--N 1.353 0.797 0 C-N-CA 124.39 3.393 . . . . 0.0 113.572 178.04 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo . . . . . 0 CA--C 1.552 1.422 0 CA-C-O 120.682 0.201 . . . . 0.0 112.149 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 10.6 t -42.97 145.9 0.44 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.796 2.038 . . . . 0.0 111.972 174.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.13 -27.95 3.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 124.081 0.952 . . . . 0.0 112.613 -175.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 7.9 pt -141.39 -24.65 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 117.727 2.492 . . . . 0.0 117.727 -172.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.7 m -77.02 -64.61 1.09 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 120.617 1.553 . . . . 0.0 114.398 -174.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -153.03 -10.08 0.16 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -171.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 87.16 10.21 71.93 Favored Glycine 0 CA--C 1.541 1.691 0 CA-C-N 119.959 1.254 . . . . 0.0 113.13 -176.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -64.72 155.22 83.02 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 128.589 2.755 . . . . 0.0 113.43 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -46.72 139.51 13.7 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 124.396 3.398 . . . . 0.0 116.446 -177.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.33 13.44 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 131.436 3.894 . . . . 0.0 118.918 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.04 89.78 5.96 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.503 -1.373 . . . . 0.0 112.039 -177.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -178.59 44.58 0.09 OUTLIER Glycine 0 CA--C 1.529 0.906 0 CA-C-O 118.899 -0.945 . . . . 0.0 113.63 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 42.9 t -57.42 135.97 56.6 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.86 1.33 . . . . 0.0 110.689 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.4 mp -108.23 142.93 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 126.647 1.979 . . . . 0.0 109.037 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 95.1 t -129.76 133.41 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.419 0.628 . . . . 0.0 110.497 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -124.91 96.76 4.99 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.692 2.397 . . . . 0.0 111.087 176.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 71.54 -89.16 0.44 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 126.06 1.79 . . . . 0.0 114.075 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -124.07 0.79 8.53 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 126.238 1.815 . . . . 0.0 114.232 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 16.8 p -127.14 167.58 15.82 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.122 2.169 . . . . 0.0 109.922 178.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.51 172.18 34.23 Favored Glycine 0 CA--C 1.527 0.79 0 O-C-N 121.166 -0.959 . . . . 0.0 113.985 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -119.97 137.28 54.16 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.249 1.82 . . . . 0.0 111.192 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 60.0 tp -133.12 153.35 51.6 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.005 2.122 . . . . 0.0 111.601 -173.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 459' ' ' MET . . . . . . . . . . . . 0.256 29.4 mtt 81.89 56.7 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.204 2.202 . . . . 0.0 113.104 178.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -158.84 150.61 20.92 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 130.398 3.479 . . . . 0.0 106.824 176.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 16.1 p -78.08 171.22 15.34 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 123.164 1.459 . . . . 0.0 113.582 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.81 -36.92 77.77 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.835 175.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 11.4 m -66.66 -47.22 73.2 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 117.413 -1.279 . . . . 0.0 110.943 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 49.5 m -49.86 -52.79 30.01 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 120.53 1.514 . . . . 0.0 109.664 173.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -60.11 -43.03 95.9 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.665 1.586 . . . . 0.0 113.37 176.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -64.79 -40.68 95.63 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.63 -1.294 . . . . 0.0 111.43 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -61.95 -56.47 18.84 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.519 1.127 . . . . 0.0 110.835 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.2 pp -58.46 -33.49 69.81 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 118.461 0.573 . . . . 0.0 112.163 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -66.75 -50.38 62.94 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.216 1.406 . . . . 0.0 112.02 174.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -58.23 -38.39 76.75 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.434 1.094 . . . . 0.0 111.643 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -78.16 -1.67 33.83 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 127.051 2.14 . . . . 0.0 113.351 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.34 37.24 5.66 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 129.04 2.936 . . . . 0.0 113.922 -177.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -70.11 116.56 45.6 Favored Pre-proline 0 CA--C 1.539 0.519 0 C-N-CA 126.412 1.885 . . . . 0.0 113.734 -177.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.31 139.11 37.57 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 N-CA-C 106.799 -2.039 . . . . 0.0 106.799 169.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 53.2 t -38.63 121.91 1.15 Allowed Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 126.32 1.848 . . . . 0.0 114.37 -176.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.2 -1.24 7.66 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.063 2.509 . . . . 0.0 114.045 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 48.2 t -122.15 -60.57 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.711 1.604 . . . . 0.0 111.333 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 64.5 m -76.49 -17.84 59.07 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.731 2.012 . . . . 0.0 112.841 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 73.8 mtp85 64.52 5.38 2.64 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 127.635 2.374 . . . . 0.0 114.203 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -84.54 147.22 48.93 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.107 0.963 . . . . 0.0 113.386 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.1 120.08 5.89 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.485 2.79 . . . . 0.0 111.531 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.4 pp -59.0 141.14 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.541 1.137 . . . . 0.0 111.436 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -115.01 -38.25 3.93 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -177.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.44 167.05 31.64 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -176.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 14.2 mt -131.95 143.14 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 127.639 2.376 . . . . 0.0 108.7 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 8.4 m -134.12 150.16 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.336 1.455 . . . . 0.0 112.6 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -72.78 99.9 2.74 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 3.5 m -88.0 104.88 17.06 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -172.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -78.57 166.48 22.51 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.14 1.776 . . . . 0.0 110.701 173.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -123.15 170.45 8.23 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 126.095 1.758 . . . . 0.0 111.364 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo . . . . . 0 C--N 1.351 0.681 0 C-N-CA 123.92 3.08 . . . . 0.0 113.688 -178.713 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo . . . . . 0 CA--C 1.538 0.709 0 N-CA-C 114.186 0.802 . . . . 0.0 114.186 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 438' ' ' CYS . . . . . 0.414 ' SG ' ' N ' ' B' ' 439' ' ' VAL . 18.6 t -70.43 -175.23 0.98 Allowed 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 122.22 1.01 . . . . 0.0 112.601 175.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 439' ' ' VAL . . . . . 0.414 ' N ' ' SG ' ' B' ' 438' ' ' CYS . 3.6 p -144.4 2.75 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 126.446 1.898 . . . . 0.0 112.749 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 41.9 mt -113.97 -61.14 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.259 1.024 . . . . 0.0 111.408 -175.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 8.1 p -56.35 -83.23 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.593 1.557 . . . . 0.0 113.526 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -147.53 -7.68 0.44 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 129.867 3.267 . . . . 0.0 112.577 -177.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 85.49 39.23 8.41 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.011 0.823 . . . . 0.0 113.073 -177.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -66.1 152.33 94.02 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 124.957 1.303 . . . . 0.0 111.191 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.82 66.7 5.84 Favored 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 124.546 3.497 . . . . 0.0 113.667 -176.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -141.52 145.89 35.71 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.9 2.48 . . . . 0.0 110.374 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.29 144.74 51.16 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.103 1.761 . . . . 0.0 112.379 176.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -156.9 87.28 0.12 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 126.632 2.063 . . . . 0.0 110.781 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 45.4 t -62.09 137.16 58.21 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 117.606 0.703 . . . . 0.0 110.969 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -114.93 148.64 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 126.301 1.84 . . . . 0.0 110.174 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 38.7 t -117.69 140.97 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.071 1.348 . . . . 0.0 109.071 174.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -125.18 94.86 4.29 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.794 2.438 . . . . 0.0 107.569 175.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 62.25 -91.7 0.07 OUTLIER Glycine 0 CA--C 1.542 1.745 0 C-N-CA 124.648 1.118 . . . . 0.0 113.612 -176.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 50.4 mmtm -120.98 6.64 10.35 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 127.612 2.365 . . . . 0.0 113.296 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 30.3 p -120.73 170.22 9.65 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 128.172 2.589 . . . . 0.0 109.501 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.17 170.0 33.79 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 120.368 -1.458 . . . . 0.0 113.328 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.23 145.48 46.98 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.606 1.162 . . . . 0.0 114.135 177.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 3.6 pp -116.13 153.21 32.18 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.488 1.915 . . . . 0.0 112.421 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 21.6 ttt 70.55 66.14 0.19 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.611 2.364 . . . . 0.0 113.88 176.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -154.52 145.89 23.01 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 128.247 2.619 . . . . 0.0 107.802 175.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 29.1 p -79.54 164.96 23.46 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 120.71 1.595 . . . . 0.0 112.398 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -63.81 -34.75 78.6 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.138 177.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 37.3 m -62.55 -57.62 10.47 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.517 1.127 . . . . 0.0 110.51 176.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 33.1 m -54.12 -47.31 71.97 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 120.057 1.299 . . . . 0.0 112.469 176.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.64 -44.27 90.01 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.779 0.832 . . . . 0.0 112.554 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -64.98 -40.66 95.3 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.749 -1.22 . . . . 0.0 111.479 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -59.63 -56.61 19.76 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.927 1.291 . . . . 0.0 111.072 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.1 pp -61.84 -34.33 75.76 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -65.19 -48.97 71.56 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.402 1.081 . . . . 0.0 112.154 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -52.26 -43.69 64.5 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.739 1.616 . . . . 0.0 112.639 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -90.81 4.7 50.98 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.517 1.527 . . . . 0.0 114.141 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 65.4 t30 49.87 40.81 21.56 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.796 2.438 . . . . 0.0 113.366 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -71.04 117.23 54.43 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 126.215 1.806 . . . . 0.0 111.582 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.62 123.01 12.74 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.102 2.535 . . . . 0.0 108.571 171.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 42.7 t -22.98 122.14 0.16 Allowed Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 128.384 2.674 . . . . 0.0 115.887 -174.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -65.47 -2.37 6.03 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 122.817 2.345 . . . . 0.0 114.151 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 46.4 t -112.57 -61.68 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.595 1.558 . . . . 0.0 111.659 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 32.1 p -105.38 -6.86 19.2 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 61.94 11.07 3.94 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 127.693 2.397 . . . . 0.0 115.769 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -69.61 155.33 93.7 Favored Pre-proline 0 CA--C 1.554 1.118 0 O-C-N 121.22 -0.925 . . . . 0.0 111.861 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.85 116.95 4.91 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.703 2.935 . . . . 0.0 111.978 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 1.9 pp -65.31 147.91 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.452 1.101 . . . . 0.0 112.361 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -115.15 -62.8 1.55 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.201 1.8 . . . . 0.0 111.691 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.8 170.31 22.75 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.062 1.345 . . . . 0.0 113.431 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 7.3 mt -123.65 142.66 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 126.879 2.072 . . . . 0.0 109.038 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 9.4 m -138.27 150.14 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.788 1.235 . . . . 0.0 112.714 176.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 58.7 tp -69.85 99.9 1.46 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.003 1.321 . . . . 0.0 109.385 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 7.3 t -87.28 159.47 18.78 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -142.17 124.76 15.82 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.934 2.094 . . . . 0.0 111.212 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -84.28 -31.61 0.48 Allowed Pre-proline 0 CA--C 1.555 1.138 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 175.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 C--N 1.36 1.183 0 C-N-CA 122.995 2.464 . . . . 0.0 113.8 178.708 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo . . . . . 0 CA--C 1.537 0.643 0 N-CA-C 116.002 1.501 . . . . 0.0 116.002 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 31.6 t -55.41 145.86 21.31 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 120.46 1.482 . . . . 0.0 111.645 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 15.8 m -134.85 -13.04 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.335 1.054 . . . . 0.0 113.251 177.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 24.1 mm -110.0 -43.98 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.91 1.284 . . . . 0.0 112.451 -177.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.1 m -79.89 -66.1 0.92 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -170.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -151.18 -14.31 0.21 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -174.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 84.75 12.41 74.86 Favored Glycine 0 CA--C 1.539 1.565 0 O-C-N 120.833 -1.167 . . . . 0.0 112.328 -174.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -61.52 155.11 61.17 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 127.883 2.473 . . . . 0.0 113.311 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.99 -6.38 7.76 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.32 3.347 . . . . 0.0 117.646 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -55.79 144.75 26.43 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.24 1.416 . . . . 0.0 111.161 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.12 141.11 51.58 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.545 1.938 . . . . 0.0 113.047 -176.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -163.43 82.57 0.12 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.853 1.692 . . . . 0.0 111.918 177.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 12.1 t -63.75 147.75 50.93 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.089 0.956 . . . . 0.0 110.899 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.4 mp -115.04 141.78 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 125.801 1.64 . . . . 0.0 109.376 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 80.7 t -123.35 137.21 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.489 1.116 . . . . 0.0 109.815 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -124.63 94.89 4.33 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.697 2.399 . . . . 0.0 108.044 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 60.86 -95.53 0.09 OUTLIER Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.327 1.442 . . . . 0.0 113.895 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -110.47 3.71 19.85 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.803 2.041 . . . . 0.0 113.359 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 22.1 p -126.52 170.12 12.34 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.167 1.787 . . . . 0.0 111.592 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.4 164.39 32.47 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 120.89 -1.131 . . . . 0.0 113.413 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -120.09 117.58 28.33 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.739 1.616 . . . . 0.0 111.869 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 7.3 tt -90.64 153.06 20.59 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.951 1.701 . . . . 0.0 110.863 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 3.4 tpt 86.19 64.95 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 128.274 2.63 . . . . 0.0 113.627 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -155.75 151.48 27.35 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.27 2.228 . . . . 0.0 108.987 175.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 14.1 p -89.21 175.0 7.54 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.834 0.826 . . . . 0.0 110.456 172.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.24 -38.58 91.74 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.342 -0.849 . . . . 0.0 110.972 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 38.1 m -67.66 -44.32 78.15 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 117.453 -1.26 . . . . 0.0 110.981 177.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 57.1 m -51.27 -60.22 3.36 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 120.288 1.404 . . . . 0.0 109.683 173.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -53.15 -40.5 64.34 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.197 1.799 . . . . 0.0 113.05 177.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -61.14 -31.37 71.09 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.467 1.107 . . . . 0.0 112.022 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -59.91 -51.03 71.42 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 120.106 1.321 . . . . 0.0 110.471 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -56.51 -45.07 81.25 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.088 0.955 . . . . 0.0 110.29 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -65.98 -51.94 53.96 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.632 1.173 . . . . 0.0 113.492 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -43.91 83.3 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.016 1.727 . . . . 0.0 111.673 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -79.21 -8.92 59.4 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.082 1.753 . . . . 0.0 112.962 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 48.02 47.13 19.1 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 128.058 2.543 . . . . 0.0 111.053 -175.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -87.2 123.5 69.89 Favored Pre-proline 0 N--CA 1.469 0.509 0 C-N-CA 124.711 1.205 . . . . 0.0 113.049 -174.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.47 90.69 1.1 Allowed 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 123.756 2.971 . . . . 0.0 109.599 175.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 33.7 t 18.85 113.95 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.141 1 C-N-CA 132.934 4.494 . . . . 0.0 118.115 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.98 -0.12 3.7 Favored 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 122.636 2.224 . . . . 0.0 113.759 176.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 35.2 t -110.12 -66.67 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.816 1.647 . . . . 0.0 111.616 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 28.3 p -95.68 -5.53 42.02 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 120.258 1.39 . . . . 0.0 114.604 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? 63.5 10.09 4.64 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.469 2.307 . . . . 0.0 115.172 178.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -74.81 153.66 87.06 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 124.503 1.121 . . . . 0.0 112.208 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -72.36 107.16 2.21 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.477 2.785 . . . . 0.0 111.384 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.0 pp -58.48 141.3 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.834 1.254 . . . . 0.0 111.107 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -115.09 -49.7 2.78 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -177.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.82 169.06 24.3 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -174.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 7.6 mt -131.94 139.57 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 128.496 2.719 . . . . 0.0 108.102 175.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 16.2 m -137.87 150.27 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.405 1.482 . . . . 0.0 111.615 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 60.4 tp -68.35 99.93 1.0 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.71 0.804 . . . . 0.0 108.939 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.67 90.72 3.59 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.985 1.314 . . . . 0.0 111.955 -173.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -59.8 124.48 20.3 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.349 1.46 . . . . 0.0 112.921 -179.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -68.74 159.05 83.92 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 124.609 1.164 . . . . 0.0 111.367 176.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo . . . . . 0 CA--C 1.538 0.702 0 C-N-CA 122.98 2.453 . . . . 0.0 112.412 179.184 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 CA--C 1.545 1.055 0 N-CA-C 113.948 0.711 . . . . 0.0 113.948 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 5.5 p -59.45 177.03 0.21 Allowed 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 115.961 1.838 . . . . 0.0 115.961 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 7.9 p -134.31 -9.19 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -172.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 6.9 mt -115.0 -62.56 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 119.937 1.244 . . . . 0.0 112.961 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 11.4 p -65.76 -59.31 4.03 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -174.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 18.1 tp60 -151.76 -18.27 0.19 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 -174.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 91.0 39.63 5.72 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -173.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -95.25 155.13 39.21 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 125.8 1.64 . . . . 0.0 112.787 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -48.31 126.68 14.17 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.686 2.924 . . . . 0.0 113.703 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -55.27 97.56 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 127.407 2.283 . . . . 0.0 114.635 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -128.05 89.86 2.99 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.041 1.336 . . . . 0.0 107.705 176.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 156.02 58.78 0.01 OUTLIER Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.687 1.137 . . . . 0.0 112.395 -177.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 44.3 t -57.1 115.47 2.66 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.906 1.283 . . . . 0.0 112.005 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 450' ' ' ILE . . . . . 0.431 HD12 ' H ' ' B' ' 450' ' ' ILE . 3.0 mp -88.73 122.4 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.736 1.614 . . . . 0.0 109.696 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 95.6 t -122.64 123.26 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.822 1.249 . . . . 0.0 110.483 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -108.02 101.59 10.83 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.099 2.56 . . . . 0.0 110.703 175.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.5 -88.25 0.35 Allowed Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.842 1.687 . . . . 0.0 113.759 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -129.49 6.95 5.27 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.335 1.854 . . . . 0.0 114.333 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 43.2 p -136.68 169.98 16.83 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.421 1.888 . . . . 0.0 110.367 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -161.44 169.85 37.05 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 120.618 -1.301 . . . . 0.0 114.527 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -120.21 99.94 6.89 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.992 1.717 . . . . 0.0 110.076 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.51 92.86 8.26 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 122.87 1.319 . . . . 0.0 110.709 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 28.1 ptm -156.39 1.45 0.14 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -176.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -143.84 174.67 10.62 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.085 1.354 . . . . 0.0 111.139 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 30.6 p -101.82 175.0 5.7 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 123.032 1.396 . . . . 0.0 113.734 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.02 -40.64 77.08 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.999 1.72 . . . . 0.0 112.535 -178.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 67.3 m -61.39 -53.56 55.0 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.089 0.956 . . . . 0.0 110.251 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 73.5 m -55.46 -49.12 73.32 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.387 1.075 . . . . 0.0 110.955 175.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.24 -54.91 37.47 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.708 1.203 . . . . 0.0 112.687 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -66.08 -33.83 76.68 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.025 -1.047 . . . . 0.0 112.73 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -59.75 -52.77 64.06 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.388 1.075 . . . . 0.0 110.379 176.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 22.6 mt -52.11 -51.22 59.15 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.7 1.2 . . . . 0.0 110.063 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -53.75 -49.02 69.1 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.948 1.299 . . . . 0.0 112.469 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -62.5 -40.57 97.14 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.075 1.35 . . . . 0.0 112.019 175.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 42.4 mmt180 -71.72 -6.35 40.62 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 126.401 1.88 . . . . 0.0 113.382 175.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 35.5 t30 83.87 4.14 0.81 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 130.928 3.691 . . . . 0.0 115.761 176.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -86.68 128.47 56.42 Favored Pre-proline 0 N--CA 1.475 0.775 0 CA-C-N 120.359 1.436 . . . . 0.0 109.799 176.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.16 -75.77 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.869 2.379 . . . . 0.0 111.701 178.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 41.6 t -109.26 133.3 20.83 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 126.554 1.942 . . . . 0.0 111.294 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.31 -5.39 16.14 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.337 2.691 . . . . 0.0 113.733 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 23.9 t -110.0 -76.99 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.472 1.109 . . . . 0.0 112.454 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 22.4 p -94.87 -4.99 45.97 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.862 1.665 . . . . 0.0 114.552 -176.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 65.2 13.43 8.74 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.487 2.315 . . . . 0.0 114.655 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -64.44 128.69 93.62 Favored Pre-proline 0 CA--C 1.552 1.035 0 O-C-N 121.34 -0.85 . . . . 0.0 110.793 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -49.19 113.72 1.02 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 124.536 3.49 . . . . 0.0 115.127 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.5 pp -71.7 142.58 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.776 1.231 . . . . 0.0 112.314 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -115.14 -34.87 4.88 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.733 1.613 . . . . 0.0 113.73 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 1.4 ttp -146.73 150.84 36.16 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 12.2 mt -139.07 130.81 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 128.363 2.665 . . . . 0.0 106.698 173.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 21.0 m -137.4 150.16 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 124.941 1.296 . . . . 0.0 113.573 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 5.7 tt -64.74 99.95 0.36 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.907 1.283 . . . . 0.0 109.019 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 45.6 m -95.35 113.32 24.98 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.527 1.531 . . . . 0.0 113.683 -173.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -75.46 100.85 4.62 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.07 1.348 . . . . 0.0 110.352 175.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -75.48 156.01 85.38 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 125.406 1.482 . . . . 0.0 111.585 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo . . . . . 0 C--N 1.351 0.695 0 C-N-CA 123.504 2.803 . . . . 0.0 111.566 -179.518 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 64.5 m . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.598 ' H ' ' HD2' ' A' ' 431' ' ' PRO . 58.5 tp -124.8 -47.81 0.04 OUTLIER Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 126.869 2.067 . . . . 0.0 114.49 -179.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.598 ' HD2' ' H ' ' A' ' 430' ' ' LEU . 73.3 Cg_endo -74.42 -173.74 1.58 Allowed 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 122.555 2.17 . . . . 0.0 112.643 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 59.6 tp -53.4 -22.31 7.41 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 126.657 1.983 . . . . 0.0 114.709 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 31.8 t30 -63.59 29.71 0.01 OUTLIER 'General case' 0 CA--C 1.562 1.432 0 C-N-CA 128.882 2.873 . . . . 0.0 115.79 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -135.81 25.06 3.37 Favored 'General case' 0 CA--C 1.554 1.105 0 C-N-CA 126.842 2.057 . . . . 0.0 114.012 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 88.4 mt -54.45 -50.45 57.78 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.607 1.163 . . . . 0.0 113.61 -177.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 50.76 70.43 2.01 Favored Pre-proline 0 CA--C 1.559 1.315 0 C-N-CA 126.096 1.758 . . . . 0.0 111.915 -176.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -76.63 -169.79 0.78 Allowed 'Trans proline' 0 CA--C 1.545 1.049 1 C-N-CA 125.931 4.42 . . . . 0.0 115.089 -175.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 7.6 t -51.33 156.87 1.09 Allowed 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 128.317 2.647 . . . . 0.0 111.771 173.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 3.8 p -134.82 -2.4 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 123.847 0.859 . . . . 0.0 113.019 179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 13.1 mt -131.11 -49.61 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 C-N-CA 124.622 1.169 . . . . 0.0 112.591 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.7 m -65.99 -60.69 2.59 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.689 1.196 . . . . 0.0 113.957 -174.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -160.29 -9.21 0.05 Allowed 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -176.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 85.57 16.36 64.15 Favored Glycine 0 CA--C 1.538 1.514 0 CA-C-N 119.963 1.256 . . . . 0.0 113.245 -177.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 19.7 ptp180 -64.61 151.16 92.64 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 127.003 2.121 . . . . 0.0 112.982 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -54.48 -8.05 1.04 Allowed 'Trans proline' 0 CA--C 1.544 1.018 1 C-N-CA 125.526 4.151 . . . . 0.0 119.717 -177.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -59.79 153.89 19.56 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 120.236 1.38 . . . . 0.0 112.459 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 18.5 p30 -128.12 150.2 50.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.887 2.475 . . . . 0.0 110.779 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -172.71 80.99 0.08 OUTLIER Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.665 1.126 . . . . 0.0 113.468 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 19.8 t -65.14 142.49 58.33 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-N 118.082 0.941 . . . . 0.0 110.245 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 4.0 mp -111.88 142.47 24.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 C-N-CA 125.854 1.662 . . . . 0.0 110.773 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 98.8 t -130.05 121.61 52.22 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.585 1.154 . . . . 0.0 111.303 177.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -125.3 125.43 43.51 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 128.949 2.9 . . . . 0.0 112.977 175.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 49.92 34.96 23.94 Favored Glycine 0 CA--C 1.54 1.618 0 N-CA-C 116.578 1.391 . . . . 0.0 116.578 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm 77.42 9.21 2.59 Favored 'General case' 0 N--CA 1.489 1.498 0 C-N-CA 127.711 2.404 . . . . 0.0 114.351 -178.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 78.5 p -118.58 161.7 19.62 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 127.405 2.282 . . . . 0.0 107.641 172.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -153.17 166.29 31.52 Favored Glycine 0 CA--C 1.523 0.571 0 O-C-N 119.891 -1.756 . . . . 0.0 115.668 -177.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.4 m80 -120.12 128.49 53.5 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 126.499 1.92 . . . . 0.0 112.022 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 55.3 tp -120.59 153.23 37.08 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 127.432 2.293 . . . . 0.0 111.364 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 34.2 mtm 90.72 54.27 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 129.44 3.096 . . . . 0.0 112.804 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -155.73 163.88 39.31 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 128.316 2.646 . . . . 0.0 108.992 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 15.3 p -91.54 175.02 7.06 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 122.896 1.332 . . . . 0.0 112.828 178.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -65.15 -36.08 83.11 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.049 177.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 25.2 m -67.39 -46.32 73.61 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 117.143 -1.408 . . . . 0.0 110.547 177.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 37.9 m -48.28 -56.46 7.96 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 120.442 1.474 . . . . 0.0 109.89 173.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.53 -52.59 65.0 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.43 1.492 . . . . 0.0 112.578 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -56.79 -42.05 78.8 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 125.459 1.503 . . . . 0.0 112.243 179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -59.31 -54.02 51.61 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.012 1.725 . . . . 0.0 110.375 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . 0.254 0.4 OUTLIER -68.09 -31.14 70.55 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 179.233 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 29.6 tptp -62.88 -56.54 16.36 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.667 1.987 . . . . 0.0 112.226 175.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -62.86 -33.49 75.38 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 79.6 mtp85 -76.42 -3.16 35.6 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 125.633 1.573 . . . . 0.0 112.179 173.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 64.2 t30 48.24 42.12 17.11 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 128.066 2.546 . . . . 0.0 112.599 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 66.8 tttt -70.52 129.64 89.91 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 124.611 1.164 . . . . 0.0 112.949 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.33 123.74 8.44 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 122.616 2.211 . . . . 0.0 108.117 170.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 25.3 t -31.14 129.52 0.27 Allowed Pre-proline 0 CA--C 1.555 1.162 0 C-N-CA 128.311 2.645 . . . . 0.0 114.289 -179.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -65.58 -3.86 8.6 Favored 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 123.286 2.658 . . . . 0.0 114.74 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 43.6 t -126.09 -59.59 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 125.281 1.432 . . . . 0.0 111.259 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 63.8 m -76.0 -19.83 58.35 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.351 1.861 . . . . 0.0 113.137 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 63.5 9.14 3.98 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 127.217 2.207 . . . . 0.0 114.028 -175.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 35.8 mt-30 -82.81 137.95 43.69 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 125.007 1.323 . . . . 0.0 112.213 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -71.85 119.35 6.15 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 123.149 2.566 . . . . 0.0 108.704 174.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 6.2 pt -66.95 147.08 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 N-CA-C 114.768 1.395 . . . . 0.0 114.768 -174.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -115.16 -35.77 4.59 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 117.112 2.264 . . . . 0.0 117.112 -174.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 1.4 ttp -145.9 151.37 37.75 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.58 0.956 . . . . 0.0 113.58 -171.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 4.4 mt -137.04 136.75 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 127.62 2.368 . . . . 0.0 109.08 176.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 15.7 m -140.04 150.02 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 124.704 1.202 . . . . 0.0 112.953 177.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 55.5 mt -69.94 99.95 1.5 Allowed 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.213 1.005 . . . . 0.0 108.612 178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 26.2 m -101.26 94.89 6.18 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 126.119 1.768 . . . . 0.0 112.464 -174.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -83.7 164.11 19.84 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.401 1.48 . . . . 0.0 113.353 -179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -120.42 164.19 24.32 Favored Pre-proline 0 CA--C 1.55 0.978 0 C-N-CA 125.546 1.538 . . . . 0.0 112.555 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo . . . . . 0 C--N 1.353 0.815 0 C-N-CA 124.482 3.454 . . . . 0.0 113.915 -179.879 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 3.2 m . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 98.5 mt -62.6 148.51 90.68 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 124.32 1.048 . . . . 0.0 113.605 -177.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -76.93 -3.68 14.05 Favored 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 123.899 3.066 . . . . 0.0 113.668 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 22.3 mt -141.76 159.92 41.24 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 128.013 2.525 . . . . 0.0 108.53 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 57.12 -10.61 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 129.76 3.224 . . . . 0.0 116.88 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -73.74 49.02 0.3 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 127.205 2.202 . . . . 0.0 113.551 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 13.1 mm -78.46 62.21 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.971 1.708 . . . . 0.0 110.034 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -73.87 158.71 85.63 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 126.746 2.018 . . . . 0.0 113.25 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -79.61 178.93 6.79 Favored 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 123.446 2.764 . . . . 0.0 112.978 177.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 438' ' ' CYS . . . . . 0.403 ' SG ' ' N ' ' B' ' 439' ' ' VAL . 40.1 t -54.59 178.06 0.03 OUTLIER 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 127.583 2.353 . . . . 0.0 113.22 175.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 439' ' ' VAL . . . . . 0.403 ' N ' ' SG ' ' B' ' 438' ' ' CYS . 7.4 p -111.76 -11.47 11.76 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 126.39 1.876 . . . . 0.0 112.343 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 7.3 mt -113.91 -66.76 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 C-N-CA 124.739 1.215 . . . . 0.0 111.341 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 17.0 p -73.57 -43.73 59.09 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 120.519 1.509 . . . . 0.0 108.869 176.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 4.8 mt-30 57.87 13.5 2.13 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 128.936 2.894 . . . . 0.0 113.903 -178.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . -85.22 -27.41 33.56 Favored Glycine 0 CA--C 1.529 0.916 0 O-C-N 121.576 -0.703 . . . . 0.0 112.459 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 10.6 ptm180 -115.5 155.12 47.62 Favored Pre-proline 0 N--CA 1.474 0.743 0 C-N-CA 126.941 2.096 . . . . 0.0 115.384 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_exo -56.84 155.17 28.56 Favored 'Trans proline' 0 CA--C 1.544 0.987 0 C-N-CA 124.094 3.196 . . . . 0.0 113.238 175.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 23.8 pttm -65.47 32.03 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 127.761 2.424 . . . . 0.0 116.148 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -81.78 89.96 6.34 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.061 -1.649 . . . . 0.0 109.822 -178.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 165.93 58.8 0.03 OUTLIER Glycine 0 CA--C 1.525 0.708 0 C-N-CA 124.36 0.981 . . . . 0.0 112.401 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 43.3 t -59.3 126.29 27.06 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 118.394 1.097 . . . . 0.0 109.99 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 2.4 mp -102.07 142.81 15.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 125.187 1.395 . . . . 0.0 110.418 -176.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 88.5 t -130.01 132.88 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 123.856 0.862 . . . . 0.0 111.241 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -121.18 96.21 5.0 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 128.519 2.728 . . . . 0.0 110.047 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 71.21 -91.48 0.46 Allowed Glycine 0 CA--C 1.534 1.262 0 C-N-CA 125.716 1.627 . . . . 0.0 114.057 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -120.25 -2.19 10.16 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 126.169 1.788 . . . . 0.0 113.916 -178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 82.3 p -127.77 167.87 15.91 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.468 1.907 . . . . 0.0 109.882 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -150.67 177.52 28.67 Favored Glycine 0 CA--C 1.527 0.806 0 O-C-N 121.054 -1.029 . . . . 0.0 114.324 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.11 148.22 43.89 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 125.138 1.375 . . . . 0.0 114.524 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.8 tt -116.12 153.16 32.26 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 130.188 3.395 . . . . 0.0 110.388 -178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 29.1 tpp 78.48 30.72 0.38 Allowed 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 116.65 2.092 . . . . 0.0 116.65 170.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -136.08 149.89 48.91 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.6 1.56 . . . . 0.0 108.88 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 29.3 p -88.1 172.14 9.74 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 122.674 1.226 . . . . 0.0 113.918 -178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.17 -36.11 78.95 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.736 175.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 63.4 m -62.53 -63.5 1.21 Allowed 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.143 0.977 . . . . 0.0 109.964 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 77.5 m -53.79 -42.98 68.9 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.815 1.246 . . . . 0.0 112.754 177.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -60.67 -48.26 82.57 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.31 -0.869 . . . . 0.0 112.046 173.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -59.75 -43.22 94.37 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 120.771 -1.206 . . . . 0.0 111.205 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -57.79 -54.96 40.94 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.222 1.009 . . . . 0.0 111.09 176.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.32 -30.39 71.53 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -67.44 -48.14 68.1 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.337 1.455 . . . . 0.0 112.359 175.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 12.9 mmmm -59.01 -37.49 77.04 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.381 1.072 . . . . 0.0 111.56 176.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 39.4 tpt85 -76.21 -10.54 59.49 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 127.872 2.469 . . . . 0.0 112.393 174.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 64.1 t30 52.76 42.62 31.83 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 127.323 2.249 . . . . 0.0 111.919 -176.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 34.2 tttp -70.01 129.04 91.24 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 124.644 1.178 . . . . 0.0 113.401 -176.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.61 124.44 8.82 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 122.638 2.225 . . . . 0.0 107.579 169.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 40.2 t -30.72 128.36 0.27 Allowed Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 128.294 2.638 . . . . 0.0 114.734 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -66.53 -3.04 8.35 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.172 2.581 . . . . 0.0 114.585 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 41.8 t -127.68 -58.49 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.172 1.389 . . . . 0.0 111.619 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 60.6 m -77.31 -17.57 58.2 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.43 1.892 . . . . 0.0 112.679 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 44.6 mtm105 62.76 7.85 2.75 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.527 2.331 . . . . 0.0 114.368 -177.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 74.1 mm-40 -86.38 143.03 35.93 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 123.829 0.851 . . . . 0.0 112.914 -179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -74.38 126.46 10.38 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.359 2.706 . . . . 0.0 110.218 176.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 7.3 pt -72.19 153.8 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 -178.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -115.05 -41.84 3.28 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.515 1.526 . . . . 0.0 114.019 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.98 167.16 30.09 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -174.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 7.9 mt -134.33 137.38 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 128.097 2.559 . . . . 0.0 107.728 177.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 3.7 t -127.01 147.78 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 124.627 1.171 . . . . 0.0 112.539 -178.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.52 106.86 2.28 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.565 1.546 . . . . 0.0 107.545 176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 50.1 m -103.63 126.0 50.49 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.22 1.408 . . . . 0.0 114.214 -171.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -123.63 178.79 5.04 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 127.364 2.266 . . . . 0.0 111.823 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -127.79 163.48 42.9 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.509 1.524 . . . . 0.0 112.579 -178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo . . . . . 0 C--N 1.353 0.802 0 C-N-CA 123.931 3.088 . . . . 0.0 114.085 -179.175 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 N--CA 1.472 0.634 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -136.01 62.4 45.91 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 126.601 1.96 . . . . 0.0 112.788 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -56.49 -34.3 94.57 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.288 2.658 . . . . 0.0 113.38 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -63.83 -15.07 57.92 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 115.061 1.504 . . . . 0.0 115.061 176.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.25 -12.87 8.97 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.766 1.626 . . . . 0.0 111.789 178.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -96.61 -30.77 13.08 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.922 1.289 . . . . 0.0 113.169 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 3.9 mp -129.92 -53.94 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.72 1.608 . . . . 0.0 109.415 176.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . 0.268 38.8 mt-10 113.86 -53.38 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.335 1 C-N-CA 131.743 4.017 . . . . 0.0 117.333 174.523 . . . . . . . . 3 2 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . 0.252 45.8 Cg_exo -55.25 -82.2 0.01 OUTLIER 'Trans proline' 0 CA--C 1.552 1.382 0 C-N-CA 124.913 3.742 . . . . 0.0 116.525 -174.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 14.1 t -65.32 151.5 46.08 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-N 121.508 1.958 . . . . 0.0 109.343 174.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 13.2 m -132.59 -3.23 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 6.6 mt -133.26 -46.34 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 CA-C-N 119.4 1.0 . . . . 0.0 112.852 -178.494 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.5 m -67.55 -60.05 2.87 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 -173.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -153.89 -14.04 0.14 Allowed 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -176.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 83.94 7.15 85.96 Favored Glycine 0 CA--C 1.539 1.532 0 O-C-N 120.948 -1.095 . . . . 0.0 112.453 -173.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 20.4 ptt180 -55.01 155.04 8.98 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 129.07 2.948 . . . . 0.0 113.255 178.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -56.31 -10.25 4.51 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 125.186 3.924 . . . . 0.0 118.795 -178.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -59.37 139.17 57.29 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 125.481 1.512 . . . . 0.0 112.8 -178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.2 150.04 50.19 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 126.27 1.828 . . . . 0.0 111.106 175.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -156.34 91.6 0.12 Allowed Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.667 1.603 . . . . 0.0 111.867 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 48.3 t -64.82 133.69 52.48 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.563 0.745 . . . . 0.0 110.89 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.16 144.73 22.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 126.424 1.889 . . . . 0.0 110.896 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 74.3 t -129.99 134.62 62.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 C-N-CA 124.356 1.062 . . . . 0.0 111.198 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -125.07 94.96 4.32 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.497 2.319 . . . . 0.0 111.281 175.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 65.95 -93.32 0.18 Allowed Glycine 0 CA--C 1.535 1.317 0 C-N-CA 125.959 1.742 . . . . 0.0 114.709 178.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -111.0 -2.35 15.98 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 126.28 1.832 . . . . 0.0 114.362 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 6.5 p -130.65 170.0 14.88 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 127.229 2.212 . . . . 0.0 110.82 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -157.1 170.83 34.41 Favored Glycine 0 CA--C 1.533 1.176 0 O-C-N 120.902 -1.124 . . . . 0.0 113.854 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -120.08 140.04 51.64 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.432 1.893 . . . . 0.0 111.799 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 36.3 tp -134.67 153.26 52.07 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 127.553 2.341 . . . . 0.0 111.061 -177.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 80.0 mtp 75.46 56.89 0.06 Allowed 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 127.311 2.244 . . . . 0.0 112.054 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -151.53 148.52 28.12 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 129.391 3.076 . . . . 0.0 107.102 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 6.2 p -80.55 173.77 12.27 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 122.773 1.273 . . . . 0.0 112.321 177.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -64.38 -39.88 94.72 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.406 178.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 32.4 m -68.65 -44.52 73.98 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-O 116.505 -1.712 . . . . 0.0 110.918 178.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 53.8 m -46.64 -56.97 5.26 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 121.403 1.91 . . . . 0.0 110.926 175.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.72 -51.1 71.38 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.27 1.428 . . . . 0.0 112.778 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -58.77 -41.17 85.96 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 124.153 0.981 . . . . 0.0 112.667 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.37 -53.61 54.45 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 127.55 2.34 . . . . 0.0 110.768 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 15.0 mt -51.37 -54.42 26.66 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.658 1.183 . . . . 0.0 109.898 175.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -55.34 -48.03 74.8 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.486 1.114 . . . . 0.0 112.626 178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -59.14 -40.99 87.21 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 125.555 1.542 . . . . 0.0 111.706 176.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -77.1 7.38 5.07 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 127.427 2.291 . . . . 0.0 113.569 175.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 75.76 0.85 3.45 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 130.387 3.475 . . . . 0.0 116.302 177.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 49.2 tptt -82.54 121.13 77.93 Favored Pre-proline 0 N--CA 1.473 0.702 0 CA-C-N 120.541 1.519 . . . . 0.0 109.555 176.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -71.51 -67.37 0.03 OUTLIER 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.149 2.566 . . . . 0.0 110.325 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 15.6 t -121.53 131.42 24.45 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 127.203 2.201 . . . . 0.0 110.346 176.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -76.72 -5.44 16.0 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 123.522 2.815 . . . . 0.0 114.589 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 36.7 t -131.46 -59.21 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 CA-C-N 120.358 1.435 . . . . 0.0 113.414 -177.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 21.6 m -71.56 -29.25 64.52 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.821 1.648 . . . . 0.0 110.613 178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 84.9 mtm180 64.89 7.49 3.99 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 128.172 2.589 . . . . 0.0 113.071 -175.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -68.35 143.27 95.44 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 124.436 1.094 . . . . 0.0 110.765 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.05 110.08 2.53 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.563 2.842 . . . . 0.0 113.556 -176.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 11.3 pt -66.06 153.58 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 121.496 0.665 . . . . 0.0 112.356 178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 90.9 mm-40 -109.73 -47.53 3.34 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.071 1.348 . . . . 0.0 112.166 -177.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -157.31 170.13 23.17 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.081 1.352 . . . . 0.0 112.676 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 13.0 mt -123.65 136.5 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 127.443 2.297 . . . . 0.0 106.435 175.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 14.3 m -131.89 150.11 33.47 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -178.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -71.68 99.92 2.21 Favored 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 6.3 t -87.71 150.12 23.81 Favored 'General case' 0 N--CA 1.473 0.681 0 O-C-N 121.887 -0.508 . . . . 0.0 111.606 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -139.28 156.84 46.78 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 125.638 1.575 . . . . 0.0 111.905 -178.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 94.7 m-85 -71.47 148.49 93.25 Favored Pre-proline 0 CA--C 1.545 0.785 0 C-N-CA 124.535 1.134 . . . . 0.0 113.002 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo . . . . . 0 CA--C 1.539 0.744 0 C-N-CA 123.75 2.967 . . . . 0.0 112.385 179.483 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 40.9 m . . . . . 0 CA--C 1.539 0.556 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . 0.582 ' H ' ' HD2' ' B' ' 431' ' ' PRO . 62.2 tp -144.75 -53.32 0.02 OUTLIER Pre-proline 0 CA--C 1.55 0.953 0 C-N-CA 126.0 1.72 . . . . 0.0 114.639 -179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . 0.582 ' HD2' ' H ' ' B' ' 430' ' ' LEU . 80.1 Cg_endo -71.12 159.92 50.71 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 121.973 1.782 . . . . 0.0 113.147 -177.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 67.1 mt -54.31 -33.93 59.85 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.783 1.633 . . . . 0.0 113.453 -179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -66.27 -21.55 66.28 Favored 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.371 1.468 . . . . 0.0 113.493 178.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -109.31 -44.68 3.87 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.635 1.574 . . . . 0.0 112.539 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 45.4 mm -119.55 92.45 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 C-N-CA 126.992 2.117 . . . . 0.0 107.914 179.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -60.41 145.96 85.54 Favored Pre-proline 0 CA--C 1.553 1.09 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -178.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -79.07 179.56 6.36 Favored 'Trans proline' 0 CA--C 1.545 1.025 0 C-N-CA 124.2 3.267 . . . . 0.0 114.644 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 2.2 p -63.02 -174.52 0.07 Allowed 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 126.242 1.817 . . . . 0.0 114.865 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 5.6 p -138.65 -9.41 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 N-CA-C 115.857 1.799 . . . . 0.0 115.857 -175.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 3.9 mt -119.59 -58.83 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 120.574 1.534 . . . . 0.0 112.996 -177.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 13.7 p -67.82 -68.46 0.38 Allowed 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 116.356 1.984 . . . . 0.0 116.356 -174.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -137.2 -13.54 1.58 Allowed 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 116.427 2.01 . . . . 0.0 116.427 -169.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 77.53 35.38 36.93 Favored Glycine 0 CA--C 1.534 1.28 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -172.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -86.52 151.2 52.82 Favored Pre-proline 0 N--CA 1.479 0.986 0 C-N-CA 124.557 1.143 . . . . 0.0 113.822 -176.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -76.18 66.4 7.01 Favored 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 124.513 3.475 . . . . 0.0 113.543 -178.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -131.98 165.58 23.62 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 126.65 1.98 . . . . 0.0 112.506 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -128.18 149.94 50.22 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 128.499 2.72 . . . . 0.0 111.791 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 168.01 75.95 0.04 OUTLIER Glycine 0 CA--C 1.532 1.134 0 C-N-CA 125.913 1.72 . . . . 0.0 112.303 179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 35.7 t -62.61 141.27 58.57 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 117.759 0.779 . . . . 0.0 111.161 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 2.5 mp -105.07 139.12 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.147 0 C-N-CA 126.106 1.763 . . . . 0.0 109.654 -177.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 88.9 t -130.0 131.7 65.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 124.197 0.999 . . . . 0.0 108.885 177.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.03 99.46 6.13 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 127.644 2.378 . . . . 0.0 110.516 176.044 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 65.33 -96.55 0.24 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 126.172 1.844 . . . . 0.0 113.792 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 38.6 mtmm -110.34 1.07 18.25 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 126.066 1.746 . . . . 0.0 113.693 -179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 44.7 p -130.1 170.05 14.53 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 125.434 1.494 . . . . 0.0 112.012 -179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -154.25 170.42 32.75 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 121.246 -0.909 . . . . 0.0 114.037 177.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -120.22 112.7 19.39 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 126.295 1.838 . . . . 0.0 111.667 177.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -88.94 153.18 21.24 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 22.6 mmt 64.65 67.37 0.56 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.591 2.357 . . . . 0.0 114.54 175.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -148.97 157.87 43.75 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 129.253 3.021 . . . . 0.0 107.822 174.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 22.0 p -90.79 174.98 7.17 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 123.048 1.404 . . . . 0.0 114.13 179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.44 -31.8 72.78 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 114.584 -1.189 . . . . 0.0 111.58 176.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 44.8 m -66.7 -50.25 63.44 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.64 178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 36.3 m -47.87 -63.98 0.91 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.15 1.38 . . . . 0.0 109.868 174.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -52.74 -47.16 67.58 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 126.305 1.842 . . . . 0.0 113.654 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -60.68 -36.88 79.86 Favored 'General case' 0 N--CA 1.476 0.85 0 O-C-N 120.956 -1.09 . . . . 0.0 112.281 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 60.0 tttm -55.41 -48.16 74.81 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 124.607 1.163 . . . . 0.0 110.951 175.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 6.5 mp -62.63 -47.72 82.5 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.55 0.74 . . . . 0.0 110.001 175.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -57.09 -42.48 80.83 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -176.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -55.02 -28.36 51.48 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 11.4 ptm180 -119.59 8.84 11.33 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.856 2.062 . . . . 0.0 113.019 177.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 60.1 t30 42.29 56.39 3.69 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 127.252 2.221 . . . . 0.0 112.075 -174.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 39.9 tttm -70.0 133.04 88.14 Favored Pre-proline 0 CA--C 1.541 0.633 0 N-CA-C 114.025 1.12 . . . . 0.0 114.025 -174.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -70.95 115.16 4.14 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 122.52 2.147 . . . . 0.0 107.633 169.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 51.9 t -22.45 125.33 0.11 Allowed Pre-proline 0 CA--C 1.558 1.276 0 C-N-CA 130.146 3.378 . . . . 0.0 116.236 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -66.61 -3.94 10.06 Favored 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 123.139 2.56 . . . . 0.0 114.235 179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 45.0 t -110.26 -64.02 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 125.327 1.451 . . . . 0.0 111.488 -179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 25.0 p -105.24 1.23 27.94 Favored 'General case' 0 CA--C 1.549 0.916 0 N-CA-C 115.081 1.512 . . . . 0.0 115.081 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 63.36 11.07 5.2 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 127.73 2.412 . . . . 0.0 115.945 176.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -75.35 144.92 78.97 Favored Pre-proline 0 CA--C 1.55 0.976 0 O-C-N 121.391 -0.818 . . . . 0.0 111.916 178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -74.15 116.18 4.56 Favored 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 123.438 2.759 . . . . 0.0 111.461 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.5 pp -55.16 142.79 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 124.825 1.25 . . . . 0.0 111.929 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 8.9 tp-100 -115.04 -45.56 2.95 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.107 0.963 . . . . 0.0 113.361 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.28 166.98 30.11 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -177.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 4.0 mt -139.39 133.99 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 128.203 2.601 . . . . 0.0 107.943 176.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 27.8 m -140.02 150.24 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 124.76 1.224 . . . . 0.0 111.986 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 56.8 mt -66.91 99.82 0.67 Allowed 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 42.1 m -99.79 136.0 40.37 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.624 1.17 . . . . 0.0 112.227 -173.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -128.57 160.77 31.34 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.521 1.128 . . . . 0.0 112.619 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -145.86 155.99 51.8 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.919 1.688 . . . . 0.0 111.749 -177.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo . . . . . 0 CA--C 1.537 0.631 0 C-N-CA 123.533 2.822 . . . . 0.0 112.428 179.168 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 48.3 m . . . . . 0 CA--C 1.541 0.625 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . 0.518 ' H ' ' HD2' ' A' ' 431' ' ' PRO . 10.3 tt -129.96 -59.88 0.02 OUTLIER Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 126.976 2.11 . . . . 0.0 111.861 178.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . 0.518 ' HD2' ' H ' ' A' ' 430' ' ' LEU . 72.1 Cg_endo -69.77 161.05 47.41 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 121.834 1.69 . . . . 0.0 111.119 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 60.0 tp -53.37 -39.44 64.19 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.153 1.381 . . . . 0.0 113.628 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 23.2 m120 -80.4 -3.66 50.58 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.903 1.281 . . . . 0.0 114.033 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . 56.96 12.93 1.33 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 127.848 2.459 . . . . 0.0 116.506 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 65.2 mt -61.86 -44.77 99.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 125.407 1.483 . . . . 0.0 111.4 -179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 38.29 64.2 3.5 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 127.69 2.396 . . . . 0.0 115.007 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -72.93 -45.15 0.5 Allowed 'Trans proline' 0 CA--C 1.543 0.947 0 C-N-CA 122.722 2.282 . . . . 0.0 112.781 -178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 8.0 t -58.74 147.66 32.33 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-N 120.531 1.514 . . . . 0.0 109.594 172.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 15.9 m -130.92 -1.15 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 -179.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 10.0 mt -132.12 -47.33 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 C-N-CA 124.23 1.012 . . . . 0.0 112.237 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.8 m -68.93 -62.69 1.27 Allowed 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -173.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -155.44 -12.02 0.11 Allowed 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 115.25 1.574 . . . . 0.0 115.25 -174.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 81.53 7.89 87.66 Favored Glycine 0 CA--C 1.542 1.772 0 O-C-N 120.47 -1.394 . . . . 0.0 112.424 -173.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 33.3 ptt180 -59.09 152.45 51.27 Favored Pre-proline 0 CA--C 1.542 0.648 0 C-N-CA 129.669 3.187 . . . . 0.0 113.256 178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -74.91 73.12 4.37 Favored 'Trans proline' 0 CA--C 1.548 1.176 0 C-N-CA 124.329 3.353 . . . . 0.0 113.886 -178.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -128.91 144.12 51.09 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 127.15 2.18 . . . . 0.0 110.411 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.26 116.16 19.42 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.445 1.646 . . . . 0.0 115.445 -173.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -138.59 83.2 0.25 Allowed Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.441 1.496 . . . . 0.0 111.663 176.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 16.4 t -66.12 140.21 58.2 Favored 'General case' 0 CA--C 1.543 0.693 0 CA-C-N 118.077 0.939 . . . . 0.0 112.309 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.3 mp -115.1 141.2 32.77 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 126.832 2.053 . . . . 0.0 110.441 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 67.4 t -126.49 134.02 67.32 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.627 1.171 . . . . 0.0 111.134 178.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -118.78 98.04 6.02 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 128.451 2.7 . . . . 0.0 110.651 175.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 73.55 -87.42 0.62 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.849 1.69 . . . . 0.0 114.068 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -129.85 1.92 4.87 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.265 1.826 . . . . 0.0 113.431 -178.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 72.8 p -131.2 170.06 15.08 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.204 2.202 . . . . 0.0 109.197 178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -152.56 174.6 31.4 Favored Glycine 0 N--CA 1.466 0.69 0 O-C-N 120.541 -1.349 . . . . 0.0 113.273 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -120.09 105.84 11.39 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 124.368 1.067 . . . . 0.0 111.788 177.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 15.2 tp -81.67 153.18 26.75 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.011 2.524 . . . . 0.0 110.211 177.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 48.7 mtt 85.54 66.35 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 128.008 2.523 . . . . 0.0 111.976 178.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -158.86 145.09 16.85 Favored 'General case' 0 C--O 1.241 0.653 0 C-N-CA 127.719 2.408 . . . . 0.0 108.537 175.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 19.9 p -83.78 173.69 11.08 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 122.28 1.038 . . . . 0.0 110.746 174.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -64.72 -37.44 87.59 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.502 -0.749 . . . . 0.0 111.191 178.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 27.8 m -65.15 -49.03 71.44 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 117.132 -1.413 . . . . 0.0 110.661 177.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 32.9 m -48.06 -55.77 9.37 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-N 120.555 1.525 . . . . 0.0 110.57 174.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.55 92.4 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.846 1.258 . . . . 0.0 113.002 178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -61.52 -43.32 99.08 Favored 'General case' 0 N--CA 1.474 0.766 0 O-C-N 120.817 -1.177 . . . . 0.0 111.586 178.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 43.2 mmtm -62.52 -54.03 45.93 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.996 1.318 . . . . 0.0 111.514 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 2.5 pp -60.49 -37.72 81.98 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 118.644 0.656 . . . . 0.0 111.25 179.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 49.0 tptt -59.95 -52.11 66.79 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.186 1.395 . . . . 0.0 111.378 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 64.6 mttm -58.68 -35.99 73.48 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 125.246 1.418 . . . . 0.0 112.684 177.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 89.9 mtm180 -78.5 2.93 17.42 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.534 1.934 . . . . 0.0 113.402 175.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 28.5 m120 64.13 19.18 11.66 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 128.713 2.805 . . . . 0.0 114.62 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -72.72 135.81 80.77 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 124.693 1.197 . . . . 0.0 109.383 176.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -71.8 -85.57 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.065 0 C-N-CA 123.037 2.491 . . . . 0.0 109.804 177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 36.1 t -118.45 132.76 23.67 Favored Pre-proline 0 CA--C 1.545 0.756 0 C-N-CA 125.921 1.688 . . . . 0.0 110.874 177.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.63 -6.86 20.02 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.397 2.731 . . . . 0.0 114.119 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 40.6 t -116.36 -72.3 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 119.732 1.151 . . . . 0.0 112.752 -178.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 25.8 p -96.25 1.31 51.99 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 115.323 1.601 . . . . 0.0 115.323 -176.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 86.4 mmt-85 65.54 6.67 3.9 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 128.01 2.524 . . . . 0.0 115.665 177.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -62.16 140.98 96.09 Favored Pre-proline 0 CA--C 1.552 1.052 0 CA-C-N 119.593 1.088 . . . . 0.0 111.686 177.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -69.45 112.17 2.95 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.385 2.723 . . . . 0.0 113.725 -176.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 22.8 pt -73.73 160.14 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.702 0 C-N-CA 125.709 1.603 . . . . 0.0 113.39 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -112.55 -48.13 3.03 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.48 1.512 . . . . 0.0 113.19 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.14 170.3 22.28 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -175.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 8.1 mt -117.2 135.38 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 126.523 1.929 . . . . 0.0 107.821 173.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 37.3 t -129.48 147.9 33.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 C-N-CA 124.979 1.312 . . . . 0.0 110.334 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 487' ' ' LEU . . . . . 0.443 HD13 ' H ' ' A' ' 487' ' ' LEU 0.271 0.0 OUTLIER -81.59 116.79 21.51 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.298 1.047 . . . . 0.0 108.348 177.031 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 6.5 m -115.84 99.04 7.01 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.271 -1.331 . . . . 0.0 114.134 -169.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -68.78 171.2 8.17 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.044 1.738 . . . . 0.0 112.937 177.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -134.33 164.04 46.86 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.81 1.644 . . . . 0.0 111.121 178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo . . . . . 0 C--N 1.353 0.774 0 C-N-CA 124.341 3.361 . . . . 0.0 113.855 179.551 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 N--CA 1.473 0.678 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 96.7 mt -68.39 156.68 89.84 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.293 1.437 . . . . 0.0 110.731 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -42.82 -51.0 5.67 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 124.262 3.308 . . . . 0.0 115.827 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -64.94 -16.66 63.59 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -103.21 -25.76 13.24 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.984 1.714 . . . . 0.0 111.441 176.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -79.6 -48.66 13.41 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.737 1.615 . . . . 0.0 111.858 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 26.5 mm -83.27 68.58 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 124.583 1.153 . . . . 0.0 109.97 179.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -140.52 66.04 27.76 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 126.134 1.774 . . . . 0.0 109.512 176.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.15 -32.34 52.61 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.347 2.698 . . . . 0.0 115.5 -175.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 14.6 t -55.22 145.95 20.15 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 120.546 1.521 . . . . 0.0 111.333 175.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 29.8 m -132.22 0.1 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.53 0 C-N-CA 125.93 1.692 . . . . 0.0 113.615 178.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 1.7 mt -134.69 -48.37 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 CA-C-O 116.932 -1.509 . . . . 0.0 114.731 -178.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 25.2 p -77.68 -60.53 2.33 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 121.457 1.935 . . . . 0.0 115.16 -173.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 23.0 mm-40 -139.86 -8.32 1.22 Allowed 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 74.63 17.63 79.97 Favored Glycine 0 CA--C 1.541 1.672 0 CA-C-N 119.818 1.19 . . . . 0.0 111.356 -173.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -61.23 155.15 58.36 Favored Pre-proline 0 CA--C 1.551 0.981 0 C-N-CA 127.541 2.337 . . . . 0.0 113.858 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -70.8 -1.32 9.15 Favored 'Trans proline' 0 CA--C 1.547 1.152 0 C-N-CA 124.363 3.375 . . . . 0.0 116.141 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -60.17 156.77 14.52 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 125.941 1.696 . . . . 0.0 112.672 178.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -128.09 150.14 50.09 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.848 2.059 . . . . 0.0 110.489 177.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -163.87 67.76 0.22 Allowed Glycine 0 CA--C 1.529 0.929 0 C-N-CA 125.258 1.409 . . . . 0.0 112.417 178.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 45.0 t -57.47 128.22 35.92 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.732 1.213 . . . . 0.0 110.176 178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.3 mp -102.98 144.06 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 C-N-CA 125.06 1.344 . . . . 0.0 110.189 -178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 88.8 t -129.28 126.64 64.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 124.767 1.227 . . . . 0.0 109.697 176.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -125.18 122.52 37.29 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 128.813 2.845 . . . . 0.0 112.647 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 64.1 -77.54 0.05 OUTLIER Glycine 0 CA--C 1.539 1.552 0 C-N-CA 126.207 1.861 . . . . 0.0 114.872 179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 31.7 ttmt -146.61 2.46 0.83 Allowed 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 127.453 2.301 . . . . 0.0 113.212 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 71.5 p -131.72 170.12 15.24 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 127.575 2.35 . . . . 0.0 110.54 -177.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -144.58 171.93 25.73 Favored Glycine 0 N--CA 1.47 0.93 0 O-C-N 120.479 -1.388 . . . . 0.0 115.248 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -120.25 135.2 55.07 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.424 1.889 . . . . 0.0 113.223 175.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 4.0 pp -119.77 153.33 35.85 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.662 2.385 . . . . 0.0 110.942 174.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 11.5 tpt 94.65 53.87 0.0 OUTLIER 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 129.304 3.042 . . . . 0.0 111.689 -179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -159.93 150.17 18.61 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 127.763 2.425 . . . . 0.0 108.4 175.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 31.2 p -90.03 174.29 7.73 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 122.377 1.084 . . . . 0.0 111.591 175.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.43 -37.93 88.38 Favored 'General case' 0 CA--C 1.536 0.437 0 O-C-N 121.634 -0.667 . . . . 0.0 110.991 177.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 43.7 m -60.25 -54.37 46.52 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 117.616 -1.183 . . . . 0.0 110.48 178.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 59.5 m -51.79 -61.98 1.91 Allowed 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 119.923 1.238 . . . . 0.0 111.002 175.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -47.17 -52.37 15.79 Favored 'General case' 0 CA--C 1.547 0.861 0 O-C-N 121.037 -1.04 . . . . 0.0 112.578 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -62.21 -37.94 87.25 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.466 1.106 . . . . 0.0 112.965 176.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -60.47 -50.65 72.74 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.482 1.513 . . . . 0.0 110.625 176.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -58.25 -46.23 86.33 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 122.849 0.459 . . . . 0.0 110.242 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -55.99 -46.57 78.66 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.297 1.039 . . . . 0.0 112.276 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 60.9 mtpt -62.05 -39.1 91.21 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.624 1.569 . . . . 0.0 111.506 174.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -79.7 16.47 1.11 Allowed 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 128.066 2.546 . . . . 0.0 113.196 175.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . 0.303 0.2 OUTLIER 59.8 8.13 1.28 Allowed 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 130.667 3.587 . . . . 0.0 117.849 179.802 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -84.59 127.41 65.65 Favored Pre-proline 0 N--CA 1.474 0.731 0 CA-C-N 120.045 1.293 . . . . 0.0 108.158 173.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.33 -81.8 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 123.069 2.513 . . . . 0.0 112.263 -179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 41.3 t -81.95 131.87 55.71 Favored Pre-proline 0 CA--C 1.541 0.612 0 C-N-CA 124.425 1.09 . . . . 0.0 110.887 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -70.32 -5.28 16.18 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 122.945 2.43 . . . . 0.0 114.487 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 28.9 t -119.68 -75.9 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.986 1.266 . . . . 0.0 113.084 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 23.7 p -91.91 -1.11 57.46 Favored 'General case' 0 CA--C 1.549 0.919 0 N-CA-C 115.403 1.631 . . . . 0.0 115.403 -175.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 26.9 ttt-85 64.87 18.78 11.63 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 127.306 2.242 . . . . 0.0 115.107 178.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -65.98 156.09 85.02 Favored Pre-proline 0 CA--C 1.554 1.122 0 O-C-N 121.049 -1.032 . . . . 0.0 111.347 174.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.88 105.89 1.59 Allowed 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.71 2.94 . . . . 0.0 113.522 -177.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.16 154.26 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.091 1.356 . . . . 0.0 113.512 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 87.3 mt-30 -115.2 -43.0 3.11 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.026 2.131 . . . . 0.0 111.687 178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.91 167.55 27.79 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.977 1.311 . . . . 0.0 114.303 -176.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 18.6 mt -134.23 135.21 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 129.099 2.96 . . . . 0.0 105.919 173.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 16.0 m -133.48 150.14 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 124.428 1.091 . . . . 0.0 113.367 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.61 99.93 1.37 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 177.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.01 86.39 3.97 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.835 1.254 . . . . 0.0 112.704 -173.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -63.6 169.69 3.74 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.919 1.288 . . . . 0.0 111.88 177.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 36.5 p90 -130.51 167.28 21.75 Favored Pre-proline 0 CA--C 1.55 0.976 0 C-N-CA 125.167 1.387 . . . . 0.0 111.16 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo . . . . . 0 C--N 1.352 0.726 0 C-N-CA 124.068 3.178 . . . . 0.0 113.778 -179.786 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 39.2 m . . . . . 0 CA--C 1.539 0.527 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 96.2 mt -128.45 156.99 76.16 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.937 1.695 . . . . 0.0 112.121 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -52.72 -35.65 69.58 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.602 2.868 . . . . 0.0 114.881 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 45.7 tp -62.43 -49.36 75.75 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.594 1.158 . . . . 0.0 112.86 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -75.32 -21.77 58.17 Favored 'General case' 0 CA--C 1.545 0.787 0 O-C-N 121.561 -0.712 . . . . 0.0 112.542 177.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.36 -52.18 12.93 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.107 0.963 . . . . 0.0 110.574 176.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 23.8 mm -101.91 75.5 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 126.958 2.103 . . . . 0.0 107.245 177.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -45.33 129.43 6.01 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 126.213 1.805 . . . . 0.0 114.926 -173.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -86.78 -179.01 2.8 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.872 3.048 . . . . 0.0 115.303 -177.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 41.3 t -57.33 -167.91 0.0 OUTLIER 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 130.408 3.483 . . . . 0.0 112.778 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 9.7 p -132.74 -12.86 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 126.135 1.774 . . . . 0.0 112.748 177.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 14.3 mm -93.3 -60.1 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 C-N-CA 124.332 1.053 . . . . 0.0 108.566 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 26.5 p -87.55 -44.8 10.99 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.699 1.199 . . . . 0.0 109.768 174.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . 0.274 14.0 pt20 52.01 22.0 1.7 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 128.981 2.913 . . . . 0.0 114.777 -174.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . -94.26 -24.66 18.56 Favored Glycine 0 CA--C 1.532 1.104 0 N-CA-C 112.213 -0.355 . . . . 0.0 112.213 176.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 10.0 ptp85 -115.42 155.08 47.57 Favored Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 125.979 1.712 . . . . 0.0 115.125 -179.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -51.41 140.15 44.21 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.683 3.589 . . . . 0.0 114.54 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 57.9 pttt -67.6 28.14 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.197 0 C-N-CA 127.564 2.345 . . . . 0.0 117.091 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -77.87 89.83 4.08 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 120.46 -1.4 . . . . 0.0 110.774 -177.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 162.35 57.86 0.02 OUTLIER Glycine 0 CA--C 1.529 0.907 0 CA-C-O 119.065 -0.853 . . . . 0.0 113.523 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 78.3 m -63.14 142.91 58.2 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-N 118.687 1.243 . . . . 0.0 110.596 177.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.6 mp -115.06 144.53 22.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 C-N-CA 126.033 1.733 . . . . 0.0 111.377 -172.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 67.0 t -127.24 131.48 70.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.72 1.208 . . . . 0.0 111.657 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -119.88 97.2 5.5 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 128.681 2.792 . . . . 0.0 110.786 174.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.72 -91.48 0.33 Allowed Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.906 1.717 . . . . 0.0 114.046 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -118.88 -0.27 11.24 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 126.297 1.839 . . . . 0.0 113.849 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 67.1 p -133.24 170.08 15.96 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.603 1.961 . . . . 0.0 110.337 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -153.53 171.61 32.36 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.911 1.243 . . . . 0.0 112.899 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -120.11 133.7 55.45 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.531 1.132 . . . . 0.0 113.275 179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 25.7 tp -89.64 153.13 20.98 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 129.006 2.922 . . . . 0.0 113.882 -178.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 459' ' ' MET . . . . . . . . . . . . 0.354 25.8 ptm 59.45 57.2 3.41 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 129.28 3.032 . . . . 0.0 118.535 172.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -136.76 147.9 46.94 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.259 1.824 . . . . 0.0 108.145 170.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 31.3 p -82.04 165.24 20.82 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 120.24 1.382 . . . . 0.0 112.874 -178.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -60.32 -38.82 84.92 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.123 177.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 96.3 m -61.2 -59.42 5.34 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 117.973 -1.013 . . . . 0.0 109.693 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 54.6 m -53.93 -48.27 70.39 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.701 1.137 . . . . 0.0 112.4 178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -56.36 -51.54 67.91 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 123.554 0.742 . . . . 0.0 112.613 175.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 40.2 ttpt -62.78 -39.71 95.06 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 125.03 1.332 . . . . 0.0 112.437 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -61.85 -54.18 45.68 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 125.177 1.391 . . . . 0.0 110.457 177.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 27.2 mt -50.2 -53.05 30.72 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.426 1.091 . . . . 0.0 110.089 176.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -52.89 -51.12 62.33 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.871 1.268 . . . . 0.0 112.644 177.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -61.79 -38.9 89.8 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 125.345 1.458 . . . . 0.0 112.698 176.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 87.4 mmt-85 -75.87 -1.67 26.44 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 126.782 2.033 . . . . 0.0 113.361 176.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 35.8 t30 77.88 7.27 2.66 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 130.111 3.365 . . . . 0.0 115.482 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -78.21 123.93 85.88 Favored Pre-proline 0 CA--C 1.544 0.737 0 O-C-N 120.655 -1.278 . . . . 0.0 108.332 174.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -68.0 -76.45 0.01 OUTLIER 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.58 2.853 . . . . 0.0 111.589 -178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 27.1 t -120.33 132.16 24.21 Favored Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.637 1.975 . . . . 0.0 110.114 178.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.12 -3.22 13.49 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.461 2.774 . . . . 0.0 113.428 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 39.2 t -113.44 -71.99 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 124.816 1.246 . . . . 0.0 112.272 -177.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 26.3 p -100.96 -2.61 31.36 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.44 1.496 . . . . 0.0 114.587 -176.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 83.4 mtm180 65.89 8.67 5.51 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 128.067 2.547 . . . . 0.0 115.861 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 19.4 mm100 -62.77 124.89 85.01 Favored Pre-proline 0 CA--C 1.553 1.092 0 CA-C-N 119.357 0.981 . . . . 0.0 111.287 177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -50.38 114.49 1.46 Allowed 'Trans proline' 0 CA--C 1.542 0.883 0 C-N-CA 124.398 3.398 . . . . 0.0 114.882 -179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 16.4 pt -75.94 157.76 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 123.795 0.838 . . . . 0.0 113.233 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -115.1 -45.45 2.95 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.052 1.741 . . . . 0.0 112.749 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.68 170.09 22.82 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -177.208 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 13.9 mt -131.33 138.97 51.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.699 0 C-N-CA 128.304 2.641 . . . . 0.0 107.37 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 9.8 p -137.22 150.04 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.225 0 CA-C-N 119.728 1.149 . . . . 0.0 113.843 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -62.78 99.92 0.18 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.518 1.927 . . . . 0.0 109.412 178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 12.3 m -119.95 127.94 53.12 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.103 0.961 . . . . 0.0 112.242 -175.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -118.93 161.73 19.7 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.183 1.393 . . . . 0.0 113.518 -176.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -74.92 163.61 67.05 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 125.333 1.453 . . . . 0.0 111.697 177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo . . . . . 0 C--N 1.353 0.781 0 C-N-CA 123.925 3.083 . . . . 0.0 114.451 -178.565 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 42.0 m . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 10.0 mp -68.76 157.89 87.37 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.563 1.545 . . . . 0.0 110.173 177.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -46.38 -41.62 22.81 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 123.772 2.981 . . . . 0.0 114.897 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 2.5 pp -67.31 -21.83 65.65 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 114.838 1.421 . . . . 0.0 114.838 178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -98.74 -26.28 14.39 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 125.352 1.461 . . . . 0.0 111.348 175.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -85.78 -26.92 25.51 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.934 1.694 . . . . 0.0 114.192 -177.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 30.1 mm 57.99 85.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 C-N-CA 127.484 2.314 . . . . 0.0 111.055 -178.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -120.18 58.91 6.08 Favored Pre-proline 0 CA--C 1.557 1.212 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.08 -42.1 38.83 Favored 'Trans proline' 0 CA--C 1.545 1.074 0 C-N-CA 124.853 3.702 . . . . 0.0 114.705 177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 32.7 t -55.99 142.92 34.14 Favored 'General case' 0 CA--C 1.546 0.804 0 CA-C-N 121.502 1.956 . . . . 0.0 109.764 173.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 15.5 m -129.0 -0.36 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 124.399 1.079 . . . . 0.0 113.747 -179.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 8.9 mt -132.94 -46.83 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 C-N-CA 123.866 0.866 . . . . 0.0 112.299 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.3 m -72.13 -68.34 0.47 Allowed 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -172.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -144.29 -10.45 0.65 Allowed 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 -174.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 78.57 13.57 83.06 Favored Glycine 0 CA--C 1.542 1.766 0 CA-C-N 120.129 1.331 . . . . 0.0 112.668 -174.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 23.6 ptt180 -62.28 155.19 67.46 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 130.758 3.623 . . . . 0.0 113.952 179.078 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -67.71 -1.46 6.78 Favored 'Trans proline' 0 CA--C 1.547 1.127 0 C-N-CA 124.856 3.704 . . . . 0.0 116.211 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 39.9 ttmt -60.93 135.14 57.7 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 126.007 1.723 . . . . 0.0 110.416 176.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.08 126.65 41.62 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.439 1.496 . . . . 0.0 113.31 -176.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -150.3 78.58 0.22 Allowed Glycine 0 CA--C 1.529 0.938 0 C-N-CA 125.405 1.479 . . . . 0.0 112.102 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 76.5 m -63.75 151.56 41.73 Favored 'General case' 0 CA--C 1.542 0.657 0 CA-C-N 117.624 0.712 . . . . 0.0 110.987 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 4.6 mp -110.25 142.39 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 C-N-CA 125.794 1.637 . . . . 0.0 111.216 -174.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 64.5 t -130.02 123.44 56.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.625 1.17 . . . . 0.0 108.234 173.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.24 106.24 9.72 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.843 2.057 . . . . 0.0 112.984 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 73.35 -83.75 0.64 Allowed Glycine 0 CA--C 1.533 1.16 0 C-N-CA 125.865 1.698 . . . . 0.0 114.746 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 454' ' ' LYS . . . . . 0.436 ' HA ' ' HE2' ' B' ' 454' ' ' LYS . 0.5 OUTLIER -127.57 -10.59 5.64 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 125.858 1.663 . . . . 0.0 114.021 -177.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 78.8 p -135.46 169.97 16.67 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.309 1.443 . . . . 0.0 111.078 179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -144.32 168.8 26.56 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 124.192 0.901 . . . . 0.0 114.669 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 6.7 m80 -120.18 132.17 55.28 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.227 1.811 . . . . 0.0 112.649 177.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 4.4 pp -107.81 153.32 23.16 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 126.876 2.07 . . . . 0.0 111.872 177.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 44.0 ttm 86.19 69.16 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 128.531 2.732 . . . . 0.0 112.05 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -160.04 154.92 24.46 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 128.051 2.54 . . . . 0.0 108.538 176.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 14.3 p -90.05 174.99 7.34 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 122.354 1.073 . . . . 0.0 110.488 174.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -66.09 -31.72 72.76 Favored 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.425 -0.797 . . . . 0.0 111.616 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 40.8 m -72.25 -47.03 53.38 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 117.007 -1.473 . . . . 0.0 110.427 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 50.6 m -45.22 -57.6 3.85 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 120.306 1.412 . . . . 0.0 109.962 172.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.96 -49.89 76.16 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.234 1.814 . . . . 0.0 113.549 177.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 60.0 tttp -60.88 -37.5 82.41 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 125.091 1.356 . . . . 0.0 112.797 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -59.34 -52.15 66.88 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.966 1.306 . . . . 0.0 110.661 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 19.1 mt -57.33 -48.97 77.61 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.016 1.327 . . . . 0.0 109.978 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 25.9 tptp -56.21 -51.7 67.12 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.957 1.303 . . . . 0.0 113.244 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -52.26 -40.74 62.12 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 125.535 1.534 . . . . 0.0 113.426 179.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 32.3 ptt85 -97.45 5.99 48.88 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.684 1.594 . . . . 0.0 113.938 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 44.82 48.43 9.06 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 128.487 2.715 . . . . 0.0 112.332 -177.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 47.0 tptt -69.99 118.46 63.72 Favored Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 124.268 1.027 . . . . 0.0 111.896 -177.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -62.58 123.33 12.18 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 122.294 1.996 . . . . 0.0 107.76 172.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 52.6 t -26.85 122.25 0.23 Allowed Pre-proline 0 CA--C 1.554 1.1 0 C-N-CA 128.72 2.808 . . . . 0.0 115.742 -173.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -65.5 -3.92 8.6 Favored 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 122.657 2.238 . . . . 0.0 113.931 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 33.9 t -107.47 -62.87 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 125.527 1.531 . . . . 0.0 111.347 178.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 26.6 p -110.09 0.97 18.58 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 63.55 11.32 5.57 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 127.84 2.456 . . . . 0.0 115.953 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -68.65 151.55 97.18 Favored Pre-proline 0 CA--C 1.551 1.01 0 O-C-N 121.373 -0.83 . . . . 0.0 111.534 176.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.84 111.26 2.98 Favored 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 123.594 2.863 . . . . 0.0 112.442 -178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.9 109.97 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 C-N-CA 126.84 2.056 . . . . 0.0 109.982 179.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -107.3 -57.08 2.12 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.082 1.512 . . . . 0.0 115.082 -171.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.21 165.39 27.65 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -177.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 2.7 mt -134.96 141.41 43.09 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 C-N-CA 127.399 2.28 . . . . 0.0 109.94 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 9.8 p -139.99 148.84 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.038 0.935 . . . . 0.0 111.826 176.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.0 99.8 0.91 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 17.3 m -109.23 86.87 2.37 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 124.221 1.008 . . . . 0.0 111.502 -174.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -77.18 159.32 29.81 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -176.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -74.12 156.28 87.77 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.617 1.567 . . . . 0.0 111.964 176.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo . . . . . 0 C--N 1.352 0.744 0 C-N-CA 124.156 3.237 . . . . 0.0 114.324 178.316 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . 0.485 ' N ' HD21 ' A' ' 433' ' ' ASN . 33.2 m . . . . . 0 CA--C 1.54 0.572 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 10.9 mp -69.29 156.18 92.1 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 125.377 1.471 . . . . 0.0 110.901 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -45.35 -42.98 17.48 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 124.07 3.18 . . . . 0.0 115.957 -177.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -66.21 -14.83 62.52 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -179.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . 0.485 HD21 ' N ' ' A' ' 429' ' ' SER . 1.7 p-10 -127.23 -7.15 5.91 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.562 1.145 . . . . 0.0 113.143 177.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -61.39 -38.26 86.42 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.638 1.175 . . . . 0.0 112.943 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -75.31 7.45 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 125.978 1.711 . . . . 0.0 113.474 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 60.7 mt-10 48.55 57.41 18.17 Favored Pre-proline 0 CA--C 1.552 1.033 0 C-N-CA 126.989 2.116 . . . . 0.0 113.015 -176.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -69.31 167.52 23.6 Favored 'Trans proline' 0 CA--C 1.542 0.909 0 C-N-CA 122.718 2.279 . . . . 0.0 114.974 -177.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 8.4 t -58.44 178.38 0.1 Allowed 'General case' 0 CA--C 1.554 1.119 0 C-N-CA 127.538 2.335 . . . . 0.0 114.25 177.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 33.6 m -134.83 -0.22 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 N-CA-C 116.935 2.198 . . . . 0.0 116.935 -173.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 6.8 mt -118.93 -56.58 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 CA-C-N 121.106 1.775 . . . . 0.0 112.413 -177.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 7.8 p -51.17 -84.85 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 127.116 2.166 . . . . 0.0 114.064 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -148.47 -15.8 0.33 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 131.516 3.926 . . . . 0.0 111.998 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 92.1 69.22 1.15 Allowed Glycine 0 CA--C 1.53 1.003 0 C-N-CA 125.082 1.325 . . . . 0.0 113.009 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 12.3 ptp85 -99.21 154.47 37.29 Favored Pre-proline 0 N--CA 1.48 1.026 0 C-N-CA 125.125 1.37 . . . . 0.0 110.888 175.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -51.71 125.05 15.83 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.648 2.899 . . . . 0.0 112.056 177.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.58 99.96 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 -175.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -128.04 89.85 2.99 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.612 1.165 . . . . 0.0 107.912 176.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 151.96 58.3 0.01 OUTLIER Glycine 0 CA--C 1.528 0.845 0 C-N-CA 123.907 0.765 . . . . 0.0 112.459 -176.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 35.7 t -59.57 138.31 57.75 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 118.34 1.07 . . . . 0.0 110.943 -178.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.8 mp -114.96 140.62 35.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 C-N-CA 127.271 2.229 . . . . 0.0 110.772 -174.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 73.1 t -130.04 131.72 65.87 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 124.416 1.086 . . . . 0.0 111.641 178.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -111.42 100.96 9.45 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 127.755 2.422 . . . . 0.0 108.505 171.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 73.67 -85.0 0.65 Allowed Glycine 0 CA--C 1.534 1.246 0 C-N-CA 125.488 1.518 . . . . 0.0 112.939 -178.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -137.08 4.86 2.75 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.338 1.855 . . . . 0.0 114.348 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 51.2 p -131.37 170.04 15.19 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.467 1.907 . . . . 0.0 110.248 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -160.08 175.56 36.87 Favored Glycine 0 CA--C 1.531 1.035 0 O-C-N 120.804 -1.185 . . . . 0.0 114.561 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 10.0 m80 -120.03 100.02 6.96 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.083 1.753 . . . . 0.0 110.222 178.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 11.2 tp -76.69 92.75 3.56 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 128.212 2.605 . . . . 0.0 111.193 -177.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -169.53 -27.41 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 118.108 2.633 . . . . 0.0 118.108 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -103.35 164.06 11.88 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 120.085 1.311 . . . . 0.0 114.373 -174.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 32.0 p -85.92 168.34 14.29 Favored 'General case' 0 CA--C 1.55 0.973 0 CA-C-O 122.123 0.963 . . . . 0.0 112.241 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.07 -42.35 90.16 Favored 'General case' 0 N--CA 1.473 0.712 0 O-C-N 121.224 -0.923 . . . . 0.0 111.678 -179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 86.9 m -54.98 -58.81 6.1 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 124.334 1.054 . . . . 0.0 109.628 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 84.0 m -57.51 -43.89 84.59 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.118 1.367 . . . . 0.0 112.629 178.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.71 -50.85 69.21 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.76 0.824 . . . . 0.0 111.775 174.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -65.49 -38.49 89.91 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.292 1.037 . . . . 0.0 112.089 177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 63.8 mmtt -60.57 -52.43 65.2 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.909 1.284 . . . . 0.0 110.845 177.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 19.6 mt -50.48 -49.81 54.37 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.764 1.226 . . . . 0.0 110.273 175.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 50.9 tttt -55.37 -51.64 66.15 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.942 1.297 . . . . 0.0 112.368 177.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -60.3 -42.47 95.57 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 125.555 1.542 . . . . 0.0 111.797 175.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 50.4 mtp180 -69.68 -3.96 17.49 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 127.372 2.269 . . . . 0.0 113.209 175.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 63.96 20.12 12.06 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 128.478 2.711 . . . . 0.0 114.291 -179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 50.2 tptt -70.05 127.7 92.16 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 173.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -64.18 -56.07 0.51 Allowed 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.846 2.364 . . . . 0.0 112.057 -177.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 13.2 t -152.95 137.6 10.93 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 128.335 2.654 . . . . 0.0 108.412 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -70.08 -5.19 15.81 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.205 2.604 . . . . 0.0 114.179 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 24.7 t -120.16 -75.26 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.897 0 CA-C-N 119.99 1.268 . . . . 0.0 113.197 -178.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 10.6 p -92.19 -1.57 57.06 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 125.978 1.711 . . . . 0.0 114.516 -176.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 83.2 mtm180 61.54 24.74 14.79 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 127.635 2.374 . . . . 0.0 115.878 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -93.72 121.14 65.25 Favored Pre-proline 0 CA--C 1.558 1.279 0 CA-C-N 119.1 0.864 . . . . 0.0 109.912 174.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -42.87 112.09 0.25 Allowed 'Trans proline' 0 CA--C 1.547 1.139 1 C-N-CA 125.375 4.05 . . . . 0.0 119.727 -173.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 1.9 pp -70.59 128.69 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 126.466 1.906 . . . . 0.0 110.386 173.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -115.18 -16.59 11.54 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 -174.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . 0.495 ' SD ' HG13 ' A' ' 486' ' ' VAL . 5.7 tmm? -145.87 147.67 32.04 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.299 0.954 . . . . 0.0 112.953 -173.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 13.5 mt -137.2 133.27 47.01 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 126.736 2.014 . . . . 0.0 109.763 174.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 486' ' ' VAL . . . . . 0.495 HG13 ' SD ' ' A' ' 484' ' ' MET . 3.4 m -119.24 150.16 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 C-N-CA 125.709 1.604 . . . . 0.0 112.4 176.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.55 99.88 3.74 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 175.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 24.8 m -88.63 143.81 26.7 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -174.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -123.6 152.32 42.04 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 127.107 2.163 . . . . 0.0 110.507 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . 0.54 ' H ' ' CD ' ' A' ' 491' ' ' PRO . 56.2 p90 -138.39 -29.53 0.01 OUTLIER Pre-proline 0 CA--C 1.552 1.033 0 N-CA-C 116.986 2.217 . . . . 0.0 116.986 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 491' ' ' PRO . . . . . 0.54 ' CD ' ' H ' ' A' ' 490' ' ' PHE . 87.5 Cg_exo . . . . . 0 C--N 1.359 1.12 0 C-N-CA 123.255 2.636 . . . . 0.0 114.218 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 41.3 p . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 23.0 tp -63.97 136.76 96.87 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 125.34 1.456 . . . . 0.0 109.244 176.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_exo -44.23 -43.98 12.96 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 123.855 3.037 . . . . 0.0 115.498 -179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 71.7 mt -58.93 -36.68 75.17 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.473 1.109 . . . . 0.0 113.066 178.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -89.12 -19.01 26.06 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.599 1.56 . . . . 0.0 112.852 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -76.69 1.91 15.73 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.384 1.873 . . . . 0.0 115.192 -179.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 15.4 mm 55.5 80.1 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 127.672 2.389 . . . . 0.0 112.554 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -62.13 156.31 59.75 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 125.839 1.656 . . . . 0.0 114.771 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -78.63 -155.4 0.05 OUTLIER 'Trans proline' 0 CA--C 1.556 1.62 0 C-N-CA 125.004 3.803 . . . . 0.0 110.2 174.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 11.4 t -47.72 148.03 1.68 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.67 1.588 . . . . 0.0 111.722 175.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 25.7 t -117.93 -11.25 11.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 125.611 1.565 . . . . 0.0 112.093 -176.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 10.0 mt -128.62 -53.26 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -174.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 2.1 m -69.82 -68.97 0.38 Allowed 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.594 1.958 . . . . 0.0 115.371 -171.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -144.82 -10.24 0.6 Allowed 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -173.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.51 11.38 82.04 Favored Glycine 0 CA--C 1.542 1.764 0 CA-C-N 119.638 1.108 . . . . 0.0 112.603 -174.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 13.0 ptm180 -67.48 155.04 92.0 Favored Pre-proline 0 N--CA 1.475 0.789 0 C-N-CA 127.738 2.415 . . . . 0.0 111.957 177.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.61 142.45 13.74 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.729 2.952 . . . . 0.0 115.112 -179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 22.2 pttm -63.82 34.98 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 129.305 3.042 . . . . 0.0 116.164 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -81.35 89.77 6.12 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.491 -1.381 . . . . 0.0 108.139 -179.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 170.51 48.37 0.04 OUTLIER Glycine 0 CA--C 1.525 0.672 0 C-N-CA 123.993 0.806 . . . . 0.0 112.846 -177.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 48.4 t -55.32 133.52 49.59 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.106 1.362 . . . . 0.0 109.732 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 2.1 mp -104.53 150.18 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 126.001 1.72 . . . . 0.0 109.736 -176.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 40.2 t -124.68 140.12 48.83 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 CA-C-O 122.362 1.077 . . . . 0.0 110.652 176.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 6.8 m-70 -125.22 94.92 4.3 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 128.355 2.662 . . . . 0.0 109.106 175.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 66.63 -84.18 0.11 Allowed Glycine 0 CA--C 1.538 1.51 0 C-N-CA 124.796 1.189 . . . . 0.0 113.333 -178.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 9.1 ptpp? -130.4 0.93 4.56 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 128.057 2.543 . . . . 0.0 113.81 178.079 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 27.7 p -112.39 170.15 8.37 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 126.978 2.111 . . . . 0.0 109.735 177.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -154.17 167.49 32.33 Favored Glycine 0 CA--C 1.528 0.879 0 O-C-N 120.692 -1.255 . . . . 0.0 114.844 178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -120.08 143.11 48.31 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 125.172 1.389 . . . . 0.0 113.11 178.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 9.9 tt -126.66 153.09 45.85 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 130.434 3.493 . . . . 0.0 108.985 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 9.5 ttt 100.22 19.69 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 128.796 2.838 . . . . 0.0 114.529 176.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -140.94 152.93 45.38 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.901 1.68 . . . . 0.0 110.368 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 13.1 p -82.2 174.51 11.11 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 122.619 1.2 . . . . 0.0 113.198 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -58.51 -46.31 86.97 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.406 177.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 49.0 m -65.86 -42.84 89.91 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 117.345 -1.312 . . . . 0.0 112.391 -178.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 55.5 m -49.83 -55.36 14.49 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 120.382 1.447 . . . . 0.0 109.588 173.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -62.8 -40.75 98.31 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.622 1.569 . . . . 0.0 113.587 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -60.6 -44.02 96.75 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 125.554 1.542 . . . . 0.0 111.582 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 8.8 mtpm? -57.46 -58.37 8.6 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.108 1.363 . . . . 0.0 110.647 177.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.3 pp -64.03 -32.22 73.7 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 112.951 0.722 . . . . 0.0 112.951 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 14.5 tmtt? -67.41 -47.39 70.41 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.906 1.682 . . . . 0.0 111.434 176.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -60.08 -38.7 83.66 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.234 1.014 . . . . 0.0 111.945 176.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 40.7 mmt180 -76.59 -6.41 51.83 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 125.7 1.6 . . . . 0.0 113.018 174.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 64.3 t30 52.7 39.31 28.27 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 128.135 2.574 . . . . 0.0 112.144 -177.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -73.92 132.3 80.35 Favored Pre-proline 0 CA--C 1.539 0.555 0 C-N-CA 125.328 1.451 . . . . 0.0 112.177 -177.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -70.61 119.1 6.08 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.492 2.128 . . . . 0.0 107.612 170.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 42.9 t -20.75 125.7 0.08 OUTLIER Pre-proline 0 CA--C 1.555 1.155 0 C-N-CA 129.157 2.983 . . . . 0.0 116.44 -176.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -65.91 -1.8 5.67 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 122.845 2.363 . . . . 0.0 114.172 178.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 45.2 t -113.96 -69.51 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 125.671 1.588 . . . . 0.0 111.34 179.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 28.3 p -93.45 -7.57 44.08 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 114.863 1.431 . . . . 0.0 114.863 -178.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 10.1 mpt_? 61.4 13.52 5.07 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 127.158 2.183 . . . . 0.0 114.67 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -74.1 159.19 84.52 Favored Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 124.418 1.087 . . . . 0.0 111.806 176.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -69.61 130.2 19.1 Favored 'Trans proline' 0 CA--C 1.542 0.877 0 C-N-CA 122.973 2.449 . . . . 0.0 112.087 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -74.59 110.4 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.842 0 C-N-CA 126.161 1.784 . . . . 0.0 110.816 179.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -87.41 -61.14 1.79 Allowed 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.542 1.137 . . . . 0.0 113.303 -178.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.17 170.06 22.1 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.057 1.343 . . . . 0.0 113.922 -174.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 13.3 mt -133.03 140.69 46.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 127.714 2.405 . . . . 0.0 108.643 177.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 5.2 m -131.75 150.03 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.238 0 C-N-CA 125.215 1.406 . . . . 0.0 112.956 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.51 99.93 3.14 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 177.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.78 95.8 6.05 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.306 1.442 . . . . 0.0 112.541 -173.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -68.55 161.71 27.33 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.306 1.442 . . . . 0.0 111.209 177.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -133.29 165.4 37.03 Favored Pre-proline 0 CA--C 1.549 0.925 0 C-N-CA 125.314 1.446 . . . . 0.0 111.59 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo . . . . . 0 C--N 1.352 0.752 0 C-N-CA 124.345 3.364 . . . . 0.0 114.124 -179.592 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 43.7 m . . . . . 0 CA--C 1.54 0.572 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 52.3 tp -135.1 97.38 13.58 Favored Pre-proline 0 CA--C 1.544 0.737 0 C-N-CA 126.601 1.96 . . . . 0.0 109.622 179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -62.39 -27.89 77.87 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.676 2.25 . . . . 0.0 114.099 -176.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 63.4 tp -65.45 -36.0 82.6 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 119.189 0.904 . . . . 0.0 112.316 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -73.45 -33.71 65.03 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.844 0.858 . . . . 0.0 111.28 176.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -72.55 -59.29 2.79 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.34 1.056 . . . . 0.0 110.833 178.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 19.5 mm -84.97 62.11 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 126.723 2.009 . . . . 0.0 108.447 177.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -56.27 114.18 7.22 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 125.283 1.433 . . . . 0.0 114.067 -176.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -79.02 171.24 16.7 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.565 2.844 . . . . 0.0 113.141 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 8.0 p -68.47 -177.28 0.9 Allowed 'General case' 0 CA--C 1.553 1.084 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 176.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 16.8 m -139.09 -8.83 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 -178.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 4.2 mt -110.74 -62.26 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 121.132 1.787 . . . . 0.0 112.539 -177.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 19.7 p -65.63 -64.32 0.89 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.66 1.356 . . . . 0.0 114.66 -176.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . 0.51 HE21 ' NH2' ' A' ' 444' ' ' ARG . 43.4 mt-30 -143.64 -13.19 0.67 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 116.981 2.215 . . . . 0.0 116.981 -173.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 81.94 28.07 43.25 Favored Glycine 0 CA--C 1.536 1.381 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -172.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . 0.51 ' NH2' HE21 ' A' ' 442' ' ' GLN . 12.8 ptp180 -72.84 155.07 90.97 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 125.142 1.377 . . . . 0.0 111.534 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -70.07 1.82 4.29 Favored 'Trans proline' 0 CA--C 1.548 1.214 0 C-N-CA 124.03 3.153 . . . . 0.0 116.135 -178.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -63.56 156.71 25.67 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 127.016 2.126 . . . . 0.0 112.827 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -128.05 150.23 50.03 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 129.193 2.997 . . . . 0.0 111.956 -175.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 176.77 84.29 0.06 OUTLIER Glycine 0 CA--C 1.535 1.306 0 C-N-CA 125.3 1.428 . . . . 0.0 113.671 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 42.2 t -62.36 139.58 58.54 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.978 0.911 . . . . 0.0 111.526 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.6 mp -115.11 148.75 17.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.95 1.7 . . . . 0.0 111.043 -178.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 93.9 t -130.0 131.71 65.95 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.13 0 C-N-CA 124.316 1.047 . . . . 0.0 111.517 177.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.5 p80 -125.04 100.15 6.44 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 128.097 2.559 . . . . 0.0 112.397 176.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.69 -89.6 0.38 Allowed Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.579 1.562 . . . . 0.0 114.25 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 1.9 mptp? -120.6 -4.5 9.78 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.955 1.702 . . . . 0.0 113.797 -178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 47.4 p -131.7 170.0 15.39 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.945 1.698 . . . . 0.0 111.176 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -141.81 176.12 22.17 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 124.546 1.07 . . . . 0.0 115.159 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.11 144.64 47.52 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 127.106 2.162 . . . . 0.0 112.784 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 34.0 tp -135.13 153.17 52.09 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 128.407 2.683 . . . . 0.0 110.904 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 47.3 mtt 82.97 29.77 0.09 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 128.748 2.819 . . . . 0.0 113.528 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -134.01 139.91 46.35 Favored 'General case' 0 C--O 1.24 0.58 0 C-N-CA 127.107 2.163 . . . . 0.0 107.563 175.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 30.6 p -79.42 175.04 10.97 Favored 'General case' 0 C--O 1.24 0.582 0 CA-C-O 122.883 1.325 . . . . 0.0 113.52 -179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.52 -36.08 81.45 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.46 176.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 53.8 m -63.94 -53.12 55.27 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 117.372 -1.299 . . . . 0.0 110.508 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 28.8 m -48.98 -54.24 16.44 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-N 120.394 1.452 . . . . 0.0 111.052 175.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.97 -49.48 76.67 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.806 1.242 . . . . 0.0 112.949 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 41.1 ttmt -62.59 -41.66 99.1 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.559 1.144 . . . . 0.0 111.443 178.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -61.18 -57.96 10.28 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.0 1.72 . . . . 0.0 111.159 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 1.7 pp -59.51 -37.01 77.19 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 118.046 0.384 . . . . 0.0 111.495 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 58.2 tttp -61.9 -52.15 65.25 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.263 1.425 . . . . 0.0 111.827 175.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -59.94 -34.89 73.85 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 124.927 1.291 . . . . 0.0 112.599 176.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -78.34 2.92 16.99 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 126.625 1.97 . . . . 0.0 113.424 175.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 28.2 m120 64.16 21.01 12.42 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 128.582 2.753 . . . . 0.0 114.991 178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -70.47 134.02 86.81 Favored Pre-proline 0 CA--C 1.544 0.732 0 O-C-N 121.102 -0.999 . . . . 0.0 108.606 175.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -66.38 -56.28 0.3 Allowed 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.264 1.976 . . . . 0.0 111.223 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 1.8 t -155.2 145.26 15.72 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 129.858 3.263 . . . . 0.0 109.008 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.99 -12.47 32.53 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.018 2.478 . . . . 0.0 114.849 179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 15.3 t -140.23 -56.16 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 CA-C-N 120.707 1.594 . . . . 0.0 114.297 -177.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 16.8 m -71.5 -22.42 61.79 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.107 2.163 . . . . 0.0 112.207 -177.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 79.2 mtm-85 63.3 11.81 5.71 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 127.894 2.478 . . . . 0.0 113.527 -176.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 33.2 mt-30 -75.94 132.85 73.46 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.503 1.121 . . . . 0.0 109.02 174.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -66.02 110.11 1.66 Allowed 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 122.69 2.26 . . . . 0.0 114.412 -176.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.0 pp -65.28 141.38 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 C-N-CA 125.519 1.528 . . . . 0.0 111.836 177.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -114.98 -28.04 7.16 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.89 1.276 . . . . 0.0 114.24 -176.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -154.63 162.57 41.07 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.274 1.03 . . . . 0.0 113.699 -177.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 6.8 mt -129.19 137.71 56.35 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.659 0 C-N-CA 127.725 2.41 . . . . 0.0 107.219 176.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 12.2 p -134.27 150.03 30.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.792 1.237 . . . . 0.0 112.312 -177.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -75.21 99.74 4.1 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.489 0.716 . . . . 0.0 109.07 179.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 94.1 m -112.3 105.6 13.94 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.797 0.839 . . . . 0.0 109.599 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -87.04 161.54 18.11 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.177 1.391 . . . . 0.0 113.959 -175.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -72.08 161.32 79.47 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 126.876 2.07 . . . . 0.0 112.387 -179.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo . . . . . 0 C--N 1.353 0.766 0 C-N-CA 124.563 3.508 . . . . 0.0 114.422 178.775 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 N--CA 1.47 0.552 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 97.2 mt -69.15 158.81 85.6 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 125.389 1.476 . . . . 0.0 112.429 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -58.57 165.19 8.15 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 123.728 2.952 . . . . 0.0 113.68 177.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 7.2 tt -49.5 -39.26 33.35 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.294 1.438 . . . . 0.0 113.254 178.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -54.61 -24.73 22.61 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.84 1.656 . . . . 0.0 114.263 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -69.28 -22.49 63.81 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.36 -0.837 . . . . 0.0 112.737 176.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 35.1 mm -84.07 81.29 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 125.913 1.685 . . . . 0.0 107.421 176.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -109.48 60.79 0.3 Allowed Pre-proline 0 CA--C 1.559 1.312 0 C-N-CA 127.3 2.24 . . . . 0.0 115.07 -173.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -69.39 -45.35 1.82 Allowed 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.523 2.815 . . . . 0.0 112.563 178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 15.8 t -59.54 146.69 39.69 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 119.859 1.209 . . . . 0.0 109.295 173.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 27.6 m -131.98 -1.22 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.759 0 C-N-CA 124.488 1.115 . . . . 0.0 113.723 179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 4.1 mt -132.95 -45.33 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-N 119.431 1.014 . . . . 0.0 112.805 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 2.7 m -71.16 -60.55 2.17 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -172.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -152.17 -17.78 0.18 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -176.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 83.31 10.23 82.56 Favored Glycine 0 CA--C 1.539 1.535 0 CA-C-N 119.575 1.079 . . . . 0.0 112.439 -175.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -71.13 155.1 93.62 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 127.281 2.232 . . . . 0.0 113.237 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -56.96 7.7 0.04 OUTLIER 'Trans proline' 0 CA--C 1.553 1.449 1 C-N-CA 126.012 4.475 . . . . 0.0 120.103 -179.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -61.47 151.28 33.18 Favored 'General case' 0 N--CA 1.481 1.109 0 CA-C-N 120.652 1.569 . . . . 0.0 112.301 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 16.7 p30 -128.13 150.23 50.07 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.63 1.572 . . . . 0.0 112.336 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -167.88 79.9 0.1 Allowed Glycine 0 CA--C 1.531 1.083 0 C-N-CA 126.552 2.025 . . . . 0.0 111.523 178.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 49.1 t -68.04 135.36 52.16 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 117.719 0.76 . . . . 0.0 110.532 178.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -115.04 143.33 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.486 0 C-N-CA 125.912 1.685 . . . . 0.0 111.855 -177.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 53.2 t -129.53 137.54 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 125.156 1.382 . . . . 0.0 110.681 176.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -124.0 104.07 8.68 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 129.6 3.16 . . . . 0.0 110.472 176.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.85 -87.42 0.29 Allowed Glycine 0 CA--C 1.534 1.274 0 C-N-CA 125.437 1.494 . . . . 0.0 113.62 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -131.22 5.04 4.43 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.47 1.908 . . . . 0.0 114.308 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 82.0 p -133.97 170.05 16.21 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 126.537 1.935 . . . . 0.0 110.693 179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -159.08 174.44 36.03 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 120.781 -1.2 . . . . 0.0 113.309 179.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 15.6 m80 -120.29 144.51 47.77 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.528 1.131 . . . . 0.0 113.38 175.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 4.1 pp -110.78 153.22 25.66 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 126.333 1.853 . . . . 0.0 112.792 178.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 22.8 ttt 85.33 67.89 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 129.084 2.954 . . . . 0.0 113.116 178.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -158.1 152.18 24.15 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 128.122 2.569 . . . . 0.0 108.675 175.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 13.3 p -91.61 171.56 9.09 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-O 122.074 0.94 . . . . 0.0 111.74 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.57 -36.75 85.25 Favored 'General case' 0 N--CA 1.466 0.332 0 O-C-N 121.641 -0.662 . . . . 0.0 111.467 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 38.4 m -68.76 -50.02 53.95 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 116.528 -1.701 . . . . 0.0 109.976 178.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 19.2 m -46.19 -57.77 4.24 Favored 'General case' 0 CA--C 1.544 0.736 0 CA-C-N 121.237 1.835 . . . . 0.0 110.943 174.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.84 -51.3 67.97 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.787 1.235 . . . . 0.0 112.599 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 57.1 tptt -62.78 -37.94 88.64 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.236 -0.915 . . . . 0.0 112.778 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt -61.22 -51.21 69.94 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 126.215 1.806 . . . . 0.0 110.96 177.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 20.9 mt -54.94 -53.63 53.14 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 124.858 1.263 . . . . 0.0 109.67 175.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -52.94 -48.07 67.59 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.431 1.492 . . . . 0.0 112.644 178.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -61.45 -41.67 97.58 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.462 1.505 . . . . 0.0 112.204 175.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 89.4 mtm180 -70.82 -16.74 62.75 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 125.189 1.396 . . . . 0.0 113.613 176.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 35.3 t30 105.13 -3.99 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.89 1 C-N-CA 132.428 4.291 . . . . 0.0 115.047 175.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -80.7 123.7 82.35 Favored Pre-proline 0 N--CA 1.472 0.663 0 CA-C-N 120.784 1.629 . . . . 0.0 109.882 177.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -70.77 -69.08 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 122.823 2.349 . . . . 0.0 111.655 -179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 7.1 t -111.12 135.18 20.9 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 126.346 1.859 . . . . 0.0 111.727 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -79.88 -7.55 14.41 Favored 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 123.351 2.7 . . . . 0.0 114.261 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 29.1 t -102.93 -72.87 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 CA-C-N 119.748 1.158 . . . . 0.0 112.085 -177.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 26.5 p -100.65 -3.58 30.07 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 126.048 1.739 . . . . 0.0 113.647 -178.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . 0.338 15.5 ptp180 53.85 23.6 3.95 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 128.797 2.839 . . . . 0.0 116.026 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -65.51 146.76 98.94 Favored Pre-proline 0 CA--C 1.551 0.994 0 C-N-CA 123.361 0.664 . . . . 0.0 109.579 173.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -68.02 112.2 2.66 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.337 2.691 . . . . 0.0 113.714 -175.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.5 pp -71.63 160.04 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.879 1.672 . . . . 0.0 113.209 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -111.38 -54.06 2.64 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.471 1.908 . . . . 0.0 110.818 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.33 170.21 21.21 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.83 1.252 . . . . 0.0 113.425 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 14.7 mt -121.14 137.94 53.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.758 0 C-N-CA 127.302 2.241 . . . . 0.0 106.76 174.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 10.8 m -134.43 149.94 30.31 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 113.885 1.069 . . . . 0.0 113.885 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 52.8 mt -73.34 99.94 3.05 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.704 1.202 . . . . 0.0 108.358 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 33.5 m -116.65 112.63 21.53 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.607 1.563 . . . . 0.0 112.29 -175.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -100.7 171.06 7.93 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.775 1.63 . . . . 0.0 112.692 -178.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -139.05 156.09 72.51 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.331 1.452 . . . . 0.0 111.751 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 C--N 1.35 0.654 0 C-N-CA 123.599 2.866 . . . . 0.0 111.495 -179.828 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 41.1 m . . . . . 0 CA--C 1.54 0.573 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 54.1 tp -126.18 105.75 25.07 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 126.583 1.953 . . . . 0.0 110.735 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -48.89 152.52 4.52 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 124.106 3.204 . . . . 0.0 114.135 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 85.4 mt 63.97 -56.52 0.22 Allowed 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 129.947 3.299 . . . . 0.0 113.042 -176.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -55.14 -31.97 61.74 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.864 2.466 . . . . 0.0 113.48 177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -96.14 -7.04 36.98 Favored 'General case' 0 CA--C 1.548 0.895 0 N-CA-C 114.942 1.46 . . . . 0.0 114.942 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 49.4 mm -66.57 -51.34 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 124.123 0.969 . . . . 0.0 110.961 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 31.43 73.29 0.51 Allowed Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 128.532 2.733 . . . . 0.0 113.962 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -51.44 -57.62 2.1 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 124.423 3.416 . . . . 0.0 115.683 -177.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 8.0 t -54.55 148.0 13.15 Favored 'General case' 0 CA--C 1.55 0.974 0 C-N-CA 124.264 1.026 . . . . 0.0 111.752 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 34.8 m -128.35 -3.37 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 O-C-N 121.173 -0.955 . . . . 0.0 113.317 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 7.3 mt -129.65 -48.15 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 123.871 0.869 . . . . 0.0 112.774 -179.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.2 m -68.0 -62.81 1.23 Allowed 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 -174.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -156.87 -15.01 0.09 Allowed 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 115.461 1.652 . . . . 0.0 115.461 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 88.29 8.33 71.6 Favored Glycine 0 CA--C 1.54 1.629 0 O-C-N 120.652 -1.28 . . . . 0.0 112.657 -174.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -59.67 151.45 62.22 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 128.718 2.807 . . . . 0.0 114.336 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -75.8 88.39 1.31 Allowed 'Trans proline' 0 CA--C 1.545 1.045 0 C-N-CA 124.448 3.432 . . . . 0.0 113.258 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -136.96 161.79 35.06 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 127.375 2.27 . . . . 0.0 111.023 178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 51.0 m-20 -125.61 150.08 47.85 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.668 1.587 . . . . 0.0 109.972 -179.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -179.93 80.43 0.06 OUTLIER Glycine 0 CA--C 1.531 1.047 0 C-N-CA 126.309 1.909 . . . . 0.0 111.498 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 50.5 t -66.29 133.39 50.48 Favored 'General case' 0 N--CA 1.469 0.509 0 C-N-CA 123.877 0.871 . . . . 0.0 110.008 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -115.03 141.21 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 124.878 1.271 . . . . 0.0 110.766 -179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 92.3 t -130.01 133.96 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 C-N-CA 124.426 1.091 . . . . 0.0 111.8 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -124.92 107.88 11.32 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 128.693 2.797 . . . . 0.0 110.204 174.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 66.29 -93.6 0.2 Allowed Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.993 1.759 . . . . 0.0 113.625 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -126.16 7.19 7.18 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.72 2.008 . . . . 0.0 113.611 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 79.7 p -130.52 170.12 14.66 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 126.656 1.982 . . . . 0.0 110.541 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.33 -178.4 30.44 Favored Glycine 0 CA--C 1.531 1.039 0 O-C-N 120.816 -1.177 . . . . 0.0 115.345 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -120.07 136.51 54.55 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.038 2.135 . . . . 0.0 110.404 176.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 26.4 tp -121.38 152.97 38.42 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.615 1.966 . . . . 0.0 111.206 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 41.4 mtm 64.97 68.34 0.51 Allowed 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 127.62 2.368 . . . . 0.0 113.018 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -151.96 148.16 27.42 Favored 'General case' 0 C--O 1.241 0.626 0 C-N-CA 129.163 2.985 . . . . 0.0 107.252 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 17.2 p -77.92 165.89 23.55 Favored 'General case' 0 C--O 1.241 0.622 0 CA-C-O 122.472 1.13 . . . . 0.0 111.828 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -62.7 -38.67 91.34 Favored 'General case' 0 CA--C 1.539 0.553 0 O-C-N 121.698 -0.626 . . . . 0.0 111.165 177.316 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 23.8 m -62.16 -48.8 78.48 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 116.911 -1.519 . . . . 0.0 111.133 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 16.6 m -49.24 -51.66 31.96 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 120.809 1.64 . . . . 0.0 111.386 174.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.19 -47.06 84.61 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.42 1.088 . . . . 0.0 112.835 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -65.88 -40.57 91.73 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 121.216 -0.927 . . . . 0.0 111.937 176.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -61.43 -56.83 15.83 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 126.624 1.97 . . . . 0.0 111.471 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 2.8 pp -59.98 -35.89 75.97 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 118.133 0.424 . . . . 0.0 111.317 179.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -63.48 -48.63 76.86 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.886 1.274 . . . . 0.0 110.853 175.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -58.64 -39.36 80.32 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.314 1.446 . . . . 0.0 111.409 176.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 95.0 mtt-85 -74.12 3.79 6.53 Favored 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 127.163 2.185 . . . . 0.0 113.746 175.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 67.51 15.82 9.86 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 128.949 2.9 . . . . 0.0 115.227 178.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 5.7 tppp? -70.17 129.96 90.09 Favored Pre-proline 0 N--CA 1.475 0.802 0 O-C-N 120.832 -1.168 . . . . 0.0 109.106 175.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -67.33 -49.48 1.26 Allowed 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 122.847 2.365 . . . . 0.0 111.38 179.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 1.7 t -158.36 142.28 11.27 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 131.576 3.95 . . . . 0.0 107.995 175.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -70.76 -11.32 29.35 Favored 'Trans proline' 0 CA--C 1.544 0.992 0 C-N-CA 123.081 2.521 . . . . 0.0 115.026 -178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 17.1 t -137.75 -55.93 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 120.54 1.518 . . . . 0.0 113.739 -178.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 22.4 m -69.88 -25.47 63.72 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.739 1.616 . . . . 0.0 111.432 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 33.5 mtp-105 61.38 13.78 5.24 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 127.911 2.484 . . . . 0.0 113.244 -175.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -76.73 130.85 75.14 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.227 1.411 . . . . 0.0 108.484 174.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -64.46 109.61 1.24 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 122.549 2.166 . . . . 0.0 113.679 -176.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.1 pp -63.21 137.78 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 125.683 1.593 . . . . 0.0 111.861 177.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -115.18 -20.8 10.26 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 -176.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 2.6 ttp -150.95 146.68 26.42 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.13 0.972 . . . . 0.0 112.763 -174.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 7.6 mt -130.78 131.47 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 C-N-CA 127.478 2.311 . . . . 0.0 107.763 174.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 16.8 m -137.39 150.09 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-N 119.487 1.039 . . . . 0.0 113.707 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.18 99.87 3.52 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 10.2 t -89.41 156.19 18.85 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.372 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -135.7 170.33 16.14 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.161 2.185 . . . . 0.0 111.374 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -133.56 156.57 79.48 Favored Pre-proline 0 CA--C 1.547 0.834 0 C-N-CA 124.887 1.275 . . . . 0.0 111.706 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo . . . . . 0 CA--C 1.538 0.692 0 C-N-CA 123.434 2.756 . . . . 0.0 112.369 179.753 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 41.2 m . . . . . 0 N--CA 1.471 0.599 0 N-CA-C 113.969 1.099 . . . . 0.0 113.969 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -135.52 90.46 20.13 Favored Pre-proline 0 CA--C 1.549 0.938 0 C-N-CA 126.324 1.85 . . . . 0.0 111.669 -179.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -47.45 -31.38 13.31 Favored 'Trans proline' 0 C--N 1.354 0.828 0 C-N-CA 124.705 3.603 . . . . 0.0 115.599 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 1.6 pp -58.05 -20.18 37.31 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.064 1.745 . . . . 0.0 114.907 177.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -121.32 -2.45 9.54 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 126.189 1.796 . . . . 0.0 112.64 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -78.41 64.96 3.61 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.414 1.486 . . . . 0.0 112.756 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 28.8 mm -77.46 73.21 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.777 1.231 . . . . 0.0 109.838 178.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -138.04 67.86 48.67 Favored Pre-proline 0 CA--C 1.548 0.893 0 C-N-CA 126.454 1.902 . . . . 0.0 110.143 -179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -61.13 -38.89 63.67 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.092 2.528 . . . . 0.0 114.696 -177.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 42.2 t -56.13 143.91 31.31 Favored 'General case' 0 CA--C 1.544 0.742 0 CA-C-N 120.182 1.355 . . . . 0.0 111.029 177.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 28.5 m -123.68 -15.13 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 114.453 1.279 . . . . 0.0 114.453 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 10.5 pt -137.12 -26.41 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 -178.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.5 m -75.9 -64.47 1.08 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 120.64 1.563 . . . . 0.0 112.137 -177.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -145.39 -12.81 0.52 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 115.163 1.542 . . . . 0.0 115.163 -176.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 76.73 11.88 84.97 Favored Glycine 0 CA--C 1.544 1.886 0 CA-C-N 119.992 1.269 . . . . 0.0 112.487 -173.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -59.54 155.11 40.7 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 129.997 3.319 . . . . 0.0 113.618 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -71.65 -1.69 10.21 Favored 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 124.354 3.37 . . . . 0.0 115.463 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 54.6 tptt -52.65 146.8 9.55 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 127.042 2.137 . . . . 0.0 111.577 177.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 67.1 m-20 -116.21 150.16 37.97 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 126.757 2.023 . . . . 0.0 110.735 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -159.68 68.12 0.26 Allowed Glycine 0 CA--C 1.527 0.828 0 C-N-CA 128.169 2.795 . . . . 0.0 109.349 177.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 33.8 t -63.8 133.28 53.15 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.063 0.945 . . . . 0.0 110.429 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -114.57 143.21 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 124.35 1.06 . . . . 0.0 112.057 -175.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 89.6 t -129.08 136.84 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.926 1.29 . . . . 0.0 110.629 178.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -125.04 95.05 4.36 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 129.456 3.102 . . . . 0.0 110.096 176.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.96 -91.5 0.35 Allowed Glycine 0 CA--C 1.534 1.231 0 C-N-CA 125.809 1.671 . . . . 0.0 114.227 179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -121.49 4.34 10.18 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 126.318 1.847 . . . . 0.0 114.338 -178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 66.4 p -134.77 170.09 16.37 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 127.249 2.22 . . . . 0.0 109.903 178.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -160.18 174.45 36.93 Favored Glycine 0 CA--C 1.529 0.921 0 O-C-N 120.658 -1.276 . . . . 0.0 113.766 179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -120.26 141.99 49.46 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.906 1.282 . . . . 0.0 113.072 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.41 153.26 36.8 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 128.152 2.581 . . . . 0.0 110.526 177.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 49.5 mtt 93.17 62.96 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 129.826 3.25 . . . . 0.0 111.486 -178.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -160.01 149.59 17.97 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 127.205 2.202 . . . . 0.0 109.489 176.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 19.4 p -88.3 174.93 7.89 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 121.851 0.834 . . . . 0.0 110.232 172.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -39.81 94.77 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 121.397 -0.814 . . . . 0.0 112.416 179.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 68.9 m -68.13 -48.06 66.42 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 116.105 -1.902 . . . . 0.0 110.606 178.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 16.6 m -45.61 -59.07 2.95 Favored 'General case' 0 CA--C 1.546 0.822 0 CA-C-N 121.601 2.001 . . . . 0.0 111.263 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.88 -43.95 86.35 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.028 1.331 . . . . 0.0 114.062 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 40.5 ttpt -68.92 -42.51 76.73 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.354 -0.841 . . . . 0.0 111.777 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -62.35 -53.91 48.19 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 127.006 2.122 . . . . 0.0 112.358 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.3 pp -57.54 -36.49 71.69 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.319 0.509 . . . . 0.0 111.197 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -66.68 -46.21 76.39 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.452 0.701 . . . . 0.0 111.767 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -59.23 -35.11 73.07 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.853 1.261 . . . . 0.0 111.704 174.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 79.8 mtp180 -76.3 3.77 10.21 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 127.322 2.249 . . . . 0.0 113.457 175.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 39.3 t30 76.38 8.49 3.28 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 130.013 3.325 . . . . 0.0 115.649 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 79.8 tttt -70.14 129.46 90.64 Favored Pre-proline 0 N--CA 1.475 0.818 0 O-C-N 120.755 -1.216 . . . . 0.0 109.242 175.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -69.76 -43.23 2.78 Favored 'Trans proline' 0 CA--C 1.542 0.894 0 C-N-CA 123.072 2.515 . . . . 0.0 114.695 -176.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -146.56 149.3 36.65 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 128.251 2.62 . . . . 0.0 110.313 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.24 -17.69 61.32 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.361 2.707 . . . . 0.0 115.369 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.09 -63.31 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 -172.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 28.8 p -89.16 -19.47 25.44 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -172.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . 0.259 3.9 ptm180 94.15 4.8 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 131.252 3.821 . . . . 0.0 116.182 174.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -67.67 111.99 9.12 Favored Pre-proline 0 CA--C 1.554 1.099 0 C-N-CA 125.08 1.352 . . . . 0.0 110.387 178.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -46.64 107.84 0.13 Allowed 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 124.269 3.313 . . . . 0.0 116.099 -175.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 pp -62.86 146.95 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.559 0 C-N-CA 125.178 1.391 . . . . 0.0 113.45 -178.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 96.6 mm-40 -112.1 -29.76 7.48 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.781 1.632 . . . . 0.0 114.187 -173.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -160.03 161.34 33.97 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.63 1.172 . . . . 0.0 113.468 -179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 14.1 mt -129.51 136.48 59.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 C-N-CA 127.518 2.327 . . . . 0.0 108.231 175.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 16.9 m -137.61 150.16 25.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 C-N-CA 124.726 1.21 . . . . 0.0 113.479 179.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.22 99.85 4.86 Favored 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 177.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 1.9 t -93.79 157.61 16.06 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -129.27 143.3 50.8 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.32 1.448 . . . . 0.0 112.403 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -73.39 164.53 60.37 Favored Pre-proline 0 CA--C 1.553 1.07 0 C-N-CA 125.137 1.375 . . . . 0.0 111.56 177.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo . . . . . 0 CA--C 1.539 0.726 0 C-N-CA 124.226 3.284 . . . . 0.0 114.272 179.718 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 N--CA 1.471 0.608 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -153.96 150.08 22.03 Favored Pre-proline 0 CA--C 1.546 0.797 0 C-N-CA 126.727 2.011 . . . . 0.0 111.037 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -63.17 149.59 90.97 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 122.052 1.834 . . . . 0.0 112.728 -178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 5.1 tp 62.04 -60.76 0.11 Allowed 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 130.1 3.36 . . . . 0.0 115.205 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 37.1 t30 -65.25 -16.49 63.6 Favored 'General case' 0 CA--C 1.55 0.945 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 -175.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -63.53 -37.81 88.73 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -179.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 27.3 mm 39.01 65.97 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 127.325 2.25 . . . . 0.0 111.645 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 8.9 mp0 -40.55 102.84 0.27 Allowed Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 128.892 2.877 . . . . 0.0 114.311 -175.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -88.82 -179.1 2.09 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 124.53 3.487 . . . . 0.0 114.447 -177.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 10.0 t -61.01 159.21 11.94 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 128.228 2.611 . . . . 0.0 111.029 171.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 16.1 m -134.71 -0.63 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.378 1.071 . . . . 0.0 113.442 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 10.4 mt -133.94 -48.86 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-N 119.735 1.152 . . . . 0.0 112.866 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.5 m -67.61 -60.16 2.77 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.439 1.496 . . . . 0.0 114.228 -173.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -151.53 -16.13 0.2 Allowed 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 -174.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.62 10.69 82.95 Favored Glycine 0 CA--C 1.542 1.755 0 O-C-N 120.812 -1.18 . . . . 0.0 113.173 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -61.96 155.04 65.46 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 128.39 2.676 . . . . 0.0 112.339 178.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -66.27 1.66 2.35 Favored 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 124.459 3.439 . . . . 0.0 117.3 -177.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -60.96 144.9 52.3 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-N 119.871 1.214 . . . . 0.0 110.62 175.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 14.3 p-10 -128.19 150.07 50.17 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.68 1.992 . . . . 0.0 111.683 -178.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -162.69 98.92 0.17 Allowed Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.742 1.639 . . . . 0.0 112.51 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 46.4 t -68.21 133.2 48.47 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 123.517 0.727 . . . . 0.0 110.638 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.2 mp -113.0 135.4 52.59 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.181 1.392 . . . . 0.0 110.463 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 45.4 t -130.04 130.32 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.422 1.089 . . . . 0.0 109.65 176.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -125.2 99.09 5.93 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.908 2.083 . . . . 0.0 112.206 178.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 75.9 -84.36 0.91 Allowed Glycine 0 CA--C 1.534 1.219 0 C-N-CA 125.732 1.634 . . . . 0.0 114.711 177.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -124.99 -11.53 7.09 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.761 1.624 . . . . 0.0 114.3 -176.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 72.9 p -135.33 168.89 18.37 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.455 1.502 . . . . 0.0 110.573 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -142.96 178.44 21.24 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.35 0.976 . . . . 0.0 113.829 -178.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.3 m80 -120.27 147.03 45.49 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.866 1.266 . . . . 0.0 113.839 177.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 12.2 tp -111.4 153.27 26.3 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 128.84 2.856 . . . . 0.0 113.551 -175.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 16.7 mtt 69.47 59.74 0.31 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 127.68 2.392 . . . . 0.0 115.835 173.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -149.56 163.04 38.96 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.286 1.434 . . . . 0.0 111.046 174.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 11.6 p -87.25 174.49 8.56 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 122.393 1.092 . . . . 0.0 112.484 176.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -67.04 -40.15 87.13 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 121.72 -0.612 . . . . 0.0 111.197 177.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 27.8 m -64.73 -41.98 95.55 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 117.528 -1.225 . . . . 0.0 111.651 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 34.6 m -49.29 -63.61 1.05 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.242 1.417 . . . . 0.0 109.187 173.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -53.92 -45.17 71.11 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 126.021 1.728 . . . . 0.0 113.109 176.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 58.9 tttp -60.11 -37.26 79.47 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.756 1.222 . . . . 0.0 112.352 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -59.85 -49.34 78.1 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.446 1.099 . . . . 0.0 110.922 175.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 5.9 mp -58.75 -46.7 86.84 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 122.847 0.459 . . . . 0.0 109.882 175.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -57.39 -48.06 80.07 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 124.132 0.973 . . . . 0.0 112.906 -179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -56.83 -28.05 60.98 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 125.183 1.393 . . . . 0.0 113.911 177.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 2.0 mmp_? -107.45 -0.55 22.17 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 126.708 2.003 . . . . 0.0 112.979 179.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 60.3 t30 45.49 50.59 10.21 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.943 2.497 . . . . 0.0 111.319 -174.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 33.7 ttmt -73.33 130.6 84.08 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.601 0.761 . . . . 0.0 112.876 -174.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -70.43 115.35 4.15 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.51 2.14 . . . . 0.0 107.568 170.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 53.8 t -23.07 123.35 0.15 Allowed Pre-proline 0 CA--C 1.557 1.244 0 C-N-CA 129.211 3.005 . . . . 0.0 115.682 -176.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -65.34 -3.62 7.87 Favored 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.127 2.551 . . . . 0.0 114.531 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 47.0 t -109.08 -65.5 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 125.346 1.458 . . . . 0.0 111.31 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 24.5 p -104.63 0.74 28.82 Favored 'General case' 0 CA--C 1.551 1.001 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -176.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 62.84 10.29 4.2 Favored 'General case' 0 N--CA 1.485 1.315 0 C-N-CA 127.795 2.438 . . . . 0.0 115.898 176.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -68.68 149.28 97.99 Favored Pre-proline 0 CA--C 1.552 1.058 0 C-N-CA 123.87 0.868 . . . . 0.0 111.732 177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.39 112.96 3.47 Favored 'Trans proline' 0 CA--C 1.538 0.692 0 C-N-CA 123.662 2.908 . . . . 0.0 112.009 -178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -54.92 109.97 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.92 0 C-N-CA 126.547 1.939 . . . . 0.0 110.463 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -103.65 -55.79 2.33 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 114.779 1.4 . . . . 0.0 114.779 -172.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.31 161.87 37.18 Favored 'General case' 0 N--CA 1.476 0.826 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 -177.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 4.6 mt -135.02 136.53 51.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 C-N-CA 126.998 2.119 . . . . 0.0 108.847 179.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 16.9 m -133.21 150.01 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.935 0.894 . . . . 0.0 112.555 176.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 3.8 tt -82.53 99.75 9.69 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 178.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 5.1 t -90.87 162.66 14.7 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.157 -178.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 97.5 m-85 -131.68 148.44 52.59 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.451 1.5 . . . . 0.0 112.038 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 -78.06 160.6 73.28 Favored Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 125.444 1.498 . . . . 0.0 110.969 178.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo . . . . . 0 C--N 1.351 0.683 0 C-N-CA 123.322 2.682 . . . . 0.0 111.784 -177.796 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 10.8 mp -64.52 157.91 69.98 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.829 1.652 . . . . 0.0 111.456 178.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -60.17 -30.91 92.36 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 122.833 2.355 . . . . 0.0 113.579 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 62.8 tp -78.01 -43.01 30.74 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.83 0.852 . . . . 0.0 111.47 175.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -62.21 -33.97 75.57 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.987 1.315 . . . . 0.0 112.37 178.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -123.24 60.59 1.06 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.809 2.043 . . . . 0.0 109.857 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 435' ' ' ILE . . . . . 0.451 HG23 ' H ' ' B' ' 436' ' ' GLU . 9.6 tp -44.22 -63.54 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 C-N-CA 129.806 3.242 . . . . 0.0 114.7 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 436' ' ' GLU . . . . . 0.451 ' H ' HG23 ' B' ' 435' ' ' ILE . 64.3 mm-40 -148.85 88.82 5.1 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 126.532 1.933 . . . . 0.0 107.672 176.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.93 164.77 32.35 Favored 'Trans proline' 0 CA--C 1.537 0.659 0 C-N-CA 122.584 2.19 . . . . 0.0 113.235 -176.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 1.9 p -67.85 175.54 2.98 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 114.649 1.351 . . . . 0.0 114.649 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 34.8 m -135.94 -3.32 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 N-CA-C 115.084 1.513 . . . . 0.0 115.084 -176.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 7.7 mt -114.77 -64.43 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 120.319 1.418 . . . . 0.0 112.588 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 21.5 p -68.85 -59.19 3.25 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 31.7 tt0 -147.35 -17.8 0.39 Allowed 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.531 2.049 . . . . 0.0 116.531 -172.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 90.65 30.65 11.35 Favored Glycine 0 CA--C 1.535 1.309 0 C-N-CA 125.035 1.303 . . . . 0.0 110.778 -174.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 35.0 mtt-85 -62.65 149.38 89.09 Favored Pre-proline 0 N--CA 1.481 1.099 0 C-N-CA 124.929 1.292 . . . . 0.0 111.595 -177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.96 -10.49 29.01 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.448 2.765 . . . . 0.0 114.297 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -58.99 153.56 17.32 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 129.593 3.157 . . . . 0.0 113.002 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 12.4 p30 -128.2 150.16 50.14 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 127.319 2.248 . . . . 0.0 110.625 176.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -167.06 75.11 0.14 Allowed Glycine 0 CA--C 1.53 1.001 0 C-N-CA 127.047 2.26 . . . . 0.0 110.291 178.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 33.1 t -59.89 122.4 14.17 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.643 0.777 . . . . 0.0 111.854 -178.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 450' ' ' ILE . . . . . 0.423 HD12 ' H ' ' B' ' 450' ' ' ILE . 1.2 mp -95.66 134.09 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 124.966 1.306 . . . . 0.0 109.794 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 95.5 t -127.97 130.38 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.707 0 C-N-CA 124.279 1.032 . . . . 0.0 111.353 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.3 p80 -115.06 94.92 4.95 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 128.597 2.759 . . . . 0.0 110.12 174.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.83 -94.92 0.31 Allowed Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.856 1.693 . . . . 0.0 114.372 178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 51.2 tptt -111.97 -1.19 15.51 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 126.02 1.728 . . . . 0.0 113.648 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 70.1 p -132.28 170.01 15.66 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.655 1.582 . . . . 0.0 111.351 178.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -157.69 174.64 35.08 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 121.114 -0.991 . . . . 0.0 113.655 178.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -120.22 110.8 17.03 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.259 1.424 . . . . 0.0 111.411 176.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 9.8 tp -81.22 153.31 27.24 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 128.339 2.655 . . . . 0.0 113.033 -179.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 23.7 mtt 79.58 57.99 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 127.786 2.435 . . . . 0.0 114.663 172.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -148.8 150.27 32.77 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.992 2.117 . . . . 0.0 108.319 175.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 31.7 p -86.47 175.0 8.6 Favored 'General case' 0 C--O 1.24 0.601 0 CA-C-O 122.649 1.214 . . . . 0.0 112.798 178.008 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -64.98 -33.78 76.87 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.2 174.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 37.4 m -63.86 -54.25 37.89 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 117.284 -1.341 . . . . 0.0 109.88 177.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 21.5 m -47.58 -59.71 3.06 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 120.126 1.33 . . . . 0.0 111.234 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.95 -48.02 76.52 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.679 1.192 . . . . 0.0 113.767 -178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -66.05 -41.72 90.48 Favored 'General case' 0 N--CA 1.47 0.575 0 O-C-N 121.209 -0.932 . . . . 0.0 111.722 177.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -63.39 -54.86 30.11 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.785 1.634 . . . . 0.0 112.101 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.5 pp -59.07 -37.89 78.15 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.238 0.472 . . . . 0.0 110.926 179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 44.9 tptt -65.68 -42.99 90.62 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 123.74 0.816 . . . . 0.0 112.174 175.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -59.23 -37.86 78.54 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.031 1.332 . . . . 0.0 111.043 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 48.1 mtm105 -77.04 9.67 2.84 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 127.031 2.133 . . . . 0.0 113.646 174.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . 0.313 0.0 OUTLIER 72.56 3.4 4.67 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 130.742 3.617 . . . . 0.0 116.823 178.415 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 14.8 tppt? -72.08 131.12 85.65 Favored Pre-proline 0 CA--C 1.545 0.752 0 O-C-N 121.091 -1.006 . . . . 0.0 109.947 177.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -70.51 -72.47 0.02 OUTLIER 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.152 2.568 . . . . 0.0 109.651 176.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 9.3 t -120.92 136.26 25.43 Favored Pre-proline 0 CA--C 1.551 1.007 0 C-N-CA 127.897 2.479 . . . . 0.0 109.674 175.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.87 -8.18 19.97 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.343 2.696 . . . . 0.0 114.902 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 41.6 t -111.36 -74.84 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 119.877 1.217 . . . . 0.0 112.613 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 16.7 p -92.5 -5.4 51.9 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.57 1.548 . . . . 0.0 113.694 -177.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 61.94 16.22 7.89 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.743 2.417 . . . . 0.0 114.761 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -64.36 139.4 97.7 Favored Pre-proline 0 CA--C 1.549 0.938 0 O-C-N 121.477 -0.764 . . . . 0.0 109.796 175.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -66.54 113.64 2.79 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 C-N-CA 123.162 2.574 . . . . 0.0 112.612 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 16.5 pt -70.93 157.55 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 C-N-CA 124.54 1.136 . . . . 0.0 113.528 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -115.02 -40.7 3.44 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 126.324 1.849 . . . . 0.0 112.978 -178.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.63 167.22 31.11 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -176.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 6.9 mt -135.99 129.03 47.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 129.169 2.987 . . . . 0.0 106.369 174.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 26.8 m -139.68 150.15 22.36 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.231 0 N-CA-C 114.239 1.2 . . . . 0.0 114.239 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.9 107.22 2.57 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 174.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 23.3 m -103.18 88.23 3.09 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.212 1.805 . . . . 0.0 110.086 -175.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -60.78 153.64 23.85 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.772 2.029 . . . . 0.0 115.1 -176.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 33.0 p90 -61.88 156.12 58.51 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 126.276 1.831 . . . . 0.0 112.531 176.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo . . . . . 0 CA--C 1.538 0.709 0 C-N-CA 123.308 2.672 . . . . 0.0 112.591 179.869 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 78.4 p . . . . . 0 N--CA 1.47 0.574 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 95.8 mt -69.17 157.28 89.71 Favored Pre-proline 0 CA--C 1.547 0.854 0 C-N-CA 125.358 1.463 . . . . 0.0 111.279 177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_exo -44.31 -50.38 7.92 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 124.295 3.33 . . . . 0.0 115.323 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -64.58 -9.69 20.99 Favored 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 115.731 1.752 . . . . 0.0 115.731 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 35.5 m120 -112.72 -21.23 11.33 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.122 1.769 . . . . 0.0 111.794 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -87.65 1.73 52.91 Favored 'General case' 0 CA--C 1.548 0.866 0 C-N-CA 126.88 2.072 . . . . 0.0 114.431 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.2 pp -65.52 69.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 C-N-CA 128.095 2.558 . . . . 0.0 113.266 178.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . 0.48 ' H ' ' CD ' ' A' ' 437' ' ' PRO . 48.7 mt-10 -133.67 -42.43 0.03 OUTLIER Pre-proline 0 CA--C 1.553 1.082 0 C-N-CA 126.302 1.841 . . . . 0.0 115.667 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . 0.48 ' CD ' ' H ' ' A' ' 436' ' ' GLU . 82.5 Cg_exo -49.23 -69.32 0.07 OUTLIER 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 124.969 3.78 . . . . 0.0 117.253 -178.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 30.5 t -51.27 148.12 5.06 Favored 'General case' 0 CA--C 1.549 0.92 0 CA-C-N 120.166 1.348 . . . . 0.0 112.663 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 32.6 m -123.8 -14.9 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 -179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 9.4 pt -136.36 -26.55 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 -178.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.5 m -76.28 -60.12 2.47 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 120.719 1.599 . . . . 0.0 112.064 -177.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 17.7 tp60 -154.17 -13.76 0.13 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -176.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.51 11.55 81.75 Favored Glycine 0 CA--C 1.541 1.687 0 CA-C-N 120.011 1.278 . . . . 0.0 112.198 -173.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 9.4 ptm85 -55.97 155.05 12.69 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 129.592 3.157 . . . . 0.0 114.024 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -74.7 4.9 4.18 Favored 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 124.551 3.501 . . . . 0.0 115.762 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 51.9 tptt -58.52 157.98 8.26 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 126.182 1.793 . . . . 0.0 112.586 178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 26.0 p-10 -119.66 150.04 40.99 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 128.423 2.689 . . . . 0.0 111.898 -175.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 176.84 82.66 0.06 OUTLIER Glycine 0 CA--C 1.532 1.102 0 C-N-CA 125.575 1.56 . . . . 0.0 113.015 178.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 48.0 t -71.33 138.82 49.57 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 118.152 0.976 . . . . 0.0 109.864 176.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.6 mp -115.01 144.11 23.28 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 C-N-CA 125.651 1.58 . . . . 0.0 110.44 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 97.1 t -129.91 131.34 66.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 C-N-CA 124.242 1.017 . . . . 0.0 109.527 176.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -125.05 94.98 4.33 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.91 2.484 . . . . 0.0 111.281 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.49 -89.64 0.36 Allowed Glycine 0 CA--C 1.534 1.281 0 C-N-CA 125.689 1.614 . . . . 0.0 114.386 178.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -121.56 -0.85 9.65 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 126.348 1.859 . . . . 0.0 113.868 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 16.8 p -130.66 170.12 14.74 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 128.223 2.609 . . . . 0.0 109.787 179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -157.79 177.06 34.73 Favored Glycine 0 CA--C 1.529 0.932 0 O-C-N 120.688 -1.258 . . . . 0.0 113.947 178.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -120.34 135.91 54.87 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 125.715 1.606 . . . . 0.0 113.842 174.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 4.0 pp -119.9 153.35 36.0 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 128.294 2.638 . . . . 0.0 109.451 173.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 25.0 ttt 78.26 66.3 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 126.762 2.025 . . . . 0.0 111.094 -177.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -160.03 154.5 23.84 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 128.898 2.879 . . . . 0.0 108.314 177.007 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 22.7 p -86.91 172.21 10.23 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-O 122.113 0.959 . . . . 0.0 111.21 174.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -64.94 -35.39 81.01 Favored 'General case' 0 CA--C 1.536 0.422 0 O-C-N 121.435 -0.79 . . . . 0.0 111.223 177.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 25.2 m -64.44 -49.2 72.39 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-O 117.212 -1.375 . . . . 0.0 111.152 177.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 29.4 m -46.93 -55.58 7.83 Favored 'General case' 0 CA--C 1.547 0.847 0 CA-C-N 120.469 1.486 . . . . 0.0 109.924 174.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -59.99 -45.39 92.89 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.923 1.689 . . . . 0.0 113.52 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -60.1 -44.5 94.78 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.228 1.411 . . . . 0.0 111.523 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt -62.35 -54.09 45.51 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.341 1.057 . . . . 0.0 111.473 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.4 pp -60.87 -32.05 71.49 Favored 'General case' 0 CA--C 1.544 0.741 0 CA-C-N 118.579 0.627 . . . . 0.0 111.958 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -68.24 -48.56 64.79 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 125.269 1.428 . . . . 0.0 111.734 174.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -55.8 -43.67 77.07 Favored 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 125.632 1.573 . . . . 0.0 111.02 176.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -75.31 -6.94 52.45 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 127.067 2.147 . . . . 0.0 113.642 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 64.0 t30 50.79 41.13 26.04 Favored 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 128.074 2.55 . . . . 0.0 112.173 -177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -78.15 126.58 83.31 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 125.519 1.528 . . . . 0.0 113.367 -176.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -74.56 129.03 12.35 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 122.813 2.342 . . . . 0.0 107.526 170.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 48.2 t -27.01 123.79 0.23 Allowed Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 128.195 2.598 . . . . 0.0 115.493 -176.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.76 -1.66 6.31 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 122.959 2.439 . . . . 0.0 114.33 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 49.1 t -123.64 -59.55 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 C-N-CA 125.686 1.594 . . . . 0.0 111.233 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 69.7 m -78.12 -19.78 53.4 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 126.682 1.993 . . . . 0.0 112.84 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 61.62 11.79 4.12 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 127.339 2.255 . . . . 0.0 114.198 -177.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 75.2 mm-40 -87.17 148.19 44.36 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 123.975 0.91 . . . . 0.0 112.95 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.25 124.55 7.9 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.863 3.042 . . . . 0.0 111.97 178.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.7 pp -63.98 143.04 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.643 1.177 . . . . 0.0 112.859 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 20.2 tp60 -115.17 -40.25 3.49 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.51 1.524 . . . . 0.0 113.656 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.5 166.58 31.82 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 -176.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 8.0 mt -133.07 139.22 49.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.801 0 C-N-CA 127.534 2.333 . . . . 0.0 108.732 176.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 15.7 m -137.06 150.11 26.41 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.218 0 C-N-CA 124.944 1.297 . . . . 0.0 113.329 178.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 55.8 mt -73.29 99.87 3.0 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.294 1.037 . . . . 0.0 109.182 178.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 6.3 t -95.44 151.53 19.21 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.322 1.23 . . . . 0.0 114.322 -176.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -141.91 158.72 43.44 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.325 1.45 . . . . 0.0 112.558 -179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -80.54 158.44 71.23 Favored Pre-proline 0 CA--C 1.55 0.955 0 C-N-CA 123.842 0.857 . . . . 0.0 112.947 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo . . . . . 0 C--N 1.355 0.886 0 C-N-CA 124.565 3.51 . . . . 0.0 113.853 179.386 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 50.8 m . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 57.3 tp -62.02 -49.22 86.17 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 126.472 1.909 . . . . 0.0 115.29 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 87.4 Cg_endo -72.19 160.05 48.25 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.071 1.847 . . . . 0.0 113.333 -177.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 79.9 mt -59.16 -34.02 71.59 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.992 1.317 . . . . 0.0 111.891 177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -58.0 -16.98 14.45 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 126.151 1.78 . . . . 0.0 114.003 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -71.34 -17.4 62.44 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 113.84 1.052 . . . . 0.0 113.84 176.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 32.8 mm 46.45 83.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 127.959 2.503 . . . . 0.0 113.069 -179.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -126.25 62.02 44.36 Favored Pre-proline 0 CA--C 1.553 1.088 0 C-N-CA 125.764 1.625 . . . . 0.0 111.336 176.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -62.74 -64.07 0.08 OUTLIER 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 124.823 3.682 . . . . 0.0 115.923 -175.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 44.3 t -46.91 138.67 6.18 Favored 'General case' 0 CA--C 1.547 0.833 0 CA-C-N 121.178 1.808 . . . . 0.0 112.45 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 21.9 t -109.61 -28.74 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 C-N-CA 125.173 1.389 . . . . 0.0 112.258 -175.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 8.3 pt -138.01 -24.86 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 117.001 2.223 . . . . 0.0 117.001 -173.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.5 m -73.21 -57.67 3.86 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.731 1.605 . . . . 0.0 112.083 -176.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -154.94 -14.85 0.12 Allowed 'General case' 0 CA--C 1.545 0.752 0 N-CA-C 114.936 1.458 . . . . 0.0 114.936 -177.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 81.16 11.06 84.03 Favored Glycine 0 CA--C 1.542 1.766 0 CA-C-N 119.993 1.27 . . . . 0.0 112.513 -174.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -64.7 155.18 83.06 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 129.785 3.234 . . . . 0.0 113.122 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -69.12 4.48 1.89 Allowed 'Trans proline' 0 CA--C 1.548 1.224 0 C-N-CA 124.569 3.512 . . . . 0.0 117.055 -177.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -56.74 139.7 49.86 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 120.166 1.348 . . . . 0.0 110.59 175.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 19.3 p-10 -128.17 113.86 16.26 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.192 1.797 . . . . 0.0 114.646 -170.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -144.62 82.79 0.2 Allowed Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.55 1.548 . . . . 0.0 112.527 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 49.3 t -65.0 142.17 58.53 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-N 117.872 0.836 . . . . 0.0 110.565 178.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 2.2 mp -107.17 141.64 21.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 C-N-CA 125.816 1.646 . . . . 0.0 110.121 -177.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 96.9 t -130.09 132.79 65.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 C-N-CA 124.277 1.031 . . . . 0.0 110.398 177.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -125.01 94.98 4.34 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.313 2.245 . . . . 0.0 110.841 175.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.74 -92.44 0.24 Allowed Glycine 0 CA--C 1.534 1.275 0 C-N-CA 126.259 1.885 . . . . 0.0 114.648 178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 57.9 tttp -111.88 -7.89 14.14 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 126.334 1.854 . . . . 0.0 113.345 -178.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 19.7 p -124.24 170.01 11.19 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 126.618 1.967 . . . . 0.0 111.125 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -160.8 174.9 37.51 Favored Glycine 0 CA--C 1.532 1.099 0 O-C-N 121.088 -1.007 . . . . 0.0 113.999 179.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 4.6 m80 -120.28 113.46 20.43 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.319 1.848 . . . . 0.0 113.333 178.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -97.37 153.18 18.24 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.923 1.289 . . . . 0.0 112.023 176.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 40.1 tpp 75.58 68.51 0.07 Allowed 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.86 2.064 . . . . 0.0 111.244 177.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -157.25 150.22 23.54 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 129.293 3.037 . . . . 0.0 108.616 178.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 17.1 p -86.46 170.46 11.93 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-O 122.616 1.198 . . . . 0.0 111.781 176.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.49 -30.28 70.58 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.095 177.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 25.0 m -69.96 -50.5 41.22 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 117.303 -1.332 . . . . 0.0 109.9 177.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 35.0 m -47.65 -56.84 6.38 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-N 120.371 1.441 . . . . 0.0 110.105 173.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.15 -46.47 82.71 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.938 1.695 . . . . 0.0 113.403 178.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -65.86 -37.43 86.15 Favored 'General case' 0 N--CA 1.471 0.579 0 O-C-N 120.561 -1.337 . . . . 0.0 111.822 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 21.2 tptp -63.49 -52.36 61.61 Favored 'General case' 0 N--CA 1.472 0.638 0 C-N-CA 124.122 0.969 . . . . 0.0 111.105 177.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.6 pp -61.59 -30.32 70.6 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.073 0.397 . . . . 0.0 111.704 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -68.58 -46.06 70.38 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.033 1.333 . . . . 0.0 111.829 173.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -57.64 -42.44 83.41 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.864 1.265 . . . . 0.0 110.982 174.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -72.78 -11.05 60.46 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.459 1.904 . . . . 0.0 113.528 175.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 63.8 t30 52.41 40.45 29.49 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 127.814 2.446 . . . . 0.0 111.754 -175.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -74.2 116.13 49.69 Favored Pre-proline 0 CA--C 1.54 0.562 0 C-N-CA 126.357 1.863 . . . . 0.0 113.781 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -70.1 132.49 22.89 Favored 'Trans proline' 0 CA--C 1.542 0.907 0 C-N-CA 122.41 2.073 . . . . 0.0 107.671 170.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 47.1 t -32.58 125.11 0.39 Allowed Pre-proline 0 CA--C 1.555 1.135 0 C-N-CA 127.656 2.382 . . . . 0.0 115.214 -175.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.94 -3.18 10.94 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.146 2.564 . . . . 0.0 114.381 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 42.6 t -124.74 -60.01 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 C-N-CA 125.076 1.35 . . . . 0.0 111.726 -179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 58.6 m -75.01 -18.78 60.29 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.635 1.974 . . . . 0.0 112.432 -179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 35.2 ttt180 64.6 5.12 2.56 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 127.554 2.342 . . . . 0.0 114.081 -177.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 74.9 mm-40 -83.8 148.99 55.78 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 124.204 1.002 . . . . 0.0 113.144 -178.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -74.11 124.04 8.77 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 123.037 2.491 . . . . 0.0 110.405 176.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.2 pp -60.95 128.61 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 124.526 1.13 . . . . 0.0 110.932 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 23.8 mt-30 -115.08 -26.82 7.55 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 -175.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 1.7 ttp -149.86 150.35 31.8 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.241 1.016 . . . . 0.0 112.624 -175.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 10.4 mt -137.24 130.05 43.56 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 127.138 2.175 . . . . 0.0 107.941 174.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 27.0 m -140.07 150.23 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.202 0 C-N-CA 124.378 1.071 . . . . 0.0 112.913 178.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 66.6 tp -63.7 99.89 0.25 Allowed 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.065 1.746 . . . . 0.0 108.683 176.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 41.4 m -110.8 108.48 18.33 Favored 'General case' 0 N--CA 1.476 0.867 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -170.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -85.72 178.41 7.35 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.239 1.816 . . . . 0.0 112.997 179.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 31.1 p90 -129.84 168.64 15.78 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 125.953 1.701 . . . . 0.0 111.552 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo . . . . . 0 C--N 1.353 0.798 0 C-N-CA 124.249 3.299 . . . . 0.0 113.887 179.968 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 43.2 m . . . . . 0 CA--C 1.54 0.584 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 46.3 tp -133.65 89.89 29.73 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 126.546 1.939 . . . . 0.0 109.829 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -58.42 -37.87 92.86 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.881 2.387 . . . . 0.0 114.057 -175.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 4.4 pp -63.37 -13.55 40.59 Favored 'General case' 0 CA--C 1.544 0.727 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -106.1 -25.07 12.19 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.435 1.494 . . . . 0.0 111.689 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -83.61 -43.77 15.29 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.977 1.311 . . . . 0.0 113.045 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 2.1 mp -82.17 85.82 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 125.79 1.636 . . . . 0.0 107.223 178.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -53.44 126.63 47.41 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 126.817 2.047 . . . . 0.0 113.793 -176.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -76.47 -172.07 1.28 Allowed 'Trans proline' 0 CA--C 1.549 1.233 0 C-N-CA 124.471 3.448 . . . . 0.0 113.036 179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 6.7 p -60.29 173.04 0.72 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.646 1.579 . . . . 0.0 114.579 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 28.6 m -130.75 -3.61 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 -175.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 4.5 mt -117.88 -59.99 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.751 0 CA-C-N 120.529 1.513 . . . . 0.0 112.796 -178.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 7.0 p -69.39 -68.75 0.38 Allowed 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -174.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 23.8 mm-40 -144.56 -13.95 0.57 Allowed 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 116.465 2.024 . . . . 0.0 116.465 -171.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 88.92 40.86 6.09 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 124.426 1.012 . . . . 0.0 110.859 -174.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -97.83 155.31 37.26 Favored Pre-proline 0 N--CA 1.481 1.107 0 C-N-CA 125.854 1.662 . . . . 0.0 112.406 178.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -44.08 121.44 2.98 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.949 3.1 . . . . 0.0 114.461 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.14 31.86 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.302 0 C-N-CA 131.127 3.771 . . . . 0.0 118.944 -176.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -76.58 89.85 3.32 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 119.952 -1.718 . . . . 0.0 109.541 -178.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 164.97 57.21 0.02 OUTLIER Glycine 0 CA--C 1.533 1.157 0 CA-C-O 119.049 -0.862 . . . . 0.0 114.085 -177.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 52.5 t -57.24 138.58 54.54 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 118.899 1.35 . . . . 0.0 110.91 178.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.4 mp -115.13 136.18 52.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 C-N-CA 126.687 1.995 . . . . 0.0 109.216 -178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 90.1 t -127.28 132.42 69.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 123.634 0.774 . . . . 0.0 110.924 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -124.35 106.14 10.0 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.011 2.525 . . . . 0.0 111.471 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 68.46 -89.92 0.23 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.703 1.621 . . . . 0.0 114.177 178.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -124.69 -0.97 7.99 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.152 1.781 . . . . 0.0 113.997 -178.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 54.9 p -133.25 170.02 16.04 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 125.898 1.679 . . . . 0.0 110.296 179.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -152.01 175.12 30.87 Favored Glycine 0 CA--C 1.526 0.771 0 O-C-N 120.88 -1.138 . . . . 0.0 113.512 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -120.28 145.64 46.87 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.045 1.338 . . . . 0.0 114.181 178.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 94.8 mt -123.35 153.48 40.25 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 129.504 3.122 . . . . 0.0 110.686 177.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 50.5 mtt 90.7 31.39 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 128.757 2.823 . . . . 0.0 113.37 179.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -139.42 134.9 33.01 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.739 2.016 . . . . 0.0 107.583 173.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 22.1 p -80.98 175.11 10.97 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 122.667 1.222 . . . . 0.0 112.842 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.9 -36.93 70.73 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.731 0.812 . . . . 0.0 112.254 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 87.7 m -66.38 -52.56 45.57 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 124.197 0.999 . . . . 0.0 110.748 177.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 98.5 m -52.41 -50.54 62.32 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.31 1.044 . . . . 0.0 110.747 175.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.9 -44.54 91.23 Favored 'General case' 0 CA--C 1.545 0.75 0 C-N-CA 125.177 1.391 . . . . 0.0 112.769 177.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt -61.92 -43.26 99.21 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.785 1.234 . . . . 0.0 111.099 178.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -61.58 -57.11 13.39 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.117 0.967 . . . . 0.0 111.255 177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.0 pp -59.11 -33.44 70.85 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 118.373 0.533 . . . . 0.0 112.227 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -68.05 -50.71 53.56 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.393 1.477 . . . . 0.0 112.217 175.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -56.81 -40.39 75.9 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.698 1.599 . . . . 0.0 111.502 176.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -79.93 -0.97 37.31 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 127.409 2.284 . . . . 0.0 113.403 176.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 46.24 39.22 5.9 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 128.866 2.866 . . . . 0.0 113.752 -177.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 29.6 tttp -69.98 127.93 92.06 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 125.478 1.511 . . . . 0.0 114.01 -176.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -75.09 128.19 11.22 Favored 'Trans proline' 0 CA--C 1.546 1.108 0 C-N-CA 122.834 2.356 . . . . 0.0 107.864 169.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 32.3 t -29.72 128.99 0.24 Allowed Pre-proline 0 CA--C 1.558 1.26 0 C-N-CA 128.07 2.548 . . . . 0.0 115.106 -177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -66.74 -2.56 7.81 Favored 'Trans proline' 0 CA--C 1.544 0.99 0 C-N-CA 123.181 2.588 . . . . 0.0 114.617 -179.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 53.5 t -127.07 -59.48 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 C-N-CA 125.393 1.477 . . . . 0.0 111.476 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 65.0 m -77.14 -24.59 51.61 Favored 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 126.595 1.958 . . . . 0.0 112.671 -178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 36.8 ttt180 62.44 9.91 3.66 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 127.128 2.171 . . . . 0.0 113.81 -175.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -81.81 151.33 67.48 Favored Pre-proline 0 CA--C 1.549 0.926 0 C-N-CA 124.134 0.973 . . . . 0.0 113.068 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -77.46 121.09 5.47 Favored 'Trans proline' 0 CA--C 1.544 0.979 0 C-N-CA 123.978 3.119 . . . . 0.0 111.919 177.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.6 pp -70.55 153.35 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 124.988 1.315 . . . . 0.0 112.231 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 18.7 tp60 -115.01 -48.6 2.82 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.1 170.27 20.36 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 -176.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 7.9 mt -127.21 138.57 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.087 2.155 . . . . 0.0 108.396 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 16.8 m -133.87 150.09 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 C-N-CA 124.52 1.128 . . . . 0.0 112.215 178.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 74.6 mt -68.56 99.85 1.04 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.849 0.86 . . . . 0.0 109.57 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 12.1 m -99.4 116.52 31.74 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.059 1.344 . . . . 0.0 114.271 -173.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -102.65 170.45 8.01 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.437 1.895 . . . . 0.0 111.921 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 49.0 p90 -136.25 157.91 74.63 Favored Pre-proline 0 CA--C 1.546 0.813 0 C-N-CA 125.793 1.637 . . . . 0.0 112.132 -176.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 CA--C 1.538 0.69 0 C-N-CA 123.347 2.698 . . . . 0.0 112.478 179.789 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 81.2 p . . . . . 0 N--CA 1.472 0.648 0 N-CA-C 114.174 1.175 . . . . 0.0 114.174 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -62.43 -59.72 12.05 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 125.901 1.68 . . . . 0.0 113.689 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -73.59 156.72 49.31 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.137 1.891 . . . . 0.0 111.894 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 63.8 tp -48.91 -47.34 43.47 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.566 1.546 . . . . 0.0 113.678 -178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -63.0 -7.55 5.51 Favored 'General case' 0 CA--C 1.549 0.908 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -112.44 -9.14 13.85 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.818 1.647 . . . . 0.0 113.058 178.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 74.7 mt -71.56 -46.93 60.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 119.074 0.852 . . . . 0.0 109.065 175.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 39.19 67.67 2.31 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 127.717 2.407 . . . . 0.0 113.606 179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -77.82 163.11 29.12 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.317 2.678 . . . . 0.0 114.857 -177.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -63.69 -179.74 0.4 Allowed 'General case' 0 CA--C 1.551 0.989 0 C-N-CA 125.131 1.372 . . . . 0.0 114.359 176.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 19.3 m -131.06 -4.56 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 N-CA-C 115.795 1.776 . . . . 0.0 115.795 -177.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 3.5 mt -121.63 -62.65 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 120.947 1.703 . . . . 0.0 113.677 -178.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 31.4 p -70.61 -67.83 0.47 Allowed 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 -174.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 24.1 mm-40 -140.98 -10.05 1.0 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 116.825 2.158 . . . . 0.0 116.825 -172.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 85.16 33.93 16.15 Favored Glycine 0 CA--C 1.531 1.084 0 CA-C-N 119.64 1.109 . . . . 0.0 110.759 -175.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 44.0 mtt-85 -65.61 136.39 96.02 Favored Pre-proline 0 N--CA 1.477 0.882 0 CA-C-O 117.272 -1.347 . . . . 0.0 110.763 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -73.87 67.12 4.91 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 124.538 3.492 . . . . 0.0 111.235 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 60.1 mtpt -141.75 153.4 44.57 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 128.508 2.723 . . . . 0.0 111.423 -174.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 66.0 m-80 -128.09 120.57 27.69 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.9 1.68 . . . . 0.0 111.8 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -136.04 70.8 0.49 Allowed Glycine 0 CA--C 1.529 0.956 0 C-N-CA 125.652 1.596 . . . . 0.0 111.176 178.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 51.0 t -54.65 123.09 12.13 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.196 1.398 . . . . 0.0 110.49 179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.32 138.16 20.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 C-N-CA 124.937 1.295 . . . . 0.0 109.801 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 96.0 t -129.97 130.48 66.22 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 123.78 0.832 . . . . 0.0 110.254 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.13 105.03 8.85 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 128.603 2.761 . . . . 0.0 110.76 176.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 65.84 -93.75 0.19 Allowed Glycine 0 CA--C 1.534 1.27 0 C-N-CA 125.868 1.699 . . . . 0.0 114.147 179.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -120.69 -0.14 10.27 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 126.457 1.903 . . . . 0.0 113.529 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 36.1 p -124.42 165.23 18.11 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.71 2.004 . . . . 0.0 110.638 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -158.81 169.57 35.17 Favored Glycine 0 CA--C 1.532 1.106 0 O-C-N 120.985 -1.072 . . . . 0.0 113.908 178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 8.7 m80 -120.33 138.67 53.59 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 126.619 1.968 . . . . 0.0 113.227 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.7 pp -120.74 153.32 37.15 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 126.813 2.045 . . . . 0.0 112.352 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 30.1 ttm 108.66 -7.35 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 C-N-CA 131.08 3.752 . . . . 0.0 114.441 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -99.96 154.63 18.23 Favored 'General case' 0 CA--C 1.544 0.738 0 O-C-N 120.903 -1.123 . . . . 0.0 111.557 177.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 30.4 p -84.6 175.1 9.47 Favored 'General case' 0 C--O 1.24 0.559 0 CA-C-O 123.344 1.545 . . . . 0.0 113.594 178.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.41 -28.35 69.72 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 114.52 -1.218 . . . . 0.0 111.791 174.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 83.7 m -72.2 -51.02 23.06 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 119.567 1.076 . . . . 0.0 110.253 177.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 67.9 m -49.66 -54.8 16.5 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 124.662 1.185 . . . . 0.0 110.386 173.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.37 -49.46 76.1 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.209 1.403 . . . . 0.0 112.931 177.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -60.0 -40.07 87.95 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 124.952 1.301 . . . . 0.0 112.168 178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -61.72 -52.98 62.06 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.38 1.072 . . . . 0.0 110.978 176.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 44.9 mt -52.22 -49.93 62.98 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.184 0.993 . . . . 0.0 110.107 175.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.69 -54.14 49.54 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.988 1.315 . . . . 0.0 112.681 178.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -54.86 -43.54 73.18 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.903 1.681 . . . . 0.0 112.281 177.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -78.88 -6.93 57.35 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 126.835 2.054 . . . . 0.0 113.366 177.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 62.4 t30 49.4 42.55 22.5 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 128.521 2.729 . . . . 0.0 112.082 -175.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 50.0 tptt -75.47 117.04 60.32 Favored Pre-proline 0 N--CA 1.47 0.539 0 C-N-CA 125.552 1.541 . . . . 0.0 113.116 -176.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.9 130.93 21.34 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.106 1.871 . . . . 0.0 108.834 171.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 41.5 t -33.0 125.53 0.41 Allowed Pre-proline 0 CA--C 1.552 1.049 0 C-N-CA 128.298 2.639 . . . . 0.0 114.168 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -66.88 -1.45 6.05 Favored 'Trans proline' 0 CA--C 1.545 1.037 0 C-N-CA 123.112 2.541 . . . . 0.0 114.307 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 47.2 t -123.67 -59.14 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 C-N-CA 125.698 1.599 . . . . 0.0 111.346 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 81.8 m -76.83 -14.39 59.91 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.364 1.866 . . . . 0.0 113.027 -178.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . 0.304 14.7 ptm180 55.23 13.43 0.85 Allowed 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 128.496 2.718 . . . . 0.0 115.108 -175.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 73.9 mm-40 -89.53 144.33 31.89 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 123.938 0.895 . . . . 0.0 112.294 178.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -68.71 122.32 9.26 Favored 'Trans proline' 0 CA--C 1.538 0.71 0 C-N-CA 123.158 2.572 . . . . 0.0 109.442 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 1.8 pt -64.89 137.76 24.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.681 0 O-C-N 121.661 -0.649 . . . . 0.0 112.132 -178.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 84.2 mt-30 -115.2 -33.74 5.24 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 117.234 2.309 . . . . 0.0 117.234 -174.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -143.27 152.18 41.4 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 123.82 0.848 . . . . 0.0 113.236 -171.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 5.1 mt -141.03 131.04 26.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.595 0 C-N-CA 127.649 2.38 . . . . 0.0 109.038 176.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 27.7 m -140.12 150.13 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 124.985 1.314 . . . . 0.0 111.928 176.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 2.2 tt -66.1 105.9 1.49 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.569 1.148 . . . . 0.0 108.273 177.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.2 96.58 7.3 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 114.407 1.262 . . . . 0.0 114.407 -171.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -74.02 171.47 13.43 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 126.086 1.754 . . . . 0.0 113.295 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -132.78 168.19 19.11 Favored Pre-proline 0 CA--C 1.553 1.063 0 C-N-CA 127.554 2.342 . . . . 0.0 110.474 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo . . . . . 0 C--N 1.352 0.758 0 C-N-CA 124.425 3.417 . . . . 0.0 113.983 -178.84 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 79.5 p . . . . . 0 N--CA 1.472 0.654 0 N-CA-C 114.29 1.218 . . . . 0.0 114.29 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 10.4 mp -67.42 156.81 87.58 Favored Pre-proline 0 CA--C 1.551 0.997 0 C-N-CA 125.554 1.541 . . . . 0.0 112.114 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -71.24 176.56 7.71 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.522 2.815 . . . . 0.0 112.126 177.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -52.84 -19.57 2.62 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.381 1.623 . . . . 0.0 115.381 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -59.76 -23.4 63.2 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.826 1.25 . . . . 0.0 112.602 175.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -72.34 -10.19 59.47 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.279 1.432 . . . . 0.0 113.972 177.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 42.5 mm -82.84 84.52 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 125.206 1.402 . . . . 0.0 108.089 177.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -56.03 -34.23 23.94 Favored Pre-proline 0 CA--C 1.555 1.137 0 N-CA-C 118.8 2.889 . . . . 0.0 118.8 -176.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . 0.278 87.9 Cg_exo -43.25 -80.33 0.02 OUTLIER 'Trans proline' 0 CA--C 1.553 1.462 0 C-N-CA 125.173 3.916 . . . . 0.0 117.477 -175.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 28.4 t -67.06 150.67 48.88 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 121.899 2.136 . . . . 0.0 109.342 174.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 4.1 p -134.52 -1.68 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 O-C-N 121.221 -0.925 . . . . 0.0 113.301 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 7.2 mt -135.55 -45.66 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 124.057 0.943 . . . . 0.0 112.974 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.3 m -69.45 -59.49 2.95 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 113.898 1.073 . . . . 0.0 113.898 -173.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -152.02 -16.37 0.18 Allowed 'General case' 0 CA--C 1.541 0.605 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -175.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 80.34 17.01 74.88 Favored Glycine 0 CA--C 1.539 1.591 0 O-C-N 120.973 -1.079 . . . . 0.0 111.865 -174.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 -72.21 155.06 91.96 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 127.549 2.34 . . . . 0.0 112.607 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.0 71.05 5.14 Favored 'Trans proline' 0 CA--C 1.55 1.29 0 C-N-CA 123.929 3.086 . . . . 0.0 113.363 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 31.7 mmmt -129.32 143.17 50.74 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 127.959 2.504 . . . . 0.0 108.842 176.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -128.02 150.27 50.0 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.115 1.366 . . . . 0.0 112.593 -176.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -151.12 80.39 0.19 Allowed Glycine 0 CA--C 1.528 0.895 0 C-N-CA 128.076 2.751 . . . . 0.0 109.201 178.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 42.2 t -63.55 119.09 9.15 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.505 1.122 . . . . 0.0 110.794 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.419 ' H ' HD12 ' A' ' 450' ' ' ILE . 0.3 OUTLIER -102.07 141.71 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 124.768 1.227 . . . . 0.0 111.745 -177.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 90.0 t -130.08 133.53 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.778 1.231 . . . . 0.0 111.931 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -124.99 95.03 4.35 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 128.53 2.732 . . . . 0.0 110.685 175.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.4 -97.74 0.41 Allowed Glycine 0 CA--C 1.533 1.214 0 C-N-CA 125.73 1.633 . . . . 0.0 114.561 178.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -107.86 -2.71 19.63 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 126.224 1.81 . . . . 0.0 113.168 -178.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 51.0 p -132.25 170.01 15.64 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.124 1.77 . . . . 0.0 110.808 -178.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -161.26 175.99 37.84 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 125.201 1.381 . . . . 0.0 112.233 179.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -120.29 142.58 48.96 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.754 1.222 . . . . 0.0 113.927 178.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 4.6 pp -111.32 153.25 26.23 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.522 1.929 . . . . 0.0 112.0 175.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 459' ' ' MET . . . . . . . . . . . . 0.253 25.2 mmt 70.42 68.94 0.2 Allowed 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 128.08 2.552 . . . . 0.0 114.996 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -154.23 138.52 16.63 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 128.659 2.784 . . . . 0.0 106.757 171.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 6.3 p -77.57 172.33 13.53 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 120.224 1.375 . . . . 0.0 112.127 177.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.36 -44.95 95.28 Favored 'General case' 0 CA--C 1.534 0.332 0 O-C-N 121.648 -0.657 . . . . 0.0 111.117 178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 29.2 m -62.67 -44.37 96.42 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-O 116.664 -1.636 . . . . 0.0 111.375 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 35.5 m -48.1 -69.97 0.11 Allowed 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 120.704 1.593 . . . . 0.0 110.541 175.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -50.33 -49.12 54.77 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 125.526 1.53 . . . . 0.0 112.539 178.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 64.9 tttp -57.13 -42.5 81.03 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.602 0.761 . . . . 0.0 112.49 177.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -61.51 -45.49 93.97 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.815 1.246 . . . . 0.0 111.746 178.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -58.1 -46.92 84.71 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 174.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 43.5 tptt -57.35 -46.21 83.55 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.004 0.922 . . . . 0.0 112.204 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -61.07 -34.01 74.23 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 125.001 1.32 . . . . 0.0 112.326 174.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 86.6 mtm180 -81.82 0.72 38.11 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 126.663 1.985 . . . . 0.0 113.407 175.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 84.11 -2.28 1.05 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 131.242 3.817 . . . . 0.0 115.516 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 5.8 tppp? -79.55 130.26 68.68 Favored Pre-proline 0 CA--C 1.545 0.774 0 CA-C-N 119.815 1.189 . . . . 0.0 109.366 176.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.34 -92.74 0.01 OUTLIER 'Trans proline' 0 CA--C 1.548 1.199 0 C-N-CA 123.375 2.717 . . . . 0.0 112.22 -179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 43.7 t -65.8 130.36 94.47 Favored Pre-proline 0 CA--C 1.547 0.83 0 C-N-CA 124.477 1.111 . . . . 0.0 112.532 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -74.55 -1.67 11.38 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 123.255 2.636 . . . . 0.0 114.062 177.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 32.8 t -122.01 -72.1 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 119.972 1.26 . . . . 0.0 113.359 -178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 29.8 p -92.87 -9.27 40.85 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -175.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 77.55 12.85 1.95 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 128.518 2.727 . . . . 0.0 115.138 176.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -64.9 156.93 78.15 Favored Pre-proline 0 CA--C 1.551 1.005 0 C-N-CA 124.606 1.163 . . . . 0.0 112.049 175.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.99 100.34 1.2 Allowed 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 124.035 3.157 . . . . 0.0 113.284 -178.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 pp -79.09 155.76 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.651 1.181 . . . . 0.0 112.355 179.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -115.02 -26.92 7.53 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.845 1.258 . . . . 0.0 113.756 -179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.95 164.81 33.08 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 124.473 1.109 . . . . 0.0 113.914 -177.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 14.2 mt -132.6 132.43 59.94 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.683 0 C-N-CA 128.444 2.698 . . . . 0.0 106.359 173.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 24.0 m -134.74 150.2 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 64.3 tp -73.05 99.91 2.87 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.19 1.796 . . . . 0.0 108.624 175.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 2.5 t -93.21 163.94 13.43 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 58.4 m-85 -135.59 177.76 7.57 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 127.671 2.388 . . . . 0.0 110.942 -178.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -124.34 157.97 62.86 Favored Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 125.306 1.443 . . . . 0.0 111.387 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo . . . . . 0 C--N 1.351 0.675 0 C-N-CA 123.111 2.541 . . . . 0.0 111.455 -179.646 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 39.9 m . . . . . 0 CA--C 1.54 0.585 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 91.1 mt -135.8 156.24 77.46 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 127.172 2.189 . . . . 0.0 110.79 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -62.1 -22.33 74.03 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 123.057 2.505 . . . . 0.0 113.466 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.9 -63.86 0.98 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.486 1.514 . . . . 0.0 109.004 174.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -54.23 -29.59 47.03 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.727 1.611 . . . . 0.0 113.245 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -62.65 -20.01 64.38 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 124.612 1.165 . . . . 0.0 113.983 178.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 24.0 mm -81.93 71.14 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 CA-C-O 122.413 1.101 . . . . 0.0 108.8 176.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -131.39 60.78 54.94 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 125.843 1.657 . . . . 0.0 112.595 -178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -60.81 -49.1 9.14 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 123.922 3.082 . . . . 0.0 113.668 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 27.5 t -55.25 143.33 28.35 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 120.876 1.671 . . . . 0.0 110.18 173.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 32.6 m -121.23 -14.69 7.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 9.9 pt -137.09 -26.17 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 N-CA-C 116.08 1.882 . . . . 0.0 116.08 -178.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.2 m -77.67 -59.64 2.7 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 120.549 1.522 . . . . 0.0 112.512 -176.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -151.88 -15.53 0.19 Allowed 'General case' 0 CA--C 1.544 0.726 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -176.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.89 9.47 84.39 Favored Glycine 0 CA--C 1.541 1.714 0 CA-C-N 119.946 1.248 . . . . 0.0 112.544 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -56.56 155.07 14.93 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 129.427 3.091 . . . . 0.0 113.616 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -72.43 2.93 4.58 Favored 'Trans proline' 0 CA--C 1.548 1.177 0 C-N-CA 124.91 3.74 . . . . 0.0 115.817 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 54.9 tptt -59.05 142.95 49.97 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.887 2.075 . . . . 0.0 111.62 178.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -128.1 122.45 32.07 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.371 1.469 . . . . 0.0 112.73 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -138.97 75.21 0.38 Allowed Glycine 0 CA--C 1.53 0.977 0 C-N-CA 126.46 1.981 . . . . 0.0 110.516 177.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 31.4 t -62.85 138.29 58.49 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.017 0.909 . . . . 0.0 110.282 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 1.4 mp -109.09 142.03 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 C-N-CA 125.317 1.447 . . . . 0.0 109.928 -177.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 96.0 t -124.12 131.92 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.293 1.037 . . . . 0.0 110.288 179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -123.08 100.06 6.68 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 129.02 2.928 . . . . 0.0 110.725 177.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.97 -93.5 0.27 Allowed Glycine 0 CA--C 1.533 1.208 0 C-N-CA 125.914 1.721 . . . . 0.0 113.783 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 26.2 pttm -120.63 4.71 10.6 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.463 1.905 . . . . 0.0 114.061 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 60.5 p -132.58 170.12 15.63 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 126.701 2.0 . . . . 0.0 110.417 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -151.24 174.19 30.51 Favored Glycine 0 CA--C 1.528 0.845 0 O-C-N 120.925 -1.109 . . . . 0.0 113.799 178.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.28 108.14 13.81 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 125.982 1.713 . . . . 0.0 111.741 174.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 48.3 tp -92.01 153.07 19.67 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 127.075 2.15 . . . . 0.0 110.153 176.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 21.9 ttt 80.31 67.58 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 127.588 2.355 . . . . 0.0 111.778 178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -159.87 147.67 16.88 Favored 'General case' 0 C--O 1.241 0.638 0 C-N-CA 129.705 3.202 . . . . 0.0 107.353 177.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 17.9 p -84.33 173.64 10.78 Favored 'General case' 0 C--O 1.241 0.626 0 CA-C-O 122.447 1.118 . . . . 0.0 111.457 175.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -63.71 -34.19 77.32 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.134 177.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 22.2 m -70.4 -45.87 65.12 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 117.086 -1.435 . . . . 0.0 110.687 178.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 41.1 m -50.79 -53.76 29.23 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 120.946 1.703 . . . . 0.0 110.143 173.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -59.77 -40.29 87.75 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.412 1.485 . . . . 0.0 113.065 177.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -68.09 -40.98 82.54 Favored 'General case' 0 N--CA 1.471 0.606 0 O-C-N 120.85 -1.156 . . . . 0.0 111.182 175.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -60.23 -54.15 49.19 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 125.352 1.461 . . . . 0.0 112.135 178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.1 pp -58.18 -36.63 73.35 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 118.923 0.783 . . . . 0.0 111.309 179.029 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 14.2 tmtt? -65.24 -49.96 67.63 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.768 1.627 . . . . 0.0 111.35 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -58.88 -39.57 81.8 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 124.956 1.302 . . . . 0.0 111.967 177.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 90.5 mtm180 -73.5 0.15 13.31 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 126.468 1.907 . . . . 0.0 113.506 175.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 55.5 t30 61.46 24.01 14.18 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 128.298 2.639 . . . . 0.0 113.949 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -79.42 133.64 59.64 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.455 1.102 . . . . 0.0 108.904 177.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -65.41 -68.25 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.586 2.191 . . . . 0.0 108.927 176.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 34.1 t -143.01 125.13 8.68 Favored Pre-proline 0 CA--C 1.545 0.776 0 C-N-CA 127.511 2.325 . . . . 0.0 109.315 174.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -73.54 -2.26 11.89 Favored 'Trans proline' 0 CA--C 1.545 1.032 0 C-N-CA 123.105 2.537 . . . . 0.0 113.382 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 25.4 t -111.18 -64.41 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 124.978 1.311 . . . . 0.0 112.234 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 27.9 p -109.89 2.5 19.87 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.244 1.418 . . . . 0.0 114.786 -177.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 63.48 7.98 3.3 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 128.061 2.544 . . . . 0.0 116.518 175.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -67.28 135.73 93.5 Favored Pre-proline 0 CA--C 1.553 1.071 0 CA-C-N 119.097 0.862 . . . . 0.0 110.649 176.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -69.73 115.56 4.14 Favored 'Trans proline' 0 CA--C 1.54 0.779 0 C-N-CA 123.409 2.739 . . . . 0.0 113.423 -176.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.9 pp -70.61 151.38 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 125.286 1.434 . . . . 0.0 114.047 -179.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 9.1 tp-100 -115.0 -44.2 3.05 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.842 2.057 . . . . 0.0 113.448 -177.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.41 166.79 31.55 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -175.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 10.1 mt -133.76 136.37 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 128.646 2.778 . . . . 0.0 107.789 176.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 19.5 m -140.02 150.16 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.64 102.56 0.93 Allowed 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 177.178 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 7.1 m -94.73 95.65 8.87 Favored 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -173.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -75.0 156.68 36.0 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.977 1.311 . . . . 0.0 112.685 179.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -86.06 164.89 37.03 Favored Pre-proline 0 CA--C 1.552 1.034 0 C-N-CA 125.708 1.603 . . . . 0.0 111.819 177.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo . . . . . 0 C--N 1.353 0.801 0 C-N-CA 124.2 3.267 . . . . 0.0 114.598 -179.61 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 49.8 m . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 17.8 tp -54.82 136.1 65.29 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 125.597 1.559 . . . . 0.0 111.112 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_exo -37.67 -46.2 1.84 Allowed 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 124.96 3.773 . . . . 0.0 115.905 -179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 47.8 tp -53.41 -29.47 35.15 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.091 1.757 . . . . 0.0 115.014 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 18.9 p30 -112.46 -7.69 13.91 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.874 1.27 . . . . 0.0 112.969 175.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -82.2 -33.6 29.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.374 1.07 . . . . 0.0 112.35 178.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 5.3 mm 66.01 18.87 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.554 1.099 0 C-N-CA 126.32 1.848 . . . . 0.0 112.801 178.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 52.98 73.34 0.95 Allowed Pre-proline 0 CA--C 1.557 1.223 0 C-N-CA 126.199 1.799 . . . . 0.0 111.226 -179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -74.4 178.86 6.48 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 125.261 3.974 . . . . 0.0 117.379 -171.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 16.2 t -55.99 161.85 2.14 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 128.951 2.9 . . . . 0.0 111.319 172.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 18.8 m -129.65 -14.98 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 177.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 10.5 pt -137.29 -26.74 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 N-CA-C 116.067 1.877 . . . . 0.0 116.067 -178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.7 m -76.17 -57.8 3.66 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-N 120.646 1.566 . . . . 0.0 111.936 -178.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -149.0 -18.98 0.3 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 -177.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 80.69 11.14 84.33 Favored Glycine 0 CA--C 1.54 1.603 0 O-C-N 120.959 -1.088 . . . . 0.0 113.366 -176.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 -69.53 155.1 94.15 Favored Pre-proline 0 CA--C 1.549 0.932 0 C-N-CA 127.976 2.51 . . . . 0.0 113.548 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -52.54 -9.03 0.48 Allowed 'Trans proline' 0 CA--C 1.545 1.043 1 C-N-CA 125.965 4.443 . . . . 0.0 119.309 -179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -58.41 141.43 51.52 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-N 120.227 1.376 . . . . 0.0 111.569 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.18 150.14 50.14 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.021 2.128 . . . . 0.0 111.777 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -159.94 85.19 0.12 Allowed Glycine 0 CA--C 1.527 0.799 0 C-N-CA 126.262 1.887 . . . . 0.0 110.046 176.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 42.3 t -58.54 139.11 56.26 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-N 117.839 0.819 . . . . 0.0 111.467 -177.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.8 mp -115.13 140.87 34.24 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.446 0 C-N-CA 126.074 1.749 . . . . 0.0 109.596 179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 60.0 t -127.38 136.04 61.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.767 0.827 . . . . 0.0 109.47 175.309 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -125.11 94.85 4.29 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 127.752 2.421 . . . . 0.0 109.818 175.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 58.78 -99.61 0.13 Allowed Glycine 0 CA--C 1.534 1.273 0 C-N-CA 126.175 1.845 . . . . 0.0 114.71 179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -86.55 -19.86 28.83 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.881 1.673 . . . . 0.0 114.636 -176.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 67.6 p -133.07 170.06 15.93 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 124.856 1.262 . . . . 0.0 112.729 -176.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -142.36 169.19 25.54 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.575 1.083 . . . . 0.0 113.968 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.18 134.0 55.36 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.95 1.7 . . . . 0.0 112.047 178.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -115.51 153.43 31.17 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 128.999 2.92 . . . . 0.0 111.473 -179.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 459' ' ' MET . . . . . . . . . . . . 0.424 19.1 ptp 70.4 69.36 0.21 Allowed 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 128.714 2.806 . . . . 0.0 113.881 -178.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -158.31 143.24 16.35 Favored 'General case' 0 C--O 1.243 0.739 0 C-N-CA 130.25 3.42 . . . . 0.0 105.864 174.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 21.8 p -79.64 174.99 11.02 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 119.787 1.176 . . . . 0.0 111.846 178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -63.38 -31.39 72.53 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 121.421 -0.799 . . . . 0.0 110.735 176.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 25.6 m -70.46 -44.63 67.37 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 117.542 -1.218 . . . . 0.0 110.987 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 60.1 m -51.37 -53.9 31.76 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-N 120.426 1.466 . . . . 0.0 109.433 172.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.62 -47.12 83.08 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 125.566 1.547 . . . . 0.0 112.648 176.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -61.14 -40.54 94.19 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.096 1.358 . . . . 0.0 111.718 178.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -59.29 -55.02 40.19 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.607 1.163 . . . . 0.0 110.591 176.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 23.9 mt -51.62 -50.36 60.41 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.704 1.202 . . . . 0.0 110.109 177.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -59.44 -54.79 42.61 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.755 1.222 . . . . 0.0 114.153 178.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 44.7 mmtm -60.17 -38.45 83.25 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 125.149 1.38 . . . . 0.0 112.584 179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 31.2 mmm180 -82.19 -4.22 56.57 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 125.537 1.535 . . . . 0.0 112.902 175.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 49.07 50.71 17.48 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 129.055 2.942 . . . . 0.0 112.151 -178.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -70.02 148.98 96.33 Favored Pre-proline 0 CA--C 1.539 0.532 0 C-N-CA 123.514 0.726 . . . . 0.0 112.642 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -81.95 11.86 2.99 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 124.016 3.144 . . . . 0.0 113.435 177.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 34.6 t 73.24 88.66 0.08 OUTLIER Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 128.493 2.717 . . . . 0.0 108.585 -173.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.75 -23.19 25.69 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 123.27 2.646 . . . . 0.0 114.869 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 20.1 t -73.32 -51.71 24.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.459 0 C-N-CA 126.567 1.947 . . . . 0.0 113.213 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 26.1 p -128.59 0.39 5.54 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 -174.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 66.56 30.12 8.61 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 127.485 2.314 . . . . 0.0 114.841 175.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -107.48 102.87 46.47 Favored Pre-proline 0 CA--C 1.554 1.135 0 C-N-CA 126.695 1.998 . . . . 0.0 111.112 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -48.45 124.53 10.86 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 124.06 3.173 . . . . 0.0 115.235 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.4 pp -57.52 151.48 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.716 2.007 . . . . 0.0 113.327 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -115.03 -57.27 2.28 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.057 1.343 . . . . 0.0 112.018 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.64 170.22 20.78 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 4.4 mt -121.47 148.24 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 126.867 2.067 . . . . 0.0 108.603 175.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 6.2 m -134.48 150.18 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 125.808 1.643 . . . . 0.0 111.189 176.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.91 99.9 4.66 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 175.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 56.9 m -79.27 156.02 28.28 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.952 0.901 . . . . 0.0 112.545 -176.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -138.53 164.09 30.33 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.981 2.112 . . . . 0.0 110.257 178.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 2.0 p90 -124.05 168.82 11.81 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 125.944 1.698 . . . . 0.0 110.907 -178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo . . . . . 0 C--N 1.348 0.547 0 C-N-CA 123.14 2.56 . . . . 0.0 110.895 178.3 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -51.62 119.57 13.64 Favored Pre-proline 0 CA--C 1.553 1.061 0 C-N-CA 127.248 2.219 . . . . 0.0 110.364 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_exo -43.26 -44.86 10.07 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 124.985 3.79 . . . . 0.0 117.11 -175.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 63.4 mt -62.51 -34.91 77.82 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.781 0.832 . . . . 0.0 112.79 178.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -86.59 -21.4 26.86 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.121 1.368 . . . . 0.0 112.518 177.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -76.07 -13.09 60.22 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 125.452 1.501 . . . . 0.0 113.928 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 8.4 mm 52.14 59.46 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 127.265 2.226 . . . . 0.0 111.928 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 5.08 78.32 0.04 OUTLIER Pre-proline 0 N--CA 1.482 1.147 0 C-N-CA 130.124 3.37 . . . . 0.0 116.239 178.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -79.93 170.85 16.14 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 123.312 2.675 . . . . 0.0 115.085 -177.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 438' ' ' CYS . . . . . 0.406 ' SG ' ' N ' ' B' ' 439' ' ' VAL . 21.3 t -68.17 -175.95 0.66 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 125.969 1.708 . . . . 0.0 112.506 174.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 439' ' ' VAL . . . . . 0.406 ' N ' ' SG ' ' B' ' 438' ' ' CYS . 6.0 p -141.84 -1.66 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.481 1.513 . . . . 0.0 114.193 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 19.4 mt -118.74 -65.78 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 120.072 1.305 . . . . 0.0 113.393 -176.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 22.8 p -52.67 -74.69 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.788 0 N-CA-C 114.447 1.277 . . . . 0.0 114.447 -177.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -141.0 -11.34 0.98 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.571 2.348 . . . . 0.0 113.311 -177.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 79.61 30.69 43.39 Favored Glycine 0 CA--C 1.536 1.364 0 O-C-N 121.556 -0.715 . . . . 0.0 112.634 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 14.9 ptp180 -69.73 155.05 94.19 Favored Pre-proline 0 CA--C 1.546 0.823 0 C-N-CA 125.737 1.615 . . . . 0.0 111.95 178.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.89 -2.19 0.32 Allowed 'Trans proline' 0 CA--C 1.549 1.257 1 C-N-CA 125.778 4.319 . . . . 0.0 118.982 -179.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 49.6 mmtm -73.26 142.43 47.23 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.5 1.52 . . . . 0.0 111.861 179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.31 149.98 50.27 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.335 1.854 . . . . 0.0 111.692 174.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -160.14 84.73 0.12 Allowed Glycine 0 CA--C 1.53 0.978 0 C-N-CA 126.453 1.977 . . . . 0.0 111.295 177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 33.3 t -61.26 137.09 58.24 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 123.914 0.886 . . . . 0.0 111.402 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.07 147.19 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 C-N-CA 126.215 1.806 . . . . 0.0 110.427 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 33.7 t -127.51 138.48 54.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 124.151 0.98 . . . . 0.0 110.527 175.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -125.05 95.02 4.34 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 128.868 2.867 . . . . 0.0 109.935 175.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 69.53 -93.36 0.37 Allowed Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.824 1.678 . . . . 0.0 113.804 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -117.48 -0.31 11.96 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 126.408 1.883 . . . . 0.0 113.532 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 47.4 p -127.13 170.06 12.77 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.469 1.908 . . . . 0.0 110.15 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -159.09 170.93 35.55 Favored Glycine 0 N--CA 1.468 0.772 0 O-C-N 120.592 -1.317 . . . . 0.0 114.062 179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.02 139.15 52.94 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 125.264 1.425 . . . . 0.0 112.01 178.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 56.0 tp -130.02 153.2 48.66 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.737 2.415 . . . . 0.0 110.995 -176.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 28.1 ttm 95.21 29.16 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 129.061 2.944 . . . . 0.0 113.783 176.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -133.14 151.38 51.99 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 126.629 1.972 . . . . 0.0 109.556 176.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 22.3 p -75.43 168.86 19.19 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 122.881 1.324 . . . . 0.0 113.312 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -65.21 -35.18 80.27 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 114.968 -1.014 . . . . 0.0 110.919 177.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 19.7 m -64.14 -52.9 56.9 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 118.095 -0.955 . . . . 0.0 109.89 176.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 18.1 m -53.51 -52.89 58.16 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 119.727 1.149 . . . . 0.0 111.239 175.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -51.85 -41.39 61.8 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 125.267 1.427 . . . . 0.0 112.669 173.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 59.0 tptt -69.93 -27.35 64.69 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.045 1.338 . . . . 0.0 113.266 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -57.54 -42.28 82.65 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 120.18 1.355 . . . . 0.0 111.202 176.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -54.56 -44.54 73.01 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 124.957 1.303 . . . . 0.0 110.099 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -66.06 -50.29 64.67 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.451 0.7 . . . . 0.0 111.444 177.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -53.45 -41.63 66.31 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 125.419 1.488 . . . . 0.0 113.758 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -99.33 11.32 39.43 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 125.424 1.49 . . . . 0.0 114.845 179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 63.3 t30 47.89 60.66 3.41 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 127.212 2.205 . . . . 0.0 113.803 -179.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -121.58 143.35 37.78 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 128.693 2.797 . . . . 0.0 108.985 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.92 -85.23 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.19 0 C-N-CA 122.798 2.332 . . . . 0.0 112.853 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 5.7 t -127.02 140.37 37.63 Favored Pre-proline 0 CA--C 1.549 0.907 0 C-N-CA 127.01 2.124 . . . . 0.0 111.328 -179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -75.54 -5.56 16.69 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 123.514 2.809 . . . . 0.0 114.412 -179.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 55.1 t -119.32 -74.22 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.736 1.153 . . . . 0.0 112.602 -177.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 24.6 p -93.85 0.6 56.3 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 125.611 1.564 . . . . 0.0 114.007 -177.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 58.71 14.62 3.25 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 128.193 2.597 . . . . 0.0 115.892 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 73.7 mm-40 -68.58 138.99 91.28 Favored Pre-proline 0 CA--C 1.552 1.034 0 CA-C-N 119.244 0.929 . . . . 0.0 110.645 177.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.75 113.05 2.61 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.562 2.842 . . . . 0.0 113.757 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.6 pp -69.16 159.34 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 C-N-CA 125.357 1.463 . . . . 0.0 113.758 -179.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 31.1 tt0 -115.12 -56.83 2.33 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.991 2.116 . . . . 0.0 111.243 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.96 170.21 19.9 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.568 1.147 . . . . 0.0 113.51 -179.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 10.5 mt -118.25 138.11 49.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.67 0 C-N-CA 127.62 2.368 . . . . 0.0 106.191 174.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 14.7 p -129.02 147.19 33.39 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.081 0 CA-C-N 119.382 0.992 . . . . 0.0 113.497 -177.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -70.3 99.92 1.63 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.979 1.311 . . . . 0.0 107.876 176.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 6.0 t -98.87 155.17 17.52 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -177.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -144.56 167.17 23.17 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.395 1.878 . . . . 0.0 111.269 -178.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 32.6 p90 -123.36 153.34 65.4 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 125.333 1.453 . . . . 0.0 111.689 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo . . . . . 0 C--N 1.351 0.693 0 C-N-CA 123.592 2.861 . . . . 0.0 111.546 -179.063 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 63.7 m . . . . . 0 CA--C 1.538 0.513 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 91.1 mt -41.48 -51.31 8.79 Favored Pre-proline 0 CA--C 1.546 0.806 0 C-N-CA 126.581 1.952 . . . . 0.0 115.804 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -59.97 -8.12 7.39 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.428 2.085 . . . . 0.0 114.762 179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 26.0 mt -117.5 -61.38 1.71 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.402 1.881 . . . . 0.0 111.464 177.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -77.78 -9.38 58.99 Favored 'General case' 0 CA--C 1.546 0.818 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 -177.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -119.9 -49.98 2.3 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.131 0.972 . . . . 0.0 111.919 -179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.7 mp -66.44 -28.59 43.9 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 C-N-CA 124.751 1.221 . . . . 0.0 110.95 176.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 47.84 72.9 1.11 Allowed Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 127.301 2.24 . . . . 0.0 113.121 179.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -73.33 -102.47 0.01 OUTLIER 'Trans proline' 0 CA--C 1.552 1.415 1 C-N-CA 125.379 4.053 . . . . 0.0 112.042 -178.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 23.0 t -63.59 154.86 31.4 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 119.747 1.158 . . . . 0.0 110.154 174.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 31.0 m -129.43 -14.61 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 114.463 1.282 . . . . 0.0 114.463 178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 10.4 pt -137.08 -26.4 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.4 m -73.68 -60.76 2.1 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 120.921 1.691 . . . . 0.0 112.051 -178.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -153.54 -13.85 0.15 Allowed 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -176.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 80.08 8.9 87.23 Favored Glycine 0 CA--C 1.541 1.682 0 O-C-N 120.747 -1.221 . . . . 0.0 112.853 -175.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 15.5 ptm180 -62.17 155.01 67.55 Favored Pre-proline 0 N--CA 1.476 0.851 0 C-N-CA 128.175 2.59 . . . . 0.0 113.415 -179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 79.6 Cg_endo -75.03 75.22 3.78 Favored 'Trans proline' 0 CA--C 1.546 1.079 0 C-N-CA 124.143 3.229 . . . . 0.0 113.611 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -135.02 148.01 49.81 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 127.994 2.518 . . . . 0.0 109.218 176.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -128.05 148.09 50.54 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.013 0.925 . . . . 0.0 111.367 -177.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -159.1 86.62 0.12 Allowed Glycine 0 CA--C 1.532 1.126 0 C-N-CA 125.872 1.701 . . . . 0.0 112.822 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 49.3 t -68.63 136.2 52.62 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-N 117.896 0.848 . . . . 0.0 110.115 177.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.0 140.32 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 C-N-CA 124.811 1.244 . . . . 0.0 111.448 -178.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 93.3 t -126.89 131.4 71.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.138 1.375 . . . . 0.0 111.742 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -114.23 94.98 5.05 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 128.608 2.763 . . . . 0.0 109.727 174.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.82 -91.41 0.42 Allowed Glycine 0 CA--C 1.535 1.29 0 C-N-CA 126.218 1.866 . . . . 0.0 113.97 179.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -121.93 5.11 9.91 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 126.506 1.922 . . . . 0.0 113.494 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 74.6 p -135.6 170.06 16.55 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.018 2.127 . . . . 0.0 109.823 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -160.14 179.18 35.84 Favored Glycine 0 N--CA 1.47 0.908 0 O-C-N 120.538 -1.351 . . . . 0.0 114.45 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.6 m80 -120.41 133.87 55.36 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.239 1.415 . . . . 0.0 113.849 174.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -110.16 153.26 24.99 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.596 1.558 . . . . 0.0 111.487 173.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 41.8 ttm 99.73 60.0 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 129.825 3.25 . . . . 0.0 112.487 177.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -160.05 158.31 30.22 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 126.306 1.842 . . . . 0.0 110.936 178.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 13.7 p -88.71 175.07 7.67 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-O 122.441 1.115 . . . . 0.0 111.63 173.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.6 -37.16 84.3 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 121.028 -1.045 . . . . 0.0 110.672 177.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 26.6 m -63.21 -49.69 73.19 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 117.18 -1.391 . . . . 0.0 109.847 176.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 60.0 m -47.12 -56.23 6.95 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 120.35 1.432 . . . . 0.0 110.291 173.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -56.85 -47.3 80.69 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.905 1.682 . . . . 0.0 114.398 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 9.3 ptpp? -74.4 -31.64 62.4 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-N 120.055 1.298 . . . . 0.0 112.682 178.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -62.63 -55.5 26.49 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.897 1.679 . . . . 0.0 110.942 177.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 2.3 pp -59.0 -37.88 77.89 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 117.8 0.273 . . . . 0.0 111.131 178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 65.3 tttm -63.11 -49.3 74.96 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.121 1.368 . . . . 0.0 111.759 176.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -58.0 -39.6 78.66 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.598 1.559 . . . . 0.0 111.561 176.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 58.2 mtt180 -76.0 5.56 6.45 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 127.078 2.151 . . . . 0.0 113.866 175.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 45.3 t30 65.21 18.72 11.53 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 128.771 2.828 . . . . 0.0 115.438 177.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 48.5 tptt -70.13 130.04 90.07 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 120.821 -1.174 . . . . 0.0 108.82 175.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -66.77 -51.3 0.93 Allowed 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.772 2.315 . . . . 0.0 111.695 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 3.4 t -153.85 140.08 12.6 Favored Pre-proline 0 CA--C 1.546 0.826 0 C-N-CA 129.375 3.07 . . . . 0.0 108.019 174.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -71.29 -6.37 19.03 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.261 2.641 . . . . 0.0 114.583 -179.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 46.4 t -125.08 -70.86 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 119.829 1.195 . . . . 0.0 113.404 -176.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 24.6 p -97.13 3.62 51.58 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.803 1.641 . . . . 0.0 114.797 -175.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 85.2 mtm180 59.62 20.21 8.81 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 127.763 2.425 . . . . 0.0 116.054 175.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 78.1 mm-40 -81.04 115.99 59.65 Favored Pre-proline 0 CA--C 1.552 1.048 0 C-N-CA 124.544 1.138 . . . . 0.0 109.376 175.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -47.32 108.32 0.16 Allowed 'Trans proline' 0 CA--C 1.545 1.064 0 C-N-CA 124.373 3.382 . . . . 0.0 117.264 -175.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.0 pp -66.41 134.52 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 126.124 1.77 . . . . 0.0 112.14 177.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 18.6 mt-30 -115.24 -16.61 11.5 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.55 1.54 . . . . 0.0 115.026 -176.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 1.8 ttp -150.32 148.17 28.51 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.122 0.969 . . . . 0.0 113.021 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 14.4 mt -131.99 139.42 50.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 127.363 2.265 . . . . 0.0 107.936 173.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 10.0 m -134.68 150.23 30.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 124.565 1.146 . . . . 0.0 113.403 177.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 63.5 tp -70.13 99.87 1.56 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 173.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 4.8 t -98.98 159.1 15.2 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 -172.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -142.6 171.18 14.4 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 127.392 2.277 . . . . 0.0 111.606 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -138.54 156.63 73.15 Favored Pre-proline 0 CA--C 1.548 0.882 0 C-N-CA 125.98 1.712 . . . . 0.0 111.028 179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo . . . . . 0 C--N 1.351 0.674 0 C-N-CA 123.627 2.884 . . . . 0.0 111.482 -179.61 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 77.7 p . . . . . 0 CA--C 1.541 0.61 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 96.6 mt -71.97 165.86 46.11 Favored Pre-proline 0 CA--C 1.554 1.116 0 C-N-CA 125.742 1.617 . . . . 0.0 111.913 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -58.54 164.05 9.81 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.266 2.644 . . . . 0.0 113.713 177.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -56.19 -22.19 27.57 Favored 'General case' 0 N--CA 1.475 0.785 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -65.24 -34.28 77.99 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.112 0.965 . . . . 0.0 111.3 175.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -90.28 -52.76 4.77 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.764 1.625 . . . . 0.0 110.192 175.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 28.6 mm -83.89 72.42 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 125.134 1.373 . . . . 0.0 109.559 178.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -82.03 -14.14 0.21 Allowed Pre-proline 0 CA--C 1.562 1.429 0 N-CA-C 118.856 2.909 . . . . 0.0 118.856 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_exo -43.44 -78.62 0.02 OUTLIER 'Trans proline' 0 CA--C 1.55 1.318 0 C-N-CA 124.78 3.653 . . . . 0.0 117.361 -177.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 40.0 t -61.26 145.82 49.99 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 121.838 2.108 . . . . 0.0 109.684 175.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 35.3 m -123.15 -15.17 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 N-CA-C 114.567 1.321 . . . . 0.0 114.567 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 8.4 pt -137.66 -25.32 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -178.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.8 m -77.28 -63.64 1.32 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 120.656 1.571 . . . . 0.0 112.211 -176.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -144.16 -11.74 0.64 Allowed 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -177.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 75.84 16.16 80.84 Favored Glycine 0 CA--C 1.545 1.914 0 CA-C-N 120.117 1.326 . . . . 0.0 112.42 -174.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 33.7 ptt180 -65.58 155.2 86.4 Favored Pre-proline 0 CA--C 1.548 0.892 0 C-N-CA 130.484 3.513 . . . . 0.0 113.021 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_endo -68.96 -3.61 11.82 Favored 'Trans proline' 0 CA--C 1.546 1.089 0 C-N-CA 124.161 3.241 . . . . 0.0 115.956 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 13.4 mptt -59.35 134.7 57.25 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.341 1.456 . . . . 0.0 110.17 177.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -128.24 138.68 52.54 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.22 1.808 . . . . 0.0 110.344 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -139.25 83.58 0.24 Allowed Glycine 0 CA--C 1.526 0.779 0 C-N-CA 127.482 2.467 . . . . 0.0 109.761 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 50.7 t -59.4 138.52 57.63 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.01 0.924 . . . . 0.0 111.013 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.05 142.4 28.07 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 C-N-CA 125.647 1.579 . . . . 0.0 109.478 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 14.5 t -116.81 142.31 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 124.325 1.05 . . . . 0.0 109.463 175.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -125.11 94.83 4.28 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 128.016 2.527 . . . . 0.0 107.165 175.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 60.87 -91.85 0.06 OUTLIER Glycine 0 CA--C 1.541 1.706 0 C-N-CA 124.759 1.171 . . . . 0.0 113.829 -177.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -118.71 6.17 11.56 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 127.441 2.297 . . . . 0.0 113.514 179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 41.5 p -121.74 170.21 9.97 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 127.629 2.372 . . . . 0.0 110.441 179.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -162.6 167.48 37.11 Favored Glycine 0 CA--C 1.531 1.062 0 O-C-N 120.598 -1.313 . . . . 0.0 114.688 177.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -120.12 141.31 49.94 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 125.552 1.541 . . . . 0.0 113.034 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 79.8 mt -119.26 153.21 35.37 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.268 2.627 . . . . 0.0 110.959 177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 20.2 mmt 76.44 65.25 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.588 2.355 . . . . 0.0 113.19 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -155.81 135.02 12.2 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 129.749 3.22 . . . . 0.0 105.438 172.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 13.1 p -77.22 174.72 10.42 Favored 'General case' 0 C--O 1.241 0.63 0 CA-C-N 120.958 1.708 . . . . 0.0 111.96 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.47 -37.22 82.82 Favored 'General case' 0 CA--C 1.538 0.513 0 O-C-N 121.59 -0.694 . . . . 0.0 111.827 177.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 84.7 m -72.49 -44.21 62.58 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-O 116.194 -1.86 . . . . 0.0 110.684 177.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 53.0 m -46.36 -57.33 4.72 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 121.596 1.998 . . . . 0.0 110.474 173.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.03 -52.42 65.34 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.482 1.513 . . . . 0.0 112.663 177.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 39.9 ttpt -59.82 -38.58 82.4 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 121.091 -1.006 . . . . 0.0 113.083 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -62.19 -48.05 81.76 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.153 1.781 . . . . 0.0 111.416 178.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 14.5 mt -54.88 -50.73 68.02 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.894 0.878 . . . . 0.0 109.631 175.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 87.9 mttt -55.86 -46.5 78.2 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.155 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -58.59 -42.23 87.58 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.244 1.417 . . . . 0.0 111.725 175.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -76.35 0.45 19.45 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 127.407 2.283 . . . . 0.0 113.713 175.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 71.73 6.92 5.81 Favored 'General case' 0 CA--C 1.551 0.987 0 C-N-CA 129.71 3.204 . . . . 0.0 115.508 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -82.11 135.88 47.48 Favored Pre-proline 0 CA--C 1.544 0.75 0 O-C-N 120.664 -1.272 . . . . 0.0 109.342 175.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -78.06 -110.22 0.01 OUTLIER 'Trans proline' 0 CA--C 1.55 1.286 0 C-N-CA 123.212 2.608 . . . . 0.0 108.78 176.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 15.2 t -70.7 139.64 86.22 Favored Pre-proline 0 CA--C 1.556 1.183 0 O-C-N 120.76 -1.213 . . . . 0.0 112.65 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -77.17 -4.23 14.57 Favored 'Trans proline' 0 CA--C 1.55 1.319 0 C-N-CA 123.612 2.875 . . . . 0.0 114.115 175.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 61.3 t -129.02 -68.29 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 N-CA-C 114.709 1.374 . . . . 0.0 114.709 -174.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 29.6 p -88.08 -6.37 57.96 Favored 'General case' 0 CA--C 1.545 0.774 0 CA-C-N 120.393 1.451 . . . . 0.0 113.575 -177.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 61.27 9.18 2.39 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 128.487 2.715 . . . . 0.0 115.12 176.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -66.39 153.38 92.91 Favored Pre-proline 0 CA--C 1.55 0.965 0 CA-C-N 118.763 0.71 . . . . 0.0 111.925 179.799 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -65.48 119.88 6.98 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.357 2.705 . . . . 0.0 113.01 -177.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 pp -68.65 159.5 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 125.567 1.547 . . . . 0.0 112.91 179.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -115.08 -60.72 1.85 Allowed 'General case' 0 CA--C 1.541 0.635 0 C-N-CA 126.036 1.735 . . . . 0.0 110.893 179.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -159.99 170.32 21.57 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.679 1.992 . . . . 0.0 112.581 -177.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 13.2 mt -115.98 135.47 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 C-N-CA 126.388 1.875 . . . . 0.0 108.036 174.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 15.0 m -134.3 150.0 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.578 1.151 . . . . 0.0 112.595 177.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.58 99.94 5.93 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 109.143 -0.688 . . . . 0.0 109.143 179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 56.1 m -101.03 104.03 15.16 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 123.199 0.6 . . . . 0.0 111.313 -178.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 93.9 m-85 -78.63 172.48 13.63 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 127.811 2.444 . . . . 0.0 112.45 178.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -115.6 167.03 10.79 Favored Pre-proline 0 CA--C 1.55 0.98 0 C-N-CA 126.254 1.822 . . . . 0.0 111.787 178.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo . . . . . 0 C--N 1.351 0.702 0 C-N-CA 124.104 3.203 . . . . 0.0 113.785 179.352 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 77.8 p . . . . . 0 N--CA 1.469 0.52 0 N-CA-C 114.252 1.204 . . . . 0.0 114.252 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -67.66 156.44 88.97 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 125.367 1.467 . . . . 0.0 110.319 177.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -45.78 -50.93 8.93 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.798 2.998 . . . . 0.0 114.413 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 3.9 pp -64.56 -22.33 66.94 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.587 1.328 . . . . 0.0 114.587 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 38.7 t30 -93.08 -23.8 18.51 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.022 1.329 . . . . 0.0 112.283 178.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -89.06 -1.94 58.33 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 126.596 1.959 . . . . 0.0 115.253 -177.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 51.5 mm -51.23 -69.74 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.068 0 C-N-CA 126.254 1.822 . . . . 0.0 112.55 -178.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -146.57 97.88 4.27 Favored Pre-proline 0 CA--C 1.547 0.829 0 C-N-CA 125.927 1.691 . . . . 0.0 110.216 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -77.55 160.97 31.51 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.147 2.564 . . . . 0.0 112.672 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 15.0 p -70.19 -179.02 1.82 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 124.921 1.288 . . . . 0.0 112.7 177.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 27.6 m -126.08 -3.81 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 115.27 1.581 . . . . 0.0 115.27 -177.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 4.7 mt -121.88 -62.42 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.717 0 CA-C-N 120.147 1.339 . . . . 0.0 113.498 -178.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . 0.256 3.6 p -66.69 -61.95 1.7 Allowed 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 -173.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 18.2 tp60 -154.61 -15.47 0.12 Allowed 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 116.051 1.871 . . . . 0.0 116.051 -175.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 100.44 51.19 1.24 Allowed Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.878 1.704 . . . . 0.0 110.585 -176.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -105.75 155.0 38.93 Favored Pre-proline 0 N--CA 1.482 1.159 0 C-N-CA 125.291 1.436 . . . . 0.0 112.526 -176.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -46.62 118.8 2.8 Favored 'Trans proline' 0 CA--C 1.537 0.675 0 C-N-CA 123.252 2.635 . . . . 0.0 113.877 -178.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.47 29.13 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 129.375 3.07 . . . . 0.0 118.818 -175.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.77 89.84 2.32 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 120.288 -1.507 . . . . 0.0 109.207 177.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 170.09 42.01 0.03 OUTLIER Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.034 1.302 . . . . 0.0 112.118 -177.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 45.4 t -49.96 121.35 5.28 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.673 1.589 . . . . 0.0 111.846 -178.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.403 HD12 ' H ' ' A' ' 450' ' ' ILE . 4.4 mp -83.45 123.85 39.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 125.689 1.595 . . . . 0.0 107.718 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 96.5 t -127.08 123.15 61.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 CA-C-O 121.679 0.752 . . . . 0.0 111.061 -179.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -120.3 106.81 12.24 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 128.113 2.565 . . . . 0.0 111.393 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.65 -92.22 0.43 Allowed Glycine 0 CA--C 1.533 1.158 0 C-N-CA 125.749 1.642 . . . . 0.0 113.934 178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -127.06 4.44 6.47 Favored 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 126.574 1.95 . . . . 0.0 113.183 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 60.1 p -133.53 170.15 15.94 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 126.32 1.848 . . . . 0.0 110.668 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -159.26 173.91 36.13 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 124.326 0.965 . . . . 0.0 113.301 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 8.2 m80 -120.11 131.82 55.19 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.899 1.28 . . . . 0.0 112.784 178.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . 0.437 HD23 ' N ' ' A' ' 459' ' ' MET . 1.9 tt -92.85 153.27 18.93 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 129.487 3.115 . . . . 0.0 112.133 -178.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 459' ' ' MET . . . . . 0.437 ' N ' HD23 ' A' ' 458' ' ' LEU . 16.0 ttp 86.5 31.07 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 127.964 2.506 . . . . 0.0 117.213 169.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -139.28 135.01 33.39 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.018 1.327 . . . . 0.0 108.801 173.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 26.3 p -79.59 175.01 11.0 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 123.051 1.405 . . . . 0.0 114.317 -177.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.24 -41.06 78.84 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.678 1.191 . . . . 0.0 111.869 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 78.8 m -60.8 -53.0 62.66 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.721 1.208 . . . . 0.0 110.358 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 90.5 m -52.08 -53.7 39.22 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 124.561 1.144 . . . . 0.0 111.056 175.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -56.02 -50.16 71.66 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.363 1.065 . . . . 0.0 112.671 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -64.91 -38.17 90.07 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.212 1.005 . . . . 0.0 112.414 178.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -61.02 -52.99 62.65 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 125.359 1.464 . . . . 0.0 110.573 177.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 29.8 mt -51.77 -51.47 56.07 Favored 'General case' 0 N--CA 1.467 0.377 0 C-N-CA 124.397 1.079 . . . . 0.0 109.782 175.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -54.22 -48.63 70.85 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.175 0.99 . . . . 0.0 112.342 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 10.0 mtpm? -59.86 -41.55 91.7 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 125.326 1.45 . . . . 0.0 111.983 175.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 28.5 mmm180 -75.72 -0.99 22.78 Favored 'General case' 0 N--CA 1.485 1.289 0 C-N-CA 127.065 2.146 . . . . 0.0 113.44 176.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 38.9 t30 75.44 7.1 4.02 Favored 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 130.086 3.354 . . . . 0.0 115.425 178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -80.89 128.7 70.56 Favored Pre-proline 0 CA--C 1.543 0.697 0 O-C-N 120.612 -1.305 . . . . 0.0 109.154 175.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -75.11 -87.82 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.149 0 C-N-CA 123.326 2.684 . . . . 0.0 110.415 178.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 37.4 t -96.78 132.44 26.07 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 125.67 1.588 . . . . 0.0 111.031 178.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.56 -4.7 14.89 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.272 2.648 . . . . 0.0 113.794 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 24.4 t -112.46 -74.19 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 119.772 1.169 . . . . 0.0 112.634 -177.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 25.4 p -95.82 -3.64 45.23 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 125.422 1.489 . . . . 0.0 114.318 -177.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 67.12 10.58 7.81 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 127.75 2.42 . . . . 0.0 115.162 176.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -62.97 149.68 89.81 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 124.0 0.92 . . . . 0.0 111.663 177.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -68.77 106.89 1.56 Allowed 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.892 3.061 . . . . 0.0 113.682 -176.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 1.5 pp -71.86 145.77 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 125.352 1.461 . . . . 0.0 111.405 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -115.22 -24.25 8.57 Favored 'General case' 0 N--CA 1.472 0.653 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.2 168.13 27.88 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -176.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 10.0 mt -139.29 132.49 37.9 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 128.784 2.833 . . . . 0.0 106.731 174.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 30.5 m -140.11 150.08 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 C-N-CA 125.003 1.321 . . . . 0.0 112.153 -178.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 64.5 mt -69.54 99.84 1.33 Allowed 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.632 0.729 . . . . 0.0 109.295 179.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -105.15 112.67 25.88 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 125.89 1.676 . . . . 0.0 113.601 -174.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 5.9 p90 -127.83 169.05 14.33 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.903 1.281 . . . . 0.0 113.854 -177.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -73.55 159.67 84.07 Favored Pre-proline 0 CA--C 1.549 0.935 0 C-N-CA 127.098 2.159 . . . . 0.0 112.821 -179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo . . . . . 0 C--N 1.351 0.698 0 C-N-CA 123.562 2.842 . . . . 0.0 111.501 178.787 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 41.8 m . . . . . 0 CA--C 1.54 0.583 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 96.1 mt -137.68 161.27 61.21 Favored Pre-proline 0 CA--C 1.546 0.793 0 C-N-CA 127.601 2.36 . . . . 0.0 110.363 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_exo -49.98 -34.12 36.56 Favored 'Trans proline' 0 C--N 1.353 0.814 0 C-N-CA 123.683 2.922 . . . . 0.0 114.279 177.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 57.1 mt -57.26 -32.36 66.51 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.276 1.83 . . . . 0.0 113.106 177.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -103.29 -12.38 17.31 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.403 1.481 . . . . 0.0 112.65 177.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -73.81 -47.36 39.23 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.732 0.813 . . . . 0.0 110.07 176.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 21.5 mm -85.44 83.37 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 122.269 1.033 . . . . 0.0 108.942 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 76.0 mt-10 -116.52 -68.55 0.02 OUTLIER Pre-proline 0 CA--C 1.541 0.606 0 CA-C-O 117.251 -1.357 . . . . 0.0 110.469 176.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_endo -73.32 155.09 51.38 Favored 'Trans proline' 0 CA--C 1.544 0.989 0 C-N-CA 122.207 1.938 . . . . 0.0 113.255 -179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 8.5 p -66.98 -163.32 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 126.832 2.053 . . . . 0.0 115.021 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 96.4 t -125.67 -22.72 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -174.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 2.5 mt -129.4 -56.8 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 N-CA-C 115.343 1.608 . . . . 0.0 115.343 -171.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 27.8 p -69.19 -61.97 1.57 Allowed 'General case' 0 CA--C 1.545 0.759 0 N-CA-C 116.65 2.093 . . . . 0.0 116.65 -172.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 23.7 tt0 -148.75 -9.09 0.36 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 116.716 2.117 . . . . 0.0 116.716 -173.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 86.59 30.56 21.14 Favored Glycine 0 CA--C 1.534 1.248 0 O-C-N 120.693 -1.254 . . . . 0.0 111.196 -175.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 44.6 mtt-85 -65.44 135.98 96.08 Favored Pre-proline 0 N--CA 1.477 0.892 0 C-N-CA 125.526 1.53 . . . . 0.0 111.388 -177.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.78 77.88 1.79 Allowed 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 123.815 3.01 . . . . 0.0 110.328 178.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -150.05 160.67 43.46 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 127.024 2.13 . . . . 0.0 113.188 -170.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 21.4 p-10 -128.21 150.11 50.17 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 128.967 2.907 . . . . 0.0 111.104 178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 176.45 76.92 0.05 OUTLIER Glycine 0 CA--C 1.532 1.144 0 C-N-CA 125.825 1.678 . . . . 0.0 112.323 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 19.7 t -61.55 140.69 58.08 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.934 0.894 . . . . 0.0 111.869 -179.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 2.0 mp -109.96 140.8 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 126.257 1.823 . . . . 0.0 109.281 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 94.6 t -130.06 135.39 61.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-O 121.659 0.742 . . . . 0.0 110.891 179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -125.04 100.09 6.42 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 128.192 2.597 . . . . 0.0 110.728 174.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.55 -94.14 0.27 Allowed Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.005 1.764 . . . . 0.0 114.323 178.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -116.9 -0.33 12.26 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 126.274 1.83 . . . . 0.0 113.457 -178.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 16.5 p -129.88 166.06 20.76 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.512 1.125 . . . . 0.0 110.793 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.11 166.82 33.19 Favored Glycine 0 CA--C 1.528 0.871 0 O-C-N 121.015 -1.053 . . . . 0.0 113.976 179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 4.9 m80 -115.65 116.69 28.54 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.768 2.027 . . . . 0.0 110.682 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 43.2 tp -107.97 153.1 23.56 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 127.516 2.327 . . . . 0.0 110.63 -179.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 62.5 mtt 105.73 -5.09 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 130.92 3.688 . . . . 0.0 115.686 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -99.87 160.5 14.26 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 119.432 1.014 . . . . 0.0 111.305 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 21.7 p -79.64 173.45 12.58 Favored 'General case' 0 C--O 1.239 0.538 0 CA-C-O 123.198 1.475 . . . . 0.0 113.874 178.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.63 -23.62 65.37 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 114.46 -1.245 . . . . 0.0 111.612 174.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 51.4 m -73.94 -50.76 18.59 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 117.823 -1.084 . . . . 0.0 110.145 178.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 60.7 m -49.0 -53.2 21.0 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.777 1.231 . . . . 0.0 110.476 173.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -57.72 -49.58 76.06 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.861 1.664 . . . . 0.0 112.927 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 24.8 ttmm -61.42 -40.67 95.27 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.826 -1.171 . . . . 0.0 111.655 177.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -62.31 -54.53 39.29 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.98 1.712 . . . . 0.0 111.328 177.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.3 pp -62.91 -31.84 73.0 Favored 'General case' 0 N--CA 1.474 0.746 0 O-C-N 121.71 -0.619 . . . . 0.0 112.034 177.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -68.29 -46.65 69.78 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 125.052 1.341 . . . . 0.0 112.226 175.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 46.8 mttp -58.45 -40.97 84.05 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.464 1.105 . . . . 0.0 111.503 175.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 89.5 mtm180 -74.88 -8.43 56.44 Favored 'General case' 0 N--CA 1.481 1.122 0 C-N-CA 125.566 1.546 . . . . 0.0 113.118 174.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 50.45 41.05 24.5 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 128.47 2.708 . . . . 0.0 111.74 -176.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 16.5 ttmm -71.73 127.56 90.72 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 125.385 1.474 . . . . 0.0 114.053 -175.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -74.76 127.55 10.95 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 122.808 2.338 . . . . 0.0 107.333 169.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 40.9 t -30.62 125.44 0.3 Allowed Pre-proline 0 CA--C 1.555 1.159 0 C-N-CA 127.914 2.486 . . . . 0.0 115.2 -176.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.1 -1.78 6.83 Favored 'Trans proline' 0 CA--C 1.544 0.991 0 C-N-CA 123.072 2.515 . . . . 0.0 114.328 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 58.4 t -124.04 -59.8 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.796 1.638 . . . . 0.0 111.17 -179.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 85.7 m -75.11 -22.54 58.17 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.089 1.756 . . . . 0.0 112.766 -179.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 9.0 mpt_? 62.5 9.12 3.22 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 127.161 2.184 . . . . 0.0 113.419 -175.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -83.1 146.72 52.22 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 124.769 1.227 . . . . 0.0 112.266 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -73.67 121.94 7.44 Favored 'Trans proline' 0 CA--C 1.542 0.885 0 C-N-CA 123.18 2.587 . . . . 0.0 110.375 175.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.4 pp -61.05 144.12 14.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.22 1.008 . . . . 0.0 111.369 178.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 20.1 tp60 -115.02 -38.87 3.77 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 -177.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.75 165.85 35.3 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -177.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 8.2 mt -135.36 135.83 51.59 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 127.674 2.389 . . . . 0.0 108.475 176.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 20.0 m -140.01 150.05 21.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.126 0.97 . . . . 0.0 113.312 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -70.95 100.0 1.89 Allowed 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 36.5 m -96.64 88.95 4.79 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.794 1.237 . . . . 0.0 111.483 -174.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -61.81 129.05 39.16 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.946 1.698 . . . . 0.0 112.892 -178.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -47.71 -40.48 30.68 Favored Pre-proline 0 CA--C 1.551 0.987 0 N-CA-C 118.817 2.895 . . . . 0.0 118.817 -176.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_exo . . . . . 0 C--N 1.355 0.896 0 C-N-CA 123.979 3.119 . . . . 0.0 115.028 -178.256 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 5.0 t . . . . . 0 CA--C 1.541 0.597 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 91.0 mt -140.74 156.92 68.75 Favored Pre-proline 0 CA--C 1.543 0.683 0 C-N-CA 128.276 2.63 . . . . 0.0 109.341 177.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -47.87 -45.97 22.99 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.536 2.824 . . . . 0.0 113.973 178.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 2.3 pp -66.1 -14.29 61.51 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -101.79 -26.9 13.3 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.686 1.594 . . . . 0.0 110.672 175.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -79.45 26.92 0.28 Allowed 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 127.517 2.327 . . . . 0.0 113.181 176.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -60.23 -25.58 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 127.38 2.272 . . . . 0.0 115.017 179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 49.55 68.41 3.51 Favored Pre-proline 0 CA--C 1.558 1.276 0 C-N-CA 126.205 1.802 . . . . 0.0 111.285 -174.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.62 -179.55 2.93 Favored 'Trans proline' 0 CA--C 1.544 1.02 1 C-N-CA 126.129 4.552 . . . . 0.0 117.417 -173.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 11.2 t -50.53 153.21 1.68 Allowed 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 128.323 2.649 . . . . 0.0 111.892 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 22.0 m -135.35 -0.37 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 C-N-CA 124.656 1.183 . . . . 0.0 113.708 178.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 8.2 mt -128.73 -48.18 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 CA-C-N 119.565 1.075 . . . . 0.0 112.255 -179.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 1.9 m -71.2 -68.93 0.41 Allowed 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -173.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 58.7 mt-30 -146.55 -11.39 0.46 Allowed 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 115.313 1.598 . . . . 0.0 115.313 -173.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.5 16.78 70.19 Favored Glycine 0 CA--C 1.541 1.717 0 CA-C-N 119.836 1.198 . . . . 0.0 113.051 -175.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 11.8 ptp85 -57.47 154.3 24.49 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 127.22 2.208 . . . . 0.0 112.499 178.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -66.18 -10.23 26.53 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 123.807 3.005 . . . . 0.0 116.388 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -59.39 147.52 35.97 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.201 1.4 . . . . 0.0 112.05 177.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -128.33 150.16 50.2 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.21 2.604 . . . . 0.0 111.667 -179.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -168.44 86.35 0.09 OUTLIER Glycine 0 CA--C 1.535 1.312 0 C-N-CA 126.252 1.882 . . . . 0.0 112.517 179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 47.7 t -60.4 142.94 54.3 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.686 1.194 . . . . 0.0 110.862 178.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.8 mp -115.0 132.21 64.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.578 1.551 . . . . 0.0 109.595 -178.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 69.6 t -115.56 129.05 72.51 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 124.337 1.055 . . . . 0.0 108.591 176.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -125.08 94.95 4.32 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.184 2.194 . . . . 0.0 112.74 -179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 77.06 -77.77 1.48 Allowed Glycine 0 CA--C 1.535 1.284 0 C-N-CA 126.048 1.785 . . . . 0.0 113.899 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -135.22 -10.17 2.24 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 126.36 1.864 . . . . 0.0 113.754 -178.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 42.1 p -122.61 170.07 10.39 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 127.418 2.287 . . . . 0.0 110.084 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -157.33 170.19 34.45 Favored Glycine 0 CA--C 1.532 1.135 0 O-C-N 120.893 -1.129 . . . . 0.0 114.186 179.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -119.99 145.19 47.02 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 126.619 1.968 . . . . 0.0 112.231 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 35.3 tp -121.71 153.07 38.69 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.832 2.053 . . . . 0.0 109.962 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 25.1 ttt 82.44 68.97 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 128.483 2.713 . . . . 0.0 112.42 -178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -160.12 151.08 19.09 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 129.169 2.987 . . . . 0.0 107.192 175.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 23.0 p -85.89 174.99 8.89 Favored 'General case' 0 C--O 1.241 0.614 0 CA-C-O 122.397 1.094 . . . . 0.0 111.195 175.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -63.37 -33.68 76.07 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 121.482 -0.761 . . . . 0.0 110.726 177.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 21.3 m -68.28 -48.52 64.78 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 117.39 -1.29 . . . . 0.0 110.655 176.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 31.4 m -48.33 -54.72 12.82 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 120.373 1.442 . . . . 0.0 110.007 173.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -59.8 -43.31 94.53 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.633 1.573 . . . . 0.0 113.12 177.543 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -64.61 -40.97 96.43 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.752 -1.217 . . . . 0.0 111.631 177.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -59.67 -55.41 34.75 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.151 1.38 . . . . 0.0 110.921 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.4 pp -62.46 -32.75 73.67 Favored 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -69.58 -43.66 72.38 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.826 1.25 . . . . 0.0 113.069 175.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 29.5 tptp -54.8 -38.79 67.76 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 125.713 1.605 . . . . 0.0 111.868 177.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 31.7 mmt180 -91.76 -0.2 57.53 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 126.566 1.946 . . . . 0.0 113.331 177.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 64.8 t30 47.74 45.84 18.27 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 128.429 2.692 . . . . 0.0 112.627 -178.325 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 15.4 ttmm -70.12 126.39 92.38 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.159 1.384 . . . . 0.0 113.148 -177.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -74.89 129.29 12.3 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 122.843 2.362 . . . . 0.0 107.91 170.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 53.6 t -31.94 123.89 0.37 Allowed Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 127.337 2.255 . . . . 0.0 114.655 -177.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.51 -1.68 7.0 Favored 'Trans proline' 0 CA--C 1.545 1.048 0 C-N-CA 123.2 2.6 . . . . 0.0 114.136 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 48.2 t -122.6 -60.96 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 125.913 1.685 . . . . 0.0 111.002 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 86.0 m -76.54 -19.13 58.25 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 126.468 1.907 . . . . 0.0 113.319 -178.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 81.3 mtp180 62.29 6.78 1.99 Allowed 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 127.18 2.192 . . . . 0.0 113.81 -175.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 14.0 mm100 -75.67 146.27 79.88 Favored Pre-proline 0 CA--C 1.552 1.021 0 C-N-CA 125.843 1.657 . . . . 0.0 113.382 -179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -78.02 120.19 4.93 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 124.159 3.239 . . . . 0.0 111.656 177.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.5 pp -63.09 141.48 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 C-N-CA 124.055 0.942 . . . . 0.0 112.785 179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 -115.1 -45.64 2.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.462 1.505 . . . . 0.0 114.495 -177.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.52 169.1 25.43 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -173.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 4.7 mt -133.65 143.43 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 128.453 2.701 . . . . 0.0 108.451 175.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 15.4 m -139.95 150.17 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 C-N-CA 125.957 1.703 . . . . 0.0 111.214 177.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -71.33 99.95 2.05 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 176.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.94 102.39 14.75 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.364 1.066 . . . . 0.0 110.757 -176.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -72.53 143.13 48.44 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.656 1.182 . . . . 0.0 112.41 179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 35.1 p90 -66.42 166.81 15.28 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 126.126 1.77 . . . . 0.0 112.201 177.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo . . . . . 0 C--N 1.354 0.819 0 C-N-CA 124.136 3.224 . . . . 0.0 114.398 -179.302 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 43.3 m . . . . . 0 N--CA 1.471 0.59 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 22.4 tp -144.6 139.91 15.99 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 126.974 2.11 . . . . 0.0 109.224 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -42.48 -66.29 0.16 Allowed 'Trans proline' 0 C--N 1.352 0.76 0 C-N-CA 124.47 3.447 . . . . 0.0 116.134 -177.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -61.04 -30.31 70.24 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -67.12 -38.73 86.13 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 123.912 0.885 . . . . 0.0 111.263 176.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -78.35 -46.48 19.93 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 124.783 1.233 . . . . 0.0 112.604 178.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 70.1 mt -70.74 -38.71 74.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 125.73 1.612 . . . . 0.0 112.385 -178.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 55.0 61.67 8.67 Favored Pre-proline 0 CA--C 1.553 1.08 0 C-N-CA 125.986 1.714 . . . . 0.0 111.696 -174.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -77.27 -171.08 1.06 Allowed 'Trans proline' 0 CA--C 1.549 1.24 0 C-N-CA 124.666 3.577 . . . . 0.0 113.09 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 12.5 t -56.41 173.03 0.19 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.002 1.721 . . . . 0.0 113.607 177.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 34.3 m -132.37 1.82 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 115.958 1.836 . . . . 0.0 115.958 -175.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 15.0 mt -121.73 -60.99 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-N 120.39 1.45 . . . . 0.0 113.016 -177.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 12.9 p -54.34 -78.49 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.528 1.531 . . . . 0.0 114.607 -177.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 -150.63 -12.86 0.24 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 127.34 2.256 . . . . 0.0 113.19 -176.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 96.73 45.74 2.63 Favored Glycine 0 CA--C 1.533 1.19 0 C-N-CA 124.388 0.995 . . . . 0.0 113.187 -179.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -84.33 155.34 63.18 Favored Pre-proline 0 N--CA 1.477 0.887 0 C-N-CA 126.095 1.758 . . . . 0.0 111.265 175.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -39.96 125.37 1.65 Allowed 'Trans proline' 0 CA--C 1.543 0.93 0 C-N-CA 124.716 3.611 . . . . 0.0 114.541 -179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -67.37 63.97 0.07 Allowed 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 128.977 2.911 . . . . 0.0 113.5 -177.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -109.09 89.82 3.11 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.585 1.154 . . . . 0.0 108.034 179.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 164.66 51.58 0.02 OUTLIER Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.155 0.884 . . . . 0.0 112.85 -178.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 42.5 t -61.32 141.45 57.58 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.31 1.055 . . . . 0.0 109.887 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.11 137.79 47.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 125.717 1.607 . . . . 0.0 110.104 -174.78 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 83.0 t -126.52 128.81 71.58 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.006 0.923 . . . . 0.0 112.116 -177.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -111.31 94.89 5.2 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 128.713 2.805 . . . . 0.0 109.318 173.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 67.31 -96.02 0.32 Allowed Glycine 0 CA--C 1.536 1.357 0 C-N-CA 125.657 1.599 . . . . 0.0 114.186 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -112.51 0.93 15.67 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 126.374 1.87 . . . . 0.0 113.565 -178.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 49.4 p -132.15 170.04 15.56 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 125.959 1.704 . . . . 0.0 110.515 179.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -161.18 177.19 37.62 Favored Glycine 0 CA--C 1.528 0.867 0 O-C-N 120.615 -1.303 . . . . 0.0 113.573 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -120.29 140.19 51.61 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.479 1.512 . . . . 0.0 112.333 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -119.9 92.87 3.89 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.925 1.29 . . . . 0.0 112.13 179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.58 -13.59 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 119.073 2.99 . . . . 0.0 119.073 -178.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -129.52 165.42 21.7 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 119.799 1.181 . . . . 0.0 114.041 -174.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 29.8 p -78.78 168.8 19.21 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 122.541 1.162 . . . . 0.0 111.376 175.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -58.4 -39.4 79.6 Favored 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.36 -0.838 . . . . 0.0 112.069 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 62.6 m -60.55 -55.94 27.37 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.108 0.963 . . . . 0.0 110.025 178.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 62.8 m -57.41 -45.15 84.91 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.191 0.996 . . . . 0.0 112.087 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.55 -39.88 81.46 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.024 1.329 . . . . 0.0 112.99 174.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -71.97 -39.35 69.38 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.101 1.36 . . . . 0.0 111.16 177.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 25.4 mtpp -56.52 -54.49 45.27 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.582 1.153 . . . . 0.0 111.965 178.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . 0.315 0.0 OUTLIER -63.19 -27.25 69.23 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 119.547 1.067 . . . . 0.0 113.317 179.499 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 2.0 tmtp? -70.1 -45.11 67.62 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 125.413 1.485 . . . . 0.0 110.275 175.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 45.0 mmtm -61.31 -35.76 78.27 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 124.929 1.292 . . . . 0.0 111.672 174.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 5.3 mmp_? -76.93 -1.17 27.23 Favored 'General case' 0 N--CA 1.486 1.369 0 C-N-CA 126.451 1.9 . . . . 0.0 113.338 174.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 51.8 t30 65.18 22.01 12.18 Favored 'General case' 0 CA--C 1.549 0.92 0 C-N-CA 128.918 2.887 . . . . 0.0 114.966 178.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -72.56 137.22 80.58 Favored Pre-proline 0 CA--C 1.544 0.735 0 O-C-N 120.969 -1.082 . . . . 0.0 109.382 176.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -63.52 -52.47 1.9 Allowed 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.465 2.11 . . . . 0.0 112.872 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 2.4 t -153.23 142.7 14.88 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 129.252 3.021 . . . . 0.0 108.482 175.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -74.33 -6.67 18.7 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.141 2.561 . . . . 0.0 114.187 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 46.2 t -123.1 -71.43 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 119.997 1.271 . . . . 0.0 113.996 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 27.6 p -94.07 -5.3 47.72 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 -175.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 70.1 15.32 7.65 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 127.897 2.479 . . . . 0.0 115.397 175.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 22.8 mm100 -74.69 132.96 77.14 Favored Pre-proline 0 CA--C 1.549 0.917 0 CA-C-N 119.309 0.958 . . . . 0.0 109.194 173.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -65.01 110.28 1.47 Allowed 'Trans proline' 0 CA--C 1.542 0.893 0 C-N-CA 122.947 2.431 . . . . 0.0 114.486 -175.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.4 pp -64.27 155.33 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 125.536 1.534 . . . . 0.0 113.21 178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -114.38 -46.59 2.97 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.798 2.039 . . . . 0.0 112.74 -176.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.12 170.09 21.35 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -178.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 14.9 mt -126.05 136.6 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 127.913 2.485 . . . . 0.0 107.492 176.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 12.7 p -123.68 148.02 27.86 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 124.344 1.057 . . . . 0.0 113.505 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -68.23 99.93 0.97 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.316 1.046 . . . . 0.0 108.193 176.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 26.6 m -96.13 103.7 15.6 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.004 1.722 . . . . 0.0 113.565 -173.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -89.66 75.74 7.4 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 122.585 1.183 . . . . 0.0 110.477 178.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -63.93 -29.92 4.5 Favored Pre-proline 0 CA--C 1.554 1.113 0 N-CA-C 116.99 2.219 . . . . 0.0 116.99 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo . . . . . 0 C--N 1.358 1.028 0 C-N-CA 123.265 2.644 . . . . 0.0 113.898 -179.582 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 73.6 p . . . . . 0 CA--C 1.54 0.584 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 7.4 tt -70.71 -59.68 3.57 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 125.836 1.654 . . . . 0.0 112.5 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -75.66 171.49 18.11 Favored 'Trans proline' 0 CA--C 1.541 0.859 0 C-N-CA 122.296 1.997 . . . . 0.0 112.443 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 4.3 pp -57.27 -18.73 17.76 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 125.173 1.389 . . . . 0.0 114.567 178.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -62.16 -5.71 2.51 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 126.515 1.926 . . . . 0.0 114.317 178.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -64.99 -27.73 69.03 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 125.172 1.389 . . . . 0.0 113.405 176.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 29.6 mm 41.12 88.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 C-N-CA 129.32 3.048 . . . . 0.0 114.346 179.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -66.79 -35.18 8.82 Favored Pre-proline 0 CA--C 1.559 1.32 0 N-CA-C 116.985 2.217 . . . . 0.0 116.985 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -73.95 -104.11 0.01 OUTLIER 'Trans proline' 0 CA--C 1.556 1.607 0 C-N-CA 124.092 3.195 . . . . 0.0 114.149 -177.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 23.8 t -63.65 148.06 49.95 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 120.704 1.593 . . . . 0.0 110.201 177.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 29.4 m -132.06 -0.46 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.001 0.921 . . . . 0.0 113.444 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 6.4 mt -134.86 -46.22 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 CA-C-N 119.441 1.019 . . . . 0.0 112.981 -179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 3.2 m -68.8 -64.19 0.91 Allowed 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 -173.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -154.14 -10.32 0.14 Allowed 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.959 1.466 . . . . 0.0 114.959 -175.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 82.26 14.36 76.84 Favored Glycine 0 CA--C 1.541 1.714 0 O-C-N 120.693 -1.254 . . . . 0.0 113.261 -176.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 37.1 ptt180 -59.53 154.39 44.88 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 127.729 2.411 . . . . 0.0 112.867 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -76.79 68.89 7.05 Favored 'Trans proline' 0 CA--C 1.548 1.216 0 C-N-CA 124.081 3.187 . . . . 0.0 112.68 178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -135.02 147.05 49.57 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 126.057 1.743 . . . . 0.0 111.457 179.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -128.27 141.54 51.41 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.011 1.324 . . . . 0.0 111.06 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -136.11 76.31 0.38 Allowed Glycine 0 CA--C 1.525 0.657 0 C-N-CA 126.839 2.161 . . . . 0.0 108.76 175.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 85.2 m -66.89 108.98 2.75 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.404 0.682 . . . . 0.0 110.918 -177.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . 0.564 ' H ' HD12 ' A' ' 450' ' ' ILE . 0.8 OUTLIER -78.72 140.47 16.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 C-N-CA 126.451 1.9 . . . . 0.0 109.993 -178.074 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 77.9 t -129.63 132.67 66.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 124.093 0.957 . . . . 0.0 110.707 179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -124.61 98.31 5.67 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 128.691 2.796 . . . . 0.0 110.118 177.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 66.31 -95.07 0.24 Allowed Glycine 0 CA--C 1.534 1.272 0 C-N-CA 126.056 1.789 . . . . 0.0 114.057 179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 49.7 mmtm -113.85 1.19 14.7 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 126.288 1.835 . . . . 0.0 113.753 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 81.9 p -131.27 170.03 15.16 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 126.095 1.758 . . . . 0.0 111.258 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.4 174.26 34.2 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.023 -1.048 . . . . 0.0 113.716 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -120.32 145.0 47.54 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.026 1.331 . . . . 0.0 112.978 175.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -123.37 153.21 40.67 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.421 2.288 . . . . 0.0 111.263 177.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 52.0 mtt 97.5 48.96 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 130.148 3.379 . . . . 0.0 113.503 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -155.3 148.13 24.38 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.257 1.823 . . . . 0.0 109.68 176.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 7.7 p -83.3 175.18 10.08 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-O 122.672 1.225 . . . . 0.0 112.236 176.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -59.09 -46.8 87.36 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 115.16 -0.927 . . . . 0.0 112.02 179.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 88.7 m -69.13 -41.52 77.23 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-O 116.353 -1.784 . . . . 0.0 111.926 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 46.4 m -47.16 -59.4 3.18 Favored 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 121.522 1.965 . . . . 0.0 110.405 175.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -63.03 -46.36 87.91 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.531 1.532 . . . . 0.0 113.689 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -60.19 -41.93 93.99 Favored 'General case' 0 N--CA 1.476 0.826 0 O-C-N 120.645 -1.284 . . . . 0.0 111.824 179.067 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -61.79 -56.6 17.8 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 126.26 1.824 . . . . 0.0 111.221 177.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 3.4 pp -60.48 -37.26 80.49 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.205 0.457 . . . . 0.0 111.271 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.18 -48.36 80.39 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.71 1.204 . . . . 0.0 111.753 175.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 60.0 tptt -58.54 -37.87 76.58 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 125.384 1.474 . . . . 0.0 111.636 176.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 77.6 mtp85 -74.98 6.08 4.49 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 127.322 2.249 . . . . 0.0 113.7 175.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 39.8 t30 73.41 9.81 5.06 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 129.662 3.185 . . . . 0.0 115.601 177.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -72.42 131.12 85.08 Favored Pre-proline 0 N--CA 1.474 0.768 0 O-C-N 120.791 -1.193 . . . . 0.0 109.19 175.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -71.07 -82.06 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.283 2.655 . . . . 0.0 109.682 178.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 32.3 t -123.16 130.76 24.45 Favored Pre-proline 0 CA--C 1.545 0.75 0 C-N-CA 126.672 1.989 . . . . 0.0 109.471 175.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.23 -1.39 10.52 Favored 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 123.328 2.685 . . . . 0.0 113.874 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 37.6 t -118.19 -78.28 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 124.754 1.222 . . . . 0.0 111.946 -177.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 18.5 p -89.98 0.15 57.25 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 125.389 1.476 . . . . 0.0 114.427 -177.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 12.4 mpt_? 62.46 6.97 2.15 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 127.883 2.473 . . . . 0.0 115.525 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -60.51 138.04 92.5 Favored Pre-proline 0 CA--C 1.551 0.987 0 CA-C-N 119.25 0.932 . . . . 0.0 111.172 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.23 114.28 3.37 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.196 2.597 . . . . 0.0 112.317 -177.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 20.3 pt -76.76 158.85 5.27 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 125.096 1.358 . . . . 0.0 114.159 -177.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 33.5 tt0 -115.19 -43.4 3.08 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.142 1.777 . . . . 0.0 114.04 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.93 170.03 23.07 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -171.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 3.2 pt -141.97 145.57 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.637 0 C-N-CA 129.923 3.289 . . . . 0.0 108.209 169.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 11.4 m -137.69 150.17 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 C-N-CA 126.139 1.776 . . . . 0.0 109.619 177.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.15 99.87 0.94 Allowed 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.88 142.31 27.9 Favored 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 -172.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -128.48 179.63 5.55 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.231 2.212 . . . . 0.0 111.188 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -134.54 158.19 75.67 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 125.088 1.355 . . . . 0.0 111.407 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 C--N 1.352 0.743 0 C-N-CA 123.2 2.6 . . . . 0.0 111.381 -179.561 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 72.9 p . . . . . 0 N--CA 1.473 0.697 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 85.8 mt -145.94 161.64 39.02 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 129.579 3.152 . . . . 0.0 108.378 177.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -48.69 -41.36 38.03 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.228 2.619 . . . . 0.0 114.517 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 1.1 pp -67.88 -8.95 40.72 Favored 'General case' 0 CA--C 1.55 0.96 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 176.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -121.99 -10.88 8.58 Favored 'General case' 0 CA--C 1.548 0.887 0 C-N-CA 126.771 2.028 . . . . 0.0 112.703 179.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -74.77 43.34 0.19 Allowed 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 127.447 2.299 . . . . 0.0 113.549 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 71.3 mt -63.62 -39.82 86.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 C-N-CA 125.948 1.699 . . . . 0.0 110.625 179.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 35.3 66.17 1.65 Allowed Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 128.294 2.638 . . . . 0.0 114.942 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -78.28 -105.67 0.01 OUTLIER 'Trans proline' 0 CA--C 1.553 1.437 0 C-N-CA 124.178 3.252 . . . . 0.0 110.889 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 35.3 t -65.22 153.3 41.39 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 120.466 1.484 . . . . 0.0 110.014 174.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 67.5 t -129.09 -14.59 2.42 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 125.656 1.582 . . . . 0.0 111.848 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 7.1 mt -133.24 -45.8 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.467 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -173.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.2 m -67.44 -65.19 0.72 Allowed 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.465 1.506 . . . . 0.0 113.981 -173.036 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -146.8 -12.55 0.44 Allowed 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -175.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 76.82 10.56 86.01 Favored Glycine 0 CA--C 1.545 1.949 0 CA-C-N 119.893 1.224 . . . . 0.0 112.418 -173.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 31.4 ptt180 -58.45 154.34 33.96 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 129.424 3.09 . . . . 0.0 112.866 179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -77.32 68.69 7.41 Favored 'Trans proline' 0 CA--C 1.549 1.246 0 C-N-CA 124.146 3.231 . . . . 0.0 113.031 179.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -131.61 149.03 52.64 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.821 2.049 . . . . 0.0 110.681 178.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 54.0 m-20 -128.03 149.99 50.13 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.166 1.387 . . . . 0.0 111.077 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -155.06 84.89 0.14 Allowed Glycine 0 CA--C 1.531 1.047 0 C-N-CA 127.038 2.256 . . . . 0.0 111.163 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 42.0 t -67.73 120.27 13.81 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.2 1.0 . . . . 0.0 110.148 178.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.5 mp -93.68 139.7 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 C-N-CA 125.561 1.544 . . . . 0.0 109.918 -179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 93.6 t -130.07 127.6 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 C-N-CA 124.748 1.219 . . . . 0.0 108.748 175.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -125.2 95.09 4.35 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 126.886 2.074 . . . . 0.0 111.632 177.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 71.55 -87.28 0.43 Allowed Glycine 0 CA--C 1.534 1.264 0 C-N-CA 125.689 1.614 . . . . 0.0 115.172 178.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -122.52 -4.36 8.78 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 126.25 1.82 . . . . 0.0 113.765 -177.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 30.0 p -129.66 170.16 14.16 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 127.648 2.379 . . . . 0.0 110.056 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -158.69 171.27 35.37 Favored Glycine 0 CA--C 1.53 1.014 0 O-C-N 120.981 -1.074 . . . . 0.0 113.505 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 3.6 m80 -120.02 137.43 54.1 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.936 1.694 . . . . 0.0 112.838 178.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 33.2 tp -121.63 153.16 38.47 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 129.023 2.929 . . . . 0.0 110.054 -179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 19.7 mmt 80.89 57.37 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 127.617 2.367 . . . . 0.0 112.959 177.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -154.0 153.56 32.18 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 128.222 2.609 . . . . 0.0 109.493 176.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 10.3 p -85.51 175.07 9.03 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-O 122.343 1.068 . . . . 0.0 111.926 175.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.24 -36.76 85.14 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 118.705 -0.664 . . . . 0.0 112.374 178.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 87.0 m -73.61 -42.11 61.95 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 117.074 -1.441 . . . . 0.0 111.142 178.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 55.3 m -48.57 -54.91 12.68 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 120.638 1.563 . . . . 0.0 109.548 172.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -60.72 -49.75 76.26 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.142 1.777 . . . . 0.0 113.262 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 23.9 ttmm -58.97 -41.09 86.7 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.796 1.238 . . . . 0.0 111.734 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -58.9 -55.26 37.43 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.41 1.084 . . . . 0.0 110.552 176.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.73 -30.47 71.44 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -69.03 -47.81 64.49 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 125.213 1.405 . . . . 0.0 112.377 174.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 12.4 mmmm -59.53 -40.49 87.35 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 124.811 1.244 . . . . 0.0 111.407 176.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 30.1 mmm180 -75.23 -7.89 55.12 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.721 1.609 . . . . 0.0 112.93 174.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 51.68 43.59 29.79 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 128.823 2.849 . . . . 0.0 112.091 -178.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -70.05 117.64 55.97 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 125.238 1.415 . . . . 0.0 112.095 -177.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -80.93 74.4 5.56 Favored 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 124.558 3.505 . . . . 0.0 111.193 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 30.7 t 22.4 105.13 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.33 0 C-N-CA 130.561 3.544 . . . . 0.0 117.093 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.03 -19.5 8.78 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 123.79 2.993 . . . . 0.0 115.681 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 46.6 t -102.82 -63.68 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 126.52 1.928 . . . . 0.0 112.219 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 84.8 m -78.25 -18.75 54.95 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.288 1.835 . . . . 0.0 113.871 -176.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 63.24 7.01 2.61 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 127.878 2.471 . . . . 0.0 114.074 -176.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -83.84 149.59 57.02 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 124.302 1.041 . . . . 0.0 112.793 -179.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.78 124.23 9.56 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.528 2.819 . . . . 0.0 112.212 179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -54.99 117.23 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 126.671 1.988 . . . . 0.0 110.388 177.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -115.1 -46.32 2.91 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -174.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 1.1 ttp -143.18 155.1 44.47 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-N 119.699 1.136 . . . . 0.0 113.419 -174.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 12.8 mt -138.14 136.23 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 127.063 2.145 . . . . 0.0 109.506 175.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 16.2 m -138.65 150.18 23.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 C-N-CA 125.5 1.52 . . . . 0.0 112.761 176.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 1.5 tt -74.95 99.95 3.99 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.313 1.045 . . . . 0.0 109.346 -179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 7.4 t -90.13 155.35 19.1 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.645 0.98 . . . . 0.0 113.645 -178.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -134.39 162.89 30.97 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.642 1.977 . . . . 0.0 112.703 -178.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -93.4 167.64 13.63 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 125.277 1.431 . . . . 0.0 110.89 176.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo . . . . . 0 C--N 1.351 0.675 0 C-N-CA 124.1 3.2 . . . . 0.0 113.72 -179.854 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 37.8 m . . . . . 0 CA--C 1.541 0.602 0 N-CA-C 113.864 1.061 . . . . 0.0 113.864 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 92.8 mt -136.19 160.12 68.25 Favored Pre-proline 0 CA--C 1.543 0.711 0 C-N-CA 127.434 2.293 . . . . 0.0 110.756 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -60.36 -22.63 71.88 Favored 'Trans proline' 0 CA--C 1.541 0.844 0 C-N-CA 122.907 2.405 . . . . 0.0 113.557 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 79.0 mt -67.8 -35.25 78.31 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.746 1.218 . . . . 0.0 111.709 175.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -87.11 -19.43 28.55 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 125.469 1.508 . . . . 0.0 112.871 178.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -69.1 39.02 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 127.954 2.502 . . . . 0.0 115.619 -178.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 37.2 mm -57.44 -50.76 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.725 0 C-N-CA 127.099 2.16 . . . . 0.0 110.858 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -150.53 154.59 35.67 Favored Pre-proline 0 CA--C 1.544 0.742 0 C-N-CA 128.013 2.525 . . . . 0.0 109.522 176.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -95.48 156.06 1.6 Allowed 'Trans proline' 0 CA--C 1.552 1.404 0 C-N-CA 123.529 2.819 . . . . 0.0 111.824 172.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 1.7 t -68.53 166.42 17.02 Favored 'General case' 0 CA--C 1.559 1.322 0 C-N-CA 126.114 1.766 . . . . 0.0 109.966 169.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 99.3 t -127.03 -18.5 2.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 O-C-N 120.346 -1.471 . . . . 0.0 111.971 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 8.3 mt -133.03 -47.06 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 119.43 1.014 . . . . 0.0 113.707 -172.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.4 m -62.86 -54.83 32.73 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.163 1.385 . . . . 0.0 113.222 -175.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -160.46 -12.75 0.05 Allowed 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 85.8 1.22 87.3 Favored Glycine 0 CA--C 1.542 1.775 0 O-C-N 120.731 -1.231 . . . . 0.0 113.533 -176.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 9.0 ptm180 -59.16 154.98 37.39 Favored Pre-proline 0 CA--C 1.547 0.833 0 C-N-CA 129.301 3.04 . . . . 0.0 114.034 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -71.41 115.67 4.38 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.413 2.742 . . . . 0.0 111.685 177.791 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 22.3 tptm -171.12 146.14 2.36 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 129.162 2.985 . . . . 0.0 108.773 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -112.12 150.21 31.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 128.091 2.557 . . . . 0.0 113.216 -174.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . 171.08 82.76 0.05 OUTLIER Glycine 0 CA--C 1.532 1.094 0 C-N-CA 126.263 1.887 . . . . 0.0 112.587 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.32 144.22 55.98 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.139 0.97 . . . . 0.0 110.776 177.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 3.0 mp -115.09 140.86 34.21 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 C-N-CA 125.387 1.475 . . . . 0.0 110.371 -177.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 98.7 t -130.06 130.23 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 124.12 0.968 . . . . 0.0 109.256 175.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 2.9 p80 -124.97 95.14 4.39 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 127.521 2.328 . . . . 0.0 111.141 177.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.96 -88.17 0.38 Allowed Glycine 0 CA--C 1.534 1.279 0 C-N-CA 126.069 1.795 . . . . 0.0 114.197 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -123.4 -1.63 8.59 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 126.567 1.947 . . . . 0.0 113.465 -178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 16.4 p -127.04 170.1 12.68 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 127.423 2.289 . . . . 0.0 110.373 178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -158.75 176.44 35.63 Favored Glycine 0 CA--C 1.531 1.085 0 O-C-N 120.992 -1.067 . . . . 0.0 114.046 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -120.19 142.39 49.04 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 125.884 1.674 . . . . 0.0 112.059 177.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 45.7 tp -129.66 150.49 50.96 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 127.476 2.31 . . . . 0.0 109.962 178.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 27.8 mtm 76.21 58.41 0.05 OUTLIER 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 129.495 3.118 . . . . 0.0 112.18 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -148.83 153.96 38.84 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 127.033 2.133 . . . . 0.0 110.561 177.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 14.3 p -83.36 169.38 15.69 Favored 'General case' 0 C--O 1.241 0.62 0 CA-C-O 122.345 1.069 . . . . 0.0 112.79 176.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -65.49 -37.6 87.29 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 121.747 -0.595 . . . . 0.0 111.768 178.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 27.6 m -63.58 -46.26 86.67 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 117.388 -1.292 . . . . 0.0 111.787 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 46.2 m -48.52 -56.1 9.23 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 120.417 1.462 . . . . 0.0 110.453 174.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -60.64 -43.54 97.43 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.974 1.709 . . . . 0.0 113.08 177.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 3.6 tppp? -62.55 -42.3 99.45 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.642 1.177 . . . . 0.0 111.616 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -59.73 -56.47 21.41 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.185 1.394 . . . . 0.0 111.083 176.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.2 pp -62.39 -35.3 78.76 Favored 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 119.23 -0.414 . . . . 0.0 111.793 178.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -64.6 -48.12 76.11 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.358 0.981 . . . . 0.0 112.047 175.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -56.4 -43.53 79.39 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.676 1.59 . . . . 0.0 111.554 177.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -76.58 -5.23 46.83 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 126.382 1.873 . . . . 0.0 113.59 176.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 54.7 36.69 26.78 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 127.68 2.392 . . . . 0.0 111.734 -176.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 46.8 tptt -81.31 114.88 52.72 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 126.642 1.977 . . . . 0.0 111.835 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -69.34 129.33 17.84 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 122.292 1.995 . . . . 0.0 108.121 172.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 42.6 t -12.88 117.78 0.04 OUTLIER Pre-proline 0 CA--C 1.554 1.124 0 C-N-CA 129.739 3.216 . . . . 0.0 116.19 -177.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -64.3 -0.13 2.65 Favored 'Trans proline' 0 CA--C 1.546 1.103 0 C-N-CA 123.141 2.561 . . . . 0.0 114.694 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 53.1 t -123.21 -60.11 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 C-N-CA 126.145 1.778 . . . . 0.0 111.216 179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 82.1 m -79.17 -15.29 58.3 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.499 1.92 . . . . 0.0 113.557 -178.093 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . 0.295 51.8 ptt85 53.52 17.05 1.05 Allowed 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 128.175 2.59 . . . . 0.0 115.029 -174.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -85.26 150.13 53.99 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 124.226 1.011 . . . . 0.0 112.335 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -70.3 118.4 5.66 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 123.703 2.936 . . . . 0.0 112.167 179.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -62.64 129.01 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 125.354 1.461 . . . . 0.0 111.149 178.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 19.6 tp60 -109.54 -41.52 4.56 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -177.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.04 166.97 31.19 Favored 'General case' 0 N--CA 1.475 0.823 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 5.4 mt -135.17 138.67 48.39 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 127.471 2.309 . . . . 0.0 108.943 177.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 17.0 m -139.8 150.0 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.186 0 N-CA-C 114.098 1.147 . . . . 0.0 114.098 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 64.8 mt -73.8 99.86 3.3 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 176.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 14.4 t -98.12 150.69 21.17 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.768 0.827 . . . . 0.0 112.844 -178.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -144.4 172.79 12.46 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.3 1.84 . . . . 0.0 111.661 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -117.99 162.11 31.12 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 124.442 1.097 . . . . 0.0 111.878 178.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo . . . . . 0 C--N 1.353 0.785 0 C-N-CA 124.243 3.295 . . . . 0.0 114.054 179.796 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 45.4 m . . . . . 0 CA--C 1.539 0.539 0 N-CA-C 113.85 1.055 . . . . 0.0 113.85 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 95.3 mt -65.59 156.14 83.53 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 124.93 1.292 . . . . 0.0 111.862 178.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_exo -46.25 -40.53 21.96 Favored 'Trans proline' 0 C--N 1.354 0.835 0 C-N-CA 124.966 3.777 . . . . 0.0 117.174 -177.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -137.64 -26.56 0.97 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 179.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -72.61 -35.44 67.85 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.687 0.795 . . . . 0.0 112.874 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . 50.24 15.48 0.2 Allowed 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 127.421 2.288 . . . . 0.0 116.939 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 31.8 mm 69.76 -60.5 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 129.103 2.961 . . . . 0.0 112.514 -177.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 30.24 76.07 0.37 Allowed Pre-proline 0 CA--C 1.552 1.046 0 C-N-CA 129.331 3.053 . . . . 0.0 114.837 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -51.96 -60.98 0.58 Allowed 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 124.445 3.43 . . . . 0.0 114.932 -178.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 1.5 t -50.69 142.7 10.74 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.563 1.545 . . . . 0.0 111.356 176.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 32.9 m -122.3 -1.22 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.934 1.294 . . . . 0.0 114.012 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 19.4 mt -123.21 -53.38 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 C-N-CA 123.838 0.855 . . . . 0.0 112.027 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 2.4 m -71.88 -69.83 0.37 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.437 1.495 . . . . 0.0 114.355 -172.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -159.89 -1.16 0.07 Allowed 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 -176.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 91.61 11.78 60.26 Favored Glycine 0 CA--C 1.539 1.563 0 CA-C-N 120.222 1.374 . . . . 0.0 113.998 -177.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 5.8 ptm180 -59.71 155.23 41.76 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 127.391 2.276 . . . . 0.0 112.76 176.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.11 146.55 37.95 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.468 2.779 . . . . 0.0 113.935 179.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.91 36.8 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -81.11 89.8 6.0 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 120.368 -1.457 . . . . 0.0 108.968 178.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 162.85 57.56 0.02 OUTLIER Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.762 1.649 . . . . 0.0 111.208 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 53.5 t -61.32 134.86 57.41 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 123.382 0.673 . . . . 0.0 110.254 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.23 137.23 37.52 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 126.248 1.819 . . . . 0.0 109.71 -176.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 86.0 t -130.06 129.06 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 124.011 0.924 . . . . 0.0 109.061 176.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -125.17 95.41 4.48 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.762 2.025 . . . . 0.0 111.701 176.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 73.19 -85.79 0.59 Allowed Glycine 0 CA--C 1.534 1.267 0 C-N-CA 125.844 1.688 . . . . 0.0 114.963 178.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 454' ' ' LYS . . . . . 0.452 ' HA ' ' HE2' ' B' ' 454' ' ' LYS . 0.6 OUTLIER -123.97 -7.66 7.79 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 126.188 1.795 . . . . 0.0 113.584 -177.418 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 28.1 p -125.51 170.1 11.77 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 127.179 2.192 . . . . 0.0 110.65 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -154.72 174.95 32.96 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 121.28 -0.888 . . . . 0.0 114.084 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -120.25 142.56 48.93 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.359 1.463 . . . . 0.0 113.446 177.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 1.5 pp -129.58 153.29 48.21 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.306 2.643 . . . . 0.0 110.625 177.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 28.9 tpp 93.8 -7.09 0.13 Allowed 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 128.976 2.91 . . . . 0.0 113.442 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -99.99 144.9 28.5 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.394 1.078 . . . . 0.0 109.404 175.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 15.4 p -82.35 174.42 11.14 Favored 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 122.196 0.998 . . . . 0.0 112.591 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -60.08 -37.07 78.83 Favored 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.499 -0.75 . . . . 0.0 112.16 178.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 60.5 m -73.69 -41.85 62.08 Favored 'General case' 0 C--O 1.238 0.462 0 CA-C-O 117.751 -1.119 . . . . 0.0 110.767 179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 27.6 m -53.07 -57.3 10.87 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-N 119.767 1.167 . . . . 0.0 109.172 171.174 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -50.56 -48.34 57.52 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.243 1.817 . . . . 0.0 112.967 176.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 6.7 ttpm? -61.21 -30.29 70.34 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.306 1.442 . . . . 0.0 112.635 178.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 53.6 tptt -61.26 -43.62 98.58 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 119.424 1.011 . . . . 0.0 111.55 175.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -57.55 -39.61 77.04 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.427 0.691 . . . . 0.0 110.219 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -68.65 -50.75 48.74 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 122.987 0.515 . . . . 0.0 111.841 176.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -53.97 -45.04 71.25 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 125.892 1.677 . . . . 0.0 112.156 178.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 31.0 mmm180 -82.93 -7.62 59.65 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 126.501 1.92 . . . . 0.0 113.584 177.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 50.33 50.72 18.17 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 127.813 2.445 . . . . 0.0 111.292 -176.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 50.7 tptt -100.73 115.7 65.03 Favored Pre-proline 0 CA--C 1.539 0.529 0 C-N-CA 126.572 1.949 . . . . 0.0 113.323 -175.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -67.57 129.13 19.4 Favored 'Trans proline' 0 CA--C 1.543 0.925 0 C-N-CA 122.51 2.14 . . . . 0.0 107.823 171.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 48.3 t -17.02 118.97 0.06 OUTLIER Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 129.951 3.3 . . . . 0.0 116.447 -174.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -65.16 0.73 2.44 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.554 2.836 . . . . 0.0 114.277 178.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 43.3 t -127.61 -60.41 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.7 1.6 . . . . 0.0 111.283 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 63.2 m -77.5 -16.04 58.94 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.58 1.952 . . . . 0.0 113.637 -177.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 84.5 mmt-85 60.0 7.8 1.27 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 127.239 2.216 . . . . 0.0 114.401 -175.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 74.7 mm-40 -79.19 149.36 72.74 Favored Pre-proline 0 CA--C 1.547 0.842 0 O-C-N 121.461 -0.774 . . . . 0.0 112.117 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -69.3 123.28 10.1 Favored 'Trans proline' 0 CA--C 1.539 0.765 0 C-N-CA 123.027 2.485 . . . . 0.0 110.788 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -59.75 109.97 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.804 0 C-N-CA 125.205 1.402 . . . . 0.0 109.761 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -96.55 -58.17 2.12 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.571 1.149 . . . . 0.0 113.541 -174.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -143.49 162.97 34.43 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 114.735 1.383 . . . . 0.0 114.735 -177.635 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 13.3 mt -137.41 136.64 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 C-N-CA 127.316 2.246 . . . . 0.0 108.599 177.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 19.4 m -136.25 150.19 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.473 1.109 . . . . 0.0 113.5 178.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 5.1 tt -68.27 103.15 1.52 Allowed 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.668 1.587 . . . . 0.0 107.654 175.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 5.7 t -98.02 161.75 13.57 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 113.902 1.075 . . . . 0.0 113.902 -175.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -129.77 130.59 45.57 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.457 1.903 . . . . 0.0 111.254 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 490' ' ' PHE . . . . . 0.509 ' H ' ' CD ' ' B' ' 491' ' ' PRO . 44.3 p90 -134.03 -27.36 0.02 OUTLIER Pre-proline 0 CA--C 1.551 1.011 0 N-CA-C 117.123 2.268 . . . . 0.0 117.123 -178.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 491' ' ' PRO . . . . . 0.509 ' CD ' ' H ' ' B' ' 490' ' ' PHE . 89.2 Cg_exo . . . . . 0 C--N 1.359 1.121 0 C-N-CA 123.182 2.588 . . . . 0.0 114.321 -179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 4.4 t . . . . . 0 CA--C 1.541 0.611 0 CA-C-O 121.192 0.52 . . . . 0.0 112.266 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 9.8 mp -69.08 148.78 97.78 Favored Pre-proline 0 CA--C 1.544 0.736 0 C-N-CA 125.245 1.418 . . . . 0.0 110.615 179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -63.46 -23.73 71.0 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 122.638 2.225 . . . . 0.0 113.175 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 72.2 mt -60.5 -44.71 95.7 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 125.262 1.425 . . . . 0.0 113.426 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -93.18 -15.9 25.45 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 112.86 0.689 . . . . 0.0 112.86 177.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -87.67 -51.91 5.62 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.945 0.898 . . . . 0.0 112.929 -177.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 19.8 mm -84.01 73.49 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 122.152 0.977 . . . . 0.0 110.372 -178.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -139.77 61.14 17.65 Favored Pre-proline 0 CA--C 1.553 1.079 0 C-N-CA 125.655 1.582 . . . . 0.0 110.967 178.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.38 -31.26 52.56 Favored 'Trans proline' 0 C--N 1.354 0.832 0 C-N-CA 122.939 2.426 . . . . 0.0 116.187 -175.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 46.3 t -56.65 144.48 32.07 Favored 'General case' 0 CA--C 1.547 0.837 0 CA-C-N 120.607 1.548 . . . . 0.0 111.153 178.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 32.1 m -123.1 -15.31 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 114.343 1.238 . . . . 0.0 114.343 -179.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 10.2 pt -137.52 -25.73 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 N-CA-C 115.76 1.763 . . . . 0.0 115.76 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 441' ' ' CYS . . . . . 0.419 ' CB ' HH21 ' A' ' 444' ' ' ARG . 3.7 m -75.23 -65.3 0.9 Allowed 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 120.72 1.6 . . . . 0.0 111.709 -177.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 62.2 mt-30 -145.98 -11.13 0.5 Allowed 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 78.23 9.69 86.79 Favored Glycine 0 CA--C 1.546 1.978 0 CA-C-N 120.35 1.432 . . . . 0.0 112.824 -174.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . 0.419 HH21 ' CB ' ' A' ' 441' ' ' CYS . 26.4 ptt180 -57.94 155.24 24.62 Favored Pre-proline 0 CA--C 1.545 0.759 0 C-N-CA 131.565 3.946 . . . . 0.0 114.164 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.6 -5.85 15.21 Favored 'Trans proline' 0 CA--C 1.544 1.011 0 C-N-CA 124.33 3.353 . . . . 0.0 115.495 179.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -54.58 139.77 37.18 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 126.503 1.921 . . . . 0.0 110.461 176.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.14 150.1 50.13 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.182 1.793 . . . . 0.0 112.855 -179.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -157.39 88.14 0.12 Allowed Glycine 0 CA--C 1.532 1.119 0 C-N-CA 126.306 1.907 . . . . 0.0 112.32 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 48.9 t -65.16 133.06 50.74 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 117.765 0.782 . . . . 0.0 110.647 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -110.9 144.22 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.931 1.692 . . . . 0.0 110.948 -177.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 72.7 t -129.92 134.63 62.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 C-N-CA 124.528 1.131 . . . . 0.0 111.624 177.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.23 97.35 5.19 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 128.894 2.877 . . . . 0.0 110.569 174.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 65.46 -99.31 0.38 Allowed Glycine 0 CA--C 1.535 1.287 0 C-N-CA 125.859 1.695 . . . . 0.0 114.349 178.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -103.68 -6.29 21.72 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.032 1.733 . . . . 0.0 113.582 -178.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 44.4 p -131.5 170.07 15.21 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.384 1.473 . . . . 0.0 111.422 -179.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -151.55 173.42 30.89 Favored Glycine 0 CA--C 1.528 0.854 0 C-N-CA 125.313 1.435 . . . . 0.0 112.216 178.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -120.06 146.48 45.87 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.222 1.009 . . . . 0.0 113.451 179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.15 153.16 27.42 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 128.34 2.656 . . . . 0.0 111.721 -177.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 6.8 tpt 71.69 65.01 0.15 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 127.275 2.23 . . . . 0.0 114.323 174.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -150.9 154.93 38.1 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.635 2.374 . . . . 0.0 109.374 175.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 1.8 p -90.28 171.1 9.72 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 119.218 0.917 . . . . 0.0 111.195 174.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -65.43 -36.6 84.42 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.325 -0.859 . . . . 0.0 111.345 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 32.6 m -70.02 -42.4 73.03 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 117.623 -1.18 . . . . 0.0 110.944 177.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 56.4 m -50.07 -61.16 2.31 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.693 1.197 . . . . 0.0 108.642 173.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.0 -45.29 75.07 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.783 1.633 . . . . 0.0 113.251 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 64.4 tttm -58.61 -37.21 75.38 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 124.661 1.185 . . . . 0.0 112.316 178.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -58.37 -44.12 88.71 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.271 1.028 . . . . 0.0 111.06 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 6.7 mp -65.62 -45.09 84.42 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 123.008 0.523 . . . . 0.0 109.924 174.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -56.27 -47.4 78.65 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.51 1.524 . . . . 0.0 113.972 -176.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -54.96 -27.71 45.83 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -120.04 8.89 11.07 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 127.561 2.345 . . . . 0.0 113.187 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 38.36 60.67 1.26 Allowed 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 128.509 2.724 . . . . 0.0 112.879 -174.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 17.8 tptm -69.94 118.77 66.54 Favored Pre-proline 0 N--CA 1.473 0.68 0 C-N-CA 125.485 1.514 . . . . 0.0 113.225 -176.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -55.44 121.91 10.77 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.319 2.679 . . . . 0.0 109.088 170.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 53.2 t -29.68 121.12 0.3 Allowed Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 128.413 2.685 . . . . 0.0 115.32 -174.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -66.41 -3.97 9.86 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 122.901 2.4 . . . . 0.0 113.907 179.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 39.2 t -107.15 -64.75 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.472 1.509 . . . . 0.0 111.294 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 24.6 p -107.8 3.27 24.28 Favored 'General case' 0 CA--C 1.551 0.982 0 N-CA-C 115.425 1.639 . . . . 0.0 115.425 -176.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 71.8 mtp85 63.64 8.66 3.81 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 128.182 2.593 . . . . 0.0 116.424 176.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -71.22 147.84 93.51 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 123.882 0.873 . . . . 0.0 111.853 177.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -75.7 106.83 2.34 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 123.609 2.872 . . . . 0.0 112.607 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 pp -59.65 135.82 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.011 0 C-N-CA 124.704 1.202 . . . . 0.0 111.246 177.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -115.15 -30.74 6.24 Favored 'General case' 0 N--CA 1.474 0.727 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -177.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.29 165.62 34.34 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 -175.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 6.9 mt -133.25 140.19 47.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 C-N-CA 127.611 2.365 . . . . 0.0 108.269 176.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 9.5 m -126.83 146.92 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.032 0.933 . . . . 0.0 111.728 175.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.05 99.82 4.73 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 177.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 6.4 t -92.57 172.73 8.18 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.676 0.79 . . . . 0.0 113.095 -175.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -149.41 171.21 16.93 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 127.135 2.174 . . . . 0.0 111.217 -178.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 50.1 p90 -138.73 154.13 72.77 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 125.507 1.523 . . . . 0.0 110.521 176.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 CA--C 1.538 0.718 0 C-N-CA 123.458 2.772 . . . . 0.0 112.497 -179.765 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 40.2 m . . . . . 0 N--CA 1.471 0.58 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 98.0 mt -135.62 160.17 68.72 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 127.361 2.265 . . . . 0.0 110.657 179.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -49.81 -34.73 37.27 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 123.97 3.113 . . . . 0.0 114.889 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 62.1 tp -62.33 -27.98 69.43 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.64 1.576 . . . . 0.0 113.114 177.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -108.91 -2.6 18.23 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 126.186 1.794 . . . . 0.0 113.227 -178.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -70.47 5.3 1.86 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 126.87 2.068 . . . . 0.0 116.361 -178.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 30.8 mm 81.48 139.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 129.354 3.062 . . . . 0.0 111.696 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -47.12 122.54 7.78 Favored Pre-proline 0 CA--C 1.552 1.051 0 C-N-CA 127.331 2.252 . . . . 0.0 114.227 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -79.51 -171.99 1.4 Allowed 'Trans proline' 0 CA--C 1.549 1.273 0 C-N-CA 124.951 3.767 . . . . 0.0 112.522 178.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.26 166.71 0.54 Allowed 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 125.549 1.539 . . . . 0.0 114.047 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 30.0 m -130.88 -3.66 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 N-CA-C 115.003 1.483 . . . . 0.0 115.003 -175.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 32.9 mm -111.79 -61.29 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 C-N-CA 124.464 1.106 . . . . 0.0 111.33 -177.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 3.2 m -62.96 -80.14 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.676 0 C-N-CA 128.198 2.599 . . . . 0.0 114.626 -172.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 12.0 mp0 -144.12 -5.59 0.77 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.092 1.357 . . . . 0.0 114.59 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 78.83 35.28 31.9 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 119.813 1.188 . . . . 0.0 111.281 -174.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 444' ' ' ARG . . . . . 0.419 ' NH2' ' H ' ' B' ' 463' ' ' THR . 14.5 ptt180 -87.69 155.31 53.46 Favored Pre-proline 0 CA--C 1.545 0.78 0 C-N-CA 128.518 2.727 . . . . 0.0 111.843 179.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_exo -43.47 125.99 5.01 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 124.06 3.173 . . . . 0.0 114.059 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.74 41.69 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 130.392 3.477 . . . . 0.0 117.06 -177.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 44.2 t-20 -81.74 89.85 6.32 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.178 -1.576 . . . . 0.0 109.735 -179.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 168.48 59.33 0.03 OUTLIER Glycine 0 CA--C 1.529 0.935 0 C-N-CA 123.96 0.791 . . . . 0.0 113.464 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 42.6 t -58.58 134.95 57.19 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 118.367 1.084 . . . . 0.0 110.205 178.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 3.1 mp -106.1 133.77 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 C-N-CA 126.207 1.803 . . . . 0.0 108.211 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 92.6 t -120.46 130.39 74.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 CA-C-O 121.656 0.741 . . . . 0.0 110.001 178.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -125.01 109.98 13.62 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 128.448 2.699 . . . . 0.0 110.757 177.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 68.22 -89.78 0.21 Allowed Glycine 0 CA--C 1.535 1.327 0 C-N-CA 125.736 1.636 . . . . 0.0 112.938 -179.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -131.41 4.04 4.3 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.604 1.962 . . . . 0.0 114.069 179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 62.8 p -127.5 170.03 13.03 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 126.147 1.779 . . . . 0.0 110.742 178.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -150.5 171.41 30.35 Favored Glycine 0 CA--C 1.53 1.018 0 O-C-N 121.075 -1.015 . . . . 0.0 114.626 178.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 1.3 m80 -120.35 143.49 48.37 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.428 1.491 . . . . 0.0 113.975 176.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 82.8 mt -125.11 153.24 43.27 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 128.958 2.903 . . . . 0.0 111.243 178.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 60.8 mtt 107.15 -2.68 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.406 1 C-N-CA 132.027 4.131 . . . . 0.0 113.551 179.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -108.24 145.63 34.02 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.73 1.212 . . . . 0.0 109.87 175.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 14.8 p -82.01 174.88 10.83 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 122.796 1.284 . . . . 0.0 112.103 178.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -59.68 -37.75 79.64 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.633 178.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . 0.419 ' H ' ' NH2' ' B' ' 444' ' ' ARG . 87.4 m -70.62 -44.63 66.83 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 117.326 -1.321 . . . . 0.0 110.979 179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 77.3 m -50.16 -53.25 29.03 Favored 'General case' 0 CA--C 1.549 0.932 0 CA-C-N 120.462 1.483 . . . . 0.0 109.734 171.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -59.64 -43.33 93.91 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.794 1.638 . . . . 0.0 113.294 177.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 28.2 ttpp -63.15 -42.66 99.48 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.913 1.285 . . . . 0.0 111.044 178.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 59.1 tptt -59.68 -56.55 20.45 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.687 1.195 . . . . 0.0 110.944 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.62 -33.23 72.46 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 122.691 0.396 . . . . 0.0 111.928 178.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -68.18 -48.02 66.41 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.841 1.257 . . . . 0.0 112.38 175.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -58.15 -40.79 82.26 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 124.862 1.265 . . . . 0.0 111.355 176.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 29.0 mmt85 -76.49 -7.79 55.85 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 126.203 1.801 . . . . 0.0 113.475 175.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 64.0 t30 52.63 40.33 29.92 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 128.012 2.525 . . . . 0.0 112.233 -177.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 31.4 ttmt -74.55 131.37 80.09 Favored Pre-proline 0 CA--C 1.541 0.621 0 C-N-CA 125.647 1.579 . . . . 0.0 112.737 -177.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -71.9 123.54 9.41 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 122.732 2.288 . . . . 0.0 107.924 170.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 43.9 t -14.54 119.24 0.04 OUTLIER Pre-proline 0 CA--C 1.557 1.224 0 C-N-CA 130.062 3.345 . . . . 0.0 115.994 -176.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -65.8 -1.13 4.58 Favored 'Trans proline' 0 CA--C 1.544 1.012 0 C-N-CA 123.202 2.601 . . . . 0.0 114.72 -178.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 35.6 t -114.02 -60.79 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 125.281 1.432 . . . . 0.0 111.919 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 28.0 p -114.77 6.69 15.63 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 115.17 1.545 . . . . 0.0 115.17 -176.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . 0.31 13.8 ptm180 54.07 14.86 0.77 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 129.288 3.035 . . . . 0.0 117.56 177.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -68.02 152.32 96.52 Favored Pre-proline 0 CA--C 1.555 1.14 0 C-N-CA 123.852 0.861 . . . . 0.0 111.722 176.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -74.1 106.17 2.17 Favored 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 124.034 3.156 . . . . 0.0 113.344 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.3 pp -60.21 136.14 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 C-N-CA 124.621 1.169 . . . . 0.0 111.494 177.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -115.07 -40.72 3.43 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.909 1.284 . . . . 0.0 113.678 -178.031 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.21 167.46 30.3 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -176.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 6.0 mt -129.79 139.08 52.5 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.679 0 C-N-CA 127.958 2.503 . . . . 0.0 107.587 175.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 14.1 p -131.54 146.42 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 124.137 0.975 . . . . 0.0 112.427 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -68.51 99.95 1.04 Allowed 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 177.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 1.8 m -102.27 95.54 6.37 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.244 1.418 . . . . 0.0 111.687 -174.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -83.22 159.78 21.91 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.46 1.104 . . . . 0.0 113.83 -178.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -78.71 158.85 75.17 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 125.643 1.577 . . . . 0.0 112.226 177.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo . . . . . 0 C--N 1.353 0.797 0 C-N-CA 124.39 3.393 . . . . 0.0 113.572 178.04 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 75.9 p . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 27.0 tp -46.49 -46.82 48.38 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 126.655 1.982 . . . . 0.0 115.961 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.52 -15.9 42.18 Favored 'Trans proline' 0 C--N 1.354 0.86 0 CA-C-N 122.163 1.808 . . . . 0.0 114.634 -179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . . 54.3 tp -81.47 80.23 7.9 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 119.875 1.216 . . . . 0.0 109.223 176.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 47.12 1.83 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 130.322 3.449 . . . . 0.0 118.929 -179.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -72.09 33.71 0.06 Allowed 'General case' 0 CA--C 1.555 1.141 0 C-N-CA 127.403 2.281 . . . . 0.0 114.939 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 10.1 mm 56.52 64.55 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 127.565 2.346 . . . . 0.0 112.196 178.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -70.02 124.19 90.2 Favored Pre-proline 0 CA--C 1.559 1.309 0 C-N-CA 125.86 1.664 . . . . 0.0 111.514 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -75.77 -159.69 0.1 OUTLIER 'Trans proline' 0 CA--C 1.552 1.422 0 C-N-CA 125.093 3.862 . . . . 0.0 112.149 178.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 10.6 t -42.97 145.9 0.44 Allowed 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 126.796 2.038 . . . . 0.0 111.972 174.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 21.9 t -104.13 -27.95 3.08 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 124.081 0.952 . . . . 0.0 112.613 -175.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 7.9 pt -141.39 -24.65 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.605 0 N-CA-C 117.727 2.492 . . . . 0.0 117.727 -172.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.7 m -77.02 -64.61 1.09 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 120.617 1.553 . . . . 0.0 114.398 -174.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -153.03 -10.08 0.16 Allowed 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 -171.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 87.16 10.21 71.93 Favored Glycine 0 CA--C 1.541 1.691 0 CA-C-N 119.959 1.254 . . . . 0.0 113.13 -176.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 3.9 ptp180 -64.72 155.22 83.02 Favored Pre-proline 0 CA--C 1.548 0.903 0 C-N-CA 128.589 2.755 . . . . 0.0 113.43 178.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_exo -46.72 139.51 13.7 Favored 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 124.396 3.398 . . . . 0.0 116.446 -177.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.33 13.44 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 131.436 3.894 . . . . 0.0 118.918 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -81.04 89.78 5.96 Favored 'General case' 0 CA--C 1.541 0.617 0 O-C-N 120.503 -1.373 . . . . 0.0 112.039 -177.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -178.59 44.58 0.09 OUTLIER Glycine 0 CA--C 1.529 0.906 0 CA-C-O 118.899 -0.945 . . . . 0.0 113.63 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 42.9 t -57.42 135.97 56.6 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 118.86 1.33 . . . . 0.0 110.689 179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 2.4 mp -108.23 142.93 19.59 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.155 0 C-N-CA 126.647 1.979 . . . . 0.0 109.037 -178.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 95.1 t -129.76 133.41 64.9 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 121.419 0.628 . . . . 0.0 110.497 178.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -124.91 96.76 4.99 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 127.692 2.397 . . . . 0.0 111.087 176.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 71.54 -89.16 0.44 Allowed Glycine 0 CA--C 1.535 1.297 0 C-N-CA 126.06 1.79 . . . . 0.0 114.075 178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 14.8 ptmm? -124.07 0.79 8.53 Favored 'General case' 0 N--CA 1.485 1.279 0 C-N-CA 126.238 1.815 . . . . 0.0 114.232 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 16.8 p -127.14 167.58 15.82 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 127.122 2.169 . . . . 0.0 109.922 178.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.51 172.18 34.23 Favored Glycine 0 CA--C 1.527 0.79 0 O-C-N 121.166 -0.959 . . . . 0.0 113.985 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -119.97 137.28 54.16 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 126.249 1.82 . . . . 0.0 111.192 178.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 60.0 tp -133.12 153.35 51.6 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 127.005 2.122 . . . . 0.0 111.601 -173.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 459' ' ' MET . . . . . . . . . . . . 0.256 29.4 mtt 81.89 56.7 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 127.204 2.202 . . . . 0.0 113.104 178.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -158.84 150.61 20.92 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 130.398 3.479 . . . . 0.0 106.824 176.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 16.1 p -78.08 171.22 15.34 Favored 'General case' 0 CA--C 1.544 0.75 0 CA-C-O 123.164 1.459 . . . . 0.0 113.582 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -59.81 -36.92 77.77 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.835 175.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 11.4 m -66.66 -47.22 73.2 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 117.413 -1.279 . . . . 0.0 110.943 178.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 49.5 m -49.86 -52.79 30.01 Favored 'General case' 0 CA--C 1.548 0.867 0 CA-C-N 120.53 1.514 . . . . 0.0 109.664 173.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -60.11 -43.03 95.9 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.665 1.586 . . . . 0.0 113.37 176.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 56.1 tptt -64.79 -40.68 95.63 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 120.63 -1.294 . . . . 0.0 111.43 178.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt -61.95 -56.47 18.84 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 124.519 1.127 . . . . 0.0 110.835 176.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 4.2 pp -58.46 -33.49 69.81 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 118.461 0.573 . . . . 0.0 112.163 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -66.75 -50.38 62.94 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.216 1.406 . . . . 0.0 112.02 174.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 29.2 mmtp -58.23 -38.39 76.75 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.434 1.094 . . . . 0.0 111.643 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -78.16 -1.67 33.83 Favored 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 127.051 2.14 . . . . 0.0 113.351 175.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.34 37.24 5.66 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 129.04 2.936 . . . . 0.0 113.922 -177.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -70.11 116.56 45.6 Favored Pre-proline 0 CA--C 1.539 0.519 0 C-N-CA 126.412 1.885 . . . . 0.0 113.734 -177.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.31 139.11 37.57 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 N-CA-C 106.799 -2.039 . . . . 0.0 106.799 169.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 53.2 t -38.63 121.91 1.15 Allowed Pre-proline 0 CA--C 1.553 1.067 0 C-N-CA 126.32 1.848 . . . . 0.0 114.37 -176.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -69.2 -1.24 7.66 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.063 2.509 . . . . 0.0 114.045 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 48.2 t -122.15 -60.57 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 125.711 1.604 . . . . 0.0 111.333 -179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 64.5 m -76.49 -17.84 59.07 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.731 2.012 . . . . 0.0 112.841 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 73.8 mtp85 64.52 5.38 2.64 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 127.635 2.374 . . . . 0.0 114.203 -176.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -84.54 147.22 48.93 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 124.107 0.963 . . . . 0.0 113.386 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -75.1 120.08 5.89 Favored 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.485 2.79 . . . . 0.0 111.531 177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.4 pp -59.0 141.14 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 C-N-CA 124.541 1.137 . . . . 0.0 111.436 178.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -115.01 -38.25 3.93 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -177.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -155.44 167.05 31.64 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.11 1.152 . . . . 0.0 114.11 -176.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 14.2 mt -131.95 143.14 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 127.639 2.376 . . . . 0.0 108.7 176.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 8.4 m -134.12 150.16 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.336 1.455 . . . . 0.0 112.6 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -72.78 99.9 2.74 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 176.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 3.5 m -88.0 104.88 17.06 Favored 'General case' 0 N--CA 1.477 0.886 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 -172.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 59.1 m-85 -78.57 166.48 22.51 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.14 1.776 . . . . 0.0 110.701 173.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -123.15 170.45 8.23 Favored Pre-proline 0 CA--C 1.55 0.961 0 C-N-CA 126.095 1.758 . . . . 0.0 111.364 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo . . . . . 0 C--N 1.351 0.681 0 C-N-CA 123.92 3.08 . . . . 0.0 113.688 -178.713 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 43.6 m . . . . . 0 N--CA 1.467 0.386 0 N-CA-C 114.319 1.229 . . . . 0.0 114.319 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 56.0 tp -51.04 -46.95 88.33 Favored Pre-proline 0 CA--C 1.552 1.053 0 C-N-CA 124.565 1.146 . . . . 0.0 113.532 178.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -68.66 0.99 4.1 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 123.507 2.805 . . . . 0.0 114.821 176.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 8.8 tp 67.06 -70.86 0.11 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 129.849 3.26 . . . . 0.0 112.469 -176.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -64.03 4.69 0.29 Allowed 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.885 2.074 . . . . 0.0 115.176 179.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -70.48 -6.74 38.23 Favored 'General case' 0 CA--C 1.551 0.988 0 C-N-CA 126.107 1.763 . . . . 0.0 115.284 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 23.6 mm 48.7 73.43 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 C-N-CA 127.023 2.129 . . . . 0.0 112.501 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 33.87 70.08 0.89 Allowed Pre-proline 0 CA--C 1.551 0.985 0 C-N-CA 127.693 2.397 . . . . 0.0 114.006 -179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -71.12 171.13 16.54 Favored 'Trans proline' 0 CA--C 1.538 0.709 0 C-N-CA 123.106 2.537 . . . . 0.0 114.186 -176.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 438' ' ' CYS . . . . . 0.414 ' SG ' ' N ' ' B' ' 439' ' ' VAL . 18.6 t -70.43 -175.23 0.98 Allowed 'General case' 0 CA--C 1.551 1.0 0 CA-C-O 122.22 1.01 . . . . 0.0 112.601 175.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 439' ' ' VAL . . . . . 0.414 ' N ' ' SG ' ' B' ' 438' ' ' CYS . 3.6 p -144.4 2.75 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 126.446 1.898 . . . . 0.0 112.749 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 41.9 mt -113.97 -61.14 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 124.259 1.024 . . . . 0.0 111.408 -175.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 8.1 p -56.35 -83.23 0.01 OUTLIER 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.593 1.557 . . . . 0.0 113.526 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 29.2 mm-40 -147.53 -7.68 0.44 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 129.867 3.267 . . . . 0.0 112.577 -177.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 85.49 39.23 8.41 Favored Glycine 0 CA--C 1.534 1.226 0 CA-C-N 119.011 0.823 . . . . 0.0 113.073 -177.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -66.1 152.33 94.02 Favored Pre-proline 0 N--CA 1.478 0.937 0 C-N-CA 124.957 1.303 . . . . 0.0 111.191 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.82 66.7 5.84 Favored 'Trans proline' 0 CA--C 1.545 1.069 0 C-N-CA 124.546 3.497 . . . . 0.0 113.667 -176.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -141.52 145.89 35.71 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 127.9 2.48 . . . . 0.0 110.374 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.29 144.74 51.16 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.103 1.761 . . . . 0.0 112.379 176.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . -156.9 87.28 0.12 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 126.632 2.063 . . . . 0.0 110.781 177.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 45.4 t -62.09 137.16 58.21 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 117.606 0.703 . . . . 0.0 110.969 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 450' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -114.93 148.64 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 C-N-CA 126.301 1.84 . . . . 0.0 110.174 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 38.7 t -117.69 140.97 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 125.071 1.348 . . . . 0.0 109.071 174.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 2.5 m-70 -125.18 94.86 4.29 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 127.794 2.438 . . . . 0.0 107.569 175.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 62.25 -91.7 0.07 OUTLIER Glycine 0 CA--C 1.542 1.745 0 C-N-CA 124.648 1.118 . . . . 0.0 113.612 -176.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 50.4 mmtm -120.98 6.64 10.35 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 127.612 2.365 . . . . 0.0 113.296 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 30.3 p -120.73 170.22 9.65 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 128.172 2.589 . . . . 0.0 109.501 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.17 170.0 33.79 Favored Glycine 0 CA--C 1.528 0.85 0 O-C-N 120.368 -1.458 . . . . 0.0 113.328 178.319 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -120.23 145.48 46.98 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.606 1.162 . . . . 0.0 114.135 177.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 3.6 pp -116.13 153.21 32.18 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.488 1.915 . . . . 0.0 112.421 175.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 21.6 ttt 70.55 66.14 0.19 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 127.611 2.364 . . . . 0.0 113.88 176.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -154.52 145.89 23.01 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 128.247 2.619 . . . . 0.0 107.802 175.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 29.1 p -79.54 164.96 23.46 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 120.71 1.595 . . . . 0.0 112.398 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -63.81 -34.75 78.6 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.138 177.054 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 37.3 m -62.55 -57.62 10.47 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.517 1.127 . . . . 0.0 110.51 176.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 33.1 m -54.12 -47.31 71.97 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-N 120.057 1.299 . . . . 0.0 112.469 176.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -58.64 -44.27 90.01 Favored 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 123.779 0.832 . . . . 0.0 112.554 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -64.98 -40.66 95.3 Favored 'General case' 0 N--CA 1.474 0.761 0 O-C-N 120.749 -1.22 . . . . 0.0 111.479 178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 58.4 tptt -59.63 -56.61 19.76 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 124.927 1.291 . . . . 0.0 111.072 177.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 4.1 pp -61.84 -34.33 75.76 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 111.951 0.352 . . . . 0.0 111.951 178.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -65.19 -48.97 71.56 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.402 1.081 . . . . 0.0 112.154 175.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 59.7 tptt -52.26 -43.69 64.5 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 125.739 1.616 . . . . 0.0 112.639 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 35.5 ptt180 -90.81 4.7 50.98 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.517 1.527 . . . . 0.0 114.141 177.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 65.4 t30 49.87 40.81 21.56 Favored 'General case' 0 CA--C 1.549 0.941 0 C-N-CA 127.796 2.438 . . . . 0.0 113.366 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 38.8 tptt -71.04 117.23 54.43 Favored Pre-proline 0 N--CA 1.473 0.7 0 C-N-CA 126.215 1.806 . . . . 0.0 111.582 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.62 123.01 12.74 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.102 2.535 . . . . 0.0 108.571 171.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 42.7 t -22.98 122.14 0.16 Allowed Pre-proline 0 CA--C 1.556 1.189 0 C-N-CA 128.384 2.674 . . . . 0.0 115.887 -174.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -65.47 -2.37 6.03 Favored 'Trans proline' 0 CA--C 1.546 1.118 0 C-N-CA 122.817 2.345 . . . . 0.0 114.151 178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 46.4 t -112.57 -61.68 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 125.595 1.558 . . . . 0.0 111.659 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 32.1 p -105.38 -6.86 19.2 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 -177.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 81.5 mtp180 61.94 11.07 3.94 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 127.693 2.397 . . . . 0.0 115.769 178.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -69.61 155.33 93.7 Favored Pre-proline 0 CA--C 1.554 1.118 0 O-C-N 121.22 -0.925 . . . . 0.0 111.861 176.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -72.85 116.95 4.91 Favored 'Trans proline' 0 CA--C 1.541 0.827 0 C-N-CA 123.703 2.935 . . . . 0.0 111.978 179.609 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 1.9 pp -65.31 147.91 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 C-N-CA 124.452 1.101 . . . . 0.0 112.361 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -115.15 -62.8 1.55 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.201 1.8 . . . . 0.0 111.691 -179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.8 170.31 22.75 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 125.062 1.345 . . . . 0.0 113.431 -178.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 7.3 mt -123.65 142.66 39.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 126.879 2.072 . . . . 0.0 109.038 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 9.4 m -138.27 150.14 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.788 1.235 . . . . 0.0 112.714 176.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 58.7 tp -69.85 99.9 1.46 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.003 1.321 . . . . 0.0 109.385 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 7.3 t -87.28 159.47 18.78 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -176.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -142.17 124.76 15.82 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.934 2.094 . . . . 0.0 111.212 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -84.28 -31.61 0.48 Allowed Pre-proline 0 CA--C 1.555 1.138 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 175.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo . . . . . 0 C--N 1.36 1.183 0 C-N-CA 122.995 2.464 . . . . 0.0 113.8 178.708 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' SER . . . . . . . . . . . . . 58.4 m . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 113.914 1.079 . . . . 0.0 113.914 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' LEU . . . . . . . . . . . . . 22.8 tp -143.2 138.23 15.47 Favored Pre-proline 0 CA--C 1.551 0.982 0 C-N-CA 126.586 1.954 . . . . 0.0 109.948 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_exo -43.62 128.44 6.55 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 124.564 3.51 . . . . 0.0 114.009 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' LEU . . . . . . . . . . . . 0.386 3.3 pp 54.42 -23.97 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.892 1 C-N-CA 132.152 4.181 . . . . 0.0 117.145 -174.734 . . . . . . . . 3 2 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -71.44 -17.6 62.37 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.912 2.085 . . . . 0.0 111.891 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' ALA . . . . . . . . . . . . . . . -70.88 13.11 0.21 Allowed 'General case' 0 CA--C 1.556 1.186 0 C-N-CA 127.648 2.379 . . . . 0.0 113.63 174.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' ILE . . . . . . . . . . . . . 22.6 mm 72.11 78.9 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 129.071 2.948 . . . . 0.0 110.549 -177.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -135.91 61.77 43.02 Favored Pre-proline 0 CA--C 1.552 1.05 0 C-N-CA 126.03 1.732 . . . . 0.0 110.315 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_exo -64.61 -33.42 55.73 Favored 'Trans proline' 0 C--N 1.355 0.899 0 C-N-CA 122.559 2.173 . . . . 0.0 116.002 -174.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' CYS . . . . . . . . . . . . . 31.6 t -55.41 145.86 21.31 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 120.46 1.482 . . . . 0.0 111.645 178.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' VAL . . . . . . . . . . . . . 15.8 m -134.85 -13.04 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 C-N-CA 124.335 1.054 . . . . 0.0 113.251 177.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 440' ' ' ILE . . . . . . . . . . . . . 24.1 mm -110.0 -43.98 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.91 1.284 . . . . 0.0 112.451 -177.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 441' ' ' CYS . . . . . . . . . . . . . 2.1 m -79.89 -66.1 0.92 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 -170.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 442' ' ' GLN . . . . . . . . . . . . . 47.3 tt0 -151.18 -14.31 0.21 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 -174.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 443' ' ' GLY . . . . . . . . . . . . . . . 84.75 12.41 74.86 Favored Glycine 0 CA--C 1.539 1.565 0 O-C-N 120.833 -1.167 . . . . 0.0 112.328 -174.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 444' ' ' ARG . . . . . . . . . . . . . 7.5 ptp180 -61.52 155.11 61.17 Favored Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 127.883 2.473 . . . . 0.0 113.311 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 445' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_exo -61.99 -6.38 7.76 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 124.32 3.347 . . . . 0.0 117.646 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 446' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -55.79 144.75 26.43 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 125.24 1.416 . . . . 0.0 111.161 178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 447' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -128.12 141.11 51.58 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 126.545 1.938 . . . . 0.0 113.047 -176.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 448' ' ' GLY . . . . . . . . . . . . . . . -163.43 82.57 0.12 Allowed Glycine 0 CA--C 1.53 0.993 0 C-N-CA 125.853 1.692 . . . . 0.0 111.918 177.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 449' ' ' CYS . . . . . . . . . . . . . 12.1 t -63.75 147.75 50.93 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 124.089 0.956 . . . . 0.0 110.899 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 450' ' ' ILE . . . . . . . . . . . . . 1.4 mp -115.04 141.78 30.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 C-N-CA 125.801 1.64 . . . . 0.0 109.376 -179.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 451' ' ' VAL . . . . . . . . . . . . . 80.7 t -123.35 137.21 57.43 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 124.489 1.116 . . . . 0.0 109.815 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 452' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -124.63 94.89 4.33 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 127.697 2.399 . . . . 0.0 108.044 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 453' ' ' GLY . . . . . . . . . . . . . . . 60.86 -95.53 0.09 OUTLIER Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.327 1.442 . . . . 0.0 113.895 -178.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 454' ' ' LYS . . . . . . . . . . . . . 51.9 tttm -110.47 3.71 19.85 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 126.803 2.041 . . . . 0.0 113.359 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 455' ' ' THR . . . . . . . . . . . . . 22.1 p -126.52 170.12 12.34 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 126.167 1.787 . . . . 0.0 111.592 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 456' ' ' GLY . . . . . . . . . . . . . . . -156.4 164.39 32.47 Favored Glycine 0 CA--C 1.531 1.066 0 O-C-N 120.89 -1.131 . . . . 0.0 113.413 177.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 457' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -120.09 117.58 28.33 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 125.739 1.616 . . . . 0.0 111.869 179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 458' ' ' LEU . . . . . . . . . . . . . 7.3 tt -90.64 153.06 20.59 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.951 1.701 . . . . 0.0 110.863 177.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 459' ' ' MET . . . . . . . . . . . . . 3.4 tpt 86.19 64.95 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 128.274 2.63 . . . . 0.0 113.627 176.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 460' ' ' ALA . . . . . . . . . . . . . . . -155.75 151.48 27.35 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 127.27 2.228 . . . . 0.0 108.987 175.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 461' ' ' CYS . . . . . . . . . . . . . 14.1 p -89.21 175.0 7.54 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-O 121.834 0.826 . . . . 0.0 110.456 172.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 462' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -63.24 -38.58 91.74 Favored 'General case' 0 CA--C 1.537 0.477 0 O-C-N 121.342 -0.849 . . . . 0.0 110.972 178.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 463' ' ' THR . . . . . . . . . . . . . 38.1 m -67.66 -44.32 78.15 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-O 117.453 -1.26 . . . . 0.0 110.981 177.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 464' ' ' CYS . . . . . . . . . . . . . 57.1 m -51.27 -60.22 3.36 Favored 'General case' 0 CA--C 1.544 0.725 0 CA-C-N 120.288 1.404 . . . . 0.0 109.683 173.458 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 465' ' ' ALA . . . . . . . . . . . . . . . -53.15 -40.5 64.34 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 126.197 1.799 . . . . 0.0 113.05 177.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 466' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -61.14 -31.37 71.09 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.467 1.107 . . . . 0.0 112.022 178.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 467' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -59.91 -51.03 71.42 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 120.106 1.321 . . . . 0.0 110.471 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 468' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -56.51 -45.07 81.25 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.088 0.955 . . . . 0.0 110.29 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 469' ' ' LYS . . . . . . . . . . . . . 57.7 tptt -65.98 -51.94 53.96 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.632 1.173 . . . . 0.0 113.492 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 470' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.23 -43.91 83.3 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.016 1.727 . . . . 0.0 111.673 178.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 471' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -79.21 -8.92 59.4 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 126.082 1.753 . . . . 0.0 112.962 176.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 472' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 48.02 47.13 19.1 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 128.058 2.543 . . . . 0.0 111.053 -175.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 473' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -87.2 123.5 69.89 Favored Pre-proline 0 N--CA 1.469 0.509 0 C-N-CA 124.711 1.205 . . . . 0.0 113.049 -174.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 474' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.47 90.69 1.1 Allowed 'Trans proline' 0 CA--C 1.545 1.052 0 C-N-CA 123.756 2.971 . . . . 0.0 109.599 175.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 475' ' ' CYS . . . . . . . . . . . . . 33.7 t 18.85 113.95 0.0 OUTLIER Pre-proline 0 CA--C 1.555 1.141 1 C-N-CA 132.934 4.494 . . . . 0.0 118.115 -179.448 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 476' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.98 -0.12 3.7 Favored 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 122.636 2.224 . . . . 0.0 113.759 176.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 477' ' ' VAL . . . . . . . . . . . . . 35.2 t -110.12 -66.67 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 125.816 1.647 . . . . 0.0 111.616 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 478' ' ' CYS . . . . . . . . . . . . . 28.3 p -95.68 -5.53 42.02 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 120.258 1.39 . . . . 0.0 114.604 -178.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 479' ' ' ARG . . . . . . . . . . . . . 9.5 mpt_? 63.5 10.09 4.64 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.469 2.307 . . . . 0.0 115.172 178.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 480' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -74.81 153.66 87.06 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 124.503 1.121 . . . . 0.0 112.208 177.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 481' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -72.36 107.16 2.21 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.477 2.785 . . . . 0.0 111.384 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 482' ' ' ILE . . . . . . . . . . . . . 2.0 pp -58.48 141.3 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 124.834 1.254 . . . . 0.0 111.107 179.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 483' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -115.09 -49.7 2.78 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -177.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 484' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.82 169.06 24.3 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.339 1.607 . . . . 0.0 115.339 -174.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 485' ' ' ILE . . . . . . . . . . . . . 7.6 mt -131.94 139.57 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 128.496 2.719 . . . . 0.0 108.102 175.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 486' ' ' VAL . . . . . . . . . . . . . 16.2 m -137.87 150.27 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 125.405 1.482 . . . . 0.0 111.615 176.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 487' ' ' LEU . . . . . . . . . . . . . 60.4 tp -68.35 99.93 1.0 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.71 0.804 . . . . 0.0 108.939 176.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 488' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -104.67 90.72 3.59 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.985 1.314 . . . . 0.0 111.955 -173.045 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 489' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -59.8 124.48 20.3 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.349 1.46 . . . . 0.0 112.921 -179.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 490' ' ' PHE . . . . . . . . . . . . . 31.3 p90 -68.74 159.05 83.92 Favored Pre-proline 0 CA--C 1.554 1.123 0 C-N-CA 124.609 1.164 . . . . 0.0 111.367 176.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 491' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo . . . . . 0 CA--C 1.538 0.702 0 C-N-CA 122.98 2.453 . . . . 0.0 112.412 179.184 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 429' ' ' SER . . . . . . . . . . . . . 43.2 m . . . . . 0 CA--C 1.54 0.587 0 N-CA-C 113.985 1.106 . . . . 0.0 113.985 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 430' ' ' LEU . . . . . . . . . . . . . 49.0 tp -137.43 93.36 12.8 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 126.567 1.947 . . . . 0.0 110.579 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 431' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -57.43 -8.92 4.33 Favored 'Trans proline' 0 CA--C 1.545 1.072 0 C-N-CA 124.774 3.65 . . . . 0.0 117.455 -179.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 432' ' ' LEU . . . . . . . . . . . . . 38.3 tp -68.0 82.97 0.21 Allowed 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 127.154 2.182 . . . . 0.0 112.618 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 433' ' ' ASN . . . . . . . . . . . . . 18.3 m120 61.1 -12.51 0.05 OUTLIER 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 129.228 3.011 . . . . 0.0 117.327 178.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 434' ' ' ALA . . . . . . . . . . . . . . . -30.63 90.13 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 130.909 3.683 . . . . 0.0 116.101 -178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 435' ' ' ILE . . . . . . . . . . . . . 4.4 mm 56.72 27.46 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.997 0 C-N-CA 128.297 2.639 . . . . 0.0 113.285 177.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 436' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 23.72 76.37 0.24 Allowed Pre-proline 0 CA--C 1.555 1.159 0 C-N-CA 129.584 3.154 . . . . 0.0 115.227 178.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 437' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.25 174.83 7.53 Favored 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.923 3.082 . . . . 0.0 113.948 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 438' ' ' CYS . . . . . . . . . . . . . 5.5 p -59.45 177.03 0.21 Allowed 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 115.961 1.838 . . . . 0.0 115.961 -178.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 439' ' ' VAL . . . . . . . . . . . . . 7.9 p -134.31 -9.19 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.628 0 N-CA-C 115.239 1.57 . . . . 0.0 115.239 -172.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 440' ' ' ILE . . . . . . . . . . . . . 6.9 mt -115.0 -62.56 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 CA-C-N 119.937 1.244 . . . . 0.0 112.961 -177.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 441' ' ' CYS . . . . . . . . . . . . . 11.4 p -65.76 -59.31 4.03 Favored 'General case' 0 CA--C 1.544 0.721 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 -174.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 442' ' ' GLN . . . . . . . . . . . . . 18.1 tp60 -151.76 -18.27 0.19 Allowed 'General case' 0 N--CA 1.477 0.903 0 N-CA-C 116.11 1.893 . . . . 0.0 116.11 -174.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 443' ' ' GLY . . . . . . . . . . . . . . . 91.0 39.63 5.72 Favored Glycine 0 CA--C 1.533 1.193 0 N-CA-C 110.159 -1.176 . . . . 0.0 110.159 -173.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 444' ' ' ARG . . . . . . . . . . . . . 9.8 ptm180 -95.25 155.13 39.21 Favored Pre-proline 0 N--CA 1.479 0.993 0 C-N-CA 125.8 1.64 . . . . 0.0 112.787 -179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 445' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_exo -48.31 126.68 14.17 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.686 2.924 . . . . 0.0 113.703 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 446' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -55.27 97.56 0.02 OUTLIER 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 127.407 2.283 . . . . 0.0 114.635 -178.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 447' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -128.05 89.86 2.99 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.041 1.336 . . . . 0.0 107.705 176.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 448' ' ' GLY . . . . . . . . . . . . . . . 156.02 58.78 0.01 OUTLIER Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.687 1.137 . . . . 0.0 112.395 -177.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 449' ' ' CYS . . . . . . . . . . . . . 44.3 t -57.1 115.47 2.66 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.906 1.283 . . . . 0.0 112.005 -178.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 450' ' ' ILE . . . . . 0.431 HD12 ' H ' ' B' ' 450' ' ' ILE . 3.0 mp -88.73 122.4 40.09 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 125.736 1.614 . . . . 0.0 109.696 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 451' ' ' VAL . . . . . . . . . . . . . 95.6 t -122.64 123.26 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.822 1.249 . . . . 0.0 110.483 -179.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 452' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -108.02 101.59 10.83 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 128.099 2.56 . . . . 0.0 110.703 175.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 453' ' ' GLY . . . . . . . . . . . . . . . 70.5 -88.25 0.35 Allowed Glycine 0 CA--C 1.533 1.213 0 C-N-CA 125.842 1.687 . . . . 0.0 113.759 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 454' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -129.49 6.95 5.27 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.335 1.854 . . . . 0.0 114.333 -179.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 43.2 p -136.68 169.98 16.83 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 126.421 1.888 . . . . 0.0 110.367 179.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 456' ' ' GLY . . . . . . . . . . . . . . . -161.44 169.85 37.05 Favored Glycine 0 CA--C 1.53 1.003 0 O-C-N 120.618 -1.301 . . . . 0.0 114.527 178.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 457' ' ' HIS . . . . . . . . . . . . . 16.4 m80 -120.21 99.94 6.89 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 125.992 1.717 . . . . 0.0 110.076 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 458' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.51 92.86 8.26 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 122.87 1.319 . . . . 0.0 110.709 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 459' ' ' MET . . . . . . . . . . . . . 28.1 ptm -156.39 1.45 0.14 Allowed 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 -176.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -143.84 174.67 10.62 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.085 1.354 . . . . 0.0 111.139 179.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 461' ' ' CYS . . . . . . . . . . . . . 30.6 p -101.82 175.0 5.7 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-O 123.032 1.396 . . . . 0.0 113.734 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 462' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -57.02 -40.64 77.08 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.999 1.72 . . . . 0.0 112.535 -178.357 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 463' ' ' THR . . . . . . . . . . . . . 67.3 m -61.39 -53.56 55.0 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 124.089 0.956 . . . . 0.0 110.251 179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 464' ' ' CYS . . . . . . . . . . . . . 73.5 m -55.46 -49.12 73.32 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.387 1.075 . . . . 0.0 110.955 175.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 465' ' ' ALA . . . . . . . . . . . . . . . -55.24 -54.91 37.47 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.708 1.203 . . . . 0.0 112.687 177.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 466' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -66.08 -33.83 76.68 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 121.025 -1.047 . . . . 0.0 112.73 178.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 467' ' ' LYS . . . . . . . . . . . . . 16.8 tppt? -59.75 -52.77 64.06 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.388 1.075 . . . . 0.0 110.379 176.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 468' ' ' LEU . . . . . . . . . . . . . 22.6 mt -52.11 -51.22 59.15 Favored 'General case' 0 N--CA 1.468 0.464 0 C-N-CA 124.7 1.2 . . . . 0.0 110.063 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 469' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -53.75 -49.02 69.1 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.948 1.299 . . . . 0.0 112.469 178.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 470' ' ' LYS . . . . . . . . . . . . . 5.7 mptp? -62.5 -40.57 97.14 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 125.075 1.35 . . . . 0.0 112.019 175.482 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 471' ' ' ARG . . . . . . . . . . . . . 42.4 mmt180 -71.72 -6.35 40.62 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 126.401 1.88 . . . . 0.0 113.382 175.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 472' ' ' ASN . . . . . . . . . . . . . 35.5 t30 83.87 4.14 0.81 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 130.928 3.691 . . . . 0.0 115.761 176.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 473' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -86.68 128.47 56.42 Favored Pre-proline 0 N--CA 1.475 0.775 0 CA-C-N 120.359 1.436 . . . . 0.0 109.799 176.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 474' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.16 -75.77 0.01 OUTLIER 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 122.869 2.379 . . . . 0.0 111.701 178.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 475' ' ' CYS . . . . . . . . . . . . . 41.6 t -109.26 133.3 20.83 Favored Pre-proline 0 CA--C 1.546 0.791 0 C-N-CA 126.554 1.942 . . . . 0.0 111.294 -178.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 476' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.31 -5.39 16.14 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.337 2.691 . . . . 0.0 113.733 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 477' ' ' VAL . . . . . . . . . . . . . 23.9 t -110.0 -76.99 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 124.472 1.109 . . . . 0.0 112.454 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 478' ' ' CYS . . . . . . . . . . . . . 22.4 p -94.87 -4.99 45.97 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.862 1.665 . . . . 0.0 114.552 -176.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 479' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 65.2 13.43 8.74 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.487 2.315 . . . . 0.0 114.655 178.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 480' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -64.44 128.69 93.62 Favored Pre-proline 0 CA--C 1.552 1.035 0 O-C-N 121.34 -0.85 . . . . 0.0 110.793 176.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 481' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -49.19 113.72 1.02 Allowed 'Trans proline' 0 CA--C 1.542 0.882 0 C-N-CA 124.536 3.49 . . . . 0.0 115.127 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . . . . . . . . . 2.5 pp -71.7 142.58 15.22 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 124.776 1.231 . . . . 0.0 112.314 -179.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 483' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -115.14 -34.87 4.88 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.733 1.613 . . . . 0.0 113.73 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 484' ' ' MET . . . . . . . . . . . . . 1.4 ttp -146.73 150.84 36.16 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -173.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 485' ' ' ILE . . . . . . . . . . . . . 12.2 mt -139.07 130.81 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 C-N-CA 128.363 2.665 . . . . 0.0 106.698 173.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 486' ' ' VAL . . . . . . . . . . . . . 21.0 m -137.4 150.16 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.314 0 C-N-CA 124.941 1.296 . . . . 0.0 113.573 -177.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 487' ' ' LEU . . . . . . . . . . . . . 5.7 tt -64.74 99.95 0.36 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.907 1.283 . . . . 0.0 109.019 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 488' ' ' THR . . . . . . . . . . . . . 45.6 m -95.35 113.32 24.98 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 125.527 1.531 . . . . 0.0 113.683 -173.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 489' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -75.46 100.85 4.62 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.07 1.348 . . . . 0.0 110.352 175.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 490' ' ' PHE . . . . . . . . . . . . . 36.9 p90 -75.48 156.01 85.38 Favored Pre-proline 0 CA--C 1.552 1.024 0 C-N-CA 125.406 1.482 . . . . 0.0 111.585 178.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 491' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo . . . . . 0 C--N 1.351 0.695 0 C-N-CA 123.504 2.803 . . . . 0.0 111.566 -179.518 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 492' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 493' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_